JP2019167372A - Harmful arthropod controlling method using heterocyclic compound - Google Patents

Abstract

To provide a harmful arthropod controlling method.SOLUTION: Harmful arthropods can be controlled by a compound represented by formula (I): Het-Q [where Q is a group represented by the formula Q1 or the like, Het is a group represented by the formula Het1 or the like, Ris a C1-C6 alkyl group or the like, Gis a nitrogen atom or CR, Gis a nitrogen atom or CR, Gis a nitrogen atom or CR, Gis a nitrogen atom or CR, R, R, Rand Rare the same or different to represent a C1-C6 chain hydrocarbon group or the like, n is 0, 1 or 2, T is a C1-C10 chain hydrocarbon group having one or more halogen atom, or the like].SELECTED DRAWING: None

Description

  The present invention relates to a method for controlling harmful arthropods using a heterocyclic compound.

  Various compounds have been studied so far for the purpose of controlling harmful arthropods. For example, Patent Document 1 describes that certain compounds have a harmful arthropod controlling effect.

International Publication No. 2016/129684

  An object of the present invention is to provide a method for controlling harmful arthropods.

［式中、
Ｑは、式Ｑ１で示される基、式Ｑ２で示される基、又は式Ｑ３で示される基を表し、

Ｒ²は、１以上のハロゲン原子で置換されていてもよいＣ１−Ｃ６アルキル基、シクロプロピル基、又はシクロプロピルメチル基を表し、
ｎは、０、１又は２を表し、
Ｇ¹は、窒素原子又はＣＲ^3aを表し、
Ｇ²は、窒素原子又はＣＲ^3bを表し、
Ｇ³は、窒素原子又はＣＲ^3cを表し、
Ｇ⁴は、窒素原子又はＣＲ^3dを表し、
Ｒ^3a、Ｒ^3b、Ｒ^3c、及びＲ^3dは、同一又は相異なり、群Ｂより選ばれる１以上の置換基を有していてもよいＣ１−Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基を有していてもよいＣ３−Ｃ７シクロアルキル基、群Ｈより選ばれる１以上の置換基を有していてもよいフェニル基、群Ｈより選ばれる１以上の置換基を有していてもよい５もしくは６員芳香族複素環基、ＯＲ¹²、ＮＲ¹¹Ｒ¹²、ＮＲ^11aＲ^12a、ＮＲ²⁴ＮＲ¹¹Ｒ¹²、ＮＲ²⁴ＯＲ¹¹、ＮＲ¹¹Ｃ（Ｏ）Ｒ¹³、ＮＲ²⁴ＮＲ¹¹Ｃ（Ｏ）Ｒ¹³、ＮＲ¹¹Ｃ（Ｏ）ＯＲ¹⁴、ＮＲ²⁴ＮＲ¹¹Ｃ（Ｏ）ＯＲ¹⁴、ＮＲ¹¹Ｃ（Ｏ）ＮＲ³¹Ｒ³²、ＮＲ²⁴ＮＲ¹¹Ｃ（Ｏ）ＮＲ³¹Ｒ³²、Ｎ＝ＣＨＮＲ³¹Ｒ³²、Ｎ＝Ｓ（Ｏ）_pＲ¹⁵Ｒ¹⁶、Ｃ（Ｏ）Ｒ¹³、Ｃ（Ｏ）ＯＲ¹⁷、Ｃ（Ｏ）ＮＲ³¹Ｒ³²、Ｃ（Ｏ）ＮＲ¹¹Ｓ（Ｏ）₂Ｒ²³、ＣＲ³⁰＝ＮＯＲ¹⁷、ＮＲ¹¹ＣＲ²⁴＝ＮＯＲ¹⁷、シアノ基、ニトロ基、水素原子、又はハロゲン原子を表し、
ｐは、０又は１を表し、
Ａ¹は、ＮＲ⁵、酸素原子又は硫黄原子を表し、
Ｈｅｔは、式Ｈｅｔ１で示される基、式Ｈｅｔ２で示される基、又は式Ｈｅｔ３で示される基を表し、

Ａ²は、窒素原子又はＣＲ^4aを表し、
Ａ³は、窒素原子又はＣＲ^4bを表し、
Ａ⁴は、窒素原子又はＣＲ^4cを表し、
Ｗ¹は、酸素原子又は硫黄原子を表し、
Ｒ^4a、Ｒ^4b、及びＲ^4cは、同一又は相異なり、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、ニトロ基、ＯＲ¹⁸、ＮＲ¹⁸Ｒ¹⁹、シアノ基、アミノ基、ハロゲン原子、又は水素原子を表し、
Ｒ⁶は、群Ｆより選ばれる１以上の置換基を有していてもよいＣ１−Ｃ６鎖式炭化水素基、群Ｊより選ばれる１以上の置換基を有していてもよいＣ３−Ｃ６シクロアルキル基、群Ｈより選ばれる１以上の置換基を有していてもよいフェニル基、又は群Ｈより選ばれる１以上の置換基を有していてもよい５もしくは６員芳香族複素環基を表し、
Ｔは、Ｃ１−Ｃ１０鎖式炭化水素基、（Ｃ１−Ｃ５アルコキシ）Ｃ２−Ｃ５アルキル基、（Ｃ３−Ｃ５アルケニルオキシ）Ｃ２−Ｃ５アルキル基、（Ｃ３−Ｃ５アルキニルオキシ）Ｃ２−Ｃ５アルキル基、（Ｃ１−Ｃ５アルキル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、（Ｃ３−Ｃ５アルケニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、（Ｃ３−Ｃ５アルキニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、（Ｃ１−Ｃ５アルキル）−Ｃ（Ｏ）−（Ｃ１−Ｃ５アルキル）基｛該Ｃ１−Ｃ１０鎖式炭化水素基、該（Ｃ１−Ｃ５アルコキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ３−Ｃ５アルケニルオキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ３−Ｃ５アルキニルオキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ１−Ｃ５アルキル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、該（Ｃ３−Ｃ５アルケニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、該（Ｃ３−Ｃ５アルキニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、及び該（Ｃ１−Ｃ５アルキル）−Ｃ（Ｏ）−（Ｃ１−Ｃ５アルキル）基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基を有する｝、群Ｇより選ばれる１以上の置換基を有する（Ｃ３−Ｃ７シクロアルキル）Ｃ１−Ｃ３アルキル基、群Ｇより選ばれる１以上の置換基を有するＣ３−Ｃ７シクロアルキル基、ＯＲ¹、Ｓ（Ｏ）_vＲ¹、ＯＳ（Ｏ）₂Ｒ¹、ＣＨ₂ＯＲ¹、ＮＲ¹Ｒ²⁹、Ｃ（Ｏ）Ｒ¹、Ｃ（Ｏ）ＮＲ¹Ｒ²⁹、ＮＲ²⁹Ｃ（Ｏ）Ｒ¹、Ｎ＝ＣＲ¹Ｒ³⁰、式Ｔ−１で示される基、式Ｔ−２で示される基、式Ｔ−３で示される基、式Ｔ−４で示される基、式Ｔ−５で示される基、式Ｔ−６で示される基、式Ｔ−３で示される基、式Ｔ−４で示される基、式Ｔ−５で示される基、式Ｔ−６で示される基、式Ｔ−７で示される基、式Ｔ−８で示される基、式Ｔ−９で示される基、式Ｔ−１０で示される基、式Ｔ−１１で示される基、又は式Ｔ−１２で示される基を表し、

Ｘ¹は、窒素原子又はＣＲ^1aを表し、
Ｘ²は、窒素原子又はＣＲ^1bを表し、
Ｘ³は、窒素原子又はＣＲ^1cを表し、
Ｘ⁴は、窒素原子又はＣＲ^1dを表し、
Ｘ⁵は、窒素原子又はＣＲ^1eを表し、
Ｒ^1xは、１以上のハロゲン原子を有するＣ１−Ｃ５鎖式炭化水素基、ＯＲ⁷、ＯＳ（Ｏ）₂Ｒ⁷、Ｓ（Ｏ）_mＲ⁷、ＮＲ⁸Ｓ（Ｏ）₂Ｒ⁷、又はハロゲン原子を表し、
Ｒ^1a、Ｒ^1b、Ｒ^1c、Ｒ^1d、及びＲ^1eは、同一又は相異なり、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６シクロアルキル基、ハロゲン原子、又は水素原子を表し、
Ｙ¹は、ＮＲ²⁵、酸素原子又は硫黄原子を表し、
Ｙ²は、窒素原子又はＣＲ²⁶を表し、
Ｙ³は、窒素原子又はＣＲ²⁷を表し、
Ｙ⁴は、窒素原子又はＣＲ²⁸を表し、
Ｒ⁵及びＲ²⁵は、同一又は相異なり、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルコキシ基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ７シクロアルキル基、１以上のハロゲン原子を有していてもよい（Ｃ３−Ｃ７シクロアルキル）Ｃ１−Ｃ６アルキル基、又は水素原子を表し、
Ｒ²⁶、Ｒ²⁷、及びＲ²⁸は、同一又は相異なり、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６シクロアルキル基、ハロゲン原子、又は水素原子を表し、
Ｒ^1yは、１以上のハロゲン原子を有するＣ１−Ｃ５鎖式炭化水素基、ＯＲ⁷、ＯＳ（Ｏ）₂Ｒ⁷、Ｓ（Ｏ）_mＲ⁷、ＮＲ⁸Ｓ（Ｏ）₂Ｒ⁷、シアノ基、又はハロゲン原子を表し、
Ｒ^1ay及びＲ⁷は、同一又は相異なり、１以上のハロゲン原子を有するＣ１−Ｃ６鎖式炭化水素基を表し、
ｍ及びｖは、同一又は相異なり、０、１又は２を表し、
ｗ及びｔは、同一又は相異なり、０、１又は２を表し、
Ｒ¹は、Ｃ１−Ｃ１０鎖式炭化水素基、（Ｃ１−Ｃ５アルコキシ）Ｃ２−Ｃ５アルキル基、（Ｃ３−Ｃ５アルケニルオキシ）Ｃ２−Ｃ５アルキル基、（Ｃ３−Ｃ５アルキニルオキシ）Ｃ２−Ｃ５アルキル基、（Ｃ１−Ｃ５アルキル）−Ｓ（Ｏ）_t−（Ｃ２−Ｃ５アルキル）基、（Ｃ３−Ｃ５アルケニル）−Ｓ（Ｏ）_t−（Ｃ２−Ｃ５アルキル）基、（Ｃ３−Ｃ５アルキニル）−Ｓ（Ｏ）_t−（Ｃ２−Ｃ５アルキル）基、（Ｃ１−Ｃ５アルキル）−Ｃ（Ｏ）−（Ｃ１−Ｃ５アルキル）基｛該Ｃ１−Ｃ１０鎖式炭化水素基、該（Ｃ１−Ｃ５アルコキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ３−Ｃ５アルケニルオキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ３−Ｃ５アルキニルオキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ１−Ｃ５アルキル）−Ｓ（Ｏ）_t−（Ｃ２−Ｃ５アルキル）基、該（Ｃ３−Ｃ５アルケニル）−Ｓ（Ｏ）_t−（Ｃ２−Ｃ５アルキル）基、該（Ｃ３−Ｃ５アルキニル）−Ｓ（Ｏ）_t−（Ｃ２−Ｃ５アルキル）基、及び該（Ｃ１−Ｃ５アルキル）−Ｃ（Ｏ）−（Ｃ１−Ｃ５アルキル）基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基を有する｝、群Ｇより選ばれる１以上の置換基を有する（Ｃ３−Ｃ７シクロアルキル）Ｃ１−Ｃ３アルキル基、又は群Ｇより選ばれる１以上の置換基を有するＣ３−Ｃ７シクロアルキル基を表し、
Ｒ³⁰は、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、ハロゲン原子、ＯＲ³⁵、ＮＲ³⁶Ｒ³⁷、又は水素原子を表し、
Ｒ¹⁸及びＲ³⁵は、同一又は相異なり、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基を表し、
Ｒ¹⁷は、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、群Ｄより選ばれる１以上の置換基を有していてもよいフェニル基、又は水素原子を表し、
Ｒ⁸、Ｒ¹¹、Ｒ¹⁹、Ｒ²⁴、Ｒ²⁹、Ｒ³⁶及びＲ³⁷は、同一又は相異なり、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、又は水素原子を表し、
Ｒ¹²は、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、群Ｆより選ばれる１以上の置換基を有していてもよいＣ１−Ｃ６鎖式炭化水素基、群Ｊより選ばれる１以上の置換基を有していてもよいＣ３−Ｃ７シクロアルキル基、群Ｊより選ばれる１以上の置換基を有していてもよいＣ３−Ｃ７シクロアルケニル基、群Ｄより選ばれる１以上の置換基を有していてもよいフェニル基、群Ｄより選ばれる１以上の置換基を有していてもよい６員芳香族複素環基、水素原子、又はＳ（Ｏ）₂Ｒ²³を表し、
Ｒ²³は、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、又は群Ｄより選ばれる１以上の置換基を有していてもよいフェニル基を表し、
Ｒ^11a及びＲ^12aは、それらが結合する窒素原子と一緒になって、群Ｅより選ばれる１以上の置換基を有していてもよい３−７員非芳香族複素環基を表し、
Ｒ¹³は、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ７シクロアルキル基、１以上のハロゲン原子を有していてもよい（Ｃ３−Ｃ６シクロアルキル）Ｃ１−Ｃ３アルキル基、群Ｄより選ばれる１以上の置換基を有していてもよいフェニル基、群Ｄより選ばれる１以上の置換基を有していてもよい５もしくは６員芳香族複素環基、又は水素原子を表し、
Ｒ¹⁴は、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ７シクロアルキル基、１以上のハロゲン原子を有していてもよい（Ｃ３−Ｃ６シクロアルキル）Ｃ１−Ｃ３アルキル基、又はフェニルＣ１−Ｃ３アルキル基｛フェニルＣ１−Ｃ３アルキル基におけるフェニル部分は、群Ｄより選ばれる１以上の置換基を有していてもよい｝を表し、
Ｒ¹⁵及びＲ¹⁶は、同一又は相異なり、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキル基を表し、
Ｒ³¹は、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキル基、又は水素原子を表し、
Ｒ³²は、群Ｆより選ばれる１以上の置換基を有していてもよいＣ１−Ｃ６鎖式炭化水素基、群Ｊより選ばれる１以上の置換基を有していてもよいＣ３−Ｃ７シクロアルキル基、Ｓ（Ｏ）₂Ｒ²³、又は水素原子を表す。
群Ｂ：１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルコキシ基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６アルケニルオキシ基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６アルキニルオキシ基、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキルスルファニル基、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキルスルフィニル基、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキルスルホニル基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６シクロアルキル基、シアノ基、ヒドロキシ基、及びハロゲン原子からなる群。
群Ｃ：１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルコキシ基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６アルケニルオキシ基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６アルキニルオキシ基、及びハロゲン原子からなる群。
群Ｄ：１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、ヒドロキシ基、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルコキシ基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６アルケニルオキシ基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６アルキニルオキシ基、スルファニル基、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキルスルファニル基、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキルスルフィニル基、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキルスルホニル基、アミノ基、ＮＨＲ²¹、ＮＲ²¹Ｒ²²、Ｃ（Ｏ）Ｒ²¹、ＯＣ（Ｏ）Ｒ²¹、Ｃ（Ｏ）ＯＲ²¹、シアノ基、ニトロ基、及びハロゲン原子からなる群。
Ｒ²¹及びＲ²²は、同一又は相異なり、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキル基を表す。
群Ｅ：１以上のハロゲン原子を有していてもよいＣ１−Ｃ６鎖式炭化水素基、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルコキシ基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６アルケニルオキシ基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６アルキニルオキシ基、ハロゲン原子、オキソ基、ヒドロキシ基、シアノ基、及びニトロ基からなる群。
群Ｆ：１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルコキシ基、群Ｄより選ばれる１以上の置換基を有していてもよいフェニル基、群Ｄより選ばれる１以上の置換基を有していてもよい５もしくは６員芳香族複素環基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ７シクロアルキル基、群Ｃより選ばれる１以上の置換基を有していてもよい３−７員非芳香族複素環基、アミノ基、ＮＨＲ²¹、ＮＲ²¹Ｒ²²、ハロゲン原子、及びシアノ基からなる群。
群Ｇ：ハロゲン原子、Ｃ１−Ｃ６ハロアルキル基及びシアノ基からなる群。
群Ｈ：１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキル基、ＯＲ¹⁰、ＮＲ⁹Ｒ¹⁰、Ｃ（Ｏ）Ｒ¹⁰、Ｃ（Ｏ）ＮＲ⁹Ｒ¹⁰、ＯＣ（Ｏ）Ｒ⁹、ＯＣ（Ｏ）ＯＲ⁹、ＮＲ¹⁰Ｃ（Ｏ）Ｒ⁹、ＮＲ¹⁰Ｃ（Ｏ）ＯＲ⁹、Ｃ（Ｏ）ＯＲ¹⁰、ハロゲン原子、ニトロ基、シアノ基、アミノ基、及び５もしくは６員芳香族複素環基からなる群。
Ｒ⁹は、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキル基、又は１以上のハロゲン原子を有していてもよいＣ３−Ｃ６シクロアルキル基を表し、
Ｒ¹⁰は、１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキル基、１以上のハロゲン原子を有していてもよいＣ３−Ｃ６シクロアルキル基、又は水素原子を表す。
群Ｊ：１以上のハロゲン原子を有していてもよいＣ１−Ｃ６アルキル基、ハロゲン原子、及びシアノ基からなる群。］
で示される化合物又はそのＮオキシド（以下、式（Ｉ）で示される化合物又はそのＮオキシドを本化合物と記す）の有効量を有害節足動物、有害節足動物の生息場所、植物又は土壌に施用する有害節足動物の防除方法。
［２］ ［１］に記載の式（Ｉ）で示される化合物と、群（ａ）、群（ｂ）、群（ｃ）、群（ｄ）、群（ｅ）、群（ｆ）、群（ｇ）、群（ｈ）、群（ｉ）及び群（ｊ）からなる群より選ばれる１以上の成分とを含む組成物：
群（ａ）：殺虫活性成分、殺ダニ活性成分及び殺線虫活性成分からなる群；
群（ｂ）：殺菌活性成分；
群（ｃ）：植物成長調整成分；
群（ｄ）：薬害軽減成分；
群（ｅ）：共力剤；
群（ｆ）：忌避成分；
群（ｇ）：殺軟体動物成分；
群（ｈ）：昆虫フェロモン；
群（ｉ）：除草活性成分；
群（ｊ）：微生物資材。
［３］ ［２］に記載の組成物の有効量を有害節足動物、有害節足動物の生息場所、植物又は土壌に施用する有害節足動物の防除方法。
［４］ ［１］に記載の式（Ｉ）で示される化合物又は［２］に記載の組成物の有効量を保持している種子又は栄養生殖器官。 The present invention is as follows.
[1] Formula (I)

[Where:
Q represents a group represented by the formula Q1, a group represented by the formula Q2, or a group represented by the formula Q3.

R ² represents a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a cyclopropylmethyl group,
n represents 0, 1 or 2;
G ¹ represents a nitrogen atom or CR ^3a ,
G ² represents a nitrogen atom or CR ^3b ,
G ³ represents a nitrogen atom or CR ^3c ,
G ⁴ represents a nitrogen atom or CR ^3d ,
R ^3a , R ^3b , R ^3c , and R ^3d are the same or different and are selected from group E and a C1-C6 chain hydrocarbon group that may have one or more substituents selected from group B A C3-C7 cycloalkyl group optionally having one or more substituents, a phenyl group optionally having one or more substituents selected from group H, and one or more substituents selected from group H; 5 or 6-membered aromatic heterocyclic group which may have, OR ¹² , NR ¹¹ R ¹² , NR ^11a R ^12a , NR ²⁴ NR ¹¹ R ¹² , NR ²⁴ OR ¹¹ , NR ¹¹ C (O) R ¹³ , ^{NR 24 NR 11 C (O)} R 13, NR 11 C (O) OR 14, NR 24 NR 11 C (O) OR 14, NR 11 C (O) NR 31 R 32, NR 24 NR 11 C (O) NR ³¹ R ³² , N = CHNR ³¹ R ³² , N = S (O) _p R ¹⁵ R ¹⁶ , C (O) R ¹³ , C (O) OR ¹⁷ , C (O) NR ^{3 1} R ³² , C (O) NR ¹¹ S (O) ₂ R ²³ , CR ³⁰ = NOR ¹⁷ , NR ¹¹ CR ²⁴ = NOR ¹⁷ , a cyano group, a nitro group, a hydrogen atom, or a halogen atom,
p represents 0 or 1,
A ¹ represents NR ⁵ , an oxygen atom or a sulfur atom,
Het represents a group of formula Het1, a group of formula Het2, or a group of formula Het3;

A ² represents a nitrogen atom or CR ^4a ,
A ³ represents a nitrogen atom or CR ^4b ,
A ⁴ represents a nitrogen atom or CR ^4c ,
W ¹ represents an oxygen atom or a sulfur atom,
R ^4a , R ^4b , and R ^4c are the same or different and may have one or more halogen atoms, C1-C6 chain hydrocarbon group, nitro group, OR ¹⁸ , NR ¹⁸ R ¹⁹ , cyano group Represents an amino group, a halogen atom, or a hydrogen atom,
R ⁶ is a C1-C6 chain hydrocarbon group which may have one or more substituents selected from group F, and C3-C6 which may have one or more substituents selected from group J. A cycloalkyl group, a phenyl group optionally having one or more substituents selected from group H, or a 5- or 6-membered aromatic heterocyclic ring optionally having one or more substituents selected from group H Represents a group,
T is a C1-C10 chain hydrocarbon group, a (C1-C5 alkoxy) C2-C5 alkyl group, a (C3-C5 alkenyloxy) C2-C5 alkyl group, a (C3-C5 alkynyloxy) C2-C5 alkyl group, (C1-C5 alkyl) -S (O) _w- (C2-C5 alkyl) group, (C3-C5 alkenyl) -S (O) _w- (C2-C5 alkyl) group, (C3-C5 alkynyl) -S (O) _w- (C2-C5 alkyl) group, (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group {the C1-C10 chain hydrocarbon group, the (C1-C5 alkoxy) group C2-C5 alkyl group, the (C3-C5 alkenyloxy) C2-C5 alkyl group, the (C3-C5 alkynyloxy) C2-C5 alkyl group, the (C1-C5 alkyl) -S (O) _w- (C2 − 5 alkyl) group, the (C3-C5 _{alkenyl) -S (O) w - (} C2-C5 alkyl) group, the (C3-C5 _{alkynyl) -S (O) w - (} C2-C5 alkyl) group, and, The (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group has one or more substituents selected from the group consisting of a cyano group and a halogen atom}, one or more selected from the group G having substituent (C3-C7 cycloalkyl) C1-C3 alkyl group, C3-C7 cycloalkyl group having one or more substituents selected from the group ^{G, oR 1, S (O} ) v R 1, OS (O _{^{) 2 R 1, CH 2 OR}} 1, NR 1 R 29, C (O) R 1, C (O) NR 1 R 29, NR 29 C (O) R 1, N = CR 1 R 30, wherein T- A group represented by formula 1, a group represented by formula T-2, a group represented by formula T-3, and a group represented by formula T-4 A group represented by formula T-5, a group represented by formula T-6, a group represented by formula T-3, a group represented by formula T-4, a group represented by formula T-5, a formula T- Group represented by formula 6, group represented by formula T-7, group represented by formula T-8, group represented by formula T-9, group represented by formula T-10, group represented by formula T-11 Or represents a group of formula T-12,

X ¹ represents a nitrogen atom or CR ^1a ,
X ² represents a nitrogen atom or CR ^1b ,
X ³ represents a nitrogen atom or CR ^1c ,
X ⁴ represents a nitrogen atom or CR ^1d ,
X ⁵ represents a nitrogen atom or CR ^1e ,
R ^1x is a C1-C5 chain hydrocarbon group having one or more halogen atoms, OR ⁷ , OS (O) ₂ R ⁷ , S (O) _m R ⁷ , NR ⁸ S (O) ₂ R ⁷ , or Represents a halogen atom,
R ^1a , R ^1b , R ^1c , R ^1d , and R ^1e are the same or different and have a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, and having one or more halogen atoms. An optionally substituted C3-C6 cycloalkyl group, a halogen atom, or a hydrogen atom;
Y ¹ represents NR ²⁵ , an oxygen atom or a sulfur atom,
Y ² represents a nitrogen atom or CR ²⁶ ,
Y ³ represents a nitrogen atom or CR ²⁷ ,
Y ⁴ represents a nitrogen atom or CR ²⁸ ,
R ⁵ and R ²⁵ are the same or different, a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, and a C1-C6 alkoxy group optionally having one or more halogen atoms. Represents a C3-C7 cycloalkyl group optionally having one or more halogen atoms, a (C3-C7 cycloalkyl) C1-C6 alkyl group optionally having one or more halogen atoms, or a hydrogen atom. ,
R ²⁶ , R ²⁷ , and R ²⁸ are the same or different and are a C1-C6 chain hydrocarbon group that may have one or more halogen atoms, and C3 that may have one or more halogen atoms. -C6 represents a cycloalkyl group, a halogen atom, or a hydrogen atom,
R ^1y is a C1-C5 chain hydrocarbon group having one or more halogen atoms, OR ⁷ , OS (O) ₂ R ⁷ , S (O) _m R ⁷ , NR ⁸ S (O) ₂ R ⁷ , cyano Represents a group, or a halogen atom,
R ^1ay and R ⁷ are the same or different and each represents a C1-C6 chain hydrocarbon group having one or more halogen atoms,
m and v are the same or different and represent 0, 1 or 2,
w and t are the same or different and represent 0, 1 or 2,
R ¹ is a C1-C10 chain hydrocarbon group, a (C1-C5 alkoxy) C2-C5 alkyl group, a (C3-C5 alkenyloxy) C2-C5 alkyl group, a (C3-C5 alkynyloxy) C2-C5 alkyl group. , (C1-C5 alkyl) -S (O) _t- (C2-C5 alkyl) group, (C3-C5 alkenyl) -S (O) _t- (C2-C5 alkyl) group, (C3-C5 alkynyl)- S (O) _t- (C2-C5 alkyl) group, (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group {the C1-C10 chain hydrocarbon group, the (C1-C5 alkoxy) ) C2-C5 alkyl group, the (C3-C5 alkenyloxy) C2-C5 alkyl group, the (C3-C5 alkynyloxy) C2-C5 alkyl group, the (C1-C5 alkyl) -S (O) _t- ( C2 C5 alkyl) group, the (C3-C5 _{alkenyl) -S (O) t - (} C2-C5 alkyl) group, the (C3-C5 _{alkynyl) -S (O) t - (} C2-C5 alkyl) group, and, The (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group has one or more substituents selected from the group consisting of a cyano group and a halogen atom}, one or more selected from the group G A C1-C3 alkyl group having a substituent (C3-C7 cycloalkyl), or a C3-C7 cycloalkyl group having one or more substituents selected from Group G;
R ³⁰ represents a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, a halogen atom, OR ³⁵ , NR ³⁶ R ³⁷ , or a hydrogen atom,
R ¹⁸ and R ³⁵ are the same or different and each represents a C1-C6 chain hydrocarbon group which may have one or more halogen atoms,
R ¹⁷ represents a C1-C6 chain hydrocarbon group which may have one or more halogen atoms, a phenyl group which may have one or more substituents selected from Group D, or a hydrogen atom. ,
R ⁸ , R ¹¹ , R ¹⁹ , R ²⁴ , R ²⁹ , R ³⁶ and R ³⁷ are the same or different and each is a C1-C6 chain hydrocarbon group which may have one or more halogen atoms, or hydrogen Represents an atom,
R ¹² is a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, and a C1-C6 chain hydrocarbon group optionally having one or more substituents selected from Group F. C3-C7 cycloalkyl group optionally having one or more substituents selected from group J, C3-C7 cycloalkenyl group optionally having one or more substituents selected from group J, group A phenyl group optionally having one or more substituents selected from D, a 6-membered aromatic heterocyclic group optionally having one or more substituents selected from Group D, a hydrogen atom, or S ( O) ₂ R ²³
R ²³ represents a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, or a phenyl group optionally having one or more substituents selected from Group D;
R ^11a and R ^12a together with the nitrogen atom to which they are attached represent a 3-7 membered non-aromatic heterocyclic group optionally having one or more substituents selected from group E;
R ¹³ represents a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, a C3-C7 cycloalkyl group optionally having one or more halogen atoms, and one or more halogen atoms. (C3-C6 cycloalkyl) which may have C1-C3 alkyl group, phenyl group which may have one or more substituents selected from group D, one or more substituents selected from group D Represents a 5- or 6-membered aromatic heterocyclic group which may have, or a hydrogen atom,
R ¹⁴ represents a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, a C3-C7 cycloalkyl group optionally having one or more halogen atoms, and one or more halogen atoms. (C3-C6 cycloalkyl) which may have a C1-C3 alkyl group or a phenyl C1-C3 alkyl group {the phenyl moiety in the phenyl C1-C3 alkyl group has one or more substituents selected from group D May represent}
R ¹⁵ and R ¹⁶ are the same or different and each represents a C1-C6 alkyl group optionally having one or more halogen atoms,
R ³¹ represents a C1-C6 alkyl group optionally having one or more halogen atoms, or a hydrogen atom,
R ³² is a C1-C6 chain hydrocarbon group which may have one or more substituents selected from group F, and C3-C7 which may have one or more substituents selected from group J. Represents a cycloalkyl group, S (O) ₂ R ²³ , or a hydrogen atom.
Group B: C1-C6 alkoxy group optionally having one or more halogen atoms, C3-C6 alkenyloxy group optionally having one or more halogen atoms, having one or more halogen atoms A C3-C6 alkynyloxy group, a C1-C6 alkylsulfanyl group optionally having one or more halogen atoms, a C1-C6 alkylsulfinyl group optionally having one or more halogen atoms, one or more A group consisting of a C1-C6 alkylsulfonyl group optionally having a halogen atom, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, a cyano group, a hydroxy group, and a halogen atom.
Group C: C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, C1-C6 alkoxy group optionally having one or more halogen atoms, having one or more halogen atoms A group consisting of a C3-C6 alkenyloxy group which may have one, a C3-C6 alkynyloxy group which may have one or more halogen atoms, and a halogen atom.
Group D: C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, hydroxy group, C1-C6 alkoxy group optionally having one or more halogen atoms, one or more halogen atoms A C3-C6 alkenyloxy group that may have one or more, a C3-C6 alkynyloxy group that may have one or more halogen atoms, a sulfanyl group, or a C1-C6 that may have one or more halogen atoms. C6 alkylsulfanyl group, C1-C6 alkylsulfinyl group optionally having one or more halogen atoms, C1-C6 alkylsulfonyl group optionally having one or more halogen atoms, amino group, NHR ²¹ , NR ^A group consisting of ²¹ R ²² , C (O) R ²¹ , OC (O) R ²¹ , C (O) OR ²¹ , a cyano group, a nitro group, and a halogen atom.
R ²¹ and R ²² are the same or different and represent a C1-C6 alkyl group which may have one or more halogen atoms.
Group E: C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, C1-C6 alkoxy group optionally having one or more halogen atoms, having one or more halogen atoms A group consisting of a C3-C6 alkenyloxy group which may have one or more, a C3-C6 alkynyloxy group which may have one or more halogen atoms, a halogen atom, an oxo group, a hydroxy group, a cyano group, and a nitro group.
Group F: C1-C6 alkoxy group optionally having one or more halogen atoms, phenyl group optionally having one or more substituents selected from Group D, one or more substitutions selected from Group D A 5- or 6-membered aromatic heterocyclic group which may have a group, a C3-C7 cycloalkyl group which may have one or more halogen atoms, and one or more substituents selected from group C A group consisting of a 3-7 membered non-aromatic heterocyclic group, an amino group, NHR ²¹ , NR ²¹ R ²² , a halogen atom, and a cyano group, which may be optionally present.
Group G: A group consisting of a halogen atom, a C1-C6 haloalkyl group and a cyano group.
Group H: 1 or more halogen atoms optionally may C1-C6 alkyl group optionally ^{having, OR 10, NR 9 R 10} , C (O) R 10, C (O) NR 9 R 10, OC (O) R ⁹ , OC (O) OR ⁹ , NR ¹⁰ C (O) R ⁹ , NR ¹⁰ C (O) OR ⁹ , C (O) OR ¹⁰ , halogen atom, nitro group, cyano group, amino group, and 5 or 6 A group consisting of membered aromatic heterocyclic groups.
R ⁹ represents a C1-C6 alkyl group optionally having one or more halogen atoms, or a C3-C6 cycloalkyl group optionally having one or more halogen atoms,
R ¹⁰ represents a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom.
Group J: A group consisting of a C1-C6 alkyl group optionally having one or more halogen atoms, a halogen atom, and a cyano group. ]
Or an N oxide thereof (hereinafter, the compound represented by formula (I) or the N oxide thereof is referred to as the present compound) is applied to harmful arthropods, habitats, plants or soils of harmful arthropods. How to apply harmful arthropods.
[2] The compound represented by the formula (I) according to [1], a group (a), a group (b), a group (c), a group (d), a group (e), a group (f), a group A composition comprising (g), one or more components selected from the group consisting of group (h), group (i) and group (j):
Group (a): a group consisting of an insecticidal active ingredient, an acaricidal active ingredient and a nematicidal active ingredient;
Group (b): bactericidal active ingredient;
Group (c): plant growth regulating component;
Group (d): phytotoxicity reducing component;
Group (e): synergist;
Group (f): repellent ingredients;
Group (g): molluscicidal components;
Group (h): insect pheromone;
Group (i): herbicidal active ingredient;
Group (j): Microbial material.
[3] A method for controlling harmful arthropods, which comprises applying an effective amount of the composition according to [2] to harmful arthropods, habitats, plants or soil of harmful arthropods.
[4] A seed or vegetative organ holding an effective amount of the compound represented by formula (I) according to [1] or the composition according to [2].

  According to the present invention, harmful arthropods can be controlled.

The substituent in the present invention will be described.
A halogen atom means a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom.
When the substituent has two or more halogen atoms, these halogen atoms may be the same or different.
In this specification, the expression “CX-CY” means that the number of carbon atoms is X to Y. For example, the notation “C1-C6” means 1 to 6 carbon atoms.
The chain hydrocarbon group represents an alkyl group, an alkenyl group or an alkynyl group.
Examples of the alkyl group include methyl group, ethyl group, propyl group, isopropyl group, 1,1-dimethylpropyl group, 1,2-dimethylpropyl group, 1-ethylpropyl group, butyl group, sec-butyl group, tert- Examples include a butyl group, a pentyl group, a hexyl group, an octyl group, a nonyl group, and a decyl group.
Examples of the alkenyl group include a vinyl group, 1-propenyl group, 2-propenyl group, 1-methyl-1-propenyl group, 1-methyl-2-propenyl group, 1,2-dimethyl-1-propenyl group, 1- Examples include ethyl-2-propenyl group, 3-butenyl group, 4-pentenyl group, 5-hexenyl group, 7-octenyl group, nonenyl group, and decenyl group.
Examples of the alkynyl group include ethynyl group, 1-propynyl group, 2-propynyl group, 1-methyl-2-propynyl group, 1,1-dimethyl-2-propynyl group, 1-ethyl-2-propynyl group, 2- Examples include butynyl group, 4-pentynyl group, 5-hexynyl group, 7-octynyl group, noninyl group, and decynyl group.
Examples of the haloalkyl group include trifluoromethyl group, 2,2,2-trifluoroethyl group, 2-bromo-1,1,2,2-tetrafluoroethyl group, 2,2,3,3-tetrafluoro. A propyl group, 1-methyl-2,2,3,3-tetrafluoropropyl group, and a perfluorohexyl group are mentioned.
Examples of the alkoxy group include methoxy group, ethoxy group, isopropoxy group, 1,1-dimethylpropoxy group, 1,2-dimethylpropoxy group, 1-ethylpropoxy group, 1-butoxy group, tert-butoxy group, pentoxy group. Group, hexyloxy group, heptyloxy group, octyloxy group, nonyloxy group, decyloxy group, and benzyloxy group.

Examples of the cycloalkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group.
Examples of the cycloalkenyl group include a cyclopropenyl group, a cyclobutenyl group, a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group.

The 3-7-membered non-aromatic heterocyclic group is an aziridine ring, azetidine ring, pyrrolidine ring, imidazoline ring, imidazolidine ring, piperidine ring, tetrahydropyrimidine ring, hexahydropyrimidine ring, piperazine ring, azepane ring, oxazolidine ring, It represents an isoxazolidine ring, 1,3-oxazinane ring, morpholine ring, 1,4-oxazepane ring, thiazolidine ring, isothiazolidine ring, 1,3-thiazinane ring, thiomorpholine ring, or 1,4-thiazepane ring. Examples of the 3- to 7-membered non-aromatic heterocyclic group optionally having one or more substituents selected from group E include the groups shown below.

The (C1-C5 alkoxy) C2-C5 alkyl group having one or more halogen atoms represents a group in which (C1-C5 alkoxy) and / or (C2-C5 alkyl) has one or more halogen atoms. 2- (trifluoromethoxy) ethyl group, 2,2-difluoro-3-methoxypropyl group, 2,2-difluoro-3- (2,2,2-trifluoroethoxy) propyl group, and 3- (2- A chloroethoxy) propyl group.
The (C1-C5 alkylsulfanyl) C2-C5 alkyl group having one or more halogen atoms represents a group in which (C1-C5 alkylsulfanyl) and / or (C2-C5 alkyl) has one or more halogen atoms, An example is a 2,2-difluoro-2- (trifluoromethylthio) ethyl group.
The (C1-C5 alkylsulfinyl) C2-C5 alkyl group having one or more halogen atoms represents a group in which (C1-C5 alkylsulfinyl) and / or (C2-C5 alkyl) has one or more halogen atoms, An example is 2,2-difluoro-2- (trifluoromethanesulfinyl) ethyl group.
The (C1-C5 alkylsulfonyl) C2-C5 alkyl group having one or more halogen atoms represents a group in which (C1-C5 alkylsulfonyl) and / or (C2-C5 alkyl) has one or more halogen atoms, An example is 2,2-difluoro-2- (trifluoromethanesulfonyl) ethyl group.
The (C3-C7 cycloalkyl) C1-C6 alkyl group optionally having one or more halogen atoms means that (C3-C7 cycloalkyl) and / or (C1-C6 alkyl) is one or more halogen atoms. Represents a group which may have, for example, (2,2-difluorocyclopropyl) methyl group, 2-cyclopropyl-1,1,2,2-tetrafluoroethyl group, and 2- (2,2- And difluorocyclopropyl) -1,1,2,2-tetrafluoroethyl group.
The (C3-C6 cycloalkyl) C1-C3 alkyl group optionally having one or more halogen atoms means that (C3-C6 cycloalkyl) and / or (C1-C3 alkyl) is one or more halogen atoms. Represents a group which may have, for example, (2,2-difluorocyclopropyl) methyl group, 2-cyclopropyl-1,1,2,2-tetrafluoroethyl group, and 2- (2,2- And difluorocyclopropyl) -1,1,2,2-tetrafluoroethyl group.
(C3-C7 cycloalkyl) C1-C3 alkyl group having one or more substituents selected from group G is (C3-C7 cycloalkyl) and / or (C1-C3 alkyl) selected from group G Represents a group having the above substituents, for example, (2,2-difluorocyclopropyl) methyl group, [1- (trifluoromethyl) cyclopropyl] methyl group, [2- (trifluoromethyl) cyclopropyl] methyl Groups, 2-cyclopropyl-1,1,2,2-tetrafluoroethyl group, 2-cyclopropyl-3,3,3-trifluoropropyl group, and 1,1,2,2-tetrafluoro-2- And [2- (trifluoromethyl) cyclopropyl] ethyl group.
"Phenyl C1-C3 alkyl group {the phenyl moiety in the phenyl C1-C3 alkyl group may have one or more substituents selected from group D}" means, for example, a benzyl group, a 2-fluorobenzyl group 4-chlorobenzyl group, 4- (trifluoromethyl) benzyl group, and 2- [4- (trifluoromethyl) phenyl] ethyl group.
The 5- or 6-membered aromatic heterocyclic group represents a 5-membered aromatic heterocyclic group or a 6-membered aromatic heterocyclic group, and the 5-membered aromatic heterocyclic group represents a pyrrolyl group, a furyl group, a thienyl group, or a pyrazolyl group. Imidazolyl group, triazolyl group, tetrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, oxadiazolyl group, or thiadiazolyl group. The 6-membered aromatic heterocyclic group represents a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, or a tetrazinyl group.
Examples of the alkylsulfanyl group include a methylsulfanyl group, an ethylsulfanyl group, a propylsulfanyl group, and an isopropylsulfanyl group. Examples of the alkylsulfinyl group include a methylsulfinyl group, an ethylsulfinyl group, a propylsulfinyl group, and an isopropylsulfinyl group.
Examples of the alkylsulfonyl group include a methylsulfonyl group, an ethylsulfonyl group, a propylsulfonyl group, and an isopropylsulfonyl group.

  The compound may have one or more stereoisomers. Examples of stereoisomers include enantiomers, diastereomers, and geometric isomers. This compound includes each stereoisomer and a stereoisomer mixture in any ratio.

  The compound may form acid addition salts. Examples of the acid forming the acid addition salt include inorganic acids such as hydrogen chloride, phosphoric acid, and sulfuric acid, and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid. The acid addition salt can be obtained by mixing the present compound and an acid.

  Next, the manufacturing method of this compound is demonstrated.

［式中、記号は前記と同じ意味を表す。］ Manufacturing method 1
A compound represented by formula (II-1b) (hereinafter referred to as compound (II-1b)) or a compound represented by formula (II-1c) (hereinafter referred to as compound (II-1c)) is represented by formula (II 1a) (hereinafter referred to as compound (II-1a)) and an oxidant can be produced.

[Wherein the symbols have the same meaning as described above. ]

First, a method for producing compound (II-1b) from compound (II-1a) will be described.
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include halogenated hydrocarbons such as dichloromethane and chloroform (hereinafter referred to as halogenated hydrocarbons); nitriles such as acetonitrile (hereinafter referred to as nitriles); alcohols such as methanol and ethanol ( Hereinafter, they are referred to as alcohols); acetic acid; water and a mixture of two or more thereof.
Examples of the oxidizing agent used in the reaction include sodium periodate, m-chloroperbenzoic acid (hereinafter referred to as mCPBA), and hydrogen peroxide.
When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be used as necessary.
Examples of the base include sodium carbonate. When using a base for reaction, a base is normally used in the ratio of 0.01-1 mol with respect to 1 mol of compounds (II-1a).
Examples of the catalyst include tungstic acid and sodium tungstate. When using a catalyst for reaction, a catalyst is normally used in the ratio of 0.01-0.5 mol with respect to 1 mol of compounds (II-1a).
For the reaction, the oxidizing agent is usually used at a ratio of 1 to 1.2 mol with respect to 1 mol of the compound (II-1a).
The reaction temperature is usually in the range of -20 to 80 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
After completion of the reaction, water is added to the reaction mixture and extracted with an organic solvent, and the organic layer is extracted with an aqueous solution of a reducing agent (for example, sodium sulfite, sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary. Wash. Compound (II-1b) can be obtained by drying and concentrating the organic layer.

Next, a method for producing compound (II-1c) from compound (II-1b) will be described.
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and a mixture of two or more thereof.
Examples of the oxidizing agent used in the reaction include mCPBA and hydrogen peroxide.
When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be used as necessary.
Examples of the base include sodium carbonate. When using a base for reaction, a base is normally used in the ratio of 0.01-1 mol with respect to 1 mol of compounds (II-1b).
Examples of the catalyst include sodium tungstate. When using a catalyst for reaction, a catalyst is normally used in the ratio of 0.01-0.5 mol with respect to 1 mol of compounds (II-1b).
In the reaction, with respect to 1 mol of compound (II-1b), the oxidizing agent is usually used at a ratio of 1 to 2 mol.
The reaction temperature is usually in the range of -20 to 120 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
After completion of the reaction, water is added to the reaction mixture and extracted with an organic solvent, and the organic layer is extracted with an aqueous solution of a reducing agent (for example, sodium sulfite, sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary. Wash. Compound (II-1c) can be obtained by drying and concentrating the organic layer.

Compound (II-1c) can be produced by a one-step reaction (one pot) by reacting compound (II-1a) with an oxidizing agent.
The reaction is carried out according to the method for producing compound (II-1c) from compound (II-1b) using an oxidizing agent in a proportion of usually 2 to 5 mol per 1 mol of compound (II-1a). be able to.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、製造法１に準じて実施することができる。 Manufacturing method 2
The compound represented by the formula (II-2b) and the compound represented by the formula (II-2c) can be produced by reacting the compound represented by the formula (II-2a) with an oxidizing agent.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be performed according to Production Method 1.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、製造法１に準じて実施することができる。 Production method 3
The compound represented by the formula (II-3b) and the compound represented by the formula (II-3c) can be produced by reacting the compound represented by the formula (II-3a) with an oxidizing agent.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be performed according to Production Method 1.

［式中、Ｘ^bは塩素原子、又は臭素原子を表し、Ｔ^aはＯＲ¹、ＮＲ¹Ｒ²⁹、式Ｔ−５で示される基、式Ｔ−６で示される基、式Ｔ−７で示される基、又は式Ｔ−８で示される基を表し、その他の記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばテトラヒドロフラン（以下、ＴＨＦと記す）、メチルｔｅｒｔ−ブチルエーテル（以下、ＭＴＢＥと記す）等のエーテル（以下、エーテル類と記す）；トルエン、キシレン等の芳香族炭化水素（以下、芳香族炭化水素類と記す）；ニトリル類；Ｎ−メチルピロリドン（以下、ＮＭＰと記す）; Ｎ，Ｎ−ジメチルホルムアミド（以下、ＤＭＦと記す）、ジメチルスルホキシド（以下、ＤＭＳＯと記す）等の非プロトン性極性溶媒（以下、非プロトン性極性溶媒類と記す）及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる塩基としては、例えば炭酸カリウム等のアルカリ金属炭酸塩（以下、アルカリ金属炭酸塩類と記す）、又は水素化ナトリウム等のアルカリ金属水素化物（以下、アルカリ金属水素化物類と記す）が挙げられる。
反応には、化合物（ＩＩＩ−Ｍ１ａ）１モルに対して、化合物（Ｒ−１ａ）が通常１〜２モルの割合、塩基が通常１〜１０モルの割合で用いられる。
反応温度は、通常−２０℃〜１５０℃の範囲である。反応時間は通常０．５〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（ＩＩＩ−１ａａ）を得ることができる。
化合物（Ｒ−１ａ）は、市販の化合物であるか、又は既知の方法に準じて製造することができる。 Manufacturing method 4
A compound represented by formula (III-1aa) (hereinafter referred to as compound (III-1aa)) is a compound represented by formula (III-M1a) (hereinafter referred to as compound (III-M1a)), It can be produced by reacting a compound represented by R-1a) (hereinafter referred to as compound (R-1a)) in the presence of a base.

Wherein, X ^b is chlorine atom or bromine atom, T ^a is OR ^1, NR ¹ R ^29, a group represented by the formula T-5, a group represented by the formula T-6, in the formula T-7 Or a group represented by formula T-8, and other symbols have the same meanings as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers (hereinafter referred to as ethers) such as tetrahydrofuran (hereinafter referred to as THF) and methyl tert-butyl ether (hereinafter referred to as MTBE); aromatic hydrocarbons such as toluene and xylene. (Hereinafter referred to as aromatic hydrocarbons); nitriles; N-methylpyrrolidone (hereinafter referred to as NMP); N, N-dimethylformamide (hereinafter referred to as DMF), dimethyl sulfoxide (hereinafter referred to as DMSO) And aprotic polar solvents (hereinafter referred to as aprotic polar solvents) and mixtures of two or more of these.
Examples of the base used in the reaction include alkali metal carbonates such as potassium carbonate (hereinafter referred to as alkali metal carbonates), or alkali metal hydrides such as sodium hydride (hereinafter referred to as alkali metal hydrides). Can be mentioned.
In the reaction, with respect to 1 mol of compound (III-M1a), compound (R-1a) is usually used at a ratio of 1 to 2 mol, and the base is usually used at a ratio of 1 to 10 mol.
The reaction temperature is usually in the range of -20 ° C to 150 ° C. The reaction time is usually in the range of 0.5 to 24 hours.
After completion of the reaction, compound (III-1aa) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-1a) is a commercially available compound, or can be produced according to a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法４に準じて実施することができる。 Manufacturing method 5
The compound represented by the formula (III-1ba) is obtained by reacting the compound represented by the formula (III-M1b) (hereinafter referred to as the compound (III-M1b)) with the compound (R-1a) in the presence of a base. Can be manufactured.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Production Method 4.

［式中、Ｔ^bは式Ｔ−１で示される基、式Ｔ−２で示される基、式Ｔ−３で示される基、式Ｔ−４で示される基、式Ｔ−９で示される基、式Ｔ−１０で示される基、式Ｔ−１１で示される基、又は式Ｔ−１２で示される基を表し、Ｍは９−ボラビシクロ［３．３．１］ノナン−９−イル基、ボロノ基、４，４，５，５−テトラメチル−１，３，２−ジオキサボロラン−２−イル基、トリブチルスタンニル基、ＺｎＣｌ、ＭｇＣｌ、又はＭｇＢｒを表し、その他の記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、芳香族炭化水素類、非プロトン性極性溶媒類、水及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる金属触媒としては、テトラキス（トリフェニルホスフィン）パラジウム（０）、１，１’−ビス（ジフェニルホスフィノ）フェロセンパラジウム（ＩＩ）ジクロリド、トリス（ジベンジリデンアセトン）ジパラジウム（０）、酢酸パラジウム（ＩＩ）等のパラジウム触媒；ビス（シクロオクタジエン）ニッケル（０）、塩化ニッケル（ＩＩ）等のニッケル触媒；及びヨウ化銅（Ｉ）、塩化銅（Ｉ）等の銅触媒等が挙げられる。
反応には必要に応じて、配位子、塩基、及び／又はアルカリ金属ハロゲン化物を用いてもよい。
配位子としては、トリフェニルホスフィン、キサントホス、２，２’−ビス（ジフェニルホスフィノ）−１，１’−ビナフチル、１，１’−ビス（ジフェニルホスフィノ）フェロセン、２−ジシクロヘキシルホスフィノ−２’，４’，６’−トリイソプロピルビフェニル、２−ジシクロヘキシルホスフィノ−２’，６’−ジメトキシビフェニル、１，２−ビス（ジフェニルホスフィノ）エタン、２，２’−ビピリジン、２−アミノエタノール、８−ヒドロキシキノリン、及び１，１０−フェナントロリン等が挙げられる。反応に配位子を用いる場合、化合物（ＩＩＩ−Ｍ１ａ）１モルに対して、配位子が通常０．０１〜１モルの割合で用いられる。
塩基としては、例えばアルカリ金属水素化物類、アルカリ金属炭酸塩類、及びトリエチルアミン、ジイソプロピルエチルアミン、ピリジン、４−（ジメチルアミノ）ピリジン等の有機塩基類（以下、有機塩基類と記す）が挙げられる。反応に塩基を用いる場合、化合物（ＩＩＩ−Ｍ１ａ）１モルに対して、塩基が通常０．１〜５モルの割合で用いられる。
アルカリ金属ハロゲン化物としては、フッ化カリウム、フッ化ナトリウム、塩化リチウム、塩化ナトリウム等が挙げられる。反応にアルカリ金属ハロゲン化物を用いる場合、化合物（ＩＩＩ−Ｍ１ａ）１モルに対して、アルカリ金属ハロゲン化物が通常０．１〜５モルの割合で用いられる。
反応には、化合物（ＩＩＩ−Ｍ１ａ）１モルに対して、化合物（Ｒ−１ｂ）が通常１〜１０モルの割合、金属触媒が通常０．０１〜０．５モルの割合で用いられる。
反応温度は、通常−２０℃〜２００℃の範囲である。反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＩＩ−１ａｂ）を得ることができる。
化合物（Ｒ−１ｂ）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Manufacturing method 6
The compound represented by the formula (III-1ab) (hereinafter referred to as the compound (III-1ab)) is composed of the compound (III-M1a) and the compound represented by the formula (R-1b) (hereinafter referred to as the compound (R-1b)). ))) In the presence of a metal catalyst.

[Wherein, T ^b is a group represented by the formula T-1, a group represented by the formula T-2, a group represented by the formula T-3, a group represented by the formula T-4, and a formula T-9. A group, a group represented by formula T-10, a group represented by formula T-11, or a group represented by formula T-12, wherein M represents a 9-borabicyclo [3.3.1] nonan-9-yl group; , Borono group, 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group, tributylstannyl group, ZnCl, MgCl, or MgBr, and other symbols have the same meanings as described above Represents. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, aprotic polar solvents, water, and a mixture of two or more thereof.
Examples of the metal catalyst used in the reaction include tetrakis (triphenylphosphine) palladium (0), 1,1′-bis (diphenylphosphino) ferrocenepalladium (II) dichloride, tris (dibenzylideneacetone) dipalladium (0), Palladium catalysts such as palladium (II) acetate; nickel catalysts such as bis (cyclooctadiene) nickel (0) and nickel (II) chloride; and copper catalysts such as copper iodide (I) and copper (I) chloride Can be mentioned.
In the reaction, a ligand, a base, and / or an alkali metal halide may be used as necessary.
Examples of the ligand include triphenylphosphine, xanthophos, 2,2′-bis (diphenylphosphino) -1,1′-binaphthyl, 1,1′-bis (diphenylphosphino) ferrocene, 2-dicyclohexylphosphino- 2 ′, 4 ′, 6′-triisopropylbiphenyl, 2-dicyclohexylphosphino-2 ′, 6′-dimethoxybiphenyl, 1,2-bis (diphenylphosphino) ethane, 2,2′-bipyridine, 2-amino Examples include ethanol, 8-hydroxyquinoline, and 1,10-phenanthroline. When using a ligand for reaction, a ligand is normally used in the ratio of 0.01-1 mol with respect to 1 mol of compounds (III-M1a).
Examples of the base include alkali metal hydrides, alkali metal carbonates, and organic bases such as triethylamine, diisopropylethylamine, pyridine, 4- (dimethylamino) pyridine (hereinafter referred to as organic bases). When using a base for reaction, a base is normally used in the ratio of 0.1-5 mol with respect to 1 mol of compounds (III-M1a).
Examples of the alkali metal halide include potassium fluoride, sodium fluoride, lithium chloride, sodium chloride and the like. When using an alkali metal halide for the reaction, the alkali metal halide is usually used at a ratio of 0.1 to 5 mol per 1 mol of the compound (III-M1a).
In the reaction, with respect to 1 mol of compound (III-M1a), compound (R-1b) is usually used in a proportion of 1 to 10 mol, and the metal catalyst is usually used in a proportion of 0.01 to 0.5 mol.
The reaction temperature is usually in the range of -20 ° C to 200 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (III-1ab) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-1b) is a commercially available compound, or can be produced using a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法６に準じて実施することができる。 Manufacturing method 7
The compound represented by the formula (III-1bb) can be produced by reacting the compound (III-M1b) with the compound (R-1b) in the presence of a metal catalyst.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Production Method 6.

［式中、Ｔ^cはＣ１−Ｃ１０鎖式炭化水素基、（Ｃ１−Ｃ５アルコキシ）Ｃ２−Ｃ５アルキル基、（Ｃ３−Ｃ５アルケニルオキシ）Ｃ２−Ｃ５アルキル基、（Ｃ３−Ｃ５アルキニルオキシ）Ｃ２−Ｃ５アルキル基、（Ｃ１−Ｃ５アルキル）−Ｓ（Ｏ） _w −（Ｃ２−Ｃ５アルキル）基、（Ｃ３−Ｃ５アルケニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、（Ｃ３−Ｃ５アルキニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、（Ｃ１−Ｃ５アルキル）−Ｃ（Ｏ）−（Ｃ１−Ｃ５アルキル）基｛該Ｃ１−Ｃ１０鎖式炭化水素基、該（Ｃ１−Ｃ５アルコキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ３−Ｃ５アルケニルオキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ３−Ｃ５アルキニルオキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ１−Ｃ５アルキル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、該（Ｃ３−Ｃ５アルケニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、該（Ｃ３−Ｃ５アルキニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、及び該（Ｃ１−Ｃ５アルキル）−Ｃ（Ｏ）−（Ｃ１−Ｃ５アルキル）基は、各々独立して、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基を有する｝、又は群Ｇより選ばれる１以上の置換基を有するＣ３−Ｃ７シクロアルキル基を表し、その他の記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば芳香族炭化水素類、非プロトン性極性溶媒類、及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる銅としては、銅粉が好ましい。
反応には、化合物（ＩＩＩ−Ｍ１ａ）１モルに対して、化合物（Ｒ−１ｃ）が通常１〜１０モルの割合、銅が通常１〜１０モルの割合で用いられる。
反応温度は、通常４０℃〜２００℃の範囲である。反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（ＩＩＩ−１ａｃ）を得ることができる。
化合物（Ｒ−１ｃ）は、市販の化合物であるか、又は既知の方法に準じて製造することができる。 Manufacturing method 8
A compound represented by formula (III-1ac) (hereinafter referred to as compound (III-1ac)) is a compound represented by compound (III-M1a) and a compound represented by formula (R-1c) (hereinafter referred to as compound (R-1c)). Can be made to react in the presence of copper.

[Wherein, T ^c is a C1-C10 chain hydrocarbon group, (C1-C5 alkoxy) C2-C5 alkyl group, (C3-C5 alkenyloxy) C2-C5 alkyl group, (C3-C5 alkynyloxy) C2- C5 alkyl group, (C1-C5 alkyl) -S (O) _w- (C2-C5 alkyl) group, (C3-C5 alkenyl) -S (O) _w- (C2-C5 alkyl) group, (C3-C5 Alkynyl) -S (O) _w- (C2-C5 alkyl) group, (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group {the C1-C10 chain hydrocarbon group, the (C1 -C5 alkoxy) C2-C5 alkyl group, the (C3-C5 alkenyloxy) C2-C5 alkyl group, the (C3-C5 alkynyloxy) C2-C5 alkyl group, the (C1-C5 alkyl) -S (O) _w - C2-C5 alkyl) group, the (C3-C5 _{alkenyl) -S (O) w - (} C2-C5 alkyl) group, the (C3-C5 _{alkynyl) -S (O) w - (} C2-C5 alkyl) group And the (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group each independently has one or more substituents selected from the group consisting of a cyano group and a halogen atom}, or It represents a C3-C7 cycloalkyl group having one or more substituents selected from group G, and other symbols have the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include aromatic hydrocarbons, aprotic polar solvents, and mixtures of two or more thereof.
As copper used for reaction, copper powder is preferable.
In the reaction, with respect to 1 mol of compound (III-M1a), compound (R-1c) is usually used in a proportion of 1 to 10 mol, and copper is usually used in a proportion of 1 to 10 mol.
The reaction temperature is usually in the range of 40 ° C to 200 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (III-1ac) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-1c) is a commercially available compound, or can be produced according to a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法８に準じて実施することができる。 Manufacturing method 9
The compound represented by the formula (III-1bc) can be produced by reacting the compound (III-M1b) with the compound (R-1c) in the presence of copper.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Production Method 8.

［式中、Ｒ⁴⁰は、メトキシ基、エトキシ基、フェノキシ基、又はＮ（ＣＨ₃）ＯＣＨ₃を表し、その他の記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、芳香族炭化水素類が挙げられる。
反応に用いられる塩基としては、ブチルリチウム、リチウムジイソプロピルアミド、リチウム２，２，６，６−テトラメチルピペリジド、リチウムビス（トリメチルシリル）アミド等が挙げられる。
反応には、化合物（ＩＩＩ−Ｍ１ａ）１モルに対して、化合物（Ｒ−１ｄ）が通常１〜１０モルの割合、塩基が通常１．０〜２．０モルの割合で用いられる。
反応温度は、通常−１００℃〜３０℃の範囲である。反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（ＩＩＩ−１ａｄ）を得ることができる。
化合物（Ｒ−１ｄ）は、市販の化合物であるか、又は既知の方法に準じて製造することができる。 Manufacturing method 10
A compound represented by formula (III-1ad) (hereinafter referred to as compound (III-1ad)) is a compound represented by compound (III-M1a) and a compound represented by formula (R-1d) (hereinafter referred to as compound (R-1d)). In the presence of a base.

[Wherein, R ⁴⁰ represents a methoxy group, an ethoxy group, a phenoxy group, or N (CH ₃ ) OCH ₃ , and other symbols represent the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers and aromatic hydrocarbons.
Examples of the base used for the reaction include butyl lithium, lithium diisopropylamide, lithium 2,2,6,6-tetramethylpiperidide, lithium bis (trimethylsilyl) amide and the like.
In the reaction, with respect to 1 mol of compound (III-M1a), compound (R-1d) is usually used at a ratio of 1 to 10 mol, and the base is usually used at a ratio of 1.0 to 2.0 mol.
The reaction temperature is usually in the range of -100 ° C to 30 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (III-1ad) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-1d) is a commercially available compound, or can be produced according to a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法１０に準じて実施することができる。 Manufacturing method 11
The compound represented by the formula (III-1bd) can be produced by reacting the compound (III-M1b) with the compound (R-1d) in the presence of a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 10.

［式中、Ｘ^cは塩素原子、臭素原子又はヨウ素原子を表し、Ｔ^dはＣ１−Ｃ１０鎖式炭化水素基、（Ｃ１−Ｃ５アルコキシ）Ｃ２−Ｃ５アルキル基、（Ｃ３−Ｃ５アルケニルオキシ）Ｃ２−Ｃ５アルキル基、（Ｃ３−Ｃ５アルキニルオキシ）Ｃ２−Ｃ５アルキル基、（Ｃ１−Ｃ５アルキル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、（Ｃ３−Ｃ５アルケニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、（Ｃ３−Ｃ５アルキニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、（Ｃ１−Ｃ５アルキル）−Ｃ（Ｏ）−（Ｃ１−Ｃ５アルキル）基｛該Ｃ１−Ｃ１０鎖式炭化水素基、該（Ｃ１−Ｃ５アルコキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ３−Ｃ５アルケニルオキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ３−Ｃ５アルキニルオキシ）Ｃ２−Ｃ５アルキル基、該（Ｃ１−Ｃ５アルキル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、該（Ｃ３−Ｃ５アルケニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、該（Ｃ３−Ｃ５アルキニル）−Ｓ（Ｏ）_w−（Ｃ２−Ｃ５アルキル）基、及び該（Ｃ１−Ｃ５アルキル）−Ｃ（Ｏ）−（Ｃ１−Ｃ５アルキル）基は、各々独立して、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基を有する｝、群Ｇより選ばれる１以上の置換基を有する（Ｃ３−Ｃ７シクロアルキル）Ｃ１−Ｃ３アルキル基、群Ｇより選ばれる１以上の置換基を有するＣ３−Ｃ７シクロアルキル基又はＳ（Ｏ）₂Ｒ¹を表し、その他の記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、芳香族炭化水素類、非プロトン性極性溶媒類、及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる塩基としては、有機塩基類、アルカリ金属水素化物類、及びアルカリ金属炭酸塩類が挙げられる。
反応には、化合物（ＩＩＩ−Ｍ２ａ）１モルに対して、化合物（Ｒ−２）が通常１〜１０モルの割合、塩基が通常０．１〜５モルの割合で用いられる。
反応温度は、通常−２０℃〜１２０℃の範囲である。反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（ＩＩＩ−２ａ）を得ることができる。
化合物（Ｒ−２）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Production method 12
The compound represented by formula (III-2a) is composed of a compound represented by formula (III-M2a) (hereinafter referred to as compound (III-M2a)) and a compound represented by formula (R-2) (hereinafter referred to as compound). (Denoted as (R-2)) in the presence of a base.

[Wherein, X ^c represents a chlorine atom, a bromine atom or an iodine atom, and T ^d represents a C1-C10 chain hydrocarbon group, (C1-C5 alkoxy) C2-C5 alkyl group, (C3-C5 alkenyloxy) C2 -C5 alkyl group, (C3-C5 alkynyloxy) C2-C5 alkyl group, (C1-C5 alkyl) -S (O) _w- (C2-C5 alkyl) group, (C3-C5 alkenyl) -S (O) _w- (C2-C5 alkyl) group, (C3-C5 alkynyl) -S (O) _w- (C2-C5 alkyl) group, (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group {The C1-C10 chain hydrocarbon group, the (C1-C5 alkoxy) C2-C5 alkyl group, the (C3-C5 alkenyloxy) C2-C5 alkyl group, the (C3-C5 alkynyloxy) C2-C5 alkyl Group, the (C1-C5 alkyl) -S (O) _w- (C2-C5 alkyl) group, the (C3-C5 alkenyl) -S (O) _w- (C2-C5 alkyl) group, the (C3 -C5 alkynyl) -S (O) _w- (C2-C5 alkyl) group and the (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group are each independently a cyano group and One or more substituents selected from the group consisting of halogen atoms}, one or more substituents selected from group G (C3-C7 cycloalkyl) C1-C3 alkyl groups, one or more selected from group G represents C3-C7 cycloalkyl group or S (O) ₂ R ¹ has a substituent, the other symbols have the same meanings as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, aprotic polar solvents, and a mixture of two or more thereof.
Examples of the base used in the reaction include organic bases, alkali metal hydrides, and alkali metal carbonates.
In the reaction, with respect to 1 mol of compound (III-M2a), compound (R-2) is usually used at a ratio of 1 to 10 mol, and base is usually used at a ratio of 0.1 to 5 mol.
The reaction temperature is usually in the range of -20 ° C to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (III-2a) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-2) is a commercially available compound, or can be produced using a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法１２に準じて実施することができる。 Production method 13
The compound represented by the formula (III-2b) is obtained by reacting the compound represented by the formula (III-M2b) (hereinafter referred to as the compound (III-M2b)) with the compound (R-2) in the presence of a base. Can be manufactured.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 12.

［式中、記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、脂肪族ハロゲン化炭化水素類、芳香族炭化水素類、非プロトン性極性溶媒類、及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる縮合剤としては、１−エチル−３−（３−ジメチルアミノプロピル）カルボジイミド塩酸塩等が挙げられる。
反応には必要に応じて塩基を用いてもよく、塩基としては有機塩基類が挙げられる。反応に塩基を用いる場合、化合物（ＩＩＩ−Ｍ３ａ）１モルに対して、塩基が通常０．１〜１０モルの割合で用いられる。
反応には、化合物（ＩＩＩ−Ｍ３ａ）１モルに対して、化合物（Ｒ−３）が通常１〜１０モルの割合、縮合剤が通常１〜５モルの割合で用いられる。
反応温度は、通常−２０℃〜１２０℃の範囲である。反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（ＩＩＩ−３ａ）を得ることができる。
化合物（Ｒ−３）は、市販の化合物であるか、又は既知の方法に準じて製造することができる。 Manufacturing method 14
The compound represented by formula (III-3a) (hereinafter referred to as compound (III-3a)) is composed of the compound represented by formula (III-M3a) (hereinafter referred to as compound (III-M3a)) and the formula (R -3) (hereinafter referred to as compound (R-3)) can be produced by reacting in the presence of a condensing agent.

[Wherein the symbols have the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, aliphatic halogenated hydrocarbons, aromatic hydrocarbons, aprotic polar solvents, and mixtures of two or more thereof.
Examples of the condensing agent used in the reaction include 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride.
In the reaction, a base may be used as necessary, and examples of the base include organic bases. When using a base for reaction, a base is normally used in the ratio of 0.1-10 mol with respect to 1 mol of compounds (III-M3a).
In the reaction, with respect to 1 mol of compound (III-M3a), compound (R-3) is usually used in a proportion of 1 to 10 mol, and the condensing agent is usually used in a proportion of 1 to 5 mol.
The reaction temperature is usually in the range of -20 ° C to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (III-3a) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-3) is a commercially available compound, or can be produced according to a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法１４に準じて実施することができる。 Production method 15
The compound represented by the formula (III-3b) is obtained by combining the compound represented by the formula (III-M3b) (hereinafter referred to as the compound (III-M3b)) and the compound (R-3) in the presence of a condensing agent. It can be produced by reacting.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 14.

［式中、記号は前記と同じ意味を表す。］
反応は、化合物（ＩＩＩ−Ｍ２ａ）に代えて化合物（ＩＩＩ−Ｍ４ａ）を用い、化合物（Ｒ−２）に代えて化合物（Ｒ−４）を用い、製造法１２に準じて実施することができる。
化合物（Ｒ−４）は、市販の化合物であるか、又は既知の方法に準じて製造することができる。 Production method 16
The compound represented by the formula (III-4a) (hereinafter referred to as the compound (III-4a)) is composed of the compound represented by the formula (III-M4a) (hereinafter referred to as the compound (III-M4a)) and the formula (R -4) (hereinafter referred to as compound (R-4)) can be produced by reacting in the presence of a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to production method 12, using compound (III-M4a) instead of compound (III-M2a) and using compound (R-4) instead of compound (R-2). .
Compound (R-4) is a commercially available compound, or can be produced according to a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法１６に準じて実施することができる。 Manufacturing method 17
The compound represented by the formula (III-4b) is obtained by reacting the compound represented by the formula (III-M4b) (hereinafter referred to as the compound (III-M4b)) with the compound (R-4) in the presence of a base. Can be manufactured.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 16.

［式中、記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、脂肪族ハロゲン化炭化水素類、芳香族炭化水素類、非プロトン性極性溶媒類、及びこれらの２種類以上の混合物が挙げられる。
反応には必要に応じて酸を用いてもよく、酸としてはｐ−トルエンスルホン酸、１０−カンファースルホン酸等が挙げられる。反応に酸を用いる場合、化合物（ＩＩＩ−Ｍ５ａ）１モルに対して、酸が通常０．１〜１０モルの割合で用いられる。
反応には、化合物（ＩＩＩ−Ｍ５ａ）１モルに対して、化合物（Ｒ−５）が通常１〜１０モルの割合で用いられる。
反応温度は、通常−２０℃〜１８０℃の範囲である。反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（ＩＩＩ−５ａ）を得ることができる。
化合物（Ｒ−５）は、市販の化合物であるか、又は既知の方法に準じて製造することができる。 Production method 18
A compound represented by formula (III-5a) (hereinafter referred to as compound (III-5a)) is composed of a compound represented by formula (III-M5a) (hereinafter referred to as compound (III-M5a)) and a formula (R -5) (hereinafter, referred to as compound (R-5)).

[Wherein the symbols have the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, aliphatic halogenated hydrocarbons, aromatic hydrocarbons, aprotic polar solvents, and mixtures of two or more thereof.
An acid may be used in the reaction as necessary, and examples of the acid include p-toluenesulfonic acid, 10-camphorsulfonic acid and the like. When using an acid for reaction, an acid is normally used in the ratio of 0.1-10 mol with respect to 1 mol of compounds (III-M5a).
In the reaction, compound (R-5) is usually used at a ratio of 1 to 10 mol per 1 mol of compound (III-M5a).
The reaction temperature is usually in the range of -20 ° C to 180 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (III-5a) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-5) is a commercially available compound, or can be produced according to a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法１８に準じて実施することができる。 Production method 19
The compound represented by the formula (III-5b) is produced by reacting the compound represented by the formula (III-M5b) (hereinafter referred to as the compound (III-M5b)) with the compound (R-5). be able to.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Production Method 18.

［式中、記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、ハロゲン化炭化水素類、芳香族炭化水素類、非プロトン性極性溶媒類、及びこれらの２種類以上の混合物が挙げられる。
反応には必要に応じて塩基を用いてもよく、塩基としては有機塩基類が挙げられる。反応に塩基を用いる場合、化合物（ＩＩＩ−Ｍ６ａ）１モルに対して、塩基が通常０．１〜１０モルの割合で用いられる。
反応には、化合物（ＩＩＩ−Ｍ６ａ）１モルに対して、化合物（Ｒ−６）が通常１〜１０モルの割合で用いられる。
反応温度は、通常−２０℃〜１２０℃の範囲である。反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（ＩＩＩ−６ａ）を得ることができる。
化合物（Ｒ−６）は、市販の化合物であるか、又は既知の方法に準じて製造することができる。 Manufacturing method 20
The compound represented by formula (III-6a) (hereinafter referred to as compound (III-6a)) is composed of the compound represented by formula (III-M6a) (hereinafter referred to as compound (III-M6a)) and the formula (R It can manufacture by making the compound (henceforth a compound (R-6)) shown by -6) react.

[Wherein the symbols have the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, aprotic polar solvents, and mixtures of two or more thereof.
In the reaction, a base may be used as necessary, and examples of the base include organic bases. When using a base for reaction, a base is normally used in the ratio of 0.1-10 mol with respect to 1 mol of compounds (III-M6a).
In the reaction, compound (R-6) is usually used at a ratio of 1 to 10 mol per 1 mol of compound (III-M6a).
The reaction temperature is usually in the range of -20 ° C to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (III-6a) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-6) is a commercially available compound, or can be produced according to a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法２０に準じて実施することができる。 Production method 21
The compound represented by the formula (III-6b) is produced by reacting the compound represented by the formula (III-M6b) (hereinafter referred to as the compound (III-M6b)) with the compound (R-6). be able to.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 20.

［式中、記号は前記と同じ意味を表す。］
はじめに、化合物（ＩＩＩ−７ａａ）の製造法について記す。
化合物（ＩＩＩ−７ａａ）は、化合物（ＩＩＩ−Ｍ４ａ）に代えて式（ＩＩＩ−Ｍ７ａ）で示される化合物（以下、化合物（ＩＩＩ−Ｍ７ａ）と記す）を用い、化合物（Ｒ−４）に代えて式（Ｒ−４−２）で示される化合物（以下、化合物（Ｒ−４−２）と記す）を用い、製造法１６に準じて製造することができる。
化合物（Ｒ−４−２）は、市販の化合物であるか、又は既知の方法に準じて製造することができる。 Production method 22
A compound represented by formula (III-7aa) (hereinafter referred to as compound (III-7aa)), a compound represented by formula (III-7ab) (hereinafter referred to as compound (III-7ab)), and formula (III −7ac) (hereinafter referred to as compound (III-7ac)) can be produced according to the following method.

[Wherein the symbols have the same meaning as described above. ]
First, a method for producing compound (III-7aa) will be described.
The compound (III-7aa) is replaced with the compound (R-4) using a compound represented by the formula (III-M7a) (hereinafter referred to as the compound (III-M7a)) instead of the compound (III-M4a). Using the compound represented by formula (R-4-2) (hereinafter referred to as compound (R-4-2)), the compound can be produced according to Production method 16.
Compound (R-4-2) is a commercially available compound, or can be produced according to a known method.

Next, the production method of compound (III-7ab) will be described.
Compound (III-7ab) can be produced according to production method 1, using compound (III-7aa) instead of compound (II-1a).

Next, the production method of compound (III-7ac) will be described.
Compound (III-7ac) can be produced according to production method 1, using compound (III-7ab) in place of compound (II-1b).

［式中、記号は前記と同じ意味を表す。］
反応は、製造法２２に準じて実施することができる。 Manufacturing method 23
A compound represented by formula (III-7ba) (hereinafter referred to as compound (III-7ba)), a compound represented by formula (III-7bb) (hereinafter referred to as compound (III-7bb)), and formula (III -7bc) (hereinafter referred to as compound (III-7bc)) can be produced according to the following method.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 22.

［式中、記号は前記と同じ意味を表す。］
はじめに、式（ＩＩＩ−Ｍ８ａ−２）で示される化合物（以下、化合物（ＩＩＩ−Ｍ８ａ−２）と記す）の製造法について記す。
化合物（ＩＩＩ−Ｍ８ａ−２）は、式（ＩＩＩ−Ｍ８ａ−１）で示される化合物（以下、化合物（ＩＩＩ−Ｍ８ａ−１）と記す）と式（Ｒ−７）で示される化合物（以下、化合物（Ｒ−７）と記す）とを反応させることにより製造することができる。
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、芳香族炭化水素類、非プロトン性極性溶媒類、アルコール類、ニトリル類、水及びこれらの２種類以上の混合物が挙げられる。
反応は、必要に応じて塩基を使用することができる。反応に用いられる塩基としては、例えば有機塩基類及びアルカリ金属炭酸塩類が挙げられる。
反応には、化合物（ＩＩＩ−Ｍ８ａ−１）１モルに対して、化合物（Ｒ−７）が通常１〜１０モルの割合、塩基が通常０．１から５モルの割合で用いられる。
反応温度は、通常−２０℃〜２００℃の範囲である。反応時間は通常０．１〜４８時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＩＩ−Ｍ８ａ−２）を得ることができる。
化合物（Ｒ−７）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Production method 24
A compound represented by the formula (III-8a) (hereinafter referred to as compound (III-8a)) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
First, a method for producing a compound represented by the formula (III-M8a-2) (hereinafter referred to as compound (III-M8a-2)) will be described.
Compound (III-M8a-2) is a compound represented by formula (III-M8a-1) (hereinafter referred to as compound (III-M8a-1)) and a compound represented by formula (R-7) (hereinafter referred to as “compound”). It can manufacture by making a compound (it describes as a compound (R-7)) react.
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, aprotic polar solvents, alcohols, nitriles, water, and mixtures of two or more thereof.
In the reaction, a base can be used as necessary. Examples of the base used for the reaction include organic bases and alkali metal carbonates.
In the reaction, with respect to 1 mol of compound (III-M8a-1), compound (R-7) is usually used in the proportion of 1 to 10 mol, and the base is usually used in the proportion of 0.1 to 5 mol.
The reaction temperature is usually in the range of -20 ° C to 200 ° C. The reaction time is usually in the range of 0.1 to 48 hours.
After completion of the reaction, compound (III-M8a-2) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-7) is a commercially available compound, or can be produced using a known method.

Next, a method for producing a compound represented by the formula (III-M8a-3) (hereinafter referred to as compound (III-M8a-3)) will be described.
Compound (III-M8a-3) can be produced by reacting compound (III-M8a-2) with a halogenating agent.
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include alcohols, nitriles, ethers, aromatic hydrocarbons, aprotic polar solvents, halogenated hydrocarbons, water, and a mixture of two or more of these.
Examples of the halogenating agent include chlorine, bromine, iodine, N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide and the like.
In the reaction, the halogenating agent is generally used at a ratio of 1 to 20 mol per 1 mol of the compound (III-M8a-2).
The reaction temperature is usually in the range of -20 ° C to 200 ° C. The reaction time is usually in the range of 0.1 to 72 hours.
After completion of the reaction, compound (III-M8a-3) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.

Next, a method for producing compound (III-8a) from compound (III-M8a-2) will be described.
Compound (III-8a) is produced by reacting compound (III-M8a-2), a compound represented by formula (R-8) (hereinafter referred to as compound (R-8)) and a halogenating agent. be able to.
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include alcohols, nitriles, ethers, aromatic hydrocarbons, aprotic polar solvents, halogenated hydrocarbons, water, and a mixture of two or more of these.
Examples of the halogenating agent include chlorine, bromine, iodine, N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide and the like.
In the reaction, with respect to 1 mol of compound (III-M8a-2), compound (R-8) is usually used at a ratio of 1 to 20 mol, and the halogenating agent is usually used at a ratio of 1 to 20 mol.
The reaction temperature is usually in the range of -20 ° C to 200 ° C. The reaction time is usually in the range of 0.1 to 72 hours.
After completion of the reaction, compound (III-8a) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-8) is a commercially available compound, or can be produced using a known method.

Next, a method for producing compound (III-8a) from compound (III-M8a-3) will be described.
Compound (III-8a) can also be produced by reacting compound (III-M8a-3) with compound (R-8) in the presence of a metal catalyst and a base.
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include alcohols, nitriles, ethers, aromatic hydrocarbons, aprotic polar solvents, water, and a mixture of two or more thereof.
Examples of the metal catalyst used in the reaction include tetrakis (triphenylphosphine) palladium (0), 1,1′-bis (diphenylphosphino) ferrocenepalladium (II) dichloride, tris (dibenzylideneacetone) dipalladium (0), Palladium catalysts such as palladium (II) acetate, nickel catalysts such as bis (cyclooctadiene) nickel (0) and nickel (II) chloride, and copper catalysts such as copper (I) iodide and copper (I) chloride Can be mentioned.
Examples of the base used in the reaction include alkali metal hydrides, alkali metal carbonates, and organic bases.
A ligand can also be used for reaction. Examples of the ligand include triphenylphosphine, xanthophos, 2,2′-bis (diphenylphosphino) -1,1′-binaphthyl, 1,1′-bis (diphenylphosphino) ferrocene, 2-dicyclohexylphosphino- 2 ′, 4 ′, 6′-triisopropylbiphenyl, 2-dicyclohexylphosphino-2 ′, 6′-dimethoxybiphenyl, 1,2-bis (diphenylphosphino) ethane, 2,2′-bipyridine, 2-amino Examples include ethanol, 8-hydroxyquinoline, and 1,10-phenanthroline. When using a ligand for reaction, a ligand is normally used in the ratio of 0.01-1 mol with respect to 1 mol of compounds (III-M8a-3).
In the reaction, with respect to 1 mol of the compound (III-M8a-3), the compound (R-8) is usually in a proportion of 1 to 20 mol, the metal catalyst is usually in a proportion of 0.01 to 0.5 mol, and the base is Usually, it is used in a proportion of 0.1 to 5 mol.
The reaction temperature is usually in the range of -20 ° C to 200 ° C. The reaction time is usually in the range of 0.1 to 72 hours.
After completion of the reaction, compound (III-8a) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法２４の化合物（ＩＩＩ−Ｍ８ａ−１）から化合物（ＩＩＩ−Ｍ８ａ−２）を製造する方法に準じて実施することができる。 Production method 25
Compound (III-8a) is produced by reacting compound (R-7) with a compound represented by formula (III-M8a-4) (hereinafter referred to as compound (III-M8a-4)). Can do.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the method for producing compound (III-M8a-2) from compound (III-M8a-1) in Production Method 24.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、製造法２４に準じて実施することができる。 Manufacturing method 26
The compound represented by the formula (III-8b) (hereinafter referred to as the compound (III-8b)), the compound represented by the formula (III-M8b-2) and the compound represented by the formula (III-M8b-3) are: It can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to the production method 24.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法２４の化合物（ＩＩＩ−Ｍ８ａ−１）から化合物（ＩＩＩ−Ｍ８ａ−２）を製造する方法に準じて実施することができる。 Manufacturing method 27
Compound (III-8b) is produced by reacting compound (R-7) with a compound represented by formula (III-M8b-4) (hereinafter referred to as compound (III-M8b-4)). Can do.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the method for producing compound (III-M8a-2) from compound (III-M8a-1) in Production Method 24.

［式中、Ｘ^aはフッ素原子又は塩素原子を表し、その他の記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、芳香族炭化水素類、ニトリル類、非プロトン性極性溶媒類、及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる塩基としては、例えばアルカリ金属炭酸塩類、及びアルカリ金属水素化物類が挙げられる。
反応には、化合物（Ｑ１ａ）１モルに対して、化合物（ＩＶ−Ｍ１）が通常１〜２モルの割合、塩基が通常１〜１０モルの割合で用いられる。
反応温度は、通常−２０℃〜１５０℃の範囲である。反応時間は通常０．５〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（ＩＶ−１ａ）を得ることができる。
化合物（ＩＶ−Ｍ１）は、公知であるか、国際公開第2005/018557号、国際公開第2009/149188号、国際公開第2010/104818号、国際公開第2015/153304号等に記載の方法準じて製造することができる。 Production method 28
A compound represented by formula (IV-1a) (hereinafter referred to as compound (IV-1a)) is a compound represented by formula (IV-M1) (hereinafter referred to as compound (IV-M1)), and a compound represented by formula (IV-M1) It can be produced by reacting a compound represented by Q1a) (hereinafter referred to as compound (Q1a)) in the presence of a base.

[Wherein, X ^a represents a fluorine atom or a chlorine atom, and other symbols have the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, nitriles, aprotic polar solvents, and a mixture of two or more of these.
Examples of the base used in the reaction include alkali metal carbonates and alkali metal hydrides.
In the reaction, with respect to 1 mol of compound (Q1a), compound (IV-M1) is usually used at a ratio of 1 to 2 mol, and the base is usually used at a ratio of 1 to 10 mol.
The reaction temperature is usually in the range of -20 ° C to 150 ° C. The reaction time is usually in the range of 0.5 to 24 hours.
After completion of the reaction, compound (IV-1a) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (IV-M1) is publicly known or conforms to the method described in International Publication No. 2005/018557, International Publication No. 2009/149188, International Publication No. 2010/104818, International Publication No. 2015/153304, etc. Can be manufactured.

［式中、記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、芳香族炭化水素類、非プロトン性極性溶媒類、水及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる金属触媒としては、ヨウ化銅（Ｉ）、臭化銅（Ｉ）、塩化銅（Ｉ）、酸化銅（Ｉ）、トリフルオロメタンスルホン酸銅（Ｉ）ベンゼンコンプレックス、テトラキス（アセトニトリル）銅（Ｉ）ヘキサフルオロホスファート、及び２−チオフェンカルボン酸銅（Ｉ）等の銅触媒；ビス（シクロオクタジエン）ニッケル（０）、塩化ニッケル（ＩＩ）等のニッケル触媒が挙げられる。
反応は必要に応じて、配位子、塩基、又はアルカリ金属ハロゲン化物を用いてもよい。
配位子としては、トリフェニルホスフィン、キサントホス、２，２’−ビス（ジフェニルホスフィノ）−１，１’−ビナフチル、１，１’−ビス（ジフェニルホスフィノ）フェロセン、２−ジシクロヘキシルホスフィノ−２’，４’，６’−トリイソプロピルビフェニル、２−ジシクロヘキシルホスフィノ−２’，６’−ジメトキシビフェニル、１，２−ビス（ジフェニルホスフィノ）エタン、２，２’−ビピリジン、２−アミノエタノール、８−ヒドロキシキノリン、１，１０−フェナントロリン、ｔｒａｎｓ−１，２−シクロヘキサンジアミン、ｔｒａｎｓ−Ｎ，Ｎ’−ジメチルシクロヘキサン−１，２−ジアミン、及びＮ，Ｎ’−ジメチルエチレンジアミン等が挙げられる。反応に配位子を用いる場合、化合物（Ｑ１ｃ）１モルに対して、配位子が通常０．０１〜１モルの割合で用いられる。
塩基としては、例えば、有機塩基類、アルカリ金属水素化物類、及びアルカリ金属炭酸塩類が挙げられる。反応に塩基を用いる場合、化合物（Ｑ１ｃ）１モルに対して、塩基が通常０．１〜５モルの割合で用いられる。
アルカリ金属ハロゲン化物としては、フッ化カリウム、フッ化ナトリウム、塩化リチウム、塩化ナトリウム等が挙げられる。反応にアルカリ金属ハロゲン化物を用いる場合、化合物（Ｑ１ｃ）１モルに対して、アルカリ金属ハロゲン化物が通常０．１〜５モルの割合で用いられる。
反応には、化合物（Ｑ１ｃ）１モルに対して、化合物（ＩＶ−Ｍ１）が通常１〜１０モルの割合、金属触媒が通常０．０１〜２モルの割合で用いられる。
反応温度は、通常−２０℃〜２００℃の範囲である。反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＶ−１ａ）を得ることができる。 Production method 29
Compound (IV-1a) is produced by reacting compound (IV-M1) with a compound represented by formula (Q1c) (hereinafter referred to as compound (Q1c)) in the presence of a metal catalyst and a base. be able to.

[Wherein the symbols have the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, aprotic polar solvents, water, and a mixture of two or more thereof.
As the metal catalyst used in the reaction, copper iodide (I), copper bromide (I), copper chloride (I), copper oxide (I), copper trifluoromethanesulfonate (I) benzene complex, tetrakis (acetonitrile) Examples thereof include copper catalysts such as copper (I) hexafluorophosphate and copper (I) 2-thiophenecarboxylate; nickel catalysts such as bis (cyclooctadiene) nickel (0) and nickel (II) chloride.
In the reaction, a ligand, a base, or an alkali metal halide may be used as necessary.
Examples of the ligand include triphenylphosphine, xanthophos, 2,2′-bis (diphenylphosphino) -1,1′-binaphthyl, 1,1′-bis (diphenylphosphino) ferrocene, 2-dicyclohexylphosphino- 2 ′, 4 ′, 6′-triisopropylbiphenyl, 2-dicyclohexylphosphino-2 ′, 6′-dimethoxybiphenyl, 1,2-bis (diphenylphosphino) ethane, 2,2′-bipyridine, 2-amino Examples include ethanol, 8-hydroxyquinoline, 1,10-phenanthroline, trans-1,2-cyclohexanediamine, trans-N, N′-dimethylcyclohexane-1,2-diamine, and N, N′-dimethylethylenediamine. . When using a ligand for reaction, a ligand is normally used in the ratio of 0.01-1 mol with respect to 1 mol of compounds (Q1c).
Examples of the base include organic bases, alkali metal hydrides, and alkali metal carbonates. When using a base for reaction, a base is normally used in the ratio of 0.1-5 mol with respect to 1 mol of compounds (Q1c).
Examples of the alkali metal halide include potassium fluoride, sodium fluoride, lithium chloride, sodium chloride and the like. When using an alkali metal halide for the reaction, the alkali metal halide is usually used at a ratio of 0.1 to 5 mol per 1 mol of the compound (Q1c).
In the reaction, with respect to 1 mol of compound (Q1c), compound (IV-M1) is usually used in a proportion of 1 to 10 mol, and the metal catalyst is usually used in a proportion of 0.01 to 2 mol.
The reaction temperature is usually in the range of -20 ° C to 200 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (IV-1a) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、製造法２４及び製造法２９に準じて実施することができる。 Production Method 29-1
The compound represented by the formula (IV-1a-1) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Production Method 24 and Production Method 29.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法２８に準じて実施することができる。 Production method 30
The compound represented by the formula (IV-2a) (hereinafter referred to as the compound (IV-2a)) is composed of the compound (IV-M1) and the compound represented by the formula (Q2a) (hereinafter referred to as the compound (Q2a)). Can be produced in the presence of a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 28.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法２９に準じて実施することができる。 Production method 31
Compound (IV-2a) is produced by reacting compound (IV-M1) with a compound represented by formula (Q2c) (hereinafter referred to as compound (Q2c)) in the presence of a metal catalyst and a base. be able to.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 29.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法２８に準じて実施することができる。 Production method 32
The compound represented by formula (IV-3a) (hereinafter referred to as compound (IV-3a)) is composed of compound (IV-M1) and the compound represented by formula (Q3a) (hereinafter referred to as compound (Q3a)). Can be produced in the presence of a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 28.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法２９に準じて実施することができる。 Production method 33
Compound (IV-3a) is produced by reacting compound (IV-M1) with a compound represented by formula (Q3c) (hereinafter referred to as compound (Q3c)) in the presence of a metal catalyst and a base. be able to.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 29.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法４に準じて実施することができる。 Manufacturing method 34
A compound represented by formula (V-2a) (hereinafter referred to as compound (V-2a)) is composed of a compound represented by formula (V-M2a) (hereinafter referred to as compound (V-M2a)) and a compound ( It can be produced by reacting R-1a) in the presence of a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Production Method 4.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法６に準じて実施することができる。 Production method 35
The compound represented by the formula (V-2b) (hereinafter referred to as the compound (V-2b)) is composed of the compound represented by the formula (V-M2b) (hereinafter referred to as the compound (V-M2b)) and the compound ( It can be produced by reacting R-1b) with a metal catalyst.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Production Method 6.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法１２に準じて実施することができる。
化合物（Ｒ−１ｅ）は、市販の化合物であるか、又は既知の方法に準じて製造することができる。 Production method 36
The compound represented by formula (V-2c) is composed of a compound represented by formula (V-M2c) (hereinafter referred to as compound (V-M2c)) and a compound represented by formula (R-1e) (hereinafter referred to as compound). (Denoted as (R-1e)) in the presence of a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 12.
Compound (R-1e) is a commercially available compound, or can be produced according to a known method.

Production method 37
The N oxide of the compound represented by the formula (I) can be produced by reacting the compound represented by the formula (I) with an oxidizing agent. The reaction can be carried out according to, for example, the method described in Production Method 1, US Patent Application Publication No. 2018/0009778 or International Publication No. 2016/121970.

  The production method of the production intermediate is described below.

［式中、Ｒ^aは、メチル基又はエチル基を表し、その他の記号は前記と同じ意味を表す。］
式（ＩＩＩ−９ａ−２）で示される化合物（以下、化合物（ＩＩＩ−９ａ−２）と記す）は、式（ＩＩＩ−９ａ−１）で示される化合物（以下、化合物（ＩＩＩ−９ａ−１）と記す）と化合物（Ｒ−１ａ）とを塩基の存在下で反応させることにより製造することができる。反応は、製造法４に準じて実施することができる。
化合物（ＩＩＩ−９ａ−１）は、例えば国際公開第2007/146824号に記載の方法、又は国際公開第2007/103308号に記載の方法に準じて製造することができる。 Reference manufacturing method 1
Compound (III-M8a-1) and compound (III-M8a-4) can be produced according to the following scheme.

[Wherein, R ^a represents a methyl group or an ethyl group, and other symbols represent the same meaning as described above. ]
A compound represented by formula (III-9a-2) (hereinafter referred to as compound (III-9a-2)) is a compound represented by formula (III-9a-1) (hereinafter referred to as compound (III-9a-1). )) And the compound (R-1a) in the presence of a base. The reaction can be carried out according to Production Method 4.
Compound (III-9a-1) can be produced, for example, according to the method described in International Publication No. 2007/146824 or the method described in International Publication No. 2007/103308.

Next, a method for producing a compound represented by the formula (III-9a-3) (hereinafter referred to as compound (III-9a-3)) will be described.
Compound (III-9a-3) is produced by reacting compound (III-9a-2) with a compound represented by formula (R-9) (hereinafter referred to as compound (R-9)). Can do. The reaction can be performed, for example, according to the method described in International Publication No. 2016/123253.
Compound (R-9) is publicly known or can be produced according to a publicly known method.

  A compound represented by formula (III-9a-4) (hereinafter referred to as compound (III-9a-4)) can be produced by reacting compound (III-9a-3) with an acid. The reaction can be performed, for example, according to the method described in International Publication No. 2016/123253.

  Compound (III-M8a-1) can be produced by reacting compound (III-9a-4) with a halogenating agent. The reaction can be carried out according to the method described in International Publication No. 2013/191113.

  A compound represented by formula (III-9a-5) (hereinafter referred to as compound (III-9a-5)) is obtained by reacting compound (III-M8a-1) and compound (R-8) in the presence of a base. It can be produced by reacting. The reaction can be carried out according to the method described in Tetrahedron Letters, 64, 7419 (2008).

  Compound (III-M8a-4) can be produced by reacting compound (III-9a-5) with a halogenating agent. The reaction can be carried out according to the method described in International Publication No. 2013/191113.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、参考製造法１に準じて実施することができる。
式（ＩＩＩ−９ｂ−１）で示される化合物は、国際公開第2007/146824号に記載の方法、又は国際公開第2007/103308号に記載の方法に準じて製造することができる。 Reference production method 2
Compound (III-M8b-1) and compound (III-M8b-4) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Reference Production Method 1.
The compound represented by the formula (III-9b-1) can be produced according to the method described in International Publication No. 2007/146824 or the method described in International Publication No. 2007/103308.

［式中、記号は前記と同じ意味を表す。］
反応は、化合物（ＩＩＩ−Ｍ２ａ）に代えて化合物（ＩＩＩ−Ｍ１ａ−１）を用い、化合物（Ｒ−２）に代えて化合物（Ｒ−１０）を用い、製造法１２に準じて実施することができる。
化合物（Ｒ−１０）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference manufacturing method 3
A compound represented by formula (III-M1a-a) (hereinafter referred to as compound (III-M1a-a)) is a compound represented by formula (III-M1a-1) (hereinafter referred to as compound (III-M1a-1). )) And a compound represented by the formula (R-10) (hereinafter referred to as compound (R-10)) in the presence of a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction should be carried out according to production method 12, using compound (III-M1a-1) instead of compound (III-M2a) and compound (R-10) instead of compound (R-2). Can do.
Compound (R-10) is a commercially available compound, or can be produced using a known method.

［式中、Ｒ⁵¹は、メチル基、エチル基又はベンジル基を表し、その他の記号は前記と同じ意味を表す。］
式（ＩＩＩ−Ｍ１ａ−２）で示される化合物（以下、化合物（ＩＩＩ−Ｍ１ａ−２）と記す）は、式（ＩＩＩ−Ｍ１ａ−３）で示される化合物（以下、化合物（ＩＩＩ−Ｍ１ａ−３）と記す）と式（Ｒ−１１）で示される化合物（以下、化合物（Ｒ−１１）と記す）とを塩基の存在下で反応させることにより製造することができる。反応は、製造法４に準じて実施することができる。
化合物（ＩＩＩ−Ｍ１ａ−１）は、化合物（ＩＩＩ−Ｍ１ａ−２）と酸とを反応させることにより製造することができる。反応は、例えば国際公開第2016/052455号に記載の方法に準じて実施することができる。
化合物（Ｒ−１１）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference manufacturing method 4
Compound (III-M1a-1) can be produced according to the following scheme.

[Wherein, R ⁵¹ represents a methyl group, an ethyl group or a benzyl group, and other symbols have the same meaning as described above. ]
A compound represented by formula (III-M1a-2) (hereinafter referred to as compound (III-M1a-2)) is a compound represented by formula (III-M1a-3) (hereinafter referred to as compound (III-M1a-3). )) And a compound represented by the formula (R-11) (hereinafter referred to as compound (R-11)) in the presence of a base. The reaction can be carried out according to Production Method 4.
Compound (III-M1a-1) can be produced by reacting compound (III-M1a-2) with an acid. The reaction can be performed, for example, according to the method described in International Publication No. 2016/052455.
Compound (R-11) is a commercially available compound, or can be produced using a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、化合物（ＩＩＩ−Ｍ１ａ）に代えて化合物（Ｑ１ｂ）を用い、化合物（Ｒ−１ｂ）に代えて化合物（Ｒ−１２）を用い、製造法６に準じて実施することができる。
化合物（Ｒ−１２）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference production method 5
A compound represented by formula (III-Q1a-1) (hereinafter referred to as compound (III-Q1a-1)) is a compound represented by formula (R-12) (hereinafter referred to as compound (R-12)). And a compound represented by formula (Q1b) (hereinafter referred to as compound (Q1b)) in the presence of a metal catalyst.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to production method 6, using compound (Q1b) in place of compound (III-M1a) and using compound (R-12) in place of compound (R-1b).
Compound (R-12) is a commercially available compound, or can be produced using a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、化合物（ＩＩＩ−Ｍ１ａ）に代えて化合物（Ｑ２ｂ）、化合物（Ｒ−１ｂ）に代えて化合物（Ｒ−１２）を用い、製造法６に準じて実施することができる。 Reference manufacturing method 6
The compound represented by the formula (III-Q2a-1) (hereinafter referred to as the compound (III-Q2a-1)) is composed of the compound (R-12) and the compound represented by the formula (Q2b) (hereinafter referred to as the compound (Q2b)). ))) In the presence of a metal catalyst.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to production method 6, using compound (Q2b) instead of compound (III-M1a) and compound (R-12) instead of compound (R-1b).

［式中、の記号は前記と同じ意味を表す。］
反応は、化合物（ＩＩＩ−Ｍ１ａ）に代えて化合物（Ｑ３ｂ）、化合物（Ｒ−１ｂ）に代えて化合物（Ｒ−１２）を用い、製造法６に準じて実施することができる。 Reference manufacturing method 7
The compound represented by the formula (III-Q3a-1) (hereinafter referred to as the compound (III-Q3a-1)) is composed of the compound (R-12) and the compound represented by the formula (Q3b) (hereinafter referred to as the compound (Q3b)). ))) In the presence of a metal catalyst.

[In the formula, the symbol represents the same meaning as described above. ]
The reaction can be carried out according to production method 6, using compound (Q3b) instead of compound (III-M1a) and compound (R-12) instead of compound (R-1b).

［式中、記号は前記と同じ意味を表す。］
反応は、参考製造法３に準じて実施することができる。 Reference production method 8
Compound (III-M1b) is a compound represented by formula (III-M1b-1) (hereinafter referred to as compound (III-M1b-1)) and compound (R-10) in the presence of a base. It can be produced by reacting.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Reference Production Method 3.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、参考製造法４に準じて実施することができる。 Reference manufacturing method 9
Compound (III-M1b-1) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Reference Production Method 4.

［式中、記号は前記と同じ意味を表す。］
反応は、参考製造法５に準じて実施することができる。
化合物（Ｒ−１３）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference production method 10
The compound represented by the formula (III-Q1a-2) is obtained by reacting the compound represented by the formula (R-13) (hereinafter referred to as the compound (R-13)) and the compound (Q1b) in the presence of a metal catalyst. Can be manufactured.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Reference Production Method 5.
Compound (R-13) is a commercially available compound, or can be produced using a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、参考製造法５に準じて実施することができる。 Reference production method 11
The compound represented by the formula (III-Q2a-2) can be produced by reacting the compound (R-13) and the compound (Q2b) in the presence of a metal catalyst.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Reference Production Method 5.

［式中、記号は前記と同じ意味を表す。］
反応は、参考製造法５に準じて実施することができる。 Reference production method 12
The compound represented by the formula (III-Q3a-2) can be produced by reacting the compound (R-13) and the compound (Q3b) in the presence of a metal catalyst.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Reference Production Method 5.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、参考製造法４に準じて実施することができる。 Reference production method 13
Compound (III-M2a) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Reference Production Method 4.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、参考製造法４に準じて実施することができる。 Reference production method 14
Compound (III-M2b) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Reference Production Method 4.

［式中、記号は前記と同じ意味を表す。］
反応は、化合物（Ｒ−１ｄ）に代えてドライアイスを用い、製造法１０に準じて実施することができる。 Reference production method 15
Compound (III-M3a) can be produced by reacting compound (III-M1a) with dry ice in the presence of a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to production method 10, using dry ice instead of compound (R-1d).

［式中、記号は前記と同じ意味を表す。］
反応は、化合物（Ｒ−１ｄ）に代えてドライアイスを用い、製造法１０に準じて実施することができる。 Reference production method 16
Compound (III-M3b) can be produced by reacting compound (III-M1b) with dry ice in the presence of a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to production method 10, using dry ice instead of compound (R-1d).

［式中、記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、脂肪族炭化水素類、芳香族炭化水素類、アルコール類、及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる還元剤としては、水素化ホウ素ナトリウム、水素化ホウ素リチウム、水素化アルミニウムリチウム、水素化ジイソブチルアルミニウム等が挙げられる。
反応には、化合物（ＩＩＩ−Ｍ３ａ）１モルに対して、還元剤が通常１〜５モルの割合で用いられる。
反応の反応温度は、通常−２０〜１２０℃の範囲である。反応の反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（ＩＩＩ−Ｍ４ａ）を得ることができる。 Reference production method 17
Compound (III-M4a) can be produced by reacting compound (III-M3a) with a reducing agent.

[Wherein the symbols have the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, aliphatic hydrocarbons, aromatic hydrocarbons, alcohols, and mixtures of two or more thereof.
Examples of the reducing agent used in the reaction include sodium borohydride, lithium borohydride, lithium aluminum hydride, diisobutylaluminum hydride and the like.
In the reaction, the reducing agent is usually used at a ratio of 1 to 5 mol with respect to 1 mol of the compound (III-M3a).
The reaction temperature is usually in the range of -20 to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (III-M4a) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、参考製造法１７に準じて実施することができる。 Reference production method 18
Compound (III-M4b) can be produced by reacting compound (III-M3b) with a reducing agent.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Reference Production Method 17.

［式中、記号は前記と同じ意味を表す。］
式（ＩＩＩ−Ｍ５ａ−１）で示される化合物（以下、化合物（ＩＩＩ−Ｍ５ａ−１）と記す）は、化合物（ＩＩＩ−Ｍ１ａ−３）に代えて化合物（ＩＩＩ−Ｍ１ａ）を用い、化合物（Ｒ−１１）に代えてｐ−メトキシベンジルアミンを用い、参考製造法４に準じて製造することができる。
化合物（ＩＩＩ−Ｍ５ａ）は、化合物（ＩＩＩ−Ｍ１ａ−２）に代えて化合物（ＩＩＩ−Ｍ５ａ−１）を用い、参考製造法４に準じて製造することができる。 Reference production method 19
Compound (III-M5a) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
The compound represented by the formula (III-M5a-1) (hereinafter referred to as the compound (III-M5a-1)) was obtained by using the compound (III-M1a) instead of the compound (III-M1a-3), In place of R-11), p-methoxybenzylamine can be used and the compound can be produced according to Reference Production Method 4.
Compound (III-M5a) can be produced according to Reference Production Method 4 using compound (III-M5a-1) in place of compound (III-M1a-2).

［式中、記号は前記と同じ意味を表す。］
これらの反応は、参考製造法１９に準じて実施することができる。 Reference production method 20
Compound (III-M5b) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Reference Production Method 19.

［式中、記号は前記と同じ意味を表す。］
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、芳香族炭化水素類、非プロトン性極性溶媒類、及びこれらの２種類以上の混合物が挙げられる。
パラジウム触媒としては、アリルパラジウム（ＩＩ）クロリド等が挙げられる。
反応には、化合物（ＩＩＩ−Ｍ１ａ）１モルに対して、化合物（Ｒ−１４）が、通常１〜１０モルの割合、パラジウム触媒が、通常０．０１〜１モルの割合、フェノールが、通常１〜５モルの割合、カリウムｔｅｒｔ−ブトキシドが、通常０．１〜１０モルの割合で用いられる。
反応温度は、通常４０℃〜１８０℃の範囲である。反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（ＩＩＩ−Ｍ６ａ）を得ることができる。
化合物（Ｒ−１４）は、市販の化合物であるか、又は公知の方法に準じて製造することができる。 Reference manufacturing method 21
Compound (III-M6a) is obtained by combining compound (III-M1a) with a compound represented by formula (R-14) (hereinafter referred to as compound (R-14)), which is composed of a palladium catalyst, phenol and potassium tert-butoxide. It can manufacture by making it react in presence.

[Wherein the symbols have the same meaning as described above. ]
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, aprotic polar solvents, and a mixture of two or more thereof.
Examples of the palladium catalyst include allyl palladium (II) chloride.
In the reaction, with respect to 1 mol of compound (III-M1a), compound (R-14) is usually in a proportion of 1 to 10 mol, palladium catalyst is usually in a proportion of 0.01 to 1 mol, and phenol is usually in a proportion. A proportion of 1 to 5 mol, potassium tert-butoxide is usually used in a proportion of 0.1 to 10 mol.
The reaction temperature is usually in the range of 40 ° C to 180 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (III-M6a) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
Compound (R-14) is a commercially available compound, or can be produced according to a known method.

［式中、記号は前記と同じ意味を表す。］
反応は、参考製造法２１に準じて実施することができる。 Reference manufacturing method 22
Compound (III-M6b) can be produced by reacting compound (III-M1b) with compound (R-14) in the presence of a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Reference Production Method 21.

［式中、記号は前記と同じ意味を表す。］
はじめに、式（ＩＩＩ−Ｍ７ａ−１）で示される化合物（以下、化合物（ＩＩＩ−Ｍ７ａ−１）と記す）の製造法について記す。
化合物（ＩＩＩ−Ｍ７ａ−１）は、化合物（ＩＩＩ−Ｍ１ａ）とチオ安息香酸とを銅触媒及び塩基の存在下で反応させることにより製造することができる。
反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類、芳香族炭化水素類、非プロトン性極性溶媒類、水及びこれらの２種類以上の混合物が挙げられる。
反応に用いられる銅触媒としては、塩化銅（Ｉ）、臭化銅（Ｉ）、及びヨウ化銅（Ｉ）等が挙げられる。
反応に用いられる塩基としては、例えばアルカリ金属水素化物類、アルカリ金属炭酸塩類、及び有機塩基類が挙げられる。
反応には必要に応じて、配位子を用いてもよい。配位子としては、２，２’−ビピリジン、２−アミノエタノール、８−ヒドロキシキノリン、及び１，１０−フェナントロリン等が挙げられる。反応に配位子を用いる場合、化合物（ＩＩＩ−Ｍ１ａ）１モルに対して、配位子が通常０．０１〜１モルの割合で用いられる。
反応には、化合物（ＩＩＩ−Ｍ１ａ）１モルに対して、チオ安息香酸が通常１〜１０モルの割合、銅触媒が通常０．０１〜０．５モルの割合、塩基が通常０．１〜５モルの割合で用いられる。
反応温度は、通常−２０℃〜２００℃の範囲である。反応時間は通常０．１〜２４時間の範囲である。
反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＩＩ−Ｍ７ａ−１）を得ることができる。 Reference production method 23
Compound (III-M7a) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
First, a method for producing a compound represented by the formula (III-M7a-1) (hereinafter referred to as compound (III-M7a-1)) will be described.
Compound (III-M7a-1) can be produced by reacting compound (III-M1a) with thiobenzoic acid in the presence of a copper catalyst and a base.
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include ethers, aromatic hydrocarbons, aprotic polar solvents, water, and a mixture of two or more thereof.
Examples of the copper catalyst used in the reaction include copper (I) chloride, copper (I) bromide, and copper (I) iodide.
Examples of the base used in the reaction include alkali metal hydrides, alkali metal carbonates, and organic bases.
You may use a ligand for reaction as needed. Examples of the ligand include 2,2′-bipyridine, 2-aminoethanol, 8-hydroxyquinoline, 1,10-phenanthroline, and the like. When using a ligand for reaction, a ligand is normally used in the ratio of 0.01-1 mol with respect to 1 mol of compounds (III-M1a).
In the reaction, with respect to 1 mol of compound (III-M1a), thiobenzoic acid is usually in a proportion of 1 to 10 mol, copper catalyst is usually in a proportion of 0.01 to 0.5 mol, and base is usually in a proportion of 0.1 to 0.1 mol. Used in a proportion of 5 moles.
The reaction temperature is usually in the range of -20 ° C to 200 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, compound (III-M7a-1) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.

It continues and describes the manufacturing method of a compound (III-M7a).
Compound (III-M7a) can be produced, for example, according to the method described in International Publication No. 2011/068171 or the method described in Journal of Organic Chemistry, 1978, 43 (6), 1190-1192.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、参考製造法２３に準じて実施することができる。 Reference production method 24
The compound represented by the formula (III-M7b) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Reference Production Method 23.

［式中、Ｘ^dはハロゲン原子を表し、その他の記号は前記と同じ意味を表す。］
これらの反応は、製造法１に準じて実施することができる。 Reference production method 25
The compound represented by the formula (Q1e) and the compound represented by the formula (Q1f) can be produced by reacting the compound represented by the formula (Q1d) with an oxidizing agent.

[Wherein, X ^d represents a halogen atom, and other symbols have the same meaning as described above. ]
These reactions can be performed according to Production Method 1.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、製造法１に準じて実施することができる。 Reference manufacturing method 26
The compound represented by the formula (Q2e) and the compound represented by the formula (Q2f) can be produced by reacting the compound represented by the formula (Q2d) with an oxidizing agent.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be performed according to Production Method 1.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、製造法１に準じて実施することができる。 Reference manufacturing method 27
The compound represented by the formula (Q3e) and the compound represented by the formula (Q3f) can be produced by reacting the compound represented by the formula (Q3d) with an oxidizing agent.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be performed according to Production Method 1.

［式中、Ｒ⁵²はメチル基、エチル基、又は水素原子を表し、その他の記号は前記と同じ意味を表す。］ Reference production method 28
The compound represented by the formula (Q1g) (hereinafter referred to as the compound (Q1g)) can be produced according to the following scheme.

[Wherein, R ⁵² represents a methyl group, an ethyl group, or a hydrogen atom, and other symbols have the same meaning as described above. ]

First, a method for producing a compound represented by the formula (Q1g-1) (hereinafter referred to as compound (Q1g-1)) will be described.
Compound (Q1g-1) can be produced by reacting a compound represented by formula (R-15) (hereinafter referred to as compound (R-15)) with compound (R-7).
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include aromatic hydrocarbons, alcohols, nitriles, and mixtures of two or more thereof.
In the reaction, compound (R-7) is usually used at a ratio of 1 to 10 mol per 1 mol of compound (R-15).
The reaction temperature is usually in the range of 0 ° C to 200 ° C. The reaction time is usually in the range of 0.1 to 48 hours.
After completion of the reaction, the compound (Q1g-1) can be obtained by performing a normal post-treatment operation.
Compound (R-15) is a commercially available compound, or can be produced using a known method.

Next, a method for producing a compound represented by the formula (Q1g-2) (hereinafter referred to as compound (Q1g-2)) will be described.
Compound (Q1g-2) can be produced by reacting compound (Q1g-1) with a compound represented by formula (R-16) (hereinafter referred to as compound (R-16)).
The reaction is usually performed in a solvent. Examples of the solvent used in the reaction include aromatic hydrocarbons, nitriles, and mixtures of two or more of these.
For the reaction, compound (R-16) is usually used at a ratio of 1 to 10 mol per 1 mol of compound (Q1g-1).
The reaction temperature is usually in the range of 60 ° C to 120 ° C. The reaction time is usually in the range of 0.1 to 48 hours.
After completion of the reaction, the compound (Q1g-2) can be obtained by performing a normal post-treatment operation.
Compound (R-16) is a commercially available compound, or can be produced using a known method.

Next, a method for producing a compound represented by the formula (Q1g-3) (hereinafter referred to as compound (Q1g-3)) will be described.
Compound (Q1g-3) can be produced by reacting compound (Q1g-2) with N-iodosuccinimide. The reaction can be carried out according to the method for producing compound (III-M8a-3) from compound (III-M8a-2) in Production Method 24.

Next, the manufacturing method of a compound (Q1g) is described.
Compound (Q1g) can be produced by reacting compound (Q1g-2) or compound (Q1g-3) with compound (R-8). These reactions can be carried out according to the method for producing compound (III-8a) from compound (III-M8a-2) or compound (III-M8a-3) in Production Method 24.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、参考製造法２８に準じて実施することができる。
式（Ｒ−１７）で示される化合物は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference production method 29
The compound represented by the formula (Q2g) (hereinafter referred to as the compound (Q2g)) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Reference Production Method 28.
The compound represented by the formula (R-17) is a commercially available compound, or can be produced using a known method.

［式中、記号は前記と同じ意味を表す。］
式（Ｑ３ｂ−２）で示される化合物（以下、化合物（Ｑ３ｂ−２）と記す）の製造法について記す。
化合物（Ｑ３ｂ−２）は、式（Ｑ３ｂ−１）で示される化合物（以下、化合物（Ｑ３ｂ−１）と記す）とＮ−ヨードスクシンイミドとを反応させることにより製造することができる。反応は、製造法２４の化合物（ＩＩＩ−Ｍ８ａ−２）から化合物（ＩＩＩ−Ｍ８ａ−３）を製造する方法に準じて実施することができる。 Reference production method 30
The compound represented by the formula (Q3g) (hereinafter referred to as the compound (Q3g)) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
A method for producing a compound represented by the formula (Q3b-2) (hereinafter referred to as compound (Q3b-2)) will be described.
Compound (Q3b-2) can be produced by reacting a compound represented by the formula (Q3b-1) (hereinafter referred to as compound (Q3b-1)) with N-iodosuccinimide. The reaction can be carried out according to the method for producing compound (III-M8a-3) from compound (III-M8a-2) in Production Method 24.

Next, the manufacturing method of a compound (Q3g) is described.
Compound (Q3g) can be produced by reacting compound (Q3b-1) or compound (Q3b-2) with compound (R-8). These reactions can be carried out according to the method for producing compound (III-8a) from compound (III-M8a-2) or compound (III-M8a-3) in Production Method 24.

［式中、記号は前記と同じ意味を表す。］
反応は、化合物（ＩＶ−Ｍ１）の代わりに化合物（ＩＶ−Ｍ２）を用い、製造法２９に準じて実施することができる。
化合物（ＩＶ−Ｍ２）は、公知であるか、Synlett, 27(1), 67, 2016.等に記載の方法に準じて製造することができる。 Reference manufacturing method 31
A compound represented by formula (IV-M3) (hereinafter referred to as compound (IV-M3)) is a compound represented by formula (IV-M2) (hereinafter referred to as compound (IV-M2)) and a compound (Q1c). ) In the presence of a metal catalyst and a base.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to production method 29, using compound (IV-M2) instead of compound (IV-M1).
Compound (IV-M2) is publicly known or can be produced according to the method described in Synlett, 27 (1), 67, 2016.

［式中、記号は前記と同じ意味を表す。］
式（ＩＶ−Ｍ５）で示される化合物（以下、化合物（ＩＶ−Ｍ５）と記す）は、式（ＩＶ−Ｍ４）で示される化合物（以下、化合物（ＩＶ−Ｍ４）と記す）と化合物（Ｒ−１１）とを塩基の存在下で反応させることにより製造することができる。
反応は、参考製造法４に準じて実施することができる。 Reference production method 32
A compound represented by the formula (IV-M5-2) (hereinafter referred to as compound (IV-M5-2)) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
A compound represented by formula (IV-M5) (hereinafter referred to as compound (IV-M5)) is composed of a compound represented by formula (IV-M4) (hereinafter referred to as compound (IV-M4)) and a compound (R -11) in the presence of a base.
The reaction can be carried out according to Reference Production Method 4.

A compound represented by formula (IV-M5-1) (hereinafter referred to as compound (IV-M5-1)) reacts compound (IV-M5) with compound (Q1c) in the presence of a metal catalyst and a base. Can be manufactured.
The reaction can be carried out according to the production method 29.

Compound (IV-M5-2) can be produced by reacting compound (IV-M5-1) with an acid.
The reaction can be carried out according to Reference Production Method 4.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法２９に準じて実施することができる。 Reference production method 33
A compound represented by formula (IV-M6) (hereinafter referred to as compound (IV-M6)) is produced by reacting compound (IV-M2) with compound (Q2c) in the presence of a metal catalyst and a base. can do.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 29.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、参考製造法３２に準じて実施することができる。 Reference manufacturing method 34
A compound represented by formula (IV-M8-2) (hereinafter referred to as compound (IV-M8-2)) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Reference Production Method 32.

［式中、記号は前記と同じ意味を表す。］
反応は、製造法２９に準じて実施することができる。 Reference production method 35
A compound represented by formula (IV-M9) (hereinafter referred to as compound (IV-M9)) is produced by reacting compound (IV-M2) with compound (Q1c) in the presence of a metal catalyst and a base. can do.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the production method 29.

［式中、記号は前記と同じ意味を表す。］
これらの反応は、参考製造法３２に準じて実施することができる。 Reference manufacturing method 37
A compound represented by the formula (IV-M11-2) (hereinafter referred to as compound (IV-M11-2)) can be produced according to the following scheme.

[Wherein the symbols have the same meaning as described above. ]
These reactions can be carried out according to Reference Production Method 32.

［式中、記号は前記と同じ意味を表す。］
反応は、例えばTetrahedron, 63, 11862 (2007) に記載の方法に準じて実施することができる。 Reference production method 38
A compound represented by the formula (III-M1a-c) (hereinafter referred to as compound (III-M1a-c)) can be produced by reacting compound (III-M1a-a) with a sulfurizing agent. .

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the method described in, for example, Tetrahedron, 63, 11862 (2007).

［式中、記号は前記と同じ意味を表す。］
反応は、参考製造法３８に準じて実施することができる。 Reference manufacturing method 39
A compound represented by the formula (III-M1b-d) (hereinafter referred to as compound (III-M1b-d)) can be produced by reacting compound (III-M1b) with a sulfurizing agent.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to Reference Production Method 38.

［式中、記号は前記と同じ意味を表す。］
反応は、例えばJournal of the American Chemical Society, 2014, 136, 3792に記載の方法に準じて実施することができる。 Reference manufacturing method 40
The compound represented by formula (Q1i) (hereinafter referred to as compound (Q1i)) can be produced by reacting the compound represented by formula (Q1h) with silver fluoride in the presence of a metal catalyst.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the method described in Journal of the American Chemical Society, 2014, 136, 3792, for example.

［式中、記号は前記と同じ意味を表す。］
反応は、例えばJournal of the American Chemical Society, 2002, 124, 14844に記載の方法に準じて実施することができる。 Reference production method 41
A compound represented by formula (Q1j) (hereinafter referred to as compound (Q1j)) can be produced by reacting compound (Q1h) with sodium iodide in the presence of a metal catalyst.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the method described in Journal of the American Chemical Society, 2002, 124, 14844, for example.

［式中、記号は前記と同じ意味を表す。］
反応は、例えばJournal of the American Chemical Society, 2014, 136, 3792に記載の方法に準じて実施することができる。 Reference production method 42
A compound represented by formula (Q2i) (hereinafter referred to as compound (Q2i)) is obtained by combining a compound represented by formula (Q2h) (hereinafter referred to as compound (Q2h)) and silver fluoride in the presence of a metal catalyst. It can be produced by reacting.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the method described in Journal of the American Chemical Society, 2014, 136, 3792, for example.

［式中、記号は前記と同じ意味を表す。］
反応は、例えばJournal of the American Chemical Society, 2002, 124, 14844に記載の方法に準じて実施することができる。 Reference production method 43
A compound represented by formula (Q2j) (hereinafter referred to as compound (Q2j)) can be produced by reacting compound (Q2h) with sodium iodide in the presence of a metal catalyst.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the method described in Journal of the American Chemical Society, 2002, 124, 14844, for example.

［式中、記号は前記と同じ意味を表す。］
反応は、例えばJournal of the American Chemical Society, 2014, 136, 3792に記載の方法に準じて実施することができる。 Reference production method 44
A compound represented by formula (Q3i) (hereinafter referred to as compound (Q3i)) is obtained by combining a compound represented by formula (Q3h) (hereinafter referred to as compound (Q3h)) and silver fluoride in the presence of a metal catalyst. It can be produced by reacting.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the method described in Journal of the American Chemical Society, 2014, 136, 3792, for example.

［式中、記号は前記と同じ意味を表す。］
反応は、例えばJournal of the American Chemical Society, 2002, 124, 14844に記載の方法に準じて実施することができる。 Reference manufacturing method 45
The compound represented by the formula (Q3j) (hereinafter referred to as the compound (Q3j)) can be produced by reacting the compound (Q3h) with sodium iodide in the presence of a metal catalyst.

[Wherein the symbols have the same meaning as described above. ]
The reaction can be carried out according to the method described in Journal of the American Chemical Society, 2002, 124, 14844, for example.

This compound comprises the following groups (a), (b), (c), (d), (e), (f), (g), (h), (i) and One or more components selected from the group consisting of group (j) (hereinafter referred to as this component) can be used in combination or in combination.
The mixed or combined means that the present compound and the present component are used simultaneously, separately or at intervals.
When using this compound and this component simultaneously, this compound and this component may be contained in the respectively separate formulation, and may be contained in one formulation.
One aspect of the present invention includes a group (a), a group (b), a group (c), a group (d), a group (e), a group (f), a group (g), a group (h), a group ( It is a composition (hereinafter referred to as composition A) containing at least one component selected from the group consisting of i) and group (j) and this compound.

  Group (a) includes acetylcholinesterase inhibitors (eg carbamate insecticides, organophosphorus insecticides), GABAergic chloride channel blockers (eg phenylpyrazole insecticides), sodium channel modulators (eg pyrethroid insecticides) ), Nicotinic acetylcholine receptor competitive modulators (eg neonicotinoid insecticides), nicotinic acetylcholine receptor allosteric modulators, glutamatergic chloride channel allosteric modulators (eg macrolide insecticides), juvenile hormones Mimic, multi-site inhibitor, string sound organ TRPV channel modulator, mite growth inhibitor, mitochondrial ATP synthase inhibitor, oxidative phosphorylation uncoupler, nicotinic acetylcholine receptor cha Lublockers (eg nereistoxin insecticides), chitin synthesis inhibitors, molting inhibitors, ecdysone receptor agonists, octopamine receptor agonists, inhibitors of mitochondrial electron transport complex I, II, III and IV, potential It is a group consisting of an independent sodium channel blocker, an acetyl CoA carboxylase inhibitor, a ryanodine receptor modulator (eg, a diamide insecticide), a chordal organ modulator, and other insecticidal / acaricidal / nematicidal active ingredients. These are described in the classification based on the mechanism of action of IRAC.

  Group (b) includes nucleic acid synthesis inhibitors (eg, phenylamide fungicides, acylamino acid fungicides), cell division and cytoskeleton inhibitors (eg, MBC fungicides), respiratory inhibitors (eg, QoI fungicides) , QiI fungicides), amino acid synthesis and protein synthesis inhibitors (eg, anilinopyridine fungicides), signal transduction inhibitors, lipid synthesis and membrane synthesis inhibitors, sterol biosynthesis inhibitors (eg, triazoles) Bactericides), cell wall synthesis inhibitors, melanin synthesis inhibitors, plant defense inducers, multi-acting contact active bactericides, microbial bactericides, and other bactericidal active ingredients. These are described in the classification based on the mechanism of action of FRAC.

  Group (c) is a group of plant growth regulating components.

  Group (d) is a group of phytotoxicity reducing components.

  Group (e) is a group of synergists.

  Group (f) is a group of repellent components comprising bird repellent components, insect repellent components and animal repellent components.

  Group (g) is a group of molluscicidal components.

  Group (h) is a group of insect pheromones.

  Group (i) includes acetyl-CoA carboxylase (ACCase) inhibitor, acetolactate synthase (ALS) inhibitor, photosynthesis (photosystem II) inhibitor, photosystem I electron conversion agent, protoporphyrinogen oxidase (PPO) Inhibitor, phytoene desaturase system (PDS) inhibitor, 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) inhibitor, carotenoid biosynthesis inhibitor, EPSP synthase inhibitor, glutamine synthetase inhibitor, dihydroptero Inacid (DHP) synthase inhibitor, microtubule polymerization inhibitor, mitosis / microtubule formation inhibitor, inhibitor of very long chain fatty acid (VLCFA), cellulose synthesis inhibitor, uncoupling agent, lipid synthesis inhibitor , An indole acetic acid-like active agent, an auxin transfer inhibitor, and other herbicidal active ingredients. These are described in the classification based on the mechanism of action of HRAC.

  Group (j) is a microorganism having a pest control effect (for example, insecticidal activity, acaricidal activity, nematicidal activity, bactericidal activity, herbicidal activity, etc.) or a plant growth regulating effect such as rhizobia or mycorrhizal fungi A group of materials.

Below, the example of the combination of this component and this compound is described. For example, alanycarb + SX means a combination of alanycarb and SX.
The abbreviation SX means any one of the present compounds selected from the compound groups SX1 to SX2496. In addition, all of the components described below are known components, and can be obtained from commercially available preparations or produced by known methods. If this component is a microorganism, it can also be obtained from a fungus depository. The numbers in parentheses represent CAS RN (registered trademark).

Combination of this component of the above group (a) and this compound:
Abamectin + SX, acephate + SX, acequinocyl + SX, acetamiprid + SX, acetoprole + SX, acrinathrin + SX, acinathyr + acynonapyr Afidopyropen + SX, afoxolaner + SX, alanycarb + SX, aldicarb + SX, allethrin + SX, alpha-cypermethrin + SX, alpha endosulfan (alpha) -endosulfan) + SX, aluminum phosphide + SX, amitraz + SX, azadirachtin + SX, azamethiphos + SX, azinphos-ethyl + SX, azinphos- methyl) + SX, azocyclotin + SX, Celastrus angulatus bark of bark of Celastrus angulatus + SX, bendiocarb + SX, benful Benfluthrin + SX, benfuracarb + SX, bensultap + SX, benzoximate + SX, benzpyrimoxan + SX, beta-cyfluthrin + SX , Beta-cypermethrin + SX, bifenazate + SX, bifenthrin + SX, bioallethrin + SX, bioresmethrin + SX, bistrifluron + SX , Borax + SX, boric acid + SX, broflanilide + SX, bromopropylate + SX, buprofezin + SX, butocarboxim + SX, Butoxycarboxim + SX, cadusafos + SX, calcium phosphide + SX, carbaryl + SX, carbofuran + SX, carbosulfan + SX, L-tap hydrochloride + SX, cartap + SX, chinomethionat + SX, chlorantraniliprole + SX, chlordane + SX, chlorethoxyfos + SX, chlorfenapyr (chlorfenapyr) + SX, chlorfenvinphos + SX, chlorfluazuron + SX, chlormephos + SX, chlorpicrin + SX, chlorpyrifos + SX, chlorpyrifos methyl ( chlorpyrifos-methyl) + SX, chromafenozide + SX, clofentezine + SX, clothianidin + SX, concanamycin A + SX, coumaphos + SX, cryolite ( cryolite) + SX, cyanophos + SX, cyanantaniprole + SX, cycloniliprole + SX, siku Cycloprothrin + SX, cycloxaprid + SX, cyenopyrafen + SX, cyflumetofen + SX, cyfluthrin + SX, cyhalodiamide + SX, cyhalothrin + cySX (cyhexatin) + SX, cypermethrin + SX, cyphenothrin + SX, cyromazine + SX, dazomet + SX, deltamethrin + SX, demeton-S-methyl (demeton) -S-methyl) + SX, diafenthiuron + SX, diazinon + SX, dichlorvos + SX, dicloromezotiaz + SX, dicohol + SX, dicrotophos (dicrotophos) + SX, diflovidazin + SX, diflubenzuron + SX, dimefluthrin + SX, dimethoate + SX, dimethylbinphos ( dimethylvinphos) + SX, dimpropyridaz + SX, dinotefuran + SX, disodium octaborate + SX, disulfoton + SX, DNOC (2-methyl-4,6-dinitrophenol) + SX, Doramectin + SX, dried leaves of Dryopteris filix-mas + SX, emamectin benzoate + SX, empenthrin + SX, endosulfan + SX, EPN (O-ethyl O- (4-nitrophenyl) phenylphosphonothioate) + SX, epsilon-metofluthrin + SX, epsilon-momfluorothrin + SX, esfenvalerate + SX, ethiophene carb (ethiofencarb) + SX, ethion + SX, ethiprole + SX, ethoprophos + SX, etofenprox + SX, etoxazole + SX, extract of Artemis ia absinthium) + SX, Cassia nigricans extract (extract of Cassia nigricans) + SX, extract of clitoria ternatea + SX, extract of Symphytum officinale + SX, extract of Alitalia extracts or simulated blend of Chenopodium ambrosioides) + SX, extract of Tanacetum vulgare + SX, extract of Urtica dioica + SX, extract of Viscum album + SX, fanfull (famphur) + SX, fenamiphos + SX, fenazaquin + SX, fenbutatin oxide + SX, fenitrothion + SX, fenobucarb + SX, fenoxycarb + SX , Fenpropathrin + SX, fenpyroximate + SX, fenthion + SX, fenvalerate + SX, fipronil + SX, Metequin (flometoquin) + SX, flonicamid + SX, fluacrypyrim + SX, fluazaindolizine + SX, fluazuron + SX, flubendiamide + SX, full cycloxuron (flucycloxuron) + SX, flucythrinate + SX, fluensulfone + SX, flufenprox + SX, flufenoxuron + SX, flufiprole + SX, Flumethrin + SX, Flupyradifurone + SX, Flupyrimin + SX, Fluralaner + SX, Fluvalinate + SX, Fluxametamide + SX, Formetanate + SX, Fosthiazate + SX, furamethrin + SX, furathiocarb + SX, gamma-cyhalothrin + SX, GS- Mega / Kappa HXTX-Hv1a peptide (GS-omega / kappa HXTX-Hv1a peptide) + SX, Halfenprox + SX, halofenozide + SX, heptafluthrin + SX, heptenophos + SX, hexaflumuron + SX, hexythiazox + SX, potassium salt of hop beta acid + SX, hydramethylnon + SX, hydroprene + SX, imicyafos + SX, imidacloprid + SX, imidaclothiz + SX, imiprothrin + SX, indoxacarb + SX, isocycloseram + SX, isofenphos isofenphos) + SX, isoprocarb + SX, isopropyl O- (methoxyaminothiophosphoryl) salicylate + SX, isoxa On (isoxathion) + SX, ivermectin + SX, kadethrin + SX, kappa-tefluthrin + SX, kappa-bifenthrin + SX, kinoprene + SX, lamb Lambda-cyhalothrin + SX, lenoremycin + SX, lepimectin + SX, lime sulfur + SX, lotilaner + SX, lufenuron + SX, Machine oil + SX, malathion + SX, mecarbam + SX, meperfluthrin + SX, metaflumizone + SX, metam + SX, metamidophos + SX , Methidathion + SX, methiocarb + SX, metomyl + SX, metoprene + SX, methoxychlor + SX, methoxyfenozide + SX, methyl bromide + SX, me Tofluthrin + SX, metolcarb + SX, metoxadiazone + SX, mevinphos + SX, milbemectin + SX, milbemycin oxime + SX, monfluorothrin + SX, monocrotophos + SX, moxidectin + SX, nared + SX, neem oil + SX, nicotine + SX, nicotine-sulfate + SX , Nitenpyram + SX, novaluron + SX, noviflumuron + SX, oil of the seeds of Chenopodium anthelminticum + SX, omethoate + SX, oxamyl + SX, oxazosulfyl + SX, oxydemeton-methyl + SX, parathion + SX, parathion-methyl + SX, permethrin + SX, phenothrin + SX, phenthoate + SX, phorate + SX, phosalone + SX, phosmet + SX, phosphamidon + SX, phosphine + SX , Phoxim + SX, pirimicarb + SX, pirimiphos-methyl + SX, prallethrin + SX, profenfos + SX, profluthrin + SX, propargite + SX, propetamphos + SX, propoxur + SX, propylene glycol alginate + SX, prothiofos + SX, pyflubumide + SX, pimetrozine + SX, pyracrophos (pyraclofos) + SX, pyrethrin (pyrethrins) + SX, pyridaben (SX) (pyrifluquinazone) + SX, pyrimidifen + SX, pyriminostrobin + SX, pyriprole + SX, pyriproxyfen + SX, quinalphos + SX, resmethrin + SX, rotenone + SX, ryanodine + SX, sarolaner + SX, selamectin + SX, sigma-cypermethrin + SX, silafluofen + SX, boro Sodium borate + SX, sodium metaborate + SX, spinetoram + SX, spinosad + SX, spirodiclofen + SX, spiromesifen + SX , Spiropidion + SX, spirotetramat + SX, sulfluramid + SX, sulfotep + SX, sulfoxaflor + SX, sulfur + SX, Sulfuryl fluoride + SX, tartar emetic + SX, tau-fluvalinate + SX, tebufenozide + SX, tebufenpyrad + SX, tebupirimfos +
SX, teflubenzuron + SX, tefluthrin + SX, temephos + SX, terbufos + SX, terpene constituents of the extract of chenopodium ambrosioides, near ambrosioides, brand name : Terpenoid blend QRD 460) + SX, tetrachlorantraniliprole + SX, tetrachlorvinphos + SX, tetradifon + SX, tetramethrin + SX, tetramethylfurthrin ( tetramethylfluthrin) + SX, tetraniliprole + SX, theta-cypermethrin + SX, thiacloprid + SX, thiamethoxam + SX, thiocyclam + SX, thiodicarb + SX, thiofanox + SX, thiometon + SX, thiosultap-disodiu m) + SX, thiosultap-monosodium + SX, tioxazafen + SX, tolfenpyrad + SX, tralomethrin + SX, transfluthrin + SX, triazamate ) + SX, triazophos + SX, trichlorfon + SX, triflumezopyrim + SX, triflumuron + SX, trimethacarb + SX, tyclopyrazoflor + tyclopyrazoflor , Bamidothion + SX, wood extract of Quassia amara + SX, XMC (3,5-dimethylphenyl N-methylcarbamate) + SX, xylylcarb + SX, zeta-cypermethrin (zeta- cypermethrin) + SX, zinc phosphide + SX, N- [3-chloro-1- (pyridin-3-yl) -1H-pyrazol-4-yl] -N-ethyl-3- (3, 3,3-trifluoropropanesulfinyl) propanamide (1477923-37-7) + SX, 4- [5- (3,5-dichloroph enyl) -5- (trifluoromethyl) -4,5-dihydro-1,2-oxazol-3-yl] -2-methyl-N- (1-oxothietan-3-yl) benzamide (1241050-20-3) + SX, 3-methoxy-N- (5- {5- (trifluoromethyl) -5- [3- (trifluoromethyl) phenyl] -4,5-dihydro-1,2-oxazol-3-yl} indan-1-yl ) propanamide (1118626-57-5) + SX, N- [2-bromo-6-chloro-4- (1,1,1,2,3,3,3-heptafluoropropan-2-yl) phenyl] -3 -{ethyl [(pyridin-4-yl) carbonyl] amino} -2-methoxybenzamide (1429513-53-0) + SX, N- [2-bromo-6-chloro-4- (1,1,1,2) , 3,3,3-heptafluoropropan-2-yl) phenyl] -3- [ethyl (4-cyanobenzoyl) amino] -2-methoxybenzamide (1609007-65-9) + SX, N- [2-bromo-6- (difluoromethoxy) -4- (1,1,1,2,3,3,3-heptafluoropropan-2-yl) phenyl] -3- {methyl [(pyridin-4-yl) carbonyl] amino} -2-methoxybenzamide (1630969-78-6) + SX, 1- {2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl) sulfanyl] phenyl} -3- (trifluoromethyl) -1H-1,2, 4-triazol-5-amine (885026-50-6) + SX.

Combination of this component of the above group (b) and this compound:
Acibenzolar-S-methyl + SX, aldimorph + SX, ametoctradin + SX, aminopyrifen + SX, amisulbrom + SX, anilazine + SX, Azaconazole + SX, azoxystrobin + SX, basic copper sulfate + SX, benalaxyl + SX, benalaxyl-M + SX, benodanil + SX, benomyl + SX, benthiavalicarb + SX, benthivalicarb-isopropyl + SX, benzovindiflupyr + SX, binapacryl + SX, Biphenyl + SX, bitertanol + SX, bixafen + SX, blasticidin-S + SX, Bordeaux mixture + SX, boscalid + SX, bromotalonyl ( b romothalonil) + SX, bromuconazole + SX, bupirimate + SX, captafol + SX, captan + SX, carbendazim + SX, carboxin + SX, carpropamid + SX, chinomethionat + SX, chitin + SX, chloroneb + SX, chlorothalonil + SX, chlozolinate + SX, collochlorin B (colltochlorin B) ) + SX, copper (II) acetate + SX, copper (II) hydroxide + SX, copper oxychloride + SX, copper sulfate (II) ) (copper (II) sulfate) + SX, coumoxystrobin + SX, cyazofamid + SX, cyflufenamid + SX, cymoxanil + SX, cyproconazole + SX , Cyprodinil + SX, Diclobentiazox ) + SX, dichlofluanid + SX, dilocymet + SX, diclomezine + SX, dicloran + SX, dietofencarb + SX, difenoconazole + SX, difenoconazole diflumetorim) + SX, dimethachlone + SX, dimethirimol + SX, dimethomorph + SX, dimoxystrobin + SX, diniconazole + SX, diiconazole-M + SX, dinocap + SX, dipotassium hydrogenphosphite + SX, dipymetitrone + SX, dithianon + SX, dodecylbenzenesulphonic dodecylbenzenesulphonic acid (dodecylbenzenesulphonic) acid bisethylenediamine copper (II) salt) + SX, dodemorph + SX, dodine + SX, edifenphos + SX, e Xenostrobin + SX, epoxiconazole + SX, etaconazole + SX, ethaboxam + SX, ethirimol + SX, etridiazole + SX, tea tree extract from Melaleuca alternifolia) + SX, extract of reedoutria sachalinensis + SX, extract from cotyledons of lupine plantlets ("BLAD") + SX, extract of garlic Allium sativum) + SX, extract of Equisetum arvense + SX, extract of Tropaeolum majus + SX, famoxadone + SX, fenamidone + SX, fenaminstrobin ) + SX, fenarimol + SX, fenbuconazole + SX, fenfuram + SX, fenhexamid + SX, phenoxa Fenoxanil + SX, fenpiclonil + SX, fenpicoxamid + SX, fenpropidin + SX, fenpropimorph + SX, fenpyrazamine + SX, acetic acid Fentin acetate + SX, fentin chloride + SX, fentin hydroxide + SX, ferbam + SX, ferimzone + SX, florylpico Florylpicoxamid + SX, fluazinam + SX, fludioxonil + SX, flufenoxystrobin + SX, fluindapyr + SX, flumorph + SX, fluopicolide + SX, fluopyram + SX, fluopimomide + SX, fluoroimide + SX, fluoxapiprolin + SX, fluoxastrobin + SX, fluquinconazole + SX, flusilazole + SX, flusulfamide + SX, flutianil + SX, flutolanil + SX, flutriafol + SX, full Flaxapyroxad + SX, folpet + SX, fosetyl + SX, fosetyl-aluminium + SX, fuberidazole + SX, furalaxyl + SX, furametpyr ) + SX, guazatine + SX, hexaconazole + SX, hymexazole + SX, imazalil + SX, imibenconazole + SX, iminoctadine + SX, Iminoctadine triacetate + SX, inpyrfluxam + SX, iodocarb + SX, ipconazole + SX, ipfentrifluconazo Ipfentrifluconazole + SX, ipflufenoquin + SX, iprobenfos + SX, iprodione + SX, iprovalicarb + SX, isofetamid + SX, ofluc ypram ram ) + SX, isoprothiolane + SX, isopyrazam + SX, isotianil + SX, kasugamycin + SX, kresoxim-methyl + SX, laminarin + SX, oak Leaves and bark of Quercus + SX, mancozeb + SX, mandestrobin + SX, mandipropamid + SX, maneb + SX, mefentrifluconazole + SX, mepanipyrim + SX, mepronil + SX, meptyldinocap + SX, metalaxyl + SX, metalaxyl-M + SX, metconazole + SX, methasulfocarb + SX, metiram + SX, metinominostrobin + SX, metrafenone + SX, metyltetraprole + SX, Machine oil (mineral oils) + SX, microbutanil + SX, naftifine + SX, nuarimol + SX, octhilinone + SX, ofurace + SX, orysastrobin + SX , Oxadixyl + SX, oxathiapiprolin + SX, oxine-copper + SX, oxolinic acid + SX, oxpoconazole + SX, oxpoconazole fumarate (oxpoconazole fumarate) + SX, oxycarboxin + SX, oxytetracycline + SX, pefurazoate + SX, penconazole + SX, pensic Pencycuron + SX, penflufen + SX, penthiopyrad + SX, phenamacril + SX, phosphoric acid + SX, phthalide + SX, picarbutrazoz ( picarbutrazox) + SX, picoxystrobin + SX, piperalin + SX, polyoxins + SX, potassium hydrogencarbonate + SX, potassium dihydrogenphosphite + SX, probenazole + SX, prochloraz + SX, procymidone + SX, propamidine + SX, propamocarb + SX, propiconazole + SX, propineb + SX, proquinazid + SX, prothiocarb + SX, prothioconazole + SX, pydiflumetofen + SX, pyraclostrobin (pyrac) lostrobin) + SX, pyrametostrobin + SX, pyraoxystrobin + SX, pyrapropoyne + SX, pyraziflumid + SX, pyrazophos + SX, pyribencarb + SX, pyributicarb + SX, pyridachlometyl + SX, pyrifenox + SX, pyrimethanil + SX, pyrimorph + SX, pyriophenone + SX, pyrisoxazole (SX) pyrisoxazole) + SX, pyroquilon + SX, Quillaja extract + SX, quinconazole + SX, quinofumelin + SX, quinoxyfen + SX, quintozene + SX, Saponins of Chenopodium quinoa + SX, sedaxane + SX, silthiofam + SX, simeconazole + SX, carbonated water Sodium hydrogencarbonate + SX, spiroxamine + SX, streptomycin + SX, sulfur + SX, tebuconazole + SX, tebufloquin + SX, teclofthalam + SX Tecnazene + SX, terbinafine + SX, tetraconazole + SX, thiabendazole + SX, thifluzamide + SX, thiophanate + SX, thiophanate methyl ) + SX, thiram + SX, thymol + SX, thiadinyl + SX, tolclofos-methyl + SX, tolfenpyrad + SX, tolprocarb + SX, tolyl Toluylfluanid + SX, triadimefon + SX, triadimenol + SX, triazoxide + SX, triclopyrica Triclopyricarb + SX, tricyclazole + SX, triridemorph + SX, trifloxystrobin + SX, triflumizole + SX, triforine + SX, triticonazole (triticonazole) + SX, validamycin + SX, valifenalate + SX, vinclozolin + SX, yellow mustard powder + SX, zinc thiazole + SX, zineb + SX , Ziram + SX, zoxamide + SX, 3- (difluoromethyl) -N-methoxy-1-methyl-N-[(1R) -1-methyl-2- (2,3,6-trichlorophenyl ) ethyl] -1H-pyrazole-4-carboxamide (1639015-48-7) + SX, 3- (difluoromethyl) -N-methoxy-1-methyl-N-[(1S) -1-methyl-2- (2 , 3,6-trichlorophenyl) ethyl] -1H-pyrazole-4-carboxamide (1639015-49-8) + SX, 3- (difluoromethyl) -1-methyl-N- (1,1,3-trimethyl-2, 3-dihydro-1H-inden-4-yl) -1H-pyrazole-4-carboxamide (141573-94-6) + SX, 3- (difluoromethyl) -N-[(3R) -7-fluoro-1,1 , 3-trimethyl-2,3-dihydro-1H-inden-4-yl] -1-methyl-1H-pyrazole-4-carboxamide (1513466-73-3) + SX, N '-[4-({3 -[(4-chlorophenyl) methyl] -1,2,4-thiadiazol-5-yl} oxy)
-2,5-dimethylphenyl] -N-ethyl-N-methylmethanimidamide (1202781-91-6) + SX, 4- (2-bromo-4-fluorophenyl) -N- (2-chloro-6-fluorophenyl) -1 , 3-dimethyl-1H-pyrazol-5-amine (1362477-26-6) + SX, 2- [6- (3-fluoro-4-methoxyphenyl) -5-methylpyridin-2-yl] quinazoline (1257056-97 -5) + SX, 5-fluoro-2-[(4-methylphenyl) methoxy] pyrimidin-4-amine (1174376-25-0) + SX, 5-fluoro-4-imino-3-methyl-1-tosyl -3,4-dihydropyrimidin-2 (1H) -one (1616664-98-2) + SX, N '-(2,5-dimethyl-4-phenoxyphenyl) -N-ethyl-N-methylmethanimidamide (1052688-31- 9) + SX, N '-{4-[(4,5-dichlorothiazol-2-yl) oxy] -2,5-dimethylphenyl} -N-ethyl-N-methylmethanimidamide (929908-57-6) + SX, ethyl (2Z) -3-amino-2-cyano-3-phenylacrylate (39491-78-6) + SX, N-[(2-chlorothiazol-5-yl) methyl] -N-ethyl-6-methoxy-3 -nitropyridin-2-amine (1446247-98-8) + SX, α- [3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1,2-oxazol-4-yl ] -3-pyridinemethanol (1229605-96-2) + SX, (αS)-[3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1,2-oxazol-4- yl] -3-pyridinemethanol (1229606-4 6-5) + SX, (αR)-[3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1,2-oxazol-4-yl] -3-pyridinemethanol (1229606 -02-3) + SX, 2-{[3- (2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran-2-yl] methyl} -2,4-dihydro-3H-1,2, 4-triazole-3-thione (1342260-19-8) + SX, 2-{[(2R, 3S) -3- (2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran-2-yl] methyl} -2,4-dihydro-3H-1,2,4-triazole-3-thione (1638897-70-7) + SX, 2-{[(2S, 3R) -3- (2-chlorophenyl)- 2- (2,4-difluorophenyl) oxiran-2-yl] methyl} -2,4-dihydro-3H-1,2,4-triazole-3-thione (1638897-71-8) + SX, 2- { [(2R, 3R) -3- (2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran-2-yl] methyl} -2,4-dihydro-3H-1,2,4-triazole-3 -thione (1638897-72-9) + SX, 2-{[(2S, 3S) -3- (2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran-2-yl] methyl} -2, 4-dihydro-3H-1,2,4-triazole-3-thione (1638897-73-0) + SX, 1-{[3- (2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran- 2-yl] methyl} -1H-1,2,4-triazol-5-yl thiocyanate (1342260-26-7) + SX, 1-{[(2R, 3S) -3- (2-chlorophenyl) -2 -(2,4-difluorophenyl) oxiran-2-yl] methyl} -1H-1,2,4-triazol-5-yl th iocyanate (1638897-82-1) + SX, 1-{[(2S, 3R) -3- (2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran-2-yl] methyl} -1H-1 , 2,4-triazol-5-yl thiocyanate (1638897-84-3) + SX, 1-{[(2R, 3R) -3- (2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran- 2-yl] methyl} -1H-1,2,4-triazol-5-yl thiocyanate (1638897-86-5) + SX, 1-{[(2S, 3S) -3- (2-chlorophenyl) -2 -(2,4-difluorophenyl) oxiran-2-yl] methyl} -1H-1,2,4-triazol-5-yl thiocyanate (1638897-89-8) + SX, 5- (4-chlorobenzyl) -2 -(chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1394057-11-4) + SX, (1R, 2S, 5S) -5 -(4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801930-06-2) + SX, ( 1S, 2R, 5R) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801930- 07-3) + SX, (1R, 2R, 5R) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801919-53-8) + SX, (1S, 2S, 5S) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2, 4-triazol-1-ylmethyl) cycl opentan-1-ol (1801919-54-9) + SX, (1R, 2R, 5S) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2, 4-triazol-1-ylmethyl) cyclopentan-1-ol (1801919-55-0) + SX, (1S, 2S, 5R) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1 -(1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801919-56-1) + SX, (1R, 2S, 5R) -5- (4-chlorobenzyl) -2- ( chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801919-57-2) + SX, (1S, 2R, 5S) -5- ( 4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801919-58-3) + SX, methyl 3- [(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (1791398-02-1) + SX, methyl (1R, 2S, 3S) -3-[(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate ( 2080743-90-2) + SX, methyl (1S, 2R, 3R) -3-[(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol- 1-ylmethyl) cyclopentane-1-carboxylate (2080743-91-3) + SX, methyl (1R, 2R, 3R) -3-[(4-chlorophenyl) methyl] -2-h ydroxy-1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2080743-92-4) + SX, methyl (1S, 2S, 3S) -3- [ (4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2080743-93-5) + SX, methyl ( 1R, 2R, 3S) -3-[(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2080743 -94-6) + SX, methyl (1S, 2S, 3R) -3-[(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H-1,2,4-triazol-1 -ylmethyl) cyclopentane-1-carboxylate (2080743-95-7) + SX, methyl (1R, 2S, 3R) -3-[(4-chlorophenyl) methyl] -2-hydroxy-1-methyl-2- (1H -1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2081061-22-3) + SX, methyl (1S, 2R, 3S) -3-[(4-chlorophenyl) methyl] -2- hydroxy-1-methyl-2- (1H-1,2,4-triazol-1-ylmethyl) cyclopentane-1-carboxylate (2081061-23-4) + SX, 2- (chloromethyl) -5- (4-fluorobenzyl ) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1394057-13-6) + SX, (1R, 2S, 5S) -2- (chloromethyl ) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol- 1-ylmethyl) cyclopentan-1-ol (1801930-08-4) + SX, (1S, 2R, 5R) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H- 1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1801930-09-5) + SX, (1R, 2R, 3R) -2- (chloromethyl) -5- (4-fluorobenzyl) -2 -methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1638898-08-4) + SX, (1S, 2S, 3S) -2- (chloromethyl) -5 -(4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1638898-10-8) + SX, (1R, 2R, 3S) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1638898-13-1) + SX , (1S, 2S, 5R) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentan-1-ol ( 1638898-16-4) + SX, (1R, 2S, 5R) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1,2,4-triazol-1- ylmethyl) cyclopentan-1-ol (1638898-20-0) + SX, (1S, 2R, 5S) -2- (chloromethyl) -5- (4-fluorobenzyl) -2-methyl-1- (1H-1, 2,4-triazol-1-ylmethyl) cyclopentan-1-ol (1638898-24-4) + SX, 2- [2-chloro-4- (4-chlorophenoxy) phenyl] -1- (1H-1,2 , 4-triazol-1-yl) pent-3-yn-2- ol + SX, (R) -2- [2-chloro-4- (4-chlorophenoxy) phenyl] -1- (1H-1,2,4-triazol-1-yl) pent-3-yn-2- ol (1801919-59-4) + SX, (R) -2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1H-1,2,4-triazol-1-yl ) propan-1-ol (1616236-94-2) + SX, 1- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1-cyclopropyl-2- (1H-1,2,4- triazol-1-yl) ethanol + SX, (R) -1- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1-cyclopropyl-2- (1H-1,2,4-triazol- 1-yl) ethanol (1801919-60-7) + SX, (R) -2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -3-methyl-1- (1H-1,2 , 4-triazol-1-yl) butan-2-ol (1801919-61-8) + SX, methyl ({2-methyl-5- [1- (4-methoxy-2-methylphenyl) -1H-pyrazol- 3-yl] phenyl} methyl) carbamate (1605879-98-8) + SX, 2- (difluoromethyl) -N- [1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl] pyridine-3-carboxamide (1616239-21-4) + SX, 2- (difluoromethyl) -N-[(3R) -1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl] pyridine-3-carboxamide (1616239-33-8) + SX, 2- (difluoromethyl) -N- [3-ethyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl] pyridine- 3-carboxamide (18474 60-02-9) + SX, 2- (difluoromethyl) -N-[(3R) -3-ethyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl] pyridine-3- carboxamide (1952305-97-3) + SX, 2- (difluoromethyl) -N- [3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl] pyridine-3-carboxamide ( 1847460-05-2) + SX, 2- (difluoromethyl) -N-[(3R) -3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl] pyridine-3- carboxamide (1952306-00-1) + SX, (2E, 3Z) -5-{[1- (4-chlorophenyl) -1H-pyrazol-3-yl] oxy} -2- (methoxyimino) -N, 3- dimethylpent-3-enamide (1445331-27-0) + SX.

Combination of this component of the group (c) and this compound:
1-methylcyclopropene + SX, 1,3-diphenylurea + SX, 2,3,5-triiodobenzoic acid + SX, IAA ((1H-indol-3-yl) acetic acid) + SX, IBA (4- (1H-indol -3-yl) butyric acid) + SX, MCPA (2- (4-chloro-2-methylphenoxy) acetic acid) + SX, MCPB (4- (4-chloro-2-methylphenoxy) butyric acid) + SX, 4 -CPA (4-chlorophenoxyacetic acid) + SX, 5-aminolevulinic acid hydrochloride + SX, 6-benzylaminopurine + SX, abscisic acid + SX, AVG (aminoethoxyvinylglycine) + SX, ansimidol (SX), SX, butralin + SX, calcium carbonate + SX, calcium chloride + SX, calcium formate + SX, calcium peroxide + SX, calcium polysulfide + SX, sulfuric acid Calcium sulfate + SX, chlormequat-chloride + SX, chloropropham + SX, choline chloride + SX, cloprop + SX, cyanamide + SX, Ranilide + SX, daminozide + SX, decan-1-ol + SX, dichlorprop + SX, dikegulac + SX, dimethipin + SX , Diquat + SX, ethephon + SX, etychlozate + SX, flumetralin + SX, flurprimidol + SX, forchlorfenuron + SX, mononet ) + SX, Gibberellin A + SX, Gibberellin A3 + SX, Inabenfide + SX, Kinetin + SX, lipochitooligosaccharide SP104 + SX, Maleic hydrazide + , Mefluidide + SX, mepiquat-chloride + SX, oxidized glutathione + SX, pacrobutrazol + SX, pendimethalin + SX, Prohexandione-calcium + SX, prohydrojasmon + SX, pyraflufen-ethyl + SX, sintofen + SX, 1-sodium 1-naphthaleneacetate ) + SX, sodium cyanate + SX, streptmycin + SX, thidiazuron + SX, triapenthenol + SX, tribufos + SX, trinexapac ethyl (trinexapac) -ethyl) + SX, uniconazole-P + SX, 2- (naphthalen-1-yl) acetamide + SX, [4-oxo-4- (2 -Phenylethyl) amino] butyric acid + SX, 5- (trifluoromethyl) benzo [b] methyl thiophene-2-carboxylate + SX, 3-[(6-chloro-4-phenylquinazolin-2-yl) amino] -1 Propanol + SX, Strigolactone + SX, (1E) -1-[[1- [3,5-bis (trifluoromethyl) phenyl] -4-methyl-5-oxo- described in WO 2018/145979 2H-pyrrol-2-yl] oxymethylene] -3,3a, 4,8b-tetrahydroindeno [2,1-b] pyrrol-2-one + SX, (2R) -1 as described in WO 2018/145979 -[3,5-bis (trifluoromethyl) phenyl] -4-methyl-2-[(E)-(2-oxo-4,8b-dihydro-3aH-indeno [2,1-b] furan-1-ylidene ) methoxy] -2H-pyrrol-5-one + SX, (2S) -1- [3,5-bis (trifluoromethyl) phenyl] -4-methyl-2-[( E)-(2-oxo-4,8b-dihydro-3aH-indeno [2,1-b] furan-1-ylidene) methoxy] -2H-pyrrol-5-one + SX.

Combination of this component of the above group (d) and this compound:
Allidochlor + SX, benoxacor + SX, cloquintocet + SX, cloquintocet-mexyl + SX, cyometrinil + SX, cyprosulfamide + SX, dichlormid + SX, dicyclonone + SX, dimepiperate + SX, disulfoton + SX, dymron + SX, fenchlorazole + SX, fenchlorazole Fenchlorazole-ethyl + SX, fenclorim + SX, flurazole + SX, furilazole + SX, flxofenim + SX, hexim + SX, isoxadifen + SX , Isoxadifen-ethyl + SX, mecoprop + SX, mefenpyr + SX, mefenpyr-ethyl + SX, mefenpyrdi Chill (mefenpyr-diethyl) + SX, mephenate + SX, meetcamifen + SX, oxabetrinil + SX, 1,8-naphthalic anhydride + SX, 1 , 8-octamethylenediamine + SX, AD-67 (4- (dichloroacetyl) -1-oxa-4-azaspiro [4.5] decane) + SX, CL-304415 (4-carboxy- 3,4-dihydro-2H-1-benzopyran-4-acetic acid) + SX, CSB (1-bromo-4-[(chloromethyl) sulfonyl] benzene) + SX, DKA-24 (2,2-dichloro-N -[2-oxo-2- (2-propenylamino) ethyl] -N- (2-propenyl) acetamide) + SX, MG191 (2- (dichloromethyl) -2-methyl-1,3-dioxolane) + SX, MG -838 (2-propenyl 1-oxa-4-azaspiro [4.5] decane-4-carbodithioate) + SX, PPG-1292 (2,2-dichloro-N- (1,3-dioxan-2-ylmethyl) -N -(2-propenyl) acetamide) + SX, R-28725 (3- (dichloroacetyl) -2,2-dimethyl-1,3-oxazolidine) + SX, R-29148 (3- (dichloroacetyl) -2,2, 5-trimethyl-1,3-oxazolidine) + SX, TI-35 (1- (dichloroacetyl) azepane) + SX.

Combination of this component of the above group (e) and this compound:
1-dodecyl-1H-imidazole + SX, N- (2-ethylhexyl) -8,9,10-trinorborn-5-ene-2,3-dicarboximide (N -(2-ethylhexyl) -8,9,10-trinorborn-5-ene-2,3-dicarboximide) + SX, bucarpolate + SX, N, N-dibutyl-4-chlorobenzenesulfonamide (N, N -dibutyl-4-chlorobenzenesulfonamide) + SX, dietholate + SX, diethylmaleate + SX, piperonyl butoxide + SX, piperonylcyclonene + SX, piperotal + SX, propyl isome + SX, safroxan + SX, sesamex + SX, sesamolin + SX, sulfoxide + SX, Verbutin + SX, DMC (1, 1-bis (4-chlorophenyl) ethanol) + SX, FDMC (1,1-bis (4-chlorophenyl) -2,2,2-trifluoroethanol) + SX, ETN (1,2- epoxy-1,2,3,4-tetrahydronaphthalene) + SX, ETP (1,1,1-trichloro-2,3-expoxypropane) + SX, PSCP (phenylsaligenin cyclic phosphate) + SX, TBPT (S, S, S -tributyl phosphorotrithioate) + SX, TPP (triphenyl phosphate) + SX.

Combination of this component of the group (f) and this compound:
Anthraquinone + SX, chloralose + SX, acrep + SX, butopyronoxyl + SX, camphor + SX, d-camphor + SX, carboxide ) + SX, dibutyl phthalate + SX, deet + SX, dimethyl carbate + SX, dimethyl phthalate + SX, dibutyl succinate + SX , Dibutyl adipate + SX, ethohexadiol + SX, hexamid + SX, icaridin + SX, methoquin-butyl + SX, methyl neodecanamide (methylneodecanamide) + SX, 2- (octylthio) ethanol + SX, butoxypolypropylene glycol + SX, oxamate + SX, quwenzhi + SX, quyingding + SX, zengxiaon + SX, Les Rebemide + SX, copper naphthenate + SX, zinc naphthenate + SX.

Combination of this component of the above group (g) and this compound:
Bis (tributyltin) oxide + SX, allicin + SX, bromoacetamide + SX, cloethocarb + SX, copper sulfate + SX, fentin ) + SX, ferric phosphate + SX, metaldehyde + SX, niclosamide + SX, pentachlorophenol + SX, sodium pentachlorophenoxide + SX, tazimcarb + SX, tralopyril + SX, trifenmorph + SX.

Combination of this component of the group (h) and this compound:
(E) -2-hexenal + SX, (E) -2-octadecenal + SX, (E) -4-tridecen-1-yl acetate + SX, (E) -5-decen-1-yl acetate + SX, (E) -5-decen-1-ol + SX, (E) -3,3-dimethylcyclohexylideneacetaldehyde + SX, (E) -7-dodecen-1-yl acetate + SX, (E) -8-dodecen-1 -yl acetate + SX, (E) -9-dodecen-1-yl acetate + SX, (E) -10-hexadecenal + SX, (E) -11-hexadecen-1-yl acetate + SX, (E)- 11-tetradecen-1-yl acetate + SX, (E) -11-tetradecen-1-ol + SX, (E) -4-tridecen-1-yl acetate + SX, (E) -6-methylhept-2- en-4-ol + SX, (Z) -2- (3,3-dimethylcyclohexylidene) ethanol + SX, (Z) -4-decen-1-yl acetate + SX, (Z) -4-tridecen-1- yl acetate + SX, (Z) -5-decen-1-yl acetate + SX, (Z) -5-decen-1-ol + SX, (Z) -7-tetradecenal + SX, (Z) -7- dodecen-1-yl acetate + SX, (Z) -8-dodecen-1-yl acetate + SX, (Z) -9-dodecen-1-yl acetate + SX, (Z) -8-dodecen-1-ol + SX, (Z) -9-hexadecenal + SX, (Z) -10-hexadecen-1-yl acetate + SX, (Z) -11-hexadecen-1-ol + SX, (Z) -11-hexadecenal + SX, (Z) -11-hexadecen-1-yl acetate + SX, (Z) -11-octadecenal + SX, (Z) -13-octadecenal + SX, (Z) -hexad ec-13-en-11-yn-1-yl acetate + SX, (Z) -13-octadecenal + SX, (Z) -icos-13-en-10-one + SX, (Z) -7-tetradecenal + SX, (Z) -tetradec-9-en-1-ol + SX, (Z) -9-tetradecen-1-yl acetate + SX, (Z) -11-tetradecen-1-yl acetate + SX, ( Z) -13-icosen-10-one + SX, (Z, E) -7,11-hexadecadien-1-yl acetate + SX, (Z, E) -9,12-tetradecadien-1-yl acetate + SX , (E, Z) -4,10-tetradecadien-1-yl acetate + SX, (E, E) -8,10-dodecadien-1-ol + SX, (E, E) -10,12-hexadecadienal + SX, (E, E) -9,11-tetradecadien-1-yl acetate + SX, (E, Z) -2,13-octadecadien-1-ol + SX, (E, Z) -3,13-octadecadien -1-ol + SX, (E, Z) -2,13-octadecadien-1-yl acetate + SX, (E, Z) -3,13-octadecadien-1-yl acetate + SX, (E, Z) -7,9-dodecadien-1-yl acetate + SX, (E, E) -7,9-dodecadien-1-yl acetate + SX, (Z, E) -9,12-tetradecadien-1-yl acetate + SX, (Z, E) -9,11-tetradecadien-1-yl acetate + SX, (Z, E) -7,11-hexadecadien-1-yl acetate + SX, (Z, Z) -3,13- octadecadien-1-ol + SX, (Z, Z) -4,7-decadien-1-yl acetate + SX, (Z, Z) -3,13-octadecadien-1-yl acetate + SX, (Z, Z ) -7,11-hexadecadien-1-yl acetat e + SX, (Z, Z, E) -7,11,13-hexadecatrienal + SX, (5R) -5-[(1Z) -1-decen-1-yl] dihydro-2 (3H) -furanone + SX, (2R, 5R) -ethyl-1,6-dioxaspiro [4,4] nonane + SX, (2R, 5S) -ethyl-1,6-dioxaspiro [4,4] nonane + SX, (4R, 8R ) -4,8-dimethyldecanal + SX, (4R, 8S) -4,8-dimethyldecanal + SX, 2,4-dimethyl-5-ethyl-6,8-dioxabicyclo [3,2,1] octane + SX, (-)-4-methyl-3-heptanol + SX, 1,7-dioxaspiro [5,5] undecane + SX, 3-carene + SX, 3-methylcyclohex-2-en-1-one + SX, 14- methyloctadec-1-ene + SX, 4-methylnonan-5-ol + SX, 4-methylnonan-5-one + SX, 4- (3-oxobutyl) phenyl acetate + SX, dodecyl acetate + SX, dodeca-8,10 -dien-1-yl acetate + SX, ethyl (2E, 4Z) -decadienoate + SX, ethyl 4-methyloctanoate + SX, methyl 2,6,10-trimethyldodecanoate + SX, tetradecan-1-ol + SX, tetradec-11 -en-1-ol + SX, tetradec-11-en-1-yl acetate + SX, tridec-4-en-1-yl acetate + SX, (3S, 6R) -3-methyl-6-isopropenyl-9 -decen-1-yl acetate + SX, (3S, 6S) -3-methyl-6-isopropenyl-9-decen-1-yl acetate + SX, alpha-multistriatin + SX, alpha-pinene + SX, endo-brevicomin + SX, exo-brevicomin + SX, camphene + SX, codlelure + SX, codlemone + SX, cuelure + SX, disparlure + SX, dominicalure + SX, eugenol + SX, farnesol + SX, ferrolure + SX, frontalin + SX, gossyplure + SX, grandlure + SX, grandlure I + SX, grandlure II + SX, grandlure III + SX, grandlure IV + SX, hexalure + SX, ipsdienol + SX, ipsenol + SX, japonilure + SX, lineatin + SX, litlue + SX, looplure + SX, medlure + SX, megatomoic acid + SX, methyl eugenol + SX, muscalure + SX, nerolidol + SX, orfralure + SX, oryctalure + SX, ostramone + SX, rhyncolure + SX, siglure + SX, sordidin + SX, sulcatol + SX, trimedlure + SX, trimedlure A + SX, trimedlure B1 + SX, trimedlure B2 + SX, trimedlure C + SX, trunc-call + SX, (E) -verbenol + SX, (Z) -verbenol + SX, trans-verbenol + SX, (S) -verbenone + SX.

Combination of this component of the above group (i) and this compound:
2,3,6-TBA (2,3,6-trichlorobenzoic acid) + SX, 2,3,6-TBA-dimethylammonium + SX, 2,3,6-TBA Lithium salt (2,3,6-TBA-lithium) + SX, 2,3,6-TBA potassium salt (2,3,6-TBA-potassium) + SX, 2,3,6-TBA sodium salt (2 , 3,6-TBA-sodium) + SX, 2,4-D + SX, 2,4-D choline salt (2,4-D choline salt) + SX, 2,4-D BAPMA salt (2,4 -DN, N-bis (3-aminopropyl) methylamine salt) + SX, 2,4-D 2-butoxypropyl + SX, 2,4-D 2-ethylhexyl (2 , 4-D-2-ethylhexyl) + SX, 2,4-D 3-butoxypropyl + SX, 2,4-D ammonium (2,4-D-ammonium) + SX, 2,4-D butotyl (2,4-D-butotyl) + SX, 2,4-D butyl (2,4-D-butyl) + SX, 2,4-D diethylammonium (2,4 -D-diethylammonium) + SX, 2,4-D dimethylammonium (2,4-D-dimethylammonium) + SX, 2,4-D diolamine salt (2,4-D-diolamine) + SX, 2,4 -D-decylammonium + SX, 2,4-D-ethyl + SX, 2,4-D hep Ruammonium (2,4-D-heptylammonium) + SX, 2,4-D Isobutyl (2,4-D-isobutyl) + SX, 2,4-D isooctyl (2,4-D-isooctyl) + SX, 2,4-D isopropyl (2,4-D-isopropyl) + SX, 2,4-D isopropylammonium (2,4-D-isopropylammonium) + SX, 2,4-D lithium salt (2,4-D -lithium) + SX, 2,4-D meptyl (2,4-D-mepty) + SX, 2,4-D methyl (2,4-D-methyl) + SX, 2,4-D octyl (2 , 4-D-octyl) + SX, 2,4-D pentyl (2,4-D-pentyl) + SX, 2,4-D propyl (2,4-D-propyl) + SX, 2,4- D sodium salt (2,4-D-sodium) + SX, 2,4-D tefryl (2,4-D-tefuryl) + SX, 2,4-D tetradecylammonium (2,4-D-tetradecylammonium) + SX, 2,4-D triethylammonium (2,4-D-triethylammonium) SX, 2,4-D tris (2-hydroxypropyl) ammonium + SX, 2,4-D trolamine salt (2,4-D-trolamine) + SX, 2,4-DB + SX, 2,4-DB choline salt (SX), SX, 2 , 4-DB BAPMA salt (2,4-DB N, N-bis (3-aminopropyl) methylamine salt) + SX, 2,4-DB butyl (2,4-DB-butyl) + SX, 2,4-DB dimethylammonium (2,4-DB-dimethylammonium) + SX, 2,4-DB isooctyl (2,4- DB-isoctyl) + SX, 2,4-DB potassium salt (2,4-DB-potassium) + SX, 2,4-DB sodium salt (2,4-DB-sodium) + SX, acetochlor + SX, acifluorfen + SX, acifluorfen-sodium + SX, aclonifen + SX, ACN (2-amino-3-chloronaphthalene-1,4-dione) + SX , Alachlor + SX, alloxydim + SX, ametryn + SX, amicarbazone + SX, amidosulfuron + SX, aminocyclopyrachlor + SX, amino Aminocyclopyrachlor-methyl + SX, Aminocyclopyrachlor-potassium + SX, Aminopyralid + SX, Aminopyralidocholine salt pyralid choline salt) + SX, aminopyralid-potassium + SX, aminopyralid-tris (2-hydroxypropyl) ammonium) + SX, amiprophos methyl -methyl) + SX, amitrole + SX, anilofos + SX, asuram + SX, atrazine + SX, azafenidin + SX, azimsulfuron + SX, befurbutamide (beflubutamid) + SX, benazolin-ethyl + SX, bencarbazone + SX, benfluralin + SX, benfuresate + SX, bensulfuron + SX, bensulfuron-methyl methyl) + SX, bensulide + SX, bentazon + SX, benthiocarb + SX, benzfendizone + SX, benzobicyc lon) + SX, benzofenap + SX, benzthiazuron + SX, bialafosbialaphos + SX, bicyclopyrone + SX, bifenox + SX, bispyribac + SX, Bispyribac-sodium + SX, bixlozone + SX, bromacil + SX, bromobutide + SX, bromofenoxim + SX, bromoxynil + SX, bromoxynil Octanoate + SX, butachlor + SX, butafenacil + SX, butamifos + SX, butroxydim + SX, butylate + SX, cafenstrole + SX, carbetamide + SX, carfentrazone + SX, carfentrazone-ethyl + SX, chlomethoxyfen + SX, Chloramben + SX, chloridazon + SX, chlorimuron + SX, chlorimuron-ethyl + SX, chlorobromuron + SX, chlorotoluron + SX, chloroxuron (chloroxuron) + SX, chlorpropham + SX, chlorsulfuron + SX, chlorthal-dimethyl + SX, chlorthiamid + SX, cinidon + SX, sinidone ethyl (cinidon-ethyl) + SX, cinmethylin + SX, cinosulfuron + SX, clethodim + SX, clodinahop (clodinafop) + SX, clodinahop-propargyl + SX, clomazone ( clomazone) + SX, clomeprop + SX, clopyralid + SX, clopyralid choline salt + SX, clopyralid-methyl + SX, clopyralid-olamine + SX, clopyralid-potassium + SX, clopyralid-tris (2-hydroxypropyl) ammonium + SX, chloranthram ( cloransulam) + SX, cloransulam-methyl + SX, cumyluron + SX, cyanazine + SX, cycloate + SX, cyclopyranil + SX, cyclopyrimolate ( cyclopyrimorate) + SX, cyclosulfamuron + SX, cyclooxydim + SX, cyhalofop + SX, cyhalofop-butyl + SX, dalapon + SX, dazomet ( dazomet) + SX, desmedipham + SX, desmetryn + SX, di-allate + SX, dicamba + SX, dicamba choline salt + SX, dicamba BAPMA Salt (dicamba N, N-bis (3-aminopropyl) methylamine salt) + SX, dicamba-trolamine + SX, dicamba-diglycolamine + SX, dicamba dimethylammonium ( dicamba-dimethylammonium) + SX, dicamba-diolamine + SX, dicamba-isopropylammonium + SX, dicamba-methyl + SX, dicamba-olamine + SX, dicamba-potassium + SX, dicamba-sodium + SX, dichlobenil + SX, dichlorprop choline salt + SX, dichlorprop BAPMA salt (dichlorprop N, N-bis (3-aminopropyl) methylamine salt) + SX, dichlorprop-2-ethylhexyl + SX, dichlorprop-butotyl + SX, diclopropdimethylammonium Dichlorprop-dimethylammonium + SX, dichlorprop-ethylammonium + SX, dichlorprop-isoctyl + SX, dichlorprop-methyl + SX, dichlorprop-P P) + SX, dicloprop-P choline salt + SX, dicloprop-P BAPMA salt (dichlorprop-P N, N-bis (3-aminopropyl) methylamine salt) + SX, dicloprop-P 2- Ethylhexyl (dichlorprop-P-2-ethylhexyl) + SX, dichlorprop-P-dimethylammonium + SX, dichlorprop-potassium + SX, dichlorprop-sodium + SX, diclofop + SX, diclofop-methyl + SX, dicloslam + SX, difenoxuron + SX, difenzoquat + SX, diflufenica (diflufenican) + SX, diflufenzopyr + SX, diflufenzopyr-sodium + SX, dimefuron + SX, dimepiperate + SX, dimethachlor + SX , Dimethametryn + SX, dimethenamid + SX, dimethenamid-P + SX, dinitramine + SX, dinoseb + SX, dinoterb + SX, diphenamid (diphendamide) + SX, diquat-dibromide + SX, DSMA (disodium methylarsonate) + SX, dithiopyr + SX, diuron + SX, DNOC (2-methyl-4,6-dinitrophenol) + SX , Esprocarb + SX, ethalluralin + SX, ethametsulfuron + SX, ethametsulfuron-methyl + SX, ethidimuron + SX, etofumesate + ethofumesate SX, Ethoxyfen-ethyl + SX, ethoxysulfuron + SX, etobenzanid + SX, fenoxaprop + SX, fenoxaprop-ethyl + SX, phenoxa Prop P (fenoxaprop-P) + SX, fenoxaprop-P-ethyl + SX, fenoxasulfone + SX, fenquinotrione + SX, fentrazamide + SX, Fenuron + SX, flamprop-M + SX, flazasulfuron + SX, florasulam + SX, florpyrauxifen + SX, florpyrauxifenbenzyl ( florpyrauxifen-benzyl) + SX, fluazifop-flux + SX, fluazifop-butyl + SX, fluazifop-P + SX, fluazifop-P-butyl + SX, Fluazolate + SX, flucarbazone + SX, flucarbazone-sodium + SX, flucetosulfuron + SX, flufenacet + SX, flufenpyr + SX, flufenpyr-ethyl + SX, flumetsulam + SX, flumetsulam + SX, flumiclorac + SX, flumiclorac-pentyl + SX, flumi Oxazine (flumioxazin) + SX, fluometuron + SX, fluoroglycofen-ethyl + SX, flupoxam + SX, flupropanate + SX, flupirsulfuron + SX , Flupirsulfuron-methyl-sodium + SX, flurenol + SX, fluridone + SX, flurochloridone ) + SX, fluroxypyr + SX, fluroxypyr-meptyl + SX, flurtamone + SX, fluthiacet + SX, fluthiaset methyl
-methyl) + SX, fomesafen + SX, fomesafen-sodium + SX, foramsulfuron + SX, fosamine + SX, glufosinate + SX, glufosinate ammonium Glufosinate-ammonium + SX, glufosinate-P + SX, glufosinate-P-ammonium + SX, glufosinate-P-sodium + SX, glyphosate SX + glyphosate choline salt + SX, glyphosate guanidine derivative salts + SX, glyphosate isopropylamine salt + SX, glyphosate BAPMA salt (glyphosate N, N-bis) (3-aminopropyl) methylamine salt) + SX, glyphosate-ammonium + SX, glyphosate-diammonium + SX, glyphos Potassium salt (glyphosate-potassium) + SX, glyphosate-sodium salt + SX, glyphosate-trimethylsulfonium + SX, halauxifen + SX, halauxifen-methyl ) + SX, halosafen + SX, halosulfuron + SX, halosulfuron-methyl + SX, halooxyfop + SX, halooxyfop-etotyl + SX, Haloxyfop-methyl + SX, Haloxyfop-P + SX, Haloxyfop-P-etotyl + SX, Haloxyfop-P-methyl + SX, Hexazinone ( hexazinone) + SX, imazamethabenz + SX, imazamethabenz-methyl + SX, imazamox + SX, imazamox-ammonium + SX, Imazapic + SX, imazapic-ammonium + SX, imazapyr + SX, imazapyr-isopropylammonium + SX, imazaquin + SX, imazapic Quinammonium salt (imazaquin-ammonium) + SX, imazethapyr + SX, imazethapyr-ammonium + SX, imazosulfuron + SX, indanofan + SX, indaziflam + indaziflam SX, iodosulfuron + SX, iodosulfuron-methyl-sodium + SX, iofensulfuron + SX, iofensulfuron-sodium + SX, ioxynil ) + SX, ioxynil-octanoate + SX, ipfencarbazone + SX, isoproturon + SX, Isouron + SX, isoxaben + SX, isoxachlortole + SX, isoxaflutole + SX, lactofen + SX, lenacil + SX, linuron ( linuron) + SX, maleic hydrazide + SX, MCPA choline salt + SX, MCPA BAPMA salt (MCPA N, N-bis (3-aminopropyl) methylamine salt) + SX, MCPA 2- Ethylhexyl (MCPA-2-ethylhexyl) + SX, MCPA-butotyl + SX, MCPA-butyl + SX, MCPA dimethylammonium + SX, MCPA diolamine salt (MCPA-diolamine) ) + SX, MCPA ethyl (MCPA-ethyl) + SX, MCPA-isobutyl + SX, MCPA isopropyl (MCPA-isopropyl) + SX, MCPA methyl (MCPA-methyl) ) + SX, MCPA allamine salt (MCPA-olamine) + SX, MCPA sodium salt (MCPA-sodium) + SX, MCPA-trolamine salt (MCPA-trolamine) + SX, M CPB (4- (4-chloro-2-methylphenoxy) butanoic acid) + SX, MCPB choline salt + SX, MCPB BAPMA salt (MCPB N, N-bis (3-aminopropyl) methylamine salt) + SX , MCPB-ethyl + SX, MCPB-methyl + SX, MCPB-sodium + SX, mecoprop choline salt + SX, mecoprop BAPMA salt (mecoprop N , N-bis (3-aminopropyl) methylamine salt) + SX, mecoprop-2-ethylhexyl + SX, mecoprop-dimethylammonium + SX, mecoprop-diolamine ) + SX, mecoprop-ethadyl + SX, mecoprop-isoctyl + SX, mecoprop-methyl + SX, mecoprop-potassium + SX , Mecoprop-sodium + SX, mecoprop-trolamine + SX, mecop P (mecoprop-P) + SX, mecoprop-P choline salt + SX, mecoprop-P-2-ethylhexyl + SX, mecoprop-P dimethylammonium (mecoprop-P -dimethylammonium) + SX, mecoprop-P-isobutyl + SX, mecoprop-P-potassium + SX, mefenacet + SX, mesosulfuron + SX, mesosulfuron methyl (mesosulfuron-methyl) + SX, mesotrione + SX, metam + SX, metamifop + SX, metamitron + SX, metazachlor + SX, metazosulfuron + SX , Methabenzthiazuron + SX, methiozolin + SX, methyldymron + SX, metobromuron + SX, metolachlor + SX, metosul am) + SX, metoxuron + SX, metribuzin + SX, metsulfuron + SX, metsulfuron-methyl + SX, molinate + SX, monolinuron + SX , Naproanilide + SX, napropamide + SX, napropamide-M + SX, naptalam + SX, neburon + SX, nicosulfuron + SX, norflurazon ) + SX, oleic acid + SX, orbencarb + SX, orthosulfamuron + SX, oryzalin + SX, oxadiargyl + SX, oxadiazon + SX , Oxasulfuron + SX, oxaziclomefone + SX, oxyfluorfen + SX, paraquat + SX, paraquat-dichloride + SX, Pebulate + SX, pelargonic acid + SX, pendimethalin + SX, penoxsulam + SX, pentanochlor + SX, pentoxazone + SX, petoxamide ( pethoxamid) + SX, phenisopham + SX, phenmedipham + SX, picloram, picolinafen + SX, picolinafen + SX, pinoxaden + SX , Piperophos + SX, pretilachlor + SX, primisulfuron + SX, primisulfuron-methyl + SX, prodiamine + SX, profluazol + SX, propoxydim + SX, prometon + SX, promethrin + SX, propachlor + SX, propanil + SX, propaxa hop (propa quizafop) + SX, propazine + SX, propham + SX, propisochlor + SX, propoxycarbazone + SX, propoxycarbazone-sodium + SX, Propyrisulfuron + SX, propyzamide + SX, prosulfocarb + SX, prosulfuron + SX, pyraclonil + SX, pyrasulfotole + SX, pyrazolynate ) + SX, pyrazosulfuron + SX, pyrazosulfuron-ethyl + SX, pyrrazoxyfen + SX, pyribenzoxim + SX, pyributicarb + SX, apyridolpy , Pyridate + SX, pyriftalide + SX, pyriminobac + SX, pyriminobac-methyl + SX, Pyrimisulfan + SX, pyrithiobac + SX, pyrithiobac-sodium + SX, pyroxasulfone + SX, pyroxsulam + SX, quinclorac + SX, quinmerac + SX, quizalofop-SX + SX, quizalofop-tefuryl + SX, quizalofop-P + SX, quizalofop-P-ethyl + SX, quizalofop-P-tefuryl + SX, rimsulfuron + SX, saflufenacil + SX, sethoxydim + SX , EPTC (S-ethyl N, N-dipropylcarbamothioate) + SX, siduron + SX, simazine + SX, simetryn + SX, S-metolachlor + SX, MSMA ( sodium hydrogen methylarsonate) + SX, sulcotrione (s ulcotrione) + SX, sulfentrazone + SX, sulfometuron + SX, sulfometuron-methyl + SX, sulfosulfuron + SX, swep + SX, TCA (2,2,2-trichloroacetic acid) + SX, tebutam + SX, tebuthiuron + SX, tefuryltrione + SX, tembotrione + SX, tepraloxydim + SX, terbacil + SX, terbumeton + SX, terbutryn + SX, terbutryn + SX, taxtomin A + SX, thenylchlor + SX, thiazopy ) + SX, thidiazimin + SX, thiencarbazone + SX, thiencarbazone-methyl + SX, thifensulfuron + SX, thifensulfuron-methyl + SX , Tiafenacil + SX, thiocarbazil + SX, tolpyralate + SX, topramezone + SX, tralkoxydim + SX, triafamone + SX, tri-allate + SX, triasulfuron + SX, triaziuram + SX, tribenuron + SX, tribenuron-methyl + SX, triclopyr + SX, triclopyrbutyl (SX) triclopyr-butotyl + SX, triclopyr-ethyl + SX, trilopyr-triethylammonium + SX, tridiphane + SX, trietazine + SX, trifloxysulfuron ) + SX, trifloxysulfuron-sodium + SX, trifludimoxazin + SX, trifluralin + SX, tri Triflusulfuron + SX, triflusulfuron-methyl + SX, tritosulfuron + SX, vernolate + SX, 2-[(2,4-dichlorophenyl) methyl]- 4,4-dimethyl-1,2-oxazolidin-3-one + SX, Ethyl [(3- {2-chlor
o-4-fluoro-5- [3-methyl-4- (trifluoromethyl) -2,6-dioxo-1,2,3,6-tetrahydropyrimidin-1-yl] phenoxy} pyridin-2-yl) oxy] acetate (353292-31-6) + SX.

Combination of this component of the above group (j) and this compound:
Abbreviata caucasica + SX, Aquaria spp. (Acuaria spp.) + SX, Agamermis decaudata + SX, Agrobacterium radiobacter strain K1026 + SX, Agrobacterium Agrobacterium radiobacter strain K84 + SX, Agrobacterium vitis strain VAR03-1 (Agrobacterium vitis strain VAR03-1) + SX, Allantonema spp. + SX, Alternaria destoluene 59 strains (Alternaria destruens strain 59) + SX, Alternaria destruens + SX, Ampelomyces quisqualis strain AQ10 + SX, Amphimermis spp. (Amphimermis spp.) + SX, Ars Arthrobotrys dactyloides + SX, Arthrobotrys superba + SX, Ashersonia Alleyrodes (Aschersonia aleyrodes) + SX, Aspergillus flavus strain AF36 (Aspergillus flavus strain AF36) + SX, Aspergillus flavus strain NRRL21882 (Aspergillus flavus strain NRRL21882) + SX, Aureobasidium pullulans strain DSM14940 (Aureobasidium pullulans strain 40) , Aureobasidium pullulans strain DSM14941 + SX, Azopirillum + SX, Azorizobium kaurino dance ZB-SK-5 (Azorhizobiuma caulinodans strain ZB-SK-5) + SX, Azotobacter crococcus Azotobacter chroococcum strain H23 + SX, Azotobacter chroocuccum + SX, Azotobacter cyst + SX, Azotobacter vinelandi ATCC12837 SX, Bacillus acidocaldarius + SX, bee Rus acidoterrestris + SX, Bacillus albolactis + SX, Bacillus alcalophilus + SX, Bacillus alvei + SX, Bacillus aminoglucosidicus (Bacillus aminoglucosidicus) + SX, Bacillus aminovorans + SX, Bacillus amyloliquefaciens (Aveo (TM) EZ Nematicide) (Bacillus amyloliquefaciens (Aveo (TM) EZ Nematicide)) + SX, Bacillus amylorike Facilens strain AT332 (Bacillus amyloliquefaciens strain AT332) + SX, Bacillus amyloliquefaciens strain B3 (Bacillus amyloliquefaciens strain B3) + SX, Bacillus amyloliquefaciens strain D747 (Bacillus amyloliquefaciens strain D747) + SX, Bacillus Liquefaciens DB101 strain (Bacillus amyloliquefaciens strain DB101) + SX, Bacillus amyloliquefaciens DB102 strain (Bacillus amyloliquefaciens strain DB102) + SX, Bacillus amyloliquefaciens strain FZB24 + SX, Bacillus amyloliquefaciens strain FZB42 strain (Bacillus amyloliquefaciens strain FZB42) + SX Ens GB03 (Bacillus amyloliquefaciens strain GB03) + SX, Bacillus amyloliquefaciens strain IN937a + SX, Bacillus amyloliquefaciens strain MBI600 (Bacillus amyloliquefaciens strain MBI600) + SX, Bacillus amyloliquefaciens strain MBI600 Facilens strain QST713 (Bacillus amyloliquefaciens strain QST713) + SX, Bacillus amyloliquefaciens isolate strain B246 (Bacillus amyloliquefaciens isolate strain B246) + SX, Bacillus amyloliquefaciens strain F727 (Bacillus amyloliquefaciens strain F727) Bacillus amyloliquefaciens plantarum subspecies D747 (Bacillus a myloliquefaciens subsp. Plantarum strain D747) + SX, Bacillus amylolyticus + SX, Bacillus aneurinolyticus + SX, Bacillus agri + SX, Bacillus atrophaeus (Bacillus atrophaeus) + SX, Bacillus azotoformans + SX, Bacillus badius + SX, Bacillus cereus strain BP01 + SX, Bacillus cereus CNCM I-1562 strain ( Bacillus cereus CNCM strain I-1562) + SX, Bacillus chitinosporus strain AQ746 + SX, Bacillus chitinosporus strain CM-1 + SX, Bacillus circulans ) + SX, Bacillus coagulans strain TQ33 (Bacillus coagulans strain TQ33) + SX, Bacillus fastidiosus + SX, Bacillus coagulans strain TQ33 Films GB-126 strain (Bacillus firmus strain GB-126) + SX, Bacillus firmus strain I-1582 (Bacillus firmus strain I-1582) + SX, Bacillus lacticola + SX, Bacillus lactimolbus ( Bacillus lactimorbus + SX, Bacillus lactis + SX, Bacillus lautus + SX, Bacillus lentus + SX, Bacillus lentus + SX, Bacillus licheniformis H -2 strain (Bacillus licheniformis strain HB-2) + SX, Bacillus licheniformis strain SB3086 (Bacillus licheniformis strain SB3086) + SX, Bacillus maroccanus + SX, Bacillus medusa + SX, Bacillus medusa Megathelium YFM3.25 (Bacillus megaterium strain YFM3.25) + SX, Bacillus methylotrophicus strain BAC-9912 (Bacillus methylotrophicus strain BAC-9912) + SX, Bacillus methiens (Baci llus metiens) + SX, Bacillus mojavensis strain SR11 + SX, Bacillus mycoides strain AQ726 + SX, Bacillus mycoides isolate J + SX, Bacillus Bacillus nematocida + SX, Bacillus nigrificans + SX, Bacillus nigrum + SX, Bacillus popilliae + SX, Bacillus cyclosaccharic ) + SX, Bacillus pumilus strain AQ717 (Bacillus pumilus strain AQ717) + SX, Bacillus pumilus strain BUF-33 + SX, Bacillus pumilus strain GB34 (Bacillus pumilus strain GB34) + SX , Bacillus pumilus strain QST2808 (Bacillus pumilus strain QST2808) + SX, Bacillus siamensis + SX, Bacillus simplex CGF2856 (Bacillus semenx) implex strain CGF2856) + SX, Bacillus smithii + SX, Bacillus sp. strain AQ175 (Bacillus sp. strain AQ175) + SX, Bacillus sp. strain AQ177 (Bacillus sp. strain AQ177) + SX, Bacillus sp. AQ178 (Bacillus sp. Strain AQ178) + SX, Bacillus sphaericus strain 2362 (Bacillus sphaericus strain 2362) + SX, Bacillus sphaericus strain ABTS1743 (Bacillus sphaericus strain ABTS1743) + SX, Bacillus sphaericus antigenic H5a5spha strain Serotype strain H5a5b) + SX, Bacillus subtilis strain AQ153 (Bacillus subtilis strain AQ153) + SX, Bacillus subtilis strain AQ743 (Bacillus subtilis strain AQ743) + SX, Bacillus subtilis strain C-3102 (Bacillus subtilis strain C-3102) + SX, Bacillus subtilis strain D747 (Bacillus subtilis strain D747) + SX, Bacillus subtilis strain DB101 (SX) + SX, Bacillus subtilis strain FZB24 (Bacillus subtilis strain FZB24) + SX, Bachi Rus subtilis strain GB03 (Bacillus subtilis strain GB03) + SX, Bacillus subtilis strain HAI0404 (Bacillus subtilis strain HAI0404) + SX, Bacillus subtilis strain IAB / BS03 (Bacillus subtilis strain IAB / BS03) + SX, Bacillus subtilis MBI 600 Strain (Bacillus subtilis strain MBI600) + SX, Bacillus subtilis strain QST30002 / AQ30002 (Bacillus subtilis strain QST30002 / AQ30002) + SX, Bacillus subtilis strain QST30004 / AQ30004 strain (Bacillus subtilis strain QST30004 / AQ30004) + SX Strain (Bacillus subtilis strain QST713) + SX, Bacillus subtilis strain QST714 (Bacillus subtilis strain QST714) + SX, Bacillus subtilis var amyloliquefaciens strain FZB24 (Bacillus subtilis var. Amyloliquefaciens strain FZB24) Strain (Bacillus subtilis strain Y1336) + SX, Bacillus subtilis subsp. Natto + SX, Bacillus tequila Cis NII-0943 strain (Bacillus tequilensis strain NII-0943) + SX, Bacillus thuringiensis strain AQ52 (Bacillus thuringiensis strain AQ52) + SX, Bacillus thuringiensis strain BD # 32 (Bacillus thuringiensis strain BD # 32) + SX, Bacillus thuringiensis CR-371 (Bacillus thuringiensis strain CR-371) + SX, Bacillus thuringiensis strain EX297512 (Bacillus thuringiensis strain EX297512) + SX, Bacillus thuringiensis IZAWA subspecies ABTS-1857 (Bacillus thuringiensis subsp) Aizawai strain ABTS-1857) + SX, Bacillus thuringiensis subsp. Aizawai strain GC-91 + SX, Bacillus thuringiensis Aisawai subspecies Serotype H-7 (Bacillus thuringiensis subsp.Aizawai Serotype H-7) + SX, Bacillus thuringiensis subsp. Kurstaki strain ABTS351 + SX, Bacillus thuringiensis subsp. Bacillus thuringiensis subsp. Kurstaki strain BMP123 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG234 + SX, Bacillus thuringiensis cristaki Subspecies EG7841 strain (Bacillus thuringiensis subsp. Kurstaki strain EG7841) + SX, Bacillus thuringiensis subsp. Kurstaki strain EVB113-19 + SX, Bacillus thuringiensis cristaki subspecies F810 strain (Bacillus thuringiensis subsp. Kurstaki strain F810) + SX, Bacillus thuringiensis cristaki subspecies HD-1 strain (Bacillus thuringiensis subsp. Kurstaki strain HD-1) + SX, Bacillus thuringiensis substratum PB54 strain (Bacillus thuringiensis subsp. Kurstaki strain PB54) + SX, Bacillus thuringen Kristaki subsp. SA-11 strain (Bacillus thuringiensis subsp. Kurstaki strain SA-11) + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-12 + SX, Bacillus・ Thuringiensis subsp. Morrisoni + SX, Bacillus thuringiensis subsp. Tenebriosis strain NB176 + SX, Bacillus thuringiensis subsp. Morrisoni MPPL002 Strain (Bacillus thuringiensis subsp. Thuringiensis strain MPPL002) + SX, Bacillus thuringiensis subsp. Var.colmeri + SX, Bacillus thuringiensis Darmstadiensis variant 24-91 (Bacillus thuringiensis subsp. var.darmstadiensis strain 24-91) + SX, Bacillus thuringiensis Dendrolimus varieties (Baci varus dendrolimus) + SX, Bacillus thuringiensis subsp. var. galleriae + SX, Bacillus thuringiensis islaerensis subspecies BMP144 (B
acillus thuringiensis subsp.israelensis strain BMP144) + SX, Bacillus thuringiensis israelensis subspecies AM65-52 (Bacillus thuringiensis subsp. israelensis strain AM65-52) + SX, Bacillus thuringiensis japonensis variant buibui strain (Bacillus var. japonensis strain buibui) + SX, Bacillus thuringiensis subsp. var.aegypti + SX, Bacillus thuringiensis 7216 variant (Bacillus thuringiensis var. 7216) + SX, Bacillus thuringien C. San Diego Variant M-7 (Bacillus thuringiensis var.sandiego strain M-7) + SX, Bacillus thuringiensis T36 Variant (Bacillus thuringiensis var. T36) + SX, BT crop protein Cry1Ab (BT crop protein Cry1Ab) + SX, BT crop protein Cry1Ac (BT crop protein Cry1Ac) + SX, BT crop protein Cry1Fa (BT crop protein Cry1Fa) + SX, BT crop protein Protein Cry1A.105 (BT crop protein Cry1A.105) + SX, BT crop protein Cry2Ab (BT crop protein Cry2Ab) + SX, BT crop protein Vip3A (BT crop protein Vry3A) + SX, BT crop protein mCry3A ( BT crop protein Cry3A) + SX, BT crop protein Cry3Ab (BT crop protein Cry3Ab) + SX, BT crop protein Cry3Bb (BT crop protein Cry3Bb) + SX, BT crop protein Cry34Ab1 / Cry35Ab1 (BT crop protein Cry34Ab1 / Cry35Ab1 ) + SX, Bacillus uniflagellate + SX, Bacillus uniflagellatus + SX, Bacteria spp. (Bacteria spp.) + SX, Bacteriophage michiganesis bacteriophage of ganflagellatus ) + SX, Bacteriophage active against Xanthomonas campestris pv.vesicatoria and Pseudomonas syringae pv.tomato + SX, Bacteriophage active against Clavibacter michiganensis subsp.michiganensis + SX, Boberia vassiana ANT-03 strain (Bea uveria bassiana strain ANT-03) + SX, Beauveria bassiana strain ATCC74040 (Beauveria bassiana strain ATCC74040) + SX, Beauveria bassiana GHA strain (Beauveria bassiana strain GHA) + SX, Beauveria bassiana strain PPRI 5339 strain (Beauveria bassiana strain PPRI 5339 ) + SX, Beauveria brongniartii + SX, Beddingia siridicola + SX, Bovienema spp. + SX, Brevibacillus brevis strain 2904 (Brevibacillus breSX strain + 904) Brevibacillus brevis strain SS86-3 (Brevibacillus brevis strain SS86-3) + SX, Brevibacillus brevis strain SS86-4 (Brevibacillus brevis strain SS86-4) + SX, Brevibacillus brevis strain SS86-5 (Brevibacillus brevis strain SS86-3) SS86-5) + SX, Brevibacillus laterosporus strain ATCC64 (Brevibacillus laterosporus strain ATCC64) + SX, Brevibacillus laterosporus strain BPM3 (Brevibacillus laterosporus strain BPM3) + SX, Brevibacillus laterosporus strain G4 (Brevibacillus laterosporus strain G4) + SX, Brevibacillus laterosporus NCIMB 41419 (Brevibacillus laterosporus strain NCIMB 41419) + SX, Brevibacillus laterosporus strain NRS11 Brevibacillus laterosporus strain NRS1645 (Brevibacillus laterosporus strain NRS1645) + SX, Burkholderia cepacia type Wisconsin strain J82 + SX, Burkholderia cepacia Wisconur type Mholder (B54) strain M54) + SX, Burkholderia cepacia + SX, Burkholderia gladii strain BA-7 + SX, Burkholderia rinojensis strain A396 ) + SX, Cameronia spp. (Cameronia spp.) + SX, Deer・ Canadian thistle fungus + SX, Candida oleophila strain O + SX, Candida saitoana + SX, Candida spp. (Candida spp.) + SX, ketium・ Cupreum (Chaetomium cupreum) + SX, Chitowoodiella ovofilamenta + SX, Chromobacterium subtsugae strain PRAA4-1T (Chromobacterium subtsugae strain PRAA4-1T) + SX, Cladosporium cladospolio Ides strain H39 (Cladosporium cladosporioides strain H39) + SX, Clonostakis rosea + SX, Conidiobolus obscurus + SX, Coniocilium minitans CGMCC8325 strain (ConiothyrGM・ Minitans CON / M / 91-08 (Coniothyrium minitans strain CON / M / 91-08) + SX, Contortylenchus spp. + SX, chestnut Cryptococcus albidus + SX, colicimermis spp. (Culicimermis spp.) + SX, Dactyllela ellipsospora + SX, Dectylaria thaumasia RAY strain RAY209) + SX, Dilophosphora alopecuri + SX, Diploriaena spp. + SX, Empidomermis spp. + SX, Entomophthora virulenta + SX Erwinia carotovora subsp.Carotobola strain CGE234M403 (Erwinia carotovora subsp.carotovora strain CGE234M403) + SX, Filipjevimermis leipsandra + SX, Fusarium oxysporum Fo47 strain +・ Prasarifertam (Fusariumproliferatum) + SX, Gastromelmis spp (Gastromermis spp.) + SX, Gliocladium catenulatum strain J1446 + SX, gluconacetobacter diazotrophicus + SX, Gongylonema spp. , Gynopoecilia pseudovipara + SX, Harpin protein + SX, Heterorhabditis bacteriophora + SX, Heterorhabditis baujardi + SX, Hetero Heterorhabditis heliothidis + SX, Heterorhabditis indica + SX, Heterorhabditis marelatus + SX, Heterorhabditis megidis + Heterorhabditis megidis + Heterorhabditis megidis・ Zealandica (Heterorhabditis zealandi ca) + SX, Hexamermis spp. + SX, Hirsutella minnesotensis + SX, Hirsutella rsiliensis + SX, Hirsutella thompsonii SX + Hirsutella thompsonii + SX Miss spp. (Hydromermis spp.) + SX, Isaria fumosorosea + SX, Isomermis spp. + SX, Lactobacillus acidophilus + SX, Lactobacillus brevis (brevis) + SX, Lactobacillus plantarum + SX, Lactobacillus spp. + SX, Lagenidium giganteum + SX, Lecanicillium lecanii KV01 Lecanicillium lecanii conidia of strain DAOM198499 + SX, Lecanicillium lecanii DAOM216596 Conidia of Lecanicillium lecanii conidia of strain DAOM216596 + SX, Lecanicillium muscarium (formerly Verticillium lecanii) strain Ve6 + SX, Limnomermis spp. + SX, Rhizobacter antibio Chicks 13-1 (Lysobacter antibioticus strain 13-1) + SX, Rhizobacter enzymogenes strain C3 (Lysobacter enzymogenes strain C3) + SX, Maupasina weissi + SX, Mermis nigrescens + SX, Mesomermis spp. + SX, Metarhizium anisopliae strain F52 + SX, Metarhizium anisopliae var.acridum + SX, Priaso BIPESCO 5 / F52 strain (Metarhizium anisopliae var. Anisopliae BIPESCO 5 / F52) + SX, Metarhizium f lavoviride) + SX, Meshschnikowia dimerum + SX, Metschnikowia fructicola strain NRRLY-30752 + SX, Microsphaeropsis ochracea + SX, SX, Microsphaeropsis ochracea Monacrosporium phymatopagum + SX, Mucor hiemalis + SX, Muscodor albus strain 620 + SX, Muscodor albus strain QST 20799 (Muscodor albus strain QST 20799) + SX Muscodor albus strain SA13 (Muscodor albus strain SA13) + SX, Muscodor roseus strain A3-5 (Muscodor roseus strain A3-5) + SX, Milotesium verrucaria strain AARC-0255 (Myrothecium verrucaria strain AARC-0255) + SX, Neomesomermis spp. + SX, Neoparasitylenchus rugulosi + SX, Nomura Air Lily CG128 (Nomuraea rileyi) strain CG128) + SX, Nomura Air Lily GU87401 (Nomuraea rileyi strain GU87401) + SX, Nomura Air Lily SA86101 (Nomuraea rileyi strain SA86101) + SX, Nomura Air Lily SR86151 (Nomuraea rileyi strain SR86151) + SX, Nomura Lily VA9101 (Nomuraea rileyi strain VA9101) + SX, Nosema locustae + SX, Octomyomermis spp. + SX, Ophiostoma piliferum strain D97 + SX, Apopka 97 strain (currently known as Apopka strain 97) (Pecilomyces fumosoroseus Apopka strain 97, Now, Isaria fumosorosea Apopka strain 97) + SX, Paecilomyces lilacinus strain 251 (Paecilomyces lilacinus strain 251) + SX, Pekiromyces tenuipes strain T1 (Paecilomyces tenuipes strain T1) + SX, Pekyromyces barriotti Q-09 (Paecilomyces variotii strain Q-09) + SX, Paenibacillus alvei strain 2771 (Paenibacillus alvei strain 2771) + SX, Paenibacillus alvei strain 46C3 + SX, Paenibacillus alvei strain III2E (Paenibacillus alvei strain III2E) + SX Paenibacillus alvei strain III3DT-1A (Paenibacillus alvei strain III3DT-1A) + SX, Paenibacillus alvei strain T36 + SX, Paenibacillus macerans + SX, Paenibacillus polymixer (SX) Paenibacillus polymyxa strain AC-1) + SX, Paenibacillus polymyxa strain BS-0105 + SX, Paenibacillus popilliae + SX, Pandora delphacis + SX, Pantoea Agglomerans strain E325 (Pantoea agglomerans strain E325) + SX, Pantoea vagans strain C9-1 (Pantoea vagans strain C9-1) + SX, Parasa Taferenkusu spp. (Parasitaphelenchus spp.) + SX, parasite Le hub de Sevilla spp. (Parasitorhabditis spp.) + SX, Parasa Iti Ren box spp. (Parasitylenchus spp.) + SX, Pasutsuria -
Nishizawae strain Pn1 (Pasteuria nishizawae strain Pn1) + SX, Pasturia penetrans + SX, Pasteuria ramose + SX, Pasturia usgae + SX, Pectovorum ec ) + SX, Penicillium bilaiae strain ATCC22348 (Penicillium bilaiae strain ATCC22348) + SX, Penicillium citrinum strain VFI-51 (Penicillium citrinum strain VFI-51) + SX, Penicillium vermiculatum + SX, Per Perutilimermis culicis + SX, Pasturia thoynei + SX, Phasmarhabditis hermaphrodita + SX, Ferrebiopsis gigantea VRA1992 strain (phlebiopsis gigantea) + SX, Physaloptera spp. (Physaloptera spp.) + SX, Phytopasola Palmi Phytophthora palmivora + SX, Pichia anomala strain WRL-076 (Pichia anomala strain WRL-076) + SX, Pichia guilliermondii strain Z1 + SX, Pichia guilliermonde Z8 strain (pichia guilliermondii strain Z8) ) + SX, Pochonia chlamydosporia isolate strain PC10 + SX, Pochonia chlamydosporia + SX, Protrellatus spp. + SX, P. aeruginosa PN1 strain PN1) + SX, Pseudomonas aeruginosa strain WS-1 + SX, Pseudomonas aureofaciens strain TX-1 + SX, Pseudomonas cepacia Wisconsin type J82 strain (Pseudomonas cepacia type Wisconsin strain J82) + SX, Pseudomonas cepacia type Wisconsin strain M54 (Pseudomonas cepacia type Wisconsin strain M54) + SX, Shi Pseudomonas chlororaphis strain 63-28 + SX, Pseudomonas chlororaphis strain AFS009 + SX, Pseudomonas chlororaphis MA342 strain (Pseudomonas chlororaphis strain MA342) + SX・ Fluorescens strain 1629RS (pseudomonas fluorescens strain 1629RS) + SX, Pseudomonas fluorescens strain A506 (pseudomonas fluorescens strain A506) + SX, Pseudomonas fluorescens strain CL145A (pseudomonas fluorescens strain CL145A) + SX, Pseudomonas strain (Pseudomonas fluorescens strain G7090) + SX, Pseudomonas fluorescens biover B strain XJ3 + SX, Pseudomonas fluorescens biover B XS18 strain (Pseudomonas fluorescens biover B strain XS18) + SX, SX Lessens biover A LRS12 (P seudomonas fluorescens biover A strain LRS12) + SX, Pseudomonas proradix + SX, Pseudomonas putida + SX, Pseudomonas reactans + SX, Pseudomonas resinmon ass SX resin , Pseudomonas rhodesiae strain HAI-0804 + SX, Pseudomonas sp. Strain CAB-02 (Pseudomonas sp. Strain CAB-02) + SX, Pseudomonas syringae strain 742RS (Pseudomonas syringae strain 742RS) + SX , Pseudomonas syringae strain MA-4 + SX, Pseudozyma flocculosa strain PF-A22UL + SX, Pterygodermattis spp. (Pterygodermatites spp.) + SX, puccinia thlaspeos strain woad + SX, Purpureocillium lilacinum + SX, Pythium oligandrum strain DV74 + SX, Pythium oligandrum strain M1 + SX, Rhodococcus globerulus strain AQ719 + SX, Romano Mermis spp. Romanomermis spp.) + SX, Saccharomyces cerevisiae strain LASO2 + SX, Scretinia minor strain IMI34414 + SX, Serratia entomophila + SX, 35 Strain (Serratia marcescens strain 35) + SX, Serratia marcescens strain SRM + SX, Seuratum cadarachense + SX, Sphaerulariopsis spp. + SX, spir Spirura guianensis + SX, Sporothrix insectorum + SX, Steinane・ Steinernema bibionis + SX, Steinernema carpocapsae + SX, Steinernema feltiae + SX, Steinernema glaseri + SX, seiin・ Steinernema riobrave + SX, Steinernema scapterisci + SX, Steinernema scarabaei + SX, Steinernema semakayai + SX, siamkayai Strelkovimermis peterseni + SX, Streptomyces acidiscabies strain RL-110T (Streptomyces acidiscabies strain RL-110T) + SX, Streptomyces candidus strain Y21007-2 (Streptomyces candidus strain Y21007-2) + SX, Streptomyces Streptomyces colombiensis + SX, Streptomyces galbus strain QST6047 (Streptomyces galbus strain QST6047) + SX, Streptomyces goshikiensis + SX, Streptomyces glyceobiis strain K61 g SX + Streptomyces lavendulae + SX, Streptomyces lydicus strain WYCD108US + SX, Streptomyces lydicus strain WYEC108 (Streptomyces lydicus strain WYEC108) + SX Streptomyces prasinus + SX, Streptomyces rimosus + SX, Streptomyces saraceticus + SX, Streptomyces sp.NRRL No.B-30145 (Streptomyces sp. strain NRRL No.B-30145) + SX, Streptomyces sp. WYE20 strain (Streptomyces sp. strain WYE20) + SX, Streptomyces sp. WYE 324 strain (Streptomyces sp. strain WYE 324) + SX, Streptomyces venezuelae + SX, Subaru spp. (Subulura spp.) + SX, Salpre Sulphuretylenchus elongatus + SX, Talaromyces flavus SAY-Y-94-01 (Talaromyces flavus strain SAY-Y-94-01) + SX, Talaromyces flavus V117b (Talaromyces flavus strain V117b) + SX, Tetrameres spp. (Tetrameres spp.) + SX, Terobania solenopsis + SX, Thiobacillus spp. + SX, Trichoderma album + SX, Trichoderma Asperoid J Trichoderma asperelloides strain JM41R) + SX, Trichoderma asperellum strain ICC012 (Trichoderma asperellum strain ICC012) + SX, Trichoderma asperellum strain T25 (Trichoderma asperellum T25) + SX, Trichoderma Aspererum strain T34 (Trichoderma asperellum strain T34) + SX, Trichoderma asperellum strain SKT-1 (Trichoderma asperellum strain SKT-1) + SX, Trichoderma asperellum strain TV1 (Trichoderma asperellum strain TV1) + SX, Trichoderma asperellum CNCM 1 1237 (Trichoderma atroviride strain CNCM 1-1237) + SX, Trichoderma atroviride strain LC52 + SX, Trichoderma atroviride strain IMI 206040 (Trichoderma atroviride strain IMI 206040) + SX, Trichoderma atroviride SC (Trichoderma atroviride strain IMI 206040) Trichoderma atroviride strain SC1) + SX, Trichoderma atroviride strain SKT-1 (Trichoderma atroviride strain S11) + SX, Trichoderma atroviride strain T11 + SX, Trichoderma agrovi strain ICC080s (ii) ) + SX, Trichoderma harzianum strain 21 (Trichoderma harzianum strain 21) + SX, Trichoderma harzi Nam DB 104 (Trichoderma harzianum strain DB 104) + SX, Trichoderma harzianum strain DSM 14944 (Trichoderma harzianum strain DSM 14944) + SX, Trichoderma harzianum strain ESALQ-1303 (Trichoderma harzianum strain ESALQ-1303) + SX, Trichoderma Haljianam ESALQ-1306 strain (Trichoderma harzianum strain ESALQ-1306) + SX, Trichoderma harzianum strain IIHR-Th-2 strain (Trichoderma harzianum strain IIHR-Th-2) + SX, Trichoderma harzianum strain ITEM908 strain (Trichoderma harzianum strain ITEM908) + SX, Trichoderma harzianum strain kd + SX, Trichoderma harzianum strain MO1 + SX, Trichoderma harzianum strain SF + SX, Trichoderma harzianum strain SF Trichoderma harzianum strain T22) + SX, Trichoderma harzianum strain T39 (Trichoderma harzianum strain T39) + SX, Trichoderma ha Trichoderma harzianum strain T78 + SX, Trichoderma harzianum strain TH35 + SX, Trichoderma harzianum rifai + SX, Trichoderma konzima (Trichoderma harzianum strain T78)・ Trichoderma lignorum + SX, Trichoderma polysporum strain IMI206039 + SX, Trichoderma spp. (Trichoderma spp.) + SX, Trichoderma stromaticum-41 Strain (Trichoderma virens strain G-41) + SX, Trichoderma virens strain GL-21 (Trichoderma virens strain GL-21, formaly Gliocladium virens GL-21) + SX, Trichoderma viride + SX, Tucumrela Paulo Metabolic Bora (Tsukamurella paurometabola) + SX, Typhula phacorrhiza strain 94671 + SX, Uro Claudium oodemanshii HRU3 strain (Ulocladium oudemansii strain HRU3) + SX, Bailimorpha spp.Q-09 strain (Vairimorpha spp. Strain Q-09) + SX, Varioborax paradoxus strain GF4526 + SX, Berty Syllium Alboatrum WCS850 (Verticillium alboatrum strain WCS850) + SX, Verticillium chlamydosporium + SX, Verticillium dahliae + SX, Verticillium regani NCIM1312 ( Verticillium lecani strain NCIM1312) + SX, Birgibacillus pantothenticus strain ATCC14576 + SX, Birgibacillus pantothenticus strain DSM491 + Vixibacillus pantothenticus strain DSM491 + SX Xanthomonas campestris + SX, ZE Rabudasu luminescence (Xenorhabdus luminescens) + SX, Zenorabudasu-Nematofira (Xenorhabdus nematophila) + SX, Zufutora-Radikansu (Zoophtora radicans) + SX, Adokusofiesu-Orana granules disease virus
BV-0001 strain (Adoxophyes orana granulosis virus strain BV-0001) + SX, Agrotis segetum nuclear polyhedrosis virus (NPV) + SX, Anagraoha falcifera nuclear polyhedrosis virus (Anagraoha falcifera NPV) + SX, Anticalcia gemmatalis mNPV + SX, Autographa californica mNPV + SX, Biston suppressoraria nuclear polyhedrosis virus (Biston suppressaria NPV) + SX, Bombyx mori NPV + SX, Cryptophlebia leucotreta GV + SX, Cydia pomonella granulosis virus V15 strain (Cydia pomonella GV strain) V15) + SX, Cydia pomonella granulosis virus V22 strain (Cydia pomonella GV strain V22) + SX, Dendrolimus puntactus cytoplasmic polyhedral virus (De ndrolimus punctatus cypovirus) + SX, Helicobelpa algera nuclear polyhedrosis virus BV-0003 (Helicoverpa armigera NPV strain BV-0003) + SX, Helicoberpa zea nuclear polyhedrosis virus (Helicoverpa zea NPV)) + SX Salicis nuclear polyhedrosis virus (Leucoma salicis NPV) + SX, Lymantria dispar nuclear polyhedrosis virus (Lymantria dispar NPV) + SX, Mamestra brassicae nuclear polyhedrosis virus (Mamestra brassicae NPV) + SX, Mamestra configurator Nuclear polyhedrosis virus (Mamestra configurata NPV) + SX, Neodiprion abietis nuclear polyhedrosis virus (Neodiprion abietis NPV) + SX, Neodiprion lecontei nuclear polyhedrosis virus (Neodiprion lecontei NPV)) + SX , Neodiprion sertifer NPV) + SX, Orgyia pseudonuclear polyhedrosis virus (Orgyia p seudotsugata NPV) + SX, Pepino mosaic virus strain CH2 isolate 1906 + SX, Petrimaea operculella granule disease virus (Phthorimaea operculella GV)) + SX, Pieris rapae granule disease virus ( Pieris rapae GV)) + SX, Plodia interpunctella GV + SX, Plutella xylostella GV)) + SX, Plutella xylostella GV + SX , Spodoptera albula mNPV) + SX, Spodoptera exempta mNPV) + SX, Spodoptera exigua nuclear polyhedrosis virus BV-0004 (Spodoptera exigua nuclear polyhedrosis virus Bpod-0004) mNPV strain BV-0004) + SX, Spodoptera frugiperda nuclear polyhedrosis virus (Spodoptera frugiperda mNPV) + SX, Spodoptera litorali Nuclear polyhedrosis virus (Spodoptera littoralis mNPV) + SX, Spodoptera litura NPV virus + SX, Tobacco mild tobamovirus strain U2 (Tobacco mild tobamovirus strain U2) + SX, zucchini yellow Group mosaic virus weak strain (Zucchini Yellow Mosaik Virus weak strain) + SX, Acaulospora spp. + SX, Ambispora spp. + SX, Archaeospora spp. + SX, Clarloy Species of the genus Deoglomus (Claroideoglomus spp., Formerly Glomus spp.) + SX, Claroideoglomus etunicatum (formerly Glomus etunicatum) + SX, Claroideoglomus claroideroid, formerly Claroideoglomus claroideroid SX, Diversispora spp. + SX, Entrophospora spp. + SX, Funelliformis (Funneliformi) s spp., formerly Glomus spp.) + SX, Fanelliformis mosseae (formerly Glomus mosseae) + SX, Geosiphon spp. + SX, Gigaspora spp. ) + SX, Gigaspora margarita + SX, Gigaspora rosea + SX, Glomus spp. + SX, Glomus aggregatum + SX, mus deserticola) + SX, Glomus monosporum + SX, Pacispora spp. + SX, Paraglomus spp. + SX, Paraglomus brasillianum, formerly Glomus brasillianum SX, Racocetra spp. + SX, Rhizophagus spp., Formerly Glomus spp. + SX, Rhizophagus clarus, formerly Glomus clarum + SX, Rhizophagus intra Rhizophagus intraradices + formerly Glomus intraradices + SX, Rhizophagus intraradices RTI-801 + SX, Rhizophagus irregularis (formerly Glomus intraradices) + SX, Rhizophagus irregularis DAOM 197198 (Rhizophagus irregularis) strain DAOM 197198) + SX, Scutellospora spp. + SX, Azorhizobium spp. + SX, Azorhizobium caulinodans + SX, Azospirillum azoillum AZ・ Brassense (Azospirillum brasilense strain Ab-V5) + SX, Azospirillum brasilence Ab-V5 (Azospirillum brasilense strain Ab-V5) + SX, Azospirillum brasilence Ab-V5 V6 strain (Azospirillum brasilense strain Ab-V6) + SX, Azospirilla・ Kaolino dance (Azospirillum caulinodans) + SX, Azospirillum halopraeferens + SX, Azospirillum irakense + SX, Azospirillum lipoferum (B) .) + SX, Bradyrhizobium elkanii + SX, Bradyrhizobium elkanii SEMIA 587 (Bradyrhizobium elkanii strain SEMIA 587) + SX, Bradyrizobium elkani SEMIA 5019 (Bradyrhizobium elkanii) SEMIA 5019) + SX, Bradyrhizobium japonicum + SX, Bradyrhizobium japonicum TA-11 strain + SX, Bradyrizobium japonicum USDA 110 strains (Bradyrhizobium japonicum strain USDA 110) + SX, Bradyrhizobium riaoningens (Bradyrhizobium liaoni) ngense) + SX, Bradyrhizobium lupini + SX, Bradyrhizobium sp. (Arachis) + SX, Bradyrhizobium sp. (Bradyrhizobium sp. (Arachis)) (Vigna)) + SX, Delftia acidovorans + SX, Delftia acidovorans strain RAY209 + SX, Metylobacterium spp. + SX, Mesozobium siseri Mesorhizobium ciceri) + SX, Mesorhizobium huakii + SX, Mesorhizobium loti + SX, Mesorhizobium spp. + SX, Rhizobium SX Rhizobium galegae) + SX, Rhizobium leguminosarum bv. Phaseoli + SX, Rhizobium leguminosarum bv. bv. Trifolii) + SX, Rhizobium trifolii + SX, Rhizobium tropici + SX, R + SX, Sinorhizobium meliloti + SX.

The component selected from the group (j) is usually prepared by a culture method known in the art. For example, when the component selected from the group (j) is a bacterium or a fungus, it is prepared by a medium known in the art and a known fermentation method. When this component is a bacterium or a fungus, the preparation contains × 10 ⁴ to 1 × 10 ¹³ CFU (colony forming unit), preferably 1 × 10 ⁸ to 1 × 10 ¹² CFU of this component per gram. . When this component is a virus, the preparation is 1 × 10 ⁴ to 1 × 10 ¹³ embedded bodies (sometimes referred to as occlurion bodies, sometimes referred to as Obs), preferably 1 × 10 ⁸ to 1 × Contains this component of 10 ¹² embedded bodies (sometimes referred to as occlurion bodies, sometimes referred to as Obs). When the component is a nematode, the preparation contains 1 × 10 ⁴ to 1 × 10 ¹³ individuals, preferably 1 × 10 ⁸ to 1 × 10 ¹² individuals per gram.

The weight ratio between the application amount of the present compound and the application amount of this component in the composition A is not particularly limited, but the type of plant to be protected, harmful arthropods to be controlled, harmful nematodes, The weight ratio can be appropriately adjusted to an optimum weight ratio depending on the type and frequency of harmful molluscs, phytopathogenic microorganisms or weeds, formulation forms, application timing, application method, application location, weather conditions, and the like. For example, in the agricultural field, when applied to plants (especially, foliage, seeds, vegetative organs) or when applied to a cultivation carrier (especially soil) for cultivating plants, the following weight ratios can be mentioned.
The weight of this component selected from group (j) means the weight of the preparation. For example, a weight ratio of 1: 500 means that the application amount of a preparation of one or more components selected from group (j) is 500 parts by weight per 1 part by weight of the compound.

  Weight ratio [(present compound) :( present component)] = 1: 10000 to 10000: 1, specifically, for example, 1: 9000, 1: 8000, 1: 7000, 1: 6000, 1: 5000, 1: 4000, 1: 3000, 1: 2000, 1: 1000, 1: 900, 1: 800, 1: 700, 1: 600, 1: 500, 1: 400, 1: 350, 1: 300, 1: 250, 1: 200, 1: 150, 1: 100, 1:90, 1:80, 1:70, 1:60, 1:50, 1:40, 1:30, 1:20, 1:19, 1: 18, 1:17, 1:16, 1:15, 1:14, 1:13, 1:12, 1:11, 1:10, 1: 9, 1: 8, 1: 7, 1: 6, 1: 5, 1: 4, 1: 3, 1: 2, 1: 1.5, 1: 1, 1.5: 1, 2: 1, 3: 1, 4: 1, 5: 1, 6 1, 7: 1, 8: 1, 9: 1, 10: 1, 11: 1, 12: 1, 13: 1, 14: 1, 15: 1, 16: 1, 17: 1, 18: 1, 19: 1, 20: 1, 30: 1, 40: 1, 50: 1, 60: 1, 70: 1, 80: 1, 90: 1, 100: 1, 150: 1, 200: 1, 250: 1, 300: 1, 400: 1, 500: 1, 600: 1, 700: 1, 800: 1, 900: 1, 1000: 1, 2000: 1, 3000: 1, 4000: 1, 5000: 1, 6000: 1, 7000: 1, 8000: 1, 9000: 1, 10000: 1.

  This compound can be used in combination with or in combination with chemical fertilizers (such as ammonium sulfate, phosphorous acid, ammonium nitrate, urea, ammonium chloride).

  When this compound or composition A is used as a harmful arthropod control composition, it is usually used as a composition further containing an inert carrier (hereinafter referred to as composition B). Composition B is usually a mixture of the present compound or composition A and an inert carrier such as a solid carrier, liquid carrier, or gaseous carrier, and a surfactant or other formulation adjuvant is added as necessary. Emulsions, oils, powders, granules, wettable powders, flowables, microcapsules, aerosols, smokers, poison baits, resin preparations, shampoos, pastes, foams, carbon dioxide preparations, tablets Etc. are formulated. These preparations may be used after being processed into mosquito coils, electric mosquito mats, liquid mosquito traps, fumigants, fumigants, sheet preparations, spot-on agents, or oral treatments. Composition B usually contains 0.0001 to 95% by weight of the present compound or composition A.

  Examples of the solid carrier include clays (kaolin clay, diatomaceous earth, bentonite, acid clay), dry silica, wet silica, talc, ceramic, and other inorganic minerals (sericite, quartz, sulfur, activated carbon, calcium carbonate, etc.), Fine powder and granular materials such as chemical fertilizers (ammonium sulfate, phosphorous acid, ammonium nitrate, urea, ammonium chloride, etc.), and synthetic resins (polyester resins such as polypropylene, polyacrylonitrile, polymethyl methacrylate, polyethylene terephthalate, nylon-6, And nylon resins such as nylon-11 and nylon-66, polyamide resins, polyvinyl chloride, polyvinylidene chloride, and vinyl chloride-propylene copolymers).

  Examples of the liquid carrier include water, alcohols (methanol, ethanol, isopropyl alcohol, butanol, hexanol, benzyl alcohol, ethylene glycol, propylene glycol, phenoxyethanol, etc.), ketones (acetone, methyl ethyl ketone, cyclohexanone, etc.), aromatic hydrocarbons (Toluene, xylene, ethylbenzene, dodecylbenzene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, kerosene, light oil, etc.), esters (ethyl acetate, butyl acetate, isopropyl myristate, Ethyl oleate, diisopropyl adipglycerate, diisobutyl adipate, propylene glycol monomethyl ether acetate, etc.), nitriles (acetonitrile, Sobutyronitrile, etc.), ethers (diisopropyl ether, 1,4-dioxane, 1,2-dimethoxyethane, diethylene glycol dimethyl ether, diethylene glycol monomethyl ether, propylene glycol monomethyl ether, dipropylene glycol monomethyl ether, 3-methoxy-3-methyl-1 -Butanol etc.), amides (DMF, dimethylacetamide etc.), sulfoxides (DMSO etc.), propylene carbonate and vegetable oils (soybean oil, cottonseed oil etc.).

  Examples of the gaseous carrier include fluorocarbon, butane gas, LPG (liquefied petroleum gas), dimethyl ether, and carbon dioxide gas.

  Examples of the surfactant include nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene alkyl aryl ether, and polyethylene glycol fatty acid ester, and anions such as alkyl sulfonate, alkyl benzene sulfonate, and alkyl sulfate. Surfactant is mentioned.

Other formulation adjuvants include sticking agents, dispersants, colorants, antifreezes and stabilizers, such as casein, gelatin, sugars (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin Derivatives, bentonite, synthetic water-soluble polymers (polyvinyl alcohol, polyvinyl pyrrolidone, polyacrylic acids, etc.), acidic isopropyl phosphate, 2,6-di-tert-butyl-4-methylphenol, and BHA (2-tert-butyl- 4-methoxyphenol and a mixture of 3-tert-butyl-4-methoxyphenol).
Examples of the colorant include a red pigment, a blue pigment, a green pigment, and a yellow pigment. Specific examples include monazole red, cyanine green, Prussian blue, and brilliant blue. In particular, in the case of granules and fine granules, a colorant can also be added to make it easier to check the granules and fine granules when applied or after application. In addition, when the composition B is applied to plant seeds and vegetative organs, a colorant can also be added to make it easier to confirm that the composition has been applied.

Examples of the base material of the resin preparation include vinyl chloride polymers and polyurethanes. These base materials include phthalic acid esters (dimethyl phthalate, dioctyl phthalate, etc.), adipic acid esters, if necessary. A plasticizer such as stearic acid may be added. The resin formulation is obtained by kneading the present compound in the base material using a normal kneading apparatus, and then molding by injection molding, extrusion molding, press molding, etc., and if necessary, further undergoes molding, cutting, etc. , Plate-like, film-like, tape-like, net-like, or string-like resin preparations. These resin preparations are processed, for example, as animal collars, animal ear tags, sheet preparations, attracting strings, or gardening supports.
Examples of the bait base include cereal flour, vegetable oil, sugar, crystalline cellulose and the like, and if necessary, antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid, and preservatives such as dehydroacetic acid. Additives for preventing accidental eating by children and pets such as pepper powder, cheese flavoring, onion flavoring, and pest-attracting flavoring such as peanut oil are added.

  By applying an effective amount of the present compound or composition A directly to harmful arthropods and / or to the habitat of harmful arthropods (plants, plant cultivation carriers, indoors, animals, wood, etc.) Can control harmful arthropods. The habitat mentioned here includes not only the place where harmful arthropods live, but also the place where they are expected to live. When controlling harmful arthropods, it is usually used in the form of Composition B.

  The plant cultivation carrier is a plant support and may be any material on which the plant can grow. Examples thereof include soil, a seedling mat, and water. Specific materials for the soil and seedling mat include, for example, sand, pumice, vermiculite, diatomaceous earth, gel material, polymer material, rock wool, glass wool, wood chip and bark.

  When the composition B is used for controlling harmful arthropods in the agricultural field, the application amount is the type of plant to be applied, the type and frequency of occurrence of harmful arthropods to be controlled, formulation form, application time, application method, It can be changed over a wide range depending on the application location and weather conditions. Usually, the application amount of one active ingredient is 1 to 10000 g per ha, preferably 5 to 5000 g, more preferably 50 to 2000 g (specifically, for example, 100 g, 200 g, 500 g). When the composition B is formulated into an emulsion, wettable powder, flowable agent, etc., the concentration of one active ingredient is usually 0.01 to 10000 ppm, preferably 0.1 to 5000 ppm, more preferably 1 to It is diluted with water so as to be 1000 ppm (specifically, for example, 10 ppm, 100 ppm, 500 ppm) and applied. When the composition B is formulated into granules, powders, etc., it is usually applied as it is.

  These preparations and water dilutions of these preparations may be sprayed directly on harmful arthropods or plants such as crops to be protected from harmful arthropods, and harmful arthropods that inhabit cultivated land You may treat to this soil in order to control.

  Moreover, it can also process by methods, such as winding the resin formulation processed into the sheet form or the string form around the crop, stretching it around the crop, and laying on the stock soil.

When the composition B is used for controlling harmful arthropods inhabiting in a house, the amount applied is one active ingredient per 1 m ² of treatment area when treated on the surface, and is usually 0.01. -1000 mg, preferably 10-500 mg, more preferably 20-400 mg (specifically, for example, 25 mg, 50 mg, 400 mg). When processing in a space, one active ingredient per 1 m ³ of processing space The amount is usually 0.01 to 500 mg. When the composition B is formulated into an emulsion, wettable powder, flowable, etc., it is usually diluted with water so that the active ingredient concentration is 0.1 to 10,000 ppm, and applied to oils, aerosols, Smoke, poison bait, etc. are applied as they are.

  When the composition B is used for controlling ectoparasites of animals (for example, domestic animals such as cattle, horses, pigs, sheep, goats, chickens, and small animals such as dogs, cats, rats, mice, etc.), It can be used in a known manner. As a specific method of use, for the purpose of systemic suppression, for example, administration by tablet, feed mixing, suppository, injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.) is intended for non-systemic suppression. In this case, for example, an oil agent or an aqueous liquid is sprayed, a pour-on treatment or a spot-on treatment is performed, the animal is washed with a shampoo preparation, or a resin preparation is attached to the animal with a collar or ear tag. When administered to animals, the amount per active ingredient is usually in the range of 0.1 to 1000 mg per kg of animal body weight.

  In the present invention, the plant includes the whole plant and a specific part of the plant. Specific parts of plants include, for example, foliage, flowers, ears, fruits, trunks, branches, canopies, seeds, vegetative organs and seedlings.

  The vegetative reproductive organ means a plant root, stem, leaf or the like that has the ability to grow when the part is separated from the main body and placed in the soil. Examples of vegetative reproductive organs include tuberous root, creeping root, bulb, corm or solid bulb, tuber, rhizome, and stolon. , Rhizopholes, cane cuttings, propagules and vine cuttings. The toothpick is sometimes referred to as a runner, and the basket is also referred to as a pearl bud, which is divided into a broad bud and a bulbil. The vine means shoots (a general term for leaves and stems, shoot) such as sweet potatoes and yams. A bulb, a bulb, a tuber, a rhizome, a stem fragment, a root bearing body or a tuberous root is collectively called a bulb. Potato cultivation begins with planting tubers in the soil, but the tubers used are commonly referred to as seed pods.

  Seedlings include seedlings and saplings.

  Examples of the treatment method of the composition B include foliage treatment, soil treatment, root treatment, shower treatment, smoke treatment, water surface treatment, seed treatment, and hydroponic liquid treatment.

Examples of the foliage treatment include a method in which the composition B is treated on the surfaces of foliage, tree trunks, fruits, flowers, or ears.
Examples of the root treatment include a method of immersing the root in a chemical solution containing the composition B, and a method of attaching a solid preparation containing the composition B to the root of the plant.
Examples of soil treatment include soil spraying, soil mixing, and chemical irrigation into soil. In addition, examples of the place where soil treatment is performed include, for example, planting holes, rowing, near planting holes, near rowing, the entire cultivation area, plant land, inter-stock, under-trunk, main trunk, cultivation soil, nursery box, raising seedling. Examples include trays and nurseries. Examples of the treatment time include the sowing time before sowing, at the time of sowing, after sowing, the seedling raising period, before planting, at the time of planting, and after the planting. Moreover, in the said soil treatment, the composition B may be processed to a plant simultaneously, and solid fertilizers, such as a paste fertilizer containing the composition B, may be applied to soil. Moreover, you may mix with an irrigation liquid, for example, the injection | pouring to irrigation equipments (irrigation tube, irrigation pipe, a sprinkler, etc.), the mixing to a streak water solution, mixing to a hydroponic liquid etc. are mentioned. In addition, the irrigation liquid and the active ingredient can be mixed in advance, and can be treated using an appropriate irrigation method such as the above irrigation method or other watering or watering.
As a shower process, the method of showering the dilution liquid of the composition B to the fruit after harvest is mentioned, for example.
The soot treatment includes, for example, a method in which the diluted solution of the composition B is made into a mist and scattered in the air so as to adhere to the foliage and fruits of the plant.
Examples of the water surface treatment include a method of spraying a chemical solution containing the composition B or a solid preparation containing the composition B on a paddy field in a flooded state.
Seed treatment includes, for example, treatment of the composition B onto seeds or vegetative reproductive organs. Specifically, for example, the suspension of the composition B is sprayed onto the seed surface or the vegetative reproductive organ surface. Spray treatment, smear treatment to apply composition B to seeds or vegetative organs, immersion treatment to immerse seeds in chemical solution of composition B for a certain period of time, coat seeds or vegetative reproductive organs with carrier containing composition B The method (film coating process, pellet coating process, etc.) to do is mentioned. As the above-mentioned vegetative reproductive organs, seed pods are particularly mentioned.
When the composition A is processed into seeds or vegetative reproductive organs, the composition A can be processed as a single preparation into the seeds or vegetative reproductive organs, or the composition A can be divided into a plurality of different preparations and divided into seeds. Alternatively, it can be processed into vegetative organs. Examples of the method of treating the composition A as a plurality of different preparations divided into multiple times include, for example, treating a preparation containing only the present compound as an active ingredient and air-drying the seeds or vegetative reproductive organs, and then containing the present ingredient. A method for treating the preparation; and a method for treating the preparation containing the present ingredient other than the treated ingredient after treating the preparation containing the present compound and the present ingredient as active ingredients and air-drying the seeds or vegetative organs .
Examples of the hydroponic liquid treatment include a method of mixing or mixing a chemical solution containing the composition B or a solid preparation containing the composition B into the hydroponic liquid (hydroponic liquid mixing treatment, hydroponic liquid mixing treatment, etc.), etc. Is mentioned.

  When the composition B is processed into seeds or vegetative reproductive organs, a composition containing at least one of the components having bactericidal activity selected from the group (b) and the group (j) is used. Is preferred. Under the present circumstances, you may process this compound to the commercially available seed or vegetative reproductive organ by which this component which has one or more bactericidal activity chosen from a group (b) and a group (j) was processed.

Manganese, copper, zinc and the like may be treated simultaneously when the composition B is treated on seeds or vegetative organs.
The seeds or vegetative organs treated with the composition B are sown or planted in a field by a usual method.

When the composition B is treated by seeds or vegetative reproductive officers, the application amount of the composition B is usually 0.001 to 100 g, preferably 0.02 to 50 g, per 1 kg of seeds or vegetative reproductive organs. The application amount per one active ingredient contained in is usually 0.001 to 100 g, preferably 0.01 to 50 g, more preferably 0.1 to 10 g per 1 kg of seeds or vegetative organs. For example, the following processing amount may be mentioned.
0.05 g of active ingredient per 1 kg of seeds or vegetative organs;
0.5 g of active ingredient per 1 kg of seeds or vegetative organs;
5g active ingredient per kg seed or vegetative organ.

  When the composition B is processed into seeds or vegetative organs, an adjuvant may be mixed with the composition B as necessary.

  When the composition B is used for controlling harmful arthropods, this compound and this component may be applied to different places. Specifically, for example, seed treated with either this compound or this component Or before and after planting a vegetative reproductive organ on a cultivation carrier (for example, soil etc.), you may apply the other to this cultivation carrier.

The seed or vegetative organ holding the present compound or composition A in the present invention means a state where the present compound or composition A is attached to the surface of the seed or vegetative reproductive organ. The seed or vegetative reproductive organ holding the present compound or composition A has a material other than this compound or composition A before and after the compound or composition A is attached to the seed or vegetative reproductive organ. It may be attached.
Moreover, when the composition A adheres as a layer on the surface of the seed or vegetative organ, the layer is composed of one layer or a plurality of layers. In the case of a plurality of layers, each layer is a layer containing one or more active ingredients, or a layer containing one or more active ingredients and a layer containing no active ingredients. Become.
The seed or vegetative organ holding the present compound or composition A is, for example, applying the composition B containing the present compound or composition A to the seed or vegetative organ using the above-mentioned seed treatment method. You can get by yo.

  More specifically, the treatment method of the composition B is planting treatment (planting hole spraying, planting hole treatment soil mixing), plant source processing (stock source spraying, strain source soil mixing, strain source irrigation, late seedling stage strain) Original treatment), grooving treatment (spreading grooving, mixing grooving soil), cropping treatment (spreading, sprinkling soil mixing, growing season sprinkling) Soil mixing at the time of sowing), full surface treatment (full surface soil application, full surface soil mixing), side surface treatment, water surface treatment (water surface application, water surface application after flooding), other soil spraying treatment (growth season foliar spraying, Under the crown or around the trunk, soil surface spray, soil surface mixing, sowing hole spray, buttocks surface spray, inter-plant spray), other irrigation treatment (soil irrigation, seedling irrigation treatment, chemical solution injection treatment, local irrigation, chemical solution (Drip ligation, Chemigation), seedling box treatment (spreading seedling box, seedling box irrigation, seedling box chemical solution flooding) Nursery tray treatment (nursery tray spraying, seedling tray irrigation, seedling tray chemical solution flooding), nursery bed treatment (seedbed spraying, nursery bed irrigation, water seedling surrogate seedling spraying, seedling soaking), floor soil mixing treatment (floor soil mixing, floor soil before sowing) Mixing, sowing before sowing at seeding, spreading after sowing at sowing, admixing with soil covering, and other treatments (mixing soil, pouring, topsoil mixing, soil mixing in raindrop, planting position treatment, spraying granule inflorescence, paste fertilizer mixing , Mixed with hydroponic liquid, mixed with hydroponic liquid).

  The composition B can be used as a pest control agent for harmful arthropods in agricultural fields such as fields, paddy fields, orchards, and non-cultivated land such as lawns and forests.

Examples of plants that can use the composition B include the following: crops; corn, rice, wheat, barley, rye, oat, sorghum, cotton, soybean, peanut, buckwheat, sugar beet, rapeseed, canola, sunflower, sugarcane, tobacco , Triticale, kidney bean, lentil, azuki bean, cowpea, mung bean, urado bean, safflower beans, pike, moss bean, tepary bean, broad bean, pea, chickpea, lentil, lupine, pigeon bean, alfalfa, etc.
Vegetables: Solanum vegetables (eggplants, tomatoes, peppers, peppers, potatoes, bell peppers, etc.), cucumbers (cucumbers, pumpkins, zucchini, watermelons, melons, squash, etc.), cruciferous vegetables (radish, turnip, horseradish, Cole rabi, Chinese cabbage, cabbage, mustard, broccoli, cauliflower, etc.), Asteraceae vegetables (burdock, shungiku, artichoke, lettuce, etc.), lily family vegetables (leek, onion, garlic, asparagus), celery family vegetables (carrot, Parsley, celery, American scallop, etc.), red crustacean vegetables (spinach, chard, etc.), perilla (vegetables, mint, basil, lavender, etc.), strawberry, sweet potato, yam, taro, etc.
Fruit trees; pears (apples, pears, Japanese pears, quince, quince, etc.), nuclear fruits (peaches, plums, nectarines, ume, sweet cherry, apricots, prunes, etc.), citrus (satsuma mandarin, orange, lemon, lime, grapefruit) ), Nuts (chestnut, walnut, hazel, almond, pistachio, cashew nut, macadamia nut, etc.), berries (blueberry, cranberry, blackberry, raspberry, etc.), grape, oyster, olive, loquat, banana, coffee, Date palm, coconut palm, etc.
Others: Cha, mulberry, flowering trees, roadside trees (ash, birch, dogwood, eucalyptus, ginkgo, lilac, maple, oak, poplar, redwood, fu, sycamore, zelkova, kurobe, mominoki, tsuga, rat, pine, spruce, yew ) Etc., flower buds, foliage plants, forest plants, fern, pastures.

  The above-mentioned plant varieties are not particularly limited as long as they are generally cultivated varieties.

  The aforementioned plants may be plants that can be produced by natural mating, plants that can be generated by mutation, F1 hybrid plants, and transgenic plants (also referred to as genetically modified plants). These plants generally have resistance to herbicides, accumulation of toxic substances against pests (also called pest resistance), suppression of susceptibility to diseases (also called disease resistance), increased yield potential, biological and abiotic It has characteristics such as improved resistance to stress factors and quality modification of the product (for example, increase / decrease in the content of specific components, change in composition, improvement in storage stability or processability).

  An F1 hybrid plant is a first-generation hybrid obtained by crossing two varieties of varieties, and is generally a plant having characteristics of hybrid strength having a trait superior to both of parents. Transgenic plants have characteristics that cannot be easily obtained by cross breeding, mutagenesis or natural recombination in the natural environment by introducing foreign genes from other organisms such as microorganisms. It is a plant that has been granted.

Examples of the technique for producing the above plant include conventional breeding techniques; gene recombination techniques; genome breeding techniques; new breeding techniques; genome editing techniques. The conventional breed improvement technique is a technique for obtaining a plant having desirable properties by mutation or crossing. Genetic recombination technology is a technology that gives a new property to an organism by removing the target gene (DNA) from a certain organism (for example, a microorganism) and introducing it into the genome of another target organism, or a plant. Antisense technology or RNA interference technology that confer new or improved properties by silencing other genes present. The genome breeding technique is a technique for improving the efficiency of breeding using genome information, and includes a DNA marker (also referred to as genome marker or gene marker) breeding technique and genomic selection. For example, DNA marker breeding is a method in which a progeny having a target useful trait gene is selected from a large number of mating progeny using a DNA marker, which is a DNA sequence that serves as a marker for the location of a specific useful trait gene on the genome. is there. By analyzing the progeny of the mating plant using a DNA marker when it is a young plant, it has a feature that the time required for breeding can be effectively shortened.
Genomic selection is a technique that creates prediction formulas from previously obtained phenotypes and genome information, and predicts characteristics without evaluating phenotypes from prediction formulas and genome information, contributing to efficient breeding. It is possible technology. New breeding techniques is a general term for breeding techniques that combine molecular biological techniques. For example, cisgenesis / intragenesis, oligonucleotide-directed mutagenesis, RNA-dependent DNA methylation, genome editing, grafting to GM rootstock or hogi, reverse breeding, agroinfiltration, seed production technology (Seed Production) Technology, SPT). The genome editing technique is a technique for converting genetic information in a sequence-specific manner, and can delete base sequences, replace amino acid sequences, introduce foreign genes, and the like. Examples of such tools include zinc finger nuclease (Zinc-Finger, ZFN), Talen (TALEN), Crisper Cassine (CRISPR / Cas9), and Crisper CP1 (CRISPER / Cpf1) that can sequence-specifically cleave DNA. And Meganuclease. In addition, there are sequence-specific genome modification techniques such as CAS9 nickase and Target-AID created by modifying the aforementioned tools.

  Examples of the plants described above include, for example, genetically modified crops in the electronic information site (http://www.isaaa.org/) of the INTERNATINAL SERVICE for the ACQUISITION of AGRI-BIOTECH APPLICATIONS, ISAAA. Plants listed in the registration database (GM APPROVAL DATABASE). More specifically, for example, herbicide-tolerant plants, pest-resistant plants, disease-resistant plants, product quality modification (for example, increase / decrease in content of components, change in composition, improvement in preservability or processability) And dwarf trait-modified plants, abiotic stress-tolerant plants, or plants with traits that are related to growth or yield.

Examples of plants given herbicide tolerance are listed below.
Mechanisms of resistance to herbicides, for example, reduce the affinity between herbicides and their targets; rapid metabolism of herbicides (such as degradation and modification) by the expression of enzymes that inactivate herbicides; Inhibition of uptake into plants; and inhibition of transfer of herbicides in plants.

Plants to which herbicide tolerance has been imparted by genetic recombination technology include, for example, protoporphyrinogen oxidase (hereinafter abbreviated as PPO) herbicides such as flumioxazin; 4-hydroxyphenylpyruvic acid such as isoxaflutol and mesotrione Dioxygenase (hereinafter abbreviated as HPPD) inhibitors; imidazolinone herbicides such as imazetapyr, acetolactate synthase (hereinafter abbreviated as ALS) inhibitors such as sulfonylurea herbicides such as thifensulfuronmethyl; glyphosate 5-enolpyruvylshikimate-3-phosphate synthase (hereinafter abbreviated as EPSPS) inhibitors; glutamine synthase inhibitors such as glufosinate; auxin-type herbicides such as 2,4-D and dicamba; There are plants with tolerance to oxynyl herbicides. Preferred herbicide-tolerant transgenic plants are wheat such as wheat, barley, rye, oat, canola, sorghum, soybean, corn, cotton, rice, rapeseed, sugar beet, sugar cane, grape, lentil, sunflower, alfalfa, pome , Fruits, coffee, tea, strawberry, buckwheat, tomato, potato, cucumber, lettuce and other vegetables, more preferably wheat, barley, rye, oats, wheat, soybean, corn, rice, grape, tomato, Potato, pear.
The specific herbicide-tolerant plants are shown below.
Glyphosate herbicide-tolerant plants: Glyphosate modified from the glyphosate-resistant EPSPS gene (CP4 epsps) derived from Agrobacterium tumefaciens strain CP4 and the glyphosate N-acetyltransferase gene derived from Bacillus licheniformis N-acetyltransferase gene (gat4601 or gat4621), glyphosate oxidase gene (goxv247) derived from Ochrobacterum anthropi strain LBAA, or EPSPS gene having a glyphosate resistant mutation derived from maize (Zea mays) ( mepsps or 2mepsps). The main plants are, for example, alfalfa (Medicago sativa), Argentine canola (Brassica napus), cotton (Gossypium hirsutum L.), creeping bentgrass (Agrostis stolonifera), corn (Zea mays L.) polish canola (Brassica rapa), Examples include potato (Solanum tube HDDrosum L.), soybean (Glycine max L.), sugar beet (Beta vulgaris) and wheat (Triticum aestivum). Several glyphosate-tolerant plants are commercially available. For example, genetically modified plants introduced with CP4 epsps are trade names including “Roundup Ready (registered trademark)”, and genetically modified plants introduced with gat4601 or gat4621 are “Optimum GAT (trademark)” and “Optimum (registered trademark)”. ) Gly canola "and other transgenic plants into which mepsps or 2mepsps have been introduced are sold under the" GlyTol (TM) "brand name. More specific glyphosate-tolerant plants include, for example, corn "Roundup Ready (trademark) Maize", "Roundup Ready (trademark) 2 Maize", "Agrisure (trademark) GT", "Agrisure (trademark) GT / CB / "LL", "Agrisure (TM) GT / RW", "Agrisure (TM) 3000GT", "YieldGard (TM) VT (TM) Rootworm (TM) RR2" and "YieldGard (TM) VT Triple"; Ready (TM) Soybean "and" Optimum GAT (TM) "; Cotton is" Roundup Ready (TM) Cotton "," Roundup Ready (TM) Flex Cotton "and" GlyTol (TM) "; Canola is" Roundup Ready (TM) " Canola "and" Optimum (R) Gly canola "; Alfalfa is" Roundup Ready (TM) Alfalfa "; Rice is" Roundup Ready Rice "; Sugarcane is" Roundup Ready (TM) sugarbeet "and" InVigor (TM) sugarbeet " Sold under the trade name "Roundup Ready (trademark) wheat" (Triticum aestivum) It has been.
Glyphosate herbicide-tolerant plants: the gene for phosphinothricin N-acetyltransferase (PAT) from Streptomyces hygroscopicus (bar), Streptomyces bilidochrome One or more of PAT gene (pat) derived from Mogenes (Streptomyes viridochromogenes) or synthesized PAT gene (pat syn) derived from Streptomyces viridochromogenes Tu494 strain (Streptomyes viridochromogenes strain Tu494) It is obtained by introducing. Major plants include, for example, Argentine canola (Brassica napus), chicory (Cichorium intybus) cotton (Gossypium hirsutum L.), corn (Zea mays L.) polish canola (Brassica rapa), rice (Oryza sativa L.), soybean (Glycine max L.) and sugar beet (Beta vulgaris). Some glufosinate-tolerant plants are commercially available. For example, transgenic plants introduced with bar or pat are sold under the trade names of “LibertyLink ™”, “InVigor ™”, or “WideStrike ™”. More specific glyphosate-tolerant plants include, for example, corn “Roundup Ready ™ 2”, “Liberty Link ™”, “Herculex ™ I”, “Herculex RW”, “Herculex XTRA ™”. , "Agrisure (trademark) GT / CB / LL", "Agrisure (trademark) CB / LL / RW" and "Bt10"; Cotton is "FiberMax (trademark) Liberty Link (trademark)"; Rice is "Liberty Link (trademark)" ) Rice ”; Canola is sold under the trade name“ inVigor ™ Canola ”; Soybean is sold under the trade name“ Liberty Link ™ Soybean ”;
Oxynyl herbicide (eg bromoxynil) resistant plant: obtained by introducing a nitrilase gene (bxn) derived from Klebsiella pneumoniae subsp. Ozaenae. Examples of main plants include Argentine canola (Brassica napus), cotton (Gossypium hirsutum L.), and tobacco (Nicotiana tabacum L.). Several oxynyl herbicide resistant plants are commercially available. For example, it is sold under the trade name including “Navigator (trademark)” or “BXN (trademark)”. As more specific oxynyl herbicide-tolerant plants, for example, cotton is sold under the trade name “BXN ™ Cotton”; Argentine canola is sold under the trademark “Navigator ™ Cotton”.
ALS herbicide-tolerant plants: Carnation (Dianthus caryophyllus) introduced with ALS herbicide-tolerant ALS gene (surB) from tobacco (Nicotiana tabacum) as a selection marker, for example, "Moondust (trademark)", "Moonshadow (trademark)""," Moonshade (trademark) "," Moonlite (trademark) "," Moonaqua (trademark) "," Moonvista (trademark) "," Moonique (trademark) "," Moonpearl (trademark) "," Moonberry (trademark) " Or it is sold under the trade name "Moonvelvet (TM)". For example, flax (Linum usitatissumum L.) into which ALS herbicide-resistant ALS gene (als) derived from Arabidopsis thaliana has been introduced is sold under the trade name of “CDC Triffid Flax”. Maize (Zea mays L.) that is resistant to sulfonylurea and imidazolinone herbicides that have been introduced with an ALS gene (zm-hra) that is resistant to ALS herbicides derived from corn is, for example, a trademark of “Optimum GAT (trademark)” It is sold by name. Soybean having resistance to an imidazolinone herbicide into which an ALS herbicide-tolerant ALS gene (csr1-2) derived from Arabidopsis thaliana has been introduced is sold under the trade name “Cultivance”, for example. Soybeans into which an ALS herbicide-tolerant ALS gene (gm-hra) derived from soybean (Glycine max) has been introduced are, for example, trademarks of “Treus (trademark)”, “Plenish (trademark)” and “Optimum GAT (trademark)”. It is sold by name. In addition, there is cotton introduced with an ALS gene (S4-HrA) resistant to ALS herbicides derived from tobacco (Nicotiana tabacum cv. Xanthi).
HPPD herbicide resistant plant: obtained by introducing HPPD gene (avhppd-03) derived from oat (Avena sativa). For example, soybeans introduced with a PAT gene (pat) derived from Streptomyes viridochromogenes at the same time as the above genes are soybeans having resistance to mesotrione and glufosinate as "Herbicide-tolerant Soybean line" It is sold under the trade name.
2,4-D-tolerant plant or ACCase herbicide-tolerant plant: introduced with the aryloxyalkanoate dioxygenase gene (aad-1) derived from Sphingobium herbicidovorans 2 Corn that is resistant to 1,4-D or ACCase herbicides is sold, for example, under the trade name “Enlist ™ Maize”. Soybeans and cottons that are resistant to 2,4-D or ACCase herbicides introduced with the allyloxyalkanoate dioxygenase gene (aad-12) from Delftia acidovorans are known, for example, It is sold under the trade name “Enlist ™ Soybean”.
Dicamba herbicide-tolerant plant: obtained by introducing a dicamba monooxygenase gene (dmo) derived from Stenotrophomonas maltophilia strain DI-6. Soybean and cotton into which the above gene has been introduced are known. A soybean (Glycine max L.) into which a glyphosate-resistant EPSPS gene (CP4 epsps) derived from Agrobacterium tumefaciens strain CP4 (Agrobacterium tumefaciens strain CP4) was introduced at the same time as the above gene is, for example, “Genuity (registered trademark) Roundup Ready (trademark) 2 Xtend (trademark) ".
Additional plants with altered herbicide tolerance are widely known, such as alfalfa, apple, barley, eucalyptus, flax, grape, lentil, rapeseed, pea, potato, rice, sugar beet, which are resistant to glyphosate. Sunflower, tobacco, tomato beetle and wheat (see, for example, US5188642, US4940835, US5633435, US5804425, US5627061); bean, cotton, soybean, pea, potato, sunflower, tomato, tobacco, resistant to dicamba Corn, sorghum and sugarcane (see for example WO2008 / 051633, US7105724 and US5670454); soybean, sugar beet, potato, tomato and tobacco resistant to glufosinate (see for example US6376754, US5646024, US5561236); 2,4 Cotton, peppers resistant to -D, Apples, tomatoes, sunflowers, tobacco, potatoes, corn, cucumbers, wheat, soybeans, sorghum and millet (see, eg, US6153401, US6100446, WO2005 / 107437, US5608147 and US5670454); ALS-inhibiting herbicides (eg, sulfonylurea herbicides) Canola, corn, millet, barley, cotton, mustard, lettuce, lentil, melon, millet, oats, nata, potato, rice, rye, sorghum, Rice that is resistant to soybeans, sugar beets, sunflowers, tobacco, tomatoes and wheat (see, for example, US5013659, WO2006 / 060634, US4761373, US5304732, US6211438, US6211439 and US6222100), particularly imidazolinone herbicides, is known, Specific mutations in the acetohydroxyacid synthase gene ( For example, rice having S653N, S654K, A122T, S653 (At) N, S654 (At) K, A122 (At) T (see, eg, US2003 / 0217381, WO2005 / 020673); HPPD-inhibiting herbicides (eg, isoxa) Isoxazole herbicides such as furtol; triketone herbicides such as sulcotrione and mesotrione; and pyrazole herbicides such as pyrazolinate) or barley, sugarcane, rice that are resistant to diketonitrile, a degradation product of isoxaflutole Corn, tobacco, soybean, cotton, rapeseed, sugar beet, wheat and potato (see, for example, WO2004 / 055191, WO1996 / 38567, WO1997 / 049816 and US6791014); and wheat, soybean resistant to PPO-inhibiting herbicides , Cotton, sugar beet, rapeseed, rice, corn, sorghum, sugar cane and sugar beet (eg, US2002 / 0073443, US2008 / 0052798, Pest Management Science, 6 1, 2005, 277-285).

  As plants to which herbicide tolerance has been imparted by conventional cultivar improvement technology or genome breeding technology, for example, rice “Clearfield (registered trademark) Rice having tolerance to imidazolinone-based ALS-inhibiting herbicides such as imazetapyr and imazamox, etc. , Wheat “Clearfield® Wheat”, sunflower “Clearfield® Sunflower”, lentils “Clearfield® lentils” and canola “Clearfield® canola” (BASF products); “ST corn” soybean resistant to sulfonylurea ALS-inhibiting herbicides such as methyl; corn “SR corn” resistant to acetyl-CoA carboxylase inhibitors such as trione oxime herbicides and aryloxyphenoxypropionic acid herbicides (Also known as “Poast Protected® corn”); Tribenuron, etc. Sunflower “ExpressSun®” resistant to sulfonylurea herbicides; Rice “Provisia® Rice” resistant to acetyl CoA carboxylase inhibitors such as quizalofop; Canola resistant to photosystem II inhibitors Triazine Tolerant Canola ”; a sorghum“ Igrowth ™ ”having resistance to imidazolinone herbicides.

  Canola "SU Canola (registered trademark)" with sulfonylurea herbicide tolerance using rapid cultivar development technology (Rapid Trait Development System, RTDS (registered trademark)) Is mentioned. RTDS (registered trademark) corresponds to the introduction of oligonucleotide-directed mutagenesis in genome editing technology. Gene repair Oligonucleotide (GRON), that is, cleaving DNA in plants through DNA and RNA chimeric oligonucleotides It is a technology that can introduce mutations without any problems. Other examples include maize with reduced herbicide tolerance and phytic acid content by deleting the endogenous gene IPK1 using zinc finger nuclease (see, eg, Nature 459, 437-441 2009); Examples include rice that has been given herbicide tolerance using cast-nine (see, for example, Rice, 7, 5 2014).

Examples of plants to which herbicide tolerance has been imparted by the new breeding technology include soybeans in which the properties possessed by GM rootstock are imparted to the hogi using a variety improvement technology using grafts. Specific examples include soybeans in which glyphosate tolerance is imparted to non-transgenic soybean spikelets using Roundup Ready (registered trademark) soybean having glyphosate tolerance as rootstocks (see Weed Technology 2013, 27, 412.). .

  Examples of plants imparted with pest resistance are listed below.

Examples of plants that have been given resistance to lepidopteran pests by genetic recombination technology include delta-endotoxin (δ-endotoxin), an insecticidal protein derived from the soil bacterium Bacillus thuringiensis (hereinafter abbreviated as Bt fungus). Maize (Zea mays L.), soybean (Glycine max L.), cotton (Gossypium hirsutum L.), rice (Oryza sativa L.), poplar (Populus sp.), Tomato (Lycopersicon esculentum) introduced with the gene to be encoded , Eggplant (Solanum melongena) and sugarcane (Saccharum sp.). Examples of delta-endotoxins that impart resistance to lepidopteran pests include Cry1A, Cry1Ab, modified Cry1Ab (partially deleted Cry1Ab), Cry1Ac, Cry1Ab-Ac (a hybrid protein in which Cry1Ab and Cry1Ac are fused), Cry1C, Cry1F, Cry1Fa2 (modified cry1F), moCry1F (modified Cry1F), Cry1A. 105 (a hybrid protein in which Cry1Ab, Cry1Ac, and Cry1F are fused), Cry2Ab2, Cry2Ae, Cry9C, Vip3A, and Vip3Aa20.
Examples of plants that have been given resistance to Coleoptera by genetic recombination technology include corn and potato introduced with a gene encoding delta-endotoxin, an insecticidal protein derived from soil bacteria Bt. . Examples of delta-endotoxins that confer resistance to Coleoptera include Cry3A, mCry3A (modified Cry3A), Cry3Bb1, Cry34Ab1, Cry35Ab1, Cry6A, Cry6Aa and mCry6Aa (modified Cry6Aa).
Examples of plants that have been given resistance to Diptera by genetic recombination technology include, for example, maize introduced with a synthetic gene encoding hybrid protein eCry3.1Ab, which is a fusion of Cry3A and Cry1Ab derived from soil bacteria Bt Cotton (Gossypium hirsutum L.) introduced with a gene encoding a trypsin inhibitor CpTI derived from (Zea mays L.) and cowpea (Vigna unguiculata). Furthermore, there are poplars and the like into which a gene encoding API, which is a protease inhibitor protein A derived from squittaria sagittifolia, and exhibits resistance to a wide range of pests.
Insecticidal proteins that impart pest resistance to plants include hybrid proteins of the above insecticidal proteins, partially missing proteins, and modified proteins. The hybrid protein is produced by a combination of different domains of a plurality of insecticidal proteins, using genetic recombination techniques, Cry1Ab-Ac and Cry1A. 105 etc. are known. As a protein lacking a part, Cry1Ab and the like lacking a part of the amino acid sequence are known. Examples of the modified protein include proteins in which one or more amino acids of natural delta-endotoxin are substituted, and Cry1Fa2, moCry1F, mCry3A, and the like are known. The modified protein includes a case where a non-naturally occurring proteolytic enzyme recognition sequence is inserted into a toxin. For example, Cry3A055 (WO2003 / 018810 in which a cathepsin G-recognition sequence is inserted into a Cry3A toxin is used. Reference).
Cotton (event MON88702) introduced with modified BT protein Cry51Aa2 (Cry51Aa2.834_16) by genetic recombination technology has been developed by Monsanto, and the genus lygus such as Lygus lineolaris, and the half-crustacea such as aphids and Frankliniella Resistant to thrips such as genus species.
Other insecticidal proteins that impart pest resistance to plants by genetic recombination techniques include, for example, insecticidal proteins derived from Bacillus cereus or Bacillus popilliae; plant insecticidal proteins Vip1, Vip2 , Vip3 (as subclasses Vip3Aa to Vip3Aj, Vip3Ba, Vip3B and Vip3Ca are known, specifically, for example, Vip3Aa20 and Vip3Aa61 are known) and Vip4; Photolabdus luminescens, etc. Insecticidal proteins from nematode symbiotic bacteria (colonizing nematodes) such as Photorhabdus spp. Or Xenorhabdus nematophilus; scorpion toxin, spider toxin Toxins produced by animals including insect-specific neurotoxins such as bee toxins; Toxins produced by filamentous fungi such as Streptomycetes venom; plant lectins such as pea lectin, barley lectin, snowdrop lectin; agglutinin; trypsin inhibitor, serine protease inhibitor, patatin, cystatin, papain inhibitor, etc. Inhibitors: Ribosome inactivating proteins (RIP) such as ricin, corn-RIP, abrin, ruffin, saporin, bryodin; steroids such as 3-hydroxysteroid oxidase, ecdysteroid-UDP-glucosyltransferase, cholesterol oxidase Metabolic enzyme; ecdysone inhibitor; HMG-CoA-reductase; ion channel inhibitor such as sodium channel inhibitor and calcium channel inhibitor; juvenile hormone esterase; diuretic hormone Receptor; stilbene synthase; bicycloalkyl benzyl synthase; it includes and glucanase; chitinases.

In addition, plants that have been imparted with pest resistance by introducing one or more insecticidal protein genes are already known, and some plants are commercially available.
Examples of cotton with insect resistance imparted include `` Bollgard (trademark) cotton '', `` BXN (trademark) Plus Bollgard (trademark) Cotton '', `` BXN (trademark) Plus, which expresses the insecticidal protein Cry1Ac derived from Bt bacteria “Bollgard ™ Cotton”, “JK 1”, “Roundup Ready ™ Bollgard ™ Cotton” and “Ingard ™”; “Herculex (Cry1Fa2)” expressing the insecticidal protein modified Cry1F (Cry1Fa2) from Bt (Trademark) I "and" Herculex (trademark) CB ";" VIPCOT (trademark) Cotton "expressing the insecticidal protein Vip3A from Bt bacteria;" Bollgard II (trademark) "expressing the insecticidal proteins Cry1Ac and Cry2Ab from Bt bacteria ) cotton '', `` Roundup Ready (TM) Bollgard II (TM) Cotton '', `` Roundup Ready (TM) Flex (TM) Bollgard II (TM) Cotton '' and `` Fivermax (TM) Liberty Link (TM) Bollgard II (TM) "Bollgard III (registered trademark)" expressing the insecticidal proteins Cry1Ac, Cry2Ab and Vip3A derived from Bt bacteria and "Bollgard (registered trademark) III x Roundup Ready (trademark) Flex (trademark)";"VIPCOT (trademark) Roundup Ready Flex (trademark) Cotton" expressing the insecticidal proteins Vip3A and Cry1Ab derived from Bt bacteria; derived from Bt bacteria "VIPCOT (registered trademark) Cotton" expressing the insecticidal proteins Vip3A and Cry1Ac of "WideStrike (trademark) Cotton" and "WideStrike (trademark) Roundup Ready (trademark) expressing the insecticidal proteins Cry1Ac and Cry1F derived from Bt bacteria Cotton "and" Widestrike (TM) Roundup Ready Flex (TM) Cotton ";" TwinLink (TM) Cotton "and" Glytol (TM) x Twinlink (TM) "expressing the insecticidal proteins Cry1Ab and Cry2Ae from Bt bacteria; "Widestrike (registered trademark) 3" and "Widestrike (trademark) x Roundup Ready Flex (trademark) x VIPCOT (trademark) Cotton" expressing insecticidal proteins Cry1Ac, Cry1F and Vip3A derived from Bt bacteria; “Glytol ™ x Twin expressing proteins Cry1Ab, Cry2Ae and Vip3A link (TM) x VIPCOT (TM) Cotton ", which are commercially available.
Examples of corn imparted with insect resistance include `` YieldGard (registered trademark) Rootworm RW '', `` YieldGard (trademark) RW + RR '', `` YieldGard (trademark) VT (expressing Cry3Bb1 derived from Bt bacteria) Trademarks) Rootworm ™ RR2 ”and“ MaxGard ™ ”;“ YieldGard® VT Triple ”and“ YieldGard ™ Plus with RR ”expressing the insecticidal proteins Cry3Bb1 and Cry1Ab from Bt bacteria; Bt "Bt Xtra (trademark) Maize" expressing insecticidal protein Cry1Ac derived from bacteria; "YieldGard Plus (registered trademark)" expressing insecticidal proteins Cry1Ab and Cry3Bb1 derived from Bt; insecticidal protein Cry1Ab derived from Bt “Bt10”, “Liberty Link ™ Yieldgard ™ Maize”, “Agrisure ™ GT / CB / LL” and “YieldGard ™ CB + RR” expressed; insecticidal protein Cry1A. “YieldGard ™ VT Pro ™” and “Genuity® VT Double Pro ™” expressing 105 and Cry2Ab2; “Agrisure® RW” expressing the insecticidal protein mCry3A from Bt bacteria And “Agrisure ™ GT / RW”; “Starlink ™ Maize” expressing the insecticidal protein Cry9C from Bt bacteria; “YieldGard ™” expressing the insecticidal protein Cry1Ab from Bt bacteria; MaizeGard (TM), NaturGard KnockOut (TM), Maximizer (TM), Roundup Ready (TM) YieldGard (TM) maize, Agrisure (TM) CB / LL, and Mavera (TM) YieldGard (Trademark) Maize ”;“ Agrisure® 3122 ”expressing the insecticidal proteins Cry1Ab, Cry1F, modified Cry3A, Cyr34Ab1 and Cyr35Ab1 derived from Bt;“ Agrisure (registered trademark) expressing the insecticidal protein Vip3Aa20 derived from Bt ” Viptera ";" Agri "expressing the insecticidal proteins Vip3Aa20 and Cry1Ab from Bt bacteria sure (registered trademark) Viptera (registered trademark) 2100 ”and“ Agrisure (registered trademark) Viptera (registered trademark) 3110 ”; Bt-derived insecticidal proteins Vip3Aa20, Cry1Ab, and“ Agrisure (registered trademark) Viptera ( (Trademark) 3100 "," Agrisure (registered trademark) Viptera (trademark) 3111) "and" Agrisure (registered trademark) Viptera (trademark) 4 "; expressing the insecticidal proteins Vip3Aa20, Cry1Ab and modified Cry1F from Bt (Registered trademark) Viptera (trademark) 3220 ";" Agrisure (registered trademark) Duracade (trademark) "expressing insecticidal protein eCry3.1Ab (Cry3A-Cry1Ab chimeric protein) derived from Bt; insecticidal protein derived from Bt eCry3.1Ab (Cry3A-Cry1Ab chimeric protein), “Agrisure® Duracade ™ 5122” expressing modified Cry3A, Cry1Ab and modified Cry1F; insecticidal protein eCry3.1Ab (Cry3A-Cry1Ab Chimeric protein), modified Cry3A, modified Cry1Ab and Vip3A variants “Agrisure® Duracade ™ 5222”; “Herculex ™ RW” expressing the insecticidal proteins Cyr34Ab1 and Cyr35Ab1 from Bt; expressing the insecticidal proteins Cyr34Ab1, Cyr35Ab1 and Cry1F from Bt “Herculex XTRA ™”; an insecticidal protein Cry1A derived from Bt bacteria. 105, “Genuity® VT Triple Pro ™” expressing Cry2Ab2 and Cry3Bb1; insecticidal proteins Cry1F, Cry2Ab, Cyr34Ab1, Cyr35Ab1, Cry3Bb1 and Cry1A. “Genuity® SmartStax ™” expressing 105; insecticidal protein modified Cry1F, Cry2Ab and Cry1A. “Power Core ™” expressing 105; “Herculex XTRA ™ RR” expressing insecticidal protein modified Cry1F, Cyr34Ab1 and Cyr35Ab1 from Bt; insecticidal protein modified Cry1F, Cyr34Ab1, Cyr35Ab1 from Bt “Optimum® Intrasect Xtreme” expressing Cry1Ab and modified Cry3A; “Optimum® Intrasect XTRA” expressing insecticidal protein modified Cry1F, Cyr34Ab1, Cyr35Ab1 and Cry1Ab derived from Bt; Examples include “Optimum® TRIsect” that expresses insecticidal protein modified Cry1F and modified Cyr3A, which are commercially available.
Examples of other pest-resistant plants include potatoes expressing the insecticidal protein Cry3A derived from Bt bacteria `` Atlantic NewLeaf (trademark) potato '', `` NewLeaf (trademark) Russet Burbank potato '', `` Lugovskoi plus '', "Elizaveta plus", "Hi-Lite NewLeaf (TM) Y potato, Superior NewLeaf (TM) potato" and "Shepody NewLeaf (TM) Y potato"; rice expressing the insecticidal proteins Cry1Ab and Cry1Ac from Bt 63 ”and“ Huahui-1 ”; soybean“ Intacta ™ Roundup Ready ™ 2 Pro ”expressing the insecticidal protein Cry1Ac derived from Bt; eggplant“ BARI Bt expressing the insecticidal protein Cry1Ac derived from Bt Begun-1, -2, -3 and -4 ", which are commercially available.
Corn worms with resistance to corn rootworms “YieldGard corn rootworm”, “YieldGard VT”, “Herculex RW”, “Herculex Rootworm” and “Agrisure CRW”; Corn with resistance to corn borer “YieldGard corn borer” , "YieldGard plus", "YieldGard VT Pro", "Agrisure CB / LL", "Agrisure 3000GT", "Hercules I", "Hercules II", "KnockOut", "NatureGard" and "StarLink"; Western bean cut worm Resistant to corn borers, black cut worms and fall army worms "Herculex I", "Herculex Xtra", "NewLeaf", "NewLeaf Y" and "NewLeaf Plus"; resistant to corn borers and corn root worms 'YieldGard Plus' with corn; Cotton with resistance to fake American tobacco "Bollg""ardI" and "Bollgard II"; cotton "Bollgard II", "WideStrike ™" resistant to fake American tobacco, cotton ball worm, fall army worm, beet army worm, cabbage looper, soybean looper and pink ball worm ”And“ VipCot ”; potatoes“ NewLeaf ”,“ NewLeaf Y ”and“ NewLeaf Plus ”having resistance to tobacco tin mega; eggplants“ Bt brinjal ”,“ Dumaguete Long Purple ”having resistance to eggplant moths, fruit bowlers and cotton ball worms "And" Mara "(see for example US5128130).
Additional plants with pest resistance are generally known, e.g., corn borer resistant rice (e.g., Molecular Breeding, Vol. 18 (2006), No. 1), lepidopterous resistant lettuce (e.g., US5349124), and rice (for example, see WO2001 / 021821) having resistance to Lepidoptera (for example, Nika maize, Ichimon disseri, rice mushrooms, corn borer, rice case worm, and rice army worm). Methods for producing such plants are generally known to those skilled in the art and are described, for example, in the above publications.

  Plants to which pest resistance has been imparted by RNA interference technology include lepidopterous pests (eg, cut worms such as corn borers, corn ear worms, black cut worms, and fall army worms) and Coleoptera pests (corn root worms) Corn that is resistant to) is marketed or developed under the trade names "SmartStax (registered trademark)", "SmartStax (registered trademark) Pro" or "Genuity (registered trademark) SmartStax Pro".

Examples of plants to which pest resistance has been imparted by conventional breeding techniques or genome breeding techniques include, for example, the aphid resistance gene “Rag1 (Resistance to Aphis glycines 1)” or “Rag2 (Resistance to Aphis glycines) 2) Soybeans resistant to soybean Aphis glycines carrying the gene (see J. Econ. Entomol., 2015, 108, 326.); Soybeans resistant to Heterodera glycines (Phytopathology) , 2016, 106, 1444.); Cotton that is resistant to Meloidogyne incognita (J. Nematol., 2009, 41, 140); Rice “Kanto BPH1” that is resistant to brown planthopper; An example is soybean “Fukuminori” which exhibits resistance.

  These pest-resistant plants are given resistance to any harmful insects (especially lepidopterous insects, Coleoptera insects, Diptera insects, Coleoptera insects), harmful spiders and harmful nematodes Has been. Plants imparted with pest resistance are preferably wheat (eg wheat, barley, rye, oat), corn, canola, sorghum, soybean, rice, rapeseed, sugar beet, sugar cane, grape, lentil, sunflower, alfalfa, Selected from berries, drupes, peanuts, coffee, tea, strawberries, turf, vegetables (e.g. tomatoes, potatoes, cucurbits and lettuce), more preferably soybean, corn, tomatoes, rice and wheat (E.g. wheat, barley, rye and oat), most preferably selected from soybean, rice, corn and wheat (e.g. wheat, barley, rye and oat).

  Examples of plants imparted with disease resistance are listed below.

Plants that have been rendered disease resistant by genetic engineering techniques, for example, express so-called `` pathogenicity related proteins '' (PRP, e.g. see EP0392225) or so-called `` antifungal proteins '' (AFP, e.g. see US6864068) Plant. Various antifungal proteins with activity against phytopathogenic fungi have been isolated from specific plant species and are common sense. Examples of such anti-pathogenic substances and plants capable of synthesizing such anti-pathogenic substances are known, for example, from EP0392225, WO1993 / 05153, WO1995 / 33818 and EP0353191. Plants that are resistant to fungicidal pathogens, viral pathogens and bacterial pathogens are created by introducing disease resistance genes. A number of resistance genes have been identified and isolated and used to improve disease resistance, such resistance genes include, for example, producing tobacco mosaic virus (TMV) resistant tobacco plants N genes introduced into TMV-sensitive tobacco lines (e.g. see US 5571706), Prf genes introduced into plants to obtain enhanced pathogenic resistance (e.g. see WO1998 / 02545), And the Rps2 gene derived from Arabidopsis thaliana used to create resistance to bacterial pathogens such as Pseudomonas syringae (see, eg, WO1995 / 028423). Plants showing a systemic acquired resistance response were obtained by introducing a nucleic acid molecule encoding the TIR domain of the N gene (see, eg, US 6630618). Further examples of known resistance genes include the Xa21 gene that has been introduced into many rice varieties (see, for example, US5952485, US5977434, WO1999 / 009151, WO1996 / 022375), for resistance to colletotrichum. Rcg1 gene (see, for example, US2006 / 225152), prp1 gene (see, for example, US5859332, WO2008 / 017706), ppv-cp gene that introduces resistance to plum poxvirus (see, for example, US PP15,154Ps), P1 gene (see, for example, US5968828), genes such as Blb1, Blb2, Blb3, RB2, and Rpi-vnt1 for introducing resistance to potato phytophthora infestans (see, for example, US7148397), LRPKml Genes (e.g. see WO1999 / 064600), P1 gene for potato virus Y resistance (e.g. see US5968828), HA5-1 gene (e.g. see US5877403 and US6046384), potato virus X (PVX) PIP genes for introducing broad resistance to viruses such as potato virus Y (PVY), potato cigar virus (PLRV) (see, for example, EP0707069), as well as Arabidopsis for obtaining fungal resistance Examples include genes such as the NI16 gene, ScaM4 gene, and ScaM5 gene (see, for example, US6706952 and EP1018553). In addition, bean golden mosaic virus (hereinafter referred to as BGMV) resistant beans are plants that have been given resistance by RNA interference technology and are double-stranded RNA genes of replication proteins. (sense and antisense ac1 gene) is introduced, and resistance to BGMV is exhibited by inhibiting the synthesis of BGMV replication protein. Methods for producing such plants are generally known to those skilled in the art and are described, for example, in the above publications.
Anti-pathogenic substances that can be expressed by such plants include, for example, ion channel blockers (sodium channel blockers, calcium channel blockers, etc.); viral KP1, KP4 and KP6 toxins; stilbene synthase; bibenzyl synthase Chitinase; glucanase; so-called “pathogenicity related proteins” (PRP; see eg EP0392225); anti-pathogenic substances produced by microorganisms (eg peptide antibiotics, heterocyclic antibiotics (eg WO1995 / 033818) And protein factors or polypeptide factors involved in plant pathogen defense (so-called “plant disease resistance genes” described in WO2003 / 000906)).
Anti-pathogenic substances produced by plants can protect plants from various pathogenic microorganisms such as fungi, viruses and bacteria. Useful plants of increasing interest in connection with the present invention are wheat (e.g. wheat, barley, rye and oats), soybeans, corn, rice, rapeseed, berries, nuclear fruits, peanuts, coffee, tea, strawberries Vines and vegetables (e.g. tomatoes, potatoes), cucurbits, papayas, melons, lentes and lettuce, more preferably soybeans, tomatoes, rice and wheat (e.g. wheat, barley, Rye and oat), and most preferably selected from soybeans, rice and wheat (eg wheat, barley, rye and oats).
Plants having resistance to fungal pathogens include, for example, soybeans having resistance to soybean rust fungi (Phakopsora pachyrhizi and Phakopsora meibomiae) (see, for example, WO2008 / 017706); potato phytophythora infestans Eggplants such as cotton, tomato, potato, etc. that are resistant to (see, for example, US5859332, US7148397, EP1334979); maize that is resistant to the genus Colletotrichum, such as Colletotrichum graminicola (eg, US2006 Apples having resistance to venturia inaequalis (see eg WO1999 / 064600); Fusarium species (eg fusarium graminearum, fusarium sporotrichioides, fusarium lateritium, fusarium pseudograminearum, fusarium sambucinum, fusarium culmorum, fusarium poae, fusarium acuminatum, plants with resistance to fusarium equiseti (eg rice, wheat, barley, rye, corn, oat, potato, melon, soybean and sorghum) (see eg US6646184, EP1477557); Examples include plants such as corn, soybean, wheat (especially wheat, barley, rye and oat) rice, tobacco, sorghum, sugarcane, potato (see, for example, US5859332, US5689046, US6706952, EP1018553, and US6020129).
Plants having resistance to bacterial pathogens include, for example, rice having resistance to xylella fastidiosa (see, for example, US6232528); rice having resistance to bacterial head blight fungus, cotton, Plants such as soybean, potato, sorghum, corn, wheat, barley, sugarcane, tomato and pepper (see, eg, WO2006 / 42145, US5952485, US5977434, WO1999 / 09151, WO1996 / 22375); against pseudomonas syringae Examples include resistant tomatoes (see, for example, Can. J. Plant Path., 1983, 5: 251-255).
Plants having resistance to viral pathogens include, for example, nuclear fruits (eg, plums, almonds, apricots, cherries, peaches, nectarines) that are resistant to plum pox virus (eg, US PP15154Ps, EP0626449); Potatoes resistant to potato virus Y (see eg US5968828); Potatoes, tomatoes and cucumbers resistant to tomato spotted wilt virus And plants such as legumes (see eg EP0626449, US5973135); maize resistant to maize streak virus (see eg US6040496); papaya ring spot virus (papaya ring spot virus) papaya resistant to virus (see eg S5877403, US6046384); cucumber mosaic Cucurbitaceae (eg, cucumber, melon, watermelon and pumpkin) and solanaceous plants (eg, potato, tobacco, tomato, eggplant, paprika, capsicum and pepper) having resistance to cucumber mosaic virus (eg, US6849780 Cucurbitaceous plants (eg, cucumber, melon, watermelon and pumpkin) having resistance to watermelon mosaic virus 2 and zucchini yellow mosaic virus (see, eg, US6015942); Potato leaf roll virus (potatoes having resistance to potato leafroll virus (see, for example, US5576202); viruses such as potato virus X, potato virus Y, and potato leafroll virus) Potatoes with broad resistance to (e.g., For example, see EP0707069); kidney beans that are resistant to Bean golden mosaic virus (see, for example, Mol Plant Microbe Interact. 2007 Jun; 20 (6): 717-26.) Can be mentioned.
There are plants that are resistant to antibiotics (eg, kanamycin, neomycin and ampicillin). The naturally occurring bacterial nptII gene expresses an enzyme that blocks the action of the antibiotics kanamycin and neomycin. The ampicillin resistance gene ampR (also known as blaTEM1) is derived from the bacterium Salmonella paratyphi and is used as a marker gene in the transformation of microorganisms and plants. ampR is involved in the synthesis of beta-lactamase, an enzyme that neutralizes the antibiotics of the penicillin group including ampicillin. Plants having resistance to antibiotics include, for example, potato, tomato, flax, canola, rapeseed, rape seed and corn (see, for example, Plant Cell Reports, 20, 2001, 610-615, Trends in Plant Science, 11, 2006, 317-319, Plant Molecular Biology, 37, 1998, 287-296, Mol Gen Genet., 257, 1998, 606-13. Plant Cell Reports, 6, 1987, 333-336, Federal Register (USA), 60, No. 113, 1995, 31139. Federal Register (USA), 67, No. 226, 2002, 70392, Federal Register (USA), 63, No. 88, 1998, 25194, Federal Register (USA), Volume 60, No.141, 1995, 37870, Canadian Food Inspection Agency, FD / OFB-095-264-A, October 1999, FD / OFB-099-127-A, see October 1999). Preferably, the plant is selected from soybeans, tomatoes and wheat (e.g. wheat, barley, rye and oats), most preferably selected from soybeans and wheat (e.g. wheat, barley, rye and oats). The
Examples of plants that have been given resistance to plant viral diseases include papaya “Rainbow”, “SunUp”, and “Huanong No. 1” that have been given resistance to papaya ringspot virus. Potato “Innate® Hibernate”, “Innate® Glaciate” and “Innate® Acclimate” showing resistance to phytophthora infestans; Potato virus Y and / or potato cigars A potato “Newleaf ™” showing resistance to virus (PLRV) can be mentioned.

  Rice that has been given resistance to blast as a plant that has been given disease resistance by conventional breeding technology or genome breeding technology; it has been given resistance to sheath blight Wheat; Wheat imparted resistance to leaf rust; Wheat imparted resistance to stripe rust; Wheat imparted resistance to stem rust; Wheat imparted resistance to powdery mildew; Wheat imparted resistance to leaf blotch; Wheat imparted resistance to glume blotch; macular disease Wheat with resistance against tan spot; barley with resistance against powdery mildew; barley with resistance against dwarf leaf rust; net Barley with resistance to net blotch; Barley with resistance to scald; Barley with resistance to Ramularia disease; Anthracnose Corn with resistance to gray leaf spot disease; maize with resistance to Goss's wilt disease; Fusarium stem rot Maize with resistance to Fusarium stalk rot; Soybean with resistance to Asian soybean rust; Soybean with resistance to phytophthora stem and root rot ; Soybeans with resistance to sudden death syndrome; against Phytophthora rot Pepper with resistance; lettuce with resistance to powdery mildew; tomato with resistance to bacterial wilt; resistance to Gemini virus Added tomato; lettuce with resistance to downy mildew; rapeseed, cabbage, Brussels sprouts, cauliflower, colored green (Borekale), broccoli, etc. with resistance to clubroot Cruciferous plants; cruciferous plants such as rapeseed, cabbage, brussels sprouts, cauliflower, colored green (Borekale), broccoli; melon caused by Fusarium oxysporum f.sp. melonis Examples include melon imparted with resistance to Fusarium wilt (see, for example, WO2009 / 000736).

As a plant to which disease resistance has been imparted by genome editing technology, the powdery mildew resistance gene (MILDEW RESISTACE LOCUS O, hereinafter abbreviated as MLO) is deleted using Talen and Crisper Cassine. Bread wheat resistant to powdery mildew (see, for example, Nat. Biotech., 32,947-951 2014); by using Crisper Cassine to delete the SlMLO1 gene, one of the MLOs, Slmlo1 tomato (Tomelo) resistant to powdery mildew (see, for example, Scientific Reports 7, Article number: 482 2017); by using the talen to edit the OsSWEET14 gene in rice, Rice that is resistant to Xanthomonas oryzae pv. Oryzae causing bacterial leaf blight (see Nat. Biotechnol. 30, 390-392 2012); uses Crisper Cassine And rice (PLoS ONE 11: e0154027. Doi: 10.1371 / journal.pone.0154027 2016) resistant to Magnaporthe oryzae causing blast disease by modifying the OsERF922 gene in rice C) Casperine is used to destroy the recessive eIF4E (eukaryotic translation initiation factor 4E) gene. -W) resistant to cucumber (Mol. PlantPathol. 17, 7 1140-1153 2016); caused by Phytophthora sojae by destroying the RXLR effector gene (Avr4 / 6) using Crisper Cassine And soybeans resistant to phytophthora stem and root rot (see Mol Plant Pathol 17 (1) 127-139 2016).

  Introduced Rvi6 (previously called HcrVf2) gene that is resistant to apple scab caused by Venturia inaequalis as a plant given disease resistance by new breeding technology An apple that is resistant to apple mold (see, for example, Plant Biotech. J., 12, 2-9, 2014); an example that gives HOKI the properties of GM rootstock, which is a variety improvement technology using grafts As a sweet cherry (Plant Biotech. J., 12, 1319-) whose nature has been transferred from a transgenic rootstock having resistance to infection to Prunus necrotic ringspot virus to a non-transgenic spikelet. 1328 2014)).

Examples of plants with modified product quality are listed below.
The product quality modification means the synthesis of the modified component or the increase or decrease in the synthesis amount of the component compared to the corresponding wild type plant. Plants with modified product quality include, for example, modified plants with increased or decreased vitamin, amino acid, protein and starch, various oil content, and modified plants with reduced nicotine content.

  Plants whose product quality has been modified by genetic recombination technology include, for example, alfalfa-derived S-adenosyl-L-methionine: trans-caffeoyl CoA 3-methyltransferase (ccomt) gene duplexes involved in lignin production Alfalfa with a gene that generates RNA and reduced lignin content by RNA interference; Triacylglyceride containing lauric acid by introducing a 12: 0 ACP thioesterase gene from Umbellularia californica involved in fatty acid synthesis Canola with increased content "Laurical (trademark) Canola"; by introducing a partial gene (gm-fad2-1) of omega-6 desaturase derived from soybean, which is a desaturase of fatty acid, Soybeans “Plenish ™” and “Treus ™” with increased oleic acid content; Genes that produce double-stranded RNA of the acyl-acyl carrier protein thioesterase gene (fatb1-A) derived from and genes that produce double-stranded RNA of the δ-12 desaturase gene (fad2-1A) derived from soybean Soybean "Vistive Gold (trademark)" in which saturated fatty acid content is reduced by introduction of potato; delta-6 desaturase gene (Pj.D6D) derived from primrose and delta-12 desaturase gene (Nc.Fad3) derived from red bread mold Genetically modified soybean in which stearidonic acid, which is one of ω3 fatty acids, was produced; bioethanol by introducing a thermostable alpha-amylase gene (amy797E) of Thermococcales sp. Maize "Enogen (registered trademark)" with enhanced production of lysine Maize “Mavera ™ Maize” and “Mavera ™ YieldGard ™ Maize” with increased lysine production by introducing a dihydrodipicolinate synthase gene (cordapA) from Corynebacterium glutamicum; By introducing the antisense gene gbss of starch-derived starch synthase (granule-bound starch synthase enzame, GBSS), potatoes "Amflora (trademark)", "amylose content in starch granules decreased and amylopectin content increased" Starch Potato ”; Asp1 double chain, a gene involved in suppression of starch degradation and asparagine production, by introducing genes pPhL and pR1 that generate double-stranded RNA of transcription factor genes PhL and R1 that promote potato-derived starch degradation Inhibition of asparagine synthesis by introducing asn1 gene that generates RNA (carcinogenic substance by heating) The purpose of this study is to suppress the accumulation of asparagine and reducing sugars involved in the production of acrylamide, and the potato “Innate”, in which the formation of black spots was suppressed by introducing the ppo5 gene that generates double-stranded RNA of the potato-derived polyphenol oxidase gene Ppo5. (Registered trademark) Cultivate, Innate (registered trademark) Generate, Innate (registered trademark) Accelerate, Innate (registered trademark) Invigorate, Innate (registered trademark) Glaciate, Innate (registered trademark) Acclimate ”And“ Innate® Hibernate ”; tobacco with reduced nicotine content by introducing the antisense gene (NtQPT1) of the quinolinate phosphoribosyltransferase gene QpTase from tobacco (Nicotiana tabacum); Narcissus pseudonarcissus ) Soil that synthesizes phytoene synthase gene (psy) and carotenoids Golden rice is a rice that can produce beta-carotene in endosperm tissue and harvest rice containing vitamin A by introducing carotene desaturase gene (crt1) derived from bacteria (Erwinia uredovora) and expressing it specifically in endosperm (Golden rice). Other examples include potato and corn with modified amylopectin content (see, for example, US6784338, US2007 / 0261136, WO1997 / 04471); canola, corn, cotton, grape, cattail with modified oil content , Catalpa, rice, soybean, rapeseed, wheat, sunflower, bittern, safflower and vernonia plants (eg, US7294759, US7157621, US5850026, US6441278, US5723761, US6380462, US6365802, WO2001 / 079499, US2006 / 0075515 and US7294759); sunflower with increased fatty acid content (see eg US6084164); soybean with reduced allergen content (see eg US6864362); tobacco with reduced nicotine content (see eg US6864362) For example, see US2006 / 0185684, WO2005 / 000352 and WO2007 / 064636); canola and soybeans with increased lysine content (eg Bio / Technolog y 13, 1995, 577-582); corn and soybeans with modified methionine, leucine, isoleucine and / or valine composition (see for example US6946589, US6905877); soybeans with increased sulfur amino acid content ( For example, see EP0929685, WO1997 / 041239); 3'-Phosphoadenosine-5'-phosphosulfate reductase derived from Escherichia coli is expressed specifically on the leaf surface Corn with increased methionine content (see PNAS, 2017, 114 (43), 11386.); increased content of free amino acids (eg asparagine, aspartic acid, serine, threonine, alanine, histidine and glutamic acid) Tomato (see eg US6727411); corn with increased amino acid content (see eg WO05 / 077117); potato with modified starch content, corn Kosi and rice (see for example WO1997 / 044471 and US7317146); tomatoes, corn, grapes, alfalfa, apples, legumes and peas with modified flavonoid content (see for example WO00 / 04175); phenolic compounds Corn, rice, sorghum, cotton and soybean with modified content (eg see US2008 / 0235829); tomatoes and canola with increased vitamin A content (eg see US6797498, US7348167); vitamin E content Increased amounts of tomato, canola, soybean, wheat, sunflower, rice, corn, barley and rye (see eg US7348167, WO2004 / 058934); alfalfa, apple, bean, corn, grape with modified flavonoid content , Tomatoes and peas (see eg WO00 / 04175). Methods for producing such plants are generally known to those skilled in the art and are described, for example, in the above-mentioned publications. Preferably, the plant is selected from soybeans, canola, tomatoes, rice and the like (eg wheat, barley, rye and oats), most preferably selected from soybeans, canola, rice, wheat and barley.

  Rapeseed “Nexera (registered trademark) Canola” producing unsaturated omega-9 fatty acids as a plant whose quality of the product has been modified by conventional breeding technology or genome breeding technology; soybean with reduced allergen content “Yumeminori”; rice for the purpose of changing to a good taste, for example, rice “Yumepirika” with a reduced amylose content is commercially available. Citrus with modified fruit characteristics (eg, fruit weight, aroma, juiciness and sugar content) is known (see Scientific Reports 7, 4721 2017).

  Examples of plants that have modified the nutrient utilization of plants include plants in which assimilation or metabolism of nitrogen or phosphorus is enhanced. Plants having nitrogen assimilation ability and nitrogen utilization ability enhanced by genetic recombination technology include, for example, canola, corn, wheat, sunflower, rice, tobacco, soybean, cotton, alfalfa, tomato, wheat, potato, sugar beet, sugarcane and Rapeseed (see, for example, WO1995 / 009911, WO1997 / 030163, US6084153, US5955651 and US6864405). Plants with improved phosphorus uptake by genetic engineering techniques include, for example, alfalfa, barley, canola, corn, cotton, tomato, rapeseed, rice, soybean, sugar beet, sugar cane, sunflower, wheat and potato (e.g. (See US7417181, US2005 / 0137386). Methods for producing such plants are generally known to those skilled in the art and are described, for example, in the above-mentioned publications. Preferably, the plant is selected from soybeans, tomatoes and wheat (eg wheat, barley, rye and oats), most preferably selected from soybeans, rice, corn and wheat.

  Plants whose fertility traits and the like have been modified by gene recombination techniques include plants in which male sterility and fertility recovery traits have been imparted to plants. For example, maize and chicory that have been given male sterility by expressing a ribonuclease gene (barnase) derived from Bacillus amyloliquefaciens in cocoon tapetum cells; a DNA adenine methylase gene (dam) derived from E. coli Maize that has been given male sterility by introducing corn-derived alpha-amylase gene (zm-aa1) that gives male sterility traits and ms45 protein gene (ms45) that gives maternal recovery traits Corn with controlled fertility traits; canola with fertility-recovering function expressed by expressing a ribonuclease inhibitor protein gene (barstar) from Bacillus in tapetum cells of pupae; bacillus giving male sterility traits Ribonuclease gene derived from fungi (b arnase) and a canola in which the fertility trait is controlled by expressing a ribonuclease inhibitory protein gene (barstar) derived from Bacillus that gives fertility recovery trait. Other plants to which fertility traits have been imparted by genetic recombination techniques include tomato, rice, mustard, wheat, soybean and sunflower (e.g., US6720481, US6281348, US5659124, US6399856, US7345222, US7230168, US6072102, EP1135982, WO2001). / 092544 and WO1996 / 040949). Methods for producing such plants are generally known to those skilled in the art and are described, for example, in the above-mentioned publications. Preferably, the plant is selected from corn, canola, soybean, rice, tomatoes and wheat grains (eg wheat), most preferably from corn, canola, soybean, rice, wheat.

  Plants with abiotic stress tolerance are drought, high salinity, high light intensity, high UV irradiation, chemical contamination (eg high heavy metal concentration), low or high temperature, limited nutrients (ie nitrogen, phosphorus) Plants exhibiting increased resistance to abiotic stress conditions such as supply and collective stress (see, for example, WO 2000/004173, WO2007 / 131699, CA2521729 and US2008 / 0229448).

  Examples of plants imparted with abiotic stress tolerance by genetic recombination technology include rice, corn, soybean, sugarcane, alfalfa, wheat, tomato, potato, barley, rapeseed, legume, oat, sorghum that are resistant to drought. And cotton (see eg WO2005 / 048693, WO2008 / 002480 and WO 2007/030001); low temperature resistant corn, soybean, wheat, cotton, rice, rapeseed and alfalfa (see eg US4731499 and WO2007 / 112122) Rice, cotton, potato, soybean, wheat, barley, rye, sorghum, alfalfa, grape, tomato, sunflower and tobacco (see, for example, US7256326, US7034139, WO / 2001/030990) that are resistant to high salinity . There is also a corn “DroughtGard (registered trademark)” (Monsanto product) into which a cold shock protein gene cspB of Bacillus subtilis has been introduced.

  As a plant imparted with abiotic stress tolerance by conventional breeding technology or genome breeding technology, for example, corn having drought tolerance is “Agrisure Artesian (registered trademark)” and “Optimum ( (Registered trademark) AQUAmax (registered trademark) ".

  Plants to which other characteristics are imparted include plants with modified maturation characteristics. Examples of alteration of maturation characteristics include delayed ripening, delayed softening and early maturation. For example, a plant whose maturation characteristics have been modified by genetic recombination technology can be preserved by introducing an S-adenosylmethion hydrolase gene (sam-K) derived from E. coli bacteriophage T3 for ethylene production of the plant hormone. Improved melon and tomato; gene lacking part of ACC synthase gene derived from tomato involved in ethylene production of plant hormones, ACC deaminase gene from Pseudomonas chlororaphis that degrades ethylene precursor ACC, Shelf by introducing one or more of tomato-derived polygalacturonase gene double-stranded RNA that degrades cell wall pectin or tomato-derived ACC oxidase gene involved in ethylene production Tomato with improved durability; polygalacturonase residue derived from tomato It includes tomatoes was improved shelf-life "FLAVR SAVR (trademark)" by introducing a gene pg to generate a double-stranded RNA of the child. Other plants whose maturation characteristics have been modified by genetic engineering techniques include, for example, tomatoes, melons, raspberries, strawberries, muskmelons, peppers and papayas whose ripening has been delayed (e.g., US 5767376, US7084321, US6107548). US5981831, WO1995 / 035387, US5952546, US5512466, WO1997 / 001952, WO1992 / 008798 and Plant Cell. 1989, 53-63. See Plant Molecular Biology, 50, 2002). Methods for producing such plants are generally known to those skilled in the art and are described, for example, in the above-mentioned publications. Preferably, the plants are fruits (eg tomatoes, vines, melons, papayas, bananas, peppers, raspberries and strawberries); nuclear fruits (eg cherries, apricots and peaches); berries (eg apples and berries) Pear); and citrus fruits (e.g., citron, lime, orange, pomelo, grapefruit, and mandarin), more preferably selected from tomato, melon, papaya, vine, apple, banana, orange and strawberry; Most preferred are tomato, melon and papaya.

  Plants to which other quality alterations have been imparted by gene recombination technology include, for example, endogenous introduction of a 3-phytase gene (phyA) derived from Aspergillus niger, a plant phytic acid degrading enzyme. Canola with enhanced phytic acid degradation “Phytaseed® Canola”; a dihydrodoflavonol-4-reductase gene from Petunia hybrida, an enzyme that produces the blue pigment delphinidin and its derivatives, and petunia, Carnation “Moondust ™”, “Moonshadow” in which flower color is controlled to be blue by introducing a flavonoid-3 ′, 5′-hydroxylase gene derived from pansy (Viola wittrockiana), salvia (Salvia splendens), or carnation (Trademark) "," Moonshade (trademark) "," Moonlite (trademark) "," Moonaqu " a (TM), "Moonvista (TM)", "Moonique (TM)", "Moonpearl (TM)", "Moonberry (TM)" and "Moonvelvet (TM)"; producing the blue pigment delphinidin and its derivatives Rose whose flower color is controlled to blue by introducing an anthocyanin-5-acyltransferase gene derived from Torenia sp. And a flavonoid-3,5'-hydroxylase gene derived from pansy; Introducing a Japanese cedar pollen antigen protein gene (7crp) tolerant to hay fever and tolerating hay fever; and introducing a phytokine-derived 3-phytase gene (phyA) to enhance degradation of endogenous phytic acid Corn; producing high quality fiber with improved fiber micronaire, increased fiber strength, length uniformity and color Cotton (see, for example, WO1996 / 26639, US7329802, US6472588 and WO2001 / 17333) can be mentioned.

  Examples of plants whose traits relating to plant growth and yield have been modified include plants with enhanced growth ability. Plants whose growth and yield traits have been modified by genetic recombination technology have been enhanced by introducing a gene (bbx32) that encodes a transcription factor that regulates the diurnal properties of Arabidopsis thaliana. Soybeans with high yields can be expected; introduction of a transcription factor gene (athb17) belonging to the homeodomain derived from Arabidopsis thaliana-14 zippers (HD-Zip) family class II HD-Zip II) increases the ear weight. As a result, corn with high yields has been developed.

  As a plant whose quality has been altered by genome editing technology, the zinc finger nuclease is used to lack the IPK1 gene encoding inositol-1,3,4,5,6-pentakisphosphate 2-kinase, an enzyme for phytic acid biosynthesis. Corn with reduced phytic acid content, "ZFN-12 maize"; deletion of the gene encoding polyphenol oxidase using crisper casnaine, which imparts browning resistance Mushrooms (see, for example, Nature., Vol 532, 21 APRIL 2016).

  As a plant whose quality has been modified by new breeding technology, for example, using cisgenesis, introducing a low polyphenole oxidase (enzyme causing browning) production gene sequence GEN-03 isolated from apples into a new apple variety In addition, the apple "Arctic (registered trademark)" that reduces polyphenole oxidase expression and does not brown The tomato (Physiol Plantarum, 124, 465-475 2005) which gave salt tolerance to the non-transgenic panicle tomato using a tree is mentioned.

  In rice, genes showing resistance to a large number of diseases, pests and abiotic stress are known, and the production of resistant varieties into which these genes have been introduced is thriving. Examples of genes showing disease resistance in rice and resistance to abiotic stress include BPH1, BPH2, BPH3, BPH4, BPH5, BPH6, BPH7, BPH8, BPH9, BPH10, BPH11, BPH12, BPH13, BPH14, BPH15, BPH17 , BPH18, BPH19, BPH20, BPH21, BPH22, BPH23, BPH24, BPH25, BPH26, BPH27, BPH28, BPH29, BPH32, qBPH-12, qBPHR-1, qBPHR-3, qBPHR-8, qBPHR-5-1qBPHR-5 -2 green planthopper resistance genes such as qBPHR-11-1 and qBPHR-11-2; white-spotted plant resistance such as WBPH1, WBPH2, WBPH3, WBPH4, WBPH5, WBPH6, OVC, qOVA-5-2, qOVA1-3, and qOVA5-1 Sex genes: Qsbph2b, Qsbph3, Qsbph3b, Qsbph3c, Qsbph3d, Qsbph4, Qsbph8, Qsbph11, Qsbph11d, Qsbph11e, Qsbph11f, Qsbph11g, Qsbph12H, etc. , GLH9, GLH10, GLH11, GLH12, GLH13, GRH1, GRH2, GRH3, GRH4, GRH5, Zlh1, Zlh2, Zlh3, qGRH-4, qGRH-2, qGRH-5, qGRH-6, qGRH-11, qG Leafhopper resistance genes such as RH-3; Nikamei resistance genes such as SB; Pii, PI65, PIZT, PI24, PI29, PI25, Pi-jnw1, PB1, PIQ6, PID3, PI67, PITQ5, PITP, PITQ6, PLM2, PISE3, IPI, PISE1, PI157, PIQ4, PI21, PIA, PIB, PIK, PIKUR1, PIKUR2, PI3, PIF, PIZH, PIR4, PIR7, PI30, PI, PIGD2, PIG, PIGD3, PIGD1, PIZ, PI (, PI18 , PIM, PI17, PI20, PI1, PI19, PI5, PISH, PI10, PI9, PI21, PI22, PI44, PI22, PI13, PII, PIB1, PIQ1, PIQ2, PIQ3, PIIS1, PII2, PI62, PI12, IPI3, PI14 , PI15, PI16, PIT, PI11, PI6, PI23, PI14, PI11, PIIS2, PIB2, PI12, PI39, PI40, PITA, PIR2-3, PIR9-2, PIR12-2, PIRF2-1, qRBR-2, qRBR -3, PI27, PI28, PI26, PIGM, PI47, PI48, PI7, PI56, PI49, PI34, PIKG, PI38, PI32, PI31, PI46, PIX, PIXY, Pita3, PI41, PI42, PI2, PI36, PI37, PIKH , PIKM, PIKP, PI35, PIZ5, PIB2, PI43, PI50, PI51, PID1, PIY1, PIY2, PI55-2, PICO39, PI55-1, PIBH8, PIR7A, PIR7B, PID2, PI33, qBFR4-1, qBFR4-2, qRBR-2, qRBR-3, qRBR-8, qRBR-1-1, qRBR-1-3, qRBR-7-1, qRBR-7-2, qRBR-9- 1, blast resistance genes such as qRBR-9-2, qRBR-9-3, qRBR-1-2, qRBR-1-4; stripe wilt resistance genes such as STVA, STVB, Stvb-i; XA21D, XA, XA40, XA NM, XA8, XA33, XA34, XA35, XA36, XA37, XA7, XA3, XA25, XA28, XA29, XA30, XA31, XA32, XA38, XA39, XA11, XA16, XA17, XA18, XA17, XA18 XB20, XA14, XA2, XA12, XA1, XA K, XA A, XA H, XA10, XA23, XA22, XA24, XA21, SERRT13, XA4, XA5, XA13, etc .; blight resistance genes such as qSB-3, qSB-7, qSB-11, qSB-9-1; sesame leaf resistance genes such as CE; yellow dwarf disease resistance genes such as YDV; Black line dwarf disease resistance gene; high temperature climbing resistance gene such as Amy1A, Amy1C, Amy3A, Amy3B; low amylose gene such as dul3, qAC9.3, rsr1, Wx, and Wx1-1; AP01, SCM2, Sd1, etc. Lodging resistance Offspring germination resistance gene such as Sdr4; low temperature resistance gene such as CTB1, CTB2, qLTG3-1; drought resistance gene such as Dro1; DEP1, Cn1a, GPS, SPIKE, PTB1, TAWAWA1, WFP, IPA1, GS3, GS5, GS6, GL3.1, GW2, GW8, qGL3, qSS7, qSW5, and other genes related to the number of seeds or seeds; Hd1, Ghd8, DTH8, and other genes that regulate day length responsiveness; FLO4, PDIL1, etc. Sex genes; LOX3 and other lipoxygenase-deficient genes (reducing old rice odor); Alk and other genes related to amylopectin chain length are known. Rice varieties in which one or more of these genes are simultaneously incorporated have been developed or marketed.

  For the above-mentioned plants, genetic recombination technology, conventional breeding technology, genome breeding technology, new breeding technology or genome editing technology are used, and abiotic stress resistance, disease resistance, weeding as described above. By crossing two or more plants with similar or different properties, such as drug resistance, pest resistance, growth and yield traits, modification of nutrient utilization, product quality modification, fertility traits, etc. Plants to which two or more properties of the parent line are added are also included.

Commercial plants tolerated to two or more herbicides include, for example, cotton “GlyTol ™ LibertyLink ™” and “GlyTol ™ LibertyLink ™” that are resistant to glyphosate and glufosinate; Corn “Roundup Ready ™ LibertyLink ™ Maize” with glyphosate and glufosinate tolerance; soybean “Enlist ™ Soybean” with glufosinate and 2,4-D tolerance; soybean with glyphosate and dicamba tolerance Genuity® Roundup Ready ™ 2 Xtend ™; Corn and soybean “OptimumGAT ™” with glyphosate and ALS inhibitor tolerance; three herbicides: glyphosate, glufosinate and 2,4-D Genetically modified soybeans “Enlist E3 ™” and “Enlist ™ Roundup Ready 2 Yield®” that are resistant to Corn “Enlist ™ Roundup Ready® Corn 2” resistant to refosate, 2,4-D and allyloxyphenoxypropionic acid (FOPs) herbicides; glyphosate, 2,4-D and allyloxyphenoxy Corn “Enlist ™ Roundup Ready® Corn 2” resistant to propionic acid (FOPs) herbicides; Cotton “Bollgard II® XtendFlex ™ Cotton” resistant to dicamba, glyphosate and glufosinate "Enlist ™ Cotton" resistant to 3 glyphosate, glufosinate and 2,4-D herbicides; 3 herbicides glyphosate, glufosinate and HPPD herbicides (eg isoxaflutol) Examples include soybean "Liberty Link (registered trademark) GT27 (trademark)" which is resistant. In addition, cotton resistant to both glufosinate and 2,4-D; cotton resistant to both glufosinate and dicamba; corn resistant to both glyphosate and 2,4-D; glyphosate and HPPD herbicide Soybeans that are resistant to both; glyphosate, glufosinate, 2,4-D, corn resistant to allyloxyphenoxypropionic acid (FOPs) and cyclohexadione (DIMs) herbicides have also been developed.
Examples of commercially available plants imparted with herbicide resistance and pest resistance include corn "YieldGard Roundup Ready (trademark)" and "YieldGard Roundup Ready 2 (trademark)" having glyphosate resistance and resistance to corn borers. Maize “Agrisure CB / LL ™” with glufosinate and corn borer resistance; maize “Yield Gard VT Root worm / RR2 ™” with glyphosate and corn rootworm resistance; Corn “Yield Gard VT Triple ™” with resistance to corn rootworm and corn borer; glufosinate and lepidopteran pest resistance (Cry1F) (eg Western bean cut worm, corn borer, black cut worm and fall) Toe with resistance to army worm) Sorghum “Herculex I ™”; corn with glyphosate resistance and corn worm resistance “YieldGard Corn Rootworm / Roundup Ready 2 ™”; glufosinate resistance and corn crustacean pest resistance (Cry3A) Corn "Agrisure GT / RW ™" with Western corn root worm, Northern corn root worm and Mexican corn root worm); glufosinate resistance and Coleoptera pest resistance (Cry34 / 35Ab1) (eg Western corn Maize “Herculex RW ™” with root worm, Northern corn root worm and Mexican corn root worm); Yield Gard VT Root worm / RR2 ™ with glyphosate resistance and corn root worm resistance ) "; Dicamba tolerance, glyphosate Sex, Gurihoshineto resistance and lepidopteran insect resistant cotton (e.g., bollworm acids and tobacco budworm, resistance to such armyworm acids) is cotton "Bollgard (R) 3 XtendFlex (registered trademark)" with.

  Examples of commercially available plants imparted with disease resistance and pest resistance include, for example, Potato virus Y resistance and pest resistance potato “Hi-Lite NewLeaf ™ Y Potato "," NewLeaf (TM) Y Russet Burbank Potato "and" Shepody NewLeaf (TM) Y Potato "; Russet Burbank Potato ”.

  Commercial plants that have been given herbicide tolerance and quality-modifying properties include, for example, canola “InVigor ™ Canola” that has been given glufosinate tolerance and fertility traits; glufosinate tolerance and fertility traits Corn “InVigor ™ Maize”; soy bean “Vistive Gold ™” with glyphosate tolerance and modified oil content.

  Examples of commercial plants with more than two traits include glyphosate tolerance, glufosinate tolerance and lepidopteran insect resistance (Cry1F) (ie against Western bean cut worms, corn borers, black cut worms and fall army worms) Corn "Herculex I / Roundup Ready 2 (Trade Mark)" resistant to glyphosate, corn rootworm and corn borer resistant "YieldGard Plus / Roundup Ready 2 (Trade Mark)"; glyphosate resistant, glufosinate Maize “Agrisure GT / CB / LL ™” with resistance and corn borer resistance; glufosinate resistance, lepidopterous pest resistance (Cry1F) and Coleoptera pest resistance (Cry34 / 35Ab1) (ie Western bean cut worm, Corn borer, black cut worm and faller -"Herculex Xtra ™" maize with lepidopterous pests such as worms and resistance to Coleopterous pests such as Western corn rootworm, Northern corn rootworm, Mexican corn rootworm, etc .; glufosinate resistance, corn borer resistance (Cry1Ab ) And Crustacea pest resistance (Cry3A) (ie, resistance to Western corn rootworm, Northern corn rootworm and Mexican corn rootworm) “Agrisure CB / LL / RW ™”; glyphosate resistance, corn borer Corn “Agrisure ™ 3000GT” with resistance (Cry1Ab) and Coleoptera (Cry3A) (ie resistance to Western corn rootworm, Northern corn rootworm and Mexican corn rootworm); glyphosate resistance, corn root Wa Maize and European corn borer resistant and high lysine corn “Mavera high-value corn”; European corn borer, Southwestern corn borer, corn ear worm, fall army worm, black cut worm and / or western bean worm Maize "Optimum (registered trademark) Leptra (trademark)" that is resistant to pests that damage the above-ground parts of plants such as glyphosate resistance, glufosinate resistance, frogeye leaf spot resistance, sudden death syndrome (sudden death Syndrome resistance, stem stem canker resistance, phytophthora stem and root rot resistance, sweet root-knot nematode resistance, stem rot resistance , Resistance to brown stem rot, soybean cyst Soybean “Credenz® soybean” with soybean cyst nematode resistance, improved iron deficiency chlorosis, and altered chloride sensitivity; multiple herbicide tolerance and Cotton `` Stoneville (registered trademark) Cotton '' given pest resistance (in order to respond to the occurrence of weeds and pests in the field in each region, ST5517GLTP, ST4848GLT, ST4949GLT, ST5020GLT, ST5115GLT, ST6182GLT, ST4747GLB2, There are nine varieties, ST4946GLB2 and ST6448GLB2.

The plants that are commercially available or developed are listed below (A1 to A550). The parentheses mean [plant name, Event Name, Event code, trademark name (Tradename)]. NA means “no information” or “unavailable information”. Many of these plants are registered databases (GM APPROVAL DATABASE) in the electronic information site (http://www.isaaa.org/) of the INTERNATINAL SERVICE for the ACQUISITION of AGRI-BIOTECH APPLICATIONS, ISAAA. It is listed.
A1: [Alfalfa, J101, MON-00101-8, Roundup Ready (trademark) Alfalfa], A2: [Alfalfa, J101 x J163, MON-00101-8 x MON-00163-7, Roundup Ready (trademark) Alfalfa], A3: [Alfalfa, J163, MON-00163-7, Roundup Ready (TM) Alfalfa], A4: [Alfalfa, KK179, MON-00179-5, HarvXtra (TM)], A5: [Alfalfa, KK179 x J101, MON -00179-5 x MON-00101-8], A6: [Apple, GD743, OKA-NB001-8, Arctic (TM) "Golden Delicious" Apple], A7: [Apple, GS784, OKA-NB002-9, Arctic (Trademark)], A8: [apple, NF872, OKA-NB003-1, Arctic (trademark) Fuji Apple], A9: [Argentina canola, 23-18-17 (Event 18), CGN-89111-8, Laurical ( Trademark) Canola], A10: [Argentina Canola, 23-198 (Event 23), CGN-89465-2, Laurical (TM) Canola], A11: [Argentina Canola, 61061, DP-061061-7], A12: [ Argentina Canola, 73396, DP-073496-4, Optimum (Register Gly canola], A13: [Argentina canola, 73396 x RF3, DP-073496-4 x ACS-BN003-6, NA], A14: [Argentina canola, GT200 (RT200), MON-89249-2, Roundup Ready (Trademark) Canola], A15: [Argentina Canola, GT73 (RT73), MON-00073-7, Roundup Ready (Trademark) Canola], A16: [Argentina Canola, HCN10 (Topas 19/2), NA, Liberty Link ( Trademark) Independence (trademark)], A17: [Argentina canola, HCN28 (T45), ACS-BN008-2, InVigor (TM) Canola], A18: [Argentina canola, HCN28 x MON88302, ACS-BN008-2 x MON- 88302-9, InVigor (TM) x TruFlex (TM) Roundup Ready (TM) Canola], A19: [Argentina Canola, HCN92 (Topas 19/2), ACS-BN007-1, Liberty Link (TM) Innovator (TM) )], A20: [Argentina canola, HCN92 x MON88302, ACS-BN007-1 x MON-88302-9, Liberty Link (TM) Innovator (TM) x TruFlex (TM) ) Roundup Ready (TM) Canola], A21: [Argentina Canola, MON88302, MON-88302-9, TruFlex (TM) Roundup Ready (TM) Canola], A22: [Argentina Canola, MON88302 x MS8 x RF3, MON- 88302-9 x ACS-BN005-8 x ACS-BN003-6, InVigor (TM) x TruFlex (TM) Roundup Ready (TM) Canola], A23: [Argentina canola, MON88302 x RF3, MON-88302-9 x ACS-BN003-6, NA], A24: [Argentina canola, MPS961, NA, Phytaseed (TM) Canola], A25: [Argentina canola, MPS962, NA, Phytaseed (TM) Canola], A26: [Argentina canola, MPS963 , NA, Phytaseed (TM) Canola], A27: [Argentina Canola, MPS964, NA, Phytaseed (TM) Canola], A28: [Argentina Canola, MPS965, NA, Phytaseed (TM) Canola], A29: [Argentina Canola, MS1 (B91-4), ACS-BN004-7, InVigor ™ Canola], A30: [Al Nchin canola, MS1 x MON88302, ACS-BN004-7 x MON-88302-9, InVigor (TM) x TruFlex (TM) Roundup Ready (TM) Canola], A31: [Argentina canola, MS1 x RF1 (PGS1), ACS-BN004-7 x ACS-BN001-4, InVigor ™ Canola], A32: [Argentina canola, MS1 x RF1 (PGS2), ACS-BN004-7 x ACS-BN002-5, InVigor ™ Canola] , A33: [Argentina canola, MS1 x RF3, ACS-BN004-7 x ACS-BN003-6, InVigor (TM) Canola], A34: [Argentina canola, MS8, ACS-BN005-8, InVigor (TM) Canola] , A35: [Argentina canola, MS8 x MON88302, ACS-BN005-8 x MON-88302-9, InVigor (TM) x TruFlex (TM) Roundup Ready (TM) Canola], A36: [Argentina canola, MS8 x RF3 , ACS-BN005-8 x ACS-BN003-6, InVigor ™ Canola], A37: [Argentina canola, MS8 x RF3 x GT73 (RT73), ACS-BN005-8 x ACS-BN003-6 x MON-00073 -7, NA], A38: [A Zentin canola, OXY-235, ACS-BN011-5, Navigator ™ Canola], A39: [Argentina canola, PHY14, NA, NA], A40: [Argentina canola, PHY23, NA, NA], A41: [Argentina Canola, PHY35, NA, NA], A42: [Argentina canola, PHY36, NA, NA], A43: [Argentina canola, RF1 (B93-101), ACS-BN001-4, InVigor ™ Canola], A44: [Argentina canola, RF1 x MON88302, CS-BN001-4 x MON-88302-9, InVigor (TM) x TruFlex (TM) Roundup Ready (TM) Canola], A45: [Argentina canola, RF2 (B94-2) , ACS-BN002-5, InVigor (TM) Canola], A46: [Argentina canola, RF2 x MON88302, ACS-BN002-5 x MON-88302-9, InVigor (TM) x TruFlex (TM) Roundup Ready (TM) ) Canola], A47: [Argentina canola, RF3, ACS-BN003-6, InVigor (TM) Canola], A48: [beans, EMBRAPA5.1, EMB-PV051-1, NA], A 49: [Carnation, 11 (7442), FLO-07442-4, Moondust (trademark)], A50: [Carnation, 11363 (1363A), FLO-11363-1, Moonshadow (trademark)], A51: [Carnation, 1226A (11226), FLO-11226-8, Moonshade (trademark)], A52: [carnation, 123.2.2 (40619), FLO-40619-7, Moonshade (trademark)], A53: [carnation, 123.2.38 (40644) ), FLO-40644-4, Moonlite ™], A54: [Carnation, 123.8.12, FLO-40689-6, Moonaqua ™], A55: [Carnation, 123.8.8 (40685), FLO-40685 -1, Moonvista (trademark)], A56: [Carnation, 1351A (11351), FLO-11351-7, Moonshade (trademark)], A57: [Carnation, 1400A (11400), FLO-11400-2, Moonshade (trademark) )], A58: [Carnation, 15, FLO-00015-2, Moondust (TM)], A59: [Carnation, 16, FLO-00016-3, Moondust (TM)], A60: [Carnation, 19907, IFD- 19907-9, Moonique (trademark)], A61: [Car , 25947, IFD-25947-1, Moonpearl (trademark)], A62: [carnation, 25958, IFD-25958-3, Moonberry (trademark)], A63: [carnation, 26407, IFD-26407-2, Moonvelvet ( Trademark)], A64: [Carnation, 4, FLO-00004-9, Moondust (Trademark)], A65: [Carnation, 66, FLO-00066-8, NA] A66: [Carnation, 959A (11959), FLO- 11959-3, Moonshade (trademark)], A67: [Carnation, 988A (11988), FLO-11988-7, Moonshade (trademark)], A68: [Chicory, RM3-3, NA, SeedLink (trademark)], A69 : [Chicory, RM3-4, NA, SeedLink (TM)], A70: [Chicory, RM3-6, NA, SeedLink (TM)], A71: [Wata, 19-51a, DD-01951A-7, NA] , A72: [Wata, 281-24-236, DAS-24236-5, NA], A73: [Wata, 281-24-236 x 3006-210-23 (MX B-13), DAS-24236-5 x DAS-21023-5, WideStrike ™ Cotton], A74: [Wata, 281-24-236 x 3006-210-23 x COT102 x 81910, DAS-24236-5 x DAS-21023-5 x SYN-IR102- 7 x DAS-81910-7, NA] , A75: [Cotton, 3006-210-23, DAS-21023-5, NA], A76: [Cotton, 3006-210-23 x 281-24-236 x MON1445, DAS-21023-5 x DAS-24236- 5 x MON-01445-2, WideStrike ™ RoundupReady ™ Cotton], A77: [Wata, 3006-210-23 x 281-24-236 x MON88913, DAS-21023-5 x DAS-24236-5 x NAMON-88913-8, Widestrike ™ RoundupReadyFlex ™ Cotton], A78: [Wata, 3006-210-23 x 281-24-236 x MON88913 x COT102, DAS-21023-5 x DAS-24236-5 x MON-88913-8 x SYN-IR102-7, Widestrike ™ RoundupReadyFlex ™ Cotton], A79: [Wata, 31707, NA, BXN ™ PlusBollgard ™ Cotton], A80: [Wata, 31803, NA, BXN (TM) PlusBollgard (TM) Cotton], A81: [Cotton, 31807 x 31808, NA, NA], A82: [Cotton, 31807, NA, BXN (TM) PlusBollgard (TM) Cotton], A83: [ Cotton, 31808, NA, BXN ™ PlusBollgard ™ Cotton], A84: [Wata, 42317, NA, BXN ™ PlusBollgard ™ Cotton], A85: [Wata, 81910, DAS-81910-7, NA], A86: [Wata BNLA-601, NA, NA], A87: [Cotton, BXN10211 (10211), BXN-10211-9, NA], A88: [Cotton, BXN10215 (10215), BXN-10215-4NA, BXN (trademark) Cotton] , A89: [cotton, BXN102 cotton 22 (10222), BXN-10222-2, BXN (trademark) Cotton], A90: [cotta, BXN10224 (10224), BXN-10224-4NA, BXN (trademark) Cotton], A91 : [Cotton, COT102 (IR102), SYN-IR102-7, VIPCOT (trademark) Cotton], A92: [Cotton, COT102 x COT67B, SYN-IR102-7NA x NASYN-IR67B-1, VIPCOT (trademark) Cotton], A93: [Cotton, COT102 x COT67B x MON88913, SYN-IR102-7NA x NASYN-IR67B-1NA x NAMON-88913-8, VIPCOT (trademark) RoundupReadyFle x (trademark) Cotton], A94: [Wata, COT102 x MON15985, SYN-IR102-7NA x NAMON-15985-7, Bollgard (registered trademark) III], A95: [Cotton, COT102 x MON15985 x MON88913, SYN-IR102-7NA x NAMON-15985-7NA x NAMON-88913-8, Bollgard (Registered trademark) III x RoundupReady (trademark) Flex (trademark)], A96: [Wata, COT102 x MON15985 x MON88913 x MON88701, SYN-IR102-7NA x NAMON-15985-7NA x NAMON-88913-8NA x NAMONNA8 8701-3, NA], A97: [Cotton, COT67B (IR67B), SYN-IR67B-1, NA], A98: [Cotton, Event1, NA, JK1], A99: [Cotton, GFMCry1A, GTL-GFM311-7 , NA], A100: [cotta, GHB119, BCS-GH005-8, NA], A101: [cotta, GHB614, BCS-GH002-5, GlyTol ™], A102: [cotta, GHB614 x LLCotton25, BCS- GH002-5NA x NAACS-GH001-3, GlyTol (trademark) LibertyLink (trademark)], A103: [Wata, GHB614 x LLCotton25 x MON15985, BCS-GH002-5NA x NAACS-GH001-3NA x NAMON-15985-7, NA ], A104: [Wata, GHB614 x MON15985, BCS-GH002-5NA x NAMON-15985, NA], A105: [Wata, GHB614 x T304-40 x GHB119, BCS-GH002-5NA x NABCS-GH004-7NA x NABCS -GH005-8, Glytol (TM) x Twinlink (TM)], A106: [Wata, GHB614 x T304-40 x GHB119 x COT102, BCS-GH002-5NA x NABCS-GH004-7NA x NABCS-GH005-8NA x NASYN -IR102-7, Glytol ™ x Twinlink ™ x VIPCOT ™ Cotton], A107: [Cotton, GK12, NA, NA], A108: [Cotton, LLCotton25, ACS-GH001-3NA, Fiberma x ( Trademark) LibertyLink (trademark)], A 109: [Wata, LLCotton25 x MON15985, ACS-GH001-3NA x NAMON-15985-7, Fiberma x (trademark) LibertyLink (trademark) BollgardII (trademark)], A110: [Wata, MLS9124, NA, NA], A111: [Cotton, MON1076, MON-89924-2, Bollgard (trademark) Cotton], A112: [Cotton, MON1445, MON-01445-2, RoundupReady (trademark) Cotton], A113: [Cotton, MON15985, MON-15985-7 , BollgardII ™ Cotton], A114: [Wata, MON15985 x MON1445, MON-15985-7NA x NAMON-01445-2, RoundupReady ™ BollgardII ™ Cotton], A115: [Wata, MON1698, MON-89383 -1, RoundupReady (trademark) Cotton], A116: [Wata, MON531, MON-00531-6, Bollgard (trademark) Cotton, Ingard (trademark)], A117: [Wata, MON531 x MON1445, MON-0531-6NA x NAMON-01445-2, RoundupReady (TM) Bollgard (TM) Cotton], A118: [Wata, MON757, MON-00757-7, Bollgard (TM) Cotton], A119: [Wata, MON88701, MONNA88701-3, NA] , A120: [Cotton, MON88701 x MON88913, MONNA88701-3NA x NAMON-88913-8, NA], A121: [Cotton, MO N88701 x MON88913 x MON15985, MONNA88701-3NA x NAMON-88913-8NA x NAMON-15985-7, Bollgard II (registered trademark) XtendFlex (trademark) Cotton], A122: [Wata, MON88913, MON-88913-8, RoundupReady ( (Trademark) Flex (trademark) Cotton], A123: [cotta, MON88913 x MON15985, MON-88913-8NA x NAMON-15985-7, RoundupReady (trademark) Flex (trademark) BollgardII (trademark) Cotton], A124: [cotta, NgweChi6Bt, NA, NgweChi6Bt], A125: [Cotton, SGK321, NA, NA], A126: [Cotton, T303-3, BCS-GH003-6, NA], A127: [Cotton, T304-40, BCS-GH004- 7, NA], A128: [Cotton, T304-40 x GHB119, BCS-GH004-7NA x NABCS-GH005-8, TwinLink (trademark) Cotton], A129: [Creeping vent glass, ASR368, SMG-36800-2, NA], A130: [Eggles, BtBrinjalEventEE1, BtBrinjalEventEE1, BARIBtBegun-1, -2, -3and-4], A131: [eucalyptus, H421, H421, GMEucalyptus], A132: [Ama, FP967 (CDCTriffid), CDC-FL001 -2, CDCTriffidFlax], A133: [Lens legume, RH44, RH44, Clearfield
Registered trademark) lentil], A134: [corn, 32138, DP-32138-132138, 2138SPTmaintainer], A135: [corn, 3272, SYN-E3272-5, Enogen (TM)], A136: [corn, 3272 x Bt11, SYN-E3272-5 x SYN-BT011-1, NA], A137: [Corn, 3272 x Bt11 x GA21, SYN-E3272-5 x SYN-BT011-1 x MON-00021-9, NA], A138: [ Corn, 3272 x Bt11 x MIR604, SYN-E3272-5 x SYN-BT011-1 x SYN-IR604-5, NA], A139: [Corn, 3272 x BT11 x MIR604 x GA21, SYN-E3272-5 x SYN- BT011-1 x SYN-IR604-5 x MON-00021-9, NA], A140: [Corn, 3272 x Bt11 x MIR604 x TC1507 x 5307 x GA21, SYN-E3272-5 x SYN-BT011-1 x SYN- IR604-5 x DAS-01507-1 x SYN-05307-1 x MON-00021-9, NA], A141: [Corn, 3272 x GA21, SYN-E3272-5 x MON-00021-9, NA], A142 : [Corn, 3272 x MIR604, SYN-E3272-5 x SYN-IR604-5, NA], A143: [Corn, 3272 x MIR604 x GA21, SYN-E3272-5 x SYN-IR604-5 x MON-00021- 9, NA], A144: Tow Rokosi, 33121, DP-033121-3, NA], A145: [corn, 4114, DP-004114-3, NA], A146: [corn, 5307, SYN-05307-1, Agrisure® Duracade ™ )], A147: [Corn, 5307 x GA21, SYN-05307-1 x MON-00021-9, NA], A148: [Corn, 5307 x MIR604 x Bt11 x TC1507 x GA21, SYN-05307-1 x SYN- IR604-5 x SYN-BT011-1 x DAS-01507-1 x MON-00021-9, Agrisure (R) Duracade (TM) 5122], A149: [corn, 5307 x MIR604 x Bt11 x TC1507 x GA21 x MIR162 SYN-05307-1 x SYN-IR604-5 x SYN-BT011-1 x DAS-01507-1 x MON-00021-9 x SYN-IR162-4, Agrisure (R) Duracade (TM) 5222], A150 : [Corn, 59122, DAS-59122-7, Hercule x (trademark) RW], A151: [Corn, 59122 x DAS40278, DAS-59122-7 x DAS-40278-9, NA], A152: [Corn, 59122 x GA21, DAS-59122-7 x MON-00021-9, NA], A153: [Corn, 59122 x MIR604, DAS-59122-7 x SYN-IR604-5, NA], A154: [Tow Sorghum, 59122 x MIR604 x GA21, DAS-59122-7 x SYN-IR604-5 x MON-00021-9, NA], A155: [Corn, 59122 x MIR604 x TC1507, DAS-59122-7 x SYN-IR604- 5 x DAS-01507-1, NA], A156: [Corn, 59122 x MIR604 x TC1507 x GA21, DAS-59122-7 x SYN-IR604-5 x DAS-01507-1 x MON-00021-9, NA] , A157: [corn, 59122 x MON810, DAS-59122-7 x MON-00810-6, NA], A158: [corn, 59122 x MON810 x MIR604, DAS-59122-7 x MON-00810-6 x SYN- IR604-5, NA], A159: [corn, 59122 x MON810 x NK603, DAS-59122-7 x MON-00810-6 x MON-00603-6, NA], A160: [corn, 59122 x MON810 x NK603 x MIR604, DAS-59122-7 x MON-00810-6 x MON-00603-6 x SYN-IR604-5, NA], A161: [corn, 59122 x MON88017, DAS-59122-7 x MON-88017-3, NA], A162: [corn, 59122 x MON88017 x DAS40278, DAS-59122-7 x MON-88017-3 x DAS-40278-9, NA], A163: [corn, 59122 x NK603, DAS-59122-7 x MON-00603-6, Herculex (quotient ) RWRoundupReady (TM) 2], A164: [Corn, 59122 x NK603 x MIR604, DAS-59122-7 x MON-00603-6 x SYN-IR604-5, NA], A165: [Corn, 59122 x TC1507 x GA21 , DAS-59122-7 x DAS-01507-1 x MON-00021-9, NA], A166: [corn, 676, PH-000676-7, NA], A167: [corn, 678, PH-000678-9 , NA], A168: [corn, 680, PH-000680-2, NA], A169: [corn, 98140, DP-098140-6, Optimum (TM) GAT (TM)], A170: [corn, 98140 x 59122, DP-098140-6 x DAS-59122-7, NA], A171: [corn, 98140 x TC1507, DP-098140-6 x DAS-01507-1, NA], A172: [corn, 98140 x TC1507 x 59122, DP-098140-6 x DAS-01507-1 x DAS-59122-7, NA], A173: [Corn, Bt10, NA, Bt10], A174: [Corn, Bt11 (X 4334CBR, X 4734CBR), SYN -BT011-1, Agrisure ™ CB / LL], A175: [corn, Bt11 x 5307, SYN-BT011-1 x SYN-05307-1, NA], A176: [corn , Bt11 x 5307 x GA21, SYN-BT011-1 x SYN-05307-1 x MON-00021-9, NA], A177: [Corn, Bt11 x 59122, SYN-BT011-1 x DAS-59122-7, NA ], A178: [Corn, Bt11 x 59122 x GA21, SYN-BT011-1 x DAS-59122-7 x MON-00021-9, NA], A179: [Corn, Bt11 x 59122 x MIR604, SYN-BT011-1 x DAS-59122-7 x SYN-IR604-5, NA], A180: [Corn, Bt11 x 59122 x MIR604 x GA21, SYN-BT011-1 x DAS-59122-7 x SYN-IR604-5 x MON-00021 -9, NA], A181: [corn, Bt11 x 59122 x MIR604 x TC1507, SYN-BT011-1 x DAS-59122-7 x SYN-IR604-5 x DAS-01507-1, NA], A182: [corn BT11 x 59122 x MIR604 x TC1507 x GA21, SYN-BT011-1 x DAS-59122-7 x SYN-IR604-5 x DAS-01507-1 x MON-00021-9, Agrisure (R) 3122], A183 : [Corn, Bt11 x 59122 x TC1507, SYN-BT011-1 x DAS-59122-7 x DAS-01507-1, NA], A184: [Corn, Bt11 x 59122 x TC1507 x GA21, SYN-BT011-1 x DAS-59122-7 x DAS-01507-1 x MON-00021-9, NA], A185: [ Sorghum, Bt11 x GA21, SYN-BT011-1 x MON-00021-9, Agrisure ™ GT / CB / LL], A186: [Corn, Bt11 x MIR162, SYN-BT011-1 x SYN-IR162-4, Agrisure (R) Viptera (TM) 2100], A187: [corn, Bt11 x MIR162 x 5307, SYN-BT011-1 x SYN-IR162-4 x SYN-05307-1, NA], A188: [corn, Bt11 x MIR162 x 5307 x GA21, SYN-BT011-1 x SYN-IR162-4 x SYN-05307-1 x MON-00021-9, NA], A189: [corn, Bt11 x MIR162 x GA21, SYN-BT011-1 x SYN-IR162-4 x MON-00021-9, Agrisure (R) Viptera (TM) 3110], A190: [corn, BT11 x MIR162 x MIR604, SYN-BT011-1 x SYN-IR162-4 x SYN- IR604-5, Agrisure® Viptera ™ 3100], A191: [corn, BT11 x MIR162 x MIR604 x 5307, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x SYN-05307 -1, NA], A192: [Corn, Bt11 x MIR162 x MIR604 x 5307 x GA21, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x SYN-05307-1 x MON-00021-9 , NA], A193: [G Corn, Bt11 x MIR162 x MIR604 x GA21, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x MON-00021-9, Agrisure (R) Viptera (TM) 3111, Agrisure (R) Viptera ™ 4], A194: [Corn, Bt11 x MIR162 x MIR604 x MON89034 x 5307 x GA21, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x MON-89034-3 x SYN- 05307-1 x MON-00021-9, NA], A195: [corn, BT11 x MIR162 x MIR604 x TC1507, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x DAS-01507-1, NA], A196: [corn, BT11 x MIR162 x MIR604 x TC1507 x 5307, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x DAS-01507-1 x SYN-05307-1, NA] , A197: [Corn, Bt11 x MIR162 x MIR604 x TC1507 x GA21, SYN-BT011-1 x SYN-IR162-4 x SYN-IR604-5 x DAS-01507-1 x MON-00021-9, NA], A198 : [Corn, Bt11 x MIR162 x MON89034, SYN-BT011-1 x SYN-IR162-4 x MON-89034-3, NA], A199: [Corn, Bt11 x MIR162 x MON89034 x GA21, SYN-BT011-1 x SYN-IR162-4 x MON-89034-3 x MON-000 21-9, NA], A200: [corn, Bt11 x MIR162 x TC1507, SYN-BT011-1 x SYN-IR162-4 x DAS-01507-1, NA], A201: [corn, Bt11 x MIR162 x TC1507 x 5307, SYN-BT011-1 x SYN-IR162-4 x DAS-01507-1 x SYN-05307-1, NA], A202: [Corn, Bt11 x MIR162 x TC1507 x 5307 x GA21, SYN-BT011-1 x SYN-IR162-4 x DAS-01507-1 x SYN-05307-1 x MON-00021-9, NA], A203: [Corn, Bt11 x MIR162 x TC1507 x GA21, SYN-BT011-1 x SYN-IR162- 4 x DAS-01507-1 x MON-00021-9, Agrisure ™ Viptera3220], A204: [corn, Bt11 x MIR604, SYN-BT011-1 x SYN-IR604-5, Agrisure ™ CB / LL / RW], A205: [corn, Bt11 x MIR604 x 5307, SYN-BT011-1 x SYN-IR604-5 x SYN-05307-1, NA], A206: [corn, Bt11 x MIR604 x 5307 x GA21, SYN- BT011-1 x SYN-IR604-5 x SYN-05307-1 x MON-00021-9, NA], A207: [Corn, BT11 x MIR604 x GA21, SYN-BT011-1 x SYN-IR604-5 x MON- 00021-9, Agrisure (trademark) 3000GT], A208: [Tomoro Bt11 x MIR604 x TC1507, SYN-BT011-1 x SYN-IR604-5 x DAS-01507-1, NA], A209: [Corn, Bt11 x MIR604 x TC1507 x 5307, SYN-BT011-1 x SYN- IR604-5 x DAS-01507-1 x SYN-05307-1, NA], A210: [Corn, Bt11 x MIR604 x TC1507 x GA21, SYN-BT011-1 x SYN-IR604-5 x DAS-01507-1 x MON-00021-9, NA], A211: [corn, Bt11 x MON89034, SYN-BT011-1 x MON-89034-3, NA], A212: [corn, Bt11 x MON89034 x GA21, SYN-BT011-1 x MON-89034-3 x MON-00021-9, NA], A213: [Maize, Bt11 x TC1507, SYN-BT011-1 x DAS-01507-1, NA], A214: [Corn, Bt11 x TC1507 x 5307, SYN-BT011-1 x DAS-01507-1 x SYN-05307-1, NA], A215: [Corn, Bt11 x TC1507 x 5307 x GA21, SYN-BT011-1 x DAS-01507-1 x SYN-05307- 1 x MON-00021-9, NA], A216: [corn, Bt11 x TC1507 x GA21, SYN-BT011-1 x DAS-01507-1 x MON-00021-9, NA], A217: [corn, Bt176 ( 176), SYN-EV176-9, NaturGardKnockOut (trademark), Max im izer ™], A218: [corn, BVLA430101, NA, NA], A219: [corn, CBH-351, ACS-ZM004-3, Starlink ™ Maize], A220: [corn, DAS40278, DAS-40278 -9, Enlist (trademark) Maize], A221: [corn, DAS40278 x NK603, DAS-40278-9 x MON-00603-6, NA], A222: [corn, DBT418, DKB-89614-9, Bt X tra (Trademark) Maize], A223: [corn, DLL25 (B16), DKB-89790-5, NA], A224: [corn, GA21, MON-00021-9, RoundupReady (TM) Maize, Agrisure (TM) GT] , A225: [corn, GA21 x MON810, MON-00021-9 x MON-00810-6, RoundupReady (TM) YieldGard (TM) maize], A226: [corn, GA21 x T25, MON-00021-9 x ACS- ZM003-2, NA], A227: [corn, HCEM485, HCEM485, NA], A228: [corn, LY038, REN-00038-3, Mavera ™ Maize], A229: [corn, LY038 x MON810, REN- 00038-3 x MON-00810-6, Mavera ™ YieldGard ™ Maize] , A230: [corn, MIR162, SYN-IR162-4, Agrisure ™ Viptera], A231: [corn, MIR162 x 5307, SYN-IR162-4 x SYN-05307-1, NA], A232: [corn, MIR162 x 5307 x GA21, SYN-IR162-4 x SYN-05307-1 x MON-00021-9, NA], A233: [Corn, MIR162 x GA21, SYN-IR162-4 x MON-00021-9, NA] , A234: [corn, MIR162 x MIR604, SYN-IR162-4 x SYN-IR604-5, NA], A235: [corn, MIR162 x MIR604 x 5307, SYN-IR162-4 x SYN-IR604-5 x SYN- 05307-1, NA], A236: [Corn, MIR162 x MIR604 x 5307 x GA21, SYN-IR162-4 x SYN-IR604-5 x SYN-05307-1 x MON-00021-9, NA], A237: [ Corn, MIR162 x MIR604 x GA21, SYN-IR162-4 x SYN-IR604-5 x MON-00021-9, NA], A238: [Corn, MIR162 x MIR604 x TC1507 x 5307, SYN-IR162-4 x SYN- IR604-5 x DAS-01507-1 x SYN-05307-1, NA], A239: [Corn, MIR162 x MIR604 x TC1507 x 5307 x GA21, SYN-IR162-4 x SYN-IR604-5 x DAS-01507- 1 x SYN-05307-1 x MON-00021-9, NA], A240: [Corn, MIR162 x MIR604 x TC1507 x GA21, SYN-IR162-4 x SYN-IR604-5 x DAS-01507-1 x MON-00021-9, NA], A241 : [Corn, MIR162 x MON89034, SYN-IR162-4 x MON-89034-3, NA], A242: [Corn, MIR162 x MON89034 x GA21, SYN-IR162-4 x MON-89034-3 x MON-00021- 9, NA], A243: [corn, MIR162 x NK603, SYN-IR162-4 x MON-00603-6, NA], A244: [corn, MIR162 x TC1507, SYN-IR162-4 x DAS-01507-1, NA], A245: [corn, MIR162 x TC1507 x 5307, SYN-IR162-4 x DAS-01507-1 x SYN-05307-1, NA], A246: [corn, MI
R162 x TC1507 x 5307 x GA21, SYN-IR162-4 x DAS-01507-1 x SYN-05307-1 x MON-00021-9, NA], A247: [Corn, MIR162 x TC1507 x GA21, SYN-IR162- 4 x DAS-01507-1 x MON-00021-9, NA], A248: [corn, MIR604, SYN-IR604-5, Agrisure ™ RW], A249: [corn, MIR604 x 5307, SYN-IR604- 5 x SYN-05307-1, NA], A250: [corn, MIR604 x 5307 x GA21, SYN-IR604-5 x SYN-05307-1 x MON-00021-9, NA], A251: [corn, MIR604 x GA21, SYN-IR604-5 x MON-00021-9, Agrisure (trademark) GT / RW], A252: [corn, MIR604 x NK603, SYN-IR604-5 x MON-00603-6, NA], A253: [ Corn, MIR604 x TC1507, SYN-IR604-5 x DAS-01507-1, Optimum (R) TRIsect (TM)], A254: [Maize, MIR604 x TC1507 x 5307, SYN-IR604-5 x DAS-01507- 1 x SYN-05307-1, NA], A255: [Corn, MIR604 x TC1507 x 5307 x GA21, SYN-IR604-5 x TC1507 x SYN-05307-1 x MON-00021-9, NA], A256: [ Corn, MIR604 x TC1507 x GA21, SYN-IR604-5 x TC1507 x MON-00021-9, NA], A257: [corn, MON801 (MON80100), MON801, NA], A258: [corn, MON802, MON-80200-7, NA], A259: [corn, MON809, PH-MON-809-2, NA], A260: [corn, MON810, MON-00810-6, YieldGard (trademark), MaizeGard (trademark)], A261: [corn, MON810 x MIR162, MON-00810-6 x SYN-IR162-4, NA], A262: [Corn, MON810 x MIR162 x NK603, MON-00810-6 x SYN-IR162-4 x MON-00603-6, NA] , A263: [corn, MON810 x MIR604, MON-00810-6 x SYN-IR604-5, NA], A264: [corn, MON810 x MON88017, MON-00810-6 x MON-88017-3, YieldGard (trademark) VTTriple], A265: [corn, MON810 x NK603 x MIR604, MON-00810-6 x MON-00603-6 x SYN-IR604-5, NA], A266: [corn, MON832, NA, RoundupReady (TM) Maize] , A267: [corn, MON863, MON-00863-5, YieldGard ™ Rootworm RW, MaxGard ™], A268: [ Sorghum, MON863 x MON810, MON-00863-5 x MON-00810-6, YieldGard ™ Plus], A269: [corn, MON863 x MON810 x NK603, MON-00603-6 x MON-00810-6 x MON- 00863-5, YieldGard ™ PluswithRR], A270: [corn, MON863 x NK603, MON-00863-5 x MON-00603-6, YieldGard ™ RW + RR], A271: [corn, MON87403, MON87403- 1, NA], A272: [corn, MON87411, MON-87411-9, NA], A273: [corn, MON87419, MON87419-8, NA], A274: [corn, MON87427, MON-87427-7, RoundupReady ( Trademark) Maize], A275: [corn, MON87427 x 59122, MON-87427-7 x DAS-59122-7, NA], A276: [corn, MON87427 x MON88017, MON-87427-7 x MON-88017-3, NA], A277: [corn, MON87427 x MON88017 x 59122, MON-87427-7 x MON-88017-3 x DAS-59122-7, NA], A278: [corn, MON87427 x MON89034, MON-87427-7 x MON-89034-3, NA], A279: [Corn, MON87427 x MON89034 x 59 122, MON-87427-7 x MON-89034-3 x DAS-59122-7, NA], A280: [Corn, MON87427 x MON89034 x MON88017, MON-87427-7 x MON-89034-3 x MON-88017- 3, NA], A281: [corn, MON87427 x MON89034 x MON88017 x 59122, MON-87427-7 x MON-89034-3 x MON-88017-3 x 59122, NA], A282: [corn, MON87427 x MON89034 x NK603, MON-87427-7 x MON-89034-3 x MON-00603-6, NA], A283: [Corn, MON87427 x MON89034 x TC1507, MON-87427-7 x MON-89034-3 x DAS-01507- 1, NA], A284: [corn, MON87427 x MON89034 x TC1507 x 59122, MON-87427-7 x MON-89034-3 x DAS-01507-1 x DAS-59122-7, NA], A285: [corn, MON87427 x MON89034 x TC1507 x MON87411 x 59122, MON-87427-7 x MON-89034-3 x DAS-01507-1 x MON-87411-9 x DAS-59122-7, NA], A286: [Corn, MON87427 x MON89034 x TC1507 x MON88017, MON-87427-7 x MON-89034-3 x DAS-01507-1 x MON-88017-3, NA], A287: [Corn, MON87427 x MON89034 x MIR162 x NK603, MON-87427 -7 x MON-89034-3 x SYN-IR162-4 x MON-00603-6, NA], A288: [Corn, MON87427 x MON89034 x TC1507 x MON88017 x 59122, MON-87427-7 x MON-89034-3 x DAS-01507-1 x MON-88017-3 x DAS-59122-7, NA], A289: [corn, MON87427 x NK603, MON-87427-7 x MON-00603-6, NA], A290: [corn , MON87427 x TC1507, MON-87427-7 x DAS-01507-1, NA], A291: [corn, MON87427 x TC1507 x 59122, MON-87427-7 x DAS-01507-1 x DAS-59122-7, NA ], A292: [Corn, MON87427 x TC1507 x MON88017, MON-87427-7 x DAS-01507-1 x MON-88017-3, NA], A293: [Corn, MON87427 x TC1507 x MON88017 x 59122, MON-87427 -7 x DAS-01507-1 x MON-88017-3 x DAS-59122-7, NA], A294: [Corn, MON87460, MON-87460-4, Genuity (R) DroughtGard (TM)], A295: [Corn, MON87460 x MON88017, MON-87460-4 x MON-88017-3, NA], A296: [Corn, MON87460 x MON89034 x MON88017, MON-87460-4 x MON-89034-3 x MON-880 17-3, NA], A297: [corn, MON87460 x MON89034 x NK603, MON-87460-4 x MON-89034-3 x MON-00603-6, NA], A298: [corn, MON87460 x NK603, MON- 87460-4 x MON-00603-6, NA], A299: [corn, MON88017, MON-88017-3, YieldGard (TM) VT (TM) Rootworm (TM) RR2], A300: [corn, MON88017 x DAS40278, MON-88017-3 x DAS-40278-9, NA], A301: [corn, MON89034, MON-89034-3, YieldGard (TM) VTPro (TM)], A302: [corn, MON89034 x 59122, MON-89034 -3 x DAS-59122-7, NA], A303: [corn, MON89034 x 59122 x DAS40278, MON-89034-3 x DAS-59122-7 x DAS-40278-9, NA], A304: [corn, MON89034 x 59122 x MON88017, MON-89034-3 x DAS-59122-7 x MON-88017-3, NA], A305: [corn, MON89034 x 59122 x MON88017 x DAS40278, MON-89034-3 x DAS-59122-7 x MON-88017-3 x DAS-40278-9, NA], A306: [Corn, MON89034 x DAS40278, MON-89034-3 x DAS-40278-9, NA] A307: [Corn, MON89034 x MON87460, MON-89034-3 x MON-87460-4, NA], A308: [Corn, MON89034 x MON88017, MON-89034-3 x MON-88017-3, Genuity (registered trademark) VTTriplePro ™], A309: [corn, MON89034 x MON88017 x DAS40278, MON-89034-3 x MON-88017-3 x DAS-40278-9, NA], A310: [corn, MON89034 x NK603, MON-89034 -3 x MON-00603-6, Genuity (R) VTDoublePro (TM)], A311: [Corn, MON89034 x NK603 x DAS40278, MON-89034-3 x MON-00603-6 x DAS-40278-9, NA ], A312: [Corn, MON89034 x TC1507, MON-89034-3 x DAS-01507-1, NA], A313: [Corn, MON89034 x TC1507 x 59122, MON-89034-3 x DAS-01507-1 x DAS -59122-7, NA], A314: [Corn, MON89034 x TC1507 x 59122 x DAS40278, MON-89034-3 x DAS-01507-1 x DAS-59122-7 x DAS-40278-9, NA], A315: [Corn, MON89034 x TC1507 x DAS40278, MON-89034-3 x DAS-01507-1 x DAS-40278-9, NA], A316: [Tori Koshi, MON89034 x TC1507 x MON88017, MON-89034-3 x DAS-01507-1 x MON-88017-3, NA], A317: [Corn, MON89034 x TC1507 x MON88017 x 59122, MON-89034-3 x DAS- 01507-1 x MON-88017-3 x DAS-59122-7, Genuity (R) SmartSta x (trademark)], A318: [Corn, MON89034 x TC1507 x MON88017 x 59122 x DAS40278, MON-89034-3 x DAS -01507-1 x MON-88017-3 x DAS-59122-7 x DAS-40278-9, NA], A319: [Corn, MON89034 x TC1507 x MON88017 x DAS40278, MON-89034-3 x DAS-01507-1 x MON-88017-3 x DAS-59122-7 x DAS-40278-9, NA], A320: [Corn, MON89034 x TC1507 x NK603, MON-89034-3 x DAS-01507-1 x MON-00603-6 , PowerCore ™], A321: [corn, MON89034 x TC1507 x NK603 x DAS40278, MON-89034-3 x DAS-01507-1 x MON-00603-6 x DAS-40278-9, NA], A322: [ Corn, MON89034 x TC1507 x NK603 x MIR162, MON-89034-3 x DAS-01507-1 x MON-00603-6 x SYN-IR162-4, NA], A323: [Corn, MON89034 x TC1507 x NK603 x MIR162 x DAS40278, MON-89034-3 x DAS-01507-1 x MON-00603-6 x SYN-IR162-4 x DAS-40278-9, PowerCore (TM) x MIR162 x Enlist (TM)], A324: [ Corn, MON89034 x GA21, MON-89034-3 x MON-00021-9, NA], A325: [corn, MS3, ACS-ZM001-9, InVigor ™ Maize], A326: [corn, MS6, ACS- ZM005-4, InVigor ™ Maize], A327: [corn, MZHG0JG, SYN-000JG-2, NA], A328: [corn, MZIR098, SYN-00098-3, NA], A329: [corn, NK603, MON-00603-6, RoundupReady (TM) 2Maize], A330: [corn, NK603 x MON810 x 4114 x MIR604, MON-00603-6 x MON-00810-6 x DP004114-3 x SYN-IR604-4, NA] , A331: [corn, NK603 x MON810, MON-00603-6 x MON-00810-6, YieldGard (trademark) CB + RR], A332: [corn, NK603 x T25, MON-00603-6 x ACS-ZM003- 2, RoundupReady (trademark) LibertyLink (trademark) Maize], A333: [corn, T14, ACS-ZM002-1, LibertyLink (trademark) Maize], A334 : [Corn, T25, ACS-ZM003-2, LibertyLink (TM) Maize], A335: [Corn, T25 x MON810, ACS-ZM003-2 x MON-00810-6, LibertyLink (TM) Yieldgard (TM) Maize] , A336: [corn, TC1507, DAS-01507-1, Hercule x (trademark) I, Herrcule x (trademark) CB], A337: [corn, TC1507 x 59122 x MON810 x MIR604 x NK603, DAS-01507-1 x DAS-59122-7 x MON-00810-6 x SYN-IR604-5 x MON-00603-6, Optimum (TM) Intrasect X treme], A338: [Corn, TC1507 x MON810 x MIR604 x NK603, DAS-01507- 1 x MON-00810-6 x SYN-IR604-5 x MON-00603-6, NA], A339: [Corn, TC1507 x 5307, DAS-01507-1 x SYN-05307-1, NA], A340: [ Corn, TC1507 x 5307 x GA21, DAS-01507-1 x SYN-05307-1 x MON-00021-9, NA], A341: [Corn, TC1507 x 59122, DAS-01507-1 x DAS-59122-7, Hercule x X TRA ™], A342: [Corn, TC1507 x 59122 x DAS40278, DAS-01507-1 x DAS-59122-7 x DAS-40278-9, NA], A343: [G Sorghum, TC1507 x 59122 x MON810, DAS-01507-1 x DAS-59122-7 x MON-00810-6, Optimum (R) AcreMax (R) X tra], A344: [Corn, TC1507 x 59122 x MON810 x MIR604, DAS-01507-1 x DAS-59122-7 x MON-00810-6 x SYN-IR604-5, Optimum (R) AcreMax (R) X Treme], A345: [Corn, TC1507 x 59122 x MON810 x NK603, DAS-01507-1 x DAS-59122-7 x MON-00810-6 x MON-00603-6, Optimum (TM) Intrasect X TRA], A346: [Corn, TC1507 x 59122 x MON88017, DAS-01507-1 x DAS-59122-7 x MON-88017-3, NA], A347: [Corn, TC1507 x 59122 x MON88017 x DAS40278, DAS-01507-1 x DAS-59122-7 x MON-88017- 3 x DAS-40278-9, NA], A348: [corn, TC1507 x 59122 x NK603, DAS-01507-1 x DAS-59122-7 x MON-00603-6, Hercule x X TRA ™ RR], A349: [corn, TC1507 x 59122 x NK603 x MIR604, DAS-01507-1 x DAS-59122-7 x MON-00603-6 x SYN-IR604-5, NA], A350: [corn, TC1507 x DAS 40278, DAS-01507-1 x DAS-40278-9, NA], A351: [Corn, TC1507 x GA21, DAS-01507-1 x MON-00021-9, NA], A352: [Corn, TC1507 x MIR162 x NK603, DAS-01507-1 x SYN-IR162-4 x MON-00603-6, Optimum (R) Leptra (TM)], A353: [corn, TC1507 x MIR604 x NK603, DAS-01507-1 x SYN- IR604-5 x MON-00603-6, Optimum ™ TRIsect], A354: [corn, TC1507 x MON810, DAS-01507-1 x MON-00, NA], A355: [corn, TC1507 x MON810 x MIR162, DAS-01507-1 x MON-00810-6 x SYN-IR162-4, NA], A356: [Corn, TC1507 x MON810 x MIR162 x
NK603, DAS-01507-1 x MON-00810-6 x SYN-IR162-4 x MON-00603-6, NA], A357: [Corn, TC1507 x MON810 x MIR604, DAS-01507-1 x MON-00810- 6 x SYN-IR604-5, NA], A358: [corn, TC1507 x MON810 x NK603, DAS-01507-1 x MON-00810-6 x MON-00603-6, Optimum (TM) Intrasect], A359: [ Corn, TC1507 x MON810 x NK603 x MIR604, DAS-01507-1 x MON-00810-6 x MON-00603-6 x SYN-IR604-5, NA], A360: [Corn, TC1507 x MON88017, DAS-01507- 1 x MON-88017-3, NA], A361: [Corn, TC1507 x MON88017 x DAS40278, DAS-01507-1 x MON-88017-3 x DAS-40278-9, NA], A362: [Corn, TC1507 x NK603, DAS-01507-1 x MON-00603-6, Hercule x ™ IRR], A363: [corn, TC1507 x NK603 x DAS40278, DAS-01507-1 x MON-00603-6 x DAS-40278-9 , NA], A364: [corn, TC6275, DAS-06275-8, NA], A365: [corn, VCO-01981-5, VCO-01981-5, NA], A366: [corn, DK404SR, DK404SR, NA ], A367: [Corn, EXP1910IT, EXP1910IT, NA], A368: [Melon, MelonA, NA, NA], A369: [Melon, MelonB, NA, NA], A370: [Papaya, 55-1, CUH-CP551-8 , Rainbow, SunUp], A371: [Papaya, 63-1, CUH-CP631-7, NA], A372: [Papaya, HuanongNo.1, NA, HuanongNo.1], A373: [Papaya, X17-2, UFL -X17CP-6, NA], A374: [Petunia, Petunia-CHS, NA, NA], A375: [Plum, C-5, ARS-PLMC5-6, NA], A376: [Polish canola, HCR-1, NA, NA], A377: [Polish canola, ZSR500, NA, Hysyn101RRRoundup-Ready (trademark)], A378: [Polish canola, ZSR502, NA, Hysyn101RRRoundup-Ready (trademark)], A379: [Polish canola, ZSR503, NA , Hysyn101RRRoundup-Ready (trademark)], A380: [Poplar, Btpoplar, poplar12 (Populusnigra), NA, NA], A381: [Poplar, Hybridpoplarclone741, NA, NA], A382: [Potato, 1210amk, NA, Lugovskoiplus], A383: [potato, 2904 / 1kgs, NA, E lizavetaplus], A384: [potato, AM04-1020, BPS-A1020-5, StarchPotato], A385: [potato, ATBT04-27, NMK-89367-8, AtlanticNewLeaf (trademark) potato], A386: [potato, ATBT04- 30, NMK-89613-2, AtlanticNewLeaf ™ potato], A387: [potato, ATBT04-31, NMK-89170-9, AtlanticNewLeaf ™ potato], A388: [potato, ATBT04-36, NMK-89279- 1, AtlanticNewLeaf (trademark) potato], A389: [potato, ATBT04-6, NMK-89761-6, AtlanticNewLeaf (trademark) potato], A390: [potato, BT06, NMK-89812-3, NewLeaf (trademark) RussetBurbankpotato] , A391: [potato, BT10, NMK-89175-5, NewLeaf (trademark) RussetBurbankpotato], A392: [potato, BT12, NMK-89601-8, NewLeaf (trademark) RussetBurbankpotato], A393: [potato, BT16, NMK- 89167-6, NewLeaf ™ RussetBurbankpotato], A394: [potato, BT17, NMK-89593-9, NewLeaf ™ RussetBurbankpotato], A395: [potato, BT18, NMK-89906-7, NewLeaf ™ RussetBurbankpotato], A396: [potato, BT23, NMK-89675-1, NewLeaf ™ RussetBurbankpotato], A397: [potato, E12, SPS-00E12-8, Innate® Cultivate], A398: [Potato, E24, SPS-00E24-2, NA], A399: [potato, EH92-527-1, BPS-25271EH92-527-1-9, Amflora (trademark)], A400: [potato, F10, SPS- 00F10-7, Innate (registered trademark) Generate], A401: [potato, F37, SPS-00F37-7, NA], A402: [potato, G11, SPS-00G11-9, NA], A403: [potato, H37 , SPS-00H37-9, NA], A404: [potato, H50, SPS-00H50-4, NA], A405: [potato, HLMT15-15, NA, Hi-LiteNewLeaf ™ Ypotato], A406: [potato , HLMT15-3, NA, Hi-LiteNewLeaf ™ Ypotato], A407: [potato, HLMT15-46, NA, Hi-LiteNewLeaf ™ Ypotato], A408: [potato, J3, SPS-000J3-4, Innate (Registered trademark) Accelerate], A409: [potato, J55, SPS-00J55-2, NA], A4 10: [potato, J78, SPS-00J78-7, NA], A411: [potato, RBMT15-101, NMK-89653-6, NewLeaf (trademark) YRussetBurbankpotato], A412: [potato, RBMT21-129, NMK-89684 -1, NewLeaf (TM) PlusRussetBurbankpotato], A413: [potato, RBMT21-152, NA, NewLeaf (TM) PlusRussetBurbankpotato], A414: [potato, RBMT21-350, NMK-89185-6, NewLeaf (TM) PlusRussetBurbankpotato], A415: [potato, RBMT22-082, NMK-89896-6, NewLeaf (TM) PlusRussetBurbankpotato], A416: [potato, RBMT22-186, NA, NewLeaf (TM) PlusRussetBurbankpotato], A417: [potato, RBMT22-238, NA NewLeaf (TM) PlusRussetBurbankpotato], A418: [potato, RBMT22-262, NA, NewLeaf (TM) PlusRussetBurbankpotato], A419: [potato, SEMT15-02, NMK-89935-9, ShepodyNewLeaf (TM) Ypotato], A420: [Potato, SEMT15-07, NA, ShepodyNewLeaf (TM) Ypotato], A421: [potato, SEMT15-15, NMK-89930- 4, ShepodyNewLeaf (trademark) Ypotato], A422: [potato, SPBT02-5, NMK-89576-1, SuperiorNewLeaf (trademark) potato], A423: [potato, SPBT02-7, NMK-89724-5, SuperiorNewLeaf (trademark) potato], A424: [potato, TIC-AR233-5, TIC-AR233-5, NA], A425: [potato, V11, SPS-00V11-6, Innate (registered trademark) Invigorate], A426: [potato, W8 , SPS-000W8-4, Innate (registered trademark) Glaciate], A427: [potato, X 17, SPS-00 X 17-5, Innate (registered trademark) Acclimate], A428: [potato, Y9, SPS-000Y9- 7, Innate (registered trademark) Hibernate], A429: [Rice, 7Crp # 10, NA, NA], A430: [Rice, GMShanyou63, NA, BTShanyou63], A431: [Rice, Huahui-1 / TT51-1, NA , Huahui-1], A432: [Rice, LLRICE06, ACS-OS001-4, LibertyLink (trademark) rice], A433: [Rice, LLRICE601, BCS-OS003-7, LibertyLink (trademark) rice], A434: [Rice , LLRICE62, ACS-OS002-5, LibertyLink (trademark) rice], A435: [Rice, Taromolaii + cry1Ab, NA, NA] A436: [Rice, CL121 x CL141 x CF X 51, CL121 x CL141 x CF X 51, Clearfield (R) Rice], A437: [Rice, IMINTA-1 x IMINTA-4, IMINTA-1 x IMINTA-4, Clearfield® Rice], A438: [Rice, PWC16, PWC16, NA], A439: [Rose, WKS82 / 130-4-1, IFD-52401-4, NA], A440: [Rose, WKS92 / 130 -9-1, IFD-52901-9, NA], A441: [soybean, 260-05 (G94-1, G94-19, G168), DD-026005-3, NA], A442: [soybean, A2704- 12, ACS-GM005-3, LibertyLink (trademark) soybean], A443: [soybean, A2704-21, ACS-GM004-2, LibertyLink (trademark) soybean], A444: [soybean, A5547-127, ACS-GM006- 4, LibertyLink (trademark) soybean], A445: [soybean, A5547-35, ACS-GM008-6, LibertyLink (trademark) soybean], A446: [soybean, CV127, BPS-CV127-9, Cultivance], A447: [ Soybean, DAS44406-6, DAS-44406-6, NA], A448: [Soybean, DAS68416-4, DAS-68416-4, Enlist ™ Soybean], A449: [Soybean, DAS68416-4 x MON89788, DAS- 68416-4 x MON-89788-1, NA], A450: [Da , DAS81419, DAS-81419-2, NA], A451: [soybean, DAS81419 x DAS44406-6, DAS-81419-2 x DAS-44406-6, NA], A452: [soybean, DP305423, DP-305423- 1, Treus (trademark) or Plenish (trademark)], A453: [soybean, DP305423 x GTS40-3-2, DP-305423-1 x MON-04032-6, NA], A454: [soybean, DP356043, DP -356043-5, OptimumGAT ™, A455: [soybean, FG72 (FG072-2, FG072-3), MST-FG072-3, NA], A456: [soybean, FG72 x A5547-127, MST-FG072 -3 x ACS-GM006-4, Liberty Link (registered trademark) GT27 (trademark)], A457: [soybean, GTS40-3-2 (40-3-2), MON-04032-6, RoundupReady (trademark) soybean ], A458: [soybean, GU262, ACS-GM003-1, LibertyLink (trademark) soybean], A459: [soybean, IND-00410-5, IND-00410-5, VerdecaHB4Soybean], A460: [soybean, MON87701, MON -87701-2, NA], A461: [soybean, MON87701 x MON89788, MON-87701-2 x MON-89788-1, Intacta ™ RoundupReady ™ 2Pro], A462: [soybean, MON87705, MON-87705 -6, VistiveGold (TM)], A463 [Soybean, MON87705 x MON87708, MON-87705-6 x MON-87708-9, NA], A464: [Soybean, MON87705 x MON87708 x MON89788, MON-87705-6 x MON-87708-9 x MON-89788-1 , NA], A465: soybean, MON87705 x MON89788, MON-87705-6 x MON-89788-1, NA], A466: [soybean, MON87708, MON-87708-9, Genuity (R) RoundupReady (TM) 2 X tend (trademark)], A467: [soybean, MON87708 x MON89788, MON-87708-9 x MON-89788-1, Roundup Ready 2 X tend (registered trademark)], A468: [soybean, MON87712, MON-87712- 4, NA], A469: [soybean, MON87751, MON-87751-7, NA], A470: [soybean, MON87751 x MON87701 x MON87708 x MON89788, MON-87751-7 x MON-87701-2 x MON87708 x MON89788, NA], A471: [soybean, MON87769, MON87769-7, NA], A472: [soybean, MON87769 x MON89788, MON-87769-7 x MON-89788-1, NA], A473: [soybean, MON89788, MON- 89788-1, Genuity® Roundup Ready 2 Yield ™], A474: [soybean, SYHT0H2, SYN-000H2-5, Herbicide-tolerant Soybeanline], A47 5: [soybean, W62, ACS-GM002-9, LibertyLink (trademark) soybean], A476: [soybean, W98, ACS-GM001-8, LibertyLink (trademark) soybean], A477: [soybean, OT96-15, OT96 -15, NA], A478: [Peppo pumpkin (Cucurbitapepo), CZW3, SEM-0CZW3-2, NA], A479: [Peppo pumpkin (Cucurbita pepo), ZW20, SEM-0ZW20-7, NA], A480: [sugar beet, GTSB77 (T9100152), SY-GTSB77-8, InVigor (trademark) sugarbeet], A481: [sugar beet, H7-1, KM-000H71-4, Roundup Ready (trademark) sugarbeet], A482: [sugar beet, T120-7, ACS-BV001-3, LibertyLink ™ sugarbeet], A483: [sugarcane, CTB141175 / 01-A, CTB141175 / 01-A, NA], A484: [sugarcane, NXI-1T, NXI-1T, NA], A485 : [Sugarcane, NXI-4T, NXI-4T, NA], A486: [sugarcane, NXI-6T, NXI-6T, NA], A487: [sunflower, X81359, X81359, Clearfield (registered trademark) Sunflower], A488: [Sweet Pepper, PK-SP01, X81359, NA], A489: [Tobacco, C / F / 93 / 08-02, NA, NA], A490: [Taba , Vector21-41, NA, NA], A491: [Tomato, 1345-4, NA, NA], A492: [Tomato, 35-1-N, NA, NA], A493: [Tomato, 5345, NA, NA ], A494: [Tomato, 8338, CGN-89322-3, NA], A495: [Tomato, B, SYN-0000B-6, NA], A496: [Tomato, Da, SYN-000DA-9, NA], A497: [Tomato, DaDongNo9, NA, NA], A498: [Tomato, F (1401F, h38F, 11013F, 7913F), SYN-0000F-1, FLAVRSAVR (trademark)], A499: [Tomato, FLAVRSAVR, CGN-89564 -2, FLAVRSAVR (trademark)], A500: [Tomato, HuafanNo1, NA, NA], A501: [Tomato, PK-TM8805R (8805R), NA, NA], A502: [Wheat, MON71800, MON-71800-3 , RoundupReady (TM) wheat], A503: [Wheat, AP205CL, AP205CL, Clearfield (R) Wheat], A504: [Wheat, AP602CL, AP602CL, Clearfield (R) Wheat], A505: [Wheat, BW255-2 x BW238-3, BW255-2 x BW238-3, Clearfield (R) Wheat], A506: [Wheat, BW7, BW7, Clearfield (R) Wheat], A507: [Wheat, Teal11A, Teal11 A, Clearfield (R) Wheat], A508: [Wheat, SWP965001, SWP965001, NA], A509: [Corn, NA, NA, Agrisure Artesian (TM)], A510: [Corn, NA, NA, Optimum (Registered) AQUAmax (registered trademark)], A511: [canola, NA, NA, SU canola (registered trademark)], A512: [canola, NA, NA, Nexera (registered trademark) Canola], A513: [soybean, NA, NA, STS soybean ", A514:" corn, NA, NA, SR corn ", A514:" sunflower, NA, NA, ExpressSun (registered trademark) ", A515: [rice, NA, NA, Golden rice], A516: [Corn, NA, NA, Post Protected (registered trademark) corn], A517: [Sunflower, NA, NA, ExpressSun (registered trademark)], A518: [Rice, NA, NA, Provisia (R) Rice], A519: [Canola, NA, NA, Triazinon Tolerant Canola], A520: [corn, NA, NA, SmartStax (registered trademark) Pro], A521: [soybean, NA, NA, Credenz (registered trademark) soybean], A522: [corn , TC15 07 x 59122, DAS-01507-1 x DAS-59122-7, Optimum (R) AcreMax (R) 1], A523: [Corn, 4
114 x MON810 x MIR604, DP-004114-3 x MON-00810-6 x SYN-IR604-5, Qrome (TM)], A524: [Cotton, NA, NA, Stoneville (R) Cotton ST5517GLTP], A525: [Wata, NA, NA, Stoneville (registered trademark) Cotton ST4848GLT], A526: [Wata, NA, NA, Stoneville (registered trademark) Cotton ST4949GLT], A527: [Wata, NA, NA, Stoneville (registered trademark) Cotton ST5020GLT ], A528: [Cotton, NA, NA, Stoneville (registered trademark) Cotton ST5115GLT], A529: [Cotton, NA, NA, Stoneville (registered trademark) Cotton ST6182GLT], A530: [Cotton, NA, NA, Stoneville (registered) (Trademark) Cotton ST4747GLB2], A531: [Cotton, NA, NA, Stoneville (registered trademark) Cotton ST4946GLB2], A532: [Cotton, NA, NA, Stoneville (registered trademark) Cotton ST6448GLB2], A533: [soybean, NA, NA , Enlist E3 ™], A534: [soybean, NA, NA, Enlist ™ Roundup Ready 2 Yield ™], A535: [corn, NA, NA, Enlist ™ Roundup Ready ™) Corn 2], A536: [Corn, NA, NA, Smartst ax (registered trademark) Enlist (trademark)], A537: [corn, NA, NA, Powercore (registered trademark) Enlist (trademark)], A538: [cotta, NA, NA, Enlist (trademark) Cotton], A539: [Cotton, NA, NA, Bollgard® 3 XtendFlex®], A540: [corn, NA, NA, SmartStax® RIB Complete® Corn], A541: [corn, NA, NA, VT Double PRO (registered trademark) RIB Complete (registered trademark) Corn], A542: [corn, NA, NA, VT Double PRO (registered trademark) Corn], A543: [corn, NA, NA, Genuity (registered trademark) ) VT Triple PRO (registered trademark) RIB Complete Corn], A544: [corn, NA, NA, Trecepta (trademark) Corn], A545: [soybean, NA, NA, fukuminori], A546: [soybean, NA, NA, Yume Minori], A547: [Corn, NA, NA, ZFN-12 maize], A548: [Rice, NA, NA, Yumepirika], A549: [Rice NA, NA, Kanto BPH1], A550: [Wata, NA, MON88702, NA], A551: [soybean, DP305423 x MON87708, DP-30542 3-1 x MON-87708-9, NA], A552: [soybean, DP305423 x MON87708 x MON89788, DP-305423-1 x MON-87708-9 x MON-89788-1, NA], A553: [soybean, DP305423 x MON89788, DP-305423-1 x MON-89788-1, NA], A554: [Wata, 3006-210-23 x 281-24-236 x MON88913 x COT102 x 81910, DAS-21023-5 x DAS- 24236-5 x MON-88913-8 x SYN-IR102-7], A555: [Wata, GHB811, BCS-GH811-4, NA], A556: [Sorghum, NA, NA, Igrowth (TM)].

  The present compound or composition A can be applied to the above-mentioned modified plants A1 to A556 or their cultivation land. When applying this compound or composition A to the above-mentioned plant, it is more preferable to apply it to the seed or vegetative organ.

  The composition B can effectively control a wide range of subjects in a cereal field, a vegetable field, a flower field, an orchard, or a non-agricultural land where normal tillage cultivation or non-tillage cultivation is performed.

  When the composition B is applied to sugarcane, in sugarcane cultivation, a sugarcane stem fragment that has been cut so as to have one knot may be used, and the size of the sugarcane stem fragment may be 2 cm to A material of 15 cm, preferably 3 cm to 8 cm may be used. Sugarcane cultivation techniques using such stem fragments are known (WO09 / 000398, WO09 / 000399, WO09 / 000400, WO09 / 000401, WO09 / 000402) and are implemented under the trade name of Prene (registered trademark). The

  When the composition B is applied to rice, it may be applied to a nursery, may be applied to paddy fields, or may be applied to rice seeds. The above-mentioned nursery place includes a nursery box or a rice seedling tray and a nursery.

  When the composition B is applied to a seedling box, the application time is not particularly limited as long as it is a seedling period from rice sowing to transplanting. The time when the composition B is treated in the seedling box at the time of sowing may be not only on the day of sowing but also on any day before or after several days of sowing. The time when the composition B is processed into the seedling box at the time of transplantation may be not only the day of transplantation but also any day from several days before the day of transplantation. During the seedling raising period, the seedlings to be transplanted are either young seedlings (seedlings before and after the 2.5 leaf stage), medium seedlings (seedlings before and after the 3.5 leaf stage), or adult seedlings (seedlings before and after the 4.5 leaf stage) The composition B can be applied in any case, although it varies depending on weather conditions and varies depending on weather conditions. Examples of the method of treating the composition B in the nursery box include a method of spraying a kneaded granule or a sand coating granule into the nursery box and a method of irrigating the seedling box with the solution of the composition B. Moreover, the composition B can also be processed on floor soil or covering soil, and can also be mixed and processed with floor soil or covering soil. In general, for example, a method for treating a pesticide during the seedling raising period. It is referred to as mixing with soil before sowing, pre-soiling treatment at sowing, post-soiling treatment at sowing, greening treatment, treatment on the day of transplantation, and simultaneous treatment of transplantation. The composition B may be processed into a seedling box by any of the above processing methods. The seedling culture medium is not particularly limited as long as it is a soil for rice seedlings, and a seedling mat other than soil may be used. The seedlings to which the composition B is applied may be cultivated by pool seedlings.

  When the composition B is applied to paddy fields, it may be used for transplanted rice or may be used for direct sowing rice. Although the method applied to a paddy field is not specifically limited, For example, the method of applying the composition B to a rice foliage part, the method of applying to paddy soil, and the method of applying to the surface of a flooded paddy field are mentioned. It is done. Moreover, it can also be applied labor-saving with the supply of water by processing chemicals such as emulsion and flowable at the source of water flowing into paddy fields such as a water inlet and an irrigation device. The time to apply to the rice stem and leaves may be any time from seedling to harvest. Preparations to be used include preparations to be applied in the form of powders, fine granules, etc., and flowables, dry flowables, wettable powders, granular wettable powders, SE drugs, aqueous solvents, granular aqueous solvents, liquids, microscopic products. Examples include emmaffusion agents, EW agents, oil agents, surf agents, and emulsions. The spraying device may be any device that is normally used, and a hand-spreading device, a power spreader, a crumpled player, a radio control helicopter, a manned helicopter, or the like can be used. In addition, the inventive composition may be sprayed by hand without using a spraying device.

  As a method for applying the composition B to paddy field soil, a method of treating the entire surface of the paddy field soil (full surface treatment), a method of treating the groove provided when sowing rice (seeding groove treatment), and a rice seed immediately below the seed 0 The method of processing to 10 centimeters, the method of processing in the shape of a streak or dot in the vicinity of a rice strain or seed (side treatment), and the like.

  When the composition B is applied to paddy soil, it can be applied simultaneously with agricultural materials such as paste fertilizer and granular fertilizer, or mixed with these agricultural materials. The time when the composition B is applied may be before sowing or before transplantation, may be simultaneously with sowing or transplanting, or may be immediately after sowing or immediately after transplanting.

  When applying simultaneously with sowing or transplanting, it may be applied using an attachment attached to the sowing or transplanting machine, or may be applied by other methods. Further, in the case of full surface treatment, it may be a period until water injection after sowing or transplanting, an intermediate drying period, or an intermittent irrigation period. When using the composition B, the soil surface of the paddy field may be dry, or the soil surface may be wet, but there may be no flooding (water depth 0 cm). When it is applied to the surface of a flooded paddy field, it can be applied at any time from sowing or transplanting to harvesting, as long as the water depth is maintained by normal rice management.

  When the composition B is used for direct seeding cultivation of rice, the rice seeds are coated with a coating material such as iron powder (iron oxide powder, reduced iron powder, atomized iron powder, electrolytic iron powder, etc.), calcium peroxide, molybdenum, molybdenum compound, etc. It may be processed. These coating materials can be used alone or in combination at any ratio. If necessary, auxiliary materials such as calcined gypsum and montmorillonite can be used for the purpose of increasing the amount or improving the fixation to rice seeds. An agent can be added. A mixture of calcium peroxide, calcined gypsum, and mineral powder is available as a commercial product. Here, the rice seed means rice seed in a state before being sown in soil such as paddy field.

  When the composition B is treated with rice seeds, the rice seeds can be cultivated by direct sowing in dry fields, wet fields and paddy fields, or can be cultivated by sowing in a seedling box. Examples of the paddy field include paddy fields that are flooded or soiled. A paddy field in a flooded state refers to a paddy field that has been plowed, filled with water, shaved, etc., and further filled with water if necessary. The paddy field in the wet soil state is a paddy field in which the amount of water is maintained to the same level as the flooded state by performing a water-falling treatment or the like from the flooded state, and the soil surface is exposed. Composition B can be dressed on rice seeds, rice seeds before germination can be immersed in a solution containing composition B, or solution containing composition B in rice seeds after germination Can also be sprayed. In any of the treatment methods, the composition B may contain one or more phytotoxicity reducing components selected from the group (d).

  The seeding machine used for rice seeding is not particularly limited as long as it is a seeding machine generally used for direct sowing cultivation of rice, such as paddy rice, upland rice, etc. For example, direct seeding machine for iron coating NDS-6 (Tetsu Maki-chan, KUBOTA Co., Ltd.), Iron coating direct sowing machine NDS-8 (Tetsu Maki-chan, Kubota Co., Ltd.), Iron coating direct sowing machine EP4-TC (Cute Tetsu Maki-chan, Kubota Co., Ltd.), Multi-purpose work machine RG6 (Manufactured by Yanmar Co., Ltd.), multipurpose working machine RG8 (manufactured by Yanmar Co., Ltd.), high-precision seeding machine PZV60 (manufactured by Iseki Agricultural Machinery Co., Ltd.) and high-precision seeding machine PZV80 (manufactured by Iseki Agricultural Machinery Co., Ltd.).

  It is preferable that iron or an oxide thereof (hereinafter referred to as iron and its oxide is referred to as “coating material A”) as a coating material to be processed on rice seeds is powdery. Examples of the powdery coating material A include reduced iron powder, atomized iron powder, electrolytic iron powder, and iron oxide powder, and these are available as commercial products. Moreover, these can also be used in mixture of 2 or more types. In the present invention, it is preferable to use reduced iron powder and / or iron oxide powder. The iron powder obtained by reducing iron oxide or iron salt with hydrogen or the like is reduced iron powder, and the iron powder obtained by jetting a high-pressure water jet of 8 to 20 MPa into the flow of molten iron is atomized iron powder or sulfuric acid. Iron powder obtained by depositing iron by electrolysis from a solution of iron or the like to obtain electrolytic iron flakes, pulverizing and annealing them with a rod mill or a vibration mill is called electrolytic iron powder. Iron oxide is an iron oxide having an oxidation number of II and / or III. The particle size of the coating material A used in the present invention is not particularly limited, but is preferably adjusted to a particle size of 10 to 100 μm. As the coating material A available as a commercial product, for example, DAE1K iron powder (DOWA (DOWA) IP (IP) Creation Co., Ltd.), DSP317 iron powder (DOWA (DOWA) IP (IP) Creation Co., Ltd.), Agricultural iron powder (manufactured by Daitetsu Kogyo Co., Ltd.), agricultural iron powder (manufactured by Tetsugen Co., Ltd.), and hematite (DOWA (DOWA) IP (IP) Creation Co., Ltd.).

When the composition B is processed into rice seeds, it may be mixed with calcined gypsum. For example, when the composition B and the coating material A are processed into rice seeds, calcined gypsum may be used as an auxiliary agent. Such calcined gypsum may be powdered calcium sulfate 1/2 hydrate (CaSO ₄ .1 / 2H ₂ O), and such calcined gypsum is commercially available. For example, KTS-1 (Yoshino Gypsum Sales Co., Ltd.) and KTS-25 (Yoshino Gypsum Sales Co., Ltd.). Moreover, what mixed the coating | covering material A and calcined gypsum may be used, and such a mixture is available as a commercial item, for example, DAE1K mix (made by DOWA (Dowa) IP (IP) Creation Co., Ltd.) is mentioned.

  The rice seed dressing treatment using the coating material A can take various forms, but is generally a known method (“Iron-coated flooded direct sowing manual 2010”, independent method of rice seed dressing treatment using iron powder). This is carried out in the same manner as the National Agricultural Research Organization of Agriculture and Food Industry, March 2010, ISBN 978-4-903078-05-2). Specifically, dried rice seeds before germination are immersed in water (sometimes referred to as soaking), drained, and then dressed with the coating material A and calcined gypsum as necessary. To do. The order of the treatment of the covering material A and the calcined gypsum may be any first, and the mixture of the covering material A and the calcined gypsum may be treated simultaneously. After performing these treatments, if necessary, after finishing with powdered gypsum as a finish, it is usually placed on a flat surface on a flat surface and dried in the shade.

  The amount of coating material A used for rice seeds is usually 100 to 2000 g for coating material A with respect to 1000 g of dry weight of rice seeds. Further, the amount of calcined gypsum in the case of powder coating with calcined gypsum is usually 5 to 100 g with respect to the dry weight of 1000 g of rice seeds. The amount is usually 0 to 50 g per 1000 g of dry weight of rice seeds.

  As calcium peroxide, a calcium peroxide simple substance prepared in a powder having a particle size of 10 to 150 μm can be used. If necessary, a composition in which mineral powder such as montmorillonite or calcined gypsum is mixed as an auxiliary material. Can also be used. Such a calcium peroxide-containing composition is available as a commercial product, and examples thereof include Culper powder granules 16 (manufactured by Hodogaya UPL Co., Ltd.).

  The rice seed dressing treatment using calcium peroxide can take various forms, but generally, a method known as a rice seed dressing treatment using calcium peroxide (Japanese Patent Laid-Open No. 61-015805) and The same operation is performed. Specifically, the dried rice seeds before germination are immersed in water (sometimes referred to as soaking), drained, and then the rice seeds are dressed with a calcium peroxide powder or a calcium peroxide-containing composition. . After carrying out these treatments, it is usually dried by placing it on a basket or the like laid on a flat surface and drying it in the shade.

  The amount of calcium peroxide or a calcium peroxide-containing composition used for rice seeds is usually 100 to 1000 g in terms of calcium peroxide alone with respect to 1000 g of dry weight of rice seeds.

  Examples of molybdenum and molybdenum compounds include molybdenum alone, molybdenum oxide, molybdic acid and its salt, molybdophosphoric acid and its salt, and molybdosilicic acid and its salt. Examples of the salt of molybdic acid include calcium molybdate, magnesium molybdate, ammonium molybdate, sodium molybdate, and potassium molybdate. Examples of molybdophosphate include ammonium molybdophosphate, sodium molybdophosphate, and potassium molybdophosphate. Such molybdenum and molybdenum compounds are commercially available, and examples thereof include molybdenum trioxide (Nippon Inorganic Chemical Industry Co., Ltd.).

  The treatment of rice seeds using molybdenum and molybdenum compounds can take various forms, but is usually carried out in the same manner as a known method for treating rice seeds using molybdenum and molybdenum compounds (WO 2011/093341). . Specifically, it is fixed to a rice seed surface using an adhesive such as polyvinyl alcohol, prepared in a solution and immersed in rice seed, and mixed with a coating material containing iron powder and / or calcium peroxide. For example, the operation of dressing rice seeds.

  In particular, “Bengara Molybdenum Coating” is known, which is a mixture of molybdenum compounds such as molybdenum trioxide, iron oxide powder (sometimes called Bengal flour) and water-resistant polyvinyl alcohol, and then treated on rice seeds (Yoshitaka Hara 2013. Improvement of Rice Seedling Establishment on Sulfate-Applied Submerged Soil by Seed Coating with Poorly Soluble Molybdenum Compounds. Plant Prod. Sci. 16 (3): 271-275), this method is also preferably performed in the present invention.

  The amount of molybdenum and molybdenum compound used for rice seeds is usually 0.01 to 10 mol in terms of molybdenum per 1000 g of dry weight of rice seeds.

Examples of the combination with the present compound or composition A coating material to be treated on rice seed include the following.
SX + iron oxide powder, SX + reduced iron powder, SX + iron oxide powder + reduced iron powder, SX + calcium peroxide, SX + molybdenum compound, SX + molybdenum compound + iron oxide powder, SX + molybdenum trioxide, SX + molybdenum trioxide + iron oxide powder, SX + iron oxide powder + calcined gypsum, SX + reduced iron powder + calcined gypsum, SX + iron oxide powder + reduced iron powder + calcined gypsum, SX + calcium peroxide + calcined gypsum, composition A + iron oxide powder, composition A + reduced iron powder, Composition A + iron oxide powder + reduced iron powder, composition A + calcium peroxide, composition A + molybdenum compound, composition A + molybdenum compound + iron oxide powder, composition A + molybdenum trioxide, composition A + molybdenum trioxide + iron oxide Powder, composition A + iron oxide powder + calcined gypsum, composition A + reduced iron powder + calcined gypsum, composition A + iron oxide powder + reduced iron powder + calcined gypsum, composition A + calcium peroxide + calcined gypsum.
Here, as the present component contained in the composition A, in particular, isothianyl, furametopyr, impylfluxam, ethaboxam, benomyl, oxolinic acid, clothianidin, fenitrothion, cartap hydrochloride, oxazosulfur, tetraniliprol, Lantraniliprole, cyantraniliprole, triflumezopyrim, flupirmine and ethiprole are preferred.

  The order of treatment of rice seeds in the above combination may be that the rice seed may be treated with the present compound or composition A and then the coating material may be treated, or the rice seed may be treated with the coating material and then the present compound or composition. A may be treated, or the present compound or composition A and the coating material may be treated simultaneously. Here, when the composition A is treated, the order of treatment of the present compound and the present component and the coating material contained in the composition A may be the order of the present compound, the present component and the coating material, or the present compound, The order of the coating material and this component may be the order of this component, this compound and the coating material, the order of this component, the coating material and this compound, or the coating material. The order of this compound and this component may be sufficient, and the order of a coating | covering material, this component, and this compound may be sufficient. Or you may process this compound, this component, and a coating | covering material simultaneously to a rice seed.

  When the composition B is applied to rice, the germination of rice seeds may be performed by immersing in water, or may be performed by immersing in water and holding in a wet state. The wet state means a state in which part or all of the surface of the rice seed after being immersed in water can be in contact with the outside air and can retain the moisture of the rice seed. For example, in the wet state, after the rice seed immersed in water is coated with a breathable material such as rice straw or cloth, water is sprayed on the coated material as necessary, or the rice seed is immersed in water. This is realized by storing rice seeds as they are in the net-like or bag-like material used in the process.

  When the composition B is used for rice, a fertilizer can be used in combination. Examples of such fertilizers include Rakuichi (registered trademark, Sumitomo Chemical Co., Ltd.), Sumishort (registered trademark, Sumitomo Chemical Co., Ltd.) and Super SR Coat (registered trademark, Sumitomo Chemical Co., Ltd.). When using a fertilizer together, you may fertilize the whole rice cultivation soil before sowing, and you may fertilize the whole rice cultivation soil after sowing or a seedling raising period. Moreover, you may fertilize in groove shape along the row | line | column sowed at the time of sowing (it may be called side stripe fertilization).

  When the composition B is applied to rice, regardless of whether it is applied to a nursery, paddy field or seed, disinfected seeds can be used to control seed infectious diseases and pests. Specifically, groups (a) and groups of prochloraz, triflumizole, pefazoate, oxolinic acid, ipconazole, fludioxonil, kasugamycin-hydrochloride, cupric hydroxide, basic copper chloride, fenitrothion, cartap hydrochloride, etc. b) One or more insecticide and fungicide components selected from the above, or Trichoderma atroviride SKT-1 strain, Talalomyces flavus SAY-Y-94-01 strain, Pseudomonas sp. CAB-02 strain, Bacillus simplex CGF2856 Seeds that have been dipped, smeared or powdered with one or more components of the microbial material selected from the group (j) such as a strain can be used.

  Applying one or more kinds of cartap hydrochloride and metaaldehyde to paddy fields before rice seeding, paddy fields before rice transplanting, paddy fields after rice seeding, or paddy fields after rice transplantation will have the effect of scallop apple mussels and monoaragai Can be controlled. Moreover, the weed which generate | occur | produces in a paddy field can be controlled by processing the component which has 1 or more types of herbicidal activity chosen from group (i) or group (j). The time when the component having the herbicidal activity is applied is not particularly limited as long as the phytotoxicity to rice caused by the component having the herbicidal activity is not a problem.

  One or more herbicidal active ingredients selected from the group (i) that can be used in paddy fields include, for example, azimusulfuron, bensulfuron methyl, chlorimuron ethyl, cyclosulfamuron, ethoxysulfuron, flucetosulfuron, halosulfuron methyl. , Imazosulfuron, orthosulfamlone, propyrisulfuron, pyrazosulfuronethyl, sinosulfuron, metsulfuronmethyl, metazosulfuron, beniocarb, molinate, esprocarb, pyributycarb, dimethylpiperate, swep, butachlor, pretilachlor, dimethrin, dimethrin, methylmethrin Propanil, mefenacet, flufenacet, chromeprop, naproanilide, bromobutide, dimelon, cumylron, etbenzani , Bentazone, Tridiphan, Carfentrazone ethyl, Fenchlorazole ethyl, Isoxadifen ethyl, Fentrazamide, Chromazone, Maleic acid hydrazide, Pyridate, Oxadichrome, cinmethyline, Benfrate, Oxadiazone, Oxadiargyl, Pentoxazone, Cihalohopbutyl Caffenstrol, ipfencarbazone, pyriminobacmethyl, bisbilivac sodium, pyrimisulphan, triamon, pyribenzoxime, pyriftalide, indhanophane, ACN, benzobicyclon, tefriltrione, mesotrione, phenquinotrione, dithiopyr, darapon, chlorthiamid , Penox slam, anilophos, benzulide, butamifos, phenoxasulfone, benzophenap Pyrazolinate, pyrazoxifene, imazametabenz, imazametabenzmethyl, imazamox, imazamox ammonium salt), imazapic, imazapic ammonium salt, imazapyr, imazaquin, imazetapill, pendimethalin, fenoxaprop ethyl, fenoxaprop P ethyl, metamihop, pyraclonyl, quinclolac, 2,4-D and its salt, MCP and its salt, MCPA and its salt, MCPB and its salt, piperophos, fluoxypyr, cyclopimolate, benzobicyclon, florpyraoxifene -Benzyl, Florpyroxifene and Taxumin A.

  Rice that can be used for Composition B refers to the cultivated species of Oryza sativa, Oryza glaberrima, and hybrids thereof among the annual plants of the genus (Oryza), which are any of Japonica, Java, and Indica. Moreover, any of sticky rice, sticky rice, sake rice, and feed rice may be used. Rice varieties are not particularly limited, and may be varieties produced by crossing or varieties produced by gene recombination techniques, as exemplified by the plant varieties described above. When applied to cultivars imparted with herbicide resistance, pest resistance or disease resistance, a particularly labor-saving control method can be used. Moreover, the multiline which mixes and cultivates several varieties in which different resistance genes were integrated may be sufficient.

  The composition A containing one or more herbicidal components selected from the group (i) or the group (j) and one or more phytotoxicity reducing components selected from the group (d) is composed of one active ingredient. It may be contained in a preparation, may be a plurality of preparations comprising a preparation containing one active ingredient and a preparation containing a plurality of active ingredients, or all active ingredients may be separate preparations. . For example, before and after planting seeds or plant reproductive organs treated with one or more phytotoxicity-reducing components selected from group (d) into the soil, a component having herbicidal activity selected from group (i) or group (j) is added to the soil. And then applying the compound to harmful arthropods, habitats of harmful arthropods, plants or soil. Moreover, in that case, you may purchase and use the commercially available seed or plant reproductive organ which processed 1 or more types of phytotoxicity reduction components chosen from group (d).

  In composition A containing one or more components having herbicidal activity selected from group (i) or group (j) and one or more plant growth regulating components selected from group (c), all active ingredients are 1 May be contained in one preparation, may be a plurality of preparations comprising a preparation containing one active ingredient and a preparation containing a plurality of active ingredients, or all active ingredients may be separate preparations. Good. When a plurality of preparations are applied, the preparations may be applied to harmful arthropods, harmful arthropod habitats, plants or soils at the same time or different times. For example, before and after planting seeds or plant reproductive organs treated with one or more plant growth regulating components selected from group (c) into soil, a component having herbicidal activity selected from group (i) or group (j) Examples of the method include treating the soil, and then applying the compound to harmful arthropods, habitats of harmful arthropods, plants, or soil. Moreover, in that case, you may purchase and use the commercially available seed or plant reproductive organ which processed one or more types of plant growth adjustment components chosen from group (c).

  In the composition A containing one or more ingredients having herbicidal activity selected from the group (i) or the group (j), all active ingredients may be contained in one preparation, or one active ingredient A plurality of preparations comprising a preparation containing and a preparation containing a plurality of active ingredients may be used, or all active ingredients may be separate preparations. When a plurality of preparations are applied, the preparations may be applied to harmful arthropods, harmful arthropod habitats, plants or soils at the same time or different times. Examples of the application time of the component having herbicidal activity include the following.

  In the case of treating one or more ingredients having herbicidal activity selected from group (i) or group (j) before sowing seeds or before planting vegetative organs or seedlings, treatment of the ingredients having herbicidal activity The timing is from 50 days before sowing or planting to immediately before sowing or planting, preferably from 30 days before sowing or planting to just before sowing or planting, more preferably from 20 days before sowing or planting. Until just before, more preferably, from 10 days before sowing or planting to just before sowing or planting.

  When one or more components having herbicidal activity selected from group (i) or group (j) are treated after seed sowing or after planting of vegetative reproductive organs or seedlings, the treatment time of the component having herbicidal activity Is preferably from immediately after sowing or planting until 50 days after sowing or planting, more preferably from immediately after sowing or planting to 3 days after sowing or planting.

  Simultaneously with seed sowing or vegetative organ or seedling planting, one or more components selected from group (i) or group (j) can be treated.

  When one or more components having herbicidal activity selected from group (i) or group (j) are treated after sowing of soybean seeds, the treatment time of the component having herbicidal activity is, for example, flowering before germination of soybean. The period is mentioned. Among the period from before the emergence of soybean to the flowering period, the period is preferably from the period before emergence of soybean to the period of 6 double leaves, and more preferably from the period before emergence of soybean to the period of 3 complex leaves.

  When one or more components having herbicidal activity selected from group (i) or group (j) are treated after sowing of corn seeds, the treatment time of the component having herbicidal activity is, for example, from before emergence to the 12th leaf stage. Preferably, it is between pre-emergence and the 8th leaf stage, more preferably between pre-emergence and the 6th leaf stage. In addition, the leaf age of corn is determined by the leaf color method (Leaf Collar Method).

  When one or more components having herbicidal activity selected from group (i) or group (j) are treated before sowing of cotton seeds, the treatment time of the component having herbicidal activity is from 50 days before sowing to immediately before sowing. Preferably, it is between 30 days before sowing and immediately before sowing, and more preferably between 20 days before sowing and immediately before sowing. When one or more components having herbicidal activity selected from group (i) or group (j) are treated after sowing of cotton seeds, the treatment time of the component having herbicidal activity is from immediately after sowing to 70 days after sowing. Between 30 days after sowing and 50 days after sowing, for example, from the time before cotton emergence to the flowering period, preferably the period from the start of tree planting to 20 cm from the base Between.

  When one or more ingredients having herbicidal activity selected from the group (i) or the group (j) are treated before sugarcane planting, the treatment time of the ingredient having herbicidal activity is from 40 days before planting to immediately before Preferably between 30 days before and just before the planting date, more preferably between 20 days before and just before the planting date. When one or more components having herbicidal activity selected from group (i) or group (j) are treated after sugarcane planting, the treatment time of the component having herbicidal activity is from immediately after planting until 40 days after planting. Preferably, it is from immediately after planting to 20 days after sowing or planting, more preferably from immediately after planting to 10 days after planting.

  By applying the composition B, depending on the plant species or plant varieties, their growth location and growth conditions (soil, climate, growing season, nutrient), improvement of plant seedling establishment rate, improvement of plant growth, high temperature or Increased tolerance or tolerance to low temperatures, improved tolerance to drought, overhumidity or salt contained in water or soil, improved flowering ability, improved ease of harvesting, accelerated maturity, increased yield, seed or Increased number, size or weight of fruit, increased plant height, increased plant weight, improved leaf greenness, increased number of healthy leaves, increased leaf area, faster flowering, number of flowers or fruit Increased number, increased fruit set, improved quality and / or nutritional value of harvested product, increased sugar content in fruit, increased gluten strength, improved storage stability of harvested product and In some cases, workability can be improved.

When the composition B is applied to a place where rice is nurtured, the application amount of the composition B is usually 5000 g or less, preferably 1000 g or less per sowing area (cultivation area) 10a, and is included in the composition B. The total amount of the present compound or composition A is usually 1000 g or less, preferably 500 g or less. In addition, the total amount of the present compound or the composition A contained in the composition B per 1 m ² where the rice is nurtured is usually 0.05 to 1000 g, preferably 0.5 to 200 g.

  When the composition B is applied to a rice seedling box, the application amount of the composition B is one box of the seedling box (about 60 cm in width and about 30 cm in length) with the total amount of the present compound or the composition A contained in the composition B. Usually, it is 0.1 to 35 g, preferably 0.2 to 20 g.

  The harmful arthropods for which the present compound and composition A are effective are harmful arthropods such as harmful insects and harmful mites; harmful nematodes and harmful molluscs; and phytopathogenic microorganisms.

  The present compound and composition A can control harmful arthropods such as harmful insects and harmful mites, harmful molluscs, and harmful nematodes. Specific examples include the following.

  Hemiptera: Laodelphax striatellus, brown planthopper (Nilaparvata lugens), white-tailed planthopper (Sogatella furcifera), corn planter (Peregrinus maidis), yellow-spotted plant (Javesella pellucida), black-tailed planthopper (Perkinsiella s) Delphacidae; Nephotettix cincticeps, Nephotettix virescens, Nephotettix nigropictus, Recilia dorsalis, Equica mp , Cornleaf Hopper (Dalbulus maidis), Whiteflies Cofana spectra, Amrasca biguttula biguttula, etc. (Cicadellidae); Mahanarva posticata, Mahanarva fimbriolata, etc. , Soybean oil Aphis glycines, cotton aphids (Aphis gossypii), European apple aphids (Aphis pomi), snowy aphids (Aphis spiraecola), peach aphids (Myzus persicae), wheat aphids (Brachycaudus helichrysi) , Rosy apple aphid (Dysaphis plantaginea), black-headed aphid (Lipaphis erysimi), tulip beetle aphid (Macrosiphum euphorbiae), potato beetle aphid (Aulacorthum padolaihum) Aphids (Rhopalosiphum maidis), citrus black aphids (Toxoptera citricida), peach beetles (Hyalopterus pruni), hyena aphids (Melanaphis sacchari), scabbard aphids (Tetraneura nigriabdominalis), citrus aphid Ovacuna lanigera), apple rotifer (Eriosoma lanigerum), English aphid (Sitobion avenae), etc. , Phylloxeridae, such as Phylloxera russelae; Adelges tsugae, Adelges piceae, Aphrastasia pectinatae, etc. ); Rice stink bug (Scotinophara lurida), black paddy bug (Scotinophara coarctata), blue stink bug (Nezara antennata), bark beetle (Eysarcoris aeneus), bark beetle (Eysarcoris yssi) Murasakishiraho Stink bugs (Eysarcoris annamita), winged stink bugs (Halyomorpha halys), southern stink bug (Nezara viridula), brown stink bug (Euschistus heros), red-banded stink bug (Piezodorus guildinii), Oebalus pugnax, Dichelops melac Pentatomidae); Scaptocoris castanea and other hornworms (Cydnidae); (Cletus punctiger), Leptoglossus australis, and so on (Coreidae); Lygaeidae; Red-faced beetle (Trigon) otylus caelestialium), Stenotus rubrovittatus, Stenodema calcarata, Lygus lineolaris, etc. (Miridae); Whitefly (Aleyrodidae), Cyanophyllus illus (Aleyrodidae) aurantii, Diaspidiotus perniciosus, Pseudaulacaspis pentagona, Unaspis yanonensis, Unaspis citri, etc. Coccidae; Icerya purchasi, Icerya seychellarum, etc .; Margarodidae; Phenacoccus solani; , Fujico scale insects (Planococcus kraunhiae), stag beetle scales (Pseudococcus comstocki), citrus scale insects (Planococcus citri), scallop scales (Pseudococcus calceolariae), stag beetle bugs (Pseudochicus longis) Pseudococcidae; Diaphorina citri, Trioza erytreae, Cacopsylla pyrisuga, Cacopsylla chinenpy, ericla copter Psyllidae such as ricola; Corythucha ciliata, Corythucha marmorata, Stephanitis nashi, Stephanitis pyrioides, etc. Texidaeular; Citex hemipterus and other lice (Cimicidae); Quesada gigas and other cicada (Cicadidae); Brazilian turtle (Triatoma inpanthans) and other triatoma spp. Red turtle (Reduviidae).

  Lepidoptera: Chilo suppressalis, dark-headed stem borers (Chilo polychrysus), white stem borers (Scirpophaga innotata), Scirpophaga incertulas, Rupela albina, Cnaphalocrocisas medinalis, Cnaphalocrocisas medinalis, Inaha casino maiga (Marasmia exigua), cotton eel (Ostrinia furnacalis), European corn borer (Ostrinia nubilalis), yellow moth (Hellula undalis), Herpetogramma rel , Rice case worms (Nymphula depunctalis), sugar cane borers (Diatraea saccharalis), egg plant fruit borers (Leucinodes orbonalis), etc. (Crambidae); Phyralidae, such as Euzophera batangensis and Cadra cautella; Spodoptera litura, Spodoptera exigua, Mythimna separata, Ms. , Spodoptera mauritia, Naranga aenescens, Spodoptera frugiperda, Spodoptera exempta, Agrotis ipsilon, afest s Trichoplusia spp., Heliothis virescens, and other Heliotis spp. Caterpillar (Anticarsia gemmatalis), cotton Leaf worm (Alabama argillacea), Hop wine borer (Hydraecia immanis), etc. (Noctuidae); Leguminous moth (Leguminivora glycinivorella), Azuki bean moth (Matsumuraeses azukivora), apple wolfberry (Adoxophyes orana fasciata), teaberry (Adoxophyes honmai), chahamaki (Homona magnanima), mandalecos moth ), Tetramoera schistaceana, Bean shoot borer (Epinotia aporema), Citrus fruit borer (Citripestis sagittiferella), European grape wine moss (Lobesia botrana), etc. (Tortricidae); (Phyllon orycter ringoniella), Carposin sasakii, Carposinidae; coffee leaf miner (Leucoptera coffeella), peach leaf moth (Lyonetia clerkella), lingon leaf moth (Lyonetia prunifella moth) Lyonetriidae); Lymantriidae such as Lymantria dispar; Euproctis pseudoconspersa such as Euproctis spp. Lymantriidae; Family (Plutellidae); American mosquitoes (Anarsia lineatella), Japanese cypress (Helcystogramma triannulella), Cotton moth (Pectinophora gossypiella), Potato moth (Phthorimaea operculella), Tuta absoluta, etc. (Arctiidae); Castonia such as Giant Sugar Cane Borer (Telchin licus) Castniidae; Cossus insularis, etc. (Cossidae); Artemidae, such as Ascotis selenaria; Geometridae, etc .; masinissa, etc .; Staphmopodidae; Acherontia lachesis, etc .; Sphingidae; The moss family (Hesperiidae) such as Parnara guttata;

  Thysanoptera: Citrus thalis (Frankliniella occidentalis), Thrips palmi, Scirtothrips dorsalis, Thrips tabaton, Thrips tabasa, Thrips tabasa Thripidae such as Echinothrips americanus and Scirtothrips perseae; Thripidae such as Haplothrips aculeatus.

  Diptera: Anthomyiidae, such as Delia platura, Delia antiqua, Pegomya cunicularia; Sugar beet root, Tetanops myopaeformis Agromyza oryzae, tomato leaffly (Liriomyza sativae), bean leaffly (Liriomyza trifolii), leafworm (Chromatomyia horticola) and other leafhoppers (Agromyzidae); Bactrocera cucurbitae), citrus fruit fly (Bactrocera dorsalis), nasal fly (Bactrocera latifrons), olive fruit fly (Bactrocera oleae), quinceland fruit fly (Bactrocera tryoni), green leaf fly (Ceratitis capitata), green fly ), Etc. (Tephritidae) ; Hydrellia griseola, Hydrellia philippina, Hydrellia sasakii, etc. (Ephydridae); Drosophila suzukii Drosophilidae; Fleaidae such as Megaselia spiracularis; Phorchoe such as Clogmia albipunctata; Psychodidae; Bradysia difformisae, etc. ); Hessian flies (Mayetiola destructor), Rice flies (Orseolia oryzae), etc. (Cecidomyiidae); Diopsis macrophthalma (Diopsidae); Glossina palpalis, Glossina morsitans, etc. japonicum) (Simuliidae) ); Phlebotominae; Tipula aino, Common Crane Fly (Tipula oleracea), European Crane Fly (Tipula paludosa), etc. Culex tritaeniorhynchus), Chilex pipiens f. Molestus, Aedes albopic, Culex pipiens pipiens, Culex vishnui sinensis), Anopheles gambiae, Anopheles stephensi, Anopheles coluzzii, Anopheles albimanus, Anopheles sundaicus, Anopheles arabiensis, Anopheles funestus, Anopheles darlingi, Anopheles darlingi, Anopheles darlingi, Anopheles darlingi Prosimulium yezoensis, clawed gebuyu Simulidae such as (Simulium ornatum); Tabanidae such as cattle (Tabanus trigonus); Musca domestica, Muscina stabulans, Stomoxys calcitrans, Haematobia irritans Muscidae; Calliphoridae; Sarcophagidae; Chironomus plumosus, Chironomus yoshimatsui, Glyptotendipes tokunagae;

  Coleoptera: Diabrotica spp., Eg, Western corn rootworm (Diabrotica virgifera virgifera), Southern corn rootworm (Diabrotica undecimpunctata howardi), Northern corn rootworm (Diabrotica barberi), Mexican corn rootworm (Diabrotica virgifera zeae)), Banded Cucumber Beetle (Diabrotica balteata), Cuabit Beetle (Diabrotica speciosa), etc. (Phyllotreta striolata), Cabbage Free Beetle (Phyllotreta cruciferae), Western Black Free Beetle (Phyllotreta pusilla), Cabbage Stem Free Beetle (Psylliodes chrysocephala), Hop Free Beetle (Psylliodes punctulata), Colorado Leaf Beetle (Leptinotars) a decemlineata), rice beetle (Oulema oryzae), grape colaspis (Colaspis brunnea), corn-free beetle (Chaetocnema pulicaria), sweet potato beetle (Chaetocnema confinis), potato-free beetle (Epitrix cucumeris), Dera ham Corn leaf beetle (Myochrous denticollis), clover beetle (Laccoptera quadrimaculata), leaf beetle (Epitrix hirtipennis) and other Chrysomelidae (Chrysomelidae); seed corn beetle (Stenolophus lecontei), slender seed corn beetle (Clivina impressifrons) Carabidae; Anomala cuprea, Anomala rufocuprea, Anomala albopilosa, Japanese beetle (Popillia japonica), Hagatokogane (Heptophylla picea), European moth The Scarabaeidae (Scarabaeidae) such as Holotrichia spp., Phyllophaga crp, such as Phyllophaga crp, and Diloboderus spp. Araecerus coffeae), Anthriibidae; Cylas formicarius, Aponidae; Brazilian weevil, Zabrotes subfasciatus; Scolytidae such as coffee berry borers (Hypothenemus hampei); weevil (Euscepes postfasciatus); Weevil (Echinocnemus squameus), rice weevil (Lissorhoptrus) oryzophilus), white-headed weevil (Rhabdoscelus lineaticollis), cotton weevil (Anthonomus grandis), white-tailed weevil (Sphenophorus venatus), southern cornbilbug (Sphenophorus callosus), soybean stalk weibill (Sternechus subsignatus) Sphenophorus levis), Sabiic gourd weevil (Scepticus griseus), Flying gourd weevil (Scepticus uniformis), Aracanthus mourei and other Aracanthus genus (Aracanthus spp.); (Tribolium castaneum), Tribolium confusum, Alphitobius diaperinus, etc .; Tenebrionidae; , Nagasinkui (Rhizopertha dominica), etc. (Bstrychidae); Leopardidae (Ptinidae); Agriotes fuscicollis, Melanonotus legatus, Anchastus spp., Conoderus spp., Ctenicera spp., Limonius spp., Aeolus spp.), Elateridae; Paederus fuscipes, Staphylinidae; Anthrenus verbasci; Dermestidae; tobacco beetle (Lasioderma serricorne), Anchoidae such as Stegobium paniceum; Anobiidae; Laemophloeidae such as Cryptolestes ferrugineus; ), Etc. (Nitidulidae).

  Orthoptera: Locusta migratoria, Moroccan grasshopper (Dociostaurus maroccanus), Australian grasshopper (Chortoicetes terminifera), red locust (Nomadacris septemfasciata), brown locust (Locustana pardalina), tree locust Locust (Calliptamus italicus), differential grass hopper (Melanoplus differentialis), two-striped grass hopper (Melanoplus bivittatus), migretry grass hopper (Melanoplus sanguinipes), red legged grass hopper (Melanoplus femurrubrum), clear winged grass hopper (Camnula pellucida) Mackerel grasshopper (Schistocerca gregaria), yellow wing draw cast (Gastrimargus musicus), spur throated locust (Austracris guttulosa), white-spotted locust (Oxya yezoensis), red-eyed snail (Ox Ya japonica), grasshoppers such as Patanga succincta (Acrididae); kerats such as Gryllotalpa orientalis; Gryllotalpidae; crickets such as European crickets (Acheta domestica) ; Tettigoniidae, such as Mormon Cricket (Anabrus simplex);

  Hymenoptera: Tenthledinidae such as Athalia rosae and Athalia japonica; Tenthredinidae; Leaf cutting ant (Atta capiguara) and other species of genus Atta spp., Genus Acromyrmex spp. , Squirrels (Formica japonica), red ants (Pristomyrmex punctutus), giant ants (Pheidole noda), cicada ants (Pheidole megacephala), black ants (Camponotus japonicus), red-tailed ants (Camponotus obscuripes), etc. Pogonomyrmex spc., Such as Pogonomyrmex occidentalis, smania auropunctata, etc. (Wasmania spp.), Asopidae (Anoplolepis gracilipes), etc. (Formicidae); (Vespa velutina), Vespidae such as Polistes jokahamae; Vorpidae (Siricidae) such as Urocerus gigas; Bethylidae.

Cockatoo (Blattodea): German cockroach (Ectobiidae), such as Blattella germanica; Black cockroach (Periplaneta fuliginosa), American cockroach (Periplaneta australasiae), Black cockroach (Periplaneta australasiae), Japanese cockroach (Periplaneta australasiae) Blatta orientalis and other cockroaches (Blattidae); Yamato termites (Reticulitermes speratus), termites (Coptotermes formosanus), American termites (Incisitermes minor), daiksite termites (Cryptotermes domesticus), taiwan termites (Odontotermes formosa) Neotermes koshunensis), white termites (Glyptotermes satsumensis), long term termites (Glyptotermes nakajimai), white termites (Glyptotermes fuscus), white termites (Hodotermopsis sjostedti), red termites (uangi termites (Goptotermes es), amamianus), Miyatake termites (Reticulitermes miyatakei), Camellia termites (Reticulitermes kanmonensis), Takasago termites (Nasutitermes takasagoensis), Nitobe termites (Pericapritermes nitobei), Musashi termites (Sinocapritermans mushatermidae)

  Flea (Siphonaptera): Plex (Pulex spp.) Such as human flea (Pulex irritans), Ctenocephalides felis (Ctenocephalides canis), Ctenocephalides spp. Xenopsylla cheopis etc., Xenopsylla spp., Sunnomi (Tunga penetrans) etc. Nosopsyllus spp.

  Psocodae: Pediculus spp. Such as head lice (Pediculus humanus capitis); Phitrus spp. Haematopinus spp .; Bovicola bovis, Bovicola ovis, Bovicola breviceps and other genus Bovicola spp .; Damalinia forficula, etc. , Linognathus spp., Such as sheep trunk parasitic white lice (Linognathus ovillus); Solenopotes spp., Such as Solenopotes capillatus; Menopon galno Cummingsia spp .; Trinoton spp .; Trichodectes canp and other Trichodectes spp .; Felicola spp., Such as Lami (Felicola subrostratus); Menacanthus spp., Such as Chicken Acropus stramineus; Werneckiella spp .; Trogium pulsatorium, etc. Family (Trogiidae); Liposcelidae or Liposcelidae, Liposcelis corrodens, Liposcelis bostrychophila, Liposcelis pearmani, Liposcelis entomophila

  Thysanura: Lepismatidae, such as Ctenolepisma villosa and Lepisma saccharina.

  Acari: Tick spider mite (Tetranychus urticae), Kandazawa spider mite (Tetranychus kanzawai), Aedes spp. ); Citrus ticks (Aculops pelekassi), Ryu citrus ticks (Phyllocoptruta citri), tomato rustic mites (Aculops lycopersici), Chinese rustic mites (Calacarus carinatus), Chinese cabbage ticks (Acaphylla theavagrans), tick moss radish Aculus schlechtendali, Aceria diospyri, Aceria tosichella, Sheevtchenkella sp., Etc .; Eriophyidae; Tenuipalpidae; Tuckerellidae (Tuckerellida) e); Tickaceae (Ixodidae), for example, Tick genus (Haemaphysalis campanulata) (Dermacentor variabilis), Dermacentor taiwanensis, Rocky mountain wood tic (Dermacentor andersoni), Dermacentor spp., Dermacentor spp., Ixodes ovatus, cat Black legged ticks (Ixodes scapularis), Western tick ticks (Ixodes pacificus), Ixodes holocyclus, Ixodes ricinus, etc. (Amblyomma spp.), Rhipicephalus microp lus), cattle ticks (Rhipicephalus annulatus), red tick ticks (Rhipicephalus sanguineus), Rhipicephalus appendiculatus, Rhipicephalus decoloratus, etc .; Arcaridae (Acaridae); Dermatophagoides farinae; Dermatophagoides pteronyshey (Dermatophagoides farinae); Dermatophagoides pteronysheyus (Cheyletus malaccensis), southern ticks (Chelacaropsis moorei), crested ticks (Cheyletidae) such as horned tick (Cheyletiella yasguri); todectes cynotis), Chorioptes spp., etc., Psoroptidae; Sarcoptidae; Listrophoridae such as Listrophorus gibbus; Listrophoridae; Dermanyssidae such as Dermanyssus gallinae; Orithonyssus sylviarum; Ornithonyssus Varnishae, such as Varroa jacobsoni, Demodexidae, Demodexidae, Demodexidae, Demodexidae, Leptotrombidium akamushi, Leptotrombidium Leptotrombi , Lombiciformae (Trombiculidae) such as Leptotrombidium scutellare

Araneae: Eutrichuridae such as Cheracanthium japonicum; Theridiidae such as Latrodectus hasseltii.
The order of Polydesmida: Paradoxosomatidae such as Oxidus gracilis, Nedyopus tambanus.
Isopoda: Armadillidiidae such as Armadillidium vulgare.
Chilopoda: Scutigeridae such as Thereuonema hilgendorfi; Scolopendridae such as Scolopendra subspinipes;
Gastropoda: Limax marginatus, Limax flavus, and other species, Limacidae; Sludge, Meghimatium bilineatum, and others Ampullariidae; Austropeplea ollula, etc. (Lymnaeidae).

  Nematoda: Aphelenchoididae such as Aphelenchoides besseyi; Pratylenchus coffeae, Pratylenchus brachyurus, PratyliRadophus et al. Pratylenchidae; Java root-knot nematode (Meloidogyne javanica), sweet potato root-knot nematode (Meloidogyne incognita); Heteroderidae such as pallida; Hoploimidae such as Rotylenchulus reniformis; Anguinidae such as Nothotylenchus acris and Ditylenchus dipsaci; Tylenchulidae such as enchulus semipenetrans; Longidoridae such as Xiphinema index; Trichodoridae; .

For the above-mentioned harmful arthropods such as harmful insects and harmful mites, harmful molluscs and harmful nematodes, variation within the species is not limited. In other words, harmful arthropods, harmful molluscs and harmful nematodes that are less sensitive (also called resistant) to certain insecticides, acaricides, molluscicides and nematicides It is. Examples of the insecticide, the acaricide, the molluscicide and the nematicide include group a1 to group a26.
Group a1: Group 1A carbamates and group 1B organophosphorus compounds of action by acetylcholinesterase inhibitor IRAC, such as alanicarb, aldicarb, bendiocarb, benfuracarb, butocarboxy Butocarboxim, butoxycarboxim, carbaryl (NAC), carbofuran, carbofuran, carbosulfan, ethiofencarb, fenobucarb (BPMC), formetanate, furthiocarb ( furathiocarb), isoprocarb (MIPC), methiocarb (methiocarb), methomyl, metolcarb, oxamyl, pirimicarb, propoxur (PHC), thiodicarb, thiophanox (thiofanox), G Triazamate, trimethacarb, xylylcarb; acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyfos Chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos (CYAP), demeton, demeton-S-methyl S-methyl, diazinon, dichlorvos (DDVP), dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos , Famphur, fenamiphos, Rothion (MEP), fenthion (MPP), fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl-O- (methoxyaminothiophosphoryl) salicylate (isopropyl-O-) (methoxyaminothiophosphoryl) salicylate), isoxathion (isoxathion), malathion (malathion), mecarbam (mecarbam), methamidophos (methidathion: DMTP), mevinphos (mevinphos), monocrotophos (monocrotophos), nared (nald: BRP) , Omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate (PAP), phorate, phosalone, phosmet (PMP) ), Phosphamidon, phoxim, pirimiphmethyl os-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyrazophos, pyridaphenthion, quinalphos, sulfotep, osprof, sprof Tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, toxaphene, triazophos, trichlorfon (DEP) and bamidothion A group.
Group a2: Group 2A cyclic diene organochlorine and group 2B phenylpyrazole compounds of action classification by GABAergic chloride channel blocker IRAC, for example, chlordane, endosulfan, dieldrin, ethiprole ), Fipronil and flufiprole.
Group a3: group 3A pyrethroids and group 3B of action classification by sodium channel modulator IRAC, eg acrinathrin, allethrin, bifenthrin, kappa-bifenthrin, bioallethrin, Bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin , Cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, sigma-methrin (sigma-) cypermethrin), cyphenothrin (cyphenoth) rin), deltamethrin, empentrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin ), Fulvalinate, tau-fluvalinate, halffenprox, heptafluthrin, imiprothrin, kadethrin, meperfluthrin, monfluorothrin ( momfluorothrin), permethrin, phenothrin, prarethrin, pyrethrin, resmethrin, silafluofen, tefluthrin, kappa-tetraflurin (kappa-tetraflurin) ), Tetramethi Flutrin (tetramethylfluthrin), tralomethrin (tralomethrin), transfluthrin (transfluthrin), benfluthrin (benfluthrin), flufenprox (flufenoprox), flumethrin (flamethrin), flamethrin (furamethrin), methfluthrin (metofluthrin), profluthrin and profluthrin (profluthrin) (dimefluthrin), a group consisting of DDT.
Group a4: Group of actions classified by the nicotinic acetylcholine receptor competitive modulator IRAC Group 4A Neonicotinoids, 4B nicotine, 4C butenolide, 4D sulfoximine and 4E mesoionics such as acetamiprid, clothianidin, Dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam, thiamethoxam, flupradifurone, sulfoxaflor, trixaprid, trix A group consisting of dicloromezotiaz and flupyrimine.
Group a5: Group 5 spinosyn system of action classification by the nicotinic acetylcholine receptor allosteric modulator IRAC, for example the group consisting of spinosad and spinetram.
Group a6: Group 6 of action classification by glutamatergic chloride channel allosteric modulator IRAC Abamectin, milbemycin, eg, abamectin, emamectin-benzoate, lepimectin, milbemectin , Dimadectin, doramectin, eprinomectin, ivermectin, latidectin, selamectin, milbemycin D, moxidectin and nemadectin .
Group a7: group 7A juvenile hormone analogs of action classification by juvenile hormone mimic IRAC, group 7B phenoxycarb and 7C pyriproxyfen, such as hydroprene, kinoprene, metoprene, phenoxycarb ( fenoxycarb) and pyriproxyfen.
Group a8: Group 9 of action classification by string organ TRPV channel modulator IRAC Group consisting of pyridine azomethine derivatives, for example, Pymetrozine and Pyrifluquinazon.
Group a9: Group 11A Bacillus thuringiensis, group 11B Bacillus sphaericus, for example, Bacillus sphaericus, Bacillus thuringiensis BD # 32 strain (Bacillus) thuringiensis strain BD # 32), Bacillus thuringiensis strain AQ52 (Bacillus thuringiensis strain AQ52), Bacillus thuringiensis subspecies ABTS-1857 (Bacillus thuringiensis subsp. aizawai strain ABTS-1857), Bacillus thuringiensis cristaki Subspecies HD-1 strain (Bacillus thuringiensis subsp.kurstaki strain HD-1), Bacillus thuringiensis subsp. Kurstaki strain BMP123, Bacillus thuringiensis subsp.kurstaki strain BMP123, Bacillus thuringiensis subsp. NB176 strain (Bacillus thuringiensis subsp.Tenebriosis strain NB176), Bacillus thuringiensis var.israelensis, Bacillus thuringiensis aegypti, Bacillus thuringiensis var. Bacillus thuringiensis var.darmstadiensis, Bacillus thuringiensis var.・ Thuringiensis Japonensis varieties (Bacillus thuringiensis var. Japonensis), Bacillus thuringiensis subsp. Morrisoni, Bacillus thuringiensis San Diego varieties (Bacillus thuringiensis) san diego), Bacillus thuringiensis subsp. Thuringiensis strain MPPL002, Bacillus thuringiensis 7216 variant (Bacillus thuringiensis var. 7216), Bacillus thuringiensis T36 variant (Bacillus thuringiensis var. Hybrid protein), Cry1C, Cry1F, Cry1Fa2 (modified cry1F), moCry1F (modified Cry1F), Cry1A. 105 (Cry1Ab, Cry1Ac, hybrid protein fused with Cry1F), Cry2Ab2, Cry2Ae, Cry9C, Vip3A, Vip3Aa20), and delta-endotoxins that confer resistance to Coleoptera (e.g. Cry3A, mCry3A (modified Cry3A)), Cry3Bb1, Cry34Ab1, Cry35Ab1).
Group a10: Group 13 of action classes with oxidative phosphorylation uncoupler IRAC perturbing proton gradient, eg group consisting of chlorfenapyr and sulfluramid.
Group a11: Group 14 nereistoxin analogs of action classified by nicotinic acetylcholine receptor channel blocker IRAC, eg, bensultap, cartap, cartap hydrochloride, thiocyclam, thiosultap Group consisting of disodium salt (thiosultap-disodium) and thiosultap-monosodium salt.
Group a12: Group 15 benzoylurea and group 16 buprofezins of action classification by chitin biosynthesis inhibitors IRAC, for example bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron ( flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noiflumuron, teflubenzuron, triflumuron and buprofezin profezin.
Group a13: Group 17 of action classification by molting inhibitor IRAC, for example, group consisting of cyromazine.
Group a14: Group 18 group of action according to the molting hormone (ecdysone) receptor agonist IRAC, for example the group consisting of chromafenozide, halofenozide, methoxyfenozide and tebufenozide.
Group a15: Group consisting of group 22A oxadiazine and group 22B semicarpazone systems, for example indoxacarb and metaflumizone, in action classification by voltage-dependent sodium channel blocker IRAC.
Group a16: Group 23 of action classes according to the acetyl CoA carboxylase inhibitor IRAC The group consisting of tetronic acid, tetramic acid derivatives such as spirodiclofen, spiromesifen and spirotetramat.
Group a17: Group 28 diamide system of action classification by ryanodine receptor modulator agent IRAC, eg chlorantraniliprole, cyantraniliprole, cycloniliprole, flubendiamide, A group consisting of tetraniliprole, cyhalodiamide and tetrachlorantraniliprole.
Group a18: Group 29 of action classification by chordal organ modulator IRAC, for example, group consisting of Flonicamid.
Group a19: Group 10 of classification of action by the tick growth inhibitor IRAC, for example, the group consisting of etoxozole, clofentezine, hexythiazox.
Group a20: group 19 of action classification by octopamine receptor agonist IRAC, eg group consisting of amitraz.
Group a21: Group 24 of action classification by mitochondrial electron transport complex IV inhibitor IRAC, for example, group consisting of phosphine.
Group a22: a group consisting of isoxazoline-based compounds, for example afoxolaner, fluralaner, sarolaner, lotilaner.
Group a23: Group 12 of action classification by mitochondrial ATP synthase inhibitor IRAC, for example, the group consisting of diafenthiuron.
Group a24: Group 20 of action classification by mitochondrial electron transport system complex III inhibitor IRAC, for example, the group consisting of acequinocyl and bifenazate.
Group a25: Mitochondrial electron transport system complex I inhibitor (METI)
Group 21 of action classification by IRAC, for example, the group consisting of pyridaben, fenpyroximate.
Group a26: a group consisting of azadiractin and pyridalyl.

Factors that decrease sensitivity include [1] decreased skin permeability, [2] enhanced metabolism, and [3] amino acid substitution of the target protein. [2] Metabolism enhancement means, for example, increased activity of metabolic enzymes (also called detoxification enzymes) such as cytochrome P450, carboxylesterase and glutathione S-transferase. . In [3], the target protein may have one or more amino acid substitutions. Moreover, it may have one or more of [1] decreased skin permeability, [2] enhanced metabolism, and [3] amino acid substitution of the target protein as a factor of decreased sensitivity.

Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites that have decreased sensitivities include the following.
Hemiptera with reduced sensitivity to one or more compounds selected from group a2;
Hemiptera with reduced sensitivity to one or more compounds selected from group a4;
Hemiptera with reduced sensitivity to one or more compounds selected from group a8;
Hemiptera with reduced sensitivity to one or more compounds selected from group a12;
Hemiptera with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4;
Hemiptera with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a8;
One or more compounds selected from group a2, and hemiptera with reduced sensitivity to buprofezin belonging to group a12;
Hemiptera with reduced sensitivity to one or more compounds selected from group a4 and one or more compounds selected from group a8;
One or more compounds selected from group a4, and Hemiptera with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from group a8, and hemiptera with reduced sensitivity to buprofezin belonging to group a12;
Hemiptera with reduced sensitivity to one or more compounds selected from group a2, one or more compounds selected from group a4, and one or more compounds selected from group a8;
Hemiptera with reduced sensitivity to one or more compounds selected from group a2, one or more compounds selected from group a4, and buprofezin belonging to group a12;
Hemiptera with reduced sensitivity to one or more compounds selected from group a2, one or more compounds selected from group a8, and buprofezin belonging to group a12;
Hemiptera with reduced sensitivity to one or more compounds selected from group a4, one or more compounds selected from group a8, and buprofezin belonging to group a12;
Hemiptera with reduced sensitivity to one or more compounds selected from group a2, one or more compounds selected from group a4, one or more compounds selected from group a8, and buprofezin belonging to group a12;
A planthopper family with reduced sensitivity to one or more compounds selected from group a2;
A planthopper with reduced sensitivity to one or more compounds selected from group a4;
A planthopper family with reduced sensitivity to one or more compounds selected from group a8;
A planthopper family with reduced sensitivity to one or more compounds selected from group a12;
A planthopper family with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4;
One or more compounds selected from group a2 and a planthopper family with reduced sensitivity to pymetrozine belonging to group a8;
One or more compounds selected from group a2, and a planthopper family with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from group a4, and a planthopper family with reduced sensitivity to pymetrozine belonging to group a8;
One or more compounds selected from group a4, and a planthopper family with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from group a2, one or more compounds selected from group a4, and a planthopper family with reduced sensitivity to pymetrozine belonging to group a8;
One or more compounds selected from group a2, one or more compounds selected from group a4, and a planthopper family with reduced sensitivity to buprofezin belonging to group a12;
A planthopper family with reduced sensitivity to one or more compounds selected from group a2, pymetrozine belonging to group a8, and buprofezin belonging to group a12;
A planthopper family with reduced sensitivity to one or more compounds selected from group a4, pymetrozine belonging to group a8, and buprofezin belonging to group a12;
One or more compounds selected from group a2, one or more compounds selected from group a4, pymetrozine belonging to group a8, and a planthopper family with reduced sensitivity to buprofezin belonging to group a12;
A brown planthopper, a brown planthopper, or a brown planthopper with reduced sensitivity to one or more compounds selected from group a2;
A brown planthopper, a brown planthopper, or a brown planthopper with reduced sensitivity to one or more compounds selected from group a4;
A brown planthopper, a brown planthopper, or a brown planthopper with reduced sensitivity to one or more compounds selected from group a8;
A brown planthopper, a brown planthopper, or a brown planthopper with reduced sensitivity to one or more compounds selected from group a12;
One or more compounds selected from group a2 and one or more compounds selected from group a4 and having reduced sensitivity to one or more compounds selected from group a4;
One or more compounds selected from group a2 and a brown planthopper, white-spotted planthopper, or brown planthopper with reduced sensitivity to pymetrozine belonging to group a8;
One or more compounds selected from group a2 and a brown planthopper, white-spotted planthopper, or brown planthopper with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from the group a4, and a brown planthopper, sedge plant, or a planthopper with reduced sensitivity to pymetrozine belonging to the group a8;
One or more compounds selected from the group a4 and a brown planthopper, white-spotted planthopper, or a brown planthopper with reduced sensitivity to buprofezin belonging to the group a12;
One or more compounds selected from the group a2, one or more compounds selected from the group a4, and a brown planthopper, white-spotted planthopper, or a brown planthopper having reduced sensitivity to pymetrozine belonging to the group a8;
One or more compounds selected from group a2, one or more compounds selected from group a4, and a brown planthopper, white-spotted planthopper, or a brown planthopper having reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from group a2, pymetrozine belonging to group a8, and a brown planthopper, white-spotted planthopper, or a brown planthopper with reduced sensitivity to buprofezin belonging to group a12;
One or more compounds selected from the group a4, pymetrozine belonging to the group a8, and a brown planthopper, white-spotted planthopper, or a brown planthopper with reduced sensitivity to the buprofezin belonging to the group a12;
One or more compounds selected from the group a2, one or more compounds selected from the group a4, pymetrozine belonging to the group a8, and a brown planthopper, white-spotted planthopper, or a brown planthopper with reduced sensitivity to the buprofezin belonging to the group a12;
Aphids with reduced sensitivity to one or more compounds selected from group a3;
Aphids with reduced sensitivity to one or more compounds selected from group a8;
Aphids with reduced sensitivity to one or more compounds selected from group a3 and one or more compounds selected from group a4;
Aphids with reduced sensitivity to one or more compounds selected from group a3 and one or more compounds selected from group a8;
Aphids with reduced sensitivity to one or more compounds selected from group a4 and one or more compounds selected from group a8;
Aphids with reduced sensitivity to one or more compounds selected from group a3, one or more compounds selected from group a4, and one or more compounds selected from group a8;
Peach aphid with reduced sensitivity to one or more compounds selected from group a1;
Cotton aphids or peach aphids with reduced sensitivity to one or more compounds selected from group a3;
Cotton aphids or peach aphids with reduced sensitivity to one or more compounds selected from group a4;
Cotton aphids or peach aphids with reduced sensitivity to one or more compounds selected from group a8;
Cotton aphids or peach aphids with reduced sensitivity to one or more compounds selected from group a3 and one or more compounds selected from group a4;
Cotton aphids or peach aphids with reduced sensitivity to one or more compounds selected from group a3 and one or more compounds selected from group a8;
Cotton aphids or peach aphids with reduced sensitivity to one or more compounds selected from group a4 and one or more compounds selected from group a8;
Cotton aphid or peach aphid with reduced sensitivity to one or more compounds selected from group a3, one or more compounds selected from group a4, and one or more compounds selected from group a8; selected from group a3 Tobacco whitefly with reduced sensitivity to one or more compounds;
Tobacco whitefly with reduced sensitivity to one or more compounds selected from group a4;
Peach aphid with reduced sensitivity to one or more compounds selected from group a1;
Cotton aphids with reduced sensitivity to carbamate compounds selected from group a1 and / or organophosphorus compounds selected from group a1;
Tobiiloca
Sedron planta with reduced sensitivity to isoprocarb, chlorpyrifos, imidacloprid, and / or buprofezin;
Amrasca biguttula biguttula with reduced sensitivity to imidacloprid, thiamethoxam, acetamiprid, thiacloprid, clothianidin, and / or dinotefuran;
Cotton aphids with reduced sensitivity to pyrimicurve and / or organophosphorus compounds selected from group a1; peach aphid with reduced sensitivity to triazamate, pyrimicarb, endosulfan, deltamethrin, lambda cihalothrin, DDT, and / or imidacloprid;
Lettuce beetle aphids with reduced sensitivity to pirimicarb, mesomil, acephate, dieldrin, and / or endosulfan;
English grain avid with reduced sensitivity to lambda cihalothrin;
Onsite whitefly with reduced sensitivity to one or more compounds selected from group a4, bifenthrin, and / or spiromesifen;
Tobacco whitefly with reduced sensitivity to pyrimifosmethyl, profenofos, endosulfan, fipronil, lambda cihalothrin, bifenthrin, alpha cypermethrin, cartap, buprofezin, spiromesifen, chlorantraniliprole, diafenthiuron, and / or azadirachtin;
Citrus lice with reduced sensitivity to chlorpyrifos, bifenthrin, cypermethrin, acetamiprid, imidacloprid, thiamethoxam, nitenpyram, and / or chlorfenapyr;
Brown stink bug with reduced sensitivity to monocrotophos, methamidophos, acephate, endosulfan, beta-cyfluthrin, and / or imidacloprid;
Lepidoptera with reduced sensitivity to one or more compounds selected from group a14;
Lepidoptera with reduced sensitivity to one or more compounds selected from group a15;
Lepidoptera with reduced sensitivity to one or more compounds selected from group a17;
Lepidoptera with reduced sensitivity to one or more compounds selected from group a14 and one or more compounds selected from group a17;
Diamondback moth with reduced sensitivity to one or more compounds selected from group a15;
Diamondback moth with reduced sensitivity to one or more compounds selected from group a17;
Corn borers with reduced sensitivity to one or more compounds selected from group a14;
Corn borers with reduced sensitivity to one or more compounds selected from group a17;
One or more compounds selected from the group a14, and a Cobb rice moth having reduced sensitivity to one or more compounds selected from the group a17;
False American tobacco moth with reduced sensitivity to one or more compounds selected from group a3;
A tobacco moth having reduced sensitivity to one or more compounds selected from group a9;
Corn earworms with reduced sensitivity to one or more compounds selected from group a9;
Chahamaki with reduced sensitivity to one or more compounds selected from group a14;
Chahamaki with reduced sensitivity to one or more compounds selected from group a17;
Chanococmon anemone with reduced sensitivity to one or more compounds selected from group a14;
Chanococmon anemone with reduced sensitivity to one or more compounds selected from group a17;
One or more compounds selected from group a14, and a chinook leaf beetle with reduced sensitivity to one or more compounds selected from group a17;
Diamondback moth with reduced sensitivity to one or more compounds selected from group a3;
Tuta absoluta with reduced sensitivity to one or more compounds selected from group a17;
Nika maiga with reduced sensitivity to endosulfan, fipronil, and / or thiosultap monosodium salt;
European corn borer with reduced sensitivity to deltamethrin and / or lambda cihalothrin;
A sugar cane borer with reduced sensitivity to Cry1Ab and / or Cry1Ac, which are delta-endotoxins;
Egg plant fruit borers with reduced sensitivity to profenofos, carbaryl, chlorpyrifos, endosulfan, deltamethrin, and / or fenvalerate;
Profenofos, chlorpyrifos, quinalphos, foxim, triazophos, mesomil, thiodicarb, endosulfan, fipronil, cypermethrin, deltamethrin, beta-cyfluthrin, spinosad, abamectin, emamectin benzoate, rufenuron, diflubenzuron, methoxyphenozide, and / or Reduced susceptibility to chlorpyrifos, deltamethrin, cypermethrin, spinosad, abamectin, emamectin benzoate, lufenuron, indoxacarb, and / or methoxyphenozide;
Yogi with reduced sensitivity to the delta-endotoxins Cry1Ab, Cry1Ac, Cry2Ab2, Cry2Ae, and / or Cry1F;
Fake American tobacco ga with reduced sensitivity to sulfophos, profenofos, monocrotophos, parathion methyl, thiodicarb, mesomil, toxaphene, endosulfan, cypermethrin, deltamethrin, DDT, and / or spinosad;
Giant tobacco with reduced sensitivity to monocrotophos, chlorpyrifos, profenofos, mesomil, thiodicarb, toxaphene, endosulfan, fenvalerate, deltamethrin, cypermethrin, DDT, indoxacarb, and / or chlorantraniliprole;
Corn earworms with reduced sensitivity to parathion methyl, cypermethrin, endosulfan, and / or DDT;
Codling moss with reduced sensitivity to lambda cihalothrin, thiacloprid, and / or methoxyphenozide;
European grape wine moss with reduced sensitivity to deltamethrin and / or indoxacarb;
Decreased sensitivity to mesomil, dieldrin, permethrin, fipronil, spinosad, abamectin, emamectin benzoate, delta-endotoxin Cry1C, lufenuron, indoxacarb, chlorantraniliprole, fulvendiamide, and / or diafenthiuron Weed
A total cell with reduced sensitivity to one or more compounds selected from group a2;
A total cell with reduced sensitivity to one or more compounds selected from group a3;
A total cell with reduced sensitivity to one or more compounds selected from group a4;
A total cell with reduced sensitivity to one or more compounds selected from group a9;
A total cell with reduced sensitivity to one or more compounds selected from group a17;
Negia thrips with reduced sensitivity to one or more compounds selected from group a3;
Negia thrips with reduced sensitivity to profenofos, chlorpyrifos, deltamethrin and / or lambda cihalothrin;
Methiocarb, mesomil, bendiocarb, formethanate, carbofuran, malathion, chlorpyrifos, diazinon, methamidophos, dimethoate, dichlorvos, acephate, metidathion, toxaphene, endosulfan, fipronil, acrinathrin, alpha cypermethrin, bifenthrin, deltamethrin Citrus thrips with reduced sensitivity to taufulvalinate, cypermethrin, fenvalerate, cyfluthrin, imidacloprid, spinosad, spinetoram, abamectin, pyriproxyfen, and / or cyantranylprol;
Diptera with reduced sensitivity to one or more compounds selected from group a2;
Diptera with reduced sensitivity to one or more compounds selected from group a3;
Diptera with reduced sensitivity to one or more compounds selected from group a4;
Diptera with reduced sensitivity to one or more compounds selected from group a9;
Diptera with reduced sensitivity to one or more compounds selected from group a17;
Tomato leafhopper with reduced sensitivity to permethrin and / or fenvalerate;
Reduced susceptibility to one or more compounds selected from group a2; reduced sensitivity to one or more compounds selected from group a2; methamidophos, parathion methyl, pyrazophos, demeton, chlorpyrifos, triazophos, permethrin, cypermethrin, DDT, spinosad, abamectin, and / or cyromazine Crustacea;
Coleoptera with reduced sensitivity to one or more compounds selected from group a3;
Coleoptera with reduced sensitivity to one or more compounds selected from group a4;
Coleoptera with reduced sensitivity to one or more compounds selected from group a9;
Coleoptera with reduced sensitivity to one or more compounds selected from group a17;
Coleoptera with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a2;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a3;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a4;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a9;
Chrysomelidae with reduced sensitivity to one or more compounds selected from group a17;
One or more compounds selected from group a2 and potato beetles with reduced sensitivity to one or more compounds selected from group a4;
Rice dwarf rice with reduced sensitivity to one or more compounds selected from group a2;
Rice dwarf rice with reduced sensitivity to one or more compounds selected from group a4;
Rice drab beetle with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4;
Diabrotica with reduced sensitivity to one or more compounds selected from group a2;
Diabrotica with reduced sensitivity to one or more compounds selected from group a3;
Diabrotica with reduced sensitivity to one or more compounds selected from group a4;
Diabrotica with reduced sensitivity to one or more compounds selected from group a9;
Paired with one or more compounds selected from group a17
Reduced sensitivity to the genus Diabrotica;
Western corn rootworm with reduced sensitivity to one or more compounds selected from group a2;
Western corn rootworm with reduced sensitivity to one or more compounds selected from group a3;
Western corn rootworm with reduced sensitivity to one or more compounds selected from group a4;
Western corn rootworm with reduced sensitivity to one or more compounds selected from group a9;
Western corn rootworm with reduced sensitivity to one or more compounds selected from group a17;
Western corn rootworm with reduced sensitivity to one or more compounds selected from group a2;
Western corn rootworm with reduced sensitivity to one or more compounds selected from group a3;
Southern corn rootworm with reduced sensitivity to one or more compounds selected from group a4;
Southern corn rootworm with reduced sensitivity to one or more compounds selected from group a9;
Southern corn rootworm with reduced sensitivity to one or more compounds selected from group a17;
Northern corn rootworm with reduced sensitivity to one or more compounds selected from group a2;
Northern corn rootworm with reduced sensitivity to one or more compounds selected from group a3;
Northern corn rootworm with reduced sensitivity to one or more compounds selected from group a4;
Northern corn rootworm with reduced sensitivity to one or more compounds selected from group a9;
Northern corn rootworm with reduced sensitivity to one or more compounds selected from group a17;
A cucabbit beetle with reduced sensitivity to one or more compounds selected from group a2;
A cucabbit beetle with reduced sensitivity to one or more compounds selected from group a3;
A cucabbit beetle with reduced sensitivity to one or more compounds selected from group a4;
A cucabbit beetle with reduced sensitivity to one or more compounds selected from group a9;
A cucabbit beetle with reduced sensitivity to one or more compounds selected from group a17;
Colorado potato beetle with reduced sensitivity to one or more compounds selected from group a2;
Colorado potato beetle with reduced sensitivity to one or more compounds selected from group a3;
Colorado potato beetle with reduced sensitivity to one or more compounds selected from group a4;
Colorado potato beetle with reduced sensitivity to one or more compounds selected from group a11;
Colorado potato beetle with reduced sensitivity to one or more compounds selected from group a17;
Kissing beetle with reduced sensitivity to one or more compounds selected from group a3;
Susceptibility to one or more compounds selected from group a4;
Kissing beetle with reduced sensitivity to one or more compounds selected from group a17;
A cabbage-free beetle with reduced sensitivity to one or more compounds selected from group a3;
A cabbage-free beetle with reduced sensitivity to one or more compounds selected from group a4;
A cabbage-free beetle with reduced sensitivity to one or more compounds selected from group a17;
Western black free beetle with reduced sensitivity to one or more compounds selected from group a3;
Western black free beetle with reduced sensitivity to one or more compounds selected from group a4;
Western black free beetle with reduced sensitivity to one or more compounds selected from group a17;
A cabbage stem-free beetle with reduced sensitivity to one or more compounds selected from group a3;
A cabbage stem-free beetle with reduced sensitivity to one or more compounds selected from group a4;
A cabbage stem-free beetle with reduced sensitivity to one or more compounds selected from group a17;
A hop-free beetle with reduced sensitivity to one or more compounds selected from group a3;
A hop-free beetle with reduced sensitivity to one or more compounds selected from group a4;
Hop-free beetle with reduced sensitivity to one or more compounds selected from group a17;
Weevil with reduced sensitivity to one or more compounds selected from group a2;
Weevilaceae with reduced sensitivity to one or more compounds selected from group a4;
One or more compounds selected from group a2 and a weevil with reduced sensitivity to one or more compounds selected from group a4;
Rice weevil with reduced sensitivity to one or more compounds selected from group a2;
Rice weevil with reduced sensitivity to one or more compounds selected from group a4;
Rice weevil with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4;
A click beetle with reduced sensitivity to one or more compounds selected from group a2;
The beetle with reduced sensitivity to one or more compounds selected from group a3;
A click beetle with reduced sensitivity to one or more compounds selected from group a4;
Okinawa Kanshakumetsuki with reduced sensitivity to one or more compounds selected from group a2;
Okinawa Kanshokumetsuki with reduced sensitivity to one or more compounds selected from Group a3;
Okinawa Kanshakumetsuki with reduced sensitivity to one or more compounds selected from Group a4;
Tobiiromubosokometsuki with reduced sensitivity to one or more compounds selected from group a2;
Tobiiromubosokometeki with reduced sensitivity to one or more compounds selected from group a3;
Tobiiromubosokometsuki with reduced sensitivity to one or more compounds selected from group a4;
A crispiness with reduced sensitivity to one or more compounds selected from group a2;
A crispiness with reduced sensitivity to one or more compounds selected from group a3;
A crispiness with reduced sensitivity to one or more compounds selected from group a4;
The genus Ashibetella with reduced sensitivity to one or more compounds selected from group a2;
The genus Ashibetella with reduced sensitivity to one or more compounds selected from group a3;
The genus Ashibetella with reduced sensitivity to one or more compounds selected from group a4;
Reduced susceptibility to one or more compounds selected from group a2;
Reduced susceptibility to one or more compounds selected from group a3;
Reduced susceptibility to one or more compounds selected from group a4;
Kutenisella sp. With reduced sensitivity to one or more compounds selected from group a2;
Kutenisella sp. With reduced sensitivity to one or more compounds selected from group a3;
Kutenisella sp. With reduced sensitivity to one or more compounds selected from group a4;
Limonius with reduced sensitivity to one or more compounds selected from group a2;
Limonius with reduced sensitivity to one or more compounds selected from group a3;
Limonius with reduced sensitivity to one or more compounds selected from group a4;
Reduced susceptibility to one or more compounds selected from group a2;
Reduced susceptibility to one or more compounds selected from group a3;
Reduced susceptibility to one or more compounds selected from group a4;
Cabbage stem-free beetle with reduced sensitivity to lambda cihalothrin;
Colorado potato beetle with reduced sensitivity to carbosulfan, carbofuran, hosalon, chlorpyrifos, azinephosmethyl, cyhalothrin, lambda cihalothrin, deltamethrin, permethrin, imidacloprid, dinotefuran, clothianidin, thiacloprid, thiamethoxam, and / or nitenpyram;
Blossom beetle with reduced sensitivity to hosalon, lambda cihalothrin, cypermethrin, alpha cypermethrin, zetacypermethrin, bifenthrin, beta-cyfluthrin, deltamethrin, esfenvalerate, taufulvalinate, and / or acetamiprid;
Mite having reduced sensitivity to one or more compounds selected from group a2;
Mite having reduced sensitivity to one or more compounds selected from group a3;
Mite having reduced sensitivity to one or more compounds selected from group a4;
Mite having reduced sensitivity to one or more compounds selected from group a9;
Mite having reduced sensitivity to one or more compounds selected from group a17;
A spider mite with reduced sensitivity to one or more compounds selected from group a19, bifenthrin, abamectin, milbemectin, acequinosyl and / or bifenacet;
Apple spider mite with reduced sensitivity to fenpropatoline, spirodiclofen, clofentezin, hexothiazox, pyridaben and / or fenpyroximate.

Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites that have been reduced in sensitivity by amino acid substitution at the target site include the following.
Cotton aphids having an amino acid substitution of R81T in the β subunit of the nicotinic acetylcholine receptor;
Peach aphid having an amino acid substitution of R81T in the β subunit of the nicotinic acetylcholine receptor;
A diamondback moth with an amino acid substitution of G4946E at the ryanodine receptor;
A diamondback moth having an amino acid substitution of F1845Y or V1848I in the sodium channel;
Seduce plant having an A2′N amino acid substitution in the GABAergic chloride channel;
Cotton aphid having an amino acid substitution of S431F and / or A302S in acetylcholinesterase;
Tobacco whitefly with L925I and / or T929V amino acid substitutions in voltage-gated sodium channels;
Peach aphid having an amino acid substitution of S431F in acetylcholinesterase;
Peach aphid with amino acid substitutions of L1014F, M918T, and / or TL932F in a voltage-gated sodium channel;
A peach aphid having an amino acid substitution of A302S and / or A302G in a GABAergic chloride channel;
Citrus thrips having an amino acid substitution of L1014F and / or M918T in a voltage-gated sodium channel;
Citrus thrips having an amino acid substitution of G275E in the α6 subunit of the nicotinic acetylcholine receptor;
Corn earworm with amino acid substitution of L1029H, V421M, V421A, V421G and / or I951V in a voltage-gated sodium channel;
False tobacco with amino acid substitutions of L1029H, D1561V, E1565G, and / or V421M in a voltage-gated sodium channel;
Colorado potato beetle having an amino acid substitution of R30K, S291G, and / or I392T on acetylcholinesterase;
Colorado potato beetle having an amino acid substitution of L1014F in a voltage-gated sodium channel;
A white planthopper having an amino acid substitution of S298P in acetylcholinesterase type 1;
A spider mite having a G323D amino acid substitution in the GluCl1 subunit of the glutamate receptor;
A spider mite having a G326E amino acid substitution in the GluCl3 subunit of the glutamate receptor;
Thrips having amino acid substitutions of M918T, M918L, T929I, V1010A, and / or L1014F in a voltage-gated sodium channel;
White lice with L925I and / or T929I amino acid substitutions in voltage-gated sodium channels;
Tuta absoluta having an amino acid substitution of G4903V, G4903E, I4746T, and / or I4746M at the ryanodine receptor;
A planthopper having an A301S amino acid substitution in a GABAergic chloride channel;
A brown planthopper having an amino acid substitution of Y151S in the α1 and α3 subunits of the nicotinic acetylcholine receptor;
A European corn borer having an amino acid substitution of L1014F in a voltage-gated sodium channel;
Apple tick with amino acid substitution of F1538I in a voltage-gated sodium channel;
A cabbage stem-free beetle with an amino acid substitution of L1014F in a voltage-gated sodium channel;
An English grain afid with an amino acid substitution of L1014F in a voltage-gated sodium channel;
A diamondback moth having an amino acid substitution of A282S, A282G, and / or A302S in a GABAergic chloride channel;
A diamondback moth having an amino acid substitution of M918I, T929I, and / or L1014F in a voltage-gated sodium channel.

  Factors that increase the activity of metabolic enzymes include, for example, overexpression of metabolic enzyme genes (also referred to as quantitative mutation) and improved affinity with drugs by amino acid substitution of metabolic enzymes (also referred to as qualitative mutation). One or more factors for increasing the activity of these metabolic enzymes may be included.

Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites that have increased metabolic enzyme activity due to overexpression of metabolic enzyme genes include the following.
Brown planthopper overexpressed CYP6ER1 (one of the cytochrome P450 genes);
Amrasca biguttula biguttula overexpressed glutathione-S-transferase gene;
Cotton aphids with overexpression of cytochrome P450 monooxygenase gene;
Tobacco whitefly overexpressing CYP6CM1 (one of the cytochrome P450-dependent monooxygenase genes);
Tobacco whitefly overexpressed cytochrome P450-dependent monoxygenase gene;
squid which overexpressed carboxylesterase gene and / or microsomal-O-demethylase gene;
codling moss overexpressed glutathione-S-transferase gene and / or cytochrome P450 monooxygenase gene;
Sugar cane borers with reduced expression of three aminopeptidases N genes (DsAPN1, DsAPN2, and DsAPN3) and / or DsCAD1 (one of the cadherin genes);
bean fly that overexpressed the cytochrome P450 gene;
Blossom beetle with overexpressed cytochrome P450 gene;
Peach aphid overexpressing CYP6CY3 (one of the cytochrome P450 genes);
peach aphid with overexpression of E4 gene which is one of carboxylesterases and / or FE4 gene which is one of carboxylesterases;
lettuce aphids with overexpressed esterase gene;
lettuce aphid overexpressed glutathione S-transferases;
Brown stink bug with overexpressed esterase gene;
Brown stink bug with overexpression of EST-2 gene, one of cholinesterase and / or EST-4 gene, one of cholinesterase;
orange thrips overexpressing the esterase gene;
Citrus thrips overexpressing cytochrome P450 monooxygenase gene;
Citrus thrips overexpressing glutathione S-transferases gene;
Giant tobacco expressing CYP337B3 (one of the cytochrome P450 genes);
Giant tobacco overexpressed cytochrome P450 monooxygenases gene;
Giant tobacco overexpressed glutathione S-transferases gene;
Giant tobacco overexpressed esterase gene;
False American tobacco moth overexpressed glutathione-S-transferase gene;
Fake American tobacco with overexpression of the esterase gene;
Fake American tobacco with overexpression of cytochrome P450 gene;
Colorado potato beetle overexpressed glutathione-S-transferase gene;
Colorado potato beetle with overexpressed esterase gene;
Colorado potato beetle overexpressed cytochrome P450 gene;
Urticae overexpressed TuGSTd14 (one of the glutathione-S-transferase genes);
Onsite whitefly that overexpressed CYP6CM1 (one of the cytochrome P450 genes);
Cytochrome P450 gene overexpressed;
CYP6BQ9 (one of cytochrome P450 genes) overexpressed;
Brown planthopper with reduced expression of CYP6AY1 (one of the cytochrome P450 genes);
brown planthopper overexpressed carboxylesterases gene;
A brown planthopper that overexpressed the gene of Nl-EST1, a kind of carboxylesterases;
Brown planthopper overexpressed CYP6ER1, CYP6AY1, and / or CYP6FU1 (one of the cytochrome P450 genes);
European corn borer with overexpressed cytochrome P450 monooxygenase gene;
European corn borer overexpressed glutathione-S-transferase gene;
apple tick with overexpression of cytochrome P450-dependent monoxygenase gene;
Cabbage stem-free beetle with overexpressed cytochrome P450 gene.

Examples of harmful arthropods, harmful molluscs and harmful nematodes such as harmful insects, harmful mites, etc. whose metabolic enzyme activity has been increased by improving the affinity of the metabolic enzyme with amino acids for substitution include the following: .
A brown planthopper having CYP6ER1vA (a variant of CYP6ER1) having amino acid substitutions of T318S, A375Δ and A376G;
A brown planter having CYP6ER1vB (a variant of CYP6ER1) having amino acid substitutions of T318S and A377Δ;
A wolfberry having a dihydrolipoamide dehydrogenase having an amino acid substitution of P45S.

  Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites that have multiple factors that increase the activity of metabolic enzymes include, for example, CYP6ER1vA and CYP6ER1vB in addition to overexpression of CYP6ER1 For example, a brown planthopper with reduced sensitivity to imidacloprid.

Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects, harmful mites, and the like that have decreased sensitivity due to a decrease in skin permeability include the following.
Greater tobacco moths with reduced sensitivity to pyrethroids (eg, cypermethrin, esfenvalerate, etc.) due to reduced cuticular penetration in the cuticle.

  The compounds and compositions A can also be used to protect plants from plant diseases caused by insect-borne viruses or insect-borne bacteria.

Examples of insect-borne viruses include the following.
Rice tungro spherical virus, Rice tungro bacilliform virus, Rice grassy stunt virus, Rice ragged stunt virus, Rice stripe virus ( Rice stripe virus, Rice black streaked dwarf virus, Southern rice black-streaked dwarf virus, Rice gall dwarf virus, Rice hoja (Rice hoja) blanca virus), Rice yellow stunt virus, Rice yellow mottle virus, Rice dwarf virus, Northern cereal mosaic virus, Barley yellow dwarf virus , Barley mild mosaic virus, Barley yellow dwarf virus-PAV, Cereal yellow dwarf virus-RPS Wheat yellow leaf virus, Oat sterile dwarf virus, Wheat streak mosaic virus, Maize dwarf mosaic virus, Maize stripe virus, Maize chlorotic mottle virus, Maize chlorotic dwarf virus, Maize rayado fino virus , Sugarcane mosaic virus, Fiji disease virus, Sugarcane yellow leaf virus, Soybean mild mosaic virus, Cycas necrotic stunt virus, Soybean dwarf virus virus), Astragalus dwarf virus, Soybean mosaic virus, Alfalfa mosaic virus, Bean yellow mosaic virus, Bean common mosaic virus ), Southern bean mosaic vii rus), peanut stunt virus, broad bean wilt virus 1, broad bean wilt virus 2, broad bean necrosis virus , Broad bean yellow vein virus, Clover yellow vein virus, Peanut mottle virus, Tobacco streak virus, Bean pod mottle virus, Cowpea chlorotic mottle virus, Mung bean yellow mosaic virus, Soybean crinkle leaf virus, Tomato chlorosis virus, Tomato spotted wilt virus, Tomato yellow leaf curl virus ), Tomato aspermy virus, tomato infectious chlorosis virus, potato cigar Rus (Potato leafroll virus), Potato virus Y, Melon yellow spot virus, Melon necrotic spot virus, Watermelon mosaic virus, Cucumber mosaic virus, Zucchini yellow mosaic virus, Turnip mosaic virus, Turnip yellow mosaic virus, Cauliflower mosaic virus, Lettuce mosaic virus, Celery mosaic virus, Beet mosaic virus, Cucurbit chlorotic yellows virus, Capsicum chlorosis virus , Beet pseudo yellows virus, Leek yellow Leak yellow stripe virus, Onion yellow dwarf virus, Sweet potato feathery mottle virus, Sweet potato shukuyo mosaic virus, Strawberry mottle virus virus), Strawberry mild yellow edge virus, Strawberry pseudo mild yellow edge virus, Strawberry crinkle virus, Strawberry vein banding virus ), Plum pox virus, Chrysanthemum stem necrosis virus, Impatiens necrotic spot virus, Iris yellow spot virus, lily microscopic virus (Lily mottle virus), lily latent virus (Lilly symptomless virus), Tulip mosaic virus.

Examples of insect-borne bacteria include the following.
Rice yellow dwarf phytoplasma (Candidatus Phytoplasma oryzae), Candidatus Phytoplasma asteris, Maize bushy stunt phytoplasma, citrus greening fungus Asian type (Candidatus Liberbacter asiaticus), citrus greening fungus African type (Candidatus Liberbacter african disease) Type (Candidatus Liberbacter americanus) etc.

The present compound and the composition A also have a feeding damage suppressing effect, a repellent effect, an egg laying suppressing effect, an infertility effect, a next generation output suppressing effect, a mating behavior inhibitory effect, a molting inhibitory effect, and an emergence inhibitory effect. As a result, crops can be protected from damage by harmful arthropods such as harmful insects and harmful mites, harmful molluscs, and harmful nematodes.

  When composition A contains at least one component selected from group (b) or group (j) having fungicidal activity, fungi, fungi, omycete, and Phytomyxea ) And plant diseases caused by phytopathogenic microorganisms such as bacteria can be controlled. Examples of fungi include Ascomycota, Basidiomycota, Blasocladiomycota, Chytridiomycota, Mucoromycota and Olpidiomycota. Specific examples include the following. In parentheses are the scientific names of the phytopathogenic microorganisms that cause each disease.

Rice diseases: rice blast (Pyricularia oryzae), sesame leaf blight (Cochliobolus miyabeanus), blight (Rhizoctonia solani), idiot seedling (Gibberella fujikuroi), yellow dwarf (Sclerophthora macrospora), rice blast and Ear blight (Epicoccum nigrum), seedling blight (Trichoderma viride, Rhizopus oryzae);
Wheat diseases: powdery mildew (Blumeria graminis), red mold (Fusarium graminearum, Fusarium avenaceum, Fusarium culmorum, Microdochium nivale), yellow rust (Puccinia striiformis), black rust (Puccinia graminis), red rust (Puccinia redosis) ), Red snow rot (Microdochium nivale, Microdochium majus), snow rot microbe nuclear disease (Typhula incarnata, Typhula ishikariensis), naked smut (Ustilago tritici), magusa smut (Tilletia caries, Tilletia controversa), eye rot (Pseudocercosporella herpotrichoides), leaf blight (Septoria tritici), blight (Stagonospora nodorum), yellow spot (Pyrenophora tritici-repentis), Rhizoctonia spp. (Rhizoctonia solani), blight (Gaeumannomyces graminis) Rice blast (Pyricularia graminis-tritici);
Diseases of barley: powdery mildew (Blumeria graminis), red mold (Fusarium graminearum, Fusarium avenaceum, Fusarium culmorum, Microdochium nivale), yellow rust (Puccinia striiformis), black rust (Puccinia graminis), small scab (Puccinia) hordei), naked smut (Ustilago nuda), cloud disease (Rhynchosporium secalis), reticular disease (Pyrenophora teres), spot disease (Cochliobolus sativus), leaf disease (Pyrenophora graminea), lambaria leaf spot disease (Ramularia collo-cygni) ), Rhizoctonia solani (Rhizoctonia solani);
Corn diseases: rust (Puccinia sorghi), southern rust (Puccinia polysora), soot rot (Setosphaeria turcica), tropical rust (Physopella zeae), sesame leaf blight (Cochliobolus heterostrophus), anthracnose (Colletotrichum graminicola) ), Gray leaf spot disease (Cercospora zeae-maydis), brown spot disease (Kabatiella zeae), Faeosphaeria leaf spot disease (Phaeosphaeria maydis), Diplodia disease (Stenocarpella maydis, Stenocarpella macrospora), Stokelot disease (Fusarium graminearum, Fusarium verticilioides, Colletotrichum graminicola), smut (Ustilago maydis), Fusoderma disease (Physoderma maydis);
Cotton diseases: Anthracnose (Colletotrichum gossypii), mildew (Ramularia areola), black spot (Alternaria macrospora, Alternaria gossypii), Black root rot disease (Thielaviopsis basicola);
Coffee diseases: rust (Hemileia vastatrix), leaf spot (Cercospora coffeicola);
Rapeseed diseases: Sclerotinia sclerotiorum, black spot disease (Alternaria brassicae), root rot disease (Phoma lingam), light leaf spot disease (Pyrenopeziza brassicae);
Diseases of sugarcane: rust (Puccinia melanocephela, Puccinia kuehnii), smut (Ustilago scitaminea);
Sunflower diseases: rust (Puccinia helianthi), downy mildew (Plasmopara halstedii);
Diseases of Citrus: Black spot (Diaporthe citri), common scab (Elsinoe fawcetti), green mold (Penicillium digitatum), blue mold (Penicillium italicum), plague (Phytophthora parasitica, Phytophthora citrophthora), mildew (Aspergillus niger) ;
Apple diseases: Monilinia mali, rot (Valsa ceratosperma), powdery mildew (Podosphaera leucotricha), spotted leaf (Alternaria alternata apple pathotype), black rot (Venturia inaequalis), anthracnose (Glomerella triculata, lem) acutatum), brown spot disease (Diplocarpon mali), ringworm disease (Botryosphaeria berengeriana), plague (Phytophtora cactorum), red star disease (Gymnosporangium juniperi-virginianae, Gymnosporangium yamadae);
Pear diseases: black spot disease (Venturia nashicola, Venturia pirina), black spot disease (Alternaria alternata Japanese pear pathotype), red star disease (Gymnosporangium haraeanum);
Peach diseases: Monilinia fructicola, black scab (Cladosporium carpophilum), homopsis spoil (Phomopsis sp.), Leaf curl (Taphrina deformans);
Grape diseases: black rot (Elsinoe ampelina), late rot (Glomerella cingulata, Colletotrichum acutatum), powdery mildew (Uncinula necator), rust (Phakopsora ampelopsidis), black lot (Guignardia bidwellii), downy mildew ( Plasmopara viticola);
Oyster diseases: Anthracnose (Gloeosporium kaki, Colletotrichum acutatum), deciduous disease (Cercospora kaki, Mycosphaerella nawae);
Diseases of cucurbits: Anthracnose (Colletotrichum lagenarium), powdery mildew (Sphaerotheca fuliginea), vine blight (Didymella bryoniae), brown spot (Corynespora cassiicola), vine split (Fusarium oxysporum), downy mildew (Pseudoperonospora cube) ), Plague (Phytophthora capsici), seedling blight (Pythium sp.);
Tomato diseases: Alternaria solani, leaf mold (Cladosporium fulvum), mold fungus (Pseudocercospora fuligena), plague (Phytophthora infestans), powdery mildew (Leveillula taurica);
Eggplant diseases: brown spot disease (Phomopsis vexans), powdery mildew (Erysiphe cichoracearum);
Diseases of cruciferous vegetables: black spot disease (Alternaria japonica), white spot disease (Cercosporella brassicae), clubroot (Plasmodiophora brassicae), downy mildew (Peronospora parasitica), white rust (Albugo candida);
Leek disease: rust (Puccinia allii);
Diseases of soybean: Purpura (Cercospora kikuchii), black scab (Elsinoe glycines), black spot (Diaporthe phaseolorum var. Sojae), rust (Phakopsora pachyrhizi), brown rot (Corynespora cassiicola), anthracnose (Colletotrichum glyce , Colletotrichum truncatum, leaf rot (Rhizoctonia solani), brown spot (Septoria glycines), spot disease (Cercospora sojina), mycorrhizal disease (Sclerotinia sclerotiorum), powdery mildew (Microsphaera diffusa), stem rot (Phytophthora sojae) Downy mildew (Peronospora manshurica), sudden death (Fusarium virguliforme), black root rot (Calonectria ilicicola), Diaporthe / Phomopsis complex (Diaporthe longicolla);
Kidney diseases: Sclerotinia sclerotiorum, rust (Uromyces appendiculatus), horn spot (Phaeoisariopsis griseola), anthrax (Colletotrichum lindemuthianum), root rot (Fusarium solani);
Peanut diseases: black astringency (Cercospora personata), brown spot (Cercospora arachidicola), white silkworm (Sclerotium rolfsii), black root rot (Calonectria ilicicola);
Pea diseases: powdery mildew (Erysiphe pisi), root rot (Fusarium solani);
Potato diseases: Summer plague (Alternaria solani), plague (Phytophthora infestans), scarlet rot (Phytophthora erythroseptica), powdery scab (Spongospora subterranea f. Sp. Subterranea), half body wilt (Verticillium albo-atrum, Verticillium) dahliae, Verticillium nigrescens), dry rot (Fusarium solani), carcinoma (Synchytrium endobioticum);
Strawberry disease: powdery mildew (Sphaerotheca humuli);
Tea diseases: net rot (Exobasidium reticulatum), white spot (Elsinoe leucospila), ring spot (Pestalotiopsis sp.), Anthracnose (Colletotrichum theae-sinensis);
Tobacco diseases: Alternaria longipes, anthracnose (Colletotrichum tabacum), downy mildew (Peronospora tabacina), plague (Phytophthora nicotianae);
Sugar beet diseases: brown spot (Cercospora beticola), leaf rot (Thanatephorus cucumeris), root rot (Thanatephorus cucumeris), black root (Aphanomyces cochlioides), rust (Uromyces betae);
Rose disease: black spot (Diplocarpon rosae), powdery mildew (Sphaerotheca pannosa); chrysanthemum disease: brown spot (Septoria chrysanthemi-indici), white rust (Puccinia horiana);
Onion diseases: white leaf blight (Botrytis cinerea, Botrytis byssoidea, Botrytis squamosa), gray rot (Botrytis allii), sclerotia rot (Botrytis squamosa); various crop diseases: gray mold (Botrytis cinerea ), Mycorrhizal disease (Sclerotinia sclerotiorum), seedling blight (Pythium aphanidermatum, Pythium irregulare, Pythium ultimum);
Radish disease: Black spot disease (Alternaria brassicicola);
Diseases of Shiba: Dollar spot disease (Sclerotinia homoeocarpa), Brown patch disease, Rhizoctonia solani, Red burn disease (Pythium aphanidermatum);
Banana disease: Sigatoka disease (Mycosphaerella fijiensis, Mycosphaerella musicola);
Disease of lentils: Ascochyta disease (Ascochyta lentis);
Chickpea disease: Ascochyta disease (Ascochyta rabiei);
Green pepper disease: Colletotrichum scovillei;
Mango disease: Anthracnose (Colletotrichum acutatum);
Fruit tree diseases: white rot (Rosellinia necatrix), purple rot (Helicobasidium mompa);
Diseases of fruits such as apples and pears after harvesting: Mucor piriformis; Aspergillus genus, Penicillium genus, Fusarium genus, Gibberella genus, Tricoderma genus, Thielaviopsis genus, Rhizopus genus, Mucor genus, Corticium genus, Phoma genus, Seed diseases caused by Rhizoctonia, Diplodia, etc.
Viral disease: lettuce big bean disease mediated by Olpidium brassicae, viral diseases of various crops mediated by Polymyxa genus (eg, Polymyxa betae and Polymyxa graminis);
Diseases caused by bacteria (Burkholderia plantarii), cucumber spotted bacterial disease (Pseudomonas syringae pv. Lachrymans), eggplant bacterial wilt (Ralstonia solanacearum), citrus scab (Xanthomonas citri) ), Soft rot of Chinese cabbage (Erwinia carotovora), potato scab (Streptomyces scabiei), corn Goss's wilt disease (Clavibacter michiganensis), grapes, olives, peach and other piercing diseases (Xylella fastidiosa), apples, peaches, cherries Agrobacterium tumefaciens of rose family plants such as.

  For the above-mentioned phytopathogenic microorganisms, the variation within the species is not particularly limited. That is, it includes those having reduced sensitivity (also referred to as resistance) to a specific fungicide. The decrease in sensitivity may be due to a mutation at the target site (point of action mutation) or may be due to a factor that is not a point of action mutation (non-point of action mutation). With regard to the action point mutation, a mutation in the nucleic acid sequence portion (open reading frame) corresponding to the amino acid sequence of the protein caused amino acid substitution in the target protein, deletion of the suppressor sequence in the promoter region, or enhancer Those in which the protein at the target site is overexpressed due to mutation such as amplification of the sequence or increase in the copy number of the gene are included. Non-acting point mutations include, for example, enhancement of the excretory function of discharging the bactericide that has flowed into the cell out of the cell by ABC transporter, MFS transporter or the like. Moreover, detoxification by metabolism of a bactericide is also mentioned.

  Examples of the specific fungicide include, for example, nucleic acid synthesis inhibitors (eg, phenylamide fungicides, acylamino acid fungicides, DNA topoisomerase type II fungicides), mitosis and cell division inhibitors (eg, MBC fungicides, N-phenyl carbamate fungicides), respiratory inhibitors (eg, QoI fungicides, QiI fungicides, SDHI fungicides), amino acid synthesis and protein synthesis inhibitors (eg, anilinopyrimidine fungicides), Signaling inhibitors (eg, phenylpyrrole fungicides, dicarboximide fungicides), lipid synthesis and cell membrane synthesis inhibitors (eg, phosphorothiolate fungicides, dithiolane fungicides, aromatic hydrocarbon fungicides, Heteroaromatic fungicides, carbamate fungicides), sterol biosynthesis inhibitors (eg triazole-based DM, etc.) Fungicides, hydroxyanilide fungicides, aminopyrazolinone fungicides), cell wall synthesis inhibitors (eg, polyoxin fungicides, carboxylic acid amide fungicides), melanin synthesis inhibitors (eg, MBI-R fungicides) , MBI-D fungicides, MBI-P fungicides), and other fungicides (for example, cyanoacetamidooxime fungicides, phenylacetamide fungicides).

Examples of the amino acid substitution at the target site include the following.
Cytochrome b: G143A, F129L or G137R;
Cyp51 protein includes A311G, A379G, A381G, A410T, A61V, D107V, D134G, D282E, D411N, E297K, F120L, F219S, F449S, F489L, F495I, G138C / R / S, G312A, G412A, G432S, G434C, G448S, G434C, G448S / Δ, G462A, G464S, G484S, G510C, G54E / K / R / V / W, G54W, H147Y, H303Y, H399P, I145F, I330T, I381V / Δ, I471T, I475T, K142R, K143E, K147Q, K175N, K197N , L50S, L98H, M145L, M220K / I / T / V, M288L, N125I, N178S, N22D, N284H, N513K, P216L, P384S, P394L, Q141H, Q88H, R467K, S188N, S208T, S297T, S405F, S508T, S509T , S524T, S52T, S79T, T289A, T440A, T454P, T469S, V101F, V136A / C / G, V490L, Y121F, Y131F / H, Y132F / H / N, Y134F, Y134F, Y136F, Y137F, Y140F / H, Y145F Y431C, Y459C / D / N / S / P / Δ, Y461D, Y461D / H / S, Y463D / H / N, Y491H or Y68N;
β-tubulin: H6L / Y, Y50C / N / S, Q134K, A165V, E198A / D / G / K / L / Q / V, F200Y, M257L, F200Y, F167Y, Q73R or L240F;
SdhB: H277R / Y, P225H / F / L / T, N230I, H272L / R / V / Y, H278Y / R, H249L / N / Y, H273Y, N225I / T, T268I / A, I269V, H242R, H257L or T253I;
SdhC: H134R, P80H / L, A85V, S73P, T90I, I86F, N88S, H154Y / R, K49E, R64K, N75S, G79R, S135R, N87S, H153R, H146R, I29V, N33T, N34T, T79I / N, W80S, A84V, N86K / S / A, G90R, R151T / S, H152R, I161S, G169D or H151R;
SdhD: H133R, H132R, S89P, G109V, D124E / N, H134R, G138V, D145G, I50F, M114V or D129E;
OS-1 (Shk1): E753K, G420D, I365N / R / S, V368F, Q369H / P, N373S, T447S, F267L, L290S, T765R, Q777R, T489I, E599K or G736Y;
ERG27: S9G, F26S, P57A, T63I, G170R, V192I, L195F, N196T, A210G, I232M, P238S / Δ, P250S, P269L, P298Δ, V309M, A314V, S336C, V365A, E368D, N369D, E375K, A378T, L400F S, Y408S, F412I / S / V / C, A461S or R496T.

Moreover, the following are mentioned as a phytopathogenic microorganism and its host plant in which the sensitivity with respect to the fungicide fell by overexpressing Cyp51 gene. Septoria tritici in wheat (reference: Pest Management Science. 2012. 68 (7) .1034-1040), Rhynchosporium secalis in barley (reference: Molecular Bilogy and Evolution. 2014. 31 (7) .1793-1802) Phakopsora pachyrhizi (Reference: Pest Management Science. 2014. 70 (3) .37
8-388), Venturia inaequalis of apple (reference: Phytopathology. 2016. 106 (6) .562-571), Penicillium digitatum of citrus (reference: Applied and Environmental Microbiology. 2000. 66 (8) .3421-3426 ).

  The phytopathogenic microorganism that can be controlled by the composition B containing one or more components having bactericidal activity selected from the group (b) or the group (j) as this component has a plurality of the amino acid substitutions described above. May be. In this case, the plurality of amino acid substitutions may be the same protein or different proteins. Moreover, you may have two or more non-action point mutations or action point mutations. For example, a phytopathogenic microorganism that causes amino acid substitutions of G143A, F129L and G137R in cytochrome b; a phytopathogenic microorganism having an amino acid substitution of G143A in cytochrome b and an amino acid substitution of A311G in Cyp51; G143A in cytochrome b; Phytopathogenic microorganisms with F129L amino acid substitution and Cyp51 with A311G amino acid substitution; cytochrome b with G143A and F129L amino acid substitutions and β-tubulin with H6L / Y amino acid substitutions Furthermore, phytopathogenic microorganisms overexpressing the Cyp51 gene.

Examples of phytopathogenic microorganisms having an action point mutation include the following. Alternaria alternata having an amino acid substitution of G143A in cytochrome b;
Alternaria arborescens having an amino acid substitution of G143A in cytochrome b;
Alternaria solani having an amino acid substitution of F129L in cytochrome b;
Alternaria tomato having an amino acid substitution of G143A in cytochrome b;
Botryotinia fuckeliana having an amino acid substitution of G143A in cytochrome b;
Glomerella graminicola having an amino acid substitution of G143A in cytochrome b;
Corynespora cassiicola having an amino acid substitution of G143A in cytochrome b;
Cercospora beticola having an amino acid substitution of G143A in cytochrome b;
Cercospora sojina having an amino acid substitution of G143A in cytochrome b;
Cladsporium carpophilum having an amino acid substitution of G143A in cytochrome b;
Colletotrichum graminicola having an amino acid substitution of G143A in cytochrome b;
Glomerella cingulata having an amino acid substitution of G143A in cytochrome b;
Blumeria graminis f. Sp. Hordei having an amino acid substitution of G143A in cytochrome b;
Blumeria graminis f. Sp. Tritici having an amino acid substitution of G143A in cytochrome b;
Parastagonospora nodorum having an amino acid substitution of G143A in cytochrome b;
Monographella nivalis having an amino acid substitution of G143A in cytochrome b;
Microdochium majus, nivale with an amino acid substitution of G143A in cytochrome b;
Mycosphaerella fijiensis having an amino acid substitution of G143A in cytochrome b;
Didymella rabiei having an amino acid substitution of G143A in cytochrome b;
Phakopsora pachyrhizi with an amino acid substitution of F129L in cytochrome b;
Plasmopara viticola having an amino acid substitution of F129L or G143A in cytochrome b;
Pleospora allii having an amino acid substitution of G143A in cytochrome b;
Podosphaera fusca having an amino acid substitution of G143A in cytochrome b;
Podosphaera xanthii having an amino acid substitution of G143A in cytochrome b;
Pseudoperonospora cubensis having an amino acid substitution of G143A in cytochrome b;
Magnaporthe oryzae having an amino acid substitution of F129L or G143A in cytochrome b;
Pyrenophora teres with F129L amino acid substitution in cytochrome b;
Pyrenophora tritici-repentis having an amino acid substitution of F129L, G137R or G143A in cytochrome b;
Pythium aphanidermatum having an amino acid substitution of F129L in cytochrome b;
Thanatephorus cucumeris having an amino acid substitution of F129L or G143A in cytochrome b;
Ramularia collo-cygni having an amino acid substitution of G143A in cytochrome b;
Rhynchosporium secalis with an amino acid substitution of G143A in cytochrome b;
Rhizoctonia solani having an amino acid substitution of F129L in cytochrome b;
Zymoseptoria tritici having amino acid substitution of F129L, G137R or G143A in cytochrome b;
Erysiphe necator having an amino acid substitution of G143A in cytochrome b;
Venturia inaequalis having an amino acid substitution of G143A in cytochrome b;
Ajellomyces capsulatus having an amino acid substitution of Y136F in Cyp51;
Aspergillus flavus having amino acid substitution of Y132N, K197N, D282E, M288L, T469S, H399P, D411N or T454P in Cyp51;
Cyp51 to N22D, S52T, G54E / K / R / V / W, Y68N, Q88H, L98H, V101F, Y121F, N125I, G138C / R / S, Q141H, H147Y, P216L, F219S, M220K / I / T / V, Aspergillus fumigatus having an amino acid substitution of T289A, S297T, P394L, Y431C, G432S, G434C, T440A, G448S, Y491H or F495I;
Aspergillus parasiticus having an amino acid substitution of G54W in Cyp51;
Cypida albicans having an amino acid substitution of A61V, Y132F / H, K143E, S405F, F449S, G464S, R467K or I471T in Cyp51;
Cercospora beticola having an amino acid substitution of E297K, I330T or P384S in Cyp51;
Blumeria graminis f. Sp. Hordei having an amino acid substitution of Y136F, K147Q or S509T in Cyp51;
Blumeria graminis f. Sp. Tritici having an amino acid substitution of C79 with S79T, Y136F, or K175N;
Filobaidiella neoformans having an amino acid substitution of Y145F or G484S in Cyp51;
Monilinia fructicola having an amino acid substitution of Y136F in Cyp51,
Mycosphaerella fijiensis having an amino acid substitution of Y136F, A313G, A381G, Y461D, G462A or Y463D / H / N in Cyp51;
Phakopsora pachyrhizi having an amino acid substitution of F120L, Y131F / H, K142R, I145F or I475T in Cyp51;
Puccinia triticina with Y134F amino acid substitution in Cyp51;
Pyrenophora teres with F489L amino acid substitution in Cyp51;
Pyrenopeziza brassicae having an amino acid substitution of S508T in Cyp51;
Saccharomyces cerevisiae having an amino acid substitution of Y140F / H in Cyp51;
Cyp51 to L50S, D107V, D134G, V136A / C / G, Y137F, M145L, N178S, S188N, S208T, N284H, H303Y, A311G, G312A, A379G, I381V / Δ, A410T, G412A, Y459C / D / N / S / Zymoseptoria tritici with amino acid substitutions of P / Δ, G460D / Δ, Y461D / H / S, V490L, G510C, N513K or S524T (;
Erysiphe necator having an amino acid substitution of Y136F in Cyp51;
Emericella nidulans having an amino acid substitution of H6L / Y, Y50N / S, Q134K, A165V, E198D / K / Q, F200Y or M257L in β-tubulin;
Botryotinia fuckeliana having an amino acid substitution of E198A / G / K / V or F200Y in β-tubulin;
Cochliobolus heterostrophus having an amino acid substitution of F167Y in β-tubulin;
Cercospora beticola having an amino acid substitution of F167Y or E198A in β-tubulin;
Gibberella fujikuroi having an amino acid substitution of Y50N, E198V or F200Y in β-tubulin;
Gibberella zeae having an amino acid substitution of Y50C, Q73R, F167Y, E198K / L / Q or F200Y in β-tubulin;
Helminthosporium solani with an amino acid substitution of E198A / Q in β-tubulin;
Hypomyces odoratus having an amino acid substitution of Y50C in β-tubulin;
Parastagonospora nodorum with amino acid substitution of H6Y in β-tubulin;
Monilinia fructicola having an amino acid substitution of H6Y or E198A / K in β-tubulin;
Monilinia laxa having an amino acid substitution of L240F in β-tubulin;
Microdochium majus, nivale with an amino acid substitution of E198A in β-tubulin;
Mycosphaerella fijiensis with an amino acid substitution of E198A in β-tubulin;
Neurospora crassa having an amino acid substitution of F167Y or E198G in β-tubulin;
Penicillium aurantiogriseum having an amino acid substitution of E198A / K or F200Y in β-tubulin;
Penicillium expansum having an amino acid substitution of F167Y or E198A / K / V on β-tubulin;
Penicillium italicum having an amino acid substitution of E198K or F200Y in β-tubulin;
Pyrenopeziza brassicae with L240F amino acid substitution in β-tubulin;
Rhynchosporium secalis with an amino acid substitution of E198G / K or F200Y in β-tubulin;
Sclerotinia homoeocarpa with E198A / K amino acid substitution in β-tubulin;
Sclerotinia sclerotiorum having an amino acid substitution of E198A in β-tubulin;
Zymoseptoria tritici with an amino acid substitution of E198A / G in β-tubulin;
Venturia inaequalis having an amino acid substitution of E198A / K, F200Y or L240F in β-tubulin;
Alternaria alternata having an amino acid substitution of H277R / Y in SdhB;
Alternaria solani having an amino acid substitution of H277R / Y in SdhB,
Botryotinia fuckeliana having an amino acid substitution of P225H / F / L / T, N230I or H272L / R / V / Y in SdhB;
Corynespora cassiicola with H278Y / R amino acid substitution in SdhB;
Stagonosporopsis cucurbitacearum having an amino acid substitution of H277R / Y in SdhB;
Eurotium oryzae having an amino acid substitution of H249L / N / Y in SdhB;
Pyrenophora teres with H277Y amino acid substitution in SdhB;
Sclerotinia sclerotiorum having an amino acid substitution of H273Y in SdhB;
Zymoseptoria tritici having an amino acid substitution of N225I / T, H273Y, T268I / A or I269V in SdhB;
Erysiphe necator having an amino acid substitution of H242R in SdhB;
Ustilago maydis having an amino acid substitution of H257L in SdhB;
Venturia inaequalis with T253I amino acid substitution in SdhB;
Alternaria alternata having an amino acid substitution of H134R in SdhC;
Botryotinia fuckeliana with P80H / L or A85V amino acid substitution in SdhC;
Corynespora cassiicola having S73P amino acid substitution in SdhC;
Eurotium oryzae with T90I amino acid substitution in SdhC;
Phakopsora pachyrhizi having an amino acid substitution of I86F, N88S or H154Y / R in SdhC;
Pyrenophora teres having an amino acid substitution of K49E, R64K, N75S, G79R, H134R or S135R in SdhC;
Ramularia collo-cygni having an amino acid substitution of N87S, H146R or H153R in SdhC;
Sclerotinia sclerotiorum having an amino acid substitution of H146R in SdhC;
Zymoseptoria tritici having an amino acid substitution of I29V, N33T, N34T, T79I / N, W80S, A84V, N86K / S / A, G90R, R151T / S, H152R or I161S in SdhC;
Erysiphe necator having an amino acid substitution of G169D in SdhC;
Venturia inaequalis having an amino acid substitution of H151R in SdhC;
Alternaria alternata having an amino acid substitution of H133R in SdhD;
Alternaria solani having an amino acid substitution of H133R in SdhD;
Botryotinia fuckeliana with H132R amino acid substitution in SdhD;
Corynespora cassiicola having S89P or G109V amino acid substitution in SdhD;
Eurotium oryzae with D124E amino acid substitution in SdhD;
Pyrenophora teres having an amino acid substitution of D124E / N, H134R, G138V or D145G in SdhD;
Sclerotinia sclerotiorum having an amino acid substitution of H132R in SdhD;
Zymoseptoria tritici having an amino acid substitution of I50F, M114V or D129E in SdhD;
Phytophthora capsici with Q1077K or V1109L / M amino acid substitution in CesA3;
Phethophthora drechsleri with V1109L amino acid substitution in CesA3;
Phethophthora infestans having G1105A / V or V1109L amino acid substitution in CesA3;
Plasmopara viticola with G1105S / V amino acid substitution in CesA3;
Pseudoperonospora cubensis having an amino acid substitution of G1105V / W in CesA3;
Alternaria brassicicola with E753K amino acid substitution in OS-1 (Shk1);
Alternaria longipes with G420D amino acid substitution in OS-1 (Shk1);
Botryotinia fuckeliana having an amino acid substitution of I365N / R / S, V368F, Q369H / P, N373S or T447S in OS-1 (Shk1);
Pleospora allii having an amino acid substitution of F267L, L290S, T765R or Q777R in OS-1 (Shk1);
Sclerotinia sclerotiorum having an amino acid substitution of T489I, E599 K or G736Y in OS-1 (Shk1);
ERG27 to S9G, F26S, P57A, T63I, G170R, V192I, L195F, N196T, A210G, I232M, P238S / Δ, P250S, P269L, P298Δ, V309M, A314V, S336C, V365A, E368D, N369D, E375K, A378T, L400F Botryotinia fuckeliana having an amino acid substitution of S, Y408S, F412I / S / V / C, A461S or R496T.

  Zymoseptoria tritic means the same species as Septoria tritici.

  This compound or composition A can also be used against fungal diseases that occur on or inside timber. “Timber” means all types of wood; and wood processed for construction (eg, high-density wood, laminated wood and plywood). Examples of the method of treating timber with the present compound or composition A include a method of bringing the present compound or composition A into contact with timber, and examples of the contact include direct application, spraying, dipping, and pouring. It is done.

  The composition A can also control weeds when the component includes one or more components selected from the group (i) or the group (j) having a herbicidal activity. The weed in the present invention means a plant whose growth is not desirable in the place. Examples of weeds include the following.

Nettic Weed (Urticaceae): Urtica urens
Polygonaceae: Polygonum convolvulus, Polygonum lapathifolium, Polygonum pensylvanicum, Polygonum persicaria, Polygonum alist, Polygonum longisetum, Polygonum longisetum, Polygonum longisetum, , Polygonum cuspidatum, Ripex japonicus, Ragex crispus, Rumex obtusifolius, Sorrel (Rumex acetosa)
Physalis Weed (Portulacaceae): Physalis (Portulaca oleracea)
Caryophyllaceae: Stellaria media, Stellaria aquatica, Cerastium holosteoides, Cerastium glomeratum, Spergula arvensis, Mannema (Silene gallica)
Pomegranate Weed (Molluginaceae): Mollugo verticillata
Chiropodiaceae: Chenopodium album, Chenopodium ambrosioides, Kochia scoparia, Salalah kali, Atriplex spp.

Amaranthaceae: Amaranthus retroflexus, Amaranthus viridis, Amaranthus lividus, Amaranthus spinosus, Amaranthus hybridus, Amaranthus hybridus, Palm Amaranthus patulus, water hemp (Amaranthus tuberculatus = Amaranthus rudis = Amaranthus tamariscinus), American marsh (Amaranthus blitoides), Amaranthus deflexus, Amaranthus quatersis (Amaranthus quitentern), Algae phil ), Sanguinaria (Alternanthera tenella)
Poppyaceae: Papaver rhoeas, Papaver dubium, Argemone mexicana
Brassicaceae: Japanese radish (Raphanus raphanistrum), radish (Raphanus sativus), Noragarashi (Sinapis arvensis), Nazuna (Capsella bursa-pastoris), Brassica juncea, Brassica napus (Brassica napus), Brassica napus (Descurainia pinnata), Red-tailed burdock (Rorippa islandica), Red-tailed pebbles (Rorippa sylvestris), Gambina (Thlaspi arvense), Miyagashi (Myagrum rugosum), Laridium virginicum, mus or pus
Capparaceae: Cleome affinis

Legaceae weeds (Fabaceae): Aeschynomene indica, zigzag joint bech (Aeschynomene rudis), Sesbania exaltata, Ebusa (Cassia obtusifolia), Cassia occidentalis, Desmogi (Desmo) adscendens, Desmodium illinoense, White clover (Trifolium repens), Kudu (Pueraria lobata), Vicia angustifolia, Raccoon peas (Indigofera hirsuta), Indigofera truxensis (Indigofera) Vigna sinensis)
Oxalidaceae: Oxalis corniculata, Oxalis stricta, Oxalis oxyptera
Geraniaceae: American caroline (Geranium carolinense), Dutch flower (Erodium cicutarium)
Euphorbiaceae: Euphorbia helioscopia, Euphorbia maculata, Euphorbia humistrata, Euphorbia esula, Euphorbia heterophyll, Euphorbia heterophyll (Acalypha australis), Tropic grotulos, Croton lobatus, Phyllanthus corcovadensis, Ricinus communis

Malvaceae: Abutilon theophrasti, Sida rhombifolia, Sida cordifolia, Sida spinosa, Sida glaziovii, Sida santaremnsis ), Ginseng (Hibiscus trionum), Carp (Anoda cristata), Carp (Malvastrum coromandelianum)
Onagraceae: Ludwigia epilobioides, Ludwigia octovalvis, Ludwigia decurre, Oenothera biennis, Oenothera laciniata
Aceraceae weed (Sterculiaceae): Waltheria indica
Violaceae: Makibasmille (Viola arvensis), Wild pansy (Viola tricolor)
Cucurbitaceae: Areciuri (Sicyos angulatus), wild cucumber (Echinocystis lobata), wild bitter gourd (Momordica charantia)
Lythraceae: Ammannia multiflora, Ammannia auriculata, Ammannia coccinea, Lythrum salicaria, Rotala indica
Elephantaceae (Elatinaceae): Elephant triandra, California water wort (Elatine californica)

Apiaceae: Seri (Oenanthe javanica), Nolanin (Daucus carota), Dungin (Conium maculatum)
Araliaceae: Hydrocotyle sibthorpioides, Brazilian Hydrocotyle ranunculoides
Ceratoophyllaceae: Matsumoto (Ceratophyllum demersum)
Cabombaceae: Cabomba caroliniana
Haloragaceae: Myrophyllum aquaticum, Fusamo (Myriophyllum verticillatum), Watermilfoil (Myriophyllum spicatum, Myriophyllum heterophyllum, etc.)
Sapindaceae: Cardiospermum halicacabum
Primulalaceae: Anagallis arvensis
Asperpiadaceae: Milkweed (Asclepias syriaca), Honey Vine Milkweed (Ampelamus albidus)
Rubiaceae: Catchweed Bed Straw (Galium aparine), Yamgra (Galium spurium var. Echinospermon), Spermacoce latifolia, Brazilian Brasiliensis, Wingdphalus buttonweed (Borreria alba)

Convolvulaceae: Japanese morning glory (Ipomoea nil), American morning glory (Ipomoea hederacea), Marva morning glory (Ipomoea purpurea), Malba American morning glory (Ipomoea hederacea var. , Ipomoea acuminata, Ipomoea hederifolia, Malbarco (Ipomoea coccinea), Ipomoea quamoclit, Ipomoea grandifolia (Ipomoea grandifolia), Ipomoea grandifolia , Convolvulus arvensis, Convolvulus arvensis, Calystegia hederacea, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis, Convolvulus arvensis mia cissoides), Jacquemontia tamnifolia
Purple weed (Boraginaceae): Forget-me-not (Myosotis arvensis)
Lamiaceae: Laury purpureum, Lamium amplexicaule, Leonotis nepetaefolia, Hyptis suarolsis (Hyptis loventa), Hyptis lophanta

Solanaceae: Datura stramonium, Solanum nigrum, Solanum americanum, Solanum ptycanthum, Solanum sarrachoum Solanum strata , Goldfish (Solanum aculeatissimum), wild tomato (Solanum sisymbriifolium), walnasbi (Solanum carolinense), physalis angulata, smooth ground cherry (Physalis subglabrata), osennari (Nicandra physalodes)
Scrophulariaceae: Veronica hederaefolia, Veronica persica, Veronica arvensis, Azena (Lindernia procumbens), American azena (Lindernia dubia), Alistia rot (Dopatrium junceum), Giant Abnomome (Gratiola japonica),
Plantaginaceae: Plantago asiatica, Plantago lanceolata, Plantago major, Callitriche palustris

  Asteraceae: Xanthium pensylvanicum, Xanthium occidentale, Xanthium italicum, wild sunflower (Helianthus annuus), chamomile (Matricaria chamomilla), dogwood forumata (Matricaria perumata) ), Otricha matricarioides, Artemisia princeps, Artemisia vulgaris, Chinese mugwort (Artemisia verlotorum), Solidago altissima, Solida altissima, Taraxacum officinga (Galinsoga parviflora), Sorgio vulgaris, Senecio brasiliensis, Senecio grisebachii, Conyza bonariensis, Giant cricket (C) onyza smatrensis), Conyza canadensis, Ragweed (Ambrosia artemisiifolia), Ambrosia trifida, Bidens tripartita, Bidens pilosa, Bidens frondo (Bidens frondo) Spring thistle (Cirsium arvense), American thistle (Cirsium vulgare), Maria thistle (Silybum marianum), Musk thistle (Carduus nutans), Skeletia (Lactuca serriola), Nogeshi (Sonchus oleraceus), Onchose asper (Sonchus asper) Wedelia glauca, Perforate black foot (Melampodium perfoliatum), Emilia sonchifolia, Tagetes minuta, Blainvillea latifolia, Tridax procumbens, Yerba po Porophyllum ruderale, Paraguay star bar (Acanthospermum australe), Bristol star bar (Acanthospermum hispidum), Cardiospermum halicacabum, Cuckoo thistle (Ageratum conyzoides), Common bone set (Eupatorium perfta), Eupatorium perfta , Dendborogiku (Erechtites hieracifolia), American Everlasting (Gamochaeta spicata), Vinelet Pichigusa (Gnaphalium spicatum), Jagelia Hitera (Jaegeria hirta), Sesame (Parthenium hysterophorus), Menamomi (Siegesbeckia or Seriskin serikins) Takasaburo (Eclipta prostrata), American Takasaburo (Eclipta alba), Tokinsou (Centipeda minima),

Osidaceae weeds (Alismataceae): Urikawa (Sagittaria pygmaea), Omodaka (Sagittaria trifolia), Omodaka (Sagittaria sagittifolia), Tilin Omodaka (Sagittaria montevidensis), Aginashi (Sagittaria aginashi), Tulum aquatica)
Limnocharitaceae: Limnocharis flava
Hydrocharitaceae: Frogbit (Limnobium spongia), Black spider (Hydrilla verticillata), Common water nymph (Najas guadalupensis)
Araceae: Button duckweed (Pistia stratiotes)
Duckweed (Lemnaceae): Lemna aoukikusa, Spirodela polyrhiza, Daphnia (Wolffia spp)
Potato getonaceae: Potato geton distinctus, pondweeds (Potamogeton crispus, Potamogeton illinoensis, Stuckenia pectinata, etc.)
Liliaceae: Wild Onion (Allium canadense), Wild Garlic (Allium vineale), Nobil (Allium macrostemon)
Weeping mallow weeds: water hyacinth (Eichhornia crassipes), American oak (Heteranthera limosa), Mizouroi (Monochoria korsakowii), oak (Monochoria vaginalis)
Commelinaceae: Commelina communis, Compositina benghalensis, Electday flower (Commelina erecta), Murdannia keisak

  Poaceae: Echinochloa crus-galli, Echinochloa oryzicola, Echinochloa crus-galli var formosensis, Late watergrass (Echinochloa oryzoides), Echiochloa colonies (Echinochloa colonies) Echinochloa crus-pavonis), Enocorogusa (Setaria viridis), Akinoenokorogusa (Setaria faberi), Echinocholo (Setaria glauca), American Enocorosa (Setaria geniculata), Meishiba (Digitaria ciliaris), Large Crabgrass (Digitaria sanguinalis) Digitaria horizontalis, Gigitaria insularis, Eleusine indica, Poa annua, Poa trivialis, Poa pratensis, Alocurus aequalis, Alopecurus aequalis pecurus myosuroides, Avena fatua, Sorghum halepense, Sorghum vulgare, Agropyron repens, Lolium multiflorum, Lolium perenne, Boar, Lolium rigid Bromus catharticus, Bromus sterilis, Bromus japonicus, Bromus secalinus, Bromus tectorum, Hordeum jubatum, Adeilops lins, Aegilops lin Pepper (Phalaris minor), Silky bentgrass (Apera spica-venti), Prickly millet (Panicum dichotomiflorum), Texas panicum (Panicum texanum), Panaxcum (Panicum maximum), Meriken prickly millet (Brachiaria platyphylla), Rugegrass en (Brachiaria ruzi) , Alexandergrass (Brachiaria plantaginea), Surinamegrass (Brachiaria decumbens), Palisadegrass (Brachiaria brizantha), Colombiagrass (Brachiaria humidicola), Cinchrus echinatus, Cenchrus pauciflorus, Narcobienise (Eriochloatum) setosum), African Beard (Chloris gayana), Bearded Sheep (Chlorisvirgata), Elephrostis pilosa, Rhynchelytrum repens, Seaweed (Dactyloctenium aegyptium), Ischaemum rugo (Ischaemum rugo) Oryza sativa), American spider (Paspalum notatum), coastal sand paspalm (Paspalum maritimum), Kyushu genus (Paspalum distichum), Kennyugrass (Pennisetum clandestinum), Hosobachikara Pennisetum setosum, Rottboellia cochinchinensis, Leptochloa chinensis, Leptochloa fascicularis, Leptochloa filiformis, Lepuscheria leuka, Leptochaia pug , Leersia oryzoides, Glyceria leptorrhiza, Glyceria acutiflora, Glyceria maxima, Agrostis gigantea, Agrostis glontea, Agrostis glontea , Eremochloa ophiuroides, Festuca arundinacea, Festuca rubra, Imperata cylindrica, Miscanthus sinensis, Switchgrass (Panicum virgatum), Bas (Zoysia japonica)

Cyperaceae: Cyperus microiria, Cyperus iria, Cyperus compressus, Cyperus difformis, Cyperus flaccidus, cyperus flaccidus, Cyperus flaccidus (Cyperus odoratus), Cyperus serotinus, Jasper (Cyperus rotundus), Yellow-headed geese (Cyperus esculentus), Kyllinga gracillima, Ida-kug (Kyllinga brevifolia), Hiderico acicularis), Kurowai (Eleocharis kuroguwai), firefly (Schoenoplectiella hotarui), firefly (Schoenoplectiella juncoides), Taiwan Yamai (Schoenoplectiella wallichii), Schoenoplectiella mucronatus, kangaret (Schoenoplectiella triangulatus), pulp (Schoenoplectiella nipponicus), Sankakui (Schoenoplectiella triqueter), Koukiyagara (Bolboschoenus koshevnikovii), Ukiyagara (Bolboschoenus fluviatilis)
Equisetaceae: Equisetum arvense, Equisetum palustre
Salviniaceae: Salvinia natans
Azollaceae: Azolla japonica, Azolla imbricata
Marsileaceae: Marsilea quadrifolia
Others: filamentous algae (Pithophora, Cladophora), mosses, moss, hornworts, cyanobacteria, ferns, perennial crops (fruits, stones, berries, nuts, citrus, hops, grapes, etc.) Sucker.

  For the above weeds, the variation within the species is not particularly limited. In other words, those having reduced sensitivity to specific herbicides (also called resistance) are also included. The decrease in sensitivity may be due to a mutation at the target site (point of action mutation) or may be due to a factor that is not a point of action mutation (non-point of action mutation). As for the action point mutation, the amino acid substitution in the protein which is the target site due to the mutation of the nucleic acid sequence part (open reading frame) corresponding to the amino acid sequence of the protein, the deletion of the suppressor sequence in the promoter region, the enhancer sequence Those in which the protein at the target site is overexpressed due to mutation such as amplification of the gene or increase in the copy number of the gene. Non-acting point mutations include increased metabolism, malabsorption, migration failure, and out-of-system excretion. Factors that enhance metabolism include those in which the activity of metabolic enzymes such as cytochrome P450 monooxygenase, arylacylamidase, esterase, and glutathione S-transferase is increased. Extravasation includes transport to the vacuole by ABC transporters.

Examples of the amino acid substitution at the target site include the following.
ALS: A122T, A122V, A122Y, P197S, P197H, P197T, P197R, P197L, P197Q, P197A, P197I, A205V, A205F, D376E, R377H, W574L, W574G, W574M, S653T, S653N, S653I, G654E or G654D;
ACCase: I1781L, I1781V, I1781T, W1999C, W1999L, A2004V, W2027C, I2041N, I2041V, D2078G or C2088R, G2096R;
PPX2: G210Δ, R98L, R98M, R98G, R98H, G399A;
EPSP: T102I, P106S, P106A or P106L.

  The weeds that can be controlled by the composition B containing one or more components having herbicidal activity selected from the group (i) or the group (j) as this component may have a plurality of the above amino acid substitutions. . In this case, the plurality of amino acid substitutions may be the same protein or different proteins. Moreover, you may have two or more non-action point mutations or action point mutations.

Examples of weeds having an action point mutation include the following.
PPX2 has a G210Δ, R98M, R98G or G399A amino acid substitution;
Water hemp having amino acid substitution of G210Δ, R98M, R98G or G399A in PPX2;
Ragweed having an amino acid substitution of R98L in PPX2;
Botanus having an amino acid substitution of R98H in PPX2;
A cypress having an amino acid substitution of T102I, P106S, P106A or P106L in EPSP;
EPSP, Baumgi having an amino acid substitution of T102I, P106S, P106A or P106L;
Japanese squirrel with T102I, P106S, P106A or P106L amino acid substitution in EPSP;
Water hemp having an amino acid substitution of T102I, P106S, P106A or P106L in EPSP;
Copterfly having an amino acid substitution of T102I, P106S, P106A or P106L in EPSP.

  The above-mentioned euphorbiaceae, water hemp and ragweed to PPX2 are resistant to PPO inhibitors such as lactofen, fomesafen and flumioxazin.

Other weeds include the following.
Over-expressed EPSP gene that reduced sensitivity to glyphosate
Resistant wormwood mugwort, giant oleaginous moss, and retinoic moss with reduced sensitivity to glyphosate involving ABC transporters.

Hereinafter, although this invention is demonstrated in more detail by a manufacture example, a formulation example, a test example, etc., this invention is not limited only to these examples.
In the present specification, Me represents a methyl group, Et represents an ethyl group, Pr represents a propyl group, i-Pr represents an isopropyl group, Bu represents a butyl group, and c-Pr represents a cyclopropyl group. Ph represents a phenyl group, Py2 represents a 2-pyridyl group, Py3 represents a 3-pyridyl group, and Py4 represents a 4-pyridyl group. When c-Pr, Ph, Py2, Py3, and Py4 have a substituent, the substituent is described together with the substitution position before the symbol. For example, 1-CN-c-Pr represents a 1-cyanocyclopropyl group, 4-CF ₃ -Py2 represents a 4- (trifluoromethyl) -2-pyridyl group, and 3,5- (CF ₃ ) ₂ -Ph represents a 3,5-bis (trifluoromethyl) phenyl group.

  First, the manufacture example of this compound is shown.

When the physical property value of the compound is measured by liquid chromatography / mass spectrometry (hereinafter referred to as LCMS), the measured molecular ion value [M + H] ⁺ and the retention time (hereinafter referred to as RT) are described. The conditions for liquid chromatography (hereinafter referred to as LC) are as follows.

[LC conditions]
Column: L-column2 ODS, inner diameter 4.6mm, length 30mm, particle diameter 3μm (Japan Chemical Substance Evaluation Research Organization)
UV measurement wavelength: 254 nm
Mobile phase: Liquid A: 0.1% formic acid aqueous solution, liquid B: 0.1% formic acid acetonitrile Flow rate: 2.0 mL / min Gradient condition: Liquid is fed with a concentration gradient described in [Table LC1].

[Table LC1]

中間体１：¹H-NMR (CDCl₃) δ: 3.53 (3H, s), 4.44 (2H, t), 5.45 (1H, d), 7.66 (1H, d). Reference production example 1
A mixture of 950 mg of 2,2,3,3,3-pentafluoro-1-propanol, 700 mg of 3-bromo-6-chloro-1-methylpyridin-2 (1H) -one, 2.1 g of cesium carbonate and 15 mL of DMF was added at room temperature. For 2 hours. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 1.06 g of intermediate 1 represented by the following formula.

Intermediate 1: ¹ H-NMR (CDCl ₃ ) δ: 3.53 (3H, s), 4.44 (2H, t), 5.45 (1H, d), 7.66 (1H, d).

中間体２：¹H-NMR (CDCl₃) δ: 3.50 (3H, s), 4.84 (2H, t), 7.91 (1H, s). Reference Production Example 1-1
According to Reference Production Example 1, using 5-bromo-2-chloro-3-methylpyrimidin-4 (3H) -one instead of 3-bromo-6-chloro-1-methylpyridin-2 (1H) -one Thus, an intermediate 2 represented by the following formula was obtained.

Intermediate 2: ¹ H-NMR (CDCl ₃ ) δ: 3.50 (3H, s), 4.84 (2H, t), 7.91 (1H, s).

中間体２０：¹H-NMR (CDCl₃) δ: 8.01 (1H, s), 5.89 (1H, s), 4.45 (2H, t), 3.59 (3H, s), 2.69 (3H, s). Reference production example 1-2
To a mixture of 1- (6-chloro-4-hydroxypyridin-3-yl) ethanone (20.3 g) and dioxane (150 mL) were sequentially added methyl iodide (8.8 mL) and cesium carbonate (46.5 g), and the mixture was stirred at room temperature for 1 hour. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain 26.2 g of a residue. To a mixture of 13.1 g of the residue, 9.1 mL of 2,2,3,3,3-pentafluoro-1-propanol and 50 mL of DMF, 30.0 g of cesium carbonate was added and stirred at room temperature for 1 hour. Water was added to the obtained mixture, and the precipitated solid was collected by filtration. The obtained solid was subjected to silica gel column chromatography to obtain 6.25 g of intermediate 20 represented by the following formula.

Intermediate 20: ¹ H-NMR (CDCl ₃ ) δ: 8.01 (1H, s), 5.89 (1H, s), 4.45 (2H, t), 3.59 (3H, s), 2.69 (3H, s).

中間体３：¹H-NMR (CDCl₃) δ: 2.66 (3H, s), 3.51 (3H, s), 4.54 (2H, t), 5.67 (1H, d), 8.22 (1H, d). Reference production example 2
To a mixture of 6.21 g of Intermediate 1, 1.3 g of bis (triphenylphosphine) palladium (II) dichloride and 30 mL of toluene was added 10.0 g of tributyl (1-ethoxyvinyl) stannane, and the mixture was stirred for 1 hour under reflux. The obtained mixture was cooled to room temperature, 10 mL of 10% aqueous potassium fluoride solution was added, and the mixture was stirred for 1 hour. The resulting mixture was extracted with MTBE. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. To the obtained residue were added 4 mL of THF and 40 mL of 2N hydrochloric acid, and the mixture was stirred at room temperature for 3 hours. The resulting mixture was extracted with MTBE. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 4.84 g of Intermediate 3 represented by the following formula.

Intermediate ^{3: 1 H-NMR (CDCl} 3) δ: 2.66 (3H, s), 3.51 (3H, s), 4.54 (2H, t), 5.67 (1H, d), 8.22 (1H, d).

中間体４：¹H-NMR (CDCl₃) δ: 3.53 (3H, s), 4.57 (2H, t), 4.76 (2H, s), 5.75 (1H, d), 8.33 (1H, d). Reference Production Example 3-1
To a mixture of 4.84 g of intermediate 3 and 100 mL of THF, 6.69 g of trimethylphenylammonium tribromide was added and stirred at room temperature for 3 hours. Water was added to the resulting mixture and extracted with MTBE. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 4.58 g of intermediate 4 represented by the following formula.

Intermediate 4: ¹ H-NMR (CDCl ₃ ) δ: 3.53 (3H, s), 4.57 (2H, t), 4.76 (2H, s), 5.75 (1H, d), 8.33 (1H, d).

中間体２１：¹H-NMR (CDCl₃) δ: 8.13 (1H, s), 6.01 (1H, s), 4.80 (2H, s), 4.50 (2H, t), 3.64 (3H, s). Reference production example 3-2
26.2 g of trimethylphenylammonium tribromide was added to a mixture of 10.0 g of the intermediate 20 and 200 mL of THF, and stirred at room temperature for 1 hour. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. To a mixture of the obtained residue, 14.0 mL of diisopropylethylamine and 200 mL of THF, 10.3 mL of diethyl phosphite was added under ice cooling, and the mixture was stirred for 2 hours under ice cooling. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 12.0 g of intermediate 21 represented by the following formula.

Intermediate 21: ¹ H-NMR (CDCl ₃ ) δ: 8.13 (1H, s), 6.01 (1H, s), 4.80 (2H, s), 4.50 (2H, t), 3.64 (3H, s).

中間体５：¹H-NMR (CDCl₃) δ: 3.50 (3H, s), 4.65 (2H, s), 4.96 (2H, t), 8.55 (1H, s). Reference production example 4
To a mixture of 21 g of intermediate 2, 3.3 g of bis (triphenylphosphine) palladium (II) dichloride and 100 mL of toluene, 24.7 g of tributyl (1-ethoxyvinyl) stannane was added and stirred for 16 hours under reflux. The resulting mixture was cooled to room temperature and filtered. The resulting filtrate was concentrated under reduced pressure. To the obtained residue, 30 mL of dioxane and 20 mL of water were added. To the resulting mixture, 17.7 g of N-bromosuccinimide was added under ice cooling, and the mixture was stirred at room temperature for 30 minutes. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 11 g of intermediate 5 represented by the following formula.

Intermediate 5: ¹ H-NMR (CDCl ₃ ) δ: 3.50 (3H, s), 4.65 (2H, s), 4.96 (2H, t), 8.55 (1H, s).

中間体６：¹H-NMR (CDCl₃) δ: 8.70 (1H, s), 8.50 (2H, dt), 7.64 (1H, d), 7.31 (1H, dd), 5.78 (1H, d), 4.55 (2H, t), 3.62 (3H, s). Reference production example 5
To a mixture of 2.2 g of Intermediate 4 and 30 mL of ethanol was added 1.04 g of 5- (trifluoromethyl) -2-aminopyridine at room temperature, and the mixture was stirred for 9 hours under reflux. The resulting mixture was cooled to room temperature and then concentrated under reduced pressure. Water was added to the obtained residue, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 2.10 g of intermediate 6 represented by the following formula.

Intermediate 6: ¹ H-NMR (CDCl ₃ ) δ: 8.70 (1H, s), 8.50 (2H, dt), 7.64 (1H, d), 7.31 (1H, dd), 5.78 (1H, d), 4.55 (2H, t), 3.62 (3H, s).

で示される化合物において、Ｔ、Ａ³、Ｒ^3b、及びＲ^3cの組み合わせが［表Ａ１］に記載のいずれかの組み合わせである化合物。
［表Ａ１］

中間体７：¹H-NMR (CDCl₃) δ: 3.46 (3H, s), 5.10 (2H, t), 6.19 (1H, d), 6.83 (1H, t), 7.21 (1H, t), 7.49 (1H, d), 8.39 (1H, d), 8.58-8.60 (2H, m).
中間体８：¹H-NMR (CDCl₃) δ: 3.47 (3H, s), 5.12 (2H, t), 6.24 (1H, d), 7.50 (1H, d), 7.58 (1H, d), 8.39 (1H, d), 8.66 (1H, s), 9.04 (1H, s).
中間体９：¹H-NMR (CDCl₃) δ: 8.76 (1H, s), 8.59 (1H, s), 8.50 (1H, s), 7.67 (1H, d), 7.33 (1H, dd), 4.99-4.92 (2H, m), 3.58 (3H, s).
中間体１０：¹H-NMR (CDCl₃) δ: 3.56 (3H, s), 4.92 (2H, t), 6.75 (1H, t), 7.15-7.19 (1H, m), 7.56 (1H, d), 8.11 (1H, d), 8.47 (1H, s), 8.74 (1H, s).
中間体１１：¹H-NMR (CDCl₃) δ: 3.55 (3H, s), 4.93 (2H, t), 7.21 (1H, d), 7.45 (1H, d), 8.25 (1H, s), 8.44 (1H, s), 8.71 (1H, s). Reference production example 6
The compounds produced according to Reference Production Example 5 and their physical properties are shown below.
Formula (A-1)

In which the combination of T, A ³ , R ^3b , and R ^3c is any combination described in [Table A1].
[Table A1]

Intermediate 7: ¹ H-NMR (CDCl ₃ ) δ: 3.46 (3H, s), 5.10 (2H, t), 6.19 (1H, d), 6.83 (1H, t), 7.21 (1H, t), 7.49 (1H, d), 8.39 (1H, d), 8.58-8.60 (2H, m).
Intermediate 8: ¹ H-NMR (CDCl ₃ ) δ: 3.47 (3H, s), 5.12 (2H, t), 6.24 (1H, d), 7.50 (1H, d), 7.58 (1H, d), 8.39 (1H, d), 8.66 (1H, s), 9.04 (1H, s).
Intermediate 9: ¹ H-NMR (CDCl ₃ ) δ: 8.76 (1H, s), 8.59 (1H, s), 8.50 (1H, s), 7.67 (1H, d), 7.33 (1H, dd), 4.99 -4.92 (2H, m), 3.58 (3H, s).
Intermediate 10: ¹ H-NMR (CDCl ₃ ) δ: 3.56 (3H, s), 4.92 (2H, t), 6.75 (1H, t), 7.15-7.19 (1H, m), 7.56 (1H, d) , 8.11 (1H, d), 8.47 (1H, s), 8.74 (1H, s).
Intermediate 11: ¹ H-NMR (CDCl ₃ ) δ: 3.55 (3H, s), 4.93 (2H, t), 7.21 (1H, d), 7.45 (1H, d), 8.25 (1H, s), 8.44 (1H, s), 8.71 (1H, s).

中間体２２：¹H-NMR (CDCl₃) δ: 8.86 (1H, s), 8.49 (1H, s), 8.36 (1H, s), 7.61 (1H, d), 7.31 (1H, d), 5.95 (1H, s), 4.50 (2H, t), 3.67 (3H, s).

Intermediate 22: ¹ H-NMR (CDCl ₃ ) δ: 8.86 (1H, s), 8.49 (1H, s), 8.36 (1H, s), 7.61 (1H, d), 7.31 (1H, d), 5.95 (1H, s), 4.50 (2H, t), 3.67 (3H, s).

中間体１２：¹H-NMR (CDCl₃) δ: 3.61 (3H, s), 4.53 (2H, t), 5.75 (1H, d), 7.15 (2H, t), 7.45-7.51 (3H, m), 7.63-7.68 (2H, m), 8.40 (1H, d), 8.63 (1H, s). Reference production example 7
A mixture of 3.6 g of intermediate 8, tetrakis (triphenylphosphine) palladium (0) 920 mg, sodium carbonate 2.53 g, 4-fluorophenylboronic acid 1.67 mg, water 10 mL, and 1,4-dioxane 40 mL. The mixture was stirred at 80 ° C. for 4 hours under a nitrogen atmosphere. The resulting mixture was cooled to room temperature and filtered. The filtrate was concentrated under reduced pressure. The obtained residue was subjected to column chromatography to obtain 3.0 g of intermediate 12 represented by the following formula.

Intermediate 12: ¹ H-NMR (CDCl ₃ ) δ: 3.61 (3H, s), 4.53 (2H, t), 5.75 (1H, d), 7.15 (2H, t), 7.45-7.51 (3H, m) , 7.63-7.68 (2H, m), 8.40 (1H, d), 8.63 (1H, s).

で示される化合物において、Ｔ、Ａ³、Ｒ^3b、及びＲ^3cの組み合わせが［表Ａ２］に記載の組み合わせである化合物。
［表Ａ２］

中間体１３： LCMS: 469 [M+H]⁺, RT = 3.63分 Reference production example 8
The compounds produced according to Reference Production Example 7 and their physical properties are shown below.
Formula (A-1)

In which the combination of T, A ³ , R ^3b , and R ^{3c is} a combination described in [Table A2].
[Table A2]

Intermediate 13: LCMS: 469 [M + H] ⁺ , RT = 3.63 min

中間体１４：¹H-NMR (CDCl₃) δ: 8.56 (1H, s), 7.77 (1H, d), 7.69 (1H, d), 7.38 (1H, dd), 5.69 (1H, d), 4.55 (2H, t), 3.60 (3H, s). Reference production example 9
To a mixture of 2.10 g of intermediate 6 and 20 mL of DMF, 1.2 g of N-iodosuccinimide was added under ice cooling, and the mixture was stirred at room temperature for 9 hours. To this mixture was added aqueous sodium thiosulfate solution. The precipitated solid was washed successively with water and MTBE and dried to obtain 2.81 g of intermediate 14 represented by the following formula.

Intermediate 14: ¹ H-NMR (CDCl ₃ ) δ: 8.56 (1H, s), 7.77 (1H, d), 7.69 (1H, d), 7.38 (1H, dd), 5.69 (1H, d), 4.55 (2H, t), 3.60 (3H, s).

で示される化合物において、Ｔ、Ｘ^e、Ａ³、Ｒ^3b、及びＲ^3cの組み合わせが［表Ａ３］に記載のいずれかの組み合わせである化合物。
［表Ａ３］

中間体１５：¹H-NMR (CDCl₃) δ: 3.58 (3H, s), 4.53 (2H, t), 5.67 (1H, d), 6.94 (1H, d), 7.16 (1H, d), 7.64 (1H, d), 7.73 (1H, d), 8.18 (1H, d).
中間体１６：¹H-NMR (CDCl₃) δ: 3.59 (3H, s), 4.53 (2H, t), 5.67 (1H, d), 7.18 (2H, t), 7.54 (3H, t), 7.63-7.68 (2H, m), 8.29 (1H, s).
中間体１７：¹H-NMR (CDCl₃) δ: 8.55 (1H, s), 8.06 (1H, s), 7.72 (1H, d), 7.42-7.40 (1H, m), 4.98-4.92 (2H, m), 3.57 (3H, s).
中間体１８：¹H-NMR (CDCl₃) δ: 3.55 (3H, s), 4.92 (2H, t), 6.94 (1H, t), 7.25-7.28 (1H, m), 7.62 (1H, d), 8.02 (1H, s), 8.17 (1H, d).
中間体１９：¹H-NMR (CDCl₃) δ: 3.55 (3H, s), 4.93 (2H, t), 7.19 (2H, t), 7.45 (1H, d), 7.54-7.58 (2H, m), 7.65 (1H, d), 8.04 (1H, s), 8.28 (1H, s). Reference production example 10
The compounds produced according to Reference Production Example 9 and their physical properties are shown below.
Formula (A-2)

A compound represented by the formula: wherein T, X ^e , A ³ , R ^3b , and R ^3c are in any combination described in [Table A3].
[Table A3]

Intermediate 15: ¹ H-NMR (CDCl ₃ ) δ: 3.58 (3H, s), 4.53 (2H, t), 5.67 (1H, d), 6.94 (1H, d), 7.16 (1H, d), 7.64 (1H, d), 7.73 (1H, d), 8.18 (1H, d).
Intermediate 16: ¹ H-NMR (CDCl ₃ ) δ: 3.59 (3H, s), 4.53 (2H, t), 5.67 (1H, d), 7.18 (2H, t), 7.54 (3H, t), 7.63 -7.68 (2H, m), 8.29 (1H, s).
Intermediate 17: ¹ H-NMR (CDCl ₃ ) δ: 8.55 (1H, s), 8.06 (1H, s), 7.72 (1H, d), 7.42-7.40 (1H, m), 4.98-4.92 (2H, m), 3.57 (3H, s).
Intermediate 18: ¹ H-NMR (CDCl ₃ ) δ: 3.55 (3H, s), 4.92 (2H, t), 6.94 (1H, t), 7.25-7.28 (1H, m), 7.62 (1H, d) , 8.02 (1H, s), 8.17 (1H, d).
Intermediate 19: ¹ H-NMR (CDCl ₃ ) δ: 3.55 (3H, s), 4.93 (2H, t), 7.19 (2H, t), 7.45 (1H, d), 7.54-7.58 (2H, m) , 7.65 (1H, d), 8.04 (1H, s), 8.28 (1H, s).

中間体２３：¹H-NMR (DMSO-D₆) δ: 8.66 (1H, s), 7.89 (1H, s), 7.80 (1H, d), 7.59 (1H, d), 6.04 (1H, s), 5.06 (2H, t), 3.54 (3H, s).

Intermediate 23: ¹ H-NMR (DMSO-D ₆ ) δ: 8.66 (1H, s), 7.89 (1H, s), 7.80 (1H, d), 7.59 (1H, d), 6.04 (1H, s) , 5.06 (2H, t), 3.54 (3H, s).

中間体２４：¹H-NMR (CDCl₃) δ: 1.24 (3H, t), 2.52 (2H, q), 3.53 (3H, s), 4.03 (2H, s), 4.57 (2H, t), 5.73 (1H, d), 8.34 (1H, d).
参考製造例１２
参考製造例１１に準じて製造した化合物及びその物性値を以下に示す。

中間体２５：¹H-NMR (CDCl₃) δ: 8.54 (1H, s), 4.96 (2H, t), 3.92 (2H, s), 3.50 (3H, s), 2.50 (2H, q), 1.24 (3H, t). Reference production example 11
To a mixture of 10.3 g of intermediate 4, 11.3 g of potassium carbonate, 80 mL of THF, and 40 mL of NMP, 2.0 mL of ethanethiol was added under ice cooling, and the mixture was stirred at room temperature for 1 hour. Water was added to the resulting mixture and extracted with MTBE. The obtained organic layer was washed with a saturated aqueous sodium hydrogen carbonate solution, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 7.5 g of intermediate 24 represented by the following formula.

Intermediate 24: ¹ H-NMR (CDCl ₃ ) δ: 1.24 (3H, t), 2.52 (2H, q), 3.53 (3H, s), 4.03 (2H, s), 4.57 (2H, t), 5.73 (1H, d), 8.34 (1H, d).
Reference production example 12
The compounds produced according to Reference Production Example 11 and their physical properties are shown below.

Intermediate 25: ¹ H-NMR (CDCl ₃ ) δ: 8.54 (1H, s), 4.96 (2H, t), 3.92 (2H, s), 3.50 (3H, s), 2.50 (2H, q), 1.24 (3H, t).

本化合物１：¹H-NMR (CDCl₃) δ: 8.82 (1H, dd), 7.73 (2H, dd), 7.40 (1H, dd), 5.66 (1H, d), 4.54 (2H, dd), 3.59 (3H, s), 2.75 (2H, q), 1.14 (3H, t). Production Example 1
2.52 g of intermediate 14, 1,4-dioxane 18 mL, tris (dibenzylideneacetone) dipalladium (0) 0.21 g, 4,5-bis (diphenylphosphino) -9,9-dimethylxanthene (hereinafter, A mixture of 0.27 g (designated Xantphos), 2.4 mL diisopropylethylamine and 0.49 mL ethanethiol was stirred under reflux for 120 minutes. Water was added to the resulting mixture and extracted with MTBE. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 1.22 g of the present compound 1 represented by the following formula.

This compound 1: ¹ H-NMR (CDCl ₃ ) δ: 8.82 (1H, dd), 7.73 (2H, dd), 7.40 (1H, dd), 5.66 (1H, d), 4.54 (2H, dd), 3.59 (3H, s), 2.75 (2H, q), 1.14 (3H, t).

で示される化合物において、Ｔ、Ａ³、Ｒ^3b、及びＲ^3cの組み合わせが［表Ａ４］に記載のいずれかの組み合わせである化合物。
［表Ａ４］

本化合物２：¹H-NMR (CDCl₃) δ: 1.11 (3H, t), 2.70 (2H, q), 3.56 (3H, s), 4.50 (2H, t), 5.62 (1H, d), 6.89 (1H, t), 7.23-7.25 (1H, m), 7.61-7.68 (2H, m), 8.44 (1H, d).
本化合物３：¹H-NMR (CDCl₃) δ: 1.13 (3H, t), 2.73 (2H, q), 3.57 (3H, s), 4.51 (2H, t), 5.63 (1H, d), 7.18 (2H, t), 7.45 (1H, d), 7.56-7.58 (2H, m), 7.69 (2H, t), 8.54 (1H, s).
本化合物４：¹H-NMR (CDCl₃) δ: 8.82-8.81 (1H, m), 8.02 (1H, s), 7.77 (1H, t), 7.44 (1H, dd), 4.94 (2H, td), 3.56 (3H, s), 2.75 (2H, q), 1.17 (3H, t).
本化合物５：¹H-NMR (CDCl₃) δ: 1.13 (3H, t), 2.70 (2H, q), 3.53 (3H, s), 4.91 (2H, t), 6.92 (1H, t), 7.25-7.29 (1H, m), 7.67 (1H, d), 7.98 (1H, s), 8.45 (1H, d).
本化合物６：¹H-NMR (CDCl₃) δ: 1.15 (3H, t), 2.72-2.73 (2H, m), 3.54 (3H, s), 4.92 (2H, t), 7.18 (2H, t), 7.47-7.50 (1H, m), 7.56 (2H, m), 7.71 (1H, d), 8.01 (1H, s), 8.57 (1H, s). Production Example 2
The compounds produced according to Production Example 1 and their physical properties are shown below.
Formula (A-3)

In which the combination of T, A ³ , R ^3b , and R ^3c is any combination described in [Table A4].
[Table A4]

Compound 2: ¹ H-NMR (CDCl ₃ ) δ: 1.11 (3H, t), 2.70 (2H, q), 3.56 (3H, s), 4.50 (2H, t), 5.62 (1H, d), 6.89 (1H, t), 7.23-7.25 (1H, m), 7.61-7.68 (2H, m), 8.44 (1H, d).
Compound 3: ¹ H-NMR (CDCl ₃ ) δ: 1.13 (3H, t), 2.73 (2H, q), 3.57 (3H, s), 4.51 (2H, t), 5.63 (1H, d), 7.18 (2H, t), 7.45 (1H, d), 7.56-7.58 (2H, m), 7.69 (2H, t), 8.54 (1H, s).
Compound 4: ¹ H-NMR (CDCl ₃ ) δ: 8.82-8.81 (1H, m), 8.02 (1H, s), 7.77 (1H, t), 7.44 (1H, dd), 4.94 (2H, td) , 3.56 (3H, s), 2.75 (2H, q), 1.17 (3H, t).
Compound 5: ¹ H-NMR (CDCl ₃ ) δ: 1.13 (3H, t), 2.70 (2H, q), 3.53 (3H, s), 4.91 (2H, t), 6.92 (1H, t), 7.25 -7.29 (1H, m), 7.67 (1H, d), 7.98 (1H, s), 8.45 (1H, d).
Compound 6: ¹ H-NMR (CDCl ₃ ) δ: 1.15 (3H, t), 2.72-2.73 (2H, m), 3.54 (3H, s), 4.92 (2H, t), 7.18 (2H, t) , 7.47-7.50 (1H, m), 7.56 (2H, m), 7.71 (1H, d), 8.01 (1H, s), 8.57 (1H, s).

本化合物１３：¹H-NMR (CDCl₃) δ: 8.82 (1H, s), 7.72 (1H, d), 7.55 (1H, s), 7.41 (1H, d), 5.95 (1H, s), 4.49 (2H, t), 3.59 (3H, s), 2.84 (2H, q), 1.18 (3H, t).

Compound 13: ¹ H-NMR (CDCl ₃ ) δ: 8.82 (1H, s), 7.72 (1H, d), 7.55 (1H, s), 7.41 (1H, d), 5.95 (1H, s), 4.49 (2H, t), 3.59 (3H, s), 2.84 (2H, q), 1.18 (3H, t).

本化合物１４：¹H-NMR (CDCl₃) δ: 1.14 (3H, t), 2.72 (2H, q), 3.58 (3H, s), 4.53 (2H, t), 5.64 (1H, d), 7.22 (1H, dd), 7.58 (1H, d), 7.69 (1H, d), 8.48-8.49 (1H, m). Production Example 3
To a mixture of 1.50 g of intermediate 24, 0.6 mL of triethylamine and 8 mL of chloroform, 0.8 mL of trimethylsilyl triflate was added dropwise at −78 ° C. and stirred at room temperature for 30 minutes. The obtained mixture was cooled to −78 ° C., 1.60 g of trimethylphenylammonium tribromide was added, and the mixture was stirred at room temperature for 1 hour. Water was added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over sodium sulfate and filtered. To the filtrate was added 0.54 g of 5-chloro-2-aminopyridine at room temperature, and the mixture was stirred for 1 hour under reflux. The obtained mixture was cooled to room temperature, saturated aqueous sodium hydrogen carbonate solution was added, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 1: 1) to obtain 0.31 g of the present compound 14 represented by the following formula.

Compound 14: ¹ H-NMR (CDCl ₃ ) δ: 1.14 (3H, t), 2.72 (2H, q), 3.58 (3H, s), 4.53 (2H, t), 5.64 (1H, d), 7.22 (1H, dd), 7.58 (1H, d), 7.69 (1H, d), 8.48-8.49 (1H, m).

で示される化合物において、Ａ³、Ｒ^3b、Ｒ^3c、及びＲ^3dの組み合わせが［表Ａ５］に記載のいずれかの組み合わせである化合物。
［表Ａ５］

本化合物８６：¹H-NMR (CDCl₃) δ: 8.58 (1H, d), 7.69 (1H, d), 7.53 (1H, d), 7.31 (1H, dd), 6.17-5.88 (1H, m), 5.66 (1H, d), 4.49 (2H, t), 3.58 (3H, s), 2.72 (2H, q), 1.13 (3H, t).
本化合物８７：¹H-NMR (CDCl₃) δ: 8.69 (1H, s), 7.68 (1H, d), 7.42 (2H, s), 6.16-5.89 (1H, m), 5.66 (1H, d), 4.48 (2H, t), 3.58 (3H, s), 2.72 (2H, q), 1.13 (3H, t).
本化合物１５：¹H-NMR (CDCl₃) δ: 1.13 (3H, t), 2.72 (2H, q), 3.58 (3H, s), 4.52 (2H, t), 5.63 (1H, d), 7.32 (1H, dd), 7.53 (1H, d), 7.69 (1H, d), 8.58 (1H, d).
本化合物１６：¹H-NMR (CDCl₃) δ: 1.13 (3H, t), 2.72 (2H, q), 3.57 (3H, s), 4.53 (2H, t), 5.64-5.66 (1H, m), 7.42 (2H, m), 7.66-7.69 (1H, m), 8.69 (1H, d).
本化合物１７：¹H-NMR (CDCl₃) δ: 8.48-8.46 (1H, m), 8.00 (1H, s), 7.68-7.65 (1H, m), 7.31-7.29 (1H, m), 6.94-6.93 (1H, m), 4.93 (2H, t), 3.55 (3H, s), 2.72 (2H, q), 1.15 (3H, t).
本化合物１８：¹H-NMR (CDCl₃) δ: 8.40-8.39 (1H, m), 7.99 (1H, s), 7.65-7.63 (1H, m), 7.23-7.19 (1H, m), 4.93 (2H, t), 3.55 (3H, s), 2.72 (2H, q), 1.16 (3H, t).
本化合物１９：¹H-NMR (CDCl₃) δ: 8.49 (1H, d), 8.00 (1H, s), 7.61 (1H, d), 7.27-7.24 (1H, m), 4.93 (2H, t), 3.55 (3H, s), 2.73 (2H, q), 1.16 (3H, t).
本化合物２０：¹H-NMR (CDCl₃) δ: 8.58 (1H, s), 7.99 (1H, d), 7.55 (1H, d), 7.34 (1H, dd), 4.92 (2H, t), 3.54 (3H, s), 2.72 (2H, q), 1.15 (3H, t).
本化合物２１：¹H-NMR (CDCl₃) δ: 8.70-8.69 (1H, m), 7.99 (1H, s), 7.46-7.45 (2H, m), 4.93 (2H, t), 3.55 (3H, s), 2.72 (2H, q), 1.15 (3H, t).
本化合物５０：¹H-NMR (CDCl₃) δ: 9.54 (1H, dd), 8.05-8.05 (2H, m), 7.73 (1H, dd), 4.95 (2H, dd), 3.56 (3H, s), 2.79 (2H, q), 1.19 (3H, t).
本化合物５１：¹H-NMR (CDCl₃) δ: 8.32 (1H, dd), 7.98 (1H, s), 7.83 (1H, dd), 7.03 (1H, dd), 4.93 (2H, dd), 3.54 (3H, s), 2.71 (2H, q), 1.14 (3H, t).
本化合物５２：¹H-NMR (CDCl₃) δ: 8.38 (1H, dd), 7.98 (1H, s), 7.65 (1H, dd), 6.92 (1H, dd), 4.93 (2H, dd), 3.54 (3H, s), 2.71 (2H, q), 1.14 (3H, t).
本化合物５３：¹H-NMR (CDCl₃) δ: 8.41 (1H, dd), 7.99 (1H, s), 7.37 (1H, dd), 6.89 (1H, dd), 4.93 (2H, dd), 3.53 (3H, s), 2.74 (2H, q), 1.15 (3H, t).
本化合物５４：¹H-NMR (CDCl₃) δ: 8.24-8.23 (1H, m), 7.98 (1H, s), 7.56 (1H, dd), 7.13 (1H, dd), 4.92 (2H, dd), 3.54 (3H, s), 2.70 (2H, q), 2.40 (3H, d), 1.14 (3H, t).
本化合物５５：¹H-NMR (CDCl₃) δ: 8.89 (1H, dd), 8.03 (1H, s), 7.74 (1H, dd), 7.41-7.38 (1H, m), 4.94 (2H, dd), 3.55 (3H, s), 2.76 (2H, q), 1.17 (3H, t).
本化合物５６：¹H-NMR (CDCl₃) δ: 9.12 (1H, dd), 8.03 (1H, s), 7.83 (1H, m), 7.68 (1H, d), 4.94 (2H, dd), 3.56 (3H, s), 2.76 (2H, q), 2.69 (3H, d), 1.18 (3H, t).
本化合物５７：¹H-NMR (CDCl₃) δ: 9.20 (1H, dd), 8.02 (1H, s), 7.84 (1H, dd), 7.66 (1H, dd), 4.94 (2H, dd), 3.99 (3H, s), 3.55 (3H, s), 2.75 (2H, q), 1.16 (3H, t).
本化合物５８：¹H-NMR (CDCl₃) δ: 8.67 (1H, s), 7.99 (1H, s), 7.97 (1H, s), 4.93 (2H, dd), 3.54 (3H, s), 2.73 (2H, q), 1.15 (3H, t).
本化合物８８：¹H-NMR (CDCl₃) δ: 8.57 (1H, s), 7.98 (2H, m), 4.93 (2H, t), 3.54 (3H, s), 2.73 (2H, q), 1.15 (3H, t).
本化合物８９：¹H-NMR (CDCl₃) δ: 8.81 (1H, s), 7.99 (2H, m), 4.93 (2H, t), 3.54 (3H, s), 2.72 (2H, q), 1.15 (3H, t). Production Example 4-1
The compounds produced according to Production Example 3 and their physical properties are shown below.
Formula (A-5)

Wherein the combination of A ³ , R ^3b , R ^3c , and R ^3d is any combination described in [Table A5].
[Table A5]

Compound 86: ¹ H-NMR (CDCl ₃ ) δ: 8.58 (1H, d), 7.69 (1H, d), 7.53 (1H, d), 7.31 (1H, dd), 6.17-5.88 (1H, m) , 5.66 (1H, d), 4.49 (2H, t), 3.58 (3H, s), 2.72 (2H, q), 1.13 (3H, t).
Compound 87: ¹ H-NMR (CDCl ₃ ) δ: 8.69 (1H, s), 7.68 (1H, d), 7.42 (2H, s), 6.16-5.89 (1H, m), 5.66 (1H, d) , 4.48 (2H, t), 3.58 (3H, s), 2.72 (2H, q), 1.13 (3H, t).
Compound 15: ¹ H-NMR (CDCl ₃ ) δ: 1.13 (3H, t), 2.72 (2H, q), 3.58 (3H, s), 4.52 (2H, t), 5.63 (1H, d), 7.32 (1H, dd), 7.53 (1H, d), 7.69 (1H, d), 8.58 (1H, d).
Compound 16: ¹ H-NMR (CDCl ₃ ) δ: 1.13 (3H, t), 2.72 (2H, q), 3.57 (3H, s), 4.53 (2H, t), 5.64-5.66 (1H, m) , 7.42 (2H, m), 7.66-7.69 (1H, m), 8.69 (1H, d).
Compound 17: ¹ H-NMR (CDCl ₃ ) δ: 8.48-8.46 (1H, m), 8.00 (1H, s), 7.68-7.65 (1H, m), 7.31-7.29 (1H, m), 6.94- 6.93 (1H, m), 4.93 (2H, t), 3.55 (3H, s), 2.72 (2H, q), 1.15 (3H, t).
Compound 18: ¹ H-NMR (CDCl ₃ ) δ: 8.40-8.39 (1H, m), 7.99 (1H, s), 7.65-7.63 (1H, m), 7.23-7.19 (1H, m), 4.93 ( 2H, t), 3.55 (3H, s), 2.72 (2H, q), 1.16 (3H, t).
Compound 19: ¹ H-NMR (CDCl ₃ ) δ: 8.49 (1H, d), 8.00 (1H, s), 7.61 (1H, d), 7.27-7.24 (1H, m), 4.93 (2H, t) , 3.55 (3H, s), 2.73 (2H, q), 1.16 (3H, t).
Compound 20: ¹ H-NMR (CDCl ₃ ) δ: 8.58 (1H, s), 7.99 (1H, d), 7.55 (1H, d), 7.34 (1H, dd), 4.92 (2H, t), 3.54 (3H, s), 2.72 (2H, q), 1.15 (3H, t).
Compound 21: ¹ H-NMR (CDCl ₃ ) δ: 8.70-8.69 (1H, m), 7.99 (1H, s), 7.46-7.45 (2H, m), 4.93 (2H, t), 3.55 (3H, s), 2.72 (2H, q), 1.15 (3H, t).
Compound 50: ¹ H-NMR (CDCl ₃ ) δ: 9.54 (1H, dd), 8.05-8.05 (2H, m), 7.73 (1H, dd), 4.95 (2H, dd), 3.56 (3H, s) , 2.79 (2H, q), 1.19 (3H, t).
Compound 51: ¹ H-NMR (CDCl ₃ ) δ: 8.32 (1H, dd), 7.98 (1H, s), 7.83 (1H, dd), 7.03 (1H, dd), 4.93 (2H, dd), 3.54 (3H, s), 2.71 (2H, q), 1.14 (3H, t).
Compound 52: ¹ H-NMR (CDCl ₃ ) δ: 8.38 (1H, dd), 7.98 (1H, s), 7.65 (1H, dd), 6.92 (1H, dd), 4.93 (2H, dd), 3.54 (3H, s), 2.71 (2H, q), 1.14 (3H, t).
Compound 53: ¹ H-NMR (CDCl ₃ ) δ: 8.41 (1H, dd), 7.99 (1H, s), 7.37 (1H, dd), 6.89 (1H, dd), 4.93 (2H, dd), 3.53 (3H, s), 2.74 (2H, q), 1.15 (3H, t).
Compound 54: ¹ H-NMR (CDCl ₃ ) δ: 8.24-8.23 (1H, m), 7.98 (1H, s), 7.56 (1H, dd), 7.13 (1H, dd), 4.92 (2H, dd) , 3.54 (3H, s), 2.70 (2H, q), 2.40 (3H, d), 1.14 (3H, t).
Compound 55: ¹ H-NMR (CDCl ₃ ) δ: 8.89 (1H, dd), 8.03 (1H, s), 7.74 (1H, dd), 7.41-7.38 (1H, m), 4.94 (2H, dd) , 3.55 (3H, s), 2.76 (2H, q), 1.17 (3H, t).
Compound 56: ¹ H-NMR (CDCl ₃ ) δ: 9.12 (1H, dd), 8.03 (1H, s), 7.83 (1H, m), 7.68 (1H, d), 4.94 (2H, dd), 3.56 (3H, s), 2.76 (2H, q), 2.69 (3H, d), 1.18 (3H, t).
Compound 57: ¹ H-NMR (CDCl ₃ ) δ: 9.20 (1H, dd), 8.02 (1H, s), 7.84 (1H, dd), 7.66 (1H, dd), 4.94 (2H, dd), 3.99 (3H, s), 3.55 (3H, s), 2.75 (2H, q), 1.16 (3H, t).
Compound 58: ¹ H-NMR (CDCl ₃ ) δ: 8.67 (1H, s), 7.99 (1H, s), 7.97 (1H, s), 4.93 (2H, dd), 3.54 (3H, s), 2.73 (2H, q), 1.15 (3H, t).
Compound 88: ¹ H-NMR (CDCl ₃ ) δ: 8.57 (1H, s), 7.98 (2H, m), 4.93 (2H, t), 3.54 (3H, s), 2.73 (2H, q), 1.15 (3H, t).
Compound 89: ¹ H-NMR (CDCl ₃ ) δ: 8.81 (1H, s), 7.99 (2H, m), 4.93 (2H, t), 3.54 (3H, s), 2.72 (2H, q), 1.15 (3H, t).

で示される化合物において、Ｑaが［表Ａ５−１］に記載のいずれかである化合物。
［表Ａ５−１］

本化合物６３：¹H-NMR (CDCl₃) δ: 8.84 (1H, dd), 8.60 (1H, dd), 8.09 (1H, s), 4.94 (2H, t), 3.55 (3H, s), 2.79 (2H, q), 1.17 (3H, t).
本化合物６４：¹H-NMR (CDCl₃) δ: 8.00 (1H, s), 7.94 (1H, d), 7.14 (1H, d), 4.94 (2H, t), 3.55 (3H, s), 2.94 (2H, q), 1.18 (3H, t).
本化合物６５：¹H-NMR (CDCl₃) δ: 9.13 (1H, s), 8.37 (1H, d), 8.05 (1H, s), 8.03 (1H, d), 4.95 (2H, t), 3.56 (3H, s), 2.77 (2H, q), 1.17 (3H, t).
本化合物６６：¹H-NMR (CDCl₃) δ: 7.94 (1H, s), 7.57 (1H, d), 6.90 (1H, d), 4.91 (2H, t), 3.53 (3H, s), 2.73 (2H, q), 1.18 (3H, t).
本化合物６７：¹H-NMR (CDCl₃) δ: 9.35 (1H, s), 8.05 (1H, s), 7.93 (1H, s), 4.98-4.92 (2H, m), 3.56 (3H, s), 2.82 (2H, q), 1.20 (3H, t).
本化合物８４：¹H-NMR (CDCl₃) δ: 8.94 (1H, d), 8.67 (1H, d), 8.09 (1H, s), 4.94 (2H, dd), 3.55 (3H, s), 2.78 (2H, q), 1.17 (3H, t).
本化合物８５：¹H-NMR (CDCl₃) δ: 8.92 (1H, d), 8.15 (1H, s), 7.33 (1H, d), 4.95 (2H, dd), 3.57 (3H, s), 2.82 (2H, q), 1.18 (3H, t).
本化合物１１２：¹H-NMR (CDCl₃) δ: 8.00 (1H, s), 7.65 (1H, d), 7.40 (1H, d), 4.94 (2H, t), 3.55 (3H, s), 2.93 (2H, q), 1.17 (3H, t). Production Example 4-2
The compounds produced according to Production Example 3 and their physical properties are shown below.
Formula (A-5-1)

In which Qa is any of those listed in [Table A5-1].
[Table A5-1]

Compound 63: ¹ H-NMR (CDCl ₃ ) δ: 8.84 (1H, dd), 8.60 (1H, dd), 8.09 (1H, s), 4.94 (2H, t), 3.55 (3H, s), 2.79 (2H, q), 1.17 (3H, t).
Compound 64: ¹ H-NMR (CDCl ₃ ) δ: 8.00 (1H, s), 7.94 (1H, d), 7.14 (1H, d), 4.94 (2H, t), 3.55 (3H, s), 2.94 (2H, q), 1.18 (3H, t).
Compound 65: ¹ H-NMR (CDCl ₃ ) δ: 9.13 (1H, s), 8.37 (1H, d), 8.05 (1H, s), 8.03 (1H, d), 4.95 (2H, t), 3.56 (3H, s), 2.77 (2H, q), 1.17 (3H, t).
Compound 66: ¹ H-NMR (CDCl ₃ ) δ: 7.94 (1H, s), 7.57 (1H, d), 6.90 (1H, d), 4.91 (2H, t), 3.53 (3H, s), 2.73 (2H, q), 1.18 (3H, t).
Compound 67: ¹ H-NMR (CDCl ₃ ) δ: 9.35 (1H, s), 8.05 (1H, s), 7.93 (1H, s), 4.98-4.92 (2H, m), 3.56 (3H, s) , 2.82 (2H, q), 1.20 (3H, t).
Compound 84: ¹ H-NMR (CDCl ₃ ) δ: 8.94 (1H, d), 8.67 (1H, d), 8.09 (1H, s), 4.94 (2H, dd), 3.55 (3H, s), 2.78 (2H, q), 1.17 (3H, t).
Compound 85: ¹ H-NMR (CDCl ₃ ) δ: 8.92 (1H, d), 8.15 (1H, s), 7.33 (1H, d), 4.95 (2H, dd), 3.57 (3H, s), 2.82 (2H, q), 1.18 (3H, t).
Compound 112: ¹ H-NMR (CDCl ₃ ) δ: 8.00 (1H, s), 7.65 (1H, d), 7.40 (1H, d), 4.94 (2H, t), 3.55 (3H, s), 2.93 (2H, q), 1.17 (3H, t).

本化合物７：¹H-NMR (CDCl₃) δ: 9.27 (1H, s), 7.82 (1H, d), 7.74 (1H, d), 7.59 (1H, dd), 5.70 (1H, d), 4.53 (2H, t), 3.78 (2H, q), 3.56 (3H, s), 1.45 (3H, t). Production Example 5
To a mixture of 1.22 g of the present compound 1 and chloroform (15 mL), 1.30 g of mCPBA (purity 70%, containing 30% water) was added under ice cooling, and the mixture was stirred at room temperature for 6 hours. A saturated aqueous sodium bicarbonate solution and an aqueous sodium thiosulfate solution were sequentially added to the resulting mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 1: 1) to obtain 0.61 g of the present compound 7 represented by the following formula.

Compound 7: ¹ H-NMR (CDCl ₃ ) δ: 9.27 (1H, s), 7.82 (1H, d), 7.74 (1H, d), 7.59 (1H, dd), 5.70 (1H, d), 4.53 (2H, t), 3.78 (2H, q), 3.56 (3H, s), 1.45 (3H, t).

で示される化合物において、Ｔ、Ａ³、Ｒ^3b、Ｒ^3c、Ｒ^3d及びｎの組み合わせが［表Ａ６］に記載のいずれかの組み合わせである化合物。
［表Ａ６］

本化合物１０１：¹H-NMR (CDCl₃) δ: 9.05 (1H, t), 7.71 (1H, d), 7.61 (1H, d), 7.50 (1H, dd), 6.14-5.86 (1H, m), 5.70 (1H, d), 4.48 (2H, t), 3.73 (2H, q), 3.55 (3H, s), 1.44 (3H, t).
本化合物１０２：¹H-NMR (CDCl₃) δ: 9.13 (1H, d), 7.70 (1H, d), 7.61 (1H, d), 7.49 (1H, d), 6.14-5.87 (1H, m), 5.70 (1H, d), 4.48 (2H, t), 3.73 (2H, q), 3.55 (3H, s), 1.43 (3H, t).
本化合物８：¹H-NMR (CDCl₃) δ: 1.41 (3H, t), 3.53 (3H, s), 3.70 (2H, q), 4.49 (2H, t), 5.66 (1H, d), 7.01 (1H, t), 7.43 (1H, t), 7.70 (2H, d), 8.89 (1H, d).
本化合物９：¹H-NMR (CDCl₃) δ: 1.43 (3H, t), 3.54 (3H, s), 3.73 (2H, q), 4.48-4.59 (2H, m), 5.67 (1H, d), 7.16-7.21 (2H, m), 7.52-7.54 (2H, m), 7.61-7.63 (1H, m), 7.71-7.77 (2H, m), 9.01 (1H, s).
本化合物２２：¹H-NMR (CDCl₃) δ: 8.95-8.96 (1H, m), 7.71 (1H, d), 7.66 (1H, m), 7.41 (1H, dd), 5.68 (1H, d), 4.52 (2H, t), 3.73 (2H, q), 3.55 (3H, s), 1.44 (3H, t).
本化合物２３：¹H-NMR (CDCl₃) δ: 9.04 (1H, d), 7.70 (1H, d), 7.61 (1H, d), 7.50 (1H, dd), 5.68 (1H, d), 4.52 (2H, t), 3.73 (2H, q), 3.55 (3H, s), 1.44 (3H, t).
本化合物２４：¹H-NMR (CDCl₃) δ: 9.13 (1H, d), 7.70 (1H, d), 7.62 (1H, m), 7.50 (1H, m), 5.68 (1H, d), 4.51 (2H, t), 3.72 (2H, q), 3.55 (3H, s), 1.43 (3H, t).
本化合物１０：¹H-NMR (CDCl₃) δ: 9.27-9.26 (1H, m), 8.04 (1H, s), 7.86 (1H, d), 7.62 (1H, dd), 4.93 (2H, td), 3.71 (2H, q), 3.53 (3H, s), 1.45 (3H, t).
本化合物１１：¹H-NMR (CDCl₃) δ: 1.41 (3H, t), 3.53 (3H, s), 3.63 (2H, q), 4.90 (2H, t), 7.05 (1H, t), 7.46 (1H, t), 7.75 (1H, d), 7.99 (1H, s), 8.88 (1H, d).
本化合物１２：¹H-NMR (CDCl₃) δ: 1.43 (3H, t), 3.51 (3H, s), 3.66 (2H, q), 4.88-4.96 (2H, m), 7.17 (2H, t), 7.53-7.54 (2H, m), 7.65 (1H, d), 7.79 (1H, d), 8.01 (1H, s), 9.00 (1H, s).
本化合物２５：¹H-NMR (CDCl₃) δ: 8.88-8.87 (1H, m), 8.00 (1H, s), 7.75-7.71 (1H, m), 7.42-7.38 (1H, m), 4.92 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.43 (3H, t).
本化合物２６：¹H-NMR (CDCl₃) δ: 8.95 (1H, d), 8.00 (1H, s), 7.69 (1H, d), 7.44 (1H, dd), 4.92 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
本化合物２７：¹H-NMR (CDCl₃) δ: 9.03 (1H, d), 8.00 (1H, s), 7.64 (1H, d), 7.54 (1H, dd), 4.92 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
本化合物２８：¹H-NMR (CDCl₃) δ: 9.12 (1H, s), 8.00 (1H, s), 7.65 (1H, d), 7.52 (1H, d), 4.92 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
本化合物３２：¹H-NMR (CDCl₃) δ: 8.67 (1H, s), 7.98 (1H, s), 7.63 (1H, d), 7.16 (1H, d), 4.90 (2H, dd), 3.62 (2H, q), 3.51 (3H, s), 2.01-1.97 (1H, m), 1.42 (3H, t), 1.08-1.03 (2H, m), 0.75 (2H, m).
本化合物３３：¹H-NMR (CDCl₃) δ: 9.17 (1H, dd), 9.00 (1H, d), 8.13 (1H, dd), 8.07 (1H, s), 7.93 (1H, d), 7.88 (1H, d), 7.72 (1H, dd), 4.95 (2H, dd), 3.74 (2H, q), 3.56 (3H, s), 1.48 (3H, t).
本化合物３４：¹H-NMR (CDCl₃) δ: 9.95 (1H, dd), 8.24 (1H, dd), 8.08 (1H, s), 7.83 (1H, dd), 4.94 (2H, dd), 3.77 (2H, q), 3.53 (3H, s), 1.49 (3H, t).
本化合物３５：¹H-NMR (CDCl₃) δ:8.76 (1H, dd), 8.00(1H, s), 7.92 (1H, dd), 7.15 (1H, dd), 4.91(2H, dd), 3.66 (2H, q), 3.51 (3H, s), 1.42 (3H, t).
本化合物３６：¹H-NMR (CDCl₃) δ: 8.69 (1H, d), 7.99 (1H, s), 6.98 (1H, d), 6.74 (1H, dd), 4.90 (2H, dd), 3.91 (3H, s), 3.60 (2H, q), 3.51 (3H, s), 1.40 (3H, t).
本化合物３７：¹H-NMR (CDCl₃) δ: 8.67 (1H, d), 7.99 (1H, s), 6.94 (1H, d), 6.72 (1H, dd), 4.90 (2H, dd), 4.11 (2H, t), 3.58 (2H, q), 3.51 (3H, s), 1.49 (3H, t), 1.40 (3H, t).
本化合物３８：¹H-NMR (CDCl₃) δ: 8.83 (1H, dd), 8.00 (1H, s), 7.73 (1H, dd), 7.04 (1H, dd), 4.91 (2H, dd), 3.66 (2H, q), 3.52 (3H, s), 1.42 (3H, t).
本化合物３９：¹H-NMR (CDCl₃) δ: 8.85 (1H, dd), 8.05 (1H, s), 7.54 (1H, dd), 7.01 (1H, dd), 4.92 (2H, dd), 3.68 (2H, q), 3.51 (3H, s), 1.43 (3H, t).
本化合物４０：¹H-NMR (CDCl₃) δ: 8.65 (1H, s), 7.99 (1H, s), 7.64 (1H, d), 7.32 (1H, dd), 4.91 (2H, dd), 3.63 (2H, q), 3.51 (3H, s), 2.42 (3H, s), 1.42 (3H, t).
本化合物４１：¹H-NMR (CDCl₃) δ: 9.25 (1H, dd), 8.03 (1H, s), 7.93 (1H, d), 7.84-7.84 (2H, m), 7.72 (1H, s), 4.92 (2H, dd), 3.70 (2H, q), 3.53 (3H, s), 1.46 (3H, t).
本化合物４２：¹H-NMR (CDCl₃) δ: 8.78 (1H, s), 8.00 (1H, s), 7.68-7.68 (2H, m), 6.73 (1H, dd), 5.84 (1H, d), 5.45 (1H, d), 4.91 (2H, dd), 3.64 (2H, q), 3.52 (3H, s), 1.43 (3H, t).
本化合物４３：¹H-NMR (CDCl₃) δ: 8.89 (1H, s), 8.00 (1H, s), 7.67-7.67 (2H, m), 5.49 (1H, s), 5.26 (1H, s), 4.91 (2H, dd), 3.64 (2H, q), 3.52 (3H, s), 2.21 (3H, s), 1.43 (3H, t).
本化合物４４：¹H-NMR (CDCl₃) δ: 9.34 (1H, dd), 8.05 (1H, s), 7.83 (1H, dd), 7.57 (1H, dd), 4.93 (2H, dd), 3.73 (2H, q), 3.53 (3H, s), 1.46 (3H, t).
本化合物４５：¹H-NMR (CDCl₃) δ: 9.55 (1H, s), 8.05 (1H, s), 8.02 (1H, dd), 7.77 (1H, d), 4.93 (2H, dd), 3.72 (2H, q), 3.53 (3H, s), 2.68 (3H, s), 1.46 (3H, t)
本化合物４６：¹H-NMR (CDCl₃) δ: 9.57 (1H, s), 8.03-8.02 (2H, m), 7.75 (1H, d), 4.92 (2H, dd), 4.00 (3H, s), 3.70 (2H, q), 3.53 (3H, s), 1.46 (3H, t).
本化合物４７：¹H-NMR (CDCl₃) 9.12 (1H, s), 8.06 (1H, s), 8.00 (1H, s), 4.92 (2H, dd), 3.67 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
本化合物４８：¹H-NMR (CDCl₃) δ: 9.20 (1H, dd), 8.26 (1H, s), 7.58 (1H, dd), 7.43 (1H, dd), 4.98-4.90 (2H, m), 3.68-3.54 (2H, m), 3.52 (3H, s), 1.56 (3H, t).
本化合物４９：¹H-NMR (CDCl₃) δ: 9.04 (1H, s), 7.99 (1H, s), 7.58 (1H, s), 4.91 (2H, dd), 3.64 (2H, q), 3.51 (3H, s), 2.52 (3H, s), 1.43 (3H, t).
本化合物９０：¹H-NMR (CDCl₃) δ: 9.03 (1H, d), 8.03 (2H, m), 4.92 (2H, t), 3.68 (2H, q), 3.52 (3H, s), 1.43 (3H, t).
本化合物１００：¹H-NMR (CDCl₃) δ: 9.24 (1H, d), 8.08 (1H, s), 7.99 (1H, s), 4.90 (2H, t), 3.67 (2H, q), 3.51 (3H, s), 1.43 (3H, t).
本化合物１０７：¹H-NMR (CDCl₃) δ: 9.48 (1H, s), 8.06 (1H, s), 7.88 (1H, d), 7.81 (1H, d), 4.94 (2H, t), 3.74 (2H, q), 3.54 (3H, s), 3.24 (2H, q), 1.47 (3H, t), 1.37 (3H, t). Production Example 6-1
The compounds produced according to Production Example 5 and their physical properties are shown below.
Formula (A-4)

In which the combination of T, A ³ , R ^3b , R ^3c , R ^3d and n is any combination described in [Table A6].
[Table A6]

Compound 101: ¹ H-NMR (CDCl ₃ ) δ: 9.05 (1H, t), 7.71 (1H, d), 7.61 (1H, d), 7.50 (1H, dd), 6.14-5.86 (1H, m) , 5.70 (1H, d), 4.48 (2H, t), 3.73 (2H, q), 3.55 (3H, s), 1.44 (3H, t).
Compound 102: ¹ H-NMR (CDCl ₃ ) δ: 9.13 (1H, d), 7.70 (1H, d), 7.61 (1H, d), 7.49 (1H, d), 6.14-5.87 (1H, m) , 5.70 (1H, d), 4.48 (2H, t), 3.73 (2H, q), 3.55 (3H, s), 1.43 (3H, t).
Compound 8: ¹ H-NMR (CDCl ₃ ) δ: 1.41 (3H, t), 3.53 (3H, s), 3.70 (2H, q), 4.49 (2H, t), 5.66 (1H, d), 7.01 (1H, t), 7.43 (1H, t), 7.70 (2H, d), 8.89 (1H, d).
Compound 9: ¹ H-NMR (CDCl ₃ ) δ: 1.43 (3H, t), 3.54 (3H, s), 3.73 (2H, q), 4.48-4.59 (2H, m), 5.67 (1H, d) , 7.16-7.21 (2H, m), 7.52-7.54 (2H, m), 7.61-7.63 (1H, m), 7.71-7.77 (2H, m), 9.01 (1H, s).
Compound 22: ¹ H-NMR (CDCl ₃ ) δ: 8.95-8.96 (1H, m), 7.71 (1H, d), 7.66 (1H, m), 7.41 (1H, dd), 5.68 (1H, d) , 4.52 (2H, t), 3.73 (2H, q), 3.55 (3H, s), 1.44 (3H, t).
Compound 23: ¹ H-NMR (CDCl ₃ ) δ: 9.04 (1H, d), 7.70 (1H, d), 7.61 (1H, d), 7.50 (1H, dd), 5.68 (1H, d), 4.52 (2H, t), 3.73 (2H, q), 3.55 (3H, s), 1.44 (3H, t).
Compound 24: ¹ H-NMR (CDCl ₃ ) δ: 9.13 (1H, d), 7.70 (1H, d), 7.62 (1H, m), 7.50 (1H, m), 5.68 (1H, d), 4.51 (2H, t), 3.72 (2H, q), 3.55 (3H, s), 1.43 (3H, t).
Compound 10: ¹ H-NMR (CDCl ₃ ) δ: 9.27-9.26 (1H, m), 8.04 (1H, s), 7.86 (1H, d), 7.62 (1H, dd), 4.93 (2H, td) , 3.71 (2H, q), 3.53 (3H, s), 1.45 (3H, t).
Compound 11: ¹ H-NMR (CDCl ₃ ) δ: 1.41 (3H, t), 3.53 (3H, s), 3.63 (2H, q), 4.90 (2H, t), 7.05 (1H, t), 7.46 (1H, t), 7.75 (1H, d), 7.99 (1H, s), 8.88 (1H, d).
Compound 12: ¹ H-NMR (CDCl ₃ ) δ: 1.43 (3H, t), 3.51 (3H, s), 3.66 (2H, q), 4.88-4.96 (2H, m), 7.17 (2H, t) , 7.53-7.54 (2H, m), 7.65 (1H, d), 7.79 (1H, d), 8.01 (1H, s), 9.00 (1H, s).
Compound 25: ¹ H-NMR (CDCl ₃ ) δ: 8.88-8.87 (1H, m), 8.00 (1H, s), 7.75-7.71 (1H, m), 7.42-7.38 (1H, m), 4.92 ( 2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.43 (3H, t).
Compound 26: ¹ H-NMR (CDCl ₃ ) δ: 8.95 (1H, d), 8.00 (1H, s), 7.69 (1H, d), 7.44 (1H, dd), 4.92 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
Compound 27: ¹ H-NMR (CDCl ₃ ) δ: 9.03 (1H, d), 8.00 (1H, s), 7.64 (1H, d), 7.54 (1H, dd), 4.92 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
Compound 28: ¹ H-NMR (CDCl ₃ ) δ: 9.12 (1H, s), 8.00 (1H, s), 7.65 (1H, d), 7.52 (1H, d), 4.92 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
Compound 32: ¹ H-NMR (CDCl ₃ ) δ: 8.67 (1H, s), 7.98 (1H, s), 7.63 (1H, d), 7.16 (1H, d), 4.90 (2H, dd), 3.62 (2H, q), 3.51 (3H, s), 2.01-1.97 (1H, m), 1.42 (3H, t), 1.08-1.03 (2H, m), 0.75 (2H, m).
Compound 33: ¹ H-NMR (CDCl ₃ ) δ: 9.17 (1H, dd), 9.00 (1H, d), 8.13 (1H, dd), 8.07 (1H, s), 7.93 (1H, d), 7.88 (1H, d), 7.72 (1H, dd), 4.95 (2H, dd), 3.74 (2H, q), 3.56 (3H, s), 1.48 (3H, t).
Compound 34: ¹ H-NMR (CDCl ₃ ) δ: 9.95 (1H, dd), 8.24 (1H, dd), 8.08 (1H, s), 7.83 (1H, dd), 4.94 (2H, dd), 3.77 (2H, q), 3.53 (3H, s), 1.49 (3H, t).
Compound 35: ¹ H-NMR (CDCl ₃ ) δ: 8.76 (1H, dd), 8.00 (1H, s), 7.92 (1H, dd), 7.15 (1H, dd), 4.91 (2H, dd), 3.66 (2H, q), 3.51 (3H, s), 1.42 (3H, t).
Compound 36: ¹ H-NMR (CDCl ₃ ) δ: 8.69 (1H, d), 7.99 (1H, s), 6.98 (1H, d), 6.74 (1H, dd), 4.90 (2H, dd), 3.91 (3H, s), 3.60 (2H, q), 3.51 (3H, s), 1.40 (3H, t).
Compound 37: ¹ H-NMR (CDCl ₃ ) δ: 8.67 (1H, d), 7.99 (1H, s), 6.94 (1H, d), 6.72 (1H, dd), 4.90 (2H, dd), 4.11 (2H, t), 3.58 (2H, q), 3.51 (3H, s), 1.49 (3H, t), 1.40 (3H, t).
Compound 38: ¹ H-NMR (CDCl ₃ ) δ: 8.83 (1H, dd), 8.00 (1H, s), 7.73 (1H, dd), 7.04 (1H, dd), 4.91 (2H, dd), 3.66 (2H, q), 3.52 (3H, s), 1.42 (3H, t).
Compound 39: ¹ H-NMR (CDCl ₃ ) δ: 8.85 (1H, dd), 8.05 (1H, s), 7.54 (1H, dd), 7.01 (1H, dd), 4.92 (2H, dd), 3.68 (2H, q), 3.51 (3H, s), 1.43 (3H, t).
Compound 40: ¹ H-NMR (CDCl ₃ ) δ: 8.65 (1H, s), 7.99 (1H, s), 7.64 (1H, d), 7.32 (1H, dd), 4.91 (2H, dd), 3.63 (2H, q), 3.51 (3H, s), 2.42 (3H, s), 1.42 (3H, t).
Compound 41: ¹ H-NMR (CDCl ₃ ) δ: 9.25 (1H, dd), 8.03 (1H, s), 7.93 (1H, d), 7.84-7.84 (2H, m), 7.72 (1H, s) , 4.92 (2H, dd), 3.70 (2H, q), 3.53 (3H, s), 1.46 (3H, t).
Compound 42: ¹ H-NMR (CDCl ₃ ) δ: 8.78 (1H, s), 8.00 (1H, s), 7.68-7.68 (2H, m), 6.73 (1H, dd), 5.84 (1H, d) , 5.45 (1H, d), 4.91 (2H, dd), 3.64 (2H, q), 3.52 (3H, s), 1.43 (3H, t).
Compound 43: ¹ H-NMR (CDCl ₃ ) δ: 8.89 (1H, s), 8.00 (1H, s), 7.67-7.67 (2H, m), 5.49 (1H, s), 5.26 (1H, s) , 4.91 (2H, dd), 3.64 (2H, q), 3.52 (3H, s), 2.21 (3H, s), 1.43 (3H, t).
Compound 44: ¹ H-NMR (CDCl ₃ ) δ: 9.34 (1H, dd), 8.05 (1H, s), 7.83 (1H, dd), 7.57 (1H, dd), 4.93 (2H, dd), 3.73 (2H, q), 3.53 (3H, s), 1.46 (3H, t).
Compound 45: ¹ H-NMR (CDCl ₃ ) δ: 9.55 (1H, s), 8.05 (1H, s), 8.02 (1H, dd), 7.77 (1H, d), 4.93 (2H, dd), 3.72 (2H, q), 3.53 (3H, s), 2.68 (3H, s), 1.46 (3H, t)
Compound 46: ¹ H-NMR (CDCl ₃ ) δ: 9.57 (1H, s), 8.03-8.02 (2H, m), 7.75 (1H, d), 4.92 (2H, dd), 4.00 (3H, s) , 3.70 (2H, q), 3.53 (3H, s), 1.46 (3H, t).
Compound 47: ¹ H-NMR (CDCl ₃ ) 9.12 (1H, s), 8.06 (1H, s), 8.00 (1H, s), 4.92 (2H, dd), 3.67 (2H, q), 3.52 (3H , s), 1.44 (3H, t).
Compound 48: ¹ H-NMR (CDCl ₃ ) δ: 9.20 (1H, dd), 8.26 (1H, s), 7.58 (1H, dd), 7.43 (1H, dd), 4.98-4.90 (2H, m) , 3.68-3.54 (2H, m), 3.52 (3H, s), 1.56 (3H, t).
Compound 49: ¹ H-NMR (CDCl ₃ ) δ: 9.04 (1H, s), 7.99 (1H, s), 7.58 (1H, s), 4.91 (2H, dd), 3.64 (2H, q), 3.51 (3H, s), 2.52 (3H, s), 1.43 (3H, t).
Compound 90: ¹ H-NMR (CDCl ₃ ) δ: 9.03 (1H, d), 8.03 (2H, m), 4.92 (2H, t), 3.68 (2H, q), 3.52 (3H, s), 1.43 (3H, t).
Compound 100: ¹ H-NMR (CDCl ₃ ) δ: 9.24 (1H, d), 8.08 (1H, s), 7.99 (1H, s), 4.90 (2H, t), 3.67 (2H, q), 3.51 (3H, s), 1.43 (3H, t).
Compound 107: ¹ H-NMR (CDCl ₃ ) δ: 9.48 (1H, s), 8.06 (1H, s), 7.88 (1H, d), 7.81 (1H, d), 4.94 (2H, t), 3.74 (2H, q), 3.54 (3H, s), 3.24 (2H, q), 1.47 (3H, t), 1.37 (3H, t).

本化合物２９：¹H-NMR (CDCl₃) δ: 9.27 (1H, s), 7.81 (1H, d), 7.60-7.59 (2H, m), 5.90 (1H, s), 4.49 (2H, t), 3.87 (2H, q), 3.59 (3H, s), 1.47 (3H, t).

Compound 29: ¹ H-NMR (CDCl ₃ ) δ: 9.27 (1H, s), 7.81 (1H, d), 7.60-7.59 (2H, m), 5.90 (1H, s), 4.49 (2H, t) , 3.87 (2H, q), 3.59 (3H, s), 1.47 (3H, t).

で示される化合物において、Ｑaが［表Ａ６−１］に記載のいずれかである化合物。
［表Ａ６−１］

本化合物６８：¹H-NMR (CDCl₃) δ: 9.30 (1H, d), 8.75 (1H, d), 8.13 (1H, s), 4.93 (2H, t), 3.79 (2H, q), 3.53 (3H, s), 1.47 (3H, t).
本化合物６９：¹H-NMR (CDCl₃) δ: 8.02 (1H, d), 7.98 (1H, s), 7.33 (1H, d), 4.92 (2H, t), 3.68 (2H, q), 3.52 (3H, s), 1.47 (3H, t).
本化合物７０：¹H-NMR (CDCl₃) δ: 9.25 (1H, s), 8.80 (1H, d), 8.15 (1H, d), 8.06 (1H, s), 4.93 (2H, t), 3.74 (2H, q), 3.54 (3H, s), 1.45 (3H, t).
本化合物７１：¹H-NMR (CDCl₃) δ: 8.28 (1H, s), 8.18 (1H, d), 6.94 (1H, d), 4.92 (2H, t), 3.51 (3H, s), 3.49-3.38 (2H, m), 1.50 (3H, t).
本化合物１１３：¹H-NMR (CDCl₃) δ: 7.97 (1H, s), 7.75 (1H, d), 7.59 (1H, d), 4.95-4.88 (2H, m), 3.67 (2H, q), 3.52 (3H, s), 1.47 (3H, t).
本化合物７２：¹H-NMR (CDCl₃) δ: 8.02 (1H, s), 7.95 (1H, d), 7.04 (1H, d), 4.91 (2H, t), 3.64 (2H, q), 3.52 (3H, s), 1.39 (3H, t).
本化合物７３：¹H-NMR (CDCl₃) δ: 10.04 (1H, s), 8.41 (1H, s), 7.96 (1H, s), 5.00-4.93 (2H, m), 3.70-3.62 (2H, m), 3.53 (3H, s), 1.61 (3H, t).
本化合物７４：¹H-NMR (CDCl₃) δ: 9.77 (1H, s), 8.09 (1H, s), 8.03 (1H, s), 4.94 (2H, t), 3.80 (2H, q), 3.54 (3H, s), 1.49 (3H, t).
本化合物９９：¹H-NMR (CDCl₃) δ: 9.38 (1H, d), 8.83 (1H, d), 8.13 (1H, s), 4.93 (2H, t), 3.79 (2H, q), 3.53 (3H, s), 1.47 (3H, t).
本化合物９１：¹H-NMR (CDCl₃) δ: 9.40 (1H, d), 8.16 (1H, s), 7.45 (1H, d), 4.94 (2H, t), 3.83 (2H, q), 3.54 (3H, s), 1.46 (3H, t). Production Example 6-2
The compounds produced according to Production Example 5 and their physical properties are shown below.
Formula (A-4-1)

In which Qa is any of those listed in [Table A6-1].
[Table A6-1]

Compound 68: ¹ H-NMR (CDCl ₃ ) δ: 9.30 (1H, d), 8.75 (1H, d), 8.13 (1H, s), 4.93 (2H, t), 3.79 (2H, q), 3.53 (3H, s), 1.47 (3H, t).
Compound 69: ¹ H-NMR (CDCl ₃ ) δ: 8.02 (1H, d), 7.98 (1H, s), 7.33 (1H, d), 4.92 (2H, t), 3.68 (2H, q), 3.52 (3H, s), 1.47 (3H, t).
Compound 70: ¹ H-NMR (CDCl ₃ ) δ: 9.25 (1H, s), 8.80 (1H, d), 8.15 (1H, d), 8.06 (1H, s), 4.93 (2H, t), 3.74 (2H, q), 3.54 (3H, s), 1.45 (3H, t).
Compound 71: ¹ H-NMR (CDCl ₃ ) δ: 8.28 (1H, s), 8.18 (1H, d), 6.94 (1H, d), 4.92 (2H, t), 3.51 (3H, s), 3.49 -3.38 (2H, m), 1.50 (3H, t).
Compound 113: ¹ H-NMR (CDCl ₃ ) δ: 7.97 (1H, s), 7.75 (1H, d), 7.59 (1H, d), 4.95-4.88 (2H, m), 3.67 (2H, q) , 3.52 (3H, s), 1.47 (3H, t).
Compound 72: ¹ H-NMR (CDCl ₃ ) δ: 8.02 (1H, s), 7.95 (1H, d), 7.04 (1H, d), 4.91 (2H, t), 3.64 (2H, q), 3.52 (3H, s), 1.39 (3H, t).
Compound 73: ¹ H-NMR (CDCl ₃ ) δ: 10.04 (1H, s), 8.41 (1H, s), 7.96 (1H, s), 5.00-4.93 (2H, m), 3.70-3.62 (2H, m), 3.53 (3H, s), 1.61 (3H, t).
Compound 74: ¹ H-NMR (CDCl ₃ ) δ: 9.77 (1H, s), 8.09 (1H, s), 8.03 (1H, s), 4.94 (2H, t), 3.80 (2H, q), 3.54 (3H, s), 1.49 (3H, t).
Compound 99: ¹ H-NMR (CDCl ₃ ) δ: 9.38 (1H, d), 8.83 (1H, d), 8.13 (1H, s), 4.93 (2H, t), 3.79 (2H, q), 3.53 (3H, s), 1.47 (3H, t).
Compound 91: ¹ H-NMR (CDCl ₃ ) δ: 9.40 (1H, d), 8.16 (1H, s), 7.45 (1H, d), 4.94 (2H, t), 3.83 (2H, q), 3.54 (3H, s), 1.46 (3H, t).

本化合物３０：¹H-NMR (CDCl₃) δ: 9.12-9.12 (1H, m), 7.96 (1H, s), 7.65-7.63 (1H, m), 7.53-7.50 (1H, m), 4.46 (2H, s), 3.67 (2H, q), 3.57 (3H, s), 1.47-1.44 (5H, m), 1.25-1.20 (2H, m). Production Example 7
150 mg of cesium carbonate was added to a mixture of 181 mg of the present compound 28, 45 mg of (1-cyanocyclopropyl) methanol and 1 mL of DMF, and the mixture was stirred at room temperature for 1 hour. Water was added to the mixture and extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 139 mg of the present compound 30 represented by the following formula.

Compound 30: ¹ H-NMR (CDCl ₃ ) δ: 9.12-9.12 (1H, m), 7.96 (1H, s), 7.65-7.63 (1H, m), 7.53-7.50 (1H, m), 4.46 ( 2H, s), 3.67 (2H, q), 3.57 (3H, s), 1.47-1.44 (5H, m), 1.25-1.20 (2H, m).

で示される化合物において、Ｔ及びＲ^3bの組み合わせが［表Ａ８］に記載のいずれかの組み合わせである化合物。
［表Ａ８］

本化合物３１：¹H-NMR (CDCl₃) δ: 9.13-9.12 (1H, m), 7.99 (1H, s), 7.65-7.63 (1H, m), 7.53-7.51 (1H, m), 4.39 (2H, s), 3.67 (2H, q), 3.56 (3H, s), 1.52 (6H, s), 1.44 (3H, t).
本化合物７８：¹H-NMR (CDCl₃) δ: 9.12 (1H, d), 8.01 (1H, s), 7.65 (1H, dd), 7.53 (1H, d), 5.96 (1H, tt), 4.87 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
本化合物７９：¹H-NMR (CDCl₃) δ: 9.13 (1H, d), 8.03 (1H, s), 7.68 (1H, dd), 7.57 (1H, d), 5.10-4.93 (1H, m), 4.90-4.84 (2H, m), 3.67 (2H, q), 3.53 (3H, s), 1.44 (3H, t).
本化合物８０：¹H-NMR (CDCl₃) δ: 9.13 (1H, s), 8.01 (1H, s), 7.66 (1H, d), 7.53 (1H, d), 4.97 (2H, t), 3.66 (2H, q), 3.53 (3H, s), 1.44 (3H, t).
本化合物８１：¹H-NMR (CDCl₃) δ: 9.13 (1H, s), 8.01 (1H, s), 7.64 (1H, d), 7.52 (1H, d), 4.55 (2H, t), 3.67 (2H, q), 3.49 (3H, s), 2.26-2.21 (2H, m), 1.43 (3H, t).
本化合物８２：¹H-NMR (CDCl₃) δ: 9.04 (1H, d), 8.01 (1H, s), 7.64 (1H, d), 7.53 (1H, dd), 5.96 (1H, tt), 4.87 (2H, t), 3.67 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
本化合物８３：¹H-NMR (CDCl₃) δ: 9.03 (1H, d), 8.01 (1H, s), 7.65 (1H, d), 7.54 (1H, dd), 4.96 (2H, t), 3.67 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
本化合物５９：9.12 (1H, s), 8.00 (1H, s), 7.65 (1H, d), 7.53 (1H, d), 4.96 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
本化合物６０：¹H-NMR (CDCl₃) δ: 9.04 (1H, d), 8.01 (1H, s), 7.65 (1H, d), 7.54 (1H, dd), 5.06-4.96 (1H, m), 4.90-4.84 (2H, m), 3.67 (2H, q), 3.53 (3H, s), 1.44 (3H, t).
本化合物１０３：¹H-NMR (CDCl₃) δ: 9.03 (1H, dd), 8.00 (1H, s), 7.64 (1H, dd), 7.54 (1H, dd), 4.85 (2H, q), 3.66 (2H, q), 3.54 (3H, s), 1.44 (3H, t).
本化合物１０４：¹H-NMR (CDCl₃) δ: 9.12 (1H, dd), 8.00 (1H, s), 7.65 (1H, dd), 7.52 (1H, dd), 4.85 (2H, q), 3.66 (2H, q), 3.54 (3H, s), 1.44 (3H, t).
本化合物１０５：¹H-NMR (CDCl₃) δ: 9.04 (1H, dd), 8.01 (1H, s), 7.63 (1H, dd), 7.53 (1H, dd), 4.71 (2H, t), 3.67 (2H, q), 3.48 (3H, s), 2.73-2.62 (2H, m), 1.44 (3H, t).
本化合物１０６：¹H-NMR (CDCl₃) δ: 9.12 (1H, s), 8.00 (1H, s), 7.64 (1H, d), 7.52 (1H, d), 4.70 (2H, t), 3.66 (2H, q), 3.48 (3H, s), 2.67 (2H, tt), 1.43 (3H, t). Production Example 8
The compounds produced according to Production Example 7 and their physical properties are shown below.
Formula (A-8)

In which the combination of T and R ^3b is any combination described in [Table A8].
[Table A8]

Compound 31: ¹ H-NMR (CDCl ₃ ) δ: 9.13-9.12 (1H, m), 7.99 (1H, s), 7.65-7.63 (1H, m), 7.53-7.51 (1H, m), 4.39 ( 2H, s), 3.67 (2H, q), 3.56 (3H, s), 1.52 (6H, s), 1.44 (3H, t).
Compound 78: ¹ H-NMR (CDCl ₃ ) δ: 9.12 (1H, d), 8.01 (1H, s), 7.65 (1H, dd), 7.53 (1H, d), 5.96 (1H, tt), 4.87 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
Compound 79: ¹ H-NMR (CDCl ₃ ) δ: 9.13 (1H, d), 8.03 (1H, s), 7.68 (1H, dd), 7.57 (1H, d), 5.10-4.93 (1H, m) , 4.90-4.84 (2H, m), 3.67 (2H, q), 3.53 (3H, s), 1.44 (3H, t).
Compound 80: ¹ H-NMR (CDCl ₃ ) δ: 9.13 (1H, s), 8.01 (1H, s), 7.66 (1H, d), 7.53 (1H, d), 4.97 (2H, t), 3.66 (2H, q), 3.53 (3H, s), 1.44 (3H, t).
Compound 81: ¹ H-NMR (CDCl ₃ ) δ: 9.13 (1H, s), 8.01 (1H, s), 7.64 (1H, d), 7.52 (1H, d), 4.55 (2H, t), 3.67 (2H, q), 3.49 (3H, s), 2.26-2.21 (2H, m), 1.43 (3H, t).
Compound 82: ¹ H-NMR (CDCl ₃ ) δ: 9.04 (1H, d), 8.01 (1H, s), 7.64 (1H, d), 7.53 (1H, dd), 5.96 (1H, tt), 4.87 (2H, t), 3.67 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
Compound 83: ¹ H-NMR (CDCl ₃ ) δ: 9.03 (1H, d), 8.01 (1H, s), 7.65 (1H, d), 7.54 (1H, dd), 4.96 (2H, t), 3.67 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
Compound 59: 9.12 (1H, s), 8.00 (1H, s), 7.65 (1H, d), 7.53 (1H, d), 4.96 (2H, t), 3.66 (2H, q), 3.52 (3H, s), 1.44 (3H, t).
Compound 60: ¹ H-NMR (CDCl ₃ ) δ: 9.04 (1H, d), 8.01 (1H, s), 7.65 (1H, d), 7.54 (1H, dd), 5.06-4.96 (1H, m) , 4.90-4.84 (2H, m), 3.67 (2H, q), 3.53 (3H, s), 1.44 (3H, t).
Compound 103: ¹ H-NMR (CDCl ₃ ) δ: 9.03 (1H, dd), 8.00 (1H, s), 7.64 (1H, dd), 7.54 (1H, dd), 4.85 (2H, q), 3.66 (2H, q), 3.54 (3H, s), 1.44 (3H, t).
Compound 104: ¹ H-NMR (CDCl ₃ ) δ: 9.12 (1H, dd), 8.00 (1H, s), 7.65 (1H, dd), 7.52 (1H, dd), 4.85 (2H, q), 3.66 (2H, q), 3.54 (3H, s), 1.44 (3H, t).
Compound 105: ¹ H-NMR (CDCl ₃ ) δ: 9.04 (1H, dd), 8.01 (1H, s), 7.63 (1H, dd), 7.53 (1H, dd), 4.71 (2H, t), 3.67 (2H, q), 3.48 (3H, s), 2.73-2.62 (2H, m), 1.44 (3H, t).
Compound 106: ¹ H-NMR (CDCl ₃ ) δ: 9.12 (1H, s), 8.00 (1H, s), 7.64 (1H, d), 7.52 (1H, d), 4.70 (2H, t), 3.66 (2H, q), 3.48 (3H, s), 2.67 (2H, tt), 1.43 (3H, t).

本化合物７５：¹H-NMR (CDCl₃) δ: 9.08 (1H, dd), 7.77 (1H, s), 7.67 (1H, dd), 7.56 (1H, dd), 5.00-4.90 (2H, m), 3.94 (3H, s), 3.41 (2H, q), 1.35 (3H, t). Production Example 8-1
A mixture of 0.50 g of the present compound 27, 1.1 g of 2,4-bis (4-methoxyphenyl) -1,3,2,4-dithiadiphosphetane-2,4-disulfide, and 2 mL of xylene, Stir for 5 hours under reflux. The resulting mixture was filtered through Celite (registered trademark) and washed with a saturated aqueous sodium thiosulfate solution. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 0.3 g of the present compound 75 represented by the following formula.

Compound 75: ¹ H-NMR (CDCl ₃ ) δ: 9.08 (1H, dd), 7.77 (1H, s), 7.67 (1H, dd), 7.56 (1H, dd), 5.00-4.90 (2H, m) , 3.94 (3H, s), 3.41 (2H, q), 1.35 (3H, t).

で示される化合物において、Ｔ及びＲ^3bの組み合わせが［表Ａ８−１］に記載のいずれかの組み合わせである化合物。
［表Ａ８−１］

本化合物７６：¹H-NMR (CDCl₃) δ: 8.99 (1H, dd), 7.77 (1H, s), 7.72 (1H, dd), 7.46 (1H, dd), 5.00-4.90 (2H, m), 3.94 (3H, s), 3.42 (2H, q), 1.34 (3H, t).
本化合物７７：¹H-NMR (CDCl₃) δ: 9.16 (1H, d), 7.77 (1H, s), 7.67 (1H, dd), 7.55 (1H, d), 5.00-4.90 (2H, m), 3.94 (3H, s), 3.41 (2H, q), 1.34 (3H, t).
本化合物９２：¹H-NMR (CDCl₃) δ: 9.08 (1H, s), 7.78 (1H, s), 7.66 (1H, d), 7.55 (1H, d), 5.97 (1H, t), 4.95-4.86 (2H, m), 3.94 (3H, s), 3.42 (2H, d), 1.34 (3H, t).
本化合物９３：¹H-NMR (CDCl₃) δ: 9.09 (1H, dd), 7.70 (1H, s), 7.60 (1H, dd), 7.48 (1H, dd), 6.04-5.76 (1H, m), 4.88-4.79 (2H, m), 3.87 (3H, s), 3.34 (2H, q), 1.27 (3H, t). Production Example 8-2
The compound manufactured according to manufacture example 8-1 and the physical-property value are shown below.
Formula (A-8-1)

In which the combination of T and R ^3b is any combination described in [Table A8-1].
[Table A8-1]

Compound 76: ¹ H-NMR (CDCl ₃ ) δ: 8.99 (1H, dd), 7.77 (1H, s), 7.72 (1H, dd), 7.46 (1H, dd), 5.00-4.90 (2H, m) , 3.94 (3H, s), 3.42 (2H, q), 1.34 (3H, t).
Compound 77: ¹ H-NMR (CDCl ₃ ) δ: 9.16 (1H, d), 7.77 (1H, s), 7.67 (1H, dd), 7.55 (1H, d), 5.00-4.90 (2H, m) , 3.94 (3H, s), 3.41 (2H, q), 1.34 (3H, t).
Compound 92: ¹ H-NMR (CDCl ₃ ) δ: 9.08 (1H, s), 7.78 (1H, s), 7.66 (1H, d), 7.55 (1H, d), 5.97 (1H, t), 4.95 -4.86 (2H, m), 3.94 (3H, s), 3.42 (2H, d), 1.34 (3H, t).
Compound 93: ¹ H-NMR (CDCl ₃ ) δ: 9.09 (1H, dd), 7.70 (1H, s), 7.60 (1H, dd), 7.48 (1H, dd), 6.04-5.76 (1H, m) , 4.88-4.79 (2H, m), 3.87 (3H, s), 3.34 (2H, q), 1.27 (3H, t).

中間体２６：ＬＣ−ＭＳ：２１９（−） Reference production example 13
To a mixture of 9.49 g of chloroacetic acid and 15 mL of water, 16.7 mL of triethylamine was added at 0 ° C. over 30 minutes. To the obtained mixture, 16.1 g of 2-amino-5- (trifluoromethyl) pyridine was added and stirred for 2 hours under reflux. The obtained mixture was filtered, and the filtrate was washed with water. The obtained solid was dried to obtain 11.0 g of a crude product of intermediate 26 represented by the following formula.

Intermediate 26: LC-MS: 219 (−)

中間体２７：¹H-NMR (CDCl₃) δ: 8.45 (1H, d), 7.69 (1H, s), 7.67 (1H, dd), 7.36 (1H, dd). Reference production example 14
A mixture of 4.40 g of the intermediate 26 crude product obtained in Reference Production Example 13, 22.37 g of phosphorus oxybromide and 50 mL of toluene was stirred under reflux for 5 hours. The obtained mixture was dropped into an aqueous sodium hydroxide solution and extracted with toluene. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain 4.7 g of intermediate 27 represented by the following formula.

Intermediate 27: ¹ H-NMR (CDCl ₃ ) δ: 8.45 (1H, d), 7.69 (1H, s), 7.67 (1H, dd), 7.36 (1H, dd).

中間体２８：¹H-NMR (CDCl₃) δ: 8.68 (2H, m), 8.52 (1H, s), 7.65 (1H, d), 7.40 (1H, dd), 6.22 (1H, dd), 5.98 (1H, d), 4.41 (2H, dd). Reference production example 15
500 mg of intermediate 27, 4- (2,2,3,3,3-pentafluoropropoxy) -2-pyridinone 453 mg, trans-N, N-dimethylcyclohexane-1,2-diamine 97 mg, copper iodide (I ) A mixture of 130 mg, lithium tert-butoxide 328 mg, and NMP 5 mL was stirred at 120 ° C. for 5 hours. Water was added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 80 mg of intermediate 28 represented by the following formula.

Intermediate 28: ¹ H-NMR (CDCl ₃ ) δ: 8.68 (2H, m), 8.52 (1H, s), 7.65 (1H, d), 7.40 (1H, dd), 6.22 (1H, dd), 5.98 (1H, d), 4.41 (2H, dd).

で示される化合物において、Ａ³が［表Ａ１５］に記載のいずれかである化合物。
［表Ａ１５］

中間体３１：¹H-NMR (CDCl₃) δ: 8.66 (1H, d), 8.54 (1H, s), 8.29 (1H, d), 7.45 (1H, d), 7.31 (1H, dd), 6.20 (1H, dd), 5.97 (1H, d), 4.41 (2H, t).
中間体４０：ＬＣ−ＭＳ：４３９，４４１（＋） Reference Production Example 15-1
The compounds produced according to Reference Production Example 15 and their physical properties are shown below.
Formula (A-15)

In which A ³ is any one of those listed in [Table A15].
[Table A15]

Intermediate 31: ¹ H-NMR (CDCl ₃ ) δ: 8.66 (1H, d), 8.54 (1H, s), 8.29 (1H, d), 7.45 (1H, d), 7.31 (1H, dd), 6.20 (1H, dd), 5.97 (1H, d), 4.41 (2H, t).
Intermediate 40: LC-MS: 439, 441 (+)

中間体３２：¹H-NMR (CDCl₃) δ: 9.37 (1H, d), 8.65 (1H, d), 8.55 (1H, s), 7.70 (1H, d), 7.45 (1H, d), 6.00 (1H, d), 4.89 (2H, t). Reference Production Example 15-2
6-bromo-2-trifluoromethylimidazo [1,2-a] pyridine 2120 mg, 4- (2,2,3,3,3-pentafluoropropoxy) pyrimidin-6 (1H) -one 3730 mg, pyridine-2 -A mixture of 394 mg of carboxylic acid, 609 mg of copper (I) iodide, 5210 mg of cesium carbonate, and 20 mL of NMP was stirred at 120 ° C for 8 hours. Water was added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 100 mg of intermediate 32 represented by the following formula.

Intermediate 32: ¹ H-NMR (CDCl ₃ ) δ: 9.37 (1H, d), 8.65 (1H, d), 8.55 (1H, s), 7.70 (1H, d), 7.45 (1H, d), 6.00 (1H, d), 4.89 (2H, t).

中間体２９：¹H-NMR (CDCl₃) δ: 8.54 (1H, s), 7.73 (1H, d), 7.52-7.47 (1H, m), 7.40 (1H, d), 6.15 (1H, dd), 5.97 (1H, d), 4.42 (2H, dd). Reference Production Example 16
To a mixture of 110 mg of the intermediate 28 and 10 mL of acetonitrile, 64 mg of N-iodosuccinimide was added under ice cooling, and the mixture was stirred at room temperature for 5 hours. A sodium thiosulfate aqueous solution was added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain 130 mg of intermediate 29 represented by the following formula.

Intermediate 29: ¹ H-NMR (CDCl ₃ ) δ: 8.54 (1H, s), 7.73 (1H, d), 7.52-7.47 (1H, m), 7.40 (1H, d), 6.15 (1H, dd) , 5.97 (1H, d), 4.42 (2H, dd).

で示される化合物において、Ａ³及びＲ^3bの組み合わせが［表Ａ１６］に記載のいずれかの組み合わせである化合物。
［表Ａ１６］

中間体３３：¹H-NMR (CDCl₃) δ: 8.32 (1H, d), 7.51 (1H, d), 7.42-7.39 (2H, m), 6.13 (1H, dd), 5.96 (1H, d), 4.41 (2H, t).
中間体３４：¹H-NMR (CDCl₃) δ: 8.55 (1H, d), 8.19 (1H, d), 7.77 (1H, d), 7.53 (1H, dd), 5.98 (1H, d), 4.87 (2H, t).
中間体４１：¹H-NMR (CDCl₃) δ: 8.34 (1H, t), 8.17 (1H, s), 7.54 (1H, d), 7.45 (1H, dd), 5.97 (1H, s), 4.86 (2H, t). Reference Production Example 16-1
The compounds produced according to Reference Production Example 16 and their physical properties are shown below.
Formula (A-16)

In which the combination of A ³ and R ^3b is any combination described in [Table A16].
[Table A16]

Intermediate 33: ¹ H-NMR (CDCl ₃ ) δ: 8.32 (1H, d), 7.51 (1H, d), 7.42-7.39 (2H, m), 6.13 (1H, dd), 5.96 (1H, d) , 4.41 (2H, t).
Intermediate 34: ¹ H-NMR (CDCl ₃ ) δ: 8.55 (1H, d), 8.19 (1H, d), 7.77 (1H, d), 7.53 (1H, dd), 5.98 (1H, d), 4.87 (2H, t).
Intermediate 41: ¹ H-NMR (CDCl ₃ ) δ: 8.34 (1H, t), 8.17 (1H, s), 7.54 (1H, d), 7.45 (1H, dd), 5.97 (1H, s), 4.86 (2H, t).

本化合物６１：ＬＣ−ＭＳ：４８８ （＋） Production Example 11
A mixture of 130 mg of intermediate 29, 1,4-dioxane 2 mL, tris (dibenzylideneacetone) dipalladium (0) 22 mg, Xantphos 29 mg, diisopropylethylamine 0.040 mL and ethanethiol 0.12 mL was stirred at reflux for 270 minutes. . Water was added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain 140 mg of a crude product of the present compound 61 represented by the following formula.

Compound 61: LC-MS: 488 (+)

で示される化合物において、Ａ³及びＲ^3bの組み合わせが［表Ａ１１］に記載のいずれかの組み合わせである化合物。
［表Ａ１１］

本化合物９４：¹H-NMR (CDCl₃) δ: 8.60 (1H, d), 7.57-7.31 (3H, m), 6.14-6.09 (1H, m), 5.96 (1H, d), 4.41 (2H, t), 2.77 (2H, q), 1.19 (3H, t).
本化合物９５：¹H-NMR (CDCl₃) δ: 8.85 (1H, s), 8.10 (1H, s), 7.80 (1H, d), 7.56 (1H, dd), 5.98 (1H, s), 4.87 (2H, t), 2.81 (2H, q), 1.21 (3H, t).
本化合物１０８：¹H-NMR (CDCl₃) δ: 8.62 (1H, d), 8.09 (1H, d), 7.58 (1H, d), 7.48 (1H, dd), 5.97 (1H, s), 4.86 (3H, t), 2.78 (2H, q), 1.20 (3H, t). Production Example 11-1
The compounds produced according to Production Example 11 and their physical properties are shown below.
Formula (A-11)

In which the combination of A ³ and R ^3b is any combination described in [Table A11].
[Table A11]

Compound 94: ¹ H-NMR (CDCl ₃ ) δ: 8.60 (1H, d), 7.57-7.31 (3H, m), 6.14-6.09 (1H, m), 5.96 (1H, d), 4.41 (2H, t), 2.77 (2H, q), 1.19 (3H, t).
Compound 95: ¹ H-NMR (CDCl ₃ ) δ: 8.85 (1H, s), 8.10 (1H, s), 7.80 (1H, d), 7.56 (1H, dd), 5.98 (1H, s), 4.87 (2H, t), 2.81 (2H, q), 1.21 (3H, t).
Compound 108: ¹ H-NMR (CDCl ₃ ) δ: 8.62 (1H, d), 8.09 (1H, d), 7.58 (1H, d), 7.48 (1H, dd), 5.97 (1H, s), 4.86 (3H, t), 2.78 (2H, q), 1.20 (3H, t).

本化合物６２：¹H-NMR (CDCl₃) δ: 9.25 (1H, s), 7.88 (1H, d), 7.69 (1H, dd), 7.42 (1H, d), 6.17 (1H, dd), 5.91 (1H, d), 4.41 (2H, dd), 3.66 (2H, q), 1.46 (3H, t). Production Example 12
To a mixture of 140 mg of the crude product of Compound 61 obtained in Production Example 11 and 3 mL of chloroform, 260 mg of mCPBA (purity 70%, containing 30% water) was added under ice cooling, and the mixture was stirred at room temperature for 4 hours. A saturated aqueous sodium bicarbonate solution and an aqueous sodium thiosulfate solution were sequentially added to the resulting mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 76 mg of the present compound 62 represented by the following formula.

Compound 62: ¹ H-NMR (CDCl ₃ ) δ: 9.25 (1H, s), 7.88 (1H, d), 7.69 (1H, dd), 7.42 (1H, d), 6.17 (1H, dd), 5.91 (1H, d), 4.41 (2H, dd), 3.66 (2H, q), 1.46 (3H, t).

で示される化合物において、Ａ³、Ｒ^3b及びｎの組み合わせが［表Ａ１２］に記載のいずれかの組み合わせである化合物。
［表Ａ１２］

本化合物９６：¹H-NMR (CDCl₃) δ: 9.03 (1H, d), 7.66-7.62 (2H, m), 7.40 (1H, d), 6.15 (1H, dd), 5.90 (1H, d), 4.41 (2H, t), 3.61 (2H, q), 1.45 (3H, t).
本化合物１０９：LC-MS: 578 [M+H]⁺ RT = 1.92分
本化合物９７：¹H-NMR (CDCl₃) δ: 9.26 (1H, s), 8.18 (1H, s), 7.93 (1H, d), 7.74 (1H, dd), 5.94 (1H, s), 4.87 (2H, m), 3.59 (2H, q), 1.44 (3H, t).
本化合物１１０：LC-MS: 515 [M+H]⁺ RT = 2.00分
本化合物１１１：LC-MS: 531 [M+H]⁺ Production Example 12-1
The compounds produced according to Production Example 12 and their physical properties are shown below.
Formula (A-12)

In which the combination of A ³ , R ^3b and n is any combination described in [Table A12].
[Table A12]

Compound 96: ¹ H-NMR (CDCl ₃ ) δ: 9.03 (1H, d), 7.66-7.62 (2H, m), 7.40 (1H, d), 6.15 (1H, dd), 5.90 (1H, d) , 4.41 (2H, t), 3.61 (2H, q), 1.45 (3H, t).
Compound 109: LC-MS: 578 [M + H] ⁺ RT = 1.92 minutes Compound 97: ¹ H-NMR (CDCl ₃ ) δ: 9.26 (1H, s), 8.18 (1H, s), 7.93 (1H , d), 7.74 (1H, dd), 5.94 (1H, s), 4.87 (2H, m), 3.59 (2H, q), 1.44 (3H, t).
Compound 110: LC-MS: 515 [M + H] ⁺ RT = 2.00 minutes Compound 111: LC-MS: 531 [M + H] ⁺

中間体３０ Reference Production Example 17
A mixture of 100 mg of the crude product of Compound 28, 1 mL of 2N aqueous sodium hydroxide solution and 1 mL of DMF is stirred at 60 ° C. for 1 hour. Water is added to the resulting mixture and extracted with ethyl acetate. The resulting organic layer is dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue is subjected to silica gel column chromatography to obtain an intermediate 30 represented by the following formula.

Intermediate 30

Production Example 13
A mixture of 100 mg of the intermediate 30 obtained in Reference Production Example 17, 282 mg of 2,2,3,3-tetrafluoropropyl triflate, 360 mg of cesium carbonate and 1 mL of DMF is stirred at 60 ° C. for 1 hour. Water is added to the resulting mixture and extracted with ethyl acetate. The resulting organic layer is dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue is subjected to silica gel column chromatography to give compound 78.

中間体３５：¹H-NMR (CDCl₃) δ: 8.42-8.41 (1H, m), 7.66 (1H, d), 7.41 (1H, dd). Reference Production Example 18
The compounds produced in accordance with Reference Production Example 16 using Intermediate 27 instead of Intermediate 28 and their physical properties are shown below.

Intermediate 35: ¹ H-NMR (CDCl ₃ ) δ: 8.42-8.41 (1H, m), 7.66 (1H, d), 7.41 (1H, dd).

中間体３６：¹H-NMR (CDCl₃) δ: 8.75 (1H, d), 7.69 (1H, d), 7.44 (1H, dd), 2.79 (2H, q), 1.23 (3H, t). Reference Production Example 19
A compound produced according to Production Example 11 using Intermediate 35 instead of Intermediate 29 and the physical properties thereof are shown below.

Intermediate 36: ¹ H-NMR (CDCl ₃ ) δ: 8.75 (1H, d), 7.69 (1H, d), 7.44 (1H, dd), 2.79 (2H, q), 1.23 (3H, t).

中間体３７：¹H-NMR (CDCl₃) δ: 9.42 (1H, s), 7.82 (1H, d), 7.65 (1H, dd), 3.41 (2H, q), 1.37 (3H, t). Reference Production Example 20
A compound produced according to Production Example 12 using Intermediate 36 instead of Compound 61 and its physical properties are shown below.

Intermediate 37: ¹ H-NMR (CDCl ₃ ) δ: 9.42 (1H, s), 7.82 (1H, d), 7.65 (1H, dd), 3.41 (2H, q), 1.37 (3H, t).

中間体３８：¹H-NMR (CDCl₃) δ: 9.23 (1H, s), 8.37 (1H, s), 8.12 (1H, d), 7.76 (1H, d), 5.92 (2H, br s), 3.32 (2H, q), 1.39 (3H, t). Reference Production Example 21
1.79 g of intermediate 37, 1.16 g of di-tert-butyl 1,2-hydrazine dicarboxylate, 3.18 g of tripotassium phosphate, 0.19 g of copper (I) iodide, 0 of pyridine-2-carboxylic acid A mixture of 12 g and 20 mL NMP was stirred at 100 ° C. for 12 hours. Water was added to the resulting mixture and extracted with chloroform. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. 10 mL of trifluoroacetic acid was added to a mixture of the obtained residue and 10 mL of THF under ice cooling, and the mixture was stirred at room temperature for 6 hours. Water was added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 0.45 g of an intermediate 38 represented by the following formula.

Intermediate 38: ¹ H-NMR (CDCl ₃ ) δ: 9.23 (1H, s), 8.37 (1H, s), 8.12 (1H, d), 7.76 (1H, d), 5.92 (2H, br s), 3.32 (2H, q), 1.39 (3H, t).

中間体３９：¹H-NMR (CDCl₃) δ: 9.23 (1H, s), 7.98 (1H, s), 7.94 (1H, d), 7.72 (1H, d), 3.56 (2H, q), 1.45 (3H, t). Reference Production Example 22
A mixture of 93 mg of Intermediate 38, 51 mg of mucochloroacid, and 0.9 mL of 10% hydrochloric acid was stirred at 100 ° C. for 8 hours. Water was added to the resulting mixture and extracted with chloroform. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 30 mg of intermediate 39 represented by the following formula.

Intermediate 39: ¹ H-NMR (CDCl ₃ ) δ: 9.23 (1H, s), 7.98 (1H, s), 7.94 (1H, d), 7.72 (1H, d), 3.56 (2H, q), 1.45 (3H, t).

本化合物９８：¹H-NMR (CDCl₃) δ: 10.24 (1H, s), 9.47 (1H, s), 7.76 (1H, d), 7.68 (1H, d), 5.38 (2H, t), 3.47 (2H, q), 1.36 (3H, t). Production Example 14
To a mixture of 30 mg of intermediate 39, 2,2,3,3,3-pentafluoro-1-propanol 30 mg and DMF 2 mL, 195 mg of cesium carbonate was added and stirred at room temperature for 1 hour. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 20 mg of the present compound 98 represented by the following formula.

Compound 98: ¹ H-NMR (CDCl ₃ ) δ: 10.24 (1H, s), 9.47 (1H, s), 7.76 (1H, d), 7.68 (1H, d), 5.38 (2H, t), 3.47 (2H, q), 1.36 (3H, t).

  Next, the example of this compound manufactured according to either the manufacture example described in an Example and the manufacturing method described in this specification is shown below.

で示される化合物（以下、化合物（Ｌ−１）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1と記す）。 Formula (L-1)

In the compound represented by (hereinafter referred to as compound (L-1)), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX1).

In the compound (L-1), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX2).
In the compound (L-1), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX3).
In the compound (L-1), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is any substituent described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX4).
In the compound (L-1), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is any one of the substitutions described in [Table 1A] to [Table 6A] A compound which is a group (hereinafter referred to as compound group SX5).
In compound (L-1), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX6).
In compound (L-1), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX7).
In compound (L-1), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any of the substituents described below (hereinafter referred to as compound group SX8).
In compound (L-1), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX9).
In the compound (L-1), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX10).
In the compound (L-1), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX11).
In the compound (L-1), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX12).
In compound (L-1), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX13).
In the compound (L-1), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX14).
In the compound (L-1), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX15).
In the compound (L-1), R ^3b and R ^3c are hydrogen atoms, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX16).
In the compound (L-1), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX17).
In the compound (L-1), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX18).
In the compound (L-1), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a hydrogen atom, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX2291).
In the compound (L-1), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2292).
In the compound (L-1), R ^3b is a chlorine atom, R ^3c is a hydroxy group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX2293).
In the compound (L-1), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX2294).
In the compound (L-1), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX2295).
In the compound (L-1), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an isopropyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX2296).
In the compound (L-1), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [ A compound which is any one of the substituents described in Table 6A] (hereinafter referred to as compound group SX2297).
In the compound (L-1), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a hydrogen atom, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX2298).
In the compound (L-1), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX2299).
In the compound (L-1), R ^3b is a bromine atom, R ^3c is a hydroxy group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX2300).
In the compound (L-1), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX2301).
In the compound (L-1), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX2302).
In the compound (L-1), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an isopropyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX2303).
In the compound (L-1), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [ A compound which is any one of the substituents described in Table 6A] (hereinafter referred to as compound group SX2304).
In the compound (L-1), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a hydrogen atom, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2305).
In the compound (L-1), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2306).
In the compound (L-1), R ^3b is an iodine atom, R ^3c is a hydroxy group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2307).
In the compound (L-1), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX2308).
In the compound (L-1), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX2309).
In the compound (L-1), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an isopropyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX2310).
In the compound (L-1), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 1A] A compound which is any one of the substituents described in Table 6A] (hereinafter referred to as compound group SX2311).

で示される化合物（以下、化合物（Ｌ−２）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX19と記す）。
化合物（Ｌ−２）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX20と記す）。
化合物（Ｌ−２）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX21と記す）。
化合物（Ｌ−２）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX22と記す）。
化合物（Ｌ−２）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX23と記す）。
化合物（Ｌ−２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX24と記す）。
化合物（Ｌ−２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX25と記す）。
化合物（Ｌ−２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX26と記す）。
化合物（Ｌ−２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX27と記す）。
化合物（Ｌ−２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX28と記す）。
化合物（Ｌ−２）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX29と記す）。
化合物（Ｌ−２）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX30と記す）。
化合物（Ｌ−２）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX31と記す）。
化合物（Ｌ−２）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX32と記す）。
化合物（Ｌ−２）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX33と記す）。
化合物（Ｌ−２）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX34と記す）。
化合物（Ｌ−２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX35と記す）。
化合物（Ｌ−２）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX36と記す）。 Formula (L-2)

In the compound represented by (hereinafter referred to as compound (L-2)), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX19).
In the compound (L-2), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX20).
In the compound (L-2), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX21).
In the compound (L-2), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX22).
In the compound (L-2), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX23).
In the compound (L-2), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX24).
In compound (L-2), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX25).
In compound (L-2), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX26).
In compound (L-2), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX27).
In the compound (L-2), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX28).
In the compound (L-2), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX29).
In the compound (L-2), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX30).
In the compound (L-2), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX31).
In the compound (L-2), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX32).
In the compound (L-2), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX33).
In the compound (L-2), R ^3b and R ^3c are hydrogen atoms, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX34).
In the compound (L-2), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX35).
In the compound (L-2), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX36).

で示される化合物（以下、化合物（Ｌ−３）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX37と記す）。
化合物（Ｌ−３）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX38と記す）。
化合物（Ｌ−３）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX39と記す）。
化合物（Ｌ−３）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX40と記す）。
化合物（Ｌ−３）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX41と記す）。
化合物（Ｌ−３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX42と記す）。
化合物（Ｌ−３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX43と記す）。
化合物（Ｌ−３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX44と記す）。
化合物（Ｌ−３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX45と記す）。
化合物（Ｌ−３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX46と記す）。
化合物（Ｌ−３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX47と記す）。
化合物（Ｌ−３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX48と記す）。
化合物（Ｌ−３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX49と記す）。
化合物（Ｌ−３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX50と記す）。
化合物（Ｌ−３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX51と記す）。
化合物（Ｌ−３）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX52と記す）。
化合物（Ｌ−３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX53と記す）。
化合物（Ｌ−３）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX54と記す）。 Formula (L-3)

In the compound represented by (hereinafter referred to as compound (L-3)), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX37).
In the compound (L-3), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any substituent described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX38).
In the compound (L-3), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX39).
In the compound (L-3), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX40).
In the compound (L-3), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound which is a group (hereinafter referred to as compound group SX41).
In compound (L-3), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX42).
In compound (L-3), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX43).
In compound (L-3), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any of the substituents described below (hereinafter referred to as compound group SX44).
In compound (L-3), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX45).
In the compound (L-3), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound (hereinafter, referred to as compound group SX46).
In the compound (L-3), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX47).
In the compound (L-3), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX48).
In the compound (L-3), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX49).
In the compound (L-3), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX50).
In the compound (L-3), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX51).
In the compound (L-3), R ^3b and R ^3c are hydrogen atoms, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX52).
In the compound (L-3), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX53).
In the compound (L-3), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX54).

で示される化合物（以下、化合物（Ｌ−４）と記す）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX55と記す）。
化合物（Ｌ−４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX56と記す）。
化合物（Ｌ−４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX57と記す）。
化合物（Ｌ−４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX58と記す）。
化合物（Ｌ−４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX59と記す）。
化合物（Ｌ−４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX60と記す）。
化合物（Ｌ−４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX61と記す）。
化合物（Ｌ−４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX62と記す）。
化合物（Ｌ−４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX63と記す）。
化合物（Ｌ−４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX64と記す）。
化合物（Ｌ−４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX65と記す）。
化合物（Ｌ−４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX66と記す）。
化合物（Ｌ−４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX67と記す）。
化合物（Ｌ−４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX68と記す）。
化合物（Ｌ−４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX69と記す）。
化合物（Ｌ−４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2270と記す）。
化合物（Ｌ−４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2271と記す）。
化合物（Ｌ−４）において、Ｒ^3bが塩素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2272と記す）。
化合物（Ｌ−４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2273と記す）。
化合物（Ｌ−４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2274と記す）。
化合物（Ｌ−４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2275と記す）。
化合物（Ｌ−４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2276と記す）。
化合物（Ｌ−４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2277と記す）。
化合物（Ｌ−４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2278と記す）。
化合物（Ｌ−４）において、Ｒ^3bが臭素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2279と記す）。
化合物（Ｌ−４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2280と記す）。
化合物（Ｌ−４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2281と記す）。
化合物（Ｌ−４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2282と記す）。
化合物（Ｌ−４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2283と記す）。
化合物（Ｌ−４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2284と記す）。
化合物（Ｌ−４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2285と記す）。
化合物（Ｌ−４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2286と記す）。
化合物（Ｌ−４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2287と記す）。
化合物（Ｌ−４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2288と記す）。
化合物（Ｌ−４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2289と記す）。
化合物（Ｌ−４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2290と記す）。 Formula (L-4)

In the compound represented by (hereinafter referred to as compound (L-4)), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX55).
In the compound (L-4), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an ethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX56).
In the compound (L-4), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is a propyl group, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX57).
In the compound (L-4), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX58).
In the compound (L-4), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is any substituent described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as compound group SX59).
In the compound (L-4), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX60).
In the compound (L-4), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound as a substituent (hereinafter referred to as compound group SX61).
In the compound (L-4), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound as a substituent (hereinafter referred to as compound group SX62).
In the compound (L-4), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX63).
In the compound (L-4), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX64).
In the compound (L-4), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX65).
In the compound (L-4), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX66).
In the compound (L-4), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound as a substituent (hereinafter referred to as compound group SX67).
In the compound (L-4), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound as a substituent (hereinafter referred to as compound group SX68).
In the compound (L-4), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX69).
In the compound (L-4), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2270).
In the compound (L-4), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2271).
In the compound (L-4), R ^3b is a chlorine atom, R ^3c is a hydroxy group, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2272).
In the compound (L-4), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2273).
In the compound (L-4), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2274).
In the compound (L-4), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2275).
In the compound (L-4), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX2276).
In the compound (L-4), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2277).
In compound (L-4), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2278).
In the compound (L-4), R ^3b is a bromine atom, R ^3c is a hydroxy group, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2279).
In the compound (L-4), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2280).
In the compound (L-4), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2281).
In the compound (L-4), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2282).
In the compound (L-4), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX2283).
In the compound (L-4), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2284).
In the compound (L-4), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2285).
In compound (L-4), R ^3b is an iodine atom, R ^3c is a hydroxy group, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2286).
In the compound (L-4), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2287).
In the compound (L-4), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2288).
In the compound (L-4), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2289).
In the compound (L-4), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX2290).

で示される化合物（以下、化合物（Ｌ−５）と記す）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX70と記す）。
化合物（Ｌ−５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX71と記す）。
化合物（Ｌ−５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX72と記す）。
化合物（Ｌ−５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX73と記す）。
化合物（Ｌ−５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX74と記す）。
化合物（Ｌ−５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX75と記す）。
化合物（Ｌ−５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX76と記す）。
化合物（Ｌ−５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX77と記す）。
化合物（Ｌ−５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX78と記す）。
化合物（Ｌ−５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX79と記す）。
化合物（Ｌ−５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX80と記す）。
化合物（Ｌ−５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX81と記す）。
化合物（Ｌ−５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX82と記す）。
化合物（Ｌ−５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX83と記す）。
化合物（Ｌ−５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX84と記す）。 Formula (L-5)

In the compound represented by (hereinafter referred to as compound (L-5)), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound that is any of the substituents described below (hereinafter referred to as compound group SX70).
In the compound (L-5), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX71).
In the compound (L-5), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is a propyl group, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX72).
In the compound (L-5), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX73).
In the compound (L-5), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is any substituent described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as compound group SX74).
In the compound (L-5), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX75).
In the compound (L-5), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX76).
In the compound (L-5), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX77).
In the compound (L-5), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX78).
In the compound (L-5), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX79).
In the compound (L-5), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX80).
In the compound (L-5), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound as a substituent (hereinafter referred to as compound group SX81).
In the compound (L-5), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX82).
In the compound (L-5), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX83).
In the compound (L-5), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX84).

で示される化合物（以下、化合物（Ｌ−６）と記す）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX85と記す）。
化合物（Ｌ−６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX86と記す）。
化合物（Ｌ−６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX87と記す）。
化合物（Ｌ−６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX88と記す）。
化合物（Ｌ−６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX89と記す）。
化合物（Ｌ−６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX90と記す）。
化合物（Ｌ−６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX91と記す）。
化合物（Ｌ−６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX92と記す）。
化合物（Ｌ−６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX93と記す）。
化合物（Ｌ−６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX94と記す）。
化合物（Ｌ−６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX95と記す）。
化合物（Ｌ−６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX96と記す）。
化合物（Ｌ−６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX97と記す）。
化合物（Ｌ−６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX98と記す）。
化合物（Ｌ−６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX99と記す）。 Formula (L-6)

In the compound represented by (hereinafter referred to as compound (L-6)), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX85).
In the compound (L-6), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX86).
In the compound (L-6), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX87).
In the compound (L-6), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX88).
In the compound (L-6), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is any substituent described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as compound group SX89).
In the compound (L-6), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX90).
In the compound (L-6), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX91).
In the compound (L-6), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX92).
In the compound (L-6), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX93).
In the compound (L-6), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX94).
In the compound (L-6), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX95).
In the compound (L-6), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX96).
In the compound (L-6), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX97).
In the compound (L-6), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX98).
In the compound (L-6), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX99).

で示される化合物（以下、化合物（Ｌ−７）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX100と記す）。
化合物（Ｌ−７）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX101と記す）。
化合物（Ｌ−７）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX102と記す）。
化合物（Ｌ−７）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX103と記す）。
化合物（Ｌ−７）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX104と記す）。
化合物（Ｌ−７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX105と記す）。
化合物（Ｌ−７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX106と記す）。
化合物（Ｌ−７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX107と記す）。
化合物（Ｌ−７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX108と記す）。
化合物（Ｌ−７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX109と記す）。
化合物（Ｌ−７）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX110と記す）。
化合物（Ｌ−７）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX111と記す）。
化合物（Ｌ−７）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX112と記す）。
化合物（Ｌ−７）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX113と記す）。
化合物（Ｌ−７）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX114と記す）。
化合物（Ｌ−７）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX115と記す）。
化合物（Ｌ−７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX116と記す）。
化合物（Ｌ−７）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX117と記す）。 Formula (L-7)

In the compound represented by (hereinafter referred to as compound (L-7)), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX100).
In the compound (L-7), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX101).
In the compound (L-7), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is a propyl group, and T is any substituent described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX102).
In the compound (L-7), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX103).
In compound (L-7), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX104).
In compound (L-7), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX105).
In the compound (L-7), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX106).
In compound (L-7), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX107).
In compound (L-7), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX108).
In the compound (L-7), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX109).
In the compound (L-7), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX110).
In the compound (L-7), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX111).
In the compound (L-7), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX112).
In the compound (L-7), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX113).
In the compound (L-7), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX114).
In the compound (L-7), R ^3b and R ^3c are hydrogen atoms, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX115).
In the compound (L-7), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX116).
In the compound (L-7), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX117).

で示される化合物（以下、化合物（Ｌ−８）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX118と記す）。
化合物（Ｌ−８）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX119と記す）。
化合物（Ｌ−８）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX120と記す）。
化合物（Ｌ−８）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX121と記す）。
化合物（Ｌ−８）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX122と記す）。
化合物（Ｌ−８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX123と記す）。
化合物（Ｌ−８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX124と記す）。
化合物（Ｌ−８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX125と記す）。
化合物（Ｌ−８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX126と記す）。
化合物（Ｌ−８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX127と記す）。
化合物（Ｌ−８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX128と記す）。
化合物（Ｌ−８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX129と記す）。
化合物（Ｌ−８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX130と記す）。
化合物（Ｌ−８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX131と記す）。
化合物（Ｌ−８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX132と記す）。
化合物（Ｌ−８）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX133と記す）。
化合物（Ｌ−８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX134と記す）。
化合物（Ｌ−８）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX135と記す）。 Formula (L-8)

In the compound represented by (hereinafter referred to as compound (L-8)), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX118).
In the compound (L-8), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX119).
In the compound (L-8), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX120).
In the compound (L-8), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX121).
In compound (L-8), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX122).
In compound (L-8), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX123).
In compound (L-8), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX124).
In compound (L-8), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX125).
In compound (L-8), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX126).
In the compound (L-8), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX127).
In the compound (L-8), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX128).
In the compound (L-8), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX129).
In the compound (L-8), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX130).
In the compound (L-8), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX131).
In the compound (L-8), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX132).
In the compound (L-8), R ^3b and R ^3c are hydrogen atoms, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX133).
In the compound (L-8), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX134).
In the compound (L-8), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX135).

で示される化合物（以下、化合物（Ｌ−９）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX136と記す）。
化合物（Ｌ−９）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX137と記す）。
化合物（Ｌ−９）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX138と記す）。
化合物（Ｌ−９）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX139と記す）。
化合物（Ｌ−９）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX140と記す）。
化合物（Ｌ−９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX141と記す）。
化合物（Ｌ−９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX142と記す）。
化合物（Ｌ−９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX143と記す）。
化合物（Ｌ−９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX144と記す）。
化合物（Ｌ−９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX145と記す）。
化合物（Ｌ−９）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX146と記す）。
化合物（Ｌ−９）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX147と記す）。
化合物（Ｌ−９）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX148と記す）。
化合物（Ｌ−９）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX149と記す）。
化合物（Ｌ−９）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX150と記す）。
化合物（Ｌ−９）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX151と記す）。
化合物（Ｌ−９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX152と記す）。
化合物（Ｌ−９）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX153と記す）。 Formula (L-9)

In the compound represented by (hereinafter referred to as compound (L-9)), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX136).
In the compound (L-9), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is an ethyl group, and T is any substituent described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX137).
In the compound (L-9), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is a propyl group, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX138).
In the compound (L-9), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX139).
In compound (L-9), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX140).
In compound (L-9), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX141).
In compound (L-9), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX142).
In compound (L-9), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX143).
In compound (L-9), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX144).
In the compound (L-9), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX145).
In the compound (L-9), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX146).
In the compound (L-9), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX147).
In the compound (L-9), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX148).
In the compound (L-9), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX149).
In the compound (L-9), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX150).
In the compound (L-9), R ^3b and R ^3c are hydrogen atoms, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX151).
In the compound (L-9), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX152).
In the compound (L-9), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX153).

で示される化合物（以下、化合物（Ｌ−１０）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX154と記す）。
化合物（Ｌ−１０）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX155と記す）。
化合物（Ｌ−１０）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX156と記す）。
化合物（Ｌ−１０）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX157と記す）。
化合物（Ｌ−１０）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX158と記す）。
化合物（Ｌ−１０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX159と記す）。
化合物（Ｌ−１０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX160と記す）。
化合物（Ｌ−１０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX161と記す）。
化合物（Ｌ−１０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX162と記す）。
化合物（Ｌ−１０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX163と記す）。
化合物（Ｌ−１０）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX164と記す）。
化合物（Ｌ−１０）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX165と記す）。
化合物（Ｌ−１０）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX166と記す）。
化合物（Ｌ−１０）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX167と記す）。
化合物（Ｌ−１０）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX168と記す）。
化合物（Ｌ−１０）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX169と記す）。
化合物（Ｌ−１０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX170と記す）。
化合物（Ｌ−１０）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX171と記す）。 Formula (L-10)

In the compound represented by (hereinafter referred to as compound (L-10)), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX154).
In the compound (L-10), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX155).
In the compound (L-10), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX156).
In the compound (L-10), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX157).
In compound (L-10), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX158).
In compound (L-10), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX159).
In compound (L-10), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX160).
In compound (L-10), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX161).
In compound (L-10), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX162).
In the compound (L-10), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX163).
In the compound (L-10), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX164).
In the compound (L-10), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX165).
In the compound (L-10), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX166).
In compound (L-10), R ^3b and R ^4c are a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX167).
In the compound (L-10), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX168).
In the compound (L-10), R ^3b and R ^3c are hydrogen atoms, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX169).
In the compound (L-10), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX170).
In the compound (L-10), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX171).

で示される化合物（以下、化合物（Ｌ−１１）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX172と記す）。
化合物（Ｌ−１１）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX173と記す）。
化合物（Ｌ−１１）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX174と記す）。
化合物（Ｌ−１１）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX175と記す）。
化合物（Ｌ−１１）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX176と記す）。
化合物（Ｌ−１１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX177と記す）。
化合物（Ｌ−１１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX178と記す）。
化合物（Ｌ−１１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX179と記す）。
化合物（Ｌ−１１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX180と記す）。
化合物（Ｌ−１１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX181と記す）。
化合物（Ｌ−１１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX182と記す）。
化合物（Ｌ−１１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX183と記す）。
化合物（Ｌ−１１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX184と記す）。
化合物（Ｌ−１１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX185と記す）。
化合物（Ｌ−１１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX186と記す）。
化合物（Ｌ−１１）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX187と記す）。
化合物（Ｌ−１１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX188と記す）。
化合物（Ｌ−１１）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX189と記す）。 Formula (L-11)

In the compound represented by (hereinafter referred to as compound (L-11)), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX172).
In the compound (L-11), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX173).
In the compound (L-11), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX174).
In the compound (L-11), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX175).
In compound (L-11), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound which is a group (hereinafter referred to as compound group SX176).
In compound (L-11), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX177).
In compound (L-11), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX178).
In compound (L-11), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX179).
In compound (L-11), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX180).
In the compound (L-11), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX181).
In the compound (L-11), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX182).
In the compound (L-11), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX183).
In the compound (L-11), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX184).
In the compound (L-11), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any of the substituents described below (hereinafter referred to as compound group SX185).
In the compound (L-11), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX186).
In the compound (L-11), R ^3b and R ^3c are hydrogen atoms, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX187).
In the compound (L-11), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX188).
In the compound (L-11), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX189).

で示される化合物（以下、化合物（Ｌ−１２）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX190と記す）。
化合物（Ｌ−１２）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX191と記す）。
化合物（Ｌ−１２）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX192と記す）。
化合物（Ｌ−１２）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX193と記す）。
化合物（Ｌ−１２）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX194と記す）。
化合物（Ｌ−１２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX195と記す）。
化合物（Ｌ−１２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX196と記す）。
化合物（Ｌ−１２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX197と記す）。
化合物（Ｌ−１２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX198と記す）。
化合物（Ｌ−１２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX199と記す）。
化合物（Ｌ−１２）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX200と記す）。
化合物（Ｌ−１２）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX201と記す）。
化合物（Ｌ−１２）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX202と記す）。
化合物（Ｌ−１２）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX203と記す）。
化合物（Ｌ−１２）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX204と記す）。
化合物（Ｌ−１２）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX205と記す）。
化合物（Ｌ−１２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX206と記す）。
化合物（Ｌ−１２）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX207と記す）。 Formula (L-12)

In the compound represented by (hereinafter referred to as compound (L-12)), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX190).
In the compound (L-12), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX191).
In the compound (L-12), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX192).
In the compound (L-12), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX193).
In compound (L-12), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound which is a group (hereinafter referred to as compound group SX194).
In compound (L-12), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX195).
In compound (L-12), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX196).
In compound (L-12), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX197).
In compound (L-12), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX198).
In the compound (L-12), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX199).
In the compound (L-12), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX200).
In the compound (L-12), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX201).
In the compound (L-12), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX202).
In the compound (L-12), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX203).
In the compound (L-12), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX204).
In the compound (L-12), R ^3b and R ^3c are hydrogen atoms, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX205).
In the compound (L-12), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX206).
In the compound (L-12), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX207).

で示される化合物（以下、化合物（Ｌ−１３）と記す）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX208と記す）。
化合物（Ｌ−１３）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX209と記す）。
化合物（Ｌ−１３）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX210と記す）。
化合物（Ｌ−１３）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX211と記す）。
化合物（Ｌ−１３）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX212と記す）。
化合物（Ｌ−１３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX213と記す）。
化合物（Ｌ−１３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX214と記す）。
化合物（Ｌ−１３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX215と記す）。
化合物（Ｌ−１３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX216と記す）。
化合物（Ｌ−１３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX217と記す）。
化合物（Ｌ−１３）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX218と記す）。
化合物（Ｌ−１３）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX219と記す）。
化合物（Ｌ−１３）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX220と記す）。
化合物（Ｌ−１３）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX221と記す）。
化合物（Ｌ−１３）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX222と記す）。 Formula (L-13)

In the compound represented by (hereinafter referred to as compound (L-13)), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX208).
In the compound (L-13), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX209).
In the compound (L-13), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX210).
In the compound (L-13), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX211).
In the compound (L-13), R ^3b and R ^3c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any substituent described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as Compound Group SX212).
In the compound (L-13), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX213).
In the compound (L-13), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX214).
In the compound (L-13), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX215).
In the compound (L-13), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX216).
In the compound (L-13), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX217).
In the compound (L-13), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX218).
In the compound (L-13), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX219).
In compound (L-13), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX220).
In the compound (L-13), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX221).
In the compound (L-13), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX222).

で示される化合物（以下、化合物（Ｌ−１４）と記す）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX223と記す）。
化合物（Ｌ−１４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX224と記す）。
化合物（Ｌ−１４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX225と記す）。
化合物（Ｌ−１４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX226と記す）。
化合物（Ｌ−１４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX227と記す）。
化合物（Ｌ−１４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX228と記す）。
化合物（Ｌ−１４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX229と記す）。
化合物（Ｌ−１４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX230と記す）。
化合物（Ｌ−１４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX231と記す）。
化合物（Ｌ−１４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX232と記す）。
化合物（Ｌ−１４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX233と記す）。
化合物（Ｌ−１４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX234と記す）。
化合物（Ｌ−１４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX235と記す）。
化合物（Ｌ−１４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX236と記す）。
化合物（Ｌ−１４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX237と記す）。 Formula (L-14)

In the compound represented by (hereinafter referred to as compound (L-14)), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX223).
In the compound (L-14), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX224).
In the compound (L-14), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX225).
In the compound (L-14), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX226).
In the compound (L-14), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is any substituent described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as Compound Group SX227).
In the compound (L-14), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX228).
In the compound (L-14), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX229).
In the compound (L-14), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX230).
In the compound (L-14), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX231).
In the compound (L-14), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX232).
In the compound (L-14), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX233).
In the compound (L-14), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX234).
In the compound (L-14), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX235).
In the compound (L-14), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX236).
In the compound (L-14), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX237).

で示される化合物（以下、化合物（Ｌ−１５）と記す）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX238と記す）。
化合物（Ｌ−１５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX239と記す）。
化合物（Ｌ−１５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX240と記す）。
化合物（Ｌ−１５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX241と記す）。
化合物（Ｌ−１５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX242と記す）。
化合物（Ｌ−１５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX243と記す）。
化合物（Ｌ−１５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX244と記す）。
化合物（Ｌ−１５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX245と記す）。
化合物（Ｌ−１５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX246と記す）。
化合物（Ｌ−１５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX247と記す）。
化合物（Ｌ−１５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX248と記す）。
化合物（Ｌ−１５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX249と記す）。
化合物（Ｌ−１５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX250と記す）。
化合物（Ｌ−１５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX251と記す）。
化合物（Ｌ−１５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX252と記す）。 Formula (L-15)

In the compound represented by (hereinafter referred to as compound (L-15)), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX238).
In the compound (L-15), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX239).
In the compound (L-15), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX240).
In the compound (L-15), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX241).
In the compound (L-15), R ^3b and R ^3c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any substituent described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as Compound Group SX242).
In the compound (L-15), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX243).
In the compound (L-15), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX244).
In the compound (L-15), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX245).
In compound (L-15), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX246).
In the compound (L-15), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX247).
In the compound (L-15), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX248).
In the compound (L-15), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX249).
In the compound (L-15), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX250).
In the compound (L-15), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX251).
In the compound (L-15), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX252).

で示される化合物（以下、化合物（Ｌ−１６）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX253と記す）。
化合物（Ｌ−１６）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX254と記す）。
化合物（Ｌ−１６）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX255と記す）。
化合物（Ｌ−１６）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX256と記す）。
化合物（Ｌ−１６）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX257と記す）。
化合物（Ｌ−１６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX258と記す）。
化合物（Ｌ−１６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX259と記す）。
化合物（Ｌ−１６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX260と記す）。
化合物（Ｌ−１６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX261と記す）。
化合物（Ｌ−１６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX262と記す）。
化合物（Ｌ−１６）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX263と記す）。
化合物（Ｌ−１６）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX264と記す）。
化合物（Ｌ−１６）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX265と記す）。
化合物（Ｌ−１６）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX266と記す）。
化合物（Ｌ−１６）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX267と記す）。
化合物（Ｌ−１６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX268と記す）。
化合物（Ｌ−１６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX269と記す）。
化合物（Ｌ−１６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX270と記す）。 Formula (L-16)

In the compound represented by (hereinafter, referred to as compound (L-16)), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX253).
In the compound (L-16), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX254).
In compound (L-16), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX255).
In the compound (L-16), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX256).
In compound (L-16), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX257).
In compound (L-16), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX258).
In compound (L-16), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX259).
In compound (L-16), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX260).
In compound (L-16), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX261).
In the compound (L-16), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX262).
In the compound (L-16), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX263).
In the compound (L-16), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX264).
In compound (L-16), R ^3b and R ^4c are a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any of the substituents described below (hereinafter referred to as compound group SX265).
In the compound (L-16), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX266).
In the compound (L-16), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound (hereinafter, referred to as compound group SX267).
In the compound (L-16), R ^3b and R ^3c are hydrogen atoms, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX268).
In the compound (L-16), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX269).
In the compound (L-16), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX270).

で示される化合物（以下、化合物（Ｌ−１７）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX271と記す）。
化合物（Ｌ−１７）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX272と記す）。
化合物（Ｌ−１７）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX273と記す）。
化合物（Ｌ−１７）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX274と記す）。
化合物（Ｌ−１７）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX275と記す）。
化合物（Ｌ−１７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX276と記す）。
化合物（Ｌ−１７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX277と記す）。
化合物（Ｌ−１７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX278と記す）。
化合物（Ｌ−１７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX279と記す）。
化合物（Ｌ−１７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX280と記す）。
化合物（Ｌ−１７）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX281と記す）。
化合物（Ｌ−１７）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX282と記す）。
化合物（Ｌ−１７）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX283と記す）。
化合物（Ｌ−１７）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX284と記す）。
化合物（Ｌ−１７）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX285と記す）。
化合物（Ｌ−１７）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX286と記す）。
化合物（Ｌ−１７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX287と記す）。
化合物（Ｌ−１７）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX288と記す）。 Formula (L-17)

In the compound represented by (hereinafter referred to as compound (L-17)), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX271).
In the compound (L-17), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX272).
In the compound (L-17), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX273).
In compound (L-17), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX274).
In compound (L-17), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX275).
In compound (L-17), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX276).
In compound (L-17), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX277).
In compound (L-17), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX278).
In compound (L-17), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX279).
In the compound (L-17), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX280).
In the compound (L-17), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX281).
In the compound (L-17), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX282).
In the compound (L-17), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any of the substituents described below (hereinafter referred to as compound group SX283).
In the compound (L-17), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX284).
In the compound (L-17), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX285).
In the compound (L-17), R ^3b and R ^3c are hydrogen atoms, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX286).
In the compound (L-17), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX287).
In the compound (L-17), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX288).

で示される化合物（以下、化合物（Ｌ−１８）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX289と記す）。
化合物（Ｌ−１８）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX290と記す）。
化合物（Ｌ−１８）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX291と記す）。
化合物（Ｌ−１８）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX292と記す）。
化合物（Ｌ−１８）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX293と記す）。
化合物（Ｌ−１８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX294と記す）。
化合物（Ｌ−１８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX295と記す）。
化合物（Ｌ−１８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX296と記す）。
化合物（Ｌ−１８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX297と記す）。
化合物（Ｌ−１８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX298と記す）。
化合物（Ｌ−１８）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX299と記す）。
化合物（Ｌ−１８）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX300と記す）。
化合物（Ｌ−１８）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX301と記す）。
化合物（Ｌ−１８）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX302と記す）。
化合物（Ｌ−１８）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX303と記す）。
化合物（Ｌ−１８）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX304と記す）。
化合物（Ｌ−１８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX305と記す）。
化合物（Ｌ−１８）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX306と記す）。 Formula (L-18)

In the compound represented by (hereinafter referred to as compound (L-18)), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX289).
In the compound (L-18), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX290).
In the compound (L-18), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX291).
In compound (L-18), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX292).
In compound (L-18), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX293).
In compound (L-18), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX294).
In the compound (L-18), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any of the substituents described below (hereinafter referred to as compound group SX295).
In compound (L-18), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX296).
In compound (L-18), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX297).
In the compound (L-18), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX298).
In the compound (L-18), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX299).
In the compound (L-18), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX300).
In the compound (L-18), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX301).
In the compound (L-18), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX302).
In the compound (L-18), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound (hereinafter, referred to as compound group SX303).
In the compound (L-18), R ^3b and R ^3c are hydrogen atoms, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX304).
In the compound (L-18), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX305).
In the compound (L-18), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX306).

で示される化合物（以下、化合物（Ｌ−１９）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX307と記す）。
化合物（Ｌ−１９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX308と記す）。
化合物（Ｌ−１９）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2と記す）。
化合物（Ｌ−１９）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX309と記す）。
化合物（Ｌ−１９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX310と記す）。
化合物（Ｌ−１９）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX311と記す）。 Formula (L-19)

In the compound represented by (hereinafter referred to as compound (L-19)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX307).
In the compound (L-19), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX308).
In the compound (L-19), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX2).
In the compound (L-19), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX309).
In the compound (L-19), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX310).
In the compound (L-19), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX311).

で示される化合物（以下、化合物（Ｌ−２０）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX312と記す）。
化合物（Ｌ−２０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX313と記す）。
化合物（Ｌ−２０）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX314と記す）。
化合物（Ｌ−２０）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX315と記す）。
化合物（Ｌ−２０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX316と記す）。
化合物（Ｌ−２０）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX317と記す）。 Formula (L-20)

In the compound represented by (hereinafter referred to as compound (L-20)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX312).
In the compound (L-20), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX313).
In the compound (L-20), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX314).
In the compound (L-20), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX315).
In compound (L-20), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX316).
In the compound (L-20), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX317).

で示される化合物（以下、化合物（Ｌ−２１）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX318と記す）。
化合物（Ｌ−２１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX319と記す）。
化合物（Ｌ−２１）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX320と記す）。
化合物（Ｌ−２１）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX321と記す）。
化合物（Ｌ−２１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX322と記す）。
化合物（Ｌ−２１）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX323と記す）。 Formula (L-21)

In the compound represented by (hereinafter referred to as compound (L-21)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX318).
In the compound (L-21), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX319).
In the compound (L-21), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX320).
In the compound (L-21), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX321).
In the compound (L-21), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX322).
In the compound (L-21), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX323).

で示される化合物（以下、化合物（Ｌ−２２）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX324と記す）。
化合物（Ｌ−２２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX325と記す）。
化合物（Ｌ−２２）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX326と記す）。
化合物（Ｌ−２２）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX327と記す）。
化合物（Ｌ−２２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX328と記す）。
化合物（Ｌ−２２）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX329と記す）。 Formula (L-22)

In the compound represented by (hereinafter referred to as compound (L-22)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX324).
In the compound (L-22), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX325).
In the compound (L-22), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX326).
In the compound (L-22), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX327).
In the compound (L-22), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX328).
In the compound (L-22), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX329).

で示される化合物（以下、化合物（Ｌ−２３）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX330と記す）。
化合物（Ｌ−２３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX331と記す）。
化合物（Ｌ−２３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX332と記す）。
化合物（Ｌ−２３）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX333と記す）。
化合物（Ｌ−２３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX334と記す）。
化合物（Ｌ−２３）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX335と記す）。 Formula (L-23)

In the compound represented by (hereinafter referred to as compound (L-23)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX330).
In the compound (L-23), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX331).
In the compound (L-23), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX332).
In the compound (L-23), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX333).
In the compound (L-23), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX334).
In the compound (L-23), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX335).

で示される化合物（以下、化合物（Ｌ−２４）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX336と記す）。
化合物（Ｌ−２４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX337と記す）。
化合物（Ｌ−２４）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX338と記す）。
化合物（Ｌ−２４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX339と記す）。
化合物（Ｌ−２４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX340と記す）。
化合物（Ｌ−２４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX341と記す）。 Formula (L-24)

In the compound represented by (hereinafter referred to as compound (L-24)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX336).
In the compound (L-24), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX337).
In the compound (L-24), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX338).
In the compound (L-24), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX339).
In compound (L-24), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX340).
In the compound (L-24), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX341).

で示される化合物（以下、化合物（Ｌ−２５）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX342と記す）。
化合物（Ｌ−２５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX343と記す）。
化合物（Ｌ−２５）において、Ｒ^3b及びＲ^4aが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX344と記す）。
化合物（Ｌ−２５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX345と記す）。
化合物（Ｌ−２５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX346と記す）。
化合物（Ｌ−２５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX347と記す）。 Formula (L-25)

In the compound represented by (hereinafter referred to as compound (L-25)), R ^3b , R ^3c and R ^4a are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX342).
In the compound (L-25), R ^3b is a trifluoromethyl group, R ^3c and R ^4a are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX343).
In the compound (L-25), R ^3b and R ^4a are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX344).
In the compound (L-25), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4a is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX345).
In the compound (L-25), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4a is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX346).
In the compound (L-25), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4a is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX347).

で示される化合物（以下、化合物（Ｌ−２６）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX348と記す）。
化合物（Ｌ−２６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX349と記す）。
化合物（Ｌ−２６）において、Ｒ^3b及びＲ^4aが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX350と記す）。
化合物（Ｌ−２６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX351と記す）。
化合物（Ｌ−２６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX352と記す）。
化合物（Ｌ−２６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX353と記す）。 Formula (L-26)

In the compound represented by (hereinafter referred to as compound (L-26)), R ^3b , R ^3c and R ^4a are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX348).
In the compound (L-26), R ^3b is a trifluoromethyl group, R ^3c and R ^4a are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX349).
In the compound (L-26), R ^3b and R ^4a are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX350).
In the compound (L-26), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4a is a chlorine atom, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX351).
In compound (L-26), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4a is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX352).
In the compound (L-26), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4a is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX353).

で示される化合物（以下、化合物（Ｌ−２７）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX354と記す）。
化合物（Ｌ−２７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX355と記す）。
化合物（Ｌ−２７）において、Ｒ^3b及びＲ^4aが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX356と記す）。
化合物（Ｌ−２７）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX357と記す）。
化合物（Ｌ−２７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX358と記す）。
化合物（Ｌ−２７）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX359と記す）。 Formula (L-27)

In the compound represented by (hereinafter, referred to as compound (L-27)), R ^3b , R ^3c and R ^4a are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX354).
In the compound (L-27), R ^3b is a trifluoromethyl group, R ^3c and R ^4a are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX355).
In the compound (L-27), R ^3b and R ^4a are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX356).
In the compound (L-27), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4a is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX357).
In the compound (L-27), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4a is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX358).
In the compound (L-27), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4a is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX359).

で示される化合物（以下、化合物（Ｌ−２８）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX360と記す）。
化合物（Ｌ−２８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX361と記す）。
化合物（Ｌ−２８）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX362と記す）。
化合物（Ｌ−２８）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX363と記す）。
化合物（Ｌ−２８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX364と記す）。
化合物（Ｌ−２８）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX365と記す）。 Formula (L-28)

In the compound represented by (hereinafter referred to as compound (L-28)), R ^3b , R ^3c and R ^4c are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX360).
In the compound (L-28), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX361).
In the compound (L-28), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX362).
In the compound (L-28), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4c is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX363).
In the compound (L-28), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX364).
In the compound (L-28), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX365).

で示される化合物（以下、化合物（Ｌ−２９）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX366と記す）。
化合物（Ｌ−２９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX367と記す）。
化合物（Ｌ−２９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX368と記す）。
化合物（Ｌ−２９）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX369と記す）。
化合物（Ｌ−２９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX370と記す）。
化合物（Ｌ−２９）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX371と記す）。 Formula (L-29)

In the compound represented by (hereinafter referred to as compound (L-29)), R ^3b , R ^3c and R ^4c are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX366).
In the compound (L-29), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX367).
In the compound (L-29), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX368).
In the compound (L-29), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4c is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX369).
In the compound (L-29), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX370).
In the compound (L-29), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX371).

で示される化合物（以下、化合物（Ｌ−３０）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX372と記す）。
化合物（Ｌ−３０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX373と記す）。
化合物（Ｌ−３０）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX374と記す）。
化合物（Ｌ−３０）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX375と記す）。
化合物（Ｌ−３０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX376と記す）。
化合物（Ｌ−３０）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX377と記す）。 Formula (L-30)

R ^3b , R ^3c, and R ^4c are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX372).
In the compound (L-30), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX373).
In the compound (L-30), R ^3b and R ^4c are a hydrogen atom, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX374).
In the compound (L-30), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4c is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX375).
In the compound (L-30), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX376).
In the compound (L-30), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX377).

で示される化合物（以下、化合物（Ｌ−３１）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX378と記す）。
化合物（Ｌ−３１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX379と記す）。
化合物（Ｌ−３１）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX380と記す）。
化合物（Ｌ−３１）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX381と記す）。
化合物（Ｌ−３１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX382と記す）。
化合物（Ｌ−３１）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX383と記す）。 Formula (L-31)

In the compound represented by (hereinafter referred to as compound (L-31)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX378).
In the compound (L-31), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX379).
In the compound (L-31), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX380).
In the compound (L-31), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any of the substituents described in Table 1A to Table 6A (Hereinafter referred to as compound group SX381).
In the compound (L-31), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX382).
In the compound (L-31), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX383).

で示される化合物（以下、化合物（Ｌ−３２）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX384と記す）。
化合物（Ｌ−３２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX385と記す）。
化合物（Ｌ−３２）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX386と記す）。
化合物（Ｌ−３２）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX387と記す）。
化合物（Ｌ−３２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX388と記す）。
化合物（Ｌ−３２）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX389と記す）。 Formula (L-32)

In the compound represented by (hereinafter referred to as compound (L-32)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX384).
In the compound (L-32), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX385).
In the compound (L-32), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX386).
In the compound (L-32), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX387).
In the compound (L-32), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX388).
In the compound (L-32), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX389).

で示される化合物（以下、化合物（Ｌ−３３）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX390と記す）。
化合物（Ｌ−３３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX391と記す）。
化合物（Ｌ−３３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX392と記す）。
化合物（Ｌ−３３）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX393と記す）。
化合物（Ｌ−３３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX394と記す）。
化合物（Ｌ−３３）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX395と記す）。 Formula (L-33)

In the compound represented by (hereinafter referred to as compound (L-33)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX390).
In the compound (L-33), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX391).
In the compound (L-33), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX392).
In the compound (L-33), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX393).
In the compound (L-33), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX394).
In the compound (L-33), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX395).

で示される化合物（以下、化合物（Ｌ−３４）と記す）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX396と記す）。
化合物（Ｌ−３４）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX397と記す）。
化合物（Ｌ−３４）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX398と記す）。
化合物（Ｌ−３４）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX399と記す）。
化合物（Ｌ−３４）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX400と記す）。
化合物（Ｌ−３４）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX401と記す）。
化合物（Ｌ−３４）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX402と記す）。
化合物（Ｌ−３４）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX403と記す）。
化合物（Ｌ−３４）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX404と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX405と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX406と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX407と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX408と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX409と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX410と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX411と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX412と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX413と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX414と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX415と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX416と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX417と記す）。
化合物（Ｌ−３４）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX418と記す）。
化合物（Ｌ−３４）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX419と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX420と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX421と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX422と記す）。
化合物（Ｌ−３４）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX423と記す）。 Formula (L-34)

In the compound represented by (hereinafter referred to as compound (L-34)), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A ] To [Table 6A] any one of the substituents (hereinafter, referred to as compound group SX396).
In compound (L-34), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX397).
In compound (L-34), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX398).
In compound (L-34), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX399).
In compound (L-34), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX400).
In the compound (L-34), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] A compound (hereinafter, referred to as compound group SX401).
In the compound (L-34), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is either substituent as described in these (it is hereafter described as the compound group SX402).
In the compound (L-34), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 6A]. ] A compound (hereinafter referred to as compound group SX403).
In the compound (L-34), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX404).
In compound (L-34), G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX405).
In compound (L-34), G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX406).
In compound (L-34), G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX407).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX408).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX409).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX410).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX411).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX412).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX413).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX414).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX415).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX416).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX417).
In the compound (L-34), G ¹ is CH, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX418).
In the compound (L-34), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX419).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX420).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX421).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX422).
In the compound (L-34), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX423).

で示される化合物（以下、化合物（Ｌ−３５）と記す）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX424と記す）。
化合物（Ｌ−３５）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX425と記す）。
化合物（Ｌ−３５）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX426と記す）。
化合物（Ｌ−３５）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX427と記す）。
化合物（Ｌ−３５）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX428と記す）。
化合物（Ｌ−３５）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX429と記す）。
化合物（Ｌ−３５）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX430と記す）。
化合物（Ｌ−３５）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX431と記す）。
化合物（Ｌ−３５）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX432と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX433と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX434と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX435と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX436と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX437と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX438と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX439と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX440と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX441と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX442と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX443と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX444と記す）。
化合物（Ｌ−３５）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX445と記す）。 Formula (L-35)

In the compound represented by (hereinafter, referred to as compound (L-35)), G ¹ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [ Table 6A] is any one of the substituents described below (hereinafter referred to as compound group SX424).
In the compound (L-35), G ¹ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as a compound group SX425).
In compound (L-35), G ¹ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as a compound group SX426).
In the compound (L-35), G ¹ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX427).
In the compound (L-35), G ¹ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX428).
In the compound (L-35), G ¹ is CH, R ^3b is a bromine atom, R ⁶ is a methyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as a compound group SX429).
In the compound (L-35), G ¹ is CH, R ^3b is a bromine atom, R ⁶ is an ethyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX430).
In the compound (L-35), G ¹ is CH, R ^3b is a bromine atom, R ⁶ is an ethyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX431).
In the compound (L-35), G ¹ is CH, R ^3b is a bromine atom, R ⁶ is a propyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX432).
In the compound (L-35), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX433).
In the compound (L-35), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX434).
In the compound (L-35), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX435).
In compound (L-35), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX436).
In compound (L-35), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] (Hereinafter, referred to as compound group SX437).
In compound (L-35), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX438).
In compound (L-35), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX439).
In compound (L-35), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX440).
In compound (L-35), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX441).
In compound (L-35), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX442).
In the compound (L-35), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX443).
In the compound (L-35), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX444).
In compound (L-35), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX445).

で示される化合物（以下、化合物（Ｌ−３６）と記す）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX446と記す）。
化合物（Ｌ−３６）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX447と記す）。
化合物（Ｌ−３６）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX448と記す）。
化合物（Ｌ−３６）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX449と記す）。
化合物（Ｌ−３６）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX450と記す）。
化合物（Ｌ−３６）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX451と記す）。
化合物（Ｌ−３６）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX452と記す）。
化合物（Ｌ−３６）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX453と記す）。
化合物（Ｌ−３６）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX454と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX455と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX456と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX457と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX458と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX459と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX460と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX461と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX462と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX463と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX464と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX465と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX466と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX467と記す）。
化合物（Ｌ−３６）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX468と記す）。
化合物（Ｌ−３６）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX469と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX470と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX471と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX472と記す）。
化合物（Ｌ−３６）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX473と記す）。 Formula (L-36)

In the compound represented by (hereinafter referred to as compound (L-36)), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A ] To [Table 6A] any one of the substituents (hereinafter referred to as compound group SX446).
In compound (L-36), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX447).
In compound (L-36), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX448).
In compound (L-36), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX449).
In the compound (L-36), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX450).
In the compound (L-36), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX451).
In the compound (L-36), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is one of substituents as described in the following (it is hereafter described as the compound group SX452).
In the compound (L-36), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 6A]. ] A compound (hereinafter, referred to as compound group SX453).
In the compound (L-36), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is one of substituents as described in the following (hereinafter, referred to as compound group SX454).
In compound (L-36), G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A] A compound which is any one of the substituents (hereinafter referred to as compound group SX455).
In compound (L-36), G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX456).
In compound (L-36), G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX457).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX458).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any of the substituents (hereinafter referred to as compound group SX459).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX460).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX461).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX462).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX463).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX464).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX465).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX466).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX467).
In the compound (L-36), G ¹ is CH, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX468).
In the compound (L-36), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is a substituent in any one of description (henceforth the compound group SX469).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX470).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX471).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX472).
In the compound (L-36), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX473).

で示される化合物（以下、化合物（Ｌ−３７）と記す）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX474と記す）。
化合物（Ｌ−３７）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX475と記す）。
化合物（Ｌ−３７）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX476と記す）。
化合物（Ｌ−３７）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX477と記す）。
化合物（Ｌ−３７）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX478と記す）。
化合物（Ｌ−３７）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX479と記す）。
化合物（Ｌ−３７）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX480と記す）。
化合物（Ｌ−３７）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX481と記す）。
化合物（Ｌ−３７）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX482と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX483と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX484と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX485と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX486と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX487と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX488と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX489と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX490と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX491と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX492と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX493と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX494と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX495と記す）。
化合物（Ｌ−３７）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX496と記す）。
化合物（Ｌ−３７）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX497と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX498と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX499と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX500と記す）。
化合物（Ｌ−３７）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX501と記す）。 Formula (L-37)

In the compound represented by (hereinafter referred to as compound (L-37)), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A ] To [Table 6A] as a substituent (hereinafter referred to as compound group SX474).
In compound (L-37), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX475).
In compound (L-37), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX476).
In compound (L-37), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX477).
In the compound (L-37), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX478).
In the compound (L-37), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX479).
In the compound (L-37), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX480).
In the compound (L-37), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 6A]. ] A compound (hereinafter, referred to as compound group SX481).
In the compound (L-37), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX482).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX483).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX484).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX485).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX486).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any of the substituents (hereinafter referred to as compound group SX487).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX488).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX489).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX490).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX491).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX492).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX493).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX494).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX495).
In the compound (L-37), G ¹ is CH, R ^3b is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX496).
In the compound (L-37), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX497).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX498).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX499).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX500).
In the compound (L-37), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX501).

で示される化合物（以下、化合物（Ｌ−３８）と記す）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX502と記す）。
化合物（Ｌ−３８）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX503と記す）。
化合物（Ｌ−３８）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX504と記す）。
化合物（Ｌ−３８）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX505と記す）。
化合物（Ｌ−３８）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX506と記す）。
化合物（Ｌ−３８）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX507と記す）。
化合物（Ｌ−３８）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX508と記す）。
化合物（Ｌ−３８）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX509と記す）。
化合物（Ｌ−３８）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX510と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX511と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX512と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX513と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX514と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX515と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX516と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX517と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX518と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX519と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX520と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX521と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX522と記す）。
化合物（Ｌ−３８）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX523と記す）。 Formula (L-38)

In the compound represented by (hereinafter, referred to as compound (L-38)), G ¹ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [ Table 6A] is any one of the substituents described below (hereinafter referred to as compound group SX502).
In the compound (L-38), G ¹ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX503).
In the compound (L-38), G ¹ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX504).
In the compound (L-38), G ¹ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound which is a group (hereinafter referred to as compound group SX505).
In the compound (L-38), G ¹ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in Table 1A to Table 6A A compound which is a substituent (hereinafter referred to as compound group SX506).
In the compound (L-38), G ¹ is CH, R ^3b is a bromine atom, R ⁶ is a methyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX507).
In the compound (L-38), G ¹ is CH, R ^3b is a bromine atom, R ⁶ is an ethyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as a compound group SX508).
In the compound (L-38), G ¹ is CH, R ^3b is a bromine atom, R ⁶ is an ethyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX509).
In the compound (L-38), G ¹ is CH, R ^3b is a bromine atom, R ⁶ is a propyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX510).
In the compound (L-38), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX511).
In compound (L-38), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX512).
In the compound (L-38), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX513).
In the compound (L-38), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX514).
In compound (L-38), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of those listed in Table 1A to Table 6A (Hereinafter referred to as compound group SX515).
In compound (L-38), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX516).
In compound (L-38), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX517).
In compound (L-38), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX518).
In compound (L-38), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX519).
In compound (L-38), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX520).
In the compound (L-38), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX521).
In the compound (L-38), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX522).
In compound (L-38), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX523).

で示される化合物（以下、化合物（Ｌ−３９）と記す）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX524と記す）。
化合物（Ｌ−３９）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX525と記す）。
化合物（Ｌ−３９）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX526と記す）。
化合物（Ｌ−３９）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX527と記す）。
化合物（Ｌ−３９）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX528と記す）。
化合物（Ｌ−３９）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX529と記す）。
化合物（Ｌ−３９）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX530と記す）。
化合物（Ｌ−３９）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX531と記す）。
化合物（Ｌ−３９）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX532と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX533と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX534と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX535と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX536と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX537と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX538と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX539と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX540と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX541と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX542と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX543と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX544と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX545と記す）。
化合物（Ｌ−３９）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX546と記す）。
化合物（Ｌ−３９）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX547と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX548と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX549と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX550と記す）。
化合物（Ｌ−３９）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX551と記す）。 Formula (L-39)

In the compound represented by (hereinafter referred to as compound (L-39)), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A ] To [Table 6A] as a substituent (hereinafter referred to as compound group SX524).
In compound (L-39), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX525).
In compound (L-39), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX526).
In compound (L-39), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX527).
In the compound (L-39), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX528).
In the compound (L-39), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is a substituent in any one of description (henceforth the compound group SX529).
In the compound (L-39), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX530).
In the compound (L-39), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX531).
In the compound (L-39), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX532).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX533).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX534).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX535).
In compound (L-39), G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX536).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX537).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX538).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX539).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX540).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX541).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX542).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX543).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX544).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4c is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX545).
In the compound (L-39), G ¹ is CH, R ^3b is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] A compound (hereinafter, referred to as compound group SX546).
In the compound (L-39), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 6A]. ] The compound which is either of the substituents as described in the following (hereinafter referred to as compound group SX547).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX548).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX549).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX550).
In the compound (L-39), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX551).

で示される化合物（以下、化合物（Ｌ−４０）と記す）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX552と記す）。
化合物（Ｌ−４０）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX553と記す）。
化合物（Ｌ−４０）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX554と記す）。
化合物（Ｌ−４０）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX555と記す）。
化合物（Ｌ−４０）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX556と記す）。
化合物（Ｌ−４０）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX557と記す）。
化合物（Ｌ−４０）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX558と記す）。
化合物（Ｌ−４０）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX559と記す）。
化合物（Ｌ−４０）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX560と記す）。
化合物（Ｌ−４０）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX561と記す）。
化合物（Ｌ−４０）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX562と記す）。 Formula (L-40)

In the compound represented by (hereinafter referred to as compound (L-40)), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, and T is described in [Table 1A] to [Table 6A]. A compound which is any of the substituents (hereinafter referred to as compound group SX552).
In the compound (L-40), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX553).
In the compound (L-40), compound wherein G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX554).
In the compound (L-40), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX555).
In compound (L-40), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX556).
In the compound (L-40), G ¹ is CH, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX557).
In the compound (L-40), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX558).
In the compound (L-40), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX559).
In compound (L-40), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX560).
In compound (L-40), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX561).
In the compound (L-40), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX562).

で示される化合物（以下、化合物（Ｌ−４１）と記す）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX563と記す）。
化合物（Ｌ−４１）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX564と記す）。
化合物（Ｌ−４１）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX565と記す）。
化合物（Ｌ−４１）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX566と記す）。
化合物（Ｌ−４１）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX567と記す）。
化合物（Ｌ−４１）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX568と記す）。
化合物（Ｌ−４１）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX569と記す）。
化合物（Ｌ−４１）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX570と記す）。
化合物（Ｌ−４１）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX571と記す）。
化合物（Ｌ−４１）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX572と記す）。
化合物（Ｌ−４１）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX573と記す）。 Formula (L-41)

In the compound represented by (hereinafter referred to as compound (L-41)), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, and T is described in [Table 1A] to [Table 6A]. A compound which is any of the substituents (hereinafter referred to as compound group SX563).
In the compound (L-41), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX564).
In the compound (L-41), compound wherein G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX565).
In compound (L-41), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX566).
In compound (L-41), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX567).
In the compound (L-41), G ¹ is CH, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX568).
In the compound (L-41), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX569).
In compound (L-41), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX570).
In compound (L-41), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX571).
In compound (L-41), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX572).
In the compound (L-41), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX573).

で示される化合物（以下、化合物（Ｌ−４２）と記す）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX574と記す）。
化合物（Ｌ−４２）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX575と記す）。
化合物（Ｌ−４２）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX576と記す）。
化合物（Ｌ−４２）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX577と記す）。
化合物（Ｌ−４２）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX578と記す）。
化合物（Ｌ−４２）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX579と記す）。
化合物（Ｌ−４２）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX580と記す）。
化合物（Ｌ−４２）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX581と記す）。
化合物（Ｌ−４２）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX582と記す）。
化合物（Ｌ−４２）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX583と記す）。
化合物（Ｌ−４２）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX584と記す）。 Formula (L-42)

In the compound represented by (hereinafter referred to as compound (L-42)), G ¹ is CH, R ^3b and R ^4a are hydrogen atoms, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX574).
In compound (L-42), G ¹ is CH, R ^3b is a bromine atom, R ^4a is a hydrogen atom, and T is any of the substitutions described in Table 1A to Table 6A A compound which is a group (hereinafter referred to as compound group SX575).
In the compound (L-42), compound wherein G ¹ is a nitrogen atom, R ^3b and R ^4a are hydrogen atoms, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX576).
In compound (L-42), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4a is a hydrogen atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX577).
In the compound (L-42), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4a is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX578).
In the compound (L-42), G ¹ is CH, R ^3b is a hydrogen atom, R ^4a is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX579).
In the compound (L-42), G ¹ is CH, R ^3b is a bromine atom, R ^4a is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX580).
In the compound (L-42), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ^4a is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX581).
In compound (L-42), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4a is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX582).
In compound (L-42), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4a is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX583).
In the compound (L-42), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4a is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX584).

で示される化合物（以下、化合物（Ｌ−４３）と記す）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX585と記す）。
化合物（Ｌ−４３）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX586と記す）。
化合物（Ｌ−４３）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX587と記す）。
化合物（Ｌ−４３）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX588と記す）。
化合物（Ｌ−４３）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX589と記す）。
化合物（Ｌ−４３）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX590と記す）。
化合物（Ｌ−４３）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX591と記す）。
化合物（Ｌ−４３）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX592と記す）。
化合物（Ｌ−４３）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX593と記す）。
化合物（Ｌ−４３）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX594と記す）。
化合物（Ｌ−４３）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX595と記す）。 Formula (L-43)

In the compound represented by (hereinafter referred to as compound (L-43)), G ¹ is CH, R ^3b and R ^4c are hydrogen atoms, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX585).
In the compound (L-43), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a hydrogen atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX586).
In the compound (L-43), compound wherein G ¹ is a nitrogen atom, R ^3b and R ^4c are hydrogen atoms, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX587).
In compound (L-43), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a hydrogen atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX588).
In the compound (L-43), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4c is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX589).
In the compound (L-43), G ¹ is CH, R ^3b is a hydrogen atom, R ^4c is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX590).
In the compound (L-43), G ¹ is CH, R ^3b is a bromine atom, R ^4c is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX591).
In compound (L-43), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ^4c is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX592).
In compound (L-43), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX593).
In compound (L-43), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4c is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX594).
In the compound (L-43), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4c is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX595).

で示される化合物（以下、化合物（Ｌ−４４）と記す）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX596と記す）。
化合物（Ｌ−４４）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX597と記す）。
化合物（Ｌ−４４）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX598と記す）。
化合物（Ｌ−４４）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX599と記す）。
化合物（Ｌ−４４）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX600と記す）。
化合物（Ｌ−４４）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX601と記す）。
化合物（Ｌ−４４）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX602と記す）。
化合物（Ｌ−４４）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX603と記す）。
化合物（Ｌ−４４）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX604と記す）。
化合物（Ｌ−４４）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX605と記す）。
化合物（Ｌ−４４）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX606と記す）。 Formula (L-44)

In the compound represented by (hereinafter referred to as compound (L-44)), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, and T is described in [Table 1A] to [Table 6A]. A compound which is any of the substituents (hereinafter referred to as compound group SX596).
In the compound (L-44), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound which is a group (hereinafter referred to as compound group SX597).
In the compound (L-44), compounds wherein G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX598).
In compound (L-44), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX599).
In compound (L-44), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX600).
In the compound (L-44), G ¹ is CH, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound which is a group (hereinafter referred to as compound group SX601).
In the compound (L-44), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX602).
In the compound (L-44), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX603).
In compound (L-44), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX604).
In compound (L-44), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX605).
In the compound (L-44), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX606).

で示される化合物（以下、化合物（Ｌ−４５）と記す）において、Ｇ¹がＣＨであり、Ｒ^3b及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX607と記す）。
化合物（Ｌ−４５）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX608と記す）。
化合物（Ｌ−４５）において、Ｇ¹が窒素原子であり、Ｒ^3b及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX609と記す）。
化合物（Ｌ−４５）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX610と記す）。
化合物（Ｌ−４５）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX611と記す）。
化合物（Ｌ−４５）において、Ｇ¹がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX612と記す）。
化合物（Ｌ−４５）において、Ｇ¹がＣＨであり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX613と記す）。
化合物（Ｌ−４５）において、Ｇ¹が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX614と記す）。
化合物（Ｌ−４５）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX615と記す）。
化合物（Ｌ−４５）において、Ｇ¹が窒素原子であり、Ｒ^3bがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX616と記す）。
化合物（Ｌ−４５）において、Ｇ¹が窒素原子であり、Ｒ^3bが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX617と記す）。 Formula (L-45)

In the compound represented by (hereinafter referred to as compound (L-45)), G ¹ is CH, R ^3b and R ^4b are hydrogen atoms, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX607).
In compound (L-45), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a hydrogen atom, and T is any one of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX608).
In the compound (L-45), compounds wherein G ¹ is a nitrogen atom, R ^3b and R ^4b are hydrogen atoms, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX609).
In compound (L-45), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a hydrogen atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX610).
In the compound (L-45), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX611).
In the compound (L-45), G ¹ is CH, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX612).
In the compound (L-45), G ¹ is CH, R ^3b is a bromine atom, R ^4b is a chlorine atom, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX613).
In the compound (L-45), G ¹ is a nitrogen atom, R ^3b is a hydrogen atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX614).
In compound (L-45), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX615).
In compound (L-45), G ¹ is a nitrogen atom, R ^3b is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX616).
In the compound (L-45), G ¹ is a nitrogen atom, R ^3b is a bromine atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX617).

で示される化合物（以下、化合物（Ｌ−４６）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX618と記す）。
化合物（Ｌ−４６）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX619と記す）。
化合物（Ｌ−４６）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX620と記す）。
化合物（Ｌ−４６）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX621と記す）。
化合物（Ｌ−４６）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX622と記す）。
化合物（Ｌ−４６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX623と記す）。
化合物（Ｌ−４６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX624と記す）。
化合物（Ｌ−４６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX625と記す）。
化合物（Ｌ−４６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX626と記す）。
化合物（Ｌ−４６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX627と記す）。
化合物（Ｌ−４６）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX628と記す）。
化合物（Ｌ−４６）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX629と記す）。
化合物（Ｌ−４６）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX630と記す）。
化合物（Ｌ−４６）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX631と記す）。
化合物（Ｌ−４６）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX632と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX633と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX634と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX635と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX636と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX637と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX638と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX639と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX640と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX641と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX642と記す）。
化合物（Ｌ−４６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX643と記す）。
化合物（Ｌ−４６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX644と記す）。
化合物（Ｌ−４６）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX645と記す）。
化合物（Ｌ−４６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX646と記す）。
化合物（Ｌ−４６）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX647と記す）。 Formula (L-46)

In the compound represented by (hereinafter referred to as compound (L-46)), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX618).
In the compound (L-46), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX619).
In the compound (L-46), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX620).
In compound (L-46), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX621).
In compound (L-46), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as a compound group SX622).
In compound (L-46), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX623).
In compound (L-46), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX624).
In compound (L-46), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX625).
In compound (L-46), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX626).
In the compound (L-46), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX627).
In the compound (L-46), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX628).
In the compound (L-46), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX629).
In the compound (L-46), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX630).
In the compound (L-46), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX631).
In the compound (L-46), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any of the substituents (hereinafter referred to as compound group SX632).
In the compound (L-46), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX633).
In the compound (L-46), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX634).
In the compound (L-46), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX635).
In the compound (L-46), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX636).
In the compound (L-46), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX637).
In the compound (L-46), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX638).
In the compound (L-46), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX639).
In the compound (L-46), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX640).
In the compound (L-46), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX641).
In the compound (L-46), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX642).
In the compound (L-46), R ^3b and R ^3c are hydrogen atoms, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX643).
In the compound (L-46), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX644).
In the compound (L-46), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX645).
In the compound (L-46), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX646).
In the compound (L-46), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX647).

で示される化合物（以下、化合物（Ｌ−４７）と記す）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX648と記す）。
化合物（Ｌ−４７）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX649と記す）。
化合物（Ｌ−４７）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX650と記す）。
化合物（Ｌ−４７）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX651と記す）。
化合物（Ｌ−４７）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX652と記す）。
化合物（Ｌ−４７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX653と記す）。
化合物（Ｌ−４７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX654と記す）。
化合物（Ｌ−４７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX655と記す）。
化合物（Ｌ−４７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX656と記す）。
化合物（Ｌ−４７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX657と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX658と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX659と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX660と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX661と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX662と記す）
化合物（Ｌ−４７）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX663と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX664と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX665と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX666と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX667と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX668と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX669と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX670と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX671と記す）。
化合物（Ｌ−４７）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX672と記す）。 Formula (L-47)

In the compound represented by (hereinafter referred to as compound (L-47)), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX648).
In the compound (L-47), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX649).
In the compound (L-47), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is a propyl group, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX650).
In the compound (L-47), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX651).
In the compound (L-47), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is any substituent described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as Compound Group SX652).
In the compound (L-47), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX653).
In the compound (L-47), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX654).
In the compound (L-47), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX655).
In the compound (L-47), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX656).
In the compound (L-47), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX657).
In the compound (L-47), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX658).
In the compound (L-47), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX659).
In the compound (L-47), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX660).
In the compound (L-47), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX661).
In the compound (L-47), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX662)
In the compound (L-47), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX663).
In the compound (L-47), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX664).
In the compound (L-47), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX665).
In the compound (L-47), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX666).
In the compound (L-47), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX667).
In the compound (L-47), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX668).
In the compound (L-47), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX669).
In the compound (L-47), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX670).
In the compound (L-47), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX671).
In the compound (L-47), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX672).

で示される化合物（以下、化合物（Ｌ−４８）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX673と記す）。
化合物（Ｌ−４８）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX674と記す）。
化合物（Ｌ−４８）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX675と記す）。
化合物（Ｌ−４８）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX676と記す）。
化合物（Ｌ−４８）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX677と記す）。
化合物（Ｌ−４８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX678と記す）。
化合物（Ｌ−４８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX679と記す）。
化合物（Ｌ−４８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX680と記す）。
化合物（Ｌ−４８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX681と記す）。
化合物（Ｌ−４８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX682と記す）。
化合物（Ｌ−４８）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX683と記す）。
化合物（Ｌ−４８）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX684と記す）。
化合物（Ｌ−４８）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX685と記す）。
化合物（Ｌ−４８）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX686と記す）。
化合物（Ｌ−４８）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX687と記す）。
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX688と記す）。
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX689と記す）。
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX690と記す）。
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX691と記す）。
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX692と記す）。
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX693と記す）。
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX694と記す）。
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX695と記す）。
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX696と記す）。
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX697と記す）
化合物（Ｌ−４８）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX698と記す）。
化合物（Ｌ−４８）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX699と記す）。
化合物（Ｌ−４８）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX700と記す）。
化合物（Ｌ−４８）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX701と記す）。
化合物（Ｌ−４８）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX702と記す）。 Formula (L-48)

In the compound represented by (hereinafter referred to as compound (L-48)), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX673).
In the compound (L-48), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX674).
In the compound (L-48), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX675).
In compound (L-48), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX676).
In compound (L-48), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound which is a group (hereinafter referred to as compound group SX677).
In compound (L-48), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX678).
In compound (L-48), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX679).
In compound (L-48), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX680).
In compound (L-48), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX681).
In the compound (L-48), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX682).
In the compound (L-48), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX683).
In the compound (L-48), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX684).
In the compound (L-48), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX685).
In the compound (L-48), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX686).
In the compound (L-48), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX687).
In compound (L-48), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX688).
In compound (L-48), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX689).
In compound (L-48), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX690).
In compound (L-48), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX691).
In the compound (L-48), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX692).
In the compound (L-48), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX693).
In the compound (L-48), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX694).
In the compound (L-48), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX695).
In the compound (L-48), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX696).
In the compound (L-48), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. Or any of the substituents (hereinafter referred to as compound group SX697)
In the compound (L-48), R ^3b and R ^3c are hydrogen atoms, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX698).
In the compound (L-48), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX699).
In the compound (L-48), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX700).
In the compound (L-48), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX701).
In the compound (L-48), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX702).

で示される化合物（以下、化合物（Ｌ−４９）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX703と記す）。
化合物（Ｌ−４９）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX704と記す）。
化合物（Ｌ−４９）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX705と記す）。
化合物（Ｌ−４９）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX706と記す）。
化合物（Ｌ−４９）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX707と記す）。
化合物（Ｌ−４９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX708と記す）。
化合物（Ｌ−４９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX709と記す）。
化合物（Ｌ−４９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX710と記す）。
化合物（Ｌ−４９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX711と記す）。
化合物（Ｌ−４９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX712と記す）。
化合物（Ｌ−４９）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX713と記す）。
化合物（Ｌ−４９）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX714と記す）。
化合物（Ｌ−４９）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX715と記す）。
化合物（Ｌ−４９）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX716と記す）。
化合物（Ｌ−４９）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX717と記す）
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX718と記す）。
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX719と記す）。
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX720と記す）。
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX721と記す）。
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX722と記す）。
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX723と記す）。
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX724と記す）。
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX725と記す）。
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX726と記す）。
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX727と記す）。
化合物（Ｌ−４９）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX728と記す）。
化合物（Ｌ−４９）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX729と記す）。
化合物（Ｌ−４９）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX730と記す）。
化合物（Ｌ−４９）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX731と記す）。
化合物（Ｌ−４９）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX732と記す）。 Formula (L-49)

In the compound represented by (hereinafter referred to as compound (L-49)), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is from [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX703).
In the compound (L-49), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX704).
In the compound (L-49), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX705).
In the compound (L-49), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX706).
In compound (L-49), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX707).
In compound (L-49), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX708).
In compound (L-49), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX709).
In compound (L-49), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX710).
In compound (L-49), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX711).
In the compound (L-49), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX712).
In the compound (L-49), R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX713).
In the compound (L-49), R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX714).
In the compound (L-49), R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX715).
In the compound (L-49), R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX716).
In the compound (L-49), R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. Or any of the above-mentioned substituents (hereinafter referred to as compound group SX717)
In the compound (L-49), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX718).
In the compound (L-49), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX719).
In the compound (L-49), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX720).
In the compound (L-49), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX721).
In the compound (L-49), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX722).
In the compound (L-49), R ^3b and R ^4c are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX723).
In the compound (L-49), R ^3b and R ^4c are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX724).
In the compound (L-49), R ^3b and R ^4c are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX725).
In the compound (L-49), R ^3b and R ^4c are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX726).
In the compound (L-49), R ^3b and R ^4c are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX727).
In the compound (L-49), R ^3b and R ^3c are hydrogen atoms, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX728).
In the compound (L-49), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX729).
In the compound (L-49), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX730).
In the compound (L-49), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX731).
In the compound (L-49), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX732).

で示される化合物（以下、化合物（Ｌ−５０）と記す）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX733と記す）。
化合物（Ｌ−５０）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX734と記す）。
化合物（Ｌ−５０）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX735と記す）。
化合物（Ｌ−５０）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX736と記す）。
化合物（Ｌ−５０）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX737と記す）。
化合物（Ｌ−５０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX738と記す）。
化合物（Ｌ−５０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX739と記す）。
化合物（Ｌ−５０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX740と記す）。
化合物（Ｌ−５０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX741と記す）。
化合物（Ｌ−５０）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX742と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX743と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX744と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX745と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX746と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX747と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX748と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX749と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX750と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX751と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX752と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX753と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX754と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX755と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX756と記す）。
化合物（Ｌ−５０）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX757と記す）。 Formula (L-50)

In the compound represented by (hereinafter, referred to as compound (L-50)), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX733).
In the compound (L-50), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX734).
In the compound (L-50), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX735).
In the compound (L-50), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX736).
In the compound (L-50), R ^3b and R ^3c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any substituent described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as Compound Group SX737).
In the compound (L-50), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX738).
In the compound (L-50), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX739).
In the compound (L-50), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX740).
In compound (L-50), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX741).
In the compound (L-50), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX742).
In the compound (L-50), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX743).
In the compound (L-50), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX744).
In the compound (L-50), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX745).
In the compound (L-50), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX746).
In the compound (L-50), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX747).
In the compound (L-50), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX748).
In compound (L-50), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX749).
In the compound (L-50), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX750).
In the compound (L-50), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX751).
In the compound (L-50), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX752).
In the compound (L-50), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX753).
In the compound (L-50), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX754).
In the compound (L-50), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX755).
In the compound (L-50), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX756).
In the compound (L-50), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX757).

で示される化合物（以下、化合物（Ｌ−５１）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX758と記す）。
化合物（Ｌ−５１）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX759と記す）。
化合物（Ｌ−５１）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX760と記す）。
化合物（Ｌ−５１）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX761と記す）。
化合物（Ｌ−５１）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX762と記す）。
化合物（Ｌ−５１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX763と記す）。
化合物（Ｌ−５１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX764と記す）。
化合物（Ｌ−５１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX765と記す）。
化合物（Ｌ−５１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX766と記す）。
化合物（Ｌ−５１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX767と記す）。
化合物（Ｌ−５１）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX768と記す）。
化合物（Ｌ−５１）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX769と記す）。
化合物（Ｌ−５１）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX770と記す）。
化合物（Ｌ−５１）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX771と記す）。
化合物（Ｌ−５１）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX772と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX773と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX774と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX775と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX776と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX777と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX778と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX779と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX780と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX781と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX782と記す）。
化合物（Ｌ−５１）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX783と記す）。
化合物（Ｌ−５１）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX784と記す）。
化合物（Ｌ−５１）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX785と記す）。
化合物（Ｌ−５１）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX786と記す）。
化合物（Ｌ−５１）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ^4cが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX787と記す）。 Formula (L-51)

In the compound represented by (hereinafter referred to as compound (L-51)), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX758).
In the compound (L-51), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX759).
In the compound (L-51), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX760).
In the compound (L-51), R ^3b , R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX761).
In compound (L-51), R ^3b , R ^3c and R ^4c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound which is a group (hereinafter referred to as compound group SX762).
In compound (L-51), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX763).
In compound (L-51), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX764).
In compound (L-51), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX765).
In compound (L-51), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX766).
In the compound (L-51), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX767).
In the compound (L-51), R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX768).
In the compound (L-51), R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX769).
In the compound (L-51), R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX770).
In compound (L-51), R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX771).
In the compound (L-51), R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any of the substituents (hereinafter referred to as compound group SX772).
In the compound (L-51), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX773).
In the compound (L-51), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX774).
In the compound (L-51), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX775).
In the compound (L-51), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound having any one of the substituents described below (hereinafter referred to as compound group SX776).
In the compound (L-51), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX777).
In the compound (L-51), R ^3b and R ^4c are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX778).
In the compound (L-51), R ^3b and R ^4c are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is an ethyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX779).
In the compound (L-51), R ^3b and R ^4c are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a propyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX780).
In the compound (L-51), R ^3b and R ^4c are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is an isopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX781).
In the compound (L-51), R ^3b and R ^4c are hydrogen atoms, R ^3c is a bromine atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any of the substituents (hereinafter referred to as compound group SX782).
In the compound (L-51), R ^3b and R ^3c are hydrogen atoms, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX783).
In the compound (L-51), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX784).
In the compound (L-51), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX785).
In the compound (L-51), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX786).
In the compound (L-51), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ^4c is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX787).

で示される化合物（以下、化合物（Ｌ−５２）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX788と記す）。
化合物（Ｌ−５２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c、Ｒ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX789と記す）。
化合物（Ｌ−５２）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX790と記す）。
化合物（Ｌ−５２）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX791と記す）。
化合物（Ｌ−５２）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX792と記す）
化合物（Ｌ−５２）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX793と記す）。
化合物（Ｌ−５２）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX794と記す）。
化合物（Ｌ−５２）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX795と記す）。
化合物（Ｌ−５２）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX796と記す）。
化合物（Ｌ−５２）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX797と記す）。 Formula (L-52)

In the compound represented by (hereinafter referred to as compound (L-52)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX788).
In the compound (L-52), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX789).
In the compound (L-52), compounds wherein R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX790).
In the compound (L-52), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX791).
In the compound (L-52), compounds wherein R ^3b and R ^4b are a hydrogen atom, R ^3c is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX792)
In the compound (L-52), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any one of the substituents described in Table 1A to Table 6A (Hereinafter referred to as compound group SX793).
In the compound (L-52), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX794).
In the compound (L-52), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX795).
In compound (L-52), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in Table 1A to Table 6A A compound which is such a substituent (hereinafter referred to as compound group SX796).
In the compound (L-52), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX797).

で示される化合物（以下、化合物（Ｌ−５３）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^{4 b}が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX798と記す）。
化合物（Ｌ−５３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX799と記す）。
化合物（Ｌ−５３）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX800と記す）。
化合物（Ｌ−５３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX801と記す）。
化合物（Ｌ−５３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX802と記す）。
化合物（Ｌ−５３）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX803と記す）。
化合物（Ｌ−５３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX804と記す）。
化合物（Ｌ−５３）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX805と記す）
化合物（Ｌ−５３）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX806と記す）。
化合物（Ｌ−５３）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX807と記す） Formula (L-53)

Wherein R ^3b , R ^3c and R ^{4 b} are hydrogen atoms, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX798).
In the compound (L-53), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX799).
In the compound (L-53), compounds wherein R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX800).
In the compound (L-53), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX801).
In the compound (L-53), R ^3b and R ^4b are hydrogen atoms, R ^3c is a bromine atom group, and T is any substituent described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as compound group SX802).
In the compound (L-53), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any of the substituents described in Table 1A to Table 6A (Hereinafter referred to as compound group SX803).
In the compound (L-53), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX804).
In the compound (L-53), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] Compounds that are substituents (hereinafter referred to as compound group SX805)
In the compound (L-53), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX806).
In the compound (L-53), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] Compounds that are substituents (hereinafter referred to as compound group SX807)

で示される化合物（以下、化合物（Ｌ−５４）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX808と記す）。
化合物（Ｌ−５４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX809と記す）。
化合物（Ｌ−５４）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4aが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX810と記す）。
化合物（Ｌ−５４）において、Ｒ^3b及びＲ^4aが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX811と記す）。
化合物（Ｌ−５４）において、Ｒ^3b及びＲ^4aが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX812と記す）。
化合物（Ｌ−５４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX813と記す）。
化合物（Ｌ−５４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX814と記す）。
化合物（Ｌ−５４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX815と記す）。
化合物（Ｌ−５４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX816と記す）。
化合物（Ｌ−５４）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ^4aが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX817と記す）。 Formula (L-54)

In the compound represented by (hereinafter referred to as compound (L-54)), R ^3b , R ^3c and R ^4a are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX808).
In the compound (L-54), R ^3b is a trifluoromethyl group, R ^3c and R ^4a are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX809).
In the compound (L-54), compounds wherein R ^3b is a bromine atom, R ^3c and R ^4a are hydrogen atoms, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX810).
In the compound (L-54), R ^3b and R ^4a are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX811).
In the compound (L-54), compounds wherein R ^3b and R ^4a are a hydrogen atom, R ^3c is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX812).
In the compound (L-54), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4a is a chlorine atom, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX813).
In compound (L-54), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4a is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX814).
In the compound (L-54), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4a is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX815).
In the compound (L-54), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4a is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX816).
In the compound (L-54), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ^4a is a chlorine atom, and T is any one of those described in Table 1A to Table 6A A compound which is a substituent (hereinafter referred to as compound group SX817).

で示される化合物（以下、化合物（Ｌ−５５）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX818と記す）。
化合物（Ｌ−５５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX819と記す）。
化合物（Ｌ−５５）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4cが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX820と記す）。
化合物（Ｌ−５５）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX821と記す）。
化合物（Ｌ−５５）において、Ｒ^3b及びＲ^4cが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX822と記す）。
化合物（Ｌ−５５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX823と記す）。
化合物（Ｌ−５５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX824と記す）。
化合物（Ｌ−５５）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX825と記す）。
化合物（Ｌ−５５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX826と記す）。
化合物（Ｌ−５５）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ^4cが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX827と記す）。 Formula (L-55)

In the compound represented by (hereinafter referred to as compound (L-55)), R ^3b , R ^3c and R ^4c are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX818).
In the compound (L-55), R ^3b is a trifluoromethyl group, R ^3c and R ^4c are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX819).
In the compound (L-55), compounds wherein R ^3b is a bromine atom, R ^3c and R ^4c are hydrogen atoms, and T is any of the substituents described in Table 1A to Table 6A (Hereinafter referred to as compound group SX820).
In the compound (L-55), R ^3b and R ^4c are hydrogen atoms, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX821).
In the compound (L-55), compounds wherein R ^3b and R ^4c are a hydrogen atom, R ^3c is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX822).
In the compound (L-55), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4c is a chlorine atom, and T is any of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX823).
In the compound (L-55), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX824).
In the compound (L-55), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4c is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX825).
In the compound (L-55), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4c is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX826).
In the compound (L-55), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ^4c is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX827).

で示される化合物（以下、化合物（Ｌ−５６）と記す。）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX828と記す）。
化合物（Ｌ−５６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX829と記す）。
化合物（Ｌ−５６）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX830と記す）。
化合物（Ｌ−５６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX831と記す）。
化合物（Ｌ−５６）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX832と記す）。
化合物（Ｌ−５６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX833と記す）。
化合物（Ｌ−５６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX834と記す）。
化合物（Ｌ−５６）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX835と記す）。
化合物（Ｌ−５６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX836と記す）。
化合物（Ｌ−５６）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX837と記す）。 Formula (L-56)

In the compound represented by (hereinafter referred to as compound (L-56)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX828).
In the compound (L-56), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX829).
In the compound (L-56), R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in Table 1A to Table 6A (Hereinafter referred to as compound group SX830).
In the compound (L-56), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX831).
In the compound (L-56), compounds wherein R ^3b and R ^4b are a hydrogen atom, R ^3c is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX832).
In the compound (L-56), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX833).
In compound (L-56), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound as a substituent (hereinafter referred to as compound group SX834).
In the compound (L-56), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX835).
In compound (L-56), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in Table 1A to Table 6A A compound which is such a substituent (hereinafter referred to as compound group SX836).
In the compound (L-56), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX837).

で示される化合物（以下、化合物（Ｌ−５７）と記す。）において、、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX838と記す）。
化合物（Ｌ−５７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX839と記す）。
化合物（Ｌ−５７）において、Ｒ^3bが臭素原子であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX840と記す）。
化合物（Ｌ−５７）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX841と記す）。
化合物（Ｌ−５７）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX842と記す）。
化合物（Ｌ−５７）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX843と記す）。
化合物（Ｌ−５７）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX844と記す）。
化合物（Ｌ−５７）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX845と記す）。
化合物（Ｌ−５７）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX846と記す）。
化合物（Ｌ−５７）において、Ｒ^3bが水素原子であり、Ｒ^3cが臭素原子であり、Ｒ^4bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX847と記す）。 Formula (L-57)

In the compound represented by (hereinafter, referred to as compound (L-57)), R ^3b , R ^3c and R ^4b are hydrogen atoms, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX838).
In the compound (L-57), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX839).
In the compound (L-57), compounds wherein R ^3b is a bromine atom, R ^3c and R ^4b are hydrogen atoms, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX840).
In compound (L-57), R ^3b and R ^4b are a hydrogen atom, R ^3c is a trifluoromethyl group, and T is any of the substituents described in [Table 1A] to [Table 6A]. A certain compound (hereinafter referred to as compound group SX841).
In the compound (L-57), compounds wherein R ^3b and R ^4b are a hydrogen atom, R ^3c is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX842).
In the compound (L-57), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ^4b is a chlorine atom, and T is any of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX843).
In the compound (L-57), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX844).
In the compound (L-57), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX845).
In the compound (L-57), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX846).
In the compound (L-57), R ^3b is a hydrogen atom, R ^3c is a bromine atom, R ^4b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX847).

で示される化合物（以下、化合物（Ｌ−５８）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX848と記す）。 Formula (L-58)

In the compound represented by (hereinafter referred to as compound (L-58)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as Compound Group SX848).

化合物（Ｌ−５８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX849と記す）。
化合物（Ｌ−５８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX850と記す）。
化合物（Ｌ−５８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX851と記す）。
化合物（Ｌ−５８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX852と記す）。
化合物（Ｌ−５８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX853と記す）。
化合物（Ｌ−５８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX854と記す）。
化合物（Ｌ−５８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX855と記す）。
化合物（Ｌ−５８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX856と記す）。
化合物（Ｌ−５８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX857と記す）。
化合物（Ｌ−５８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX858と記す）。
化合物（Ｌ−５８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX859と記す）。
化合物（Ｌ−５８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX860と記す）。
化合物（Ｌ−５８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX861と記す）。
化合物（Ｌ−５８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX862と記す）。
化合物（Ｌ−５８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX863と記す）。
化合物（Ｌ−５８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX864と記す）。
化合物（Ｌ−５８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX865と記す）。
化合物（Ｌ−５８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX866と記す）。
化合物（Ｌ−５８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX867と記す）。
化合物（Ｌ−５８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX868と記す）。
化合物（Ｌ−５８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX869と記す）。
化合物（Ｌ−５８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX870と記す）。
化合物（Ｌ−５８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX871と記す）。
化合物（Ｌ−５８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX872と記す）。
化合物（Ｌ−５８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX873と記す）。
化合物（Ｌ−５８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX874と記す）。
化合物（Ｌ−５８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX875と記す）。
化合物（Ｌ−５８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX876と記す）。
化合物（Ｌ−５８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX877と記す）。

In the compound (L-58), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX849).
In the compound (L-58), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX850).
In the compound (L-58), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX851).
In the compound (L-58), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX852).
In the compound (L-58), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX853).
In the compound (L-58), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX854).
In the compound (L-58), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX855).
In the compound (L-58), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX856).
In the compound (L-58), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX857).
In the compound (L-58), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX858).
In the compound (L-58), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX859).
In the compound (L-58), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX860).
In the compound (L-58), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX861).
In compound (L-58), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX862).
In the compound (L-58), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX863).
In the compound (L-58), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX864).
In the compound (L-58), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX865).
In the compound (L-58), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX866).
In the compound (L-58), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX867).
In the compound (L-58), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX868).
In the compound (L-58), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX869).
In the compound (L-58), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX870).
In the compound (L-58), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX871).
In the compound (L-58), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX872).
In the compound (L-58), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX873).
In the compound (L-58), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX874).
In the compound (L-58), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX875).
In the compound (L-58), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX876).
In the compound (L-58), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX877).

で示される化合物（以下、化合物（Ｌ−５９）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX878と記す）。
化合物（Ｌ−５９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX879と記す）。
化合物（Ｌ−５９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX880と記す）。
化合物（Ｌ−５９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX881と記す）。
化合物（Ｌ−５９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX882と記す）。
化合物（Ｌ−５９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX883と記す）。
化合物（Ｌ−５９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX884と記す）。
化合物（Ｌ−５９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX885と記す）。
化合物（Ｌ−５９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX886と記す）。
化合物（Ｌ−５９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX887と記す）。
化合物（Ｌ−５９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX888と記す）。
化合物（Ｌ−５９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX889と記す）。
化合物（Ｌ−５９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX890と記す）。
化合物（Ｌ−５９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX891と記す）。
化合物（Ｌ−５９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX892と記す）。
化合物（Ｌ−５９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX893と記す）。
化合物（Ｌ−５９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX894と記す）。
化合物（Ｌ−５９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX895と記す）。
化合物（Ｌ−５９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX896と記す）。
化合物（Ｌ−５９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX897と記す）。
化合物（Ｌ−５９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX898と記す）。
化合物（Ｌ−５９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX899と記す）。
化合物（Ｌ−５９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX900と記す）。
化合物（Ｌ−５９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX901と記す）。
化合物（Ｌ−５９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX902と記す）。
化合物（Ｌ−５９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX903と記す）。
化合物（Ｌ−５９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX904と記す）。
化合物（Ｌ−５９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX905と記す）。
化合物（Ｌ−５９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX906と記す）。
化合物（Ｌ−５９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX907と記す）。 Formula (L-59)

In the compound represented by (hereinafter referred to as compound (L-59)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX878).
In the compound (L-59), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX879).
In the compound (L-59), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX880).
In the compound (L-59), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX881).
In the compound (L-59), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX882).
In the compound (L-59), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX883).
In the compound (L-59), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX884).
In the compound (L-59), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX885).
In the compound (L-59), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX886).
In the compound (L-59), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX887).
In the compound (L-59), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX888).
In the compound (L-59), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX889).
In the compound (L-59), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX890).
In the compound (L-59), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX891).
In the compound (L-59), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX892).
In the compound (L-59), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX893).
In the compound (L-59), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX894).
In the compound (L-59), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX895).
In the compound (L-59), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX896).
In the compound (L-59), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX897).
In the compound (L-59), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX898).
In the compound (L-59), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX899).
In the compound (L-59), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX900).
In the compound (L-59), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX901).
In compound (L-59), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A]-[ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX902).
In the compound (L-59), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX903).
In the compound (L-59), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX904).
In the compound (L-59), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX905).
In the compound (L-59), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX906).
In the compound (L-59), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is ^defined in [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX907).

で示される化合物（以下、化合物（Ｌ−６０）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX908と記す）。
化合物（Ｌ−６０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX909と記す）。
化合物（Ｌ−６０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX910と記す）。
化合物（Ｌ−６０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX911と記す）。
化合物（Ｌ−６０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX912と記す）。
化合物（Ｌ−６０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX913と記す）。
化合物（Ｌ−６０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX914と記す）。
化合物（Ｌ−６０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX915と記す）。
化合物（Ｌ−６０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX916と記す）。
化合物（Ｌ−６０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX917と記す）。
化合物（Ｌ−６０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX918と記す）。
化合物（Ｌ−６０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX919と記す）。
化合物（Ｌ−６０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX920と記す）。
化合物（Ｌ−６０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX921と記す）。
化合物（Ｌ−６０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX922と記す）。
化合物（Ｌ−６０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX923と記す）。
化合物（Ｌ−６０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX924と記す）。
化合物（Ｌ−６０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX925と記す）。
化合物（Ｌ−６０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX926と記す）。
化合物（Ｌ−６０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX927と記す）。
化合物（Ｌ−６０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX928と記す）。
化合物（Ｌ−６０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX929と記す）。
化合物（Ｌ−６０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX930と記す）。
化合物（Ｌ−６０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX931と記す）。
化合物（Ｌ−６０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX932と記す）。
化合物（Ｌ−６０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX933と記す）。
化合物（Ｌ−６０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX934と記す）。
化合物（Ｌ−６０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX935と記す）。
化合物（Ｌ−６０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX936と記す）。
化合物（Ｌ−６０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX937と記す）。 Formula (L-60)

In the compound represented by (hereinafter referred to as compound (L-60)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as Compound Group SX908).
In the compound (L-60), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX909).
In the compound (L-60), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX910).
In the compound (L-60), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX911).
In the compound (L-60), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX912).
In the compound (L-60), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX913).
In the compound (L-60), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX914).
In the compound (L-60), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX915).
In the compound (L-60), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX916).
In the compound (L-60), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX917).
In the compound (L-60), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX918).
In the compound (L-60), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX919).
In the compound (L-60), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX920).
In the compound (L-60), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX921).
In the compound (L-60), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX922).
In the compound (L-60), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX923).
In the compound (L-60), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX924).
In the compound (L-60), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX925).
In the compound (L-60), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX926).
In the compound (L-60), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX927).
In the compound (L-60), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX928).
In the compound (L-60), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX929).
In the compound (L-60), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX930).
In the compound (L-60), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX931).
In compound (L-60), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX932).
In the compound (L-60), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX933).
In the compound (L-60), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX934).
In the compound (L-60), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX935).
In the compound (L-60), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX936).
In the compound (L-60), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX937).

で示される化合物（以下、化合物（Ｌ−６１）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX938と記す）。
化合物（Ｌ−６１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX939と記す）。
化合物（Ｌ−６１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX940と記す）。
化合物（Ｌ−６１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX941と記す）。
化合物（Ｌ−６１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX942と記す）。
化合物（Ｌ−６１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX943と記す）。
化合物（Ｌ−６１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX944と記す）。
化合物（Ｌ−６１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX945と記す）。
化合物（Ｌ−６１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX946と記す）。
化合物（Ｌ−６１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX947と記す）。
化合物（Ｌ−６１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX948と記す）。
化合物（Ｌ−６１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX949と記す）。
化合物（Ｌ−６１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX950と記す）。
化合物（Ｌ−６１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX951と記す）。
化合物（Ｌ−６１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX952と記す）。
化合物（Ｌ−６１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX953と記す）。
化合物（Ｌ−６１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX954と記す）。
化合物（Ｌ−６１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX955と記す）。
化合物（Ｌ−６１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX956と記す）。
化合物（Ｌ−６１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX957と記す）。
化合物（Ｌ−６１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX958と記す）。
化合物（Ｌ−６１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX959と記す）。
化合物（Ｌ−６１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX960と記す）。
化合物（Ｌ−６１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX961と記す）。
化合物（Ｌ−６１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX962と記す）。
化合物（Ｌ−６１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX963と記す）。
化合物（Ｌ−６１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX964と記す）。
化合物（Ｌ−６１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX965と記す）。
化合物（Ｌ−６１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX966と記す）。
化合物（Ｌ−６１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX967と記す）。 Formula (L-61)

In the compound represented by (hereinafter referred to as compound (L-61)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX938).
In the compound (L-61), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX939).
In the compound (L-61), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX940).
In the compound (L-61), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX941).
In the compound (L-61), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX942).
In the compound (L-61), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX943).
In the compound (L-61), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX944).
In the compound (L-61), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX945).
In the compound (L-61), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX946).
In the compound (L-61), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX947).
In the compound (L-61), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX948).
In the compound (L-61), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX949).
In the compound (L-61), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX950).
In the compound (L-61), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX951).
In the compound (L-61), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX952).
In the compound (L-61), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX953).
In the compound (L-61), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX954).
In the compound (L-61), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX955).
In the compound (L-61), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX956).
In the compound (L-61), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX957).
In the compound (L-61), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX958).
In the compound (L-61), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX959).
In the compound (L-61), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX960).
In the compound (L-61), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX961).
In the compound (L-61), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX962).
In the compound (L-61), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX963).
In the compound (L-61), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX964).
In the compound (L-61), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX965).
In the compound (L-61), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX966).
In the compound (L-61), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX967).

で示される化合物（以下、化合物（Ｌ−６２）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX968と記す）。
化合物（Ｌ−６２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX969と記す）。
化合物（Ｌ−６２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX970と記す）。
化合物（Ｌ−６２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX971と記す）。
化合物（Ｌ−６２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX972と記す）。
化合物（Ｌ−６２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX973と記す）。 Formula (L-62)

In the compound represented by (hereinafter referred to as compound (L-62)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound (hereinafter, referred to as compound group SX968).
In the compound (L-62), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX969).
In the compound (L-62), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX970).
In the compound (L-62), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX971).
In the compound (L-62), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX972).
In compound (L-62), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX973).

で示される化合物（以下、化合物（Ｌ−６３）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX974と記す）。
化合物（Ｌ−６３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX975と記す）。
化合物（Ｌ−６３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX976と記す）。
化合物（Ｌ−６３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX977と記す）。
化合物（Ｌ−６３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX978と記す）。
化合物（Ｌ−６３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX979と記す）。 Formula (L-63)

In the compound represented by (hereinafter referred to as compound (L-63)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX974).
In the compound (L-63), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX975).
In the compound (L-63), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX976).
In compound (L-63), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX977).
In the compound (L-63), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX978).
In the compound (L-63), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX979).

で示される化合物（以下、化合物（Ｌ−６４）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX980と記す）。
化合物（Ｌ−６４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX981と記す）。
化合物（Ｌ−６４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX982と記す）。
化合物（Ｌ−６４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX983と記す）。
化合物（Ｌ−６４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX984と記す）。
化合物（Ｌ−６４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX985と記す）。
化合物（Ｌ−６４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX986と記す）。
化合物（Ｌ−６４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX987と記す）。
化合物（Ｌ−６４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX988と記す）。
化合物（Ｌ−６４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX989と記す）。
化合物（Ｌ−６４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX990と記す）。
化合物（Ｌ−６４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX991と記す）。
化合物（Ｌ−６４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX992と記す）。
化合物（Ｌ−６４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX993と記す）。
化合物（Ｌ−６４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX994と記す）。
化合物（Ｌ−６４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX995と記す）。
化合物（Ｌ−６４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX996と記す）。
化合物（Ｌ−６４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX997と記す）。
化合物（Ｌ−６４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX998と記す）。
化合物（Ｌ−６４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX999と記す）。
化合物（Ｌ−６４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1000と記す）。
化合物（Ｌ−６４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1001と記す）。
化合物（Ｌ−６４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1002と記す）。
化合物（Ｌ−６４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1003と記す）。
化合物（Ｌ−６４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1004と記す）。
化合物（Ｌ−６４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1005と記す）。
化合物（Ｌ−６４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1006と記す）。
化合物（Ｌ−６４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1007と記す）。
化合物（Ｌ−６４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1008と記す）。
化合物（Ｌ−６４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1009と記す）。 Formula (L-64)

In the compound represented by (hereinafter referred to as compound (L-64)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX980).
In the compound (L-64), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX981).
In the compound (L-64), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX982).
In the compound (L-64), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX983).
In the compound (L-64), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX984).
In the compound (L-64), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX985).
In the compound (L-64), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX986).
In the compound (L-64), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX987).
In the compound (L-64), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX988).
In the compound (L-64), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX989).
In the compound (L-64), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX990).
In the compound (L-64), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX991).
In the compound (L-64), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX992).
In the compound (L-64), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX993).
In compound (L-64), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX994).
In the compound (L-64), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX995).
In the compound (L-64), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX996).
In the compound (L-64), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX997).
In the compound (L-64), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX998).
In the compound (L-64), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX999).
In the compound (L-64), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1000).
In the compound (L-64), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1001).
In the compound (L-64), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1002).
In the compound (L-64), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1003).
In compound (L-64), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1004).
In the compound (L-64), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1005).
In the compound (L-64), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1006).
In the compound (L-64), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1007).
In the compound (L-64), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1008).
In the compound (L-64), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1009).

で示される化合物（以下、化合物（Ｌ−６５）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1010と記す）。
化合物（Ｌ−６５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1011と記す）。
化合物（Ｌ−６５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1012と記す）。
化合物（Ｌ−６５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1013と記す）。
化合物（Ｌ−６５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1014と記す）。
化合物（Ｌ−６５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1015と記す）。
化合物（Ｌ−６５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1016と記す）。
化合物（Ｌ−６５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1017と記す）。
化合物（Ｌ−６５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1018と記す）。
化合物（Ｌ−６５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1019と記す）。
化合物（Ｌ−６５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1020と記す）。
化合物（Ｌ−６５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1021と記す）。
化合物（Ｌ−６５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1022と記す）。
化合物（Ｌ−６５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1023と記す）。
化合物（Ｌ−６５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1024と記す）。
化合物（Ｌ−６５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1025と記す）。
化合物（Ｌ−６５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1026と記す）。
化合物（Ｌ−６５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1027と記す）。
化合物（Ｌ−６５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1028と記す）。
化合物（Ｌ−６５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1029と記す）。
化合物（Ｌ−６５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1030と記す）。
化合物（Ｌ−６５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1031と記す）。
化合物（Ｌ−６５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1032と記す）。
化合物（Ｌ−６５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1033と記す）。
化合物（Ｌ−６５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1034と記す）。
化合物（Ｌ−６５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1035と記す）。
化合物（Ｌ−６５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1036と記す）。
化合物（Ｌ−６５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1037と記す）。
化合物（Ｌ−６５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1038と記す）。
化合物（Ｌ−６５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1039と記す）。 Formula (L-65)

In the compound represented by (hereinafter referred to as compound (L-65)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1010).
In the compound (L-65), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1011).
In the compound (L-65), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1012).
In the compound (L-65), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1013).
In the compound (L-65), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound that is any of the substituents (hereinafter referred to as compound group SX1014).
In the compound (L-65), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1015).
In the compound (L-65), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1016).
In the compound (L-65), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1017).
In the compound (L-65), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1018).
In the compound (L-65), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1019).
In the compound (L-65), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1020).
In the compound (L-65), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1021).
In the compound (L-65), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1022).
In the compound (L-65), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1023).
In compound (L-65), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1024).
In the compound (L-65), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1025).
In the compound (L-65), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1026).
In the compound (L-65), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1027).
In the compound (L-65), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1028).
In the compound (L-65), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1029).
In the compound (L-65), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1030).
In the compound (L-65), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1031).
In the compound (L-65), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1032).
In the compound (L-65), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1033).
In compound (L-65), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1034).
In the compound (L-65), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1035).
In the compound (L-65), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1036).
In the compound (L-65), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1037).
In the compound (L-65), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1038).
In the compound (L-65), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1039).

で示される化合物（以下、化合物（Ｌ−６６）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1040と記す）。
化合物（Ｌ−６６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1041と記す）。
化合物（Ｌ−６６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1042と記す）。
化合物（Ｌ−６６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1043と記す）。
化合物（Ｌ−６６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1044と記す）。
化合物（Ｌ−６６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1045と記す）。
化合物（Ｌ−６６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1046と記す）。
化合物（Ｌ−６６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1047と記す）。
化合物（Ｌ−６６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1048と記す）。
化合物（Ｌ−６６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1049と記す）。
化合物（Ｌ−６６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1050と記す）。
化合物（Ｌ−６６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1051と記す）。
化合物（Ｌ−６６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1052と記す）。
化合物（Ｌ−６６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1053と記す）。
化合物（Ｌ−６６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1054と記す）。
化合物（Ｌ−６６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1055と記す）。
化合物（Ｌ−６６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1056と記す）。
化合物（Ｌ−６６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1057と記す）。
化合物（Ｌ−６６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1058と記す）。
化合物（Ｌ−６６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1059と記す）。
化合物（Ｌ−６６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1060と記す）。
化合物（Ｌ−６６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1061と記す）。
化合物（Ｌ−６６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1062と記す）。
化合物（Ｌ−６６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1063と記す）。
化合物（Ｌ−６６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1064と記す）。
化合物（Ｌ−６６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1065と記す）。
化合物（Ｌ−６６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1066と記す）。
化合物（Ｌ−６６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1067と記す）。
化合物（Ｌ−６６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1068と記す）。
化合物（Ｌ−６６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1069と記す）。 Formula (L-66)

In the compound represented by (hereinafter referred to as compound (L-66)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as Compound Group SX1040).
In the compound (L-66), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1041).
In the compound (L-66), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1042).
In the compound (L-66), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1043).
In the compound (L-66), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1044).
In the compound (L-66), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1045).
In the compound (L-66), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1046).
In the compound (L-66), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1047).
In the compound (L-66), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1048).
In the compound (L-66), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1049).
In the compound (L-66), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1050).
In the compound (L-66), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1051).
In the compound (L-66), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1052).
In the compound (L-66), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1053).
In the compound (L-66), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1054).
In the compound (L-66), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1055).
In the compound (L-66), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1056).
In the compound (L-66), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1057).
In the compound (L-66), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1058).
In compound (L-66), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1059).
In the compound (L-66), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1060).
In the compound (L-66), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1061).
In the compound (L-66), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1062).
In the compound (L-66), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1063).
In the compound (L-66), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ The compound which is any substituent described in Table 15A] (hereinafter referred to as compound group SX1064).
In the compound (L-66), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1065).
In the compound (L-66), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1066).
In the compound (L-66), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1067).
In the compound (L-66), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1068).
In the compound (L-66), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1069).

で示される化合物（以下、化合物（Ｌ−６７）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1070と記す）。
化合物（Ｌ−６７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1071と記す）。
化合物（Ｌ−６７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1072と記す）。
化合物（Ｌ−６７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1073と記す）。
化合物（Ｌ−６７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1074と記す）。
化合物（Ｌ−６７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1075と記す）。
化合物（Ｌ−６７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1076と記す）。
化合物（Ｌ−６７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1077と記す）。
化合物（Ｌ−６７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1078と記す）。
化合物（Ｌ−６７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1079と記す）。
化合物（Ｌ−６７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1080と記す）。
化合物（Ｌ−６７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1081と記す）。
化合物（Ｌ−６７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1082と記す）。
化合物（Ｌ−６７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1083と記す）。
化合物（Ｌ−６７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1084と記す）。
化合物（Ｌ−６７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1085と記す）。
化合物（Ｌ−６７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1086と記す）。
化合物（Ｌ−６７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1087と記す）。
化合物（Ｌ−６７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1088と記す）。
化合物（Ｌ−６７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1089と記す）。
化合物（Ｌ−６７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1090と記す）。
化合物（Ｌ−６７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1091と記す）。
化合物（Ｌ−６７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1092と記す）。
化合物（Ｌ−６７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1093と記す）。
化合物（Ｌ−６７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1094と記す）。
化合物（Ｌ−６７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1095と記す）。
化合物（Ｌ−６７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1096と記す）。
化合物（Ｌ−６７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1097と記す）。
化合物（Ｌ−６７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1098と記す）。
化合物（Ｌ−６７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1099と記す）。 Formula (L-67)

In the compound represented by (hereinafter referred to as compound (L-67)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1070).
In the compound (L-67), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1071).
In the compound (L-67), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1072).
In the compound (L-67), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1073).
In the compound (L-67), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1074).
In the compound (L-67), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1075).
In the compound (L-67), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1076).
In the compound (L-67), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1077).
In the compound (L-67), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1078).
In the compound (L-67), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1079).
In the compound (L-67), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1080).
In the compound (L-67), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1081).
In the compound (L-67), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1082).
In the compound (L-67), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1083).
In the compound (L-67), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1084).
In the compound (L-67), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1085).
In the compound (L-67), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1086).
In the compound (L-67), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1087).
In the compound (L-67), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1088).
In the compound (L-67), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1089).
In the compound (L-67), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1090).
In the compound (L-67), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1091).
In the compound (L-67), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1092).
In the compound (L-67), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1093).
In the compound (L-67), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1094).
In the compound (L-67), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1095).
In the compound (L-67), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1096).
In the compound (L-67), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1097).
In the compound (L-67), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1098).
In the compound (L-67), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1099).

で示される化合物（以下、化合物（Ｌ−６８）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1100と記す）。
化合物（Ｌ−６８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1101と記す）。
化合物（Ｌ−６８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1102と記す）。
化合物（Ｌ−６８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1103と記す）。
化合物（Ｌ−６８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1104と記す）。
化合物（Ｌ−６８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1105と記す）。 Formula (L-68)

In the compound represented by formula (hereinafter referred to as compound (L-68)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX1100).
In the compound (L-68), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX1101).
In the compound (L-68), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1102).
In the compound (L-68), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1103).
In compound (L-68), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1104).
In compound (L-68), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1105).

で示される化合物（以下、化合物（Ｌ−６９）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1106と記す）。
化合物（Ｌ−６９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1107と記す）。
化合物（Ｌ−６９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1108と記す）。
化合物（Ｌ−６９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1109と記す）。
化合物（Ｌ−６９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1110と記す）。
化合物（Ｌ−６９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1111と記す）。 Formula (L-69)

In the compound represented by (hereinafter referred to as compound (L-69)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX1106).
In the compound (L-69), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as the compound group SX1107).
In the compound (L-69), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1108).
In compound (L-69), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1109).
In the compound (L-69), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1110).
In compound (L-69), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1111).

で示される化合物（以下、化合物（Ｌ−７０）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1112と記す）。
化合物（Ｌ−７０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1113と記す）。
化合物（Ｌ−７０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1114と記す）。
化合物（Ｌ−７０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1115と記す）。
化合物（Ｌ−７０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1116と記す）。
化合物（Ｌ−７０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1117と記す）。
化合物（Ｌ−７０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1118と記す）。
化合物（Ｌ−７０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1119と記す）。
化合物（Ｌ−７０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1120と記す）。
化合物（Ｌ−７０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1121と記す）。
化合物（Ｌ−７０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1122と記す）。
化合物（Ｌ−７０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1123と記す）。
化合物（Ｌ−７０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1124と記す）。
化合物（Ｌ−７０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1125と記す）。
化合物（Ｌ−７０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1126と記す）。
化合物（Ｌ−７０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1127と記す）。
化合物（Ｌ−７０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1128と記す）。
化合物（Ｌ−７０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1129と記す）。
化合物（Ｌ−７０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1130と記す）。
化合物（Ｌ−７０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1131と記す）。
化合物（Ｌ−７０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1132と記す）。
化合物（Ｌ−７０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1133と記す）。
化合物（Ｌ−７０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1134と記す）。
化合物（Ｌ−７０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1135と記す）。
化合物（Ｌ−７０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1136と記す）。
化合物（Ｌ−７０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1137と記す）。
化合物（Ｌ−７０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1138と記す）。
化合物（Ｌ−７０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1139と記す）。
化合物（Ｌ−７０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1140と記す）。
化合物（Ｌ−７０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1141と記す）。 Formula (L-70)

In the compound represented by (hereinafter referred to as compound (L-70)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1112).
In the compound (L-70), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1113).
In the compound (L-70), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1114).
In the compound (L-70), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1115).
In the compound (L-70), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1116).
In the compound (L-70), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1117).
In the compound (L-70), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1118).
In the compound (L-70), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1119).
In the compound (L-70), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1120).
In the compound (L-70), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1121).
In the compound (L-70), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1122).
In the compound (L-70), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1123).
In the compound (L-70), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1124).
In the compound (L-70), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1125).
In the compound (L-70), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1126).
In the compound (L-70), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1127).
In the compound (L-70), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1128).
In the compound (L-70), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1129).
In the compound (L-70), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1130).
In the compound (L-70), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1131).
In the compound (L-70), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1132).
In the compound (L-70), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1133).
In the compound (L-70), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1134).
In the compound (L-70), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1135).
In the compound (L-70), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1136).
In the compound (L-70), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1137).
In the compound (L-70), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1138).
In the compound (L-70), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1139).
In the compound (L-70), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1140).
In compound (L-70), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is ^defined in [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1141).

で示される化合物（以下、化合物（Ｌ−７１）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1142と記す）。
化合物（Ｌ−７１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1143と記す）。
化合物（Ｌ−７１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1144と記す）。
化合物（Ｌ−７１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1145と記す）。
化合物（Ｌ−７１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1146と記す）。
化合物（Ｌ−７１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1147と記す）。
化合物（Ｌ−７１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1148と記す）。
化合物（Ｌ−７１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1149と記す）。
化合物（Ｌ−７１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1150と記す）。
化合物（Ｌ−７１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1151と記す）。
化合物（Ｌ−７１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1152と記す）。
化合物（Ｌ−７１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1153と記す）。
化合物（Ｌ−７１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1154と記す）。
化合物（Ｌ−７１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1155と記す）。
化合物（Ｌ−７１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1156と記す）。
化合物（Ｌ−７１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1157と記す）。
化合物（Ｌ−７１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1158と記す）。
化合物（Ｌ−７１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1159と記す）。
化合物（Ｌ−７１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1160と記す）。
化合物（Ｌ−７１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1161と記す）。
化合物（Ｌ−７１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1162と記す）。
化合物（Ｌ−７１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1163と記す）。
化合物（Ｌ−７１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1164と記す）。
化合物（Ｌ−７１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1165と記す）。
化合物（Ｌ−７１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1166と記す）。
化合物（Ｌ−７１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1167と記す）。
化合物（Ｌ−７１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1168と記す）。
化合物（Ｌ−７１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1169と記す）。
化合物（Ｌ−７１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1170と記す）。
化合物（Ｌ−７１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1171と記す）。 Formula (L-71)

In the compound represented by (hereinafter referred to as compound (L-71)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1142).
In the compound (L-71), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1143).
In the compound (L-71), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1144).
In the compound (L-71), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1145).
In the compound (L-71), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1146).
In the compound (L-71), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1147).
In the compound (L-71), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1148).
In the compound (L-71), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1149).
In the compound (L-71), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1150).
In the compound (L-71), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1151).
In the compound (L-71), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1152).
In the compound (L-71), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1153).
In the compound (L-71), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1154).
In the compound (L-71), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1155).
In the compound (L-71), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1156).
In the compound (L-71), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1157).
In the compound (L-71), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1158).
In the compound (L-71), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1159).
In the compound (L-71), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1160).
In the compound (L-71), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1161).
In the compound (L-71), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1162).
In the compound (L-71), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1163).
In the compound (L-71), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1164).
In the compound (L-71), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1165).
In compound (L-71), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter, referred to as compound group SX1166).
In the compound (L-71), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1167).
In the compound (L-71), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1168).
In the compound (L-71), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1169).
In the compound (L-71), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1170).
In the compound (L-71), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1171).

で示される化合物（以下、化合物（Ｌ−７２）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1172と記す）。
化合物（Ｌ−７２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1173と記す）。
化合物（Ｌ−７２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1174と記す）。
化合物（Ｌ−７２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1175と記す）。
化合物（Ｌ−７２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1176と記す）。
化合物（Ｌ−７２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1177と記す）。
化合物（Ｌ−７２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1178と記す）。
化合物（Ｌ−７２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1179と記す）。
化合物（Ｌ−７２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1180と記す）。
化合物（Ｌ−７２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1181と記す）。
化合物（Ｌ−７２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1182と記す）。
化合物（Ｌ−７２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1183と記す）。
化合物（Ｌ−７２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1184と記す）。
化合物（Ｌ−７２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1185と記す）。
化合物（Ｌ−７２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1186と記す）。
化合物（Ｌ−７２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1187と記す）。
化合物（Ｌ−７２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1188と記す）。
化合物（Ｌ−７２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1189と記す）。
化合物（Ｌ−７２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1190と記す）。
化合物（Ｌ−７２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1191と記す）。
化合物（Ｌ−７２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1192と記す）。
化合物（Ｌ−７２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1193と記す）。
化合物（Ｌ−７２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1194と記す）。
化合物（Ｌ−７２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1195と記す）。
化合物（Ｌ−７２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1196と記す）。
化合物（Ｌ−７２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1197と記す）。
化合物（Ｌ−７２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1198と記す）。
化合物（Ｌ−７２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1199と記す）。
化合物（Ｌ−７２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1200と記す）。
化合物（Ｌ−７２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1201と記す）。 Formula (L-72)

In the compound represented by (hereinafter referred to as compound (L-72)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A to Table 15A (hereinafter referred to as compound group SX1172).
In the compound (L-72), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1173).
In the compound (L-72), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1174).
In the compound (L-72), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1175).
In the compound (L-72), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1176).
In the compound (L-72), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1177).
In the compound (L-72), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1178).
In the compound (L-72), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1179).
In the compound (L-72), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1180).
In the compound (L-72), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1181).
In the compound (L-72), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1182).
In the compound (L-72), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1183).
In the compound (L-72), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1184).
In the compound (L-72), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1185).
In compound (L-72), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A]-[ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1186).
In the compound (L-72), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1187).
In the compound (L-72), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1188).
In the compound (L-72), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1189).
In the compound (L-72), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1190).
In the compound (L-72), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1191).
In the compound (L-72), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1192).
In the compound (L-72), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1193).
In the compound (L-72), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1194).
In the compound (L-72), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1195).
In compound (L-72), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1196).
In the compound (L-72), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1197).
In the compound (L-72), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1198).
In the compound (L-72), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1199).
In the compound (L-72), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1200).
In the compound (L-72), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1201).

で示される化合物（以下、化合物（Ｌ−７３）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1202と記す）。
化合物（Ｌ−７３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1203と記す）。
化合物（Ｌ−７３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1204と記す）。
化合物（Ｌ−７３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1205と記す）。
化合物（Ｌ−７３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1206と記す）。
化合物（Ｌ−７３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1207と記す）。
化合物（Ｌ−７３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1208と記す）。
化合物（Ｌ−７３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1209と記す）。
化合物（Ｌ−７３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1210と記す）。
化合物（Ｌ−７３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1211と記す）。
化合物（Ｌ−７３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1212と記す）。
化合物（Ｌ−７３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1213と記す）。
化合物（Ｌ−７３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1214と記す）。
化合物（Ｌ−７３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1215と記す）。
化合物（Ｌ−７３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1216と記す）。
化合物（Ｌ−７３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1217と記す）。
化合物（Ｌ−７３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1218と記す）。
化合物（Ｌ−７３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1219と記す）。
化合物（Ｌ−７３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1220と記す）。
化合物（Ｌ−７３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1221と記す）。
化合物（Ｌ−７３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1222と記す）。
化合物（Ｌ−７３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1223と記す）。
化合物（Ｌ−７３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1224と記す）。
化合物（Ｌ−７３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1225と記す）。
化合物（Ｌ−７３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1226と記す）。
化合物（Ｌ−７３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1227と記す）。
化合物（Ｌ−７３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1228と記す）。
化合物（Ｌ−７３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1229と記す）。
化合物（Ｌ−７３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1230と記す）。
化合物（Ｌ−７３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1231と記す）。 Formula (L-73)

In the compound represented by (hereinafter referred to as compound (L-73)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1202).
In the compound (L-73), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1203).
In the compound (L-73), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1204).
In the compound (L-73), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1205).
In the compound (L-73), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1206).
In the compound (L-73), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1207).
In the compound (L-73), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1208).
In the compound (L-73), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1209).
In the compound (L-73), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1210).
In the compound (L-73), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1211).
In the compound (L-73), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1212).
In the compound (L-73), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1213).
In the compound (L-73), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1214).
In the compound (L-73), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1215).
In the compound (L-73), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1216).
In the compound (L-73), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1217).
In the compound (L-73), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1218).
In the compound (L-73), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1219).
In the compound (L-73), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1220).
In the compound (L-73), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1221).
In the compound (L-73), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1222).
In the compound (L-73), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1223).
In the compound (L-73), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1224).
In the compound (L-73), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1225).
In compound (L-73), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1226).
In the compound (L-73), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1227).
In the compound (L-73), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1228).
In the compound (L-73), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1229).
In the compound (L-73), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1230).
In the compound (L-73), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1231).

で示される化合物（以下、化合物（Ｌ−７４）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1232と記す）。
化合物（Ｌ−７４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1233と記す）。
化合物（Ｌ−７４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1234と記す）。
化合物（Ｌ−７４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1235と記す）。
化合物（Ｌ−７４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1236と記す）。
化合物（Ｌ−７４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1237と記す）。 Formula (L-74)

In the compound represented by formula (hereinafter referred to as compound (L-74)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX1232).
In the compound (L-74), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as the compound group SX1233).
In the compound (L-74), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1234).
In the compound (L-74), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1235).
In the compound (L-74), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1236).
In the compound (L-74), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1237).

で示される化合物（以下、化合物（Ｌ−７５）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1238と記す）。
化合物（Ｌ−７５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1239と記す）。
化合物（Ｌ−７５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1240と記す）。
化合物（Ｌ−７５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1241と記す）。
化合物（Ｌ−７５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1242と記す）。
化合物（Ｌ−７５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1243と記す）。 Formula (L-75)

In the compound represented by formula (hereinafter referred to as compound (L-75)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX1238).
In the compound (L-75), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as the compound group SX1239).
In the compound (L-75), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1240).
In the compound (L-75), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1241).
In the compound (L-75), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1242).
In the compound (L-75), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1243).

で示される化合物（以下、化合物（Ｌ−７６）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1244と記す）。
化合物（Ｌ−７６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1245と記す）。
化合物（Ｌ−７６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1246と記す）。
化合物（Ｌ−７６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1247と記す）。
化合物（Ｌ−７６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1248と記す）。
化合物（Ｌ−７６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1249と記す）。
化合物（Ｌ−７６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1250と記す）。
化合物（Ｌ−７６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1251と記す）。
化合物（Ｌ−７６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1252と記す）。
化合物（Ｌ−７６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1253と記す）。
化合物（Ｌ−７６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1254と記す）。
化合物（Ｌ−７６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1255と記す）。
化合物（Ｌ−７６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1256と記す）。
化合物（Ｌ−７６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1257と記す）。
化合物（Ｌ−７６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1258と記す）。
化合物（Ｌ−７６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1259と記す）。
化合物（Ｌ−７６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1260と記す）。
化合物（Ｌ−７６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1261と記す）。
化合物（Ｌ−７６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1262と記す）。
化合物（Ｌ−７６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1263と記す）。
化合物（Ｌ−７６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1264と記す）。
化合物（Ｌ−７６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1265と記す）。
化合物（Ｌ−７６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1266と記す）。
化合物（Ｌ−７６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1267と記す）。
化合物（Ｌ−７６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1268と記す）。
化合物（Ｌ−７６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1269と記す）。
化合物（Ｌ−７６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1270と記す）。
化合物（Ｌ−７６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1271と記す）。
化合物（Ｌ−７６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1272と記す）。
化合物（Ｌ−７６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1273と記す）。 Formula (L-76)

In the compound represented by (hereinafter referred to as compound (L-76)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1244).
In the compound (L-76), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1245).
In the compound (L-76), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1246).
In the compound (L-76), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1247).
In the compound (L-76), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1248).
In the compound (L-76), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1249).
In the compound (L-76), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1250).
In the compound (L-76), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1251).
In the compound (L-76), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1252).
In the compound (L-76), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1253).
In the compound (L-76), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1254).
In the compound (L-76), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1255).
In the compound (L-76), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1256).
In the compound (L-76), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1257).
In the compound (L-76), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1258).
In the compound (L-76), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1259).
In the compound (L-76), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1260).
In the compound (L-76), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1261).
In the compound (L-76), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1262).
In the compound (L-76), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1263).
In the compound (L-76), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1264).
In the compound (L-76), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1265).
In the compound (L-76), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1266).
In the compound (L-76), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1267).
In compound (L-76), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A]-[ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1268).
In the compound (L-76), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1269).
In the compound (L-76), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1270).
In the compound (L-76), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1271).
In the compound (L-76), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1272).
In the compound (L-76), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1273).

で示される化合物（以下、化合物（Ｌ−７７）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1274と記す）。
化合物（Ｌ−７７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1275と記す）。
化合物（Ｌ−７７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1276と記す）。
化合物（Ｌ−７７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1277と記す）。
化合物（Ｌ−７７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1278と記す）。
化合物（Ｌ−７７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1279と記す）。
化合物（Ｌ−７７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1280と記す）。
化合物（Ｌ−７７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1281と記す）。
化合物（Ｌ−７７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1282と記す）。
化合物（Ｌ−７７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1283と記す）。
化合物（Ｌ−７７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1284と記す）。
化合物（Ｌ−７７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1285と記す）。
化合物（Ｌ−７７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1286と記す）。
化合物（Ｌ−７７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1287と記す）。
化合物（Ｌ−７７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1288と記す）。
化合物（Ｌ−７７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1289と記す）。
化合物（Ｌ−７７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1290と記す）。
化合物（Ｌ−７７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1291と記す）。
化合物（Ｌ−７７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1292と記す）。
化合物（Ｌ−７７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1293と記す）。
化合物（Ｌ−７７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1294と記す）。
化合物（Ｌ−７７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1295と記す）。
化合物（Ｌ−７７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1296と記す）。
化合物（Ｌ−７７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1297と記す）。
化合物（Ｌ−７７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1298と記す）。
化合物（Ｌ−７７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1299と記す）。
化合物（Ｌ−７７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1300と記す）。
化合物（Ｌ−７７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1301と記す）。
化合物（Ｌ−７７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1302と記す）。
化合物（Ｌ−７７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1303と記す）。 Formula (L-77)

In the compound represented by (hereinafter referred to as compound (L-77)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as Compound Group SX1274).
In the compound (L-77), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1275).
In the compound (L-77), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1276).
In the compound (L-77), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1277).
In the compound (L-77), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1278).
In the compound (L-77), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1279).
In the compound (L-77), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1280).
In the compound (L-77), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1281).
In the compound (L-77), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1282).
In the compound (L-77), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1283).
In the compound (L-77), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1284).
In the compound (L-77), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1285).
In the compound (L-77), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1286).
In the compound (L-77), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1287).
In the compound (L-77), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1288).
In the compound (L-77), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1289).
In the compound (L-77), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1290).
In the compound (L-77), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1291).
In the compound (L-77), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1292).
In the compound (L-77), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1293).
In the compound (L-77), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1294).
In the compound (L-77), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1295).
In the compound (L-77), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1296).
In the compound (L-77), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1297).
In the compound (L-77), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1298).
In the compound (L-77), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1299).
In the compound (L-77), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1300).
In the compound (L-77), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1301).
In the compound (L-77), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1302).
In the compound (L-77), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1303).

で示される化合物（以下、化合物（Ｌ−７８）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1304と記す）。
化合物（Ｌ−７８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1305と記す）。
化合物（Ｌ−７８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1306と記す）。
化合物（Ｌ−７８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1307と記す）。
化合物（Ｌ−７８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1308と記す）。
化合物（Ｌ−７８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1309と記す）。
化合物（Ｌ−７８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1310と記す）。
化合物（Ｌ−７８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1311と記す）。
化合物（Ｌ−７８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1312と記す）。
化合物（Ｌ−７８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1313と記す）。
化合物（Ｌ−７８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1314と記す）。
化合物（Ｌ−７８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1315と記す）。
化合物（Ｌ−７８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1316と記す）。
化合物（Ｌ−７８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1317と記す）。
化合物（Ｌ−７８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1318と記す）。
化合物（Ｌ−７８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1319と記す）。
化合物（Ｌ−７８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1320と記す）。
化合物（Ｌ−７８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1321と記す）。
化合物（Ｌ−７８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1322と記す）。
化合物（Ｌ−７８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1323と記す）。
化合物（Ｌ−７８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1324と記す）。
化合物（Ｌ−７８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1325と記す）。
化合物（Ｌ−７８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1326と記す）。
化合物（Ｌ−７８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1327と記す）。
化合物（Ｌ−７８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1328と記す）。
化合物（Ｌ−７８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1329と記す）。
化合物（Ｌ−７８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1330と記す）。
化合物（Ｌ−７８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1331と記す）。
化合物（Ｌ−７８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1332と記す）。
化合物（Ｌ−７８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1333と記す）。 Formula (L-78)

In the compound represented by (hereinafter referred to as compound (L-78)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1304).
In the compound (L-78), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1305).
In the compound (L-78), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1306).
In the compound (L-78), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1307).
In the compound (L-78), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1308).
In the compound (L-78), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1309).
In the compound (L-78), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1310).
In the compound (L-78), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1311).
In the compound (L-78), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any substituent (hereinafter referred to as compound group SX1312).
In the compound (L-78), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1313).
In the compound (L-78), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1314).
In the compound (L-78), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1315).
In the compound (L-78), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1316).
In the compound (L-78), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1317).
In the compound (L-78), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1318).
In the compound (L-78), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1319).
In the compound (L-78), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1320).
In the compound (L-78), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1321).
In the compound (L-78), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1322).
In the compound (L-78), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1323).
In the compound (L-78), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1324).
In the compound (L-78), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1325).
In the compound (L-78), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1326).
In the compound (L-78), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1327).
In the compound (L-78), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter, referred to as compound group SX1328).
In the compound (L-78), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1329).
In the compound (L-78), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1330).
In the compound (L-78), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1331).
In the compound (L-78), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1332).
In the compound (L-78), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1333).

で示される化合物（以下、化合物（Ｌ−７９）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1334と記す）。
化合物（Ｌ−７９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1335と記す）。
化合物（Ｌ−７９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1336と記す）。
化合物（Ｌ−７９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1337と記す）。
化合物（Ｌ−７９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1338と記す）。
化合物（Ｌ−７９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1339と記す）。
化合物（Ｌ−７９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1340と記す）。
化合物（Ｌ−７９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1341と記す）。
化合物（Ｌ−７９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1342と記す）。
化合物（Ｌ−７９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1343と記す）。
化合物（Ｌ−７９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1344と記す）。
化合物（Ｌ−７９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1345と記す）。
化合物（Ｌ−７９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1346と記す）。
化合物（Ｌ−７９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1347と記す）。
化合物（Ｌ−７９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1348と記す）。
化合物（Ｌ−７９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1349と記す）。
化合物（Ｌ−７９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1350と記す）。
化合物（Ｌ−７９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1351と記す）。
化合物（Ｌ−７９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1352と記す）。
化合物（Ｌ−７９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1353と記す）。
化合物（Ｌ−７９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1354と記す）。
化合物（Ｌ−７９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1355と記す）。
化合物（Ｌ−７９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1356と記す）。
化合物（Ｌ−７９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1357と記す）。
化合物（Ｌ−７９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1358と記す）。
化合物（Ｌ−７９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1359と記す）。
化合物（Ｌ−７９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1360と記す）。
化合物（Ｌ−７９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1361と記す）。
化合物（Ｌ−７９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1362と記す）。
化合物（Ｌ−７９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1363と記す）。 Formula (L-79)

In the compound represented by (hereinafter referred to as compound (L-79)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1334).
In the compound (L-79), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1335).
In the compound (L-79), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1336).
In the compound (L-79), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1337).
In the compound (L-79), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1338).
In the compound (L-79), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1339).
In the compound (L-79), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1340).
In the compound (L-79), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1341).
In the compound (L-79), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1342).
In the compound (L-79), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1343).
In the compound (L-79), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1344).
In the compound (L-79), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1345).
In the compound (L-79), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1346).
In the compound (L-79), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1347).
In the compound (L-79), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter, referred to as compound group SX1348).
In the compound (L-79), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1349).
In the compound (L-79), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1350).
In the compound (L-79), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1351).
In the compound (L-79), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1352).
In the compound (L-79), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1353).
In the compound (L-79), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1354).
In the compound (L-79), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1355).
In the compound (L-79), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1356).
In the compound (L-79), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1357).
In compound (L-79), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1358).
In the compound (L-79), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1359).
In the compound (L-79), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1360).
In the compound (L-79), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1361).
In the compound (L-79), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1362).
In the compound (L-79), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1363).

で示される化合物（以下、化合物（Ｌ−８０）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1364と記す）。
化合物（Ｌ−８０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1365と記す）。
化合物（Ｌ−８０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1366と記す）。
化合物（Ｌ−８０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1367と記す）。
化合物（Ｌ−８０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1368と記す）。
化合物（Ｌ−８０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1369と記す）。 Formula (L-80)

In the compound represented by (hereinafter referred to as compound (L-80)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX1364).
In the compound (L-80), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX1365).
In the compound (L-80), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1366).
In the compound (L-80), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1367).
In the compound (L-80), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1368).
In the compound (L-80), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1369).

で示される化合物（以下、化合物（Ｌ−８１）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1370と記す）。
化合物（Ｌ−８１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1371と記す）。
化合物（Ｌ−８１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1372と記す）。
化合物（Ｌ−８１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1373と記す）。
化合物（Ｌ−８１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1374と記す）。
化合物（Ｌ−８１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1375と記す）。 Formula (L-81)

In the compound represented by (hereinafter, referred to as compound (L-81)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX1370).
In the compound (L-81), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX1371).
In the compound (L-81), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1372).
In the compound (L-81), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1373).
In the compound (L-81), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1374).
In compound (L-81), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1375).

で示される化合物（以下、化合物（Ｌ−８２）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1376と記す）。
化合物（Ｌ−８２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1377と記す）。
化合物（Ｌ−８２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1378と記す）。
化合物（Ｌ−８２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1379と記す）。
化合物（Ｌ−８２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1380と記す）。
化合物（Ｌ−８２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1381と記す）。
化合物（Ｌ−８２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1382と記す）。
化合物（Ｌ−８２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1383と記す）。
化合物（Ｌ−８２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1384と記す）。
化合物（Ｌ−８２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1385と記す）。
化合物（Ｌ−８２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1386と記す）。
化合物（Ｌ−８２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1387と記す）。
化合物（Ｌ−８２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1388と記す）。
化合物（Ｌ−８２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1389と記す）。
化合物（Ｌ−８２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1390と記す）。
化合物（Ｌ−８２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1391と記す）。
化合物（Ｌ−８２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1392と記す）。
化合物（Ｌ−８２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1393と記す）。
化合物（Ｌ−８２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1394と記す）。
化合物（Ｌ−８２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1395と記す）。
化合物（Ｌ−８２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1396と記す）。
化合物（Ｌ−８２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1397と記す）。
化合物（Ｌ−８２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1398と記す）。
化合物（Ｌ−８２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1399と記す）。
化合物（Ｌ−８２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1400と記す）。
化合物（Ｌ−８２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1401と記す）。
化合物（Ｌ−８２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1402と記す）。
化合物（Ｌ−８２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1403と記す）。
化合物（Ｌ−８２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1404と記す）。
化合物（Ｌ−８２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1405と記す）。 Formula (L-82)

In the compound represented by (hereinafter referred to as compound (L-82)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1376).
In the compound (L-82), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1377).
In the compound (L-82), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1378).
In the compound (L-82), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1379).
In the compound (L-82), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1380).
In the compound (L-82), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1381).
In the compound (L-82), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1382).
In the compound (L-82), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1383).
In the compound (L-82), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1384).
In the compound (L-82), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1385).
In the compound (L-82), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1386).
In the compound (L-82), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1387).
In the compound (L-82), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1388).
In the compound (L-82), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1389).
In the compound (L-82), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1390).
In the compound (L-82), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1391).
In the compound (L-82), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1392).
In the compound (L-82), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1393).
In the compound (L-82), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1394).
In the compound (L-82), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1395).
In the compound (L-82), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1396).
In the compound (L-82), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1397).
In the compound (L-82), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1398).
In the compound (L-82), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1399).
In the compound (L-82), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1400).
In the compound (L-82), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1401).
In the compound (L-82), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1402).
In the compound (L-82), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1403).
In the compound (L-82), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1404).
In the compound (L-82), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1405).

で示される化合物（以下、化合物（Ｌ−８３）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1406と記す）。
化合物（Ｌ−８３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1407と記す）。
化合物（Ｌ−８３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1408と記す）。
化合物（Ｌ−８３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1409と記す）。
化合物（Ｌ−８３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1410と記す）。
化合物（Ｌ−８３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1411と記す）。
化合物（Ｌ−８３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1412と記す）。
化合物（Ｌ−８３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1413と記す）。
化合物（Ｌ−８３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1414と記す）。
化合物（Ｌ−８３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1415と記す）。
化合物（Ｌ−８３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1416と記す）。
化合物（Ｌ−８３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1417と記す）。
化合物（Ｌ−８３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1418と記す）。
化合物（Ｌ−８３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1419と記す）。
化合物（Ｌ−８３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1420と記す）。
化合物（Ｌ−８３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1421と記す）。
化合物（Ｌ−８３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1422と記す）。
化合物（Ｌ−８３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1423と記す）。
化合物（Ｌ−８３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1424と記す）。
化合物（Ｌ−８３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1425と記す）。
化合物（Ｌ−８３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1426と記す）。
化合物（Ｌ−８３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1427と記す）。
化合物（Ｌ−８３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1428と記す）。
化合物（Ｌ−８３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1429と記す）。
化合物（Ｌ−８３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1430と記す）。
化合物（Ｌ−８３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1431と記す）。
化合物（Ｌ−８３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1432と記す）。
化合物（Ｌ−８３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1433と記す）。
化合物（Ｌ−８３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1434と記す）。
化合物（Ｌ−８３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1435と記す）。 Formula (L-83)

In the compound represented by (hereinafter referred to as compound (L-83)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1406).
In the compound (L-83), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1407).
In the compound (L-83), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1408).
In the compound (L-83), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1409).
In the compound (L-83), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound that is any of the substituents (hereinafter referred to as compound group SX1410).
In the compound (L-83), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1411).
In the compound (L-83), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1412).
In the compound (L-83), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1413).
In the compound (L-83), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1414).
In the compound (L-83), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1415).
In the compound (L-83), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1416).
In the compound (L-83), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1417).
In the compound (L-83), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1418).
In the compound (L-83), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1419).
In the compound (L-83), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1420).
In the compound (L-83), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1421).
In the compound (L-83), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1422).
In the compound (L-83), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1423).
In the compound (L-83), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1424).
In the compound (L-83), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1425).
In the compound (L-83), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1426).
In the compound (L-83), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1427).
In the compound (L-83), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1428).
In the compound (L-83), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1429).
In compound (L-83), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1430).
In the compound (L-83), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1431).
In the compound (L-83), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1432).
In the compound (L-83), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1433).
In the compound (L-83), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1434).
In the compound (L-83), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1435).

で示される化合物（以下、化合物（Ｌ−８４）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1436と記す）。
化合物（Ｌ−８４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1437と記す）。
化合物（Ｌ−８４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1438と記す）。
化合物（Ｌ−８４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1439と記す）。
化合物（Ｌ−８４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1440と記す）。
化合物（Ｌ−８４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1441と記す）。
化合物（Ｌ−８４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1442と記す）。
化合物（Ｌ−８４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1443と記す）。
化合物（Ｌ−８４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1444と記す）。
化合物（Ｌ−８４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1445と記す）。
化合物（Ｌ−８４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1446と記す）。
化合物（Ｌ−８４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1447と記す）。
化合物（Ｌ−８４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1448と記す）。
化合物（Ｌ−８４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1449と記す）。
化合物（Ｌ−８４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1450と記す）。
化合物（Ｌ−８４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1451と記す）。
化合物（Ｌ−８４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1452と記す）。
化合物（Ｌ−８４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1453と記す）。
化合物（Ｌ−８４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1454と記す）。
化合物（Ｌ−８４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1455と記す）。
化合物（Ｌ−８４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1456と記す）。
化合物（Ｌ−８４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1457と記す）。
化合物（Ｌ−８４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1458と記す）。
化合物（Ｌ−８４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1459と記す）。
化合物（Ｌ−８４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1460と記す）。
化合物（Ｌ−８４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1461と記す）。
化合物（Ｌ−８４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1462と記す）。
化合物（Ｌ−８４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1463と記す）。
化合物（Ｌ−８４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1464と記す）。
化合物（Ｌ−８４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1465と記す）。 Formula (L-84)

In the compound represented by (hereinafter referred to as compound (L-84)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as Compound Group SX1436).
In the compound (L-84), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1437).
In the compound (L-84), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1438).
In the compound (L-84), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1439).
In the compound (L-84), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1440).
In the compound (L-84), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1441).
In the compound (L-84), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1442).
In the compound (L-84), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1443).
In the compound (L-84), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1444).
In the compound (L-84), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1445).
In the compound (L-84), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1446).
In the compound (L-84), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1447).
In the compound (L-84), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1448).
In the compound (L-84), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1449).
In compound (L-84), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1450).
In the compound (L-84), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1451).
In the compound (L-84), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1452).
In the compound (L-84), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1453).
In the compound (L-84), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1454).
In the compound (L-84), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1455).
In the compound (L-84), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1456).
In the compound (L-84), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1457).
In the compound (L-84), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1458).
In the compound (L-84), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1459).
In compound (L-84), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A]-[ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1460).
In the compound (L-84), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1461).
In the compound (L-84), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1462).
In the compound (L-84), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1463).
In the compound (L-84), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1464).
In the compound (L-84), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is ^defined in [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1465).

で示される化合物（以下、化合物（Ｌ−８５）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1466と記す）。
化合物（Ｌ−８５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1467と記す）。
化合物（Ｌ−８５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1468と記す）。
化合物（Ｌ−８５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1469と記す）。
化合物（Ｌ−８５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1470と記す）。
化合物（Ｌ−８５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1471と記す）。 Formula (L-85)

In the compound represented by (hereinafter, referred to as compound (L-85)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX1466).
In the compound (L-85), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in Table 7A to Table 15A (Hereinafter referred to as compound group SX1467).
In the compound (L-85), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1468).
In compound (L-85), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1469).
In the compound (L-85), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1470).
In the compound (L-85), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1471).

で示される化合物（以下、化合物（Ｌ−８６）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1472と記す）。
化合物（Ｌ−８６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1473と記す）。
化合物（Ｌ−８６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1474と記す）。
化合物（Ｌ−８６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1475と記す）。
化合物（Ｌ−８６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1476と記す）。
化合物（Ｌ−８６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1477と記す）。 Formula (L-86)

In the compound represented by (hereinafter, referred to as compound (L-86)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX1472).
In the compound (L-86), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as the compound group SX1473).
In the compound (L-86), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1474).
In the compound (L-86), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1475).
In the compound (L-86), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1476).
In the compound (L-86), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1477).

で示される化合物（以下、化合物（Ｌ−８７）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1478と記す）。
化合物（Ｌ−８７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1479と記す）。
化合物（Ｌ−８７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1480と記す）。
化合物（Ｌ−８７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1481と記す）。
化合物（Ｌ−８７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1482と記す）。
化合物（Ｌ−８７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1483と記す）。
化合物（Ｌ−８７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1484と記す）。
化合物（Ｌ−８７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1485と記す）。
化合物（Ｌ−８７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1486と記す）。
化合物（Ｌ−８７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1487と記す）。
化合物（Ｌ−８７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1488と記す）。
化合物（Ｌ−８７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1489と記す）。
化合物（Ｌ−８７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1490と記す）。
化合物（Ｌ−８７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1491と記す）。
化合物（Ｌ−８７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1492と記す）。
化合物（Ｌ−８７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1493と記す）。
化合物（Ｌ−８７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1494と記す）。
化合物（Ｌ−８７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1495と記す）。
化合物（Ｌ−８７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1496と記す）。
化合物（Ｌ−８７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1497と記す）。
化合物（Ｌ−８７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1498と記す）。
化合物（Ｌ−８７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1499と記す）。
化合物（Ｌ−８７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1500と記す）。
化合物（Ｌ−８７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1501と記す）。
化合物（Ｌ−８７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1502と記す）。
化合物（Ｌ−８７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1503と記す）。
化合物（Ｌ−８７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1504と記す）。
化合物（Ｌ−８７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1505と記す）。
化合物（Ｌ−８７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1506と記す）。
化合物（Ｌ−８７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1507と記す）。 Formula (L-87)

In the compound represented by (hereinafter referred to as compound (L-87)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1478).
In the compound (L-87), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1479).
In the compound (L-87), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1480).
In the compound (L-87), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1481).
In the compound (L-87), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1482).
In the compound (L-87), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1483).
In the compound (L-87), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1484).
In the compound (L-87), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1485).
In the compound (L-87), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1486).
In the compound (L-87), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1487).
In the compound (L-87), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1488).
In the compound (L-87), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1489).
In the compound (L-87), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1490).
In the compound (L-87), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1491).
In the compound (L-87), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1492).
In the compound (L-87), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1493).
In the compound (L-87), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1494).
In the compound (L-87), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1495).
In the compound (L-87), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1496).
In the compound (L-87), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1497).
In the compound (L-87), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1498).
In the compound (L-87), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1499).
In the compound (L-87), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter referred to as compound group SX1500).
In the compound (L-87), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1501).
In compound (L-87), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1502).
In the compound (L-87), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1503).
In the compound (L-87), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1504).
In the compound (L-87), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1505).
In the compound (L-87), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1506).
In the compound (L-87), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1507).

で示される化合物（以下、化合物（Ｌ−８８）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1508と記す）。
化合物（Ｌ−８８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1509と記す）。
化合物（Ｌ−８８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1510と記す）。
化合物（Ｌ−８８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1511と記す）。
化合物（Ｌ−８８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1512と記す）。
化合物（Ｌ−８８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1513と記す）。
化合物（Ｌ−８８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1514と記す）。
化合物（Ｌ−８８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1515と記す）。
化合物（Ｌ−８８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1516と記す）。
化合物（Ｌ−８８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1517と記す）。
化合物（Ｌ−８８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1518と記す）。
化合物（Ｌ−８８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1519と記す）。
化合物（Ｌ−８８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1520と記す）。
化合物（Ｌ−８８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1521と記す）。
化合物（Ｌ−８８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1522と記す）。
化合物（Ｌ−８８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1523と記す）。
化合物（Ｌ−８８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1524と記す）。
化合物（Ｌ−８８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1525と記す）。
化合物（Ｌ−８８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1526と記す）。
化合物（Ｌ−８８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1527と記す）。
化合物（Ｌ−８８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1528と記す）。
化合物（Ｌ−８８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1529と記す）。
化合物（Ｌ−８８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1530と記す）。
化合物（Ｌ−８８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1531と記す）。
化合物（Ｌ−８８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1532と記す）。
化合物（Ｌ−８８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1533と記す）。
化合物（Ｌ−８８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1534と記す）。
化合物（Ｌ−８８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1535と記す）。
化合物（Ｌ−８８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1536と記す）。
化合物（Ｌ−８８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1537と記す）。 Formula (L-88)

In the compound represented by (hereinafter referred to as compound (L-88)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1508).
In the compound (L-88), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1509).
In the compound (L-88), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1510).
In the compound (L-88), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1511).
In the compound (L-88), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1512).
In the compound (L-88), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1513).
In the compound (L-88), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1514).
In the compound (L-88), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1515).
In the compound (L-88), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1516).
In the compound (L-88), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1517).
In the compound (L-88), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1518).
In the compound (L-88), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1519).
In the compound (L-88), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1520).
In the compound (L-88), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1521).
In the compound (L-88), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1522).
In the compound (L-88), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1523).
In the compound (L-88), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1524).
In the compound (L-88), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1525).
In the compound (L-88), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1526).
In the compound (L-88), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1527).
In the compound (L-88), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1528).
In the compound (L-88), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1529).
In the compound (L-88), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1530).
In the compound (L-88), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1531).
In the compound (L-88), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1532).
In the compound (L-88), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1533).
In the compound (L-88), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1534).
In the compound (L-88), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1535).
In the compound (L-88), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1536).
In the compound (L-88), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1537).

で示される化合物（以下、化合物（Ｌ−８９）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1538と記す）。
化合物（Ｌ−８９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1539と記す）。
化合物（Ｌ−８９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1540と記す）。
化合物（Ｌ−８９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1541と記す）。
化合物（Ｌ−８９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1542と記す）。
化合物（Ｌ−８９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1543と記す）。
化合物（Ｌ−８９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1544と記す）。
化合物（Ｌ−８９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1545と記す）。
化合物（Ｌ−８９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1546と記す）。
化合物（Ｌ−８９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1547と記す）。
化合物（Ｌ−８９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1548と記す）。
化合物（Ｌ−８９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1549と記す）。
化合物（Ｌ−８９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1550と記す）。
化合物（Ｌ−８９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1551と記す）。
化合物（Ｌ−８９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1552と記す）。
化合物（Ｌ−８９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1553と記す）。
化合物（Ｌ−８９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1554と記す）。
化合物（Ｌ−８９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1555と記す）。
化合物（Ｌ−８９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1556と記す）。
化合物（Ｌ−８９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1557と記す）。
化合物（Ｌ−８９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1558と記す）。
化合物（Ｌ−８９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1559と記す）。
化合物（Ｌ−８９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1560と記す）。
化合物（Ｌ−８９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1561と記す）。
化合物（Ｌ−８９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1562と記す）。
化合物（Ｌ−８９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1563と記す）。
化合物（Ｌ−８９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1564と記す）。
化合物（Ｌ−８９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1565と記す）。
化合物（Ｌ−８９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1566と記す）。
化合物（Ｌ−８９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1567と記す）。 Formula (L-89)

In the compound represented by (hereinafter referred to as compound (L-89)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1538).
In the compound (L-89), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1539).
In the compound (L-89), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1540).
In the compound (L-89), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1541).
In the compound (L-89), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1542).
In the compound (L-89), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1543).
In the compound (L-89), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1544).
In the compound (L-89), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1545).
In the compound (L-89), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1546).
In the compound (L-89), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1547).
In the compound (L-89), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1548).
In the compound (L-89), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1549).
In the compound (L-89), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1550).
In the compound (L-89), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1551).
In the compound (L-89), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1552).
In the compound (L-89), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1553).
In the compound (L-89), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1554).
In the compound (L-89), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1555).
In the compound (L-89), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1556).
In the compound (L-89), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1557).
In the compound (L-89), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1558).
In the compound (L-89), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1559).
In the compound (L-89), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1560).
In the compound (L-89), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1561).
In the compound (L-89), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1562).
In the compound (L-89), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1563).
In the compound (L-89), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1564).
In the compound (L-89), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1565).
In the compound (L-89), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1566).
In the compound (L-89), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1567).

で示される化合物（以下、化合物（Ｌ−９０）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1568と記す）。
化合物（Ｌ−９０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1569と記す）。
化合物（Ｌ−９０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1570と記す）。
化合物（Ｌ−９０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1571と記す）。
化合物（Ｌ−９０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1572と記す）。
化合物（Ｌ−９０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1573と記す）。
化合物（Ｌ−９０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1574と記す）。
化合物（Ｌ−９０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1575と記す）。
化合物（Ｌ−９０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1576と記す）。
化合物（Ｌ−９０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1577と記す）。
化合物（Ｌ−９０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1578と記す）。
化合物（Ｌ−９０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1579と記す）。
化合物（Ｌ−９０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1580と記す）。
化合物（Ｌ−９０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1581と記す）。
化合物（Ｌ−９０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1582と記す）。
化合物（Ｌ−９０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1583と記す）。
化合物（Ｌ−９０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1584と記す）。
化合物（Ｌ−９０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1585と記す）。
化合物（Ｌ−９０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1586と記す）。
化合物（Ｌ−９０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1587と記す）。
化合物（Ｌ−９０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1588と記す）。
化合物（Ｌ−９０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1589と記す）。
化合物（Ｌ−９０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1590と記す）。
化合物（Ｌ−９０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1591と記す）。
化合物（Ｌ−９０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1592と記す）。
化合物（Ｌ−９０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1593と記す）。
化合物（Ｌ−９０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1594と記す）。
化合物（Ｌ−９０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1595と記す）。
化合物（Ｌ−９０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1596と記す）。
化合物（Ｌ−９０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1597と記す）。 Formula (L-90)

In the compound represented by (hereinafter referred to as compound (L-90)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1568).
In the compound (L-90), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1569).
In the compound (L-90), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1570).
In the compound (L-90), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1571).
In the compound (L-90), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1572).
In the compound (L-90), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1573).
In the compound (L-90), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1574).
In the compound (L-90), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1575).
In the compound (L-90), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1576).
In the compound (L-90), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1577).
In the compound (L-90), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1578).
In the compound (L-90), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1579).
In the compound (L-90), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1580).
In the compound (L-90), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1581).
In compound (L-90), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1582).
In the compound (L-90), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1583).
In the compound (L-90), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1584).
In the compound (L-90), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1585).
In the compound (L-90), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1586).
In the compound (L-90), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1587).
In the compound (L-90), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1588).
In the compound (L-90), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1589).
In the compound (L-90), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1590).
In the compound (L-90), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1591).
In compound (L-90), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1592).
In the compound (L-90), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1593).
In the compound (L-90), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1594).
In the compound (L-90), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1595).
In the compound (L-90), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1596).
In the compound (L-90), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1597).

で示される化合物（以下、化合物（Ｌ−９１）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1598と記す）。
化合物（Ｌ−９１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1599と記す）。
化合物（Ｌ−９１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1600と記す）。
化合物（Ｌ−９１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1601と記す）。
化合物（Ｌ−９１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1602と記す）。
化合物（Ｌ−９１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1603と記す）。 Formula (L-91)

In the compound represented by (hereinafter, referred to as compound (L-91)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX1598).
In the compound (L-91), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX1599).
In the compound (L-91), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1600).
In the compound (L-91), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1601).
In the compound (L-91), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1602).
In the compound (L-91), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1603).

で示される化合物（以下、化合物（Ｌ−９２）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1604と記す）。
化合物（Ｌ−９２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1605と記す）。
化合物（Ｌ−９２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1606と記す）。
化合物（Ｌ−９２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1607と記す）。
化合物（Ｌ−９２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1608と記す）。
化合物（Ｌ−９２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1609と記す）。 Formula (L-92)

In the compound represented by (hereinafter referred to as compound (L-92)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX1604).
In the compound (L-92), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX1605).
In the compound (L-92), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1606).
In the compound (L-92), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1607).
In the compound (L-92), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1608).
In the compound (L-92), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1609).

で示される化合物（以下、化合物（Ｌ−９３）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1610と記す）。
化合物（Ｌ−９３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1611と記す）。
化合物（Ｌ−９３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1612と記す）。
化合物（Ｌ−９３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1613と記す）。
化合物（Ｌ−９３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1614と記す）。
化合物（Ｌ−９３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1615と記す）。
化合物（Ｌ−９３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1616と記す）。
化合物（Ｌ−９３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1617と記す）。
化合物（Ｌ−９３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1618と記す）。
化合物（Ｌ−９３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1619と記す）。
化合物（Ｌ−９３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1620と記す）。
化合物（Ｌ−９３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1621と記す）。
化合物（Ｌ−９３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1622と記す）。
化合物（Ｌ−９３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1623と記す）。
化合物（Ｌ−９３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1624と記す）。
化合物（Ｌ−９３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1625と記す）。
化合物（Ｌ−９３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1626と記す）。
化合物（Ｌ−９３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1627と記す）。
化合物（Ｌ−９３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1628と記す）。
化合物（Ｌ−９３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1629と記す）。
化合物（Ｌ−９３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1630と記す）。
化合物（Ｌ−９３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1631と記す）。
化合物（Ｌ−９３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1632と記す）。
化合物（Ｌ−９３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1633と記す）。
化合物（Ｌ−９３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1634と記す）。
化合物（Ｌ−９３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1635と記す）。
化合物（Ｌ−９３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1636と記す）。
化合物（Ｌ−９３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1637と記す）。
化合物（Ｌ−９３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1638と記す）。
化合物（Ｌ−９３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1639と記す）。 Formula (L-93)

In the compound represented by (hereinafter referred to as compound (L-93)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as Compound Group SX1610).
In the compound (L-93), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1611).
In the compound (L-93), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1612).
In the compound (L-93), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1613).
In the compound (L-93), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound that is any of the substituents (hereinafter referred to as compound group SX1614).
In the compound (L-93), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1615).
In the compound (L-93), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1616).
In the compound (L-93), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1617).
In the compound (L-93), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1618).
In the compound (L-93), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1619).
In the compound (L-93), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1620).
In the compound (L-93), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1621).
In the compound (L-93), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1622).
In the compound (L-93), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1623).
In the compound (L-93), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1624).
In the compound (L-93), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1625).
In the compound (L-93), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1626).
In the compound (L-93), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1627).
In the compound (L-93), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1628).
In the compound (L-93), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1629).
In the compound (L-93), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1630).
In the compound (L-93), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1631).
In the compound (L-93), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1632).
In the compound (L-93), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1633).
In compound (L-93), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1634).
In the compound (L-93), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1635).
In the compound (L-93), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1636).
In the compound (L-93), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1637).
In the compound (L-93), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1638).
In the compound (L-93), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1639).

で示される化合物（以下、化合物（Ｌ−９４）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1640と記す）。
化合物（Ｌ−９４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1641と記す）。
化合物（Ｌ−９４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1642と記す）。
化合物（Ｌ−９４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1643と記す）。
化合物（Ｌ−９４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1644と記す）。
化合物（Ｌ−９４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1645と記す）。
化合物（Ｌ−９４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1646と記す）。
化合物（Ｌ−９４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1647と記す）。
化合物（Ｌ−９４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1648と記す）。
化合物（Ｌ−９４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1649と記す）。
化合物（Ｌ−９４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1650と記す）。
化合物（Ｌ−９４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1651と記す）。
化合物（Ｌ−９４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1652と記す）。
化合物（Ｌ−９４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1653と記す）。
化合物（Ｌ−９４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1654と記す）。
化合物（Ｌ−９４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1655と記す）。
化合物（Ｌ−９４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1656と記す）。
化合物（Ｌ−９４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1657と記す）。
化合物（Ｌ−９４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1658と記す）。
化合物（Ｌ−９４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1659と記す）。
化合物（Ｌ−９４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1660と記す）。
化合物（Ｌ−９４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1661と記す）。
化合物（Ｌ−９４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1662と記す）。
化合物（Ｌ−９４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1663と記す）。
化合物（Ｌ−９４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1664と記す）。
化合物（Ｌ−９４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1665と記す）。
化合物（Ｌ−９４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1666と記す）。
化合物（Ｌ−９４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1667と記す）。
化合物（Ｌ−９４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1668と記す）。
化合物（Ｌ−９４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1669と記す）。 Formula (L-94)

In the compound represented by (hereinafter referred to as compound (L-94)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1640).
In the compound (L-94), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1641).
In the compound (L-94), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1642).
In the compound (L-94), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1643).
In the compound (L-94), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1644).
In the compound (L-94), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1645).
In the compound (L-94), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1646).
In the compound (L-94), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1647).
In the compound (L-94), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1648).
In the compound (L-94), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1649).
In the compound (L-94), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1650).
In the compound (L-94), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1651).
In the compound (L-94), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1652).
In the compound (L-94), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1653).
In the compound (L-94), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1654).
In the compound (L-94), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1655).
In the compound (L-94), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1656).
In the compound (L-94), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1657).
In the compound (L-94), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1658).
In the compound (L-94), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1659).
In the compound (L-94), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1660).
In the compound (L-94), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1661).
In the compound (L-94), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1662).
In the compound (L-94), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1663).
In the compound (L-94), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1664).
In the compound (L-94), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1665).
In the compound (L-94), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1666).
In the compound (L-94), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1667).
In the compound (L-94), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1668).
In the compound (L-94), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1669).

で示される化合物（以下、化合物（Ｌ−９５）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1670と記す）。
化合物（Ｌ−９５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1671と記す）。
化合物（Ｌ−９５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1672と記す）。
化合物（Ｌ−９５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1673と記す）。
化合物（Ｌ−９５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1674と記す）。
化合物（Ｌ−９５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1675と記す）。
化合物（Ｌ−９５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1676と記す）。
化合物（Ｌ−９５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1677と記す）。
化合物（Ｌ−９５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1678と記す）。
化合物（Ｌ−９５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1679と記す）。
化合物（Ｌ−９５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1680と記す）。
化合物（Ｌ−９５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1681と記す）。
化合物（Ｌ−９５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1682と記す）。
化合物（Ｌ−９５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1683と記す）。
化合物（Ｌ−９５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1684と記す）。
化合物（Ｌ−９５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1685と記す）。
化合物（Ｌ−９５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1686と記す）。
化合物（Ｌ−９５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1687と記す）。
化合物（Ｌ−９５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1688と記す）。
化合物（Ｌ−９５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1689と記す）。
化合物（Ｌ−９５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1690と記す）。
化合物（Ｌ−９５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1691と記す）。
化合物（Ｌ−９５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1692と記す）。
化合物（Ｌ−９５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1693と記す）。
化合物（Ｌ−９５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1694と記す）。
化合物（Ｌ−９５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1695と記す）。
化合物（Ｌ−９５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1696と記す）。
化合物（Ｌ−９５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1697と記す）。
化合物（Ｌ−９５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1698と記す）。
化合物（Ｌ−９５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1699と記す）。 Formula (L-95)

In the compound represented by (hereinafter referred to as compound (L-95)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1670).
In the compound (L-95), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1671).
In the compound (L-95), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1672).
In the compound (L-95), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1673).
In the compound (L-95), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1674).
In the compound (L-95), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1675).
In the compound (L-95), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1676).
In the compound (L-95), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1677).
In the compound (L-95), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1678).
In the compound (L-95), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1679).
In the compound (L-95), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1680).
In the compound (L-95), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1681).
In the compound (L-95), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1682).
In the compound (L-95), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1683).
In the compound (L-95), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1684).
In the compound (L-95), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1685).
In the compound (L-95), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1686).
In the compound (L-95), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1687).
In the compound (L-95), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1688).
In the compound (L-95), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1689).
In the compound (L-95), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1690).
In the compound (L-95), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1691).
In the compound (L-95), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1692).
In the compound (L-95), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1693).
In the compound (L-95), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1694).
In the compound (L-95), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1695).
In the compound (L-95), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1696).
In the compound (L-95), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1697).
In the compound (L-95), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1698).
In the compound (L-95), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1699).

で示される化合物（以下、化合物（Ｌ−９６）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1700と記す）。
化合物（Ｌ−９６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1701と記す）。
化合物（Ｌ−９６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1702と記す）。
化合物（Ｌ−９６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1703と記す）。
化合物（Ｌ−９６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1704と記す）。
化合物（Ｌ−９６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1705と記す）。
化合物（Ｌ−９６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1706と記す）。
化合物（Ｌ−９６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1707と記す）。
化合物（Ｌ−９６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1708と記す）。
化合物（Ｌ−９６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1709と記す）。
化合物（Ｌ−９６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1710と記す）。
化合物（Ｌ−９６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1711と記す）。
化合物（Ｌ−９６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1712と記す）。
化合物（Ｌ−９６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1713と記す）。
化合物（Ｌ−９６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1714と記す）。
化合物（Ｌ−９６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1715と記す）。
化合物（Ｌ−９６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1716と記す）。
化合物（Ｌ−９６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1717と記す）。
化合物（Ｌ−９６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1718と記す）。
化合物（Ｌ−９６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1719と記す）。
化合物（Ｌ−９６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1720と記す）。
化合物（Ｌ−９６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1721と記す）。
化合物（Ｌ−９６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1722と記す）。
化合物（Ｌ−９６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1723と記す）。
化合物（Ｌ−９６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1724と記す）。
化合物（Ｌ−９６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1725と記す）。
化合物（Ｌ−９６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1726と記す）。
化合物（Ｌ−９６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1727と記す）。
化合物（Ｌ−９６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1728と記す）。
化合物（Ｌ−９６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1729と記す）。 Formula (L-96)

In the compound represented by (hereinafter referred to as compound (L-96)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1700).
In the compound (L-96), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1701).
In the compound (L-96), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1702).
In the compound (L-96), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1703).
In the compound (L-96), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1704).
In the compound (L-96), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1705).
In the compound (L-96), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1706).
In the compound (L-96), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1707).
In the compound (L-96), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1708).
In the compound (L-96), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1709).
In the compound (L-96), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1710).
In the compound (L-96), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1711).
In the compound (L-96), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1712).
In the compound (L-96), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1713).
In the compound (L-96), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1714).
In the compound (L-96), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1715).
In the compound (L-96), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1716).
In the compound (L-96), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1717).
In the compound (L-96), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1718).
In the compound (L-96), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1719).
In the compound (L-96), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1720).
In the compound (L-96), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1721).
In the compound (L-96), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1722).
In the compound (L-96), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1723).
In compound (L-96), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1724).
In the compound (L-96), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1725).
In the compound (L-96), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1726).
In the compound (L-96), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1727).
In the compound (L-96), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1728).
In the compound (L-96), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1729).

で示される化合物（以下、化合物（Ｌ−９７）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1730と記す）。
化合物（Ｌ−９７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1731と記す）。
化合物（Ｌ−９７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1732と記す）。
化合物（Ｌ−９７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1733と記す）。
化合物（Ｌ−９７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1734と記す）。
化合物（Ｌ−９７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1735と記す）。 Formula (L-97)

In the compound represented by formula (hereinafter referred to as compound (L-97)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX1730).
In the compound (L-97), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as the compound group SX1731).
In the compound (L-97), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1732).
In the compound (L-97), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1733).
In the compound (L-97), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1734).
In the compound (L-97), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1735).

で示される化合物（以下、化合物（Ｌ−９８）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1736と記す）。
化合物（Ｌ−９８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1737と記す）。
化合物（Ｌ−９８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1738と記す）。
化合物（Ｌ−９８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1739と記す）。
化合物（Ｌ−９８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1740と記す）。
化合物（Ｌ−９８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1741と記す）。 Formula (L-98)

In the compound represented by (hereinafter, referred to as compound (L-98)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX1736).
In the compound (L-98), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as the compound group SX1737).
In the compound (L-98), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1738).
In the compound (L-98), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1739).
In compound (L-98), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1740).
In the compound (L-98), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1741).

で示される化合物（以下、化合物（Ｌ−９９）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1742と記す）。
化合物（Ｌ−９９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1743と記す）。
化合物（Ｌ−９９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1744と記す）。
化合物（Ｌ−９９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1745と記す）。
化合物（Ｌ−９９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1746と記す）。
化合物（Ｌ−９９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1747と記す）。
化合物（Ｌ−９９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1748と記す）。
化合物（Ｌ−９９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1749と記す）。
化合物（Ｌ−９９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1750と記す）。
化合物（Ｌ−９９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1751と記す）。
化合物（Ｌ−９９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1752と記す）。
化合物（Ｌ−９９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1753と記す）。
化合物（Ｌ−９９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1754と記す）。
化合物（Ｌ−９９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1755と記す）。
化合物（Ｌ−９９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1756と記す）。
化合物（Ｌ−９９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1757と記す）。
化合物（Ｌ−９９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1758と記す）。
化合物（Ｌ−９９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1759と記す）。
化合物（Ｌ−９９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1760と記す）。
化合物（Ｌ−９９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1761と記す）。
化合物（Ｌ−９９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1762と記す）。
化合物（Ｌ−９９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1763と記す）。
化合物（Ｌ−９９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1764と記す）。
化合物（Ｌ−９９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1765と記す）。
化合物（Ｌ−９９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1766と記す）。
化合物（Ｌ−９９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1767と記す）。
化合物（Ｌ−９９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1768と記す）。
化合物（Ｌ−９９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1769と記す）。
化合物（Ｌ−９９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1770と記す）。
化合物（Ｌ−９９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1771と記す）。 Formula (L-99)

In the compound represented by (hereinafter referred to as compound (L-99)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1742).
In the compound (L-99), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1743).
In the compound (L-99), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1744).
In the compound (L-99), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1745).
In the compound (L-99), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1746).
In the compound (L-99), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1747).
In the compound (L-99), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1748).
In the compound (L-99), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1749).
In the compound (L-99), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1750).
In the compound (L-99), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1751).
In the compound (L-99), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1752).
In the compound (L-99), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1753).
In the compound (L-99), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1754).
In the compound (L-99), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1755).
In the compound (L-99), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1756).
In the compound (L-99), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1757).
In the compound (L-99), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1758).
In the compound (L-99), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1759).
In the compound (L-99), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1760).
In the compound (L-99), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1761).
In the compound (L-99), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1762).
In the compound (L-99), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1763).
In the compound (L-99), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1764).
In the compound (L-99), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1765).
In compound (L-99), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1766).
In the compound (L-99), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1767).
In the compound (L-99), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1768).
In the compound (L-99), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1769).
In the compound (L-99), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1770).
In the compound (L-99), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1771).

で示される化合物（以下、化合物（Ｌ−１００）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1772と記す）。
化合物（Ｌ−１００）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1773と記す）。
化合物（Ｌ−１００）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1774と記す）。
化合物（Ｌ−１００）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1775と記す）。
化合物（Ｌ−１００）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1776と記す）。
化合物（Ｌ−１００）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1777と記す）。
化合物（Ｌ−１００）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1778と記す）。
化合物（Ｌ−１００）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1779と記す）。
化合物（Ｌ−１００）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1780と記す）。
化合物（Ｌ−１００）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1781と記す）。
化合物（Ｌ−１００）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1782と記す）。
化合物（Ｌ−１００）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1783と記す）。
化合物（Ｌ−１００）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1784と記す）。
化合物（Ｌ−１００）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1785と記す）。
化合物（Ｌ−１００）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1786と記す）。
化合物（Ｌ−１００）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1787と記す）。
化合物（Ｌ−１００）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1788と記す）。
化合物（Ｌ−１００）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1789と記す）。
化合物（Ｌ−１００）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1790と記す）。
化合物（Ｌ−１００）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1791と記す）。
化合物（Ｌ−１００）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1792と記す）。
化合物（Ｌ−１００）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1793と記す）。
化合物（Ｌ−１００）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1794と記す）。
化合物（Ｌ−１００）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1795と記す）。
化合物（Ｌ−１００）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1796と記す）。
化合物（Ｌ−１００）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1797と記す）。
化合物（Ｌ−１００）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1798と記す）。
化合物（Ｌ−１００）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1799と記す）。
化合物（Ｌ−１００）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1800と記す）。
化合物（Ｌ−１００）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1801と記す）。 Formula (L-100)

In the compound represented by (hereinafter referred to as compound (L-100)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1772).
In the compound (L-100), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1773).
In the compound (L-100), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1774).
In the compound (L-100), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1775).
In the compound (L-100), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1776).
In the compound (L-100), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1777).
In the compound (L-100), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1778).
In the compound (L-100), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1779).
In the compound (L-100), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1780).
In the compound (L-100), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1781).
In the compound (L-100), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1782).
In the compound (L-100), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1783).
In the compound (L-100), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1784).
In the compound (L-100), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1785).
In the compound (L-100), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter, referred to as compound group SX1786).
In the compound (L-100), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1787).
In the compound (L-100), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1788).
In the compound (L-100), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1789).
In the compound (L-100), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1790).
In the compound (L-100), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1791).
In the compound (L-100), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1792).
In the compound (L-100), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1793).
In the compound (L-100), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1794).
In the compound (L-100), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1795).
In the compound (L-100), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1796).
In the compound (L-100), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1797).
In the compound (L-100), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1798).
In the compound (L-100), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1799).
In the compound (L-100), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1800).
In the compound (L-100), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1801).

で示される化合物（以下、化合物（Ｌ−１０１）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1802と記す）。
化合物（Ｌ−１０１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1803と記す）。
化合物（Ｌ−１０１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1804と記す）。
化合物（Ｌ−１０１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1805と記す）。
化合物（Ｌ−１０１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1806と記す）。
化合物（Ｌ−１０１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1807と記す）。
化合物（Ｌ−１０１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1808と記す）。
化合物（Ｌ−１０１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1809と記す）。
化合物（Ｌ−１０１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1810と記す）。
化合物（Ｌ−１０１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1811と記す）。
化合物（Ｌ−１０１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1812と記す）。
化合物（Ｌ−１０１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1813と記す）。
化合物（Ｌ−１０１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1814と記す）。
化合物（Ｌ−１０１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1815と記す）。
化合物（Ｌ−１０１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1816と記す）。
化合物（Ｌ−１０１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1817と記す）。
化合物（Ｌ−１０１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1818と記す）。
化合物（Ｌ−１０１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1819と記す）。
化合物（Ｌ−１０１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1820と記す）。
化合物（Ｌ−１０１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1821と記す）。
化合物（Ｌ−１０１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1822と記す）。
化合物（Ｌ−１０１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1823と記す）。
化合物（Ｌ−１０１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1824と記す）。
化合物（Ｌ−１０１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1825と記す）。
化合物（Ｌ−１０１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1826と記す）。
化合物（Ｌ−１０１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1827と記す）。
化合物（Ｌ−１０１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1828と記す）。
化合物（Ｌ−１０１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1829と記す）。
化合物（Ｌ−１０１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1830と記す）。
化合物（Ｌ−１０１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1831と記す）。 Formula (L-101)

In the compound represented by (hereinafter referred to as compound (L-101)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1802).
In the compound (L-101), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1803).
In the compound (L-101), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1804).
In the compound (L-101), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1805).
In the compound (L-101), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1806).
In the compound (L-101), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1807).
In the compound (L-101), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1808).
In the compound (L-101), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1809).
In the compound (L-101), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1810).
In the compound (L-101), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1811).
In the compound (L-101), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1812).
In the compound (L-101), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1813).
In the compound (L-101), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1814).
In the compound (L-101), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1815).
In the compound (L-101), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1816).
In the compound (L-101), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1817).
In the compound (L-101), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1818).
In the compound (L-101), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1819).
In the compound (L-101), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1820).
In the compound (L-101), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1821).
In the compound (L-101), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1822).
In the compound (L-101), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1823).
In the compound (L-101), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1824).
In the compound (L-101), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1825).
In compound (L-101), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1826).
In the compound (L-101), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1827).
In the compound (L-101), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1828).
In the compound (L-101), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1829).
In the compound (L-101), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1830).
In the compound (L-101), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1831).

で示される化合物（以下、化合物（Ｌ−１０２）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1832と記す）。
化合物（Ｌ−１０２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1833と記す）。
化合物（Ｌ−１０２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1834と記す）。
化合物（Ｌ−１０２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1835と記す）。
化合物（Ｌ−１０２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1836と記す）。
化合物（Ｌ−１０２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1837と記す）。
化合物（Ｌ−１０２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1838と記す）。
化合物（Ｌ−１０２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1839と記す）。
化合物（Ｌ−１０２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1840と記す）。
化合物（Ｌ−１０２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1841と記す）。
化合物（Ｌ−１０２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1842と記す）。
化合物（Ｌ−１０２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1843と記す）。
化合物（Ｌ−１０２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1844と記す）。
化合物（Ｌ−１０２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1845と記す）。
化合物（Ｌ−１０２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1846と記す）。
化合物（Ｌ−１０２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1847と記す）。
化合物（Ｌ−１０２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1848と記す）。
化合物（Ｌ−１０２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1849と記す）。
化合物（Ｌ−１０２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1850と記す）。
化合物（Ｌ−１０２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1851と記す）。
化合物（Ｌ−１０２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1852と記す）。
化合物（Ｌ−１０２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1853と記す）。
化合物（Ｌ−１０２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1854と記す）。
化合物（Ｌ−１０２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1855と記す）。
化合物（Ｌ−１０２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1856と記す）。
化合物（Ｌ−１０２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1857と記す）。
化合物（Ｌ−１０２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1858と記す）。
化合物（Ｌ−１０２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1859と記す）。
化合物（Ｌ−１０２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1860と記す）。
化合物（Ｌ−１０２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1861と記す）。 Formula (L-102)

In the compound represented by (hereinafter referred to as compound (L-102)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1832).
In the compound (L-102), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1833).
In the compound (L-102), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1834).
In the compound (L-102), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1835).
In the compound (L-102), a G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is cyclopropyl group, R ^3c is, according to Table 7A] ~ [Table 15A] A compound which is any of the substituents (hereinafter referred to as compound group SX1836).
In the compound (L-102), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1837).
In the compound (L-102), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1838).
In the compound (L-102), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1839).
In the compound (L-102), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1840).
In the compound (L-102), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1841).
In the compound (L-102), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1842).
In the compound (L-102), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1843).
In the compound (L-102), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1844).
In the compound (L-102), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1845).
In the compound (L-102), a G ¹ is CH, a G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, R ^3c is, Table 7A] ~ [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1846).
In the compound (L-102), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1847).
In the compound (L-102), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1848).
In the compound (L-102), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1849).
In the compound (L-102), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1850).
In the compound (L-102), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1851).
In the compound (L-102), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1852).
In the compound (L-102), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1853).
In the compound (L-102), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1854).
In the compound (L-102), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1855).
In the compound (L-102), a G ¹ is nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, R ^3c is, Table 7A] ~ [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1856).
In the compound (L-102), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1857).
In the compound (L-102), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1858).
In the compound (L-102), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1859).
In the compound (L-102), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1860).
In the compound (L-102), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1861).

で示される化合物（以下、化合物（Ｌ−１０３）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1862と記す）。
化合物（Ｌ−１０３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1863と記す）。
化合物（Ｌ−１０３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1864と記す）。
化合物（Ｌ−１０３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1865と記す）。
化合物（Ｌ−１０３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1866と記す）。
化合物（Ｌ−１０３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1867と記す）。 Formula (L-103)

In the compound represented by (hereinafter referred to as compound (L-103)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX1862).
In the compound (L-103), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX1863).
In compound (L-103), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1864).
In compound (L-103), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1865).
In compound (L-103), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1866).
In compound (L-103), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1867).

で示される化合物（以下、化合物（Ｌ−１０４）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1868と記す）。
化合物（Ｌ−１０４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1869と記す）。
化合物（Ｌ−１０４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1870と記す）。
化合物（Ｌ−１０４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1871と記す）。
化合物（Ｌ−１０４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1872と記す）。
化合物（Ｌ−１０４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1873と記す）。 Formula (L-104)

In the compound represented by (hereinafter referred to as compound (L-104)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX1868).
In the compound (L-104), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX1869).
In the compound (L-104), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1870).
In the compound (L-104), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1871).
In the compound (L-104), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1872).
In the compound (L-104), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1873).

で示される化合物（以下、化合物（Ｌ−１０５）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1874と記す）。
化合物（Ｌ−１０５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1875と記す）。
化合物（Ｌ−１０５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1876と記す）。
化合物（Ｌ−１０５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1877と記す）。
化合物（Ｌ−１０５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1878と記す）。
化合物（Ｌ−１０５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1879と記す）。
化合物（Ｌ−１０５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1880と記す）。
化合物（Ｌ−１０５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1881と記す）。
化合物（Ｌ−１０５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1882と記す）。
化合物（Ｌ−１０５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1883と記す）。
化合物（Ｌ−１０５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1884と記す）。
化合物（Ｌ−１０５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1885と記す）。
化合物（Ｌ−１０５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1886と記す）。
化合物（Ｌ−１０５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1887と記す）。
化合物（Ｌ−１０５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1888と記す）。
化合物（Ｌ−１０５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1889と記す）。
化合物（Ｌ−１０５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1890と記す）。
化合物（Ｌ−１０５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1891と記す）。
化合物（Ｌ−１０５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1892と記す）。
化合物（Ｌ−１０５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1893と記す）。
化合物（Ｌ−１０５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1894と記す）。
化合物（Ｌ−１０５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1895と記す）。
化合物（Ｌ−１０５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1896と記す）。
化合物（Ｌ−１０５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1897と記す）。
化合物（Ｌ−１０５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1898と記す）。
化合物（Ｌ−１０５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1899と記す）。
化合物（Ｌ−１０５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1900と記す）。
化合物（Ｌ−１０５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1901と記す）。
化合物（Ｌ−１０５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1902と記す）。
化合物（Ｌ−１０５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1903と記す）。 Formula (L-105)

In the compound represented by (hereinafter referred to as compound (L-105)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1874).
In the compound (L-105), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1875).
In the compound (L-105), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1876).
In the compound (L-105), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1877).
In the compound (L-105), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1878).
In the compound (L-105), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1879).
In the compound (L-105), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1880).
In the compound (L-105), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1881).
In the compound (L-105), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1882).
In the compound (L-105), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1883).
In the compound (L-105), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1884).
In the compound (L-105), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1885).
In the compound (L-105), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1886).
In the compound (L-105), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1887).
In the compound (L-105), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1888).
In the compound (L-105), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1889).
In the compound (L-105), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1890).
In the compound (L-105), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1891).
In the compound (L-105), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1892).
In the compound (L-105), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1893).
In the compound (L-105), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1894).
In the compound (L-105), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1895).
In the compound (L-105), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1896).
In the compound (L-105), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1897).
In the compound (L-105), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1898).
In the compound (L-105), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1899).
In the compound (L-105), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1900).
In the compound (L-105), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1901).
In the compound (L-105), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1902).
In the compound (L-105), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1903).

で示される化合物（以下、化合物（Ｌ−１０６）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1904と記す）。
化合物（Ｌ−１０６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1905と記す）。
化合物（Ｌ−１０６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1906と記す）。
化合物（Ｌ−１０６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1907と記す）。
化合物（Ｌ−１０６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1908と記す）。
化合物（Ｌ−１０６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1909と記す）。
化合物（Ｌ−１０６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1910と記す）。
化合物（Ｌ−１０６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1911と記す）。
化合物（Ｌ−１０６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1912と記す）。
化合物（Ｌ−１０６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1913と記す）。
化合物（Ｌ−１０６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1914と記す）。
化合物（Ｌ−１０６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1915と記す）。
化合物（Ｌ−１０６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1916と記す）。
化合物（Ｌ−１０６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1917と記す）。
化合物（Ｌ−１０６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1918と記す）。
化合物（Ｌ−１０６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1919と記す）。
化合物（Ｌ−１０６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1920と記す）。
化合物（Ｌ−１０６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1921と記す）。
化合物（Ｌ−１０６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1922と記す）。
化合物（Ｌ−１０６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1923と記す）。
化合物（Ｌ−１０６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1924と記す）。
化合物（Ｌ−１０６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1925と記す）。
化合物（Ｌ−１０６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1926と記す）。
化合物（Ｌ−１０６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1927と記す）。
化合物（Ｌ−１０６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1928と記す）。
化合物（Ｌ−１０６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1929と記す）。
化合物（Ｌ−１０６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1930と記す）。
化合物（Ｌ−１０６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1931と記す）。
化合物（Ｌ−１０６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1932と記す）。
化合物（Ｌ−１０６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1933と記す）。 Formula (L-106)

In the compound represented by (hereinafter referred to as compound (L-106)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1904).
In the compound (L-106), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1905).
In the compound (L-106), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1906).
In the compound (L-106), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1907).
In the compound (L-106), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1908).
In the compound (L-106), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1909).
In the compound (L-106), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1910).
In the compound (L-106), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1911).
In the compound (L-106), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1912).
In the compound (L-106), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1913).
In the compound (L-106), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1914).
In the compound (L-106), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1915).
In the compound (L-106), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1916).
In the compound (L-106), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1917).
In the compound (L-106), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1918).
In the compound (L-106), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1919).
In the compound (L-106), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1920).
In the compound (L-106), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1921).
In the compound (L-106), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1922).
In the compound (L-106), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1923).
In the compound (L-106), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1924).
In the compound (L-106), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1925).
In the compound (L-106), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1926).
In the compound (L-106), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1927).
In the compound (L-106), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1928).
In the compound (L-106), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1929).
In the compound (L-106), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1930).
In the compound (L-106), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1931).
In the compound (L-106), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1932).
In the compound (L-106), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1933).

で示される化合物（以下、化合物（Ｌ−１０７）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1934と記す）。
化合物（Ｌ−１０７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1935と記す）。
化合物（Ｌ−１０７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1936と記す）。
化合物（Ｌ−１０７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1937と記す）。
化合物（Ｌ−１０７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1938と記す）。
化合物（Ｌ−１０７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1939と記す）。
化合物（Ｌ−１０７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1940と記す）。
化合物（Ｌ−１０７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1941と記す）。
化合物（Ｌ−１０７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1942と記す）。
化合物（Ｌ−１０７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1943と記す）。
化合物（Ｌ−１０７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1944と記す）。
化合物（Ｌ−１０７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1945と記す）。
化合物（Ｌ−１０７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1946と記す）。
化合物（Ｌ−１０７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1947と記す）。
化合物（Ｌ−１０７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1948と記す）。
化合物（Ｌ−１０７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1949と記す）。
化合物（Ｌ−１０７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1950と記す）。
化合物（Ｌ−１０７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1951と記す）。
化合物（Ｌ−１０７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1952と記す）。
化合物（Ｌ−１０７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1953と記す）。
化合物（Ｌ−１０７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1954と記す）。
化合物（Ｌ−１０７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1955と記す）。
化合物（Ｌ−１０７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1956と記す）。
化合物（Ｌ−１０７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1957と記す）。
化合物（Ｌ−１０７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1958と記す）。
化合物（Ｌ−１０７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1959と記す）。
化合物（Ｌ−１０７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1960と記す）。
化合物（Ｌ−１０７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1961と記す）。
化合物（Ｌ−１０７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1962と記す）。
化合物（Ｌ−１０７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1963と記す）。 Formula (L-107)

In the compound represented by (hereinafter referred to as compound (L-107)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX1934).
In the compound (L-107), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1935).
In the compound (L-107), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1936).
In the compound (L-107), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1937).
In the compound (L-107), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1938).
In the compound (L-107), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1939).
In the compound (L-107), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1940).
In the compound (L-107), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1941).
In the compound (L-107), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1942).
In the compound (L-107), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1943).
In the compound (L-107), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1944).
In the compound (L-107), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1945).
In the compound (L-107), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1946).
In the compound (L-107), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1947).
In the compound (L-107), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ Table 15A] is any one of the substituents described below (hereinafter referred to as compound group SX1948).
In the compound (L-107), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1949).
In the compound (L-107), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1950).
In the compound (L-107), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1951).
In the compound (L-107), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1952).
In the compound (L-107), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1953).
In the compound (L-107), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1954).
In the compound (L-107), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1955).
In the compound (L-107), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1956).
In the compound (L-107), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1957).
In the compound (L-107), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1958).
In the compound (L-107), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1959).
In the compound (L-107), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1960).
In the compound (L-107), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1961).
In the compound (L-107), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1962).
In the compound (L-107), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1963).

で示される化合物（以下、化合物（Ｌ−１０８）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1964と記す）。
化合物（Ｌ−１０８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1965と記す）。
化合物（Ｌ−１０８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1966と記す）。
化合物（Ｌ−１０８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1967と記す）。
化合物（Ｌ−１０８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1968と記す）。
化合物（Ｌ−１０８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1969と記す）。
化合物（Ｌ−１０８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1970と記す）。
化合物（Ｌ−１０８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1971と記す）。
化合物（Ｌ−１０８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1972と記す）。
化合物（Ｌ−１０８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1973と記す）。
化合物（Ｌ−１０８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1974と記す）。
化合物（Ｌ−１０８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1975と記す）。
化合物（Ｌ−１０８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1976と記す）。
化合物（Ｌ−１０８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1977と記す）。
化合物（Ｌ−１０８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1978と記す）。
化合物（Ｌ−１０８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1979と記す）。
化合物（Ｌ−１０８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1980と記す）。
化合物（Ｌ−１０８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1981と記す）。
化合物（Ｌ−１０８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1982と記す）。
化合物（Ｌ−１０８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1983と記す）。
化合物（Ｌ−１０８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1984と記す）。
化合物（Ｌ−１０８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1985と記す）。
化合物（Ｌ−１０８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1986と記す）。
化合物（Ｌ−１０８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1987と記す）。
化合物（Ｌ−１０８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1988と記す）。
化合物（Ｌ−１０８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1989と記す）。
化合物（Ｌ−１０８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1990と記す）。
化合物（Ｌ−１０８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1991と記す）。
化合物（Ｌ−１０８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1992と記す）。
化合物（Ｌ−１０８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1993と記す）。 Formula (L-108)

In the compound represented by (hereinafter referred to as compound (L-108)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A to Table 15A (hereinafter referred to as compound group SX1964).
In the compound (L-108), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1965).
In the compound (L-108), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1966).
In the compound (L-108), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1967).
In the compound (L-108), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1968).
In the compound (L-108), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1969).
In the compound (L-108), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1970).
In the compound (L-108), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1971).
In the compound (L-108), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX1972).
In the compound (L-108), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX1973).
In the compound (L-108), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1974).
In the compound (L-108), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1975).
In the compound (L-108), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1976).
In the compound (L-108), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1977).
In the compound (L-108), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1978).
In the compound (L-108), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1979).
In the compound (L-108), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1980).
In the compound (L-108), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1981).
In the compound (L-108), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1982).
In the compound (L-108), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1983).
In the compound (L-108), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1984).
In the compound (L-108), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1985).
In the compound (L-108), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1986).
In the compound (L-108), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1987).
In the compound (L-108), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1988).
In the compound (L-108), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1989).
In the compound (L-108), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1990).
In the compound (L-108), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX1991).
In the compound (L-108), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX1992).
In the compound (L-108), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX1993).

で示される化合物（以下、化合物（Ｌ−１０９）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1994と記す）。
化合物（Ｌ−１０９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1995と記す）。
化合物（Ｌ−１０９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1996と記す）。
化合物（Ｌ−１０９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1997と記す）。
化合物（Ｌ−１０９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1998と記す）。
化合物（Ｌ−１０９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX1999と記す）。 Formula (L-109)

In the compound represented by formula (hereinafter referred to as compound (L-109)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX1994).
In the compound (L-109), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX1995).
In the compound (L-109), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1996).
In the compound (L-109), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1997).
In the compound (L-109), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1998).
In the compound (L-109), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX1999).

で示される化合物（以下、化合物（Ｌ−１１０）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2000と記す）。
化合物（Ｌ−１１０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2001と記す）。
化合物（Ｌ−１１０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2002と記す）。
化合物（Ｌ−１１０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2003と記す）。
化合物（Ｌ−１１０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2004と記す）。
化合物（Ｌ−１１０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2005と記す）。 Formula (L-110)

In the compound represented by (hereinafter referred to as compound (L-110)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX2000).
In the compound (L-110), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX2001).
In the compound (L-110), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2002).
In compound (L-110), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2003).
In compound (L-110), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2004).
In compound (L-110), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2005).

で示される化合物（以下、化合物（Ｌ−１１１）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2006と記す）。
化合物（Ｌ−１１１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2007と記す）。
化合物（Ｌ−１１１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2008と記す）。
化合物（Ｌ−１１１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2009と記す）。
化合物（Ｌ−１１１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2010と記す）。
化合物（Ｌ−１１１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2011と記す）。
化合物（Ｌ−１１１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2012と記す）。
化合物（Ｌ−１１１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2013と記す）。
化合物（Ｌ−１１１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2014と記す）。
化合物（Ｌ−１１１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2015と記す）。
化合物（Ｌ−１１１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2016と記す）。
化合物（Ｌ−１１１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2017と記す）。
化合物（Ｌ−１１１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2018と記す）。
化合物（Ｌ−１１１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2019と記す）。
化合物（Ｌ−１１１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2020と記す）。
化合物（Ｌ−１１１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2021と記す）。
化合物（Ｌ−１１１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2022と記す）。
化合物（Ｌ−１１１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2023と記す）。
化合物（Ｌ−１１１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2024と記す）。
化合物（Ｌ−１１１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2025と記す）。
化合物（Ｌ−１１１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2026と記す）。
化合物（Ｌ−１１１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2027と記す）。
化合物（Ｌ−１１１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2028と記す）。
化合物（Ｌ−１１１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2029と記す）。
化合物（Ｌ−１１１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2030と記す）。
化合物（Ｌ−１１１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2031と記す）。
化合物（Ｌ−１１１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2032と記す）。
化合物（Ｌ−１１１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2033と記す）。
化合物（Ｌ−１１１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2034と記す）。
化合物（Ｌ−１１１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2035と記す）。 Formula (L-111)

In the compound represented by (hereinafter referred to as compound (L-111)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as Compound Group SX2006).
In the compound (L-111), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2007).
In the compound (L-111), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2008).
In the compound (L-111), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2009).
In the compound (L-111), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX2010).
In the compound (L-111), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2011).
In the compound (L-111), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2012).
In the compound (L-111), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2013).
In the compound (L-111), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2014).
In the compound (L-111), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2015).
In the compound (L-111), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2016).
In the compound (L-111), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2017).
In the compound (L-111), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2018).
In the compound (L-111), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2019).
In the compound (L-111), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2020).
In the compound (L-111), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2021).
In the compound (L-111), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2022).
In the compound (L-111), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2023).
In the compound (L-111), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2024).
In the compound (L-111), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is ^defined in [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2025).
In the compound (L-111), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2026).
In the compound (L-111), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2027).
In the compound (L-111), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2028).
In the compound (L-111), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2029).
In compound (L-111), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2030).
In the compound (L-111), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2031).
In the compound (L-111), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2032).
In the compound (L-111), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2033).
In the compound (L-111), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2034).
In the compound (L-111), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2035).

で示される化合物（以下、化合物（Ｌ−１１２）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2036と記す）。
化合物（Ｌ−１１２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2037と記す）。
化合物（Ｌ−１１２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2038と記す）。
化合物（Ｌ−１１２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2039と記す）。
化合物（Ｌ−１１２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2040と記す）。
化合物（Ｌ−１１２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2041と記す）。
化合物（Ｌ−１１２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2042と記す）。
化合物（Ｌ−１１２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2043と記す）。
化合物（Ｌ−１１２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2044と記す）。
化合物（Ｌ−１１２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2045と記す）。
化合物（Ｌ−１１２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2046と記す）。
化合物（Ｌ−１１２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2047と記す）。
化合物（Ｌ−１１２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2048と記す）。
化合物（Ｌ−１１２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2049と記す）。
化合物（Ｌ−１１２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2050と記す）。
化合物（Ｌ−１１２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2051と記す）。
化合物（Ｌ−１１２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2052と記す）。
化合物（Ｌ−１１２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2053と記す）。
化合物（Ｌ−１１２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2054と記す）。
化合物（Ｌ−１１２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2055と記す）。
化合物（Ｌ−１１２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2056と記す）。
化合物（Ｌ−１１２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2057と記す）。
化合物（Ｌ−１１２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2058と記す）。
化合物（Ｌ−１１２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2059と記す）。
化合物（Ｌ−１１２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2060と記す）。
化合物（Ｌ−１１２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2061と記す）。
化合物（Ｌ−１１２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2062と記す）。
化合物（Ｌ−１１２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2063と記す）。
化合物（Ｌ−１１２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2064と記す）。
化合物（Ｌ−１１２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2065と記す）。 Formula (L-112)

In the compound represented by (hereinafter referred to as compound (L-112)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX2036).
In the compound (L-112), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2037).
In the compound (L-112), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2038).
In the compound (L-112), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2039).
In the compound (L-112), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2040).
In the compound (L-112), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2041).
In the compound (L-112), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2042).
In the compound (L-112), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2043).
In the compound (L-112), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2044).
In the compound (L-112), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2045).
In the compound (L-112), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2046).
In the compound (L-112), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2047).
In the compound (L-112), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2048).
In the compound (L-112), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2049).
In the compound (L-112), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2050).
In the compound (L-112), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2051).
In the compound (L-112), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2052).
In the compound (L-112), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2053).
In the compound (L-112), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2054).
In the compound (L-112), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2055).
In the compound (L-112), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2056).
In the compound (L-112), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2057).
In the compound (L-112), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2058).
In the compound (L-112), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2059).
In the compound (L-112), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2060).
In the compound (L-112), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2061).
In the compound (L-112), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2062).
In the compound (L-112), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2063).
In the compound (L-112), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2064).
In the compound (L-112), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2065).

で示される化合物（以下、化合物（Ｌ−１１３）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2066と記す）。
化合物（Ｌ−１１３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2067と記す）。
化合物（Ｌ−１１３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2068と記す）。
化合物（Ｌ−１１３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2069と記す）。
化合物（Ｌ−１１３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2070と記す）。
化合物（Ｌ−１１３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2071と記す）。
化合物（Ｌ−１１３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2072と記す）。
化合物（Ｌ−１１３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2073と記す）。
化合物（Ｌ−１１３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2074と記す）。
化合物（Ｌ−１１３）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2075と記す）。
化合物（Ｌ−１１３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2076と記す）。
化合物（Ｌ−１１３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2077と記す）。
化合物（Ｌ−１１３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2078と記す）。
化合物（Ｌ−１１３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2079と記す）。
化合物（Ｌ−１１３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2080と記す）。
化合物（Ｌ−１１３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2081と記す）。
化合物（Ｌ−１１３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2082と記す）。
化合物（Ｌ−１１３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2083と記す）。
化合物（Ｌ−１１３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2084と記す）。
化合物（Ｌ−１１３）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2085と記す）。
化合物（Ｌ−１１３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2086と記す）。
化合物（Ｌ−１１３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2087と記す）。
化合物（Ｌ−１１３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2088と記す）。
化合物（Ｌ−１１３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2089と記す）。
化合物（Ｌ−１１３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2090と記す）。
化合物（Ｌ−１１３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2091と記す）。
化合物（Ｌ−１１３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2092と記す）。
化合物（Ｌ−１１３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2093と記す）。
化合物（Ｌ−１１３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2094と記す）。
化合物（Ｌ−１１３）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2095と記す）。 Formula (L-113)

In the compound represented by (hereinafter referred to as compound (L-113)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX2066).
In the compound (L-113), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2067).
In the compound (L-113), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2068).
In the compound (L-113), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2069).
In the compound (L-113), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX2070).
In the compound (L-113), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2071).
In the compound (L-113), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2072).
In the compound (L-113), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2073).
In the compound (L-113), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX2074).
In the compound (L-113), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2075).
In the compound (L-113), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2076).
In the compound (L-113), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2077).
In the compound (L-113), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2078).
In the compound (L-113), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2079).
In the compound (L-113), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2080).
In the compound (L-113), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2081).
In the compound (L-113), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2082).
In the compound (L-113), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2083).
In the compound (L-113), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2084).
In the compound (L-113), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2085).
In the compound (L-113), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2086).
In the compound (L-113), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2087).
In the compound (L-113), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2088).
In the compound (L-113), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2089).
In compound (L-113), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2090).
In the compound (L-113), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2091).
In the compound (L-113), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2092).
In the compound (L-113), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2093).
In the compound (L-113), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2094).
In the compound (L-113), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2095).

で示される化合物（以下、化合物（Ｌ−１１４）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2096と記す）。
化合物（Ｌ−１１４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2097と記す）。
化合物（Ｌ−１１４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2098と記す）。
化合物（Ｌ−１１４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2099と記す）。
化合物（Ｌ−１１４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2100と記す）。
化合物（Ｌ−１１４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2101と記す）。
化合物（Ｌ−１１４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2102と記す）。
化合物（Ｌ−１１４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2103と記す）。
化合物（Ｌ−１１４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2104と記す）。
化合物（Ｌ−１１４）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2105と記す）。
化合物（Ｌ−１１４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2106と記す）。
化合物（Ｌ−１１４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2107と記す）。
化合物（Ｌ−１１４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2108と記す）。
化合物（Ｌ−１１４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2109と記す）。
化合物（Ｌ−１１４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2110と記す）。
化合物（Ｌ−１１４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2111と記す）。
化合物（Ｌ−１１４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2112と記す）。
化合物（Ｌ−１１４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2113と記す）。
化合物（Ｌ−１１４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2114と記す）。
化合物（Ｌ−１１４）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2115と記す）。
化合物（Ｌ−１１４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2116と記す）。
化合物（Ｌ−１１４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2117と記す）。
化合物（Ｌ−１１４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2118と記す）。
化合物（Ｌ−１１４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2119と記す）。
化合物（Ｌ−１１４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2120と記す）。
化合物（Ｌ−１１４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2121と記す）。
化合物（Ｌ−１１４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2122と記す）。
化合物（Ｌ−１１４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2123と記す）。
化合物（Ｌ−１１４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2124と記す）。
化合物（Ｌ−１１４）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2125と記す）。 Formula (L-114)

In the compound represented by (hereinafter referred to as compound (L-114)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as Compound Group SX2096).
In the compound (L-114), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2097).
In the compound (L-114), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2098).
In the compound (L-114), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2099).
In the compound (L-114), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2100).
In the compound (L-114), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2101).
In the compound (L-114), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2102).
In the compound (L-114), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2103).
In the compound (L-114), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2104).
In the compound (L-114), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2105).
In the compound (L-114), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2106).
In the compound (L-114), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2107).
In the compound (L-114), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2108).
In the compound (L-114), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2109).
In the compound (L-114), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2110).
In the compound (L-114), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2111).
In the compound (L-114), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2112).
In the compound (L-114), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2113).
In the compound (L-114), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2114).
In the compound (L-114), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2115).
In the compound (L-114), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2116).
In the compound (L-114), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2117).
In the compound (L-114), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2118).
In the compound (L-114), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2119).
In compound (L-114), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2120).
In the compound (L-114), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2121).
In the compound (L-114), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2122).
In the compound (L-114), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2123).
In the compound (L-114), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2124).
In the compound (L-114), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2125).

で示される化合物（以下、化合物（Ｌ−１１５）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2126と記す）。
化合物（Ｌ−１１５）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2127と記す）。
化合物（Ｌ−１１５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2128と記す）。
化合物（Ｌ−１１５）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2129と記す）。
化合物（Ｌ−１１５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2130と記す）。
化合物（Ｌ−１１５）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2131と記す）。 Formula (L-115)

In the compound represented by (hereinafter referred to as compound (L-115)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX2126).
In the compound (L-115), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as the compound group SX2127).
In the compound (L-115), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2128).
In the compound (L-115), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2129).
In compound (L-115), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2130).
In compound (L-115), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2131).

で示される化合物（以下、化合物（Ｌ−１１６）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2132と記す）。
化合物（Ｌ−１１６）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2133と記す）。
化合物（Ｌ−１１６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2134と記す）。
化合物（Ｌ−１１６）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2135と記す）。
化合物（Ｌ−１１６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2136と記す）。
化合物（Ｌ−１１６）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2137と記す）。 Formula (L-116)

In the compound represented by (hereinafter referred to as compound (L-116)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or any one of the substituents described below (hereinafter referred to as compound group SX2132).
In the compound (L-116), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as the compound group SX2133).
In the compound (L-116), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2134).
In the compound (L-116), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2135).
In the compound (L-116), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2136).
In compound (L-116), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2137).

で示される化合物（以下、化合物（Ｌ−１１７）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2138と記す）。
化合物（Ｌ−１１７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2139と記す）。
化合物（Ｌ−１１７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2140と記す）。
化合物（Ｌ−１１７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピルで基あり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2141と記す）。
化合物（Ｌ−１１７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2142と記す）。
化合物（Ｌ−１１７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2143と記す）。
化合物（Ｌ−１１７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2144と記す）。
化合物（Ｌ−１１７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2145と記す）。
化合物（Ｌ−１１７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2146と記す）。
化合物（Ｌ−１１７）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2147と記す）。
化合物（Ｌ−１１７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2148と記す）。
化合物（Ｌ−１１７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2149と記す）。
化合物（Ｌ−１１７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2150と記す）。
化合物（Ｌ−１１７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2151と記す）。
化合物（Ｌ−１１７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2152と記す）。
化合物（Ｌ−１１７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2153と記す）。
化合物（Ｌ−１１７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2154と記す）。
化合物（Ｌ−１１７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2155と記す）。
化合物（Ｌ−１１７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2156と記す）。
化合物（Ｌ−１１７）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2157と記す）。
化合物（Ｌ−１１７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2158と記す）。
化合物（Ｌ−１１７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2159と記す）。
化合物（Ｌ−１１７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2160と記す）。
化合物（Ｌ−１１７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2161と記す）。
化合物（Ｌ−１１７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2162と記す）。
化合物（Ｌ−１１７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2163と記す）。
化合物（Ｌ−１１７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2164と記す）。
化合物（Ｌ−１１７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2165と記す）。
化合物（Ｌ−１１７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2166と記す）。
化合物（Ｌ−１１７）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2167と記す）。 Formula (L-117)

In the compound represented by (hereinafter referred to as compound (L-117)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX2138).
In the compound (L-117), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2139).
In the compound (L-117), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2140).
In the compound (L-117), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is isopropyl, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2141).
In the compound (L-117), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2142).
In the compound (L-117), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2143).
In the compound (L-117), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2144).
In the compound (L-117), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2145).
In the compound (L-117), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2146).
In the compound (L-117), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX2147).
In the compound (L-117), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2148).
In the compound (L-117), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2149).
In the compound (L-117), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2150).
In the compound (L-117), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2151).
In the compound (L-117), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2152).
In the compound (L-117), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2153).
In the compound (L-117), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2154).
In the compound (L-117), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2155).
In the compound (L-117), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2156).
In the compound (L-117), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2157).
In the compound (L-117), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2158).
In the compound (L-117), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2159).
In the compound (L-117), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2160).
In the compound (L-117), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2161).
In the compound (L-117), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2162).
In the compound (L-117), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2163).
In the compound (L-117), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2164).
In the compound (L-117), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2165).
In the compound (L-117), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2166).
In the compound (L-117), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2167).

で示される化合物（以下、化合物（Ｌ−１１８）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2168と記す）。
化合物（Ｌ−１１８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2169と記す）。
化合物（Ｌ−１１８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2170と記す）。
化合物（Ｌ−１１８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2171と記す）。
化合物（Ｌ−１１８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2172と記す）。
化合物（Ｌ−１１８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2173と記す）。
化合物（Ｌ−１１８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2174と記す）。
化合物（Ｌ−１１８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2175と記す）。
化合物（Ｌ−１１８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2176と記す）。
化合物（Ｌ−１１８）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2177と記す）。
化合物（Ｌ−１１８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2178と記す）。
化合物（Ｌ−１１８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2179と記す）。
化合物（Ｌ−１１８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2180と記す）。
化合物（Ｌ−１１８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2181と記す）。
化合物（Ｌ−１１８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2182と記す）。
化合物（Ｌ−１１８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2183と記す）。
化合物（Ｌ−１１８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2184と記す）。
化合物（Ｌ−１１８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2185と記す）。
化合物（Ｌ−１１８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2186と記す）。
化合物（Ｌ−１１８）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2187と記す）。
化合物（Ｌ−１１８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2188と記す）。
化合物（Ｌ−１１８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2189と記す）。
化合物（Ｌ−１１８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2190と記す）。
化合物（Ｌ−１１８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2191と記す）。
化合物（Ｌ−１１８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2192と記す）。
化合物（Ｌ−１１８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2193と記す）。
化合物（Ｌ−１１８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2194と記す）。
化合物（Ｌ−１１８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2195と記す）。
化合物（Ｌ−１１８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2196と記す）。
化合物（Ｌ−１１８）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2197と記す）。 Formula (L-118)

In the compound represented by (hereinafter referred to as compound (L-118)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as Compound Group SX2168).
In the compound (L-118), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2169).
In the compound (L-118), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2170).
In the compound (L-118), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2171).
In the compound (L-118), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2172).
In the compound (L-118), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2173).
In the compound (L-118), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2174).
In the compound (L-118), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2175).
In the compound (L-118), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2176).
In the compound (L-118), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound that is any of the substituents (hereinafter referred to as compound group SX2177).
In the compound (L-118), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2178).
In the compound (L-118), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2179).
In the compound (L-118), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2180).
In the compound (L-118), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2181).
In the compound (L-118), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2182).
In the compound (L-118), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2183).
In the compound (L-118), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2184).
In the compound (L-118), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2185).
In the compound (L-118), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2186).
In the compound (L-118), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2187).
In the compound (L-118), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2188).
In the compound (L-118), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2189).
In the compound (L-118), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2190).
In the compound (L-118), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2191).
In the compound (L-118), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2192).
In the compound (L-118), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2193).
In the compound (L-118), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2194).
In the compound (L-118), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2195).
In the compound (L-118), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2196).
In the compound (L-118), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2197).

で示される化合物（以下、化合物（Ｌ−１１９）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2198と記す）。
化合物（Ｌ−１１９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2199と記す）。
化合物（Ｌ−１１９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2200と記す）。
化合物（Ｌ−１１９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2201と記す）。
化合物（Ｌ−１１９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2202と記す）。
化合物（Ｌ−１１９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2203と記す）。
化合物（Ｌ−１１９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2204と記す）。
化合物（Ｌ−１１９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2205と記す）。
化合物（Ｌ−１１９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2206と記す）。
化合物（Ｌ−１１９）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2207と記す）。
化合物（Ｌ−１１９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2208と記す）。
化合物（Ｌ−１１９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2209と記す）。
化合物（Ｌ−１１９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2210と記す）。
化合物（Ｌ−１１９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2211と記す）。
化合物（Ｌ−１１９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2212と記す）。
化合物（Ｌ−１１９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2213と記す）。
化合物（Ｌ−１１９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2214と記す）。
化合物（Ｌ−１１９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2215と記す）。
化合物（Ｌ−１１９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2216と記す）。
化合物（Ｌ−１１９）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2217と記す）。
化合物（Ｌ−１１９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2218と記す）。
化合物（Ｌ−１１９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2219と記す）。
化合物（Ｌ−１１９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2220と記す）。
化合物（Ｌ−１１９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2221と記す）。
化合物（Ｌ−１１９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2222と記す）。
化合物（Ｌ−１１９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2223と記す）。
化合物（Ｌ−１１９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2224と記す）。
化合物（Ｌ−１１９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2225と記す）。
化合物（Ｌ−１１９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2226と記す）。
化合物（Ｌ−１１９）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2227と記す）。 Formula (L-119)

In the compound represented by (hereinafter referred to as compound (L-119)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ A compound which is any one of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as compound group SX2198).
In the compound (L-119), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2199).
In the compound (L-119), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2200).
In the compound (L-119), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2201).
In the compound (L-119), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2202).
In the compound (L-119), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2203).
In the compound (L-119), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2204).
In the compound (L-119), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2205).
In the compound (L-119), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2206).
In the compound (L-119), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2207).
In the compound (L-119), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2208).
In the compound (L-119), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2209).
In the compound (L-119), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2210).
In the compound (L-119), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2211).
In compound (L-119), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2212).
In the compound (L-119), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2213).
In the compound (L-119), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2214).
In the compound (L-119), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2215).
In the compound (L-119), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2216).
In the compound (L-119), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A]-[ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2217).
In the compound (L-119), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2218).
In the compound (L-119), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2219).
In the compound (L-119), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2220).
In the compound (L-119), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2221).
In the compound (L-119), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2222).
In the compound (L-119), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2223).
In the compound (L-119), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2224).
In the compound (L-119), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2225).
In the compound (L-119), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2226).
In the compound (L-119), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2227).

で示される化合物（以下、化合物（Ｌ−１２０）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ⁶がメチル基であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2228と記す）。
化合物（Ｌ−１２０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2229と記す）。
化合物（Ｌ−１２０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2230と記す）。
化合物（Ｌ−１２０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2231と記す）。
化合物（Ｌ−１２０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2232と記す）。
化合物（Ｌ−１２０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2233と記す）。
化合物（Ｌ−１２０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2234と記す）。
化合物（Ｌ−１２０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2235と記す）。
化合物（Ｌ−１２０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2236と記す）。
化合物（Ｌ−１２０）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2237と記す）。
化合物（Ｌ−１２０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2238と記す）。
化合物（Ｌ−１２０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2239と記す）。
化合物（Ｌ−１２０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2240と記す）。
化合物（Ｌ−１２０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2241と記す）。
化合物（Ｌ−１２０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2242と記す）。
化合物（Ｌ−１２０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2243と記す）。
化合物（Ｌ−１２０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2244と記す）。
化合物（Ｌ−１２０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2245と記す）。
化合物（Ｌ−１２０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2246と記す）。
化合物（Ｌ−１２０）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2247と記す）。
化合物（Ｌ−１２０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2248と記す）。
化合物（Ｌ−１２０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2249と記す）。
化合物（Ｌ−１２０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2250と記す）。
化合物（Ｌ−１２０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2251と記す）。
化合物（Ｌ−１２０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2252と記す）。
化合物（Ｌ−１２０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2253と記す）。
化合物（Ｌ−１２０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2254と記す）。
化合物（Ｌ−１２０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2255と記す）。
化合物（Ｌ−１２０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2256と記す）。
化合物（Ｌ−１２０）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2257と記す）。 Formula (L-120)

In the compound represented by (hereinafter referred to as compound (L-120)), G ¹ and G ⁴ are CH, R ⁶ is a methyl group, R ^3b is a hydrogen atom, and R ^3c is [ Compounds that are any of the substituents described in Table 7A] to [Table 15A] (hereinafter referred to as Compound Group SX2228).
In the compound (L-120), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2229).
In the compound (L-120), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2230).
In the compound (L-120), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2231).
In the compound (L-120), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is described in [Table 7A] to [Table 15A]. A compound which is any of the substituents (hereinafter referred to as compound group SX2232).
In the compound (L-120), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2233).
In the compound (L-120), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2234).
In the compound (L-120), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2235).
In the compound (L-120), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2236).
In the compound (L-120), G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is described in [Table 7A] to [Table 15A]. A compound that is any of the substituents (hereinafter referred to as compound group SX2237).
In the compound (L-120), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2238).
In the compound (L-120), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2239).
In the compound (L-120), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7] 15A] (hereinafter, referred to as compound group SX2240).
In the compound (L-120), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2241).
In the compound (L-120), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2242).
In the compound (L-120), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2243).
In the compound (L-120), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2244).
In the compound (L-120), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2245).
In the compound (L-120), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2246).
In the compound (L-120), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2247).
In the compound (L-120), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a methyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2248).
In the compound (L-120), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an ethyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2249).
In the compound (L-120), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a propyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2250).
In the compound (L-120), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3c is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2251).
In the compound (L-120), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3c is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2252).
In the compound (L-120), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2253).
In the compound (L-120), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2254).
In the compound (L-120), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2255).
In the compound (L-120), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and R ^3b is [Table 7A] to [Table 7]. 15A] (hereinafter, referred to as compound group SX2256).
In the compound (L-120), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and R ^3b is [Table 7A] to [ A compound which is any one of the substituents described in Table 15A] (hereinafter referred to as compound group SX2257).

で示される化合物（以下、化合物（Ｌ−１２１）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2258と記す）。
化合物（Ｌ−１２１）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2259と記す）。
化合物（Ｌ−１２１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2260と記す）。
化合物（Ｌ−１２１）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2261と記す）。
化合物（Ｌ−１２１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2262と記す）。
化合物（Ｌ−１２１）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2263と記す）。 Formula (L-121)

In the compound represented by (hereinafter referred to as compound (L-121)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX2258).
In the compound (L-121), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX2259).
In the compound (L-121), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2260).
In compound (L-121), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2261).
In the compound (L-121), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2262).
In compound (L-121), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2263).

で示される化合物（以下、化合物（Ｌ−１２２）と記す。）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2264と記す）。
化合物（Ｌ−１２２）において、Ｇ¹及びＧ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2265と記す）。
化合物（Ｌ−１２２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2266と記す）。
化合物（Ｌ−１２２）において、Ｇ¹がＣＨであり、Ｇ⁴が窒素原子であり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2267と記す）。
化合物（Ｌ−１２２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3bが水素原子であり、Ｒ^3cが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2268と記す）。
化合物（Ｌ−１２２）において、Ｇ¹が窒素原子であり、Ｇ⁴がＣＨであり、Ｒ^3cが水素原子であり、Ｒ^3bが、［表７Ａ］〜［表１５Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2269と記す）。 Formula (L-122)

In the compound represented by (hereinafter, referred to as compound (L-122)), G ¹ and G ⁴ are CH, R ^3b is a hydrogen atom, and R ^3c is [Table 7A] to [Table 15A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX2264).
In the compound (L-122), compounds wherein G ¹ and G ⁴ are CH, R ^3c is a hydrogen atom, and R ^3b is any one of the substituents described in [Table 7A] to [Table 15A] (Hereinafter referred to as compound group SX2265).
In the compound (L-122), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2266).
In the compound (L-122), G ¹ is CH, G ⁴ is a nitrogen atom, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2267).
In the compound (L-122), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3b is a hydrogen atom, and R ^3c is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2268).
In the compound (L-122), G ¹ is a nitrogen atom, G ⁴ is CH, R ^3c is a hydrogen atom, and R ^3b is any one of those described in [Table 7A] to [Table 15A] A compound which is a substituent (hereinafter referred to as compound group SX2269).

で示される化合物（以下、化合物（Ｌ−１２３）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2312と記す）。
化合物（Ｌ−１２３）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2313と記す）。
化合物（Ｌ−１２３）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2314と記す）。
化合物（Ｌ−１２３）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2315と記す）。
化合物（Ｌ−１２３）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2316と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2317と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2318と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2319と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2320と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2321と記す）。
化合物（Ｌ−１２３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2322と記す）。
化合物（Ｌ−１２３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2323と記す）。
化合物（Ｌ−１２３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2324と記す）。
化合物（Ｌ−１２３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2325と記す）。
化合物（Ｌ−１２３）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2326と記す）。
化合物（Ｌ−１２３）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2327と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2328と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2329と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子でありＲ^4bが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2330と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2331と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが塩素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2332と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2333と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2334と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2335と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2336と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2337と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2338と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが臭素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2339と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2340と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2341と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2342と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2343と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2344と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2345と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2346と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2347と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2348と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2349と記す）。
化合物（Ｌ−１２３）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2350と記す）。 Formula (L-123)

In the compound represented by (hereinafter referred to as compound (L-123)), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX2312).
In the compound (L-123), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX2313).
In the compound (L-123), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX2314).
In the compound (L-123), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX2315).
In compound (L-123), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound which is a group (hereinafter referred to as compound group SX2316).
In the compound (L-123), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2317).
In the compound (L-123), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2318).
In the compound (L-123), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2319).
In the compound (L-123), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX2320).
In the compound (L-123), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX2321).
In the compound (L-123), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX2322).
In the compound (L-123), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2323).
In the compound (L-123), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2324).
In the compound (L-123), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX2325).
In the compound (L-123), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX2326).
In the compound (L-123), R ^3b and R ^3c are hydrogen atoms, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2327).
In the compound (L-123), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX2328).
In the compound (L-123), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX2329).
In the compound (L-123), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a hydrogen atom, and T is [Table 1A] to [Table 6A]. ] The compound which is any one of substituents as described in the following (hereinafter referred to as compound group SX2330).
In the compound (L-123), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2331).
In the compound (L-123), R ^3b is a chlorine atom, R ^3c is a hydroxy group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2332).
In the compound (L-123), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX2333).
In the compound (L-123), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX2334).
In the compound (L-123), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an isopropyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2335).
In the compound (L-123), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [ A compound which is any one of the substituents described in Table 6A] (hereinafter referred to as compound group SX2336).
In the compound (L-123), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a hydrogen atom, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX2337).
In the compound (L-123), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2338).
In the compound (L-123), R ^3b is a bromine atom, R ^3c is a hydroxy group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2339).
In the compound (L-123), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX2340).
In the compound (L-123), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2341).
In the compound (L-123), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an isopropyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2342).
In the compound (L-123), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [ A compound which is any one of the substituents described in Table 6A] (hereinafter referred to as compound group SX2343).
In the compound (L-123), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a hydrogen atom, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX2344).
In the compound (L-123), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2345).
In the compound (L-123), R ^3b is an iodine atom, R ^3c is a hydroxy group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2346).
In the compound (L-123), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX2347).
In the compound (L-123), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX2348).
In the compound (L-123), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an isopropyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX2349).
In the compound (L-123), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is [Table 1A]-[ A compound which is any one of the substituents described in Table 6A] (hereinafter referred to as compound group SX2350).

で示される化合物（以下、化合物（Ｌ−１２４）と記す）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2351と記す）。
化合物（Ｌ−１２４）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2352と記す）。
化合物（Ｌ−１２４）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群S2353と記す）。
化合物（Ｌ−１２４）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2354と記す）。
化合物（Ｌ−１２４）において、Ｒ^3b、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2355と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2356と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2356と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2357と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2358と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3c及びＲ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2359と記す）。
化合物（Ｌ−１２４）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2360と記す）。
化合物（Ｌ−１２４）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2361と記す）。
化合物（Ｌ−１２４）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2362と記す）。
化合物（Ｌ−１２４）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2363と記す）。
化合物（Ｌ−１２４）において、Ｒ^3b及びＲ^4bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2364と記す）。
化合物（Ｌ−１２４）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2365と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2366と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ^4bが塩素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2367と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2368と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2369と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが塩素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2370と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2371と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2372と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2373と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2374と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2375と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2376と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが臭素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2377と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2378と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2379と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2380と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2381と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2382と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2383と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ^4bが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2384と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2385と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2386と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2387と記す）。
化合物（Ｌ−１２４）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ^4bが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2388と記す）。 Formula (L-124)

In the compound represented by (hereinafter referred to as compound (L-124)), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as a compound group SX2351).
In the compound (L-124), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX2352).
In the compound (L-124), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group S2353).
In the compound (L-124), R ^3b , R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX2354).
In compound (L-124), R ^3b , R ^3c and R ^4b are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any of the substitutions described in [Table 1A] to [Table 6A] A compound as a group (hereinafter referred to as compound group SX2355).
In compound (L-124), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2356).
In the compound (L-124), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2356).
In the compound (L-124), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX2357).
In compound (L-124), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2358).
In the compound (L-124), R ^3b is a trifluoromethyl group, R ^3c and R ^4b are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or a compound having any one of the substituents described below (hereinafter referred to as compound group SX2359).
In the compound (L-124), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX2360).
In the compound (L-124), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2361).
In the compound (L-124), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2362).
In the compound (L-124), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any one of the substituents described below (hereinafter referred to as compound group SX2363).
In the compound (L-124), R ^3b and R ^4b are hydrogen atoms, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [Table 6A]. Or any one of the substituents described below (hereinafter referred to as compound group SX2364).
In the compound (L-124), R ^3b and R ^3c are hydrogen atoms, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2365).
In the compound (L-124), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX2366).
In the compound (L-124), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ^4b is a chlorine atom, R ⁶ is a methyl group, and T is [Table 1A] to A compound which is any one of the substituents described in [Table 6A] (hereinafter referred to as compound group SX2367).
In the compound (L-124), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a hydrogen atom, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX2368).
In the compound (L-124), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2369).
In the compound (L-124), R ^3b is a chlorine atom, R ^3c is a hydroxy group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX2370).
In the compound (L-124), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2371).
In the compound (L-124), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2372).
In the compound (L-124), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an isopropyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2373).
In the compound (L-124), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [ A compound which is any one of the substituents described in Table 6A] (hereinafter referred to as compound group SX2374).
In the compound (L-124), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a hydrogen atom, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2375).
In the compound (L-124), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2376).
In the compound (L-124), R ^3b is a bromine atom, R ^3c is a hydroxy group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2377).
In the compound (L-124), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2378).
In the compound (L-124), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2379).
In the compound (L-124), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an isopropyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2380).
In the compound (L-124), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [ A compound which is any one of the substituents described in Table 6A] (hereinafter referred to as compound group SX2381).
In the compound (L-124), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a hydrogen atom, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2382).
In the compound (L-124), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX2383).
In the compound (L-124), R ^3b is an iodine atom, R ^3c is a hydroxy group, R ^4b is a hydrogen atom, R ⁶ is a methyl group, and T is [Table 1A] to [Table 1]. 6A] (hereinafter, referred to as compound group SX2384).
In the compound (L-124), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an ethyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2385).
In the compound (L-124), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a propyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as a compound group SX2386).
In the compound (L-124), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is an isopropyl group, and T is [Table 1A] to [Table 1] 6A] (hereinafter, referred to as compound group SX2387).
In the compound (L-124), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ^4b is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is [Table 1A] to [ A compound which is any one of the substituents described in Table 6A] (hereinafter referred to as compound group SX2388).

で示される化合物（以下、化合物（Ｌ−１２５）と記す）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2389と記す）。
化合物（Ｌ−１２５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2390と記す）。
化合物（Ｌ−１２５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2391と記す）。
化合物（Ｌ−１２５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2392と記す）。
化合物（Ｌ−１２５）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2393と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2394と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2395と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2396と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2397と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2398と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2399と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2400と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2401と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2402と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2403と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2404と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2405と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが塩素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2406と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2407と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2408と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2409と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2410と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2411と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2412と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが臭素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2413と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2414と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2415と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2416と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2417と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2418と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2419と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2420と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2421と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2422と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2423と記す）。
化合物（Ｌ−１２５）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2424と記す）。 Formula (L-125)

In the compound represented by (hereinafter referred to as compound (L-125)), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2389).
In the compound (L-125), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an ethyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX2390).
In the compound (L-125), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is a propyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX2391).
In the compound (L-125), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX2392).
In the compound (L-125), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a cyclopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as Compound Group SX2393).
In the compound (L-125), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2394).
In the compound (L-125), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2395).
In the compound (L-125), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2396).
In the compound (L-125), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2397).
In the compound (L-125), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any of the substituents (hereinafter referred to as compound group SX2398).
In the compound (L-125), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2399).
In the compound (L-125), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2400).
In the compound (L-125), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX2401).
In the compound (L-125), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A]. A compound which is such a substituent (hereinafter referred to as compound group SX2402).
In the compound (L-125), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2403).
In the compound (L-125), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2404).
In the compound (L-125), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2405).
In the compound (L-125), R ^3b is a chlorine atom, R ^3c is a hydroxy group, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2406).
In the compound (L-125), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2407).
In the compound (L-125), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2408).
In the compound (L-125), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2409).
In the compound (L-125), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX2410).
In the compound (L-125), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2411).
In the compound (L-125), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2412).
In the compound (L-125), R ^3b is a bromine atom, R ^3c is a hydroxy group, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2413).
In the compound (L-125), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in Table 1A to Table 6A A compound which is a substituent (hereinafter referred to as compound group SX2414).
In the compound (L-125), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2415).
In the compound (L-125), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2416).
In the compound (L-125), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter referred to as compound group SX2417).
In the compound (L-125), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2418).
In the compound (L-125), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2419).
In the compound (L-125), R ^3b is an iodine atom, R ^3c is a hydroxy group, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2420).
In the compound (L-125), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2421).
In the compound (L-125), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2422).
In the compound (L-125), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2423).
In the compound (L-125), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of [Table 1A] to [Table 6A] (Hereinafter, referred to as compound group SX2424).

で示される化合物（以下、化合物（Ｌ−１２６）と記す）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2425と記す）。
化合物（Ｌ−１２６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2426と記す）。
化合物（Ｌ−１２６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2427と記す）。
化合物（Ｌ−１２６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2428と記す）。
化合物（Ｌ−１２６）において、Ｒ^3b及びＲ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2429と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2430と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2431と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2432と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2433と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがトリフルオロメチル基であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2434と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2435と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2436と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2437と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2438と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが水素原子であり、Ｒ^3cがトリフルオロメチル基であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2439と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2440と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2441と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが塩素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2442と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2443と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2444と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2445と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが塩素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2446と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2447と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2448と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが臭素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2449と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2450と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2451と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2452と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bが臭素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2453と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶が水素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2454と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2455と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cがヒドロキシ基であり、Ｒ⁶がメチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2456と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がエチル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2457と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2458と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がイソプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2459と記す）。
化合物（Ｌ−１２６）において、Ｒ^3bがヨウ素原子であり、Ｒ^3cが水素原子であり、Ｒ⁶がシクロプロピル基であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2460と記す）。 Formula (L-126)

In the compound represented by (hereinafter referred to as compound (L-126)), R ^3b and R ^3c are hydrogen atoms, R ⁶ is a methyl group, and T is defined in [Table 1A] to [Table 6A]. A compound which is any of the substituents described below (hereinafter referred to as compound group SX2425).
In the compound (L-126), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an ethyl group, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX2426).
In the compound (L-126), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is a propyl group, and T is any substituent described in [Table 1A] to [Table 6A] (Hereinafter referred to as the compound group SX2427).
In the compound (L-126), compounds wherein R ^3b and R ^3c are a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of the substituents described in [Table 1A] to [Table 6A] (Hereinafter referred to as compound group SX2428).
In the compound (L-126), R ^3b and R ^3c are a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any substituent described in [Table 1A] to [Table 6A]. Compound (hereinafter referred to as Compound Group SX2429).
In the compound (L-126), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2430).
In the compound (L-126), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2431).
In the compound (L-126), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2432).
In the compound (L-126), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2433).
In the compound (L-126), R ^3b is a trifluoromethyl group, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2434).
In the compound (L-126), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a methyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2435).
In the compound (L-126), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an ethyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2436).
In the compound (L-126), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a propyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2437).
In the compound (L-126), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is an isopropyl group, and T is any of those described in [Table 1A] to [Table 6A] A compound which is such a substituent (hereinafter referred to as compound group SX2438).
In the compound (L-126), R ^3b is a hydrogen atom, R ^3c is a trifluoromethyl group, R ⁶ is a cyclopropyl group, and T is described in [Table 1A] to [Table 6A]. A compound which is any one of the substituents (hereinafter referred to as compound group SX2439).
In the compound (L-126), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2440).
In the compound (L-126), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2441).
In the compound (L-126), R ^3b is a chlorine atom, R ^3c is a hydroxy group, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2442).
In the compound (L-126), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in Table 1A to Table 6A A compound which is a substituent (hereinafter referred to as compound group SX2443).
In the compound (L-126), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2444).
In the compound (L-126), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2445).
In the compound (L-126), R ^3b is a chlorine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX2446).
In the compound (L-126), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2447).
In the compound (L-126), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2448).
In the compound (L-126), R ^3b is a bromine atom, R ^3c is a hydroxy group, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2449).
In the compound (L-126), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2450).
In the compound (L-126), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2451).
In the compound (L-126), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2452).
In the compound (L-126), R ^3b is a bromine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX2453).
In the compound (L-126), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a hydrogen atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2454).
In the compound (L-126), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2455).
In the compound (L-126), R ^3b is an iodine atom, R ^3c is a hydroxy group, R ⁶ is a methyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2456).
In the compound (L-126), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is an ethyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2457).
In the compound (L-126), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a propyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2458).
In the compound (L-126), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is an isopropyl group, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2459).
In the compound (L-126), R ^3b is an iodine atom, R ^3c is a hydrogen atom, R ⁶ is a cyclopropyl group, and T is any one of those described in [Table 1A] to [Table 6A]. (Hereinafter, referred to as compound group SX2460).

で示される化合物（以下、化合物（Ｌ−１２７）と記す）において、ｎが０であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2461と記す）。
化合物（Ｌ−１２７）において、ｎが１であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2462と記す）。
化合物（Ｌ−１２７）において、ｎが２であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2463と記す）。
化合物（Ｌ−１２７）において、ｎが０であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2464と記す）。
化合物（Ｌ−１２７）において、ｎが１であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2465と記す）。
化合物（Ｌ−１２７）において、ｎが２であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2466と記す）。
化合物（Ｌ−１２７）において、ｎが０であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2467と記す）。
化合物（Ｌ−１２７）において、ｎが１であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2468と記す）。
化合物（Ｌ−１２７）において、ｎが２であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2469と記す）。 Formula (L-127)

In the compound represented by (hereinafter, referred to as compound (L-127)), n is 0, R ^3b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2461).
In the compound (L-127), compounds wherein n is 1, R ^3b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2462)
In the compound (L-127), compounds wherein n is 2, R ^3b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2463).
In the compound (L-127), compounds wherein n is 0, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2464)
In the compound (L-127), compounds wherein n is 1, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2465)
In the compound (L-127), compounds wherein n is 2, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2466).
In the compound (L-127), compounds wherein n is 0, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2467)
In the compound (L-127), compounds wherein n is 1, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2468)
In the compound (L-127), compounds wherein n is 2, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2469)

で示される化合物（以下、化合物（Ｌ−１２８）と記す）において、ｎが０であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2470と記す）。
化合物（Ｌ−１２８）において、ｎが１であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2471と記す）。
化合物（Ｌ−１２８）において、ｎが２であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2472と記す）。
化合物（Ｌ−１２８）において、ｎが０であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2473と記す）。
化合物（Ｌ−１２８）において、ｎが１であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2474と記す）。
化合物（Ｌ−１２８）において、ｎが２であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2475と記す）。
化合物（Ｌ−１２８）において、ｎが０であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2476と記す）。
化合物（Ｌ−１２８）において、ｎが１であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2477と記す）。
化合物（Ｌ−１２８）において、ｎが２であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2478と記す）。 Formula (L-128)

In the compound represented by (hereinafter, referred to as compound (L-128)), n is 0, R ^3b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2470).
In the compound (L-128), compounds wherein n is 1, R ^3b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2471)
In the compound (L-128), compounds wherein n is 2, R ^3b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2472)
In the compound (L-128), compounds wherein n is 0, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2473).
In the compound (L-128), compounds wherein n is 1, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2474).
In the compound (L-128), compounds wherein n is 2, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2475).
In the compound (L-128), compounds wherein n is 0, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2476)
In the compound (L-128), compounds wherein n is 1, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2477).
In the compound (L-128), compounds wherein n is 2, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2478).

で示される化合物（以下、化合物（Ｌ−１２９）と記す）において、ｎが０であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2479と記す）。
化合物（Ｌ−１２９）において、ｎが１であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2480と記す）。
化合物（Ｌ−１２９）において、ｎが２であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2481と記す）。
化合物（Ｌ−１２９）において、ｎが０であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2482と記す）。
化合物（Ｌ−１２９）において、ｎが１であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2483と記す）。
化合物（Ｌ−１２９）において、ｎが２であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2484と記す）。
化合物（Ｌ−１２９）において、ｎが０であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2485と記す）。
化合物（Ｌ−１２９）において、ｎが１であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2486と記す）。
化合物（Ｌ−１２９）において、ｎが２であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2487と記す）。 Formula (L-129)

In the compound represented by (hereinafter referred to as compound (L-129)), n is 0, R ^3b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2479).
In the compound (L-129), compounds wherein n is 1, R ^3b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2480)
In the compound (L-129), compounds wherein n is 2, R ^3b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2481)
In the compound (L-129), compounds wherein n is 0, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2482)
In the compound (L-129), compounds wherein n is 1, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2483)
In the compound (L-129), compounds wherein n is 2, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2484)
In the compound (L-129), compounds wherein n is 0, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2485)
In the compound (L-129), compounds wherein n is 1, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2486)
In the compound (L-129), compounds wherein n is 2, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2487).

で示される化合物（以下、化合物（Ｌ−１３０）と記す）において、ｎが０であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2488と記す）。
化合物（Ｌ−１３０）において、ｎが１であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2489と記す）。
化合物（Ｌ−１３０）において、ｎが２であり、Ｒ^3bが塩素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2490と記す）。
化合物（Ｌ−１３０）において、ｎが０であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2491と記す）。
化合物（Ｌ−１３０）において、ｎが１であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2492と記す）。
化合物（Ｌ−１３０）において、ｎが２であり、Ｒ^3bが臭素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2493と記す）。
化合物（Ｌ−１３０）において、ｎが０であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2494と記す）。
化合物（Ｌ−１３０）において、ｎが１であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2495と記す）。
化合物（Ｌ−１３０）において、ｎが２であり、Ｒ^3bがヨウ素原子であり、Ｔが、［表１Ａ］〜［表６Ａ］に記載のいずれかの置換基である化合物（以下、化合物群SX2496と記す）。 Formula (L-130)

In the compound represented by (hereinafter, referred to as compound (L-130)), n is 0, R ^3b is a chlorine atom, and T is any one of those described in [Table 1A] to [Table 6A] A compound which is a substituent (hereinafter referred to as compound group SX2488).
In the compound (L-130), compounds wherein n is 1, R ^3b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2489).
In the compound (L-130), compounds wherein n is 2, R ^3b is a chlorine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2490)
In the compound (L-130), compounds wherein n is 0, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2491).
In the compound (L-130), compounds wherein n is 1, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2492)
In the compound (L-130), compounds wherein n is 2, R ^3b is a bromine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2493)
In the compound (L-130), compounds wherein n is 0, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2494)
In the compound (L-130), compounds wherein n is 1, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2495).
In the compound (L-130), compounds wherein n is 2, R ^3b is an iodine atom, and T is any one of the substituents described in [Table 1A] to [Table 6A] (hereinafter, compound group) SX2496)

  Examples of the composition A include the following. The abbreviation SX means any one of the present compounds selected from the compound groups SX1 to SX2496.

  In Group 1, the combination of SX and this component is one of the following “2 active ingredient list”, and is composed of composition A consisting of 2 parts of SX and 0.5 part of this component .

  In the “2 active ingredient list”, for example, SX + spinetram means a combination of SX and spinetoram.

“2 Active ingredient list”:
SX + Spinetoram, SX + clothianidin, SX + Isotianil, SX + Frametopir, SX + Impylfluxam, SX + Orisatrobin, SX + Fusaride, SX + Validamycin A, SX + Fusaride, SX + Valididamycin A, SX + Azoxyst Robin.

In Group 2, the combination of SX and this component is any combination of the above “2 active ingredient list”, and is composed of composition A consisting of 2 parts of SX and 1.5 parts of this component. .
In Group 3, the combination of SX and the present component is any combination of the above-mentioned “2 active ingredient list”, and is composed of Composition A composed of 1 part of SX and 1 part of this component.
In group 4, the combination of SX and this component is any combination of the above-mentioned “2 active ingredient list”, and is composed of composition A consisting of 1 part of SX and 2 parts of this component.
In Group 5, the combination of SX and this component is any combination of the above-mentioned “2 active ingredient list”, and is composed of composition A consisting of 2 parts of SX and 7 parts of this component.
In group 6, the combination of SX and this component is any combination of the above “2 active ingredient list”, and is composed of composition A consisting of 1 part of SX and 5 parts of this component.
In Group 7, the combination of SX and this component is one of the above-mentioned “2 active ingredient lists”, and is composed of composition A consisting of 1 part of SX and 15 parts of this component.
In group 8, the combination of SX and this component is any combination of the above “2 active ingredient list”, and is composed of composition A consisting of 1 part of SX and 3 parts of this component.
In group 9, the combination of SX and this component is any combination of the above “2 active ingredient list”, and is composed of composition A consisting of 5 parts of SX and 6.6 parts of this component. .
In the group 10, the combination of SX and the present component is any combination of the above “2 active ingredient list”, and is composed of the composition A composed of 1 part of SX and 4 parts of the present component.
In group 11, the combination of SX and this component is any combination of the above “2 active ingredient list”, and is composed of composition A consisting of 5 parts of SX and 8 parts of this component.

  In the group 12, the combination of SX, the present component 1 and the present component 2 is a combination of any of the following “3 active ingredient lists”: 2 parts SX, 0.5 parts of the present components 1 and 1.5 The composition A is composed of 2 parts of the present component 2.

  In the “3 active ingredient list”, for example, SX + spinetoram + clothianidin means a combination of SX, spinetoram and clothianidin, this component 1 is spinetoram, and this component 2 is clothianidin.

“3 Active ingredient list”:
SX + spinetoram + clothianidin,
SX + spinetoram + isotianil,
SX + Spinetoram + Frametopil,
SX + Spinetoram + Impilfluxam,
SX + Spinetoram + Orissatrobin,
SX + clothianidin + isotianil,
SX + clothianidin + flametopil,
SX + clothianidin + impylfluxam,
SX + clothianidin + orisatrobin,
SX + Isotianil + Frametopir,
SX + Isotianil + Impylfluxam,
SX + clothianidin + fusaride,
SX + clothianidin + validamycin A,
SX + Fusaride + Validamycin A,
SX + ferrimson + fusaride,
SX + clothianidin + fusaride,
SX + clothianidin + validamycin A,
SX + Fusaride + Ferimzone,
SX + Fusaride + Validamycin A,
SX + chlorantraniliprole + clothianidin,
SX + chlorantraniliprole + imidacloprid,
SX + chlorantraniliprole + thiamethoxam,
SX + chlorantraniliprole + thiacloprid,
SX + chlorantraniliprol + full pyrazifuron,
SX + chlorantraniliprole + triflumezopyrim,
SX + chlorantraniliprole + flupirmine,
SX + chlorantraniliprole + brofuranilide,
SX + chlorantraniliprole + tefluthrin,
SX + chlorantraniliprole + bifenthrin,
SX + cyantraniprole + clothianidin,
SX + cyantraniprole + imidacloprid,
SX + cyantraniprole + thiamethoxam,
SX + cyantraniprole + thiacloprid,
SX + cyantraniprole + full pyraziflon,
SX + cyantraniprole + triflumezopyrim,
SX + cyantraniprolol + flupirmine,
SX + cyantranylprolol + brofuranilide,
SX + Cyantraniprolol + Tefluthrin,
SX + cyanantaniprolol + bifenthrin,
SX + tetraniliprole + clothianidin,
SX + tetraniliprole + imidacloprid,
SX + tetranylprolol + thiamethoxam,
SX + tetraniliprole + thiacloprid,
SX + tetraniliprole + fullpyrazyflon,
SX + tetraniliprole + triflumezopyrim,
SX + tetraniliprole + flupyrimine,
SX + tetranylprolol + brofuranilide,
SX + tetraniliprole + tefluthrin,
SX + tetraniliprole + bifenthrin,
SX + clothianidin + brofuranilide,
SX + clothianidin + tefluthrin,
SX + clothianidin + bifenthrin,
SX + imidacloprid + brofuranilide,
SX + Imidacloprid + Tefluthrin,
SX + thiamethoxam + bifenthrin,
SX + thiamethoxam + brofuranilide,
SX + thiamethoxam + teflutrin,
SX + thiamethoxam + bifenthrin,
SX + thiacloprid + brofuranilide,
SX + thiacloprid + tefluthrin,
SX + thiacloprid + bifenthrin,
SX + full pyrazifuron + brofuranilide,
SX + Full pyrazifuron + Tefluthrin,
SX + full pyrazifuron + bifenthrin,
SX + Triflumezopyrim + Brofuranilide,
SX + Triflumezopyrim + Tefluthrin,
SX + Triflumezopyrim + bifenthrin,
SX + flupirmine + brofuranilide,
SX + Flupyrimine + Tefluthrin,
SX + flupirmine + bifenthrin,
SX + Bacillus firmus strain I-1582 + clothianidin,
SX + Bacillus firmus strain I-1582 + Imidacloprid,
SX + Bacillus firmus strain I-1582 + thiamethoxam,
SX + Bacillus firmus strain I-1582 + thiacloprid,
SX + Bacillus firmus strain I-1582 + Full pyrazifuron,
SX + Bacillus firmus strain I-1582 + flupirmine,
SX + Bacillus firmus strain I-1582 + Triflumezopyrim,
SX + Bacillus firmus strain I-1582 + chlorantraniliprole,
SX + Bacillus firmus strain I-1582 + Cyantraniprolol,
SX + Bacillus firmus strain I-1582 + tetraniliprole,
SX + Bacillus firmus strain I-1582 + Tefluthrin,
SX + Bacillus firmus strain I-1582 + bifenthrin,
SX + Bacillus firmus strain I-1582 + fipronil,
SX + Bacillus firmus strain I-1582 + Brofuranilide,
SX + Pasteuria nishizawae strain Pn1 + clothianidin,
SX + Pasteuria nishizawae strain Pn1 + Imidacloprid,
SX + Pasteuria nishizawae strain Pn1 + thiamethoxam,
SX + Pasteuria nishizawae strain Pn1 + thiacloprid,
SX + Pasteuria nishizawae strain Pn1 + Full pyrazifuron,
SX + Pasteuria nishizawae strain Pn1 + Flupirmine,
SX + Pasteuria nishizawae strain Pn1 + Triflumezopyrim,
SX + Pasteuria nishizawae strain Pn1 + chlorantraniliprole,
SX + Pasteuria nishizawae strain Pn1 + Cyantraniliprol,
SX + Pasteuria nishizawae strain Pn1 + tetraniliprolol,
SX + Pasteuria nishizawae strain Pn1 + Tefluthrin,
SX + Pasteuria nishizawae strain Pn1 + bifenthrin,
SX + Pasteuria nishizawae strain Pn1 + fipronil,
SX + Pasteuria nishizawae strain Pn1 + Brofuranilide,
SX + Bradyrhizobium japonicum strain TA-11 + clothianidin,
SX + Bradyrhizobium japonicum strain TA-11 + Imidacloprid,
SX + Bradyrhizobium japonicum strain TA-11 + thiamethoxam,
SX + Bradyrhizobium japonicum strain TA-11 + thiacloprid,
SX + Bradyrhizobium japonicum strain TA-11 + Full pyrazifuron,
SX + Bradyrhizobium japonicum strain TA-11 + flupyrimine,
SX + Bradyrhizobium japonicum strain TA-11 + Triflumezopyrim,
SX + Bradyrhizobium japonicum strain TA-11 + chlorantraniliprole,
SX + Bradyrhizobium japonicum strain TA-11 + cyantraniliprole,
SX + Bradyrhizobium japonicum strain TA-11 + tetraniliprole,
SX + Bradyrhizobium japonicum strain TA-11 + Tefluthrin,
SX + Bradyrhizobium japonicum strain TA-11 + bifenthrin,
SX + Bradyrhizobium japonicum strain TA-11 + fipronil,
SX + Bradyrhizobium japonicum strain TA-11 + brofuranilide,
SX + Bacillus thuringiensis strain EX297512 + clothianidin,
SX + Bacillus thuringiensis strain EX297512 + Imidacloprid,
SX + Bacillus thuringiensis strain EX297512 + thiamethoxam,
SX + Bacillus thuringiensis strain EX297512 + thiacloprid,
SX + Bacillus thuringiensis strain EX297512 + full pyrazifuron,
SX + Bacillus thuringiensis strain EX297512 + flupirmine,
SX + Bacillus thuringiensis strain EX297512 + Triflumezopyrim,
SX + Bacillus thuringiensis strain EX297512 + chlorantraniliprole,
SX + Bacillus thuringiensis strain EX297512 + cyantraniliprole,
SX + Bacillus thuringiensis strain EX297512 + tetraniliprole,
SX + Bacillus thuringiensis strain EX297512 + Tefluthrin,
SX + Bacillus thuringiensis strain EX297512 + bifenthrin,
SX + Bacillus thuringiensis strain EX297512 + fipronil,
SX + Bacillus thuringiensis strain EX297512 + brofuranilide,
SX + Penicillium bilaiae + clothianidin,
SX + Penicillium bilaiae + imidacloprid,
SX + Penicillium bilaiae + thiamethoxam,
SX + Penicillium bilaiae + thiacloprid,
SX + Penicillium bilaiae + Full pyrazifuron,
SX + Penicillium bilaiae + Flupyrimine,
SX + Penicillium bilaiae + Triflumezopyrim,
SX + Penicillium bilaiae + chlorantraniliprole,
SX + Penicillium bilaiae + cyanantaniprolol,
SX + Penicillium bilaiae + tetraniliprolol,
SX + Penicillium bilaiae + Tefluthrin,
SX + Penicillium bilaiae + bifenthrin,
SX + Penicillium bilaiae + fipronil,
SX + Penicillium bilaiae + brofuranilide,
SX + Sinorhizobium meliloti + clothianidin,
SX + Sinorhizobium meliloti + imidacloprid,
SX + Sinorhizobium meliloti + thiamethoxam,
SX + Sinorhizobium meliloti + thiacloprid,
SX + Sinorhizobium meliloti + flupiradifuron,
SX + Sinorhizobium meliloti + flupirmine,
SX + Sinorhizobium meliloti + Triflumezopyrim,
SX + Sinorhizobium meliloti + chlorantraniliprole,
SX + Sinorhizobium meliloti + cyanantaniprolol,
SX + Sinorhizobium meliloti + tetraniliprole,
SX + Sinorhizobium meliloti + tefluthrin,
SX + Sinorhizobium meliloti + bifenthrin,
SX + Sinorhizobium meliloti + fipronil,
SX + Sinorhizobium meliloti + brofuranilide,
SX + Rhizobium leguminosarum + clothianidin,
SX + Rhizobium leguminosarum + imidacloprid,
SX + Rhizobium leguminosarum + thiamethoxam,
SX + Rhizobium leguminosarum + thiacloprid,
SX + Rhizobium leguminosarum + full pyrazifuron,
SX + Rhizobium leguminosarum + flupyrimine,
SX + Rhizobium leguminosarum + Triflumezopyrim,
SX + Rhizobium leguminosarum + chlorantraniliprole,
SX + Rhizobium leguminosarum + cyantraniprolol,
SX + Rhizobium leguminosarum + tetraniliprole,
SX + Rhizobium leguminosarum + teflutrin,
SX + Rhizobium leguminosarum + bifenthrin,
SX + Rhizobium leguminosarum + fipronil,
SX + Rhizobium leguminosarum + brofuranilide,
SX + full azaindolizine + clothianidin,
SX + full azaindolizine + imidacloprid,
SX + full azaindolizine + thiamethoxam,
SX + full azaindolizine + thiacloprid,
SX + full azaindolizine + full pyraziflon,
SX + fluazaindolizine + flupyrimine,
SX + fluazaindolizine + triflumezopyrim,
SX + full azaindolizine + chlorantraniliprole,
SX + full azaindolizine + cyantraniliprole,
SX + fluazaindolizine + tetraniliprolol,
SX + fluazaindolizine + tefluthrin,
SX + full azaindolizine + bifenthrin,
SX + fluazaindolizine + fipronil,
SX + full azaindolizine + brofuranilide,
SX + Thioxazaphen + clothianidin,
SX + Thioxazaphen + Imidacloprid,
SX + Thioxazaphen + Thiamethoxam,
SX + Thioxazaphen + thiacloprid,
SX + Thioxazaphen + Flupiradifuron,
SX + Thioxazaphen + Flupirmine,
SX + Thioxazaphen + Triflumezopyrim,
SX + Thioxazaphen + Chlorantraniliprole,
SX + Thioxazaphen + Cyantraniprolol,
SX + Thioxazaphen + tetraniliprole,
SX + Thioxazaphen + Tefluthrin,
SX + Thioxazaphen + bifenthrin,
SX + Thioxazaphen + Fipronil,
SX + Thioxazaphen + Brofuranilide,
SX + fluenesulfone + clothianidin,
SX + fluenesulfone + imidacloprid,
SX + fluenesulfone + thiamethoxam,
SX + fluenesulfone + thiacloprid,
SX + fluenesulfone + fullpyraziflon,
SX + fluenesulfone + furpyrimine,
SX + fluenesulfone + triflumezopyrim,
SX + fluenesulfone + chlorantraniliprole,
SX + fluorene sulfone + cyantraniprole,
SX + fluenesulfone + tetranyriprole,
SX + fluenesulfone + teflutrin,
SX + fluenesulfone + bifenthrin,
SX + fluenesulfone + fipronil,
SX + fluenesulfone + brofuranilide,
SX + Abamectin + clothianidin,
SX + Abamectin + Imidacloprid,
SX + Abamectin + Thiamethoxam,
SX + abamectin + thiacloprid,
SX + Abamectin + Flupiradifuron,
SX + Abamectin + Flupyrimine,
SX + Abamectin + Triflumezopyrim,
SX + Abamectin + Chlorantraniliprole,
SX + Abamectin + Cyantraniprolol,
SX + Abamectin + Tetranyliprol,
SX + Abamectin + Tefluthrin,
SX + abamectin + bifenthrin,
SX + abamectin + fipronil,
SX + Abamectin + Brofuranilide,
SX + fluopyram + clothianidin,
SX + Fluopiram + Imidacloprid,
SX + fluopyram + thiamethoxam,
SX + fluopyram + thiacloprid,
SX + full opiram + full pyraziflon,
SX + Fluopyram + Flupyrimine,
SX + fluopyram + triflumezopyrim,
SX + fluopiram + chlorantraniliprole,
SX + Fluopiram + Cyantraniprolol,
SX + fluopyram + tetraniliprole,
SX + Fluopiram + Tefluthrin,
SX + fluopyram + bifenthrin,
SX + fluopyram + fipronil,
SX + fluopyram + brofuranilide,
SX + Bacillus amyloliquefaciens + Trichoderma virens,
SX + Penicillium bilaiae + Bradyrhizobium japonicum,
SX + Penicillium bilaiae + Mesorhizobium ciceri,
SX + Bradyrhizobium japonicum + lipochitooligosaccharide,
SX + fluopyram + mefentrifluconazole,
SX + fluopyram + methyltetraprole,
SX + fluopyram + piziflumethofene,
SX + fluopyram + isoflucipram,
SX + fluopyram + aminopyrifen,
SX + fluopyram + mancozeb,
SX + full opiram + carbendazim,
SX + fluopyram + picar butrazoz,
SX + fluopyram + fluoxapiproline,
SX + fluazaindolizine + mefentrifluconazole,
SX + fluazaindolizine + methyltetraprole,
SX + fluazaindolizine + piziflumethofene,
SX + fluazaindolizine + isoflucipram,
SX + fluazaindolizine + aminopyrifen,
SX + full azaindolizine + mancozeb,
SX + full azaindolizine + carbendazim,
SX + full azaindolizine + pical butrazoz,
SX + fluazaindolizine + fluoxapiproline,
SX + fluenesulfone + mefentrifluconazole,
SX + fluorene sulfone + methyltetraprole,
SX + Fluenesulfone + Pidiflumethophene,
SX + fluene sulfone + isoflucipram,
SX + fluorene sulfone + aminopyriphene,
SX + fluene sulfone + mancozeb,
SX + fluene sulfone + carbendazim,
SX + Fluenesulfone + Picalbutrazox,
SX + fluorene sulfone + fluoxapiproline,
SX + Thioxazaphen + Mefentrifluconazole,
SX + thioxazaphen + methyltetraprole,
SX + Thioxazaphen + Pidiflumethophene,
SX + thioxazaphen + isoflucipram,
SX + thioxazaphen + aminopyrifen,
SX + thioxazaphen + mancozeb,
SX + Thioxazaphen + Carbendazim,
SX + thioxazaphen + picarbutrazox,
SX + thioxazaphen + fluoxapiproline,
SX + Bacillus firmus strain I-1582 + mefentrifluconazole,
SX + Bacillus firmus strain I-1582 + methyltetraprole,
SX + Bacillus firmus strain I-1582 + Pidiflumethofene,
SX + Bacillus firmus strain I-1582 + isoflusipram,
SX + Bacillus firmus strain I-1582 + aminopyrifen,
SX + Bacillus firmus strain I-1582 + Mancozeb,
SX + Bacillus firmus strain I-1582 + Carbendazim,
SX + Bacillus firmus strain I-1582 + Pical butrazoz,
SX + Bacillus firmus strain I-1582 + fluoxapiproline,
SX + Pasteuria nishizawae strain Pn1 + mefentrifluconazole,
SX + Pasteuria nishizawae strain Pn1 + methyltetraprole,
SX + Pasteuria nishizawae strain Pn1 + Pidiflumethophene,
SX + Pasteuria nishizawae strain Pn1 + isoflusipram,
SX + Pasteuria nishizawae strain Pn1 + aminopyrifen,
SX + Pasteuria nishizawae strain Pn1 + Mancozeb,
SX + Pasteuria nishizawae strain Pn1 + Carbendazim,
SX + Pasteuria nishizawae strain Pn1 + Picual butrazoz,
SX + Pasteuria nishizawae strain Pn1 + fluoxapiproline.

In group 13, the combination of SX, component 1 and component 2 is a combination of any of the above “3 active ingredient lists”, 2 parts of SX, 0.5 parts of component 1 and 2 parts. It is comprised from the composition A which consists of this component 2.
In the group 14, the combination of SX, component 1 and component 2 is one of the above-mentioned “3 active ingredient lists”, 2 parts of SX, 0.5 parts of component 1 and 4 parts It is comprised from the composition A which consists of this component 2.
In group 15, the combination of SX, component 1 and component 2 is one of the above-mentioned “3 active ingredient lists”, 2 parts of SX, 0.5 parts of component 1 and 7 parts It is comprised from the composition A which consists of this component 2.
In group 16, the combination of SX, component 1 and component 2 is any combination of the above “3 active ingredient list”, 2 parts of SX, 1.5 parts of component 1 and 2 parts It is comprised from the composition A which consists of this component 2.
In Group 17, the combination of SX, Component 1 and Component 2 is one of the above “3 active ingredient lists”, 2 parts of SX, 1.5 parts of Component 1 and 4 parts It is comprised from the composition A which consists of this component 2.
In group 18, the combination of SX, component 1 and component 2 is one of the above-mentioned “3 active ingredient lists”, 2 parts of SX, 1.5 parts of component 1 and 7 parts It is comprised from the composition A which consists of this component 2.
In group 19, the combination of SX, component 1 and component 2 is one of the above-mentioned “3 active ingredient lists”, 2 parts SX, 2 parts component 1 and 2.5 parts It is comprised from the composition A which consists of this component 2.
In group 20, the combination of SX, component 1 and component 2 is a combination of any of the above “3 active ingredient lists”, 1 part of SX, 1 part of component 1 and 2 parts of component It is comprised from the composition A which consists of two.
In the group 21, the combination of SX, component 1 and component 2 is any combination of the above-mentioned “3 active ingredient list”, 0.1 part of SX, 0.5 part of components 1 and 1 . Composition A consisting of 5 parts of Component 2
In the group 22, the combination of SX, component 1 and component 2 is a combination of any of the above “3 active ingredient lists”, 0.1 part of SX, 0.5 part of component 1 and 0. . Composition A composed of 3 parts of Component 2
In the group 23, the combination of SX, the present component 1 and the present component 2 is a combination of any of the above “3 active ingredient lists”, and 0.1 part of SX, 2 parts of the present components 1 and 1.5 The composition A is composed of 2 parts of the present component 2.
In the group 24, the combination of SX, component 1 and component 2 is any combination of the above “3 active ingredient list”, 5 parts of SX, 6.6 parts of component 1 and 20 parts of It is comprised from the composition A which consists of this component 2.
In Group 25, the combination of SX, Component 1 and Component 2 is one of the above-mentioned “3 active ingredient lists”, 5 parts of SX, 6.6 parts of Component 1 and 5 parts of It is comprised from the composition A which consists of this component 2.
In the group 26, the combination of SX, component 1 and component 2 is one of the above-mentioned “3 active ingredient lists”, 5 parts SX, 6.6 parts component 1 and 8 parts It is comprised from the composition A which consists of this component 2.
In the group 27, the combination of SX, component 1 and component 2 is one of the above-mentioned “3 active ingredient lists”, 1 part of SX, 1 part of component 1 and 1 part of component It is comprised from the composition A which consists of two.
In group 28, the combination of SX, component 1 and component 2 is a combination of any of the above “3 active ingredient lists”, 1 part of SX, 1 part of component 1 and 10 parts of component It is comprised from the composition A which consists of two.
In group 29, the combination of SX, component 1 and component 2 is one of the above-mentioned “3 active ingredient lists”, 1 part of SX, 10 parts of component 1 and 1 part of component It is comprised from the composition A which consists of two.
In the group 30, the combination of SX, component 1 and component 2 is one of the above-mentioned “3 active ingredient lists”, 1 part SX, 10 parts component 1 and 10 parts component It is comprised from the composition A which consists of two.
In group 31, the combination of SX, component 1 and component 2 is one of the above-mentioned “3 active ingredient lists”, 10 parts of SX, 1 part of component 1 and 1 part of component It is comprised from the composition A which consists of two.
In group 32, the combination of SX, component 1 and component 2 is a combination of any of the above “3 active ingredient lists”, 10 parts of SX, 1 part of component 1 and 10 parts of component It is comprised from the composition A which consists of two.
In the group 33, the combination of SX, component 1 and component 2 is one of the above-mentioned “3 active ingredient lists”, 10 parts of SX, 10 parts of component 1 and 1 part of component It is comprised from the composition A which consists of two.

  In the group 34, the combination of SX, main component 1, main component 2 and main component 3 is a combination of any of the following “4 active ingredient lists”: two parts SX, 0.5 parts main component 1 The composition A is composed of 1.5 parts of the present component 2 and 2 parts of the present component 3.

  In the “4 active ingredient list”, for example, SX + spinetoram + clothianidin + isothianyl means a combination of SX, spinetoram, clothianidin and isothianyl, this component 1 is spinetoram, this component 2 is clothianidin, this component 3 is isotianil.

"4 Active ingredient list":
SX + spinetoram + clothianidin + isotianil,
SX + spinetoram + clothianidin + furametopir,
SX + spinetoram + clothianidin + impylfluxam,
SX + spinetoram + isotianil + furametopir,
SX + spinetoram + isotianil + impylfluxam,
SX + clothianidin + isotianil + furametopir,
SX + clothianidin + isotianil + impylfluxam,
SX + clothianidin + ferrimzone + fusaride,
SX + clothianidin + fusaride + validamycin A,
SX + Ferimzone + Fusaride + Validamycin A,
SX + clothianidin + fusaride + validamycin A,
SX + clothianidin + fusaride + ferrimzone.

In the group 35, the combination of SX, main component 1, main component 2 and main component 3 is a combination of any of the above-mentioned “4 active ingredient lists”, 2 parts SX, 0.5 parts main component 1 , Composition A consisting of 1.5 parts of this component 2 and 4 parts of this component 3.
In the group 36, the combination of SX, main component 1, main component 2, and main component 3 is a combination of any of the above-mentioned “4 active ingredient lists”, 2 parts of SX, 0.5 parts of main component 1 It consists of a composition A consisting of 2 parts of this component 2 and 2 parts of this component 3.
In the group 37, the combination of SX, main component 1, main component 2 and main component 3 is a combination of any of the above “4 active ingredient lists”, 2 parts SX, 0.5 part main component 1 It is composed of composition A consisting of 2 parts of this component 2 and 4 parts of this component 3.
In the group 38, the combination of SX, main component 1, main component 2 and main component 3 is a combination of any of the above-mentioned “4 active ingredient lists”, 2 parts SX, 1.5 parts main component 1 It consists of a composition A consisting of 2 parts of this component 2 and 2 parts of this component 3.
In the group 39, the combination of SX, main component 1, main component 2, and main component 3 is a combination of any of the above-mentioned “4 active ingredient lists”, 2 parts SX, 1.5 parts main component 1 It is composed of composition A consisting of 2 parts of this component 2 and 4 parts of this component 3.
In the group 40, the combination of SX, main component 1, main component 2, and main component 3 is a combination of any of the above “4 active ingredient lists”, 0.1 part of SX, 0.5 part of book Consists of Composition A consisting of Component 1, 2 parts of Component 2 and 1.5 parts of Component 3.
In the group 41, the combination of SX, main component 1, main component 2, and main component 3 is a combination of any of the above “4 active ingredient lists”, 0.1 parts of SX, 0.5 parts of book Composition 1 consists of Composition A comprising Component 1, 1.5 parts of Component 2 and 0.3 parts of Component 3.
In the group 42, the combination of SX, main component 1, main component 2, and main component 3 is one of the above-mentioned “4 active ingredient lists”, and 0.1 part SX, two parts main component 1 The composition A is composed of 1.5 parts of the present component 2 and 0.3 parts of the present component 3.
In the group 43, the combination of SX, main component 1, main component 2, and main component 3 is a combination of any of the above-mentioned “4 active ingredient lists”, 5 parts of SX, 6.6 parts of main component 1 The composition A is composed of 15 parts of the present component 2 and 15 parts of the present component 3.
In the group 44, the combination of SX, main component 1, main component 2 and main component 3 is a combination of any of the above-mentioned “4 active ingredient lists”, 5 parts of SX, 6.6 parts of main component 1 The composition A is composed of 20 parts of the present component 2 and 5 parts of the present component 3.

  In the group 45, the combination of SX, main component 1, main component 2, main component 3 and main component 4 is a combination of any of the following “5 active ingredient lists”: two parts of SX, 0.5 parts This component 1 is composed of a composition A comprising 1.5 parts of this component 2, 2 parts of this component 3 and 4 parts of this component 4.

  In the “5 active ingredient list”, for example, SX + spinetoram + clothianidin + isothianyl + furametopir means a combination of SX, spinetoram, clothianidin, isothianyl and furametopir, this component 1 is spinetoram, this component 2 is clothianidin Yes, this component 3 is isotianil, and this component 4 is furametopyl.

"5 Active ingredient list":
SX + spinetoram + clothianidin + isotianil + furametopyr,
SX + spinetoram + clothianidin + isotianil + impylfluxam,
SX + clothianidin + ferrimzone + fusaride + validamycin A,
SX + clothianidin + fusaride + ferrimzone + validamycin A,

In the group 46, the combination of SX, the present component 1, the present component 2, the present component 3 and the present component 4 is any combination of the above-mentioned “5 active ingredient list”. This composition 1 consists of a composition A comprising 1.5 parts of this component 2, 2 parts of this component 3 and 2 parts of this component 4.
In the group 47, the combination of SX, main component 1, main component 2, main component 3 and main component 4 is a combination of any of the above “5 active ingredient lists”, and 0.1 part of SX, 0. It consists of composition A consisting of 5 parts of this component, 1 part of this component 2, 1.5 parts of this component 3 and 0.3 parts of this component 4.
In the group 48, the combination of SX, the present component 1, the present component 2, the present component 3 and the present component 4 is a combination of any one of the above “5 active ingredient lists”, and 5 parts of SX, 6.6 parts The composition A is composed of the present component 1, 15 parts of the present component 2, 15 parts of the present component 3 and 5 parts of the present component 4.

In group 1 ′, the combination of SX, main component 1, main component 2, main component 3, main component 4 and main component 5 is any combination of the following “6 active ingredient list”, and 1000 parts of SX It consists of a composition A consisting of 1 part of this component 1, 1 part of this component 2, 1 part of this component 3, 1 part of this component 4 and 1 part of this component 5.

  In the “6 active ingredient list”, for example, SX + metconazole + mandestrobin + fluopyram + fludioxonil + metalaxyl M means a combination of SX, metconazole, mandestrobin, fluopyram, fludioxonil and metalaxyl M. Metconazole, component 2 is mandestrobin, component 3 is fluopyram, component 4 is fludioxonil, and component 5 is metalaxyl M.

"6 Active ingredient list":
SX + metconazole + mandestrobin + fluopyram + fludioxonil + metalaxyl M,
SX + metconazole + mandestrobin + fluopyram + fludioxonil + picalbutrazox,
SX + metconazole + mandestrobin + fluopyram + thiophanate methyl + metalaxyl M,
SX + metconazole + mandestrobin + fluopyram + thiophanate methyl + picarbutrazox,
SX + metconazole + mandestrobin + fluopyram + thiabendazole + metalaxyl M,
SX + metconazole + mandestrobin + fluopyram + thiabendazole + picarbutrazox,
SX + metconazole + mandestrobin + fluopyram + thiuram + metalaxyl M,
SX + metconazole + mandestrobin + fluopyram + thiuram + picarbutrazox,
SX + metconazole + mandestrobin + fluopyram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + mandestrobin + fluopyram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + mandestrobin + fluopyram + boscalid + metalaxyl M,
SX + metconazole + mandestrobin + fluopyram + boscalid + picarbutrazoz,
SX + metconazole + mandestrobin + fluopyram + aminopyrifen + metalaxyl M,
SX + metconazole + mandestrobin + fluopyram + aminopyrifen + picarbutrazox,
SX + metconazole + mandestrobin + fluopyram + mancozeb + metalaxyl M,
SX + metconazole + mandestrobin + fluopyram + mancozeb + picarbutrazox,
SX + metconazole + mandestrobin + fluopyram + carbendazim + metalaxyl M,
SX + metconazole + mandestrobin + fluopyram + carbendazim + picarbutrazox,
SX + metconazole + mandestrobin + floxapyroxad + fludioxonil + metalaxyl M,
SX + metconazole + mandestrobin + floxapyroxad + fludioxonil + picalbutrazox,
SX + metconazole + mandestrobin + floxapyroxad + thiophanate methyl + metalaxyl M,
SX + metconazole + mandestrobin + floxapyroxad + thiophanate methyl + picarbutrazox,
SX + metconazole + mandestrobin + floxapyroxad + thiabendazole + metalaxyl M,
SX + metconazole + mandestrobin + floxapyroxad + thiabendazole + picalbutrazox,
SX + metconazole + mandestrobin + floxapyroxad + thiuram + metalaxyl M,
SX + metconazole + mandestrobin + floxapyroxad + thiuram + picarbutrazox,
SX + metconazole + mandestrobin + floxapyroxad + tolcrofosmethyl + metalaxyl M,
SX + metconazole + mandestrobin + floxapyroxad + tolcrofosmethyl + picalbutrazox,
SX + metconazole + mandestrobin + floxapyroxad + boscalid + metalaxyl M,
SX + metconazole + mandestrobin + floxapyroxad + boscalid + picarbutrazox,
SX + metconazole + mandestrobin + floxapyroxad + aminopyrifen + metalaxyl M,
SX + metconazole + mandestrobin + floxapyroxad + aminopyrifen + picalbutrazox,
SX + metconazole + mandestrobin + floxapyroxad + mancozeb + metalaxyl M,
SX + metconazole + mandestrobin + floxapyroxad + mancozeb + picarbutrazox,
SX + metconazole + mandestrobin + floxapyroxad + carbendazim + metalaxyl M,
SX + metconazole + mandestrobin + floxapyroxad + carbendazim + picarbutrazox,
SX + metconazole + mandestrobin + boscalid + fludioxonil + metalaxyl M,
SX + metconazole + mandestrobin + boscalid + fludioxonil + picarbutrazox,
SX + metconazole + mandestrobin + boscalid + thiophanate methyl + metalaxyl M,
SX + metconazole + mandestrobin + boscalid + thiophanate methyl + picarbutrazox,
SX + metconazole + mandestrobin + boscalid + thiabendazole + metalaxyl M,
SX + metconazole + mandestrobin + boscalid + thiabendazole + picarbutrazox,
SX + metconazole + mandestrobin + boscalid + thiuram + metalaxyl M,
SX + metconazole + mandestrobin + boscalid + thiuram + picarbutrazox,
SX + metconazole + mandestrobin + boscalid + tolcrofosmethyl + metalaxyl M,
SX + metconazole + mandestrobin + boscalid + tolcrofosmethyl + picarbutrazox,
SX + metconazole + mandestrobin + boscalid + boscalid + metalaxyl M,
SX + metconazole + mandestrobin + boscalid + boscalid + picarbutrazox,
SX + metconazole + mandestrobin + boscalid + aminopyrifen + metalaxyl M,
SX + metconazole + mandestrobin + boscalid + aminopyrifen + picarbutrazox,
SX + metconazole + mandestrobin + boscalid + mancozeb + metalaxyl M,
SX + metconazole + mandestrobin + boscalid + mancozeb + picarbutrazox,
SX + metconazole + mandestrobin + boscalid + carbendazim + metalaxyl M,
SX + metconazole + mandestrobin + boscalid + carbendazim + picarbutrazox,
SX + metconazole + mandestrobin + penflufen + fludioxonil + metalaxyl M,
SX + metconazole + mandestrobin + penflufen + fludioxonil + picarbutrazox,
SX + metconazole + mandestrobin + penflufen + thiophanate methyl + metalaxyl M,
SX + metconazole + mandestrobin + penflufen + thiophanate methyl + picarbutrazox,
SX + metconazole + mandestrobin + penflufen + thiabendazole + metalaxyl M,
SX + metconazole + mandestrobin + penflufen + thiabendazole + picarbutrazox,
SX + metconazole + mandestrobin + penflufen + thiuram + metalaxyl M,
SX + metconazole + mandestrobin + penflufen + thiuram + picarbutrazox,
SX + metconazole + mandestrobin + penflufen + tolcrofosmethyl + metalaxyl M,
SX + metconazole + mandestrobin + penflufen + tolcrofosmethyl + picalbutrazox,
SX + metconazole + mandestrobin + penflufen + boscalid + metalaxyl M,
SX + metconazole + mandestrobin + penflufen + boscalid + picarbutrazox,
SX + metconazole + mandestrobin + penflufen + aminopyrifen + metalaxyl M,
SX + metconazole + mandestrobin + penflufen + aminopyrifen + picarbutrazox,
SX + metconazole + mandestrobin + penflufen + mancozeb + metalaxyl M,
SX + metconazole + mandestrobin + penflufen + mancozeb + picarbutrazox,
SX + metconazole + mandestrobin + penflufen + carbendazim + metalaxyl M,
SX + metconazole + mandestrobin + penflufen + carbendazim + picarbutrazoz,
SX + metconazole + mandestrobin + tifluzamide + fludioxonil + metalaxyl M,
SX + metconazole + mandestrobin + tifluzamide + fludioxonil + picarbutrazox,
SX + metconazole + mandestrobin + tifluzamide + thiophanate methyl + metalaxyl M,
SX + metconazole + mandestrobin + tifluzamide + thiophanate methyl + picalbutrazox,
SX + metconazole + mandestrobin + tifluzamide + thiabendazole + metalaxyl M,
SX + metconazole + mandestrobin + tifluzamide + thiabendazole + picarbutrazox,
SX + metconazole + mandestrobin + tifluzamide + thiuram + metalaxyl M,
SX + metconazole + mandestrobin + tifluzamide + thiuram + picarbutrazox,
SX + metconazole + mandestrobin + tifluzamide + tolcrofosmethyl + metalaxyl M,
SX + metconazole + mandestrobin + tifluzamide + tolcrofosmethyl + picalbutrazox,
SX + metconazole + mandestrobin + tifluzamide + boscalid + metalaxyl M,
SX + metconazole + mandestrobin + tifluzamide + boscalid + picarbutrazox,
SX + metconazole + mandestrobin + tifluzamide + aminopyrifen + metalaxyl M,
SX + metconazole + mandestrobin + tifluzamide + aminopyrifen + picarbutrazox,
SX + metconazole + mandestrobin + tifluzamide + mancozeb + metalaxyl M,
SX + metconazole + mandestrobin + tifluzamide + mancozeb + picarbutrazox,
SX + metconazole + mandestrobin + tifluzamide + carbendazim + metalaxyl M,
SX + metconazole + mandestrobin + tifluzamide + carbendazim + picarbutrazox,
SX + metconazole + mandestrobin + impylfluxam + fludioxonil + metalaxyl M,
SX + metconazole + mandestrobin + impylfluxam + fludioxonil + picarbutrazox,
SX + metconazole + mandestrobin + impylfluxam + thiophanate methyl + metalaxyl M,
SX + metconazole + mandestrobin + impylfluxam + thiophanate methyl + picarbutrazox,
SX + metconazole + mandestrobin + impylfluxam + thiabendazole + metalaxyl M,
SX + metconazole + mandestrobin + impylfluxam + thiabendazole + picarbutrazox,
SX + metconazole + mandestrobin + impylfluxam + thiuram + metalaxyl M,
SX + metconazole + mandestrobin + impylfluxam + thiuram + picarbutrazox,
SX + metconazole + mandestrobin + impylfluxam + tolcrofosmethyl + metalaxyl M,
SX + metconazole + mandestrobin + impylfluxam + tolcrofosmethyl + picalbutrazox,
SX + metconazole + mandestrobin + impylfluxam + boscalid + metalaxyl M,
SX + metconazole + mandestrobin + impylfluxam + boscalid + picarbutrazoz,
SX + metconazole + mandestrobin + impylfluxam + aminopyrifen + metalaxyl M,
SX + metconazole + mandestrobin + impylfluxam + aminopyrifen + picarbutrazox,
SX + metconazole + mandestrobin + impylfluxam + mancozeb + metalaxyl M,
SX + metconazole + mandestrobin + impylfluxam + mancozeb + picarbutrazox,
SX + metconazole + mandestrobin + impylfluxam + carbendazim + metalaxyl M,
SX + metconazole + mandestrobin + impylfluxam + carbendazim + picarbutrazoz,
SX + metconazole + mandestrobin + sedaxane + fludioxonil + metalaxyl M,
SX + metconazole + mandestrobin + sedaxane + fludioxonil + picalbutrazox,
SX + metconazole + mandestrobin + sedaxane + thiophanate methyl + metalaxyl M,
SX + metconazole + mandestrobin + sedaxane + thiophanate methyl + picalbutrazox,
SX + metconazole + mandestrobin + sedaxane + thiabendazole + metalaxyl M,
SX + metconazole + mandestrobin + sedaxane + thiabendazole + picarbutrazox,
SX + metconazole + mandestrobin + sedaxane + thiuram + metalaxyl M,
SX + metconazole + mandestrobin + sedaxane + thiuram + picarbutrazox,
SX + metconazole + mandestrobin + sedaxane + tolcrofosmethyl + metalaxyl M,
SX + metconazole + mandestrobin + sedaxane + tolcrofosmethyl + picalbutrazox,
SX + metconazole + mandestrobin + sedaxane + boscalid + metalaxyl M,
SX + metconazole + mandestrobin + sedaxane + boscalid + picarbutrazox,
SX + metconazole + mandestrobin + sedaxane + aminopyrifen + metalaxyl M,
SX + metconazole + mandestrobin + sedaxane + aminopyrifen + picarbutrazox,
SX + metconazole + mandestrobin + sedaxane + mancozeb + metalaxyl M,
SX + metconazole + mandestrobin + sedaxane + mancozeb + picarbutrazox,
SX + metconazole + mandestrobin + sedaxane + carbendazim + metalaxyl M,
SX + metconazole + mandestrobin + sedaxane + carbendazim + picarbutrazox,
SX + metconazole + mandestrobin + pidiflumethophene + fludioxonil + metalaxyl M,
SX + metconazole + mandestrobin + pidiflumethophene + fludioxonil + picalbutrazox,
SX + metconazole + mandestrobin + pidiflumethofene + thiophanate methyl + metalaxyl M,
SX + metconazole + mandestrobin + pidiflumethophene + thiophanate methyl + picalbutrazox,
SX + metconazole + mandestrobin + pidiflumethofene + thiabendazole + metalaxyl M,
SX + metconazole + mandestrobin + pidiflumethophene + thiabendazole + picalbutrazoz,
SX + metconazole + mandestrobin + pidiflumethofene + thiuram + metalaxyl M,
SX + metconazole + mandestrobin + pidiflumethophene + thiuram + picarbutrazox,
SX + metconazole + mandestrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl M,
SX + metconazole + mandestrobin + pidiflumethofene + tolcrofosmethyl + picalbutrazox,
SX + metconazole + mandestrobin + pidiflumethofene + boscalid + metalaxyl M,
SX + metconazole + mandestrobin + piziflumethofene + boscalid + picarbutrazox,
SX + metconazole + mandestrobin + pidiflumethofene + aminopyrifen + metalaxyl M,
SX + metconazole + mandestrobin + pidiflumethophene + aminopyrifen + picalbutrazox,
SX + metconazole + mandestrobin + pidiflumethofene + mancozeb + metalaxyl M,
SX + metconazole + mandestrobin + pidiflumethofene + mancozeb + picarbutrazox,
SX + metconazole + mandestrobin + pidiflumethofene + carbendazim + metalaxyl M,
SX + metconazole + mandestrobin + pidiflumethofene + carbendazim + picarbutrazox,
SX + metconazole + mandestrobin + isoflucipram + fludioxonil + metalaxyl M,
SX + metconazole + mandestrobin + isoflucipram + fludioxonil + picalbutrazox,
SX + metconazole + mandestrobin + isoflucipram + thiophanate methyl + metalaxyl M,
SX + metconazole + mandestrobin + isoflucipram + thiophanate methyl + picalbutrazox,
SX + metconazole + mandestrobin + isoflucipram + thiabendazole + metalaxyl M,
SX + metconazole + mandestrobin + isoflucipram + thiabendazole + picarbutrazox,
SX + metconazole + mandestrobin + isoflucipram + thiuram + metalaxyl M,
SX + metconazole + mandestrobin + isoflucipram + thiuram + picarbutrazox,
SX + metconazole + mandestrobin + isoflucipram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + mandestrobin + isoflucipram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + mandestrobin + isoflucipram + boscalid + metalaxyl M,
SX + metconazole + mandestrobin + isoflucipram + boscalid + picarbutrazox,
SX + metconazole + mandestrobin + isoflucipram + aminopyrifen + metalaxyl M,
SX + metconazole + mandestrobin + isoflucipram + aminopyrifen + picalbutrazox,
SX + metconazole + mandestrobin + isoflucipram + mancozeb + metalaxyl M,
SX + metconazole + mandestrobin + isoflucipram + mancozeb + picarbutrazox,
SX + metconazole + mandestrobin + isoflucipram + carbendazim + metalaxyl M,
SX + metconazole + mandestrobin + isoflucipram + carbendazim + picarbutrazox,
SX + metconazole + azoxystrobin + fluopyram + fludioxonil + metalaxyl M,
SX + metconazole + azoxystrobin + fluopyram + fludioxonil + picalbutrazox,
SX + metconazole + azoxystrobin + fluopyram + thiophanate methyl + metalaxyl M,
SX + metconazole + azoxystrobin + fluopyram + thiophanate methyl + picalbutrazox,
SX + metconazole + azoxystrobin + fluopyram + thiabendazole + metalaxyl M,
SX + metconazole + azoxystrobin + fluopyram + thiabendazole + picarbutrazox,
SX + metconazole + azoxystrobin + fluopyram + thiuram + metalaxyl M,
SX + metconazole + azoxystrobin + fluopyram + thiuram + picarbutrazox,
SX + metconazole + azoxystrobin + fluopyram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + azoxystrobin + fluopyram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + azoxystrobin + fluopyram + boscalid + metalaxyl M,
SX + metconazole + azoxystrobin + fluopyram + boscalid + picarbutrazox,
SX + metconazole + azoxystrobin + fluopyram + aminopyrifen + metalaxyl M,
SX + metconazole + azoxystrobin + fluopyram + aminopyrifen + picarbutrazox,
SX + metconazole + azoxystrobin + fluopyram + mancozeb + metalaxyl M,
SX + metconazole + azoxystrobin + fluopyram + mancozeb + picarbutrazox,
SX + metconazole + azoxystrobin + fluopyram + carbendazim + metalaxyl M,
SX + metconazole + azoxystrobin + fluopyram + carbendazim + picalbutrazox,
SX + metconazole + azoxystrobin + floxapyroxad + fludioxonil + metalaxyl M,
SX + metconazole + azoxystrobin + floxapyroxad + fludioxonil + picalbutrazox,
SX + metconazole + azoxystrobin + floxapyroxad + thiophanate methyl + metalaxyl M,
SX + metconazole + azoxystrobin + floxapyroxad + thiophanate methyl + picalbutrazox,
SX + metconazole + azoxystrobin + floxapyroxad + thiabendazole + metalaxyl M,
SX + metconazole + azoxystrobin + floxapyroxado + thiabendazole + picalbutrazox,
SX + metconazole + azoxystrobin + floxapyroxad + thiuram + metalaxyl M,
SX + metconazole + azoxystrobin + floxapyroxad + thiuram + picarbutrazox,
SX + metconazole + azoxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl M,
SX + metconazole + azoxystrobin + floxapyroxad + tolcrofosmethyl + picalbutrazox,
SX + metconazole + azoxystrobin + floxapyroxad + boscalid + metalaxyl M,
SX + metconazole + azoxystrobin + floxapyroxad + boscalid + picalbutrazox,
SX + metconazole + azoxystrobin + floxapyroxad + aminopyrifen + metalaxyl M,
SX + metconazole + azoxystrobin + floxapyroxad + aminopyrifen + picalbutrazox,
SX + metconazole + azoxystrobin + floxapyroxad + mancozeb + metalaxyl M,
SX + metconazole + azoxystrobin + floxapyroxad + mancozeb + picalbutrazox,
SX + metconazole + azoxystrobin + floxapyroxad + carbendazim + metalaxyl M,
SX + metconazole + azoxystrobin + floxapyroxad + carbendazim + picalbutrazox,
SX + metconazole + azoxystrobin + boscalid + fludioxonil + metalaxyl M,
SX + metconazole + azoxystrobin + boscalid + fludioxonil + picalbutrazox,
SX + metconazole + azoxystrobin + boscalid + thiophanate methyl + metalaxyl M,
SX + metconazole + azoxystrobin + boscalid + thiophanate methyl + picalbutrazox,
SX + metconazole + azoxystrobin + boscalid + thiabendazole + metalaxyl M,
SX + metconazole + azoxystrobin + boscalid + thiabendazole + picarbutrazox,
SX + metconazole + azoxystrobin + boscalid + thiuram + metalaxyl M,
SX + metconazole + azoxystrobin + boscalid + thiuram + picarbutrazox,
SX + metconazole + azoxystrobin + boscalid + tolcrofosmethyl + metalaxyl M,
SX + metconazole + azoxystrobin + boscalid + tolcrofosmethyl + picalbutrazox,
SX + metconazole + azoxystrobin + boscalid + boscalid + metalaxyl M,
SX + metconazole + azoxystrobin + boscalid + boscalid + picarbutrazox,
SX + metconazole + azoxystrobin + boscalid + aminopyrifen + metalaxyl M,
SX + metconazole + azoxystrobin + boscalid + aminopyrifen + picarbutrazox,
SX + metconazole + azoxystrobin + boscalid + mancozeb + metalaxyl M,
SX + metconazole + azoxystrobin + boscalid + mancozeb + picarbutrazox,
SX + metconazole + azoxystrobin + boscalid + carbendazim + metalaxyl M,
SX + metconazole + azoxystrobin + boscalid + carbendazim + picarbutrazox,
SX + metconazole + azoxystrobin + penflufen + fludioxonil + metalaxyl M,
SX + metconazole + azoxystrobin + penflufen + fludioxonil + picalbutrazox,
SX + metconazole + azoxystrobin + penflufen + thiophanate methyl + metalaxyl M,
SX + metconazole + azoxystrobin + penflufen + thiophanate methyl + picalbutrazox,
SX + metconazole + azoxystrobin + penflufen + thiabendazole + metalaxyl M,
SX + metconazole + azoxystrobin + penflufen + thiabendazole + picarbutrazox,
SX + metconazole + azoxystrobin + penflufen + thiuram + metalaxyl M,
SX + metconazole + azoxystrobin + penflufen + thiuram + picarbutrazox,
SX + metconazole + azoxystrobin + penflufen + tolcrofosmethyl + metalaxyl M,
SX + metconazole + azoxystrobin + penflufen + tolcrofosmethyl + picalbutrazox,
SX + metconazole + azoxystrobin + penflufen + boscalid + metalaxyl M,
SX + metconazole + azoxystrobin + penflufen + boscalid + picarbutrazox,
SX + metconazole + azoxystrobin + penflufen + aminopyrifen + metalaxyl M,
SX + metconazole + azoxystrobin + penflufen + aminopyrifen + picarbutrazox,
SX + metconazole + azoxystrobin + penflufen + mancozeb + metalaxyl M,
SX + metconazole + azoxystrobin + penflufen + mancozeb + picarbutrazox,
SX + metconazole + azoxystrobin + penflufen + carbendazim + metalaxyl M,
SX + metconazole + azoxystrobin + penflufen + carbendazim + picarbutrazox,
SX + metconazole + azoxystrobin + tifluzamide + fludioxonil + metalaxyl M,
SX + metconazole + azoxystrobin + tifluzamide + fludioxonil + picalbutrazox,
SX + metconazole + azoxystrobin + tifluzamide + thiophanate methyl + metalaxyl M,
SX + metconazole + azoxystrobin + tifluzamide + thiophanate methyl + picalbutrazox,
SX + metconazole + azoxystrobin + thifluzamide + thiabendazole + metalaxyl M,
SX + metconazole + azoxystrobin + thifluzamide + thiabendazole + picalbutrazox,
SX + metconazole + azoxystrobin + tifluzamide + thiuram + metalaxyl M,
SX + metconazole + azoxystrobin + thifluzamide + thiuram + picarbutrazox,
SX + metconazole + azoxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl M,
SX + metconazole + azoxystrobin + tifluzamide + tolcrofosmethyl + picalbutrazox,
SX + metconazole + azoxystrobin + tifluzamide + boscalid + metalaxyl M,
SX + metconazole + azoxystrobin + tifluzamide + boscalid + picarbutrazox,
SX + metconazole + azoxystrobin + tifluzamide + aminopyrifen + metalaxyl M,
SX + metconazole + azoxystrobin + thifluzamide + aminopyrifen + picalbutrazox,
SX + metconazole + azoxystrobin + tifluzamide + mancozeb + metalaxyl M,
SX + metconazole + azoxystrobin + tifluzamide + mancozeb + picarbutrazox,
SX + metconazole + azoxystrobin + tifluzamide + carbendazim + metalaxyl M,
SX + metconazole + azoxystrobin + tifluzamide + carbendazim + picarbutrazox,
SX + metconazole + azoxystrobin + impylfluxam + fludioxonil + metalaxyl M,
SX + metconazole + azoxystrobin + impylfluxam + fludioxonil + picalbutrazox,
SX + metconazole + azoxystrobin + impylfluxam + thiophanate methyl + metalaxyl M,
SX + metconazole + azoxystrobin + impylfluxam + thiophanate methyl + picalbutrazox,
SX + metconazole + azoxystrobin + impylfluxam + thiabendazole + metalaxyl M,
SX + metconazole + azoxystrobin + impylfluxam + thiabendazole + picalbutrazox,
SX + metconazole + azoxystrobin + impylfluxam + thiuram + metalaxyl M,
SX + metconazole + azoxystrobin + impylfluxam + thiuram + picarbutrazox,
SX + metconazole + azoxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl M,
SX + metconazole + azoxystrobin + impylfluxam + tolcrofosmethyl + picalbutrazoz,
SX + metconazole + azoxystrobin + impylfluxam + boscalid + metalaxyl M,
SX + metconazole + azoxystrobin + impylfluxam + boscalid + picarbutrazox,
SX + metconazole + azoxystrobin + impylfluxam + aminopyrifen + metalaxyl M,
SX + metconazole + azoxystrobin + impylfluxam + aminopyrifen + picalbutrazox,
SX + metconazole + azoxystrobin + impylfluxam + mancozeb + metalaxyl M,
SX + metconazole + azoxystrobin + impylfluxam + mancozeb + picarbutrazoz,
SX + metconazole + azoxystrobin + impylfluxam + carbendazim + metalaxyl M,
SX + metconazole + azoxystrobin + impylfluxam + carbendazim + picarbutrazox,
SX + metconazole + azoxystrobin + sedaxane + fludioxonil + metalaxyl M,
SX + metconazole + azoxystrobin + sedaxane + fludioxonil + picalbutrazox,
SX + metconazole + azoxystrobin + sedaxane + thiophanate methyl + metalaxyl M,
SX + metconazole + azoxystrobin + sedaxane + thiophanate methyl + picalbutrazox,
SX + metconazole + azoxystrobin + sedaxane + thiabendazole + metalaxyl M,
SX + metconazole + azoxystrobin + sedaxane + thiabendazole + picarbutrazox,
SX + metconazole + azoxystrobin + sedaxane + thiuram + metalaxyl M,
SX + metconazole + azoxystrobin + sedaxane + thiuram + picarbutrazox,
SX + metconazole + azoxystrobin + sedaxane + tolcrofosmethyl + metalaxyl M,
SX + metconazole + azoxystrobin + sedaxane + tolcrofosmethyl + picalbutrazox,
SX + metconazole + azoxystrobin + sedaxane + boscalid + metalaxyl M,
SX + metconazole + azoxystrobin + sedaxane + boscalid + picarubutrazox,
SX + metconazole + azoxystrobin + sedaxane + aminopyrifen + metalaxyl M,
SX + metconazole + azoxystrobin + sedaxane + aminopyrifen + picarbutrazox,
SX + metconazole + azoxystrobin + sedaxane + mancozeb + metalaxyl M,
SX + metconazole + azoxystrobin + sedaxane + mancozeb + picarbutrazox,
SX + metconazole + azoxystrobin + sedaxane + carbendazim + metalaxyl M,
SX + metconazole + azoxystrobin + sedaxane + carbendazim + picarbutrazox,
SX + metconazole + azoxystrobin + pidiflumethophene + fludioxonil + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethophen + fludioxonil + picalbutrazox,
SX + metconazole + azoxystrobin + pidiflumethophene + thiophanate methyl + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethophene + thiophanate methyl + picalbutrazox,
SX + metconazole + azoxystrobin + pidiflumethophene + thiabendazole + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethophene + thiabendazole + picalbutrazoz,
SX + metconazole + azoxystrobin + pidiflumethophene + thiuram + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethophene + thiuram + picalbutrazox,
SX + metconazole + azoxystrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethophene + tolcrofosmethyl + picalbutrazoz,
SX + metconazole + azoxystrobin + pidiflumethophene + boscalid + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethophene + boscalid + picarbutrazox,
SX + metconazole + azoxystrobin + pidiflumethophene + aminopyrifen + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethofene + aminopyrifen + picalbutrazox,
SX + metconazole + azoxystrobin + pidiflumethophene + mancozeb + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethophene + mancozeb + pical butrazox,
SX + metconazole + azoxystrobin + pidiflumethofene + carbendazim + metalaxyl M,
SX + metconazole + azoxystrobin + pidiflumethophene + carbendazim + picalbutrazoz,
SX + metconazole + azoxystrobin + isoflucipram + fludioxonil + metalaxyl M,
SX + metconazole + azoxystrobin + isoflucipram + fludioxonil + picalbutrazox,
SX + metconazole + azoxystrobin + isoflucipram + thiophanate methyl + metalaxyl M,
SX + metconazole + azoxystrobin + isoflucipram + thiophanate methyl + picalbutrazox,
SX + metconazole + azoxystrobin + isoflucipram + thiabendazole + metalaxyl M,
SX + metconazole + azoxystrobin + isoflucipram + thiabendazole + picalbutrazox,
SX + metconazole + azoxystrobin + isoflucipram + thiuram + metalaxyl M,
SX + metconazole + azoxystrobin + isoflucipram + thiuram + picarbutrazox,
SX + metconazole + azoxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + azoxystrobin + isoflucipram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + azoxystrobin + isoflucipram + boscalid + metalaxyl M,
SX + metconazole + azoxystrobin + isoflucipram + boscalid + picarbutrazox,
SX + metconazole + azoxystrobin + isoflucipram + aminopyrifen + metalaxyl M,
SX + metconazole + azoxystrobin + isoflucipram + aminopyrifen + picalbutrazox,
SX + metconazole + azoxystrobin + isoflucipram + mancozeb + metalaxyl M,
SX + metconazole + azoxystrobin + isoflucipram + mancozeb + pical butrazox,
SX + metconazole + azoxystrobin + isoflucipram + carbendazim + metalaxyl M,
SX + metconazole + azoxystrobin + isoflucipram + carbendazim + picalbutrazox,
SX + metconazole + fluoxastrobin + fluopyram + fludioxonil + metalaxyl M,
SX + metconazole + fluoxastrobin + fluopyram + fludioxonil + picalbutrazox,
SX + metconazole + fluoxastrobin + fluopyram + thiophanate methyl + metalaxyl M,
SX + metconazole + fluoxastrobin + fluopyram + thiophanate methyl + picarbutrazox,
SX + metconazole + fluoxastrobin + fluopyram + thiabendazole + metalaxyl M,
SX + metconazole + fluoxastrobin + fluopyram + thiabendazole + picarbutrazox,
SX + metconazole + fluoxastrobin + fluopyram + thiuram + metalaxyl M,
SX + metconazole + fluoxastrobin + fluopyram + thiuram + picarbutrazox,
SX + metconazole + fluoxastrobin + fluopyram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + fluoxastrobin + fluopyram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + fluoxastrobin + fluopyram + boscalid + metalaxyl M,
SX + metconazole + fluoxastrobin + fluopyram + boscalid + picarbutrazox,
SX + metconazole + fluoxastrobin + fluopyram + aminopyrifen + metalaxyl M,
SX + metconazole + fluoxastrobin + fluopyram + aminopyrifen + picalbutrazox,
SX + metconazole + fluoxastrobin + fluopyram + mancozeb + metalaxyl M,
SX + metconazole + fluoxastrobin + fluopyram + mancozeb + picalbutrazox,
SX + metconazole + fluoxastrobin + fluopyram + carbendazim + metalaxyl M,
SX + metconazole + fluoxastrobin + fluopyram + carbendazim + picarbutrazox,
SX + metconazole + floxastrobin + floxapyroxad + fludioxonil + metalaxyl M,
SX + metconazole + floxastrobin + floxapyroxad + fludioxonil + picalbutrazox,
SX + metconazole + floxastrobin + floxapyroxad + thiophanate methyl + metalaxyl M,
SX + metconazole + floxastrobin + floxapyroxad + thiophanate methyl + picalbutrazox,
SX + metconazole + floxastrobin + floxapyroxad + thiabendazole + metalaxyl M,
SX + metconazole + floxastrobin + floxapyroxad + thiabendazole + picalbutrazox,
SX + metconazole + floxastrobin + floxapyroxad + thiuram + metalaxyl M,
SX + metconazole + floxastrobin + floxapyroxad + thiuram + picarbutrazox,
SX + metconazole + floxastrobin + floxapyroxad + tolcrofosmethyl + metalaxyl M,
SX + metconazole + floxastrobin + floxapyroxad + tolcrofosmethyl + picalbutrazox,
SX + metconazole + floxastrobin + floxapyroxad + boscalid + metalaxyl M,
SX + metconazole + floxastrobin + floxapyroxad + boscalid + picarbutrazox,
SX + Metoconazole + Fluoxastrobin + Floxapyroxad + Aminopyrifen + Metalaxyl M,
SX + metconazole + floxastrobin + floxapyroxad + aminopyrifen + picalbutrazox,
SX + metconazole + floxastrobin + floxapyroxad + mancozeb + metalaxyl M,
SX + metconazole + floxastrobin + floxapyroxad + mancozeb + picarbutrazox,
SX + metconazole + floxastrobin + floxapyroxad + carbendazim + metalaxyl M,
SX + metconazole + floxastrobin + floxapyroxad + carbendazim + picalbutrazox,
SX + metconazole + fluoxastrobin + boscalid + fludioxonil + metalaxyl M,
SX + metconazole + fluoxastrobin + boscalid + fludioxonil + picarbutrazox,
SX + metconazole + fluoxastrobin + boscalid + thiophanate methyl + metalaxyl M,
SX + metconazole + fluoxastrobin + boscalid + thiophanate methyl + picarbutrazox,
SX + metconazole + fluoxastrobin + boscalid + thiabendazole + metalaxyl M,
SX + metconazole + fluoxastrobin + boscalid + thiabendazole + picarbutrazox,
SX + metconazole + fluoxastrobin + boscalid + thiuram + metalaxyl M,
SX + metconazole + fluoxastrobin + boscalid + thiuram + picarbutrazox,
SX + metconazole + fluoxastrobin + boscalid + tolcrofosmethyl + metalaxyl M,
SX + metconazole + floxastrobin + boscalid + tolcrofosmethyl + picalbutrazox,
SX + metconazole + fluoxastrobin + boscalid + boscalid + metalaxyl M,
SX + metconazole + fluoxastrobin + boscalid + boscalid + picarbutrazox,
SX + metconazole + fluoxastrobin + boscalid + aminopyrifen + metalaxyl M,
SX + metconazole + floxastrobin + boscalid + aminopyrifen + picalbutrazox,
SX + metconazole + fluoxastrobin + boscalid + mancozeb + metalaxyl M,
SX + metconazole + floxastrobin + boscalid + mancozeb + picarbutrazox,
SX + metconazole + fluoxastrobin + boscalid + carbendazim + metalaxyl M,
SX + metconazole + fluoxastrobin + boscalid + carbendazim + picarbutrazox,
SX + metconazole + fluoxastrobin + penflufen + fludioxonil + metalaxyl M,
SX + metconazole + fluoxastrobin + penflufen + fludioxonil + picalbutrazox,
SX + metconazole + fluoxastrobin + penflufen + thiophanate methyl + metalaxyl M,
SX + metconazole + fluoxastrobin + penflufen + thiophanate methyl + picarbutrazox,
SX + metconazole + fluoxastrobin + penflufen + thiabendazole + metalaxyl M,
SX + metconazole + fluoxastrobin + penflufen + thiabendazole + picarbutrazox,
SX + metconazole + fluoxastrobin + penflufen + thiuram + metalaxyl M,
SX + metconazole + fluoxastrobin + penflufen + thiuram + picarbutrazox,
SX + metconazole + fluoxastrobin + penflufen + tolcrofosmethyl + metalaxyl M,
SX + metconazole + fluoxastrobin + penflufen + tolcrofosmethyl + picalbutrazox,
SX + metconazole + fluoxastrobin + penflufen + boscalid + metalaxyl M,
SX + metconazole + fluoxastrobin + penflufen + boscalid + picarbutrazox,
SX + metconazole + fluoxastrobin + penflufen + aminopyrifen + metalaxyl M,
SX + metconazole + fluoxastrobin + penflufen + aminopyrifen + picalbutrazox,
SX + metconazole + fluoxastrobin + penflufen + mancozeb + metalaxyl M,
SX + metconazole + fluoxastrobin + penflufen + mancozeb + picarbutrazox,
SX + metconazole + fluoxastrobin + penflufen + carbendazim + metalaxyl M,
SX + metconazole + fluoxastrobin + penflufen + carbendazim + picarbutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + fludioxonil + metalaxyl M,
SX + metconazole + fluoxastrobin + tifluzamide + fludioxonil + picalbutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + thiophanate methyl + metalaxyl M,
SX + metconazole + fluoxastrobin + tifluzamide + thiophanate methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + thiabendazole + metalaxyl M,
SX + metconazole + fluoxastrobin + tifluzamide + thiabendazole + picalbutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + thiuram + metalaxyl M,
SX + metconazole + fluoxastrobin + tifluzamide + thiuram + picarbutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + tolcrofosmethyl + metalaxyl M,
SX + metconazole + fluoxastrobin + tifluzamide + tolcrofosmethyl + picalbutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + boscalid + metalaxyl M,
SX + metconazole + fluoxastrobin + tifluzamide + boscalid + picarbutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + aminopyrifen + metalaxyl M,
SX + metconazole + fluoxastrobin + tifluzamide + aminopyrifen + picalbutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + mancozeb + metalaxyl M,
SX + metconazole + fluoxastrobin + tifluzamide + mancozeb + picarbutrazox,
SX + metconazole + fluoxastrobin + tifluzamide + carbendazim + metalaxyl M,
SX + metconazole + fluoxastrobin + tifluzamide + carbendazim + picarbutrazox,
SX + metconazole + fluoxastrobin + impylfluxam + fludioxonil + metalaxyl M,
SX + metconazole + fluoxastrobin + impylfluxam + fludioxonil + picalbutrazox,
SX + metconazole + fluoxastrobin + impylfluxam + thiophanate methyl + metalaxyl M,
SX + metconazole + fluoxastrobin + impylfluxam + thiophanate methyl + picarbutrazox,
SX + metconazole + fluoxastrobin + impylfluxam + thiabendazole + metalaxyl M,
SX + metconazole + fluoxastrobin + impylfluxam + thiabendazole + picarbutrazox,
SX + metconazole + fluoxastrobin + impylfluxam + thiuram + metalaxyl M,
SX + metconazole + fluoxastrobin + impylfluxam + thiuram + picarbutrazox,
SX + metconazole + fluoxastrobin + impylfluxam + tolcrofosmethyl + metalaxyl M,
SX + metconazole + fluoxastrobin + impylfluxam + tolcrofosmethyl + picalbutrazox,
SX + metconazole + fluoxastrobin + impylfluxam + boscalid + metalaxyl M,
SX + metconazole + fluoxastrobin + impylfluxam + boscalid + picarbutrazox,
SX + metconazole + fluoxastrobin + impylfluxam + aminopyrifen + metalaxyl M,
SX + metconazole + floxastrobin + impylfluxam + aminopyrifen + picarbutrazox,
SX + metconazole + fluoxastrobin + impylfluxam + mancozeb + metalaxyl M,
SX + metconazole + fluoxastrobin + impylfluxam + mancozeb + picarbutrazox,
SX + metconazole + fluoxastrobin + impylfluxam + carbendazim + metalaxyl M,
SX + metconazole + fluoxastrobin + impylfluxam + carbendazim + picarbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + fludioxonil + metalaxyl M,
SX + metconazole + fluoxastrobin + sedaxane + fludioxonil + picalbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + thiophanate methyl + metalaxyl M,
SX + metconazole + fluoxastrobin + sedaxane + thiophanate methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + thiabendazole + metalaxyl M,
SX + metconazole + fluoxastrobin + sedaxane + thiabendazole + picalbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + thiuram + metalaxyl M,
SX + metconazole + fluoxastrobin + sedaxane + thiuram + picarbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + tolcrofosmethyl + metalaxyl M,
SX + metconazole + fluoxastrobin + sedaxane + tolcrofosmethyl + picalbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + boscalid + metalaxyl M,
SX + metconazole + fluoxastrobin + sedaxane + boscalid + picarbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + aminopyrifen + metalaxyl M,
SX + metconazole + floxastrobin + sedaxane + aminopyrifen + picalbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + mancozeb + metalaxyl M,
SX + metconazole + fluoxastrobin + sedaxane + mancozeb + picarbutrazox,
SX + metconazole + fluoxastrobin + sedaxane + carbendazim + metalaxyl M,
SX + metconazole + fluoxastrobin + sedaxane + carbendazim + picalbutrazox,
SX + Metoconazole + Fluoxastrobin + Pidiflumethophene + Fludioxonil + Metalaxyl M,
SX + Metoconazole + Fluoxastrobin + Pidiflumethophene + Fludioxonil + Picalbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiophanate methyl + metalaxyl M,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiophanate methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethofene + thiabendazole + metalaxyl M,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiabendazole + picalbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethofene + thiuram + metalaxyl M,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiuram + picarbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl M,
SX + metconazole + fluoxastrobin + pidiflumethofene + tolcrofosmethyl + picalbutrazox,
SX + metconazole + fluoxastrobin + pidiflumethofene + boscalid + metalaxyl M,
SX + metconazole + fluoxastrobin + pidiflumethophene + boscalid + picarbutrazox,
SX + Metoconazole + Fluoxastrobin + Pidiflumethophene + Aminopyrifen + Metalaxyl M,
SX + metconazole + floxastrobin + pidiflumethophene + aminopyrifen + picalbutrazox,
SX + Metoconazole + Fluoxastrobin + Pidiflumethophene + Mancozeb + Metalaxyl M,
SX + Metoconazole + Fluoxastrobin + Pidiflumethophene + Mancozeb + Picalbutrazox,
SX + Metoconazole + Fluoxastrobin + Pidiflumethophene + Carbendazim + Metalaxyl M,
SX + metconazole + fluoxastrobin + pidiflumethophene + carbendazim + picalbutrazox,
SX + metconazole + fluoxastrobin + isoflucipram + fludioxonil + metalaxyl M,
SX + metconazole + fluoxastrobin + isoflucipram + fludioxonil + picalbutrazox,
SX + metconazole + fluoxastrobin + isoflucipram + thiophanate methyl + metalaxyl M,
SX + metconazole + fluoxastrobin + isoflucipram + thiophanate methyl + picalbutrazox,
SX + metconazole + fluoxastrobin + isoflucipram + thiabendazole + metalaxyl M,
SX + metconazole + fluoxastrobin + isoflucipram + thiabendazole + picarbutrazox,
SX + metconazole + fluoxastrobin + isoflucipram + thiuram + metalaxyl M,
SX + metconazole + fluoxastrobin + isoflucipram + thiuram + picarbutrazox,
SX + metconazole + fluoxastrobin + isoflucipram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + fluoxastrobin + isoflucipram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + fluoxastrobin + isoflucipram + boscalid + metalaxyl M,
SX + metconazole + fluoxastrobin + isoflucipram + boscalid + picarbutrazox,
SX + metconazole + fluoxastrobin + isoflucipram + aminopyrifen + metalaxyl M,
SX + metconazole + fluoxastrobin + isoflucipram + aminopyrifen + picalbutrazox,
SX + Metoconazole + Fluoxastrobin + Isoflusipram + Mancozeb + Metalaxyl M,
SX + Metoconazole + Fluoxastrobin + Isoflusipram + Mancozeb + Picalbutrazox,
SX + metconazole + fluoxastrobin + isoflucipram + carbendazim + metalaxyl M,
SX + metconazole + fluoxastrobin + isoflucipram + carbendazim + picalbutrazox,
SX + metconazole + trifloxystrobin + fluopyram + fludioxonil + metalaxyl M,
SX + metconazole + trifloxystrobin + fluopyram + fludioxonil + picalbutrazox,
SX + metconazole + trifloxystrobin + fluopyram + thiophanate methyl + metalaxyl M,
SX + metconazole + trifloxystrobin + fluopyram + thiophanate methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + fluopyram + thiabendazole + metalaxyl M,
SX + metconazole + trifloxystrobin + fluopyram + thiabendazole + picalbutrazox,
SX + metconazole + trifloxystrobin + fluopyram + thiuram + metalaxyl M,
SX + metconazole + trifloxystrobin + fluopyram + thiuram + picarbutrazox,
SX + metconazole + trifloxystrobin + fluopyram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + trifloxystrobin + fluopyram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + trifloxystrobin + fluopyram + boscalid + metalaxyl M,
SX + metconazole + trifloxystrobin + fluopyram + boscalid + picarbutrazox,
SX + metconazole + trifloxystrobin + fluopyram + aminopyrifen + metalaxyl M,
SX + metconazole + trifloxystrobin + fluopyram + aminopyrifen + picarbutrazox,
SX + metconazole + trifloxystrobin + fluopyram + mancozeb + metalaxyl M,
SX + metconazole + trifloxystrobin + fluopyram + mancozeb + picarbutrazox,
SX + metconazole + trifloxystrobin + fluopyram + carbendazim + metalaxyl M,
SX + metconazole + trifloxystrobin + fluopyram + carbendazim + picarbutrazox,
SX + metconazole + trifloxystrobin + floxapyroxad + fludioxonil + metalaxyl M,
SX + metconazole + trifloxystrobin + floxapyroxad + fludioxonil + picalbutrazox,
SX + metconazole + trifloxystrobin + floxapyroxad + thiophanate methyl + metalaxyl M,
SX + metconazole + trifloxystrobin + floxapyroxad + thiophanate methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + floxapyroxad + thiabendazole + metalaxyl M,
SX + metconazole + trifloxystrobin + floxapyroxad + thiabendazole + picalbutrazox,
SX + metconazole + trifloxystrobin + floxapyroxad + thiuram + metalaxyl M,
SX + metconazole + trifloxystrobin + floxapyroxad + thiuram + picarbutrazox,
SX + metconazole + trifloxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl M,
SX + metconazole + trifloxystrobin + floxapyroxad + tolcrofosmethyl + picalbutrazox,
SX + metconazole + trifloxystrobin + floxapyroxad + boscalid + metalaxyl M,
SX + metconazole + trifloxystrobin + floxapyroxad + boscalid + picalbutrazox,
SX + metconazole + trifloxystrobin + floxapyroxad + aminopyrifen + metalaxyl M,
SX + metconazole + trifloxystrobin + floxapyroxad + aminopyrifen + picalbutrazox,
SX + metconazole + trifloxystrobin + floxapyroxad + mancozeb + metalaxyl M,
SX + metconazole + trifloxystrobin + floxapyroxad + mancozeb + picarbutrazox,
SX + metconazole + trifloxystrobin + floxapyroxad + carbendazim + metalaxyl M,
SX + metconazole + trifloxystrobin + floxapyroxad + carbendazim + picalbutrazox,
SX + metconazole + trifloxystrobin + boscalid + fludioxonil + metalaxyl M,
SX + metconazole + trifloxystrobin + boscalid + fludioxonil + picarbutrazox,
SX + metconazole + trifloxystrobin + boscalid + thiophanate methyl + metalaxyl M,
SX + metconazole + trifloxystrobin + boscalid + thiophanate methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + boscalid + thiabendazole + metalaxyl M,
SX + metconazole + trifloxystrobin + boscalid + thiabendazole + picalbutrazox,
SX + metconazole + trifloxystrobin + boscalid + thiuram + metalaxyl M,
SX + metconazole + trifloxystrobin + boscalid + thiuram + picarbutrazox,
SX + metconazole + trifloxystrobin + boscalid + tolcrofosmethyl + metalaxyl M,
SX + metconazole + trifloxystrobin + boscalid + tolcrofosmethyl + picalbutrazox,
SX + metconazole + trifloxystrobin + boscalid + boscalid + metalaxyl M,
SX + metconazole + trifloxystrobin + boscalid + boscalid + picarbutrazox,
SX + metconazole + trifloxystrobin + boscalid + aminopyrifen + metalaxyl M,
SX + metconazole + trifloxystrobin + boscalid + aminopyrifen + picalbutrazox,
SX + metconazole + trifloxystrobin + boscalid + mancozeb + metalaxyl M,
SX + metconazole + trifloxystrobin + boscalid + mancozeb + picarbutrazox,
SX + metconazole + trifloxystrobin + boscalid + carbendazim + metalaxyl M,
SX + metconazole + trifloxystrobin + boscalid + carbendazim + picarbutrazox,
SX + metconazole + trifloxystrobin + penflufen + fludioxonil + metalaxyl M,
SX + metconazole + trifloxystrobin + penflufen + fludioxonil + picalbutrazox,
SX + metconazole + trifloxystrobin + penflufen + thiophanate methyl + metalaxyl M,
SX + metconazole + trifloxystrobin + penflufen + thiophanate methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + penflufen + thiabendazole + metalaxyl M,
SX + metconazole + trifloxystrobin + penflufen + thiabendazole + picarbutrazox,
SX + metconazole + trifloxystrobin + penflufen + thiuram + metalaxyl M,
SX + metconazole + trifloxystrobin + penflufen + thiuram + picarbutrazox,
SX + metconazole + trifloxystrobin + penflufen + tolcrofosmethyl + metalaxyl M,
SX + metconazole + trifloxystrobin + penflufen + tolcrofosmethyl + picalbutrazox,
SX + metconazole + trifloxystrobin + penflufen + boscalid + metalaxyl M,
SX + metconazole + trifloxystrobin + penflufen + boscalid + picarbutrazox,
SX + metconazole + trifloxystrobin + penflufen + aminopyrifen + metalaxyl M,
SX + metconazole + trifloxystrobin + penflufen + aminopyrifen + picarbutrazox,
SX + metconazole + trifloxystrobin + penflufen + mancozeb + metalaxyl M,
SX + metconazole + trifloxystrobin + penflufen + mancozeb + picarbutrazox,
SX + metconazole + trifloxystrobin + penflufen + carbendazim + metalaxyl M,
SX + metconazole + trifloxystrobin + penflufen + carbendazim + picarbutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + fludioxonil + metalaxyl M,
SX + metconazole + trifloxystrobin + tifluzamide + fludioxonil + picalbutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + thiophanate methyl + metalaxyl M,
SX + metconazole + trifloxystrobin + tifluzamide + thiophanate methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + thiabendazole + metalaxyl M,
SX + metconazole + trifloxystrobin + tifluzamide + thiabendazole + picalbutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + thiuram + metalaxyl M,
SX + metconazole + trifloxystrobin + tifluzamide + thiuram + picarbutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl M,
SX + metconazole + trifloxystrobin + tifluzamide + tolcrofosmethyl + picalbutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + boscalid + metalaxyl M,
SX + metconazole + trifloxystrobin + tifluzamide + boscalid + picarbutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + aminopyrifen + metalaxyl M,
SX + metconazole + trifloxystrobin + tifluzamide + aminopyrifen + picalbutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + mancozeb + metalaxyl M,
SX + metconazole + trifloxystrobin + tifluzamide + mancozeb + picarbutrazox,
SX + metconazole + trifloxystrobin + tifluzamide + carbendazim + metalaxyl M,
SX + metconazole + trifloxystrobin + tifluzamide + carbendazim + picalbutrazox,
SX + metconazole + trifloxystrobin + impylfluxam + fludioxonil + metalaxyl M,
SX + metconazole + trifloxystrobin + impylfluxam + fludioxonil + picalbutrazox,
SX + metconazole + trifloxystrobin + impylfluxam + thiophanate methyl + metalaxyl M,
SX + metconazole + trifloxystrobin + impylfluxam + thiophanate methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + impylfluxam + thiabendazole + metalaxyl M,
SX + metconazole + trifloxystrobin + impylfluxam + thiabendazole + picarbutrazox,
SX + metconazole + trifloxystrobin + impylfluxam + thiuram + metalaxyl M,
SX + metconazole + trifloxystrobin + impylfluxam + thiuram + picarbutrazoz,
SX + metconazole + trifloxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl M,
SX + metconazole + trifloxystrobin + impylfluxam + tolcrofosmethyl + picalbutrazox,
SX + metconazole + trifloxystrobin + impylfluxam + boscalid + metalaxyl M,
SX + metconazole + trifloxystrobin + impylfluxam + boscalid + picarbutrazox,
SX + metconazole + trifloxystrobin + impylfluxam + aminopyrifen + metalaxyl M,
SX + metconazole + trifloxystrobin + impylfluxam + aminopyrifen + picalbutrazox,
SX + metconazole + trifloxystrobin + impylfluxam + mancozeb + metalaxyl M,
SX + metconazole + trifloxystrobin + impylfluxam + mancozeb + pical butrazoz,
SX + metconazole + trifloxystrobin + impylfluxam + carbendazim + metalaxyl M,
SX + metconazole + trifloxystrobin + impylfluxam + carbendazim + picarbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + fludioxonil + metalaxyl M,
SX + metconazole + trifloxystrobin + sedaxane + fludioxonil + picalbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + thiophanate methyl + metalaxyl M,
SX + metconazole + trifloxystrobin + sedaxane + thiophanate methyl + picarbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + thiabendazole + metalaxyl M,
SX + metconazole + trifloxystrobin + sedaxane + thiabendazole + picarbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + thiuram + metalaxyl M,
SX + metconazole + trifloxystrobin + sedaxane + thiuram + picarbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + tolcrofosmethyl + metalaxyl M,
SX + metconazole + trifloxystrobin + sedaxane + tolcrofosmethyl + picalbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + boscalid + metalaxyl M,
SX + metconazole + trifloxystrobin + sedaxane + boscalid + picarbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + aminopyrifen + metalaxyl M,
SX + metconazole + trifloxystrobin + sedaxane + aminopyrifen + picalbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + mancozeb + metalaxyl M,
SX + metconazole + trifloxystrobin + sedaxane + mancozeb + picarbutrazox,
SX + metconazole + trifloxystrobin + sedaxane + carbendazim + metalaxyl M,
SX + metconazole + trifloxystrobin + sedaxane + carbendazim + picarbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethofene + fludioxonil + metalaxyl M,
SX + metconazole + trifloxystrobin + pidiflumethophene + fludioxonil + picalbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiophanate methyl + metalaxyl M,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiophanate methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethophene + thiabendazole + metalaxyl M,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiabendazole + picalbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethophene + thiuram + metalaxyl M,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiuram + picarbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl M,
SX + metconazole + trifloxystrobin + pidiflumethophene + tolcrofosmethyl + picalbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethofene + boscalid + metalaxyl M,
SX + metconazole + trifloxystrobin + pidiflumethofene + boscalid + picarbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethofene + aminopyrifen + metalaxyl M,
SX + metconazole + trifloxystrobin + pidiflumethofene + aminopyrifen + picalbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethofene + mancozeb + metalaxyl M,
SX + metconazole + trifloxystrobin + pidiflumethofene + mancozeb + picalbutrazox,
SX + metconazole + trifloxystrobin + pidiflumethofene + carbendazim + metalaxyl M,
SX + metconazole + trifloxystrobin + pidiflumethofene + carbendazim + picalbutrazoz,
SX + metconazole + trifloxystrobin + isoflucipram + fludioxonil + metalaxyl M,
SX + metconazole + trifloxystrobin + isoflucipram + fludioxonil + picalbutrazox,
SX + metconazole + trifloxystrobin + isoflucipram + thiophanate methyl + metalaxyl M,
SX + metconazole + trifloxystrobin + isoflucipram + thiophanate methyl + picalbutrazox,
SX + metconazole + trifloxystrobin + isoflucipram + thiabendazole + metalaxyl M,
SX + metconazole + trifloxystrobin + isoflucipram + thiabendazole + picalbutrazox,
SX + metconazole + trifloxystrobin + isoflucipram + thiuram + metalaxyl M,
SX + metconazole + trifloxystrobin + isoflucipram + thiuram + picarbutrazox,
SX + metconazole + trifloxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + trifloxystrobin + isoflucipram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + trifloxystrobin + isoflucipram + boscalid + metalaxyl M,
SX + metconazole + trifloxystrobin + isoflucipram + boscalid + picarbutrazox,
SX + metconazole + trifloxystrobin + isoflucipram + aminopyrifen + metalaxyl M,
SX + metconazole + trifloxystrobin + isoflucipram + aminopyrifen + picalbutrazox,
SX + metconazole + trifloxystrobin + isoflucipram + mancozeb + metalaxyl M,
SX + metconazole + trifloxystrobin + isoflucipram + mancozeb + picarbutrazox,
SX + metconazole + trifloxystrobin + isoflucipram + carbendazim + metalaxyl M,
SX + metconazole + trifloxystrobin + isoflucipram + carbendazim + picalbutrazox,
SX + metconazole + pyraclostrobin + fluopyram + fludioxonil + metalaxyl M,
SX + metconazole + pyraclostrobin + fluopyram + fludioxonil + picalbutrazox,
SX + metconazole + pyraclostrobin + fluopyram + thiophanate methyl + metalaxyl M,
SX + metconazole + pyraclostrobin + fluopyram + thiophanate methyl + picarbutrazox,
SX + metconazole + pyraclostrobin + fluopyram + thiabendazole + metalaxyl M,
SX + metconazole + pyraclostrobin + fluopyram + thiabendazole + picalbutrazox,
SX + metconazole + pyraclostrobin + fluopyram + thiuram + metalaxyl M,
SX + metconazole + pyraclostrobin + fluopyram + thiuram + picarbutrazox,
SX + metconazole + pyraclostrobin + fluopyram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + pyraclostrobin + fluopyram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + pyraclostrobin + fluopyram + boscalid + metalaxyl M,
SX + metconazole + pyraclostrobin + fluopyram + boscalid + picarbutrazox,
SX + metconazole + pyraclostrobin + fluopyram + aminopyrifen + metalaxyl M,
SX + metconazole + pyraclostrobin + fluopyram + aminopyrifen + picalbutrazox,
SX + metconazole + pyraclostrobin + fluopyram + mancozeb + metalaxyl M,
SX + metconazole + pyraclostrobin + fluopyram + mancozeb + picarbutrazox,
SX + metconazole + pyraclostrobin + fluopyram + carbendazim + metalaxyl M,
SX + metconazole + pyraclostrobin + fluopyram + carbendazim + picarbutrazox,
SX + metconazole + pyraclostrobin + floxapyroxad + fludioxonil + metalaxyl M,
SX + metconazole + pyraclostrobin + floxapyroxad + fludioxonil + picalbutrazox,
SX + metconazole + pyraclostrobin + floxapyroxad + thiophanate methyl + metalaxyl M,
SX + metconazole + pyraclostrobin + floxapyroxad + thiophanate methyl + picalbutrazox,
SX + metconazole + pyraclostrobin + floxapyroxad + thiabendazole + metalaxyl M,
SX + metconazole + pyraclostrobin + floxapyroxad + thiabendazole + picalbutrazox,
SX + metconazole + pyraclostrobin + floxapyroxad + thiuram + metalaxyl M,
SX + metconazole + pyraclostrobin + floxapyroxad + thiuram + picarbutrazox,
SX + metconazole + pyraclostrobin + floxapyroxad + tolcrofosmethyl + metalaxyl M,
SX + metconazole + pyraclostrobin + floxapyroxad + tolcrofosmethyl + picalbutrazox,
SX + metconazole + pyraclostrobin + floxapyroxad + boscalid + metalaxyl M,
SX + metconazole + pyraclostrobin + floxapyroxad + boscalid + picarbutrazox,
SX + metconazole + pyraclostrobin + floxapyroxad + aminopyrifen + metalaxyl M,
SX + metconazole + pyraclostrobin + floxapyroxad + aminopyrifen + picalbutrazox,
SX + metconazole + pyraclostrobin + floxapyroxad + mancozeb + metalaxyl M,
SX + metconazole + pyraclostrobin + floxapyroxad + mancozeb + pical butrazoz,
SX + metconazole + pyraclostrobin + floxapyroxad + carbendazim + metalaxyl M,
SX + metconazole + pyraclostrobin + floxapyroxad + carbendazim + picarbutrazox,
SX + metconazole + pyraclostrobin + boscalid + fludioxonil + metalaxyl M,
SX + metconazole + pyraclostrobin + boscalid + fludioxonil + picarbutrazox,
SX + metconazole + pyraclostrobin + boscalid + thiophanate methyl + metalaxyl M,
SX + metconazole + pyraclostrobin + boscalid + thiophanate methyl + picalbutrazox,
SX + metconazole + pyraclostrobin + boscalid + thiabendazole + metalaxyl M,
SX + metconazole + pyraclostrobin + boscalid + thiabendazole + picarbutrazox,
SX + metconazole + pyraclostrobin + boscalid + thiuram + metalaxyl M,
SX + metconazole + pyraclostrobin + boscalid + thiuram + picarbutrazox,
SX + metconazole + pyraclostrobin + boscalid + tolcrofosmethyl + metalaxyl M,
SX + metconazole + pyraclostrobin + boscalid + tolcrofosmethyl + picalbutrazox,
SX + metconazole + pyraclostrobin + boscalid + boscalid + metalaxyl M,
SX + metconazole + pyraclostrobin + boscalid + boscalid + picarbutrazox,
SX + metconazole + pyraclostrobin + boscalid + aminopyrifen + metalaxyl M,
SX + metconazole + pyraclostrobin + boscalid + aminopyrifen + picarbutrazox,
SX + metconazole + pyraclostrobin + boscalid + mancozeb + metalaxyl M,
SX + metconazole + pyraclostrobin + boscalid + mancozeb + picarbutrazox,
SX + metconazole + pyraclostrobin + boscalid + carbendazim + metalaxyl M,
SX + metconazole + pyraclostrobin + boscalid + carbendazim + picarbutrazox,
SX + metconazole + pyraclostrobin + penflufen + fludioxonil + metalaxyl M,
SX + metconazole + pyraclostrobin + penflufen + fludioxonil + picalbutrazox,
SX + metconazole + pyraclostrobin + penflufen + thiophanate methyl + metalaxyl M,
SX + metconazole + pyraclostrobin + penflufen + thiophanate methyl + picarbutrazox,
SX + metconazole + pyraclostrobin + penflufen + thiabendazole + metalaxyl M,
SX + metconazole + pyraclostrobin + penflufen + thiabendazole + picarbutrazox,
SX + metconazole + pyraclostrobin + penflufen + thiuram + metalaxyl M,
SX + metconazole + pyraclostrobin + penflufen + thiuram + picarbutrazox,
SX + metconazole + pyraclostrobin + penflufen + tolcrofosmethyl + metalaxyl M,
SX + metconazole + pyraclostrobin + penflufen + tolcrofosmethyl + picalbutrazox,
SX + metconazole + pyraclostrobin + penflufen + boscalid + metalaxyl M,
SX + metconazole + pyraclostrobin + penflufen + boscalid + picarbutrazox,
SX + metconazole + pyraclostrobin + penflufen + aminopyrifen + metalaxyl M,
SX + metconazole + pyraclostrobin + penflufen + aminopyrifen + picarbutrazox,
SX + metconazole + pyraclostrobin + penflufen + mancozeb + metalaxyl M,
SX + metconazole + pyraclostrobin + penflufen + mancozeb + picarbutrazox,
SX + metconazole + pyraclostrobin + penflufen + carbendazim + metalaxyl M,
SX + metconazole + pyraclostrobin + penflufen + carbendazim + picarbutrazox,
SX + metconazole + pyraclostrobin + tifluzamide + fludioxonil + metalaxyl M,
SX + metconazole + pyraclostrobin + tifluzamide + fludioxonil + picalbutrazox,
SX + metconazole + pyraclostrobin + tifluzamide + thiophanate methyl + metalaxyl M,
SX + metconazole + pyraclostrobin + tifluzamide + thiophanate methyl + picalbutrazox,
SX + metconazole + pyraclostrobin + tifluzamide + thiabendazole + metalaxyl M,
SX + metconazole + pyraclostrobin + tifluzamide + thiabendazole + picalbutrazox,
SX + metconazole + pyraclostrobin + tifluzamide + thiuram + metalaxyl M,
SX + metconazole + pyraclostrobin + tifluzamide + thiuram + picarbutrazox,
SX + metconazole + pyraclostrobin + tifluzamide + tolcrofosmethyl + metalaxyl M,
SX + metconazole + pyraclostrobin + tifluzamide + tolcrofosmethyl + picalbutrazox,
SX + metconazole + pyraclostrobin + tifluzamide + boscalid + metalaxyl M,
SX + metconazole + pyraclostrobin + tifluzamide + boscalid + picarbutrazox,
SX + metconazole + pyraclostrobin + tifluzamide + aminopyrifen + metalaxyl M,
SX + metconazole + pyraclostrobin + tifluzamide + aminopyrifen + picalbutrazox,
SX + metconazole + pyraclostrobin + tifluzamide + mancozeb + metalaxyl M,
SX + metconazole + pyraclostrobin + tifluzamide + mancozeb + pical butrazox,
SX + metconazole + pyraclostrobin + tifluzamide + carbendazim + metalaxyl M,
SX + metconazole + pyraclostrobin + tifluzamide + carbendazim + picarbutrazox,
SX + metconazole + pyraclostrobin + impylfluxam + fludioxonil + metalaxyl M,
SX + metconazole + pyraclostrobin + impylfluxam + fludioxonil + picarbutrazox,
SX + metconazole + pyraclostrobin + impylfluxam + thiophanate methyl + metalaxyl M,
SX + metconazole + pyraclostrobin + impylufluxam + thiophanate methyl + picalbutrazox,
SX + metconazole + pyraclostrobin + impylfluxam + thiabendazole + metalaxyl M,
SX + metconazole + pyraclostrobin + impylfluxam + thiabendazole + picarbutrazox,
SX + metconazole + pyraclostrobin + impylfluxam + thiuram + metalaxyl M,
SX + metconazole + pyraclostrobin + impylfluxam + thiuram + picarbutrazoz,
SX + metconazole + pyraclostrobin + impylfluxam + tolcrofosmethyl + metalaxyl M,
SX + metconazole + pyraclostrobin + impylfluxam + tolcrofosmethyl + picalbutrazoz,
SX + metconazole + pyraclostrobin + impylfluxam + boscalid + metalaxyl M,
SX + metconazole + pyraclostrobin + impylfluxam + boscalid + picarbutrazoz,
SX + metconazole + pyraclostrobin + impylfluxam + aminopyrifen + metalaxyl M,
SX + metconazole + pyraclostrobin + impylfluxam + aminopyrifen + picarbutrazox,
SX + metconazole + pyraclostrobin + impylfluxam + mancozeb + metalaxyl M,
SX + metconazole + pyraclostrobin + impylfluxam + mancozeb + picarbutrazoz,
SX + metconazole + pyraclostrobin + impylfluxam + carbendazim + metalaxyl M,
SX + metconazole + pyraclostrobin + impylfluxam + carbendazim + picarbutrazox,
SX + metconazole + pyraclostrobin + sedaxane + fludioxonil + metalaxyl M,
SX + metconazole + pyraclostrobin + sedaxane + fludioxonil + picalbutrazox,
SX + metconazole + pyraclostrobin + sedaxane + thiophanate methyl + metalaxyl M,
SX + metconazole + pyraclostrobin + sedaxane + thiophanate methyl + picalbutrazox,
SX + metconazole + pyraclostrobin + sedaxane + thiabendazole + metalaxyl M,
SX + metconazole + pyraclostrobin + sedaxane + thiabendazole + picarbutrazox,
SX + metconazole + pyraclostrobin + sedaxane + thiuram + metalaxyl M,
SX + metconazole + pyraclostrobin + sedaxane + thiuram + picarbutrazox,
SX + metconazole + pyraclostrobin + sedaxane + tolcrofosmethyl + metalaxyl M,
SX + metconazole + pyraclostrobin + sedaxane + tolcrofosmethyl + picalbutrazox,
SX + metconazole + pyraclostrobin + sedaxane + boscalid + metalaxyl M,
SX + metconazole + pyraclostrobin + sedaxane + boscalid + picarbutrazox,
SX + metconazole + pyraclostrobin + sedaxane + aminopyrifen + metalaxyl M,
SX + metconazole + pyraclostrobin + sedaxane + aminopyrifen + picalbutrazox,
SX + metconazole + pyraclostrobin + sedaxane + mancozeb + metalaxyl M,
SX + metconazole + pyraclostrobin + sedaxane + mancozeb + picarbutrazox,
SX + metconazole + pyraclostrobin + sedaxane + carbendazim + metalaxyl M,
SX + metconazole + pyraclostrobin + sedaxane + carbendazim + picarbutrazox,
SX + metconazole + pyraclostrobin + pidiflumethophene + fludioxonil + metalaxyl M,
SX + metconazole + pyraclostrobin + pidiflumethophene + fludioxonil + picalbutrazox,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiophanate methyl + metalaxyl M,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiophanate methyl + picalbutrazox,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiabendazole + metalaxyl M,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiabendazole + picalbutrazox,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiuram + metalaxyl M,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiuram + picarbutrazoz,
SX + metconazole + pyraclostrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl M,
SX + metconazole + pyraclostrobin + pidiflumethophene + tolcrofosmethyl + picalbutrazox,
SX + metconazole + pyraclostrobin + pidiflumethophene + boscalid + metalaxyl M,
SX + metconazole + pyraclostrobin + piziflumethofene + boscalid + picarbutrazox,
SX + metconazole + pyraclostrobin + pidiflumethophene + aminopyrifen + metalaxyl M,
SX + metconazole + pyraclostrobin + pidiflumethophene + aminopyrifen + picalbutrazox,
SX + metconazole + pyraclostrobin + pidiflumethophene + mancozeb + metalaxyl M,
SX + metconazole + pyraclostrobin + pidiflumethofen + mancozeb + picarbutrazox,
SX + metconazole + pyraclostrobin + pidiflumethophene + carbendazim + metalaxyl M,
SX + metconazole + pyraclostrobin + pidiflumethophene + carbendazim + pical butrazoz,
SX + metconazole + pyraclostrobin + isoflucipram + fludioxonil + metalaxyl M,
SX + metconazole + pyraclostrobin + isoflucipram + fludioxonil + picalbutrazox,
SX + metconazole + pyraclostrobin + isoflucipram + thiophanate methyl + metalaxyl M,
SX + metconazole + pyraclostrobin + isoflucipram + thiophanate methyl + picalbutrazox,
SX + metconazole + pyraclostrobin + isoflucipram + thiabendazole + metalaxyl M,
SX + metconazole + pyraclostrobin + isoflucipram + thiabendazole + picalbutrazox,
SX + metconazole + pyraclostrobin + isoflucipram + thiuram + metalaxyl M,
SX + metconazole + pyraclostrobin + isoflucipram + thiuram + picarbutrazox,
SX + metconazole + pyraclostrobin + isoflucipram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + pyraclostrobin + isoflucipram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + pyraclostrobin + isoflucipram + boscalid + metalaxyl M,
SX + metconazole + pyraclostrobin + isoflucipram + boscalid + picarbutrazox,
SX + metconazole + pyraclostrobin + isoflucipram + aminopyrifen + metalaxyl M,
SX + metconazole + pyraclostrobin + isoflucipram + aminopyrifen + picalbutrazox,
SX + metconazole + pyraclostrobin + isoflucipram + mancozeb + metalaxyl M,
SX + metconazole + pyraclostrobin + isoflucipram + mancozeb + pical butrazoz,
SX + metconazole + pyraclostrobin + isoflucipram + carbendazim + metalaxyl M,
SX + metconazole + pyraclostrobin + isoflucipram + carbendazim + picarbutrazox,
SX + metconazole + picoxystrobin + fluopyram + fludioxonil + metalaxyl M,
SX + metconazole + picoxystrobin + fluopyram + fludioxonil + picalbutrazox,
SX + metconazole + picoxystrobin + fluopyram + thiophanate methyl + metalaxyl M,
SX + metconazole + picoxystrobin + fluopyram + thiophanate methyl + picalbutrazox,
SX + metconazole + picoxystrobin + fluopyram + thiabendazole + metalaxyl M,
SX + metconazole + picoxystrobin + fluopyram + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + fluopyram + thiuram + metalaxyl M,
SX + metconazole + picoxystrobin + fluopyram + thiuram + picarbutrazox,
SX + metconazole + picoxystrobin + fluopyram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + fluopyram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + picoxystrobin + fluopyram + boscalid + metalaxyl M,
SX + metconazole + picoxystrobin + fluopyram + boscalid + picarbutrazox,
SX + metconazole + picoxystrobin + fluopyram + aminopyrifen + metalaxyl M,
SX + metconazole + picoxystrobin + fluopyram + aminopyrifen + picarbutrazox,
SX + metconazole + picoxystrobin + fluopyram + mancozeb + metalaxyl M,
SX + metconazole + picoxystrobin + fluopyram + mancozeb + picarbutrazox,
SX + metconazole + picoxystrobin + fluopyram + carbendazim + metalaxyl M,
SX + metconazole + picoxystrobin + fluopyram + carbendazim + picarbutrazox,
SX + metconazole + picoxystrobin + floxapyroxad + fludioxonil + metalaxyl M,
SX + metconazole + picoxystrobin + floxapyroxad + fludioxonil + picalbutrazox,
SX + metconazole + picoxystrobin + floxapyroxad + thiophanate methyl + metalaxyl M,
SX + metconazole + picoxystrobin + floxapyroxad + thiophanate methyl + picalbutrazox,
SX + metconazole + picoxystrobin + floxapyroxad + thiabendazole + metalaxyl M,
SX + metconazole + picoxystrobin + floxapyroxad + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + floxapyroxad + thiuram + metalaxyl M,
SX + metconazole + picoxystrobin + floxapyroxad + thiuram + picalbutrazox,
SX + metconazole + picoxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + floxapyroxado + tolcrofosmethyl + picalbutrazox,
SX + metconazole + picoxystrobin + floxapyroxad + boscalid + metalaxyl M,
SX + metconazole + picoxystrobin + floxapyroxad + boscalid + picalbutrazox,
SX + metconazole + picoxystrobin + floxapyroxad + aminopyrifen + metalaxyl M,
SX + metconazole + picoxystrobin + floxapyroxad + aminopyrifen + picalbutrazox,
SX + metconazole + picoxystrobin + floxapyroxad + mancozeb + metalaxyl M,
SX + metconazole + picoxystrobin + floxapyroxad + mancozeb + picalbutrazox,
SX + metconazole + picoxystrobin + floxapyroxad + carbendazim + metalaxyl M,
SX + metconazole + picoxystrobin + floxapyroxad + carbendazim + picalbutrazox,
SX + metconazole + picoxystrobin + boscalid + fludioxonil + metalaxyl M,
SX + metconazole + picoxystrobin + boscalid + fludioxonil + picalbutrazox,
SX + metconazole + picoxystrobin + boscalid + thiophanate methyl + metalaxyl M,
SX + metconazole + picoxystrobin + boscalid + thiophanate methyl + picalbutrazox,
SX + metconazole + picoxystrobin + boscalid + thiabendazole + metalaxyl M,
SX + metconazole + picoxystrobin + boscalid + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + boscalid + thiuram + metalaxyl M,
SX + metconazole + picoxystrobin + boscalid + thiuram + picarbutrazox,
SX + metconazole + picoxystrobin + boscalid + tolcrofosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + boscalid + tolcrofosmethyl + picalbutrazox,
SX + metconazole + picoxystrobin + boscalid + boscalid + metalaxyl M,
SX + metconazole + picoxystrobin + boscalid + boscalid + picarbutrazox,
SX + metconazole + picoxystrobin + boscalid + aminopyrifen + metalaxyl M,
SX + metconazole + picoxystrobin + boscalid + aminopyrifen + picalbutrazox,
SX + metconazole + picoxystrobin + boscalid + mancozeb + metalaxyl M,
SX + metconazole + picoxystrobin + boscalid + mancozeb + picarbutrazox,
SX + metconazole + picoxystrobin + boscalid + carbendazim + metalaxyl M,
SX + metconazole + picoxystrobin + boscalid + carbendazim + picalbutrazox,
SX + metconazole + picoxystrobin + penflufen + fludioxonil + metalaxyl M,
SX + metconazole + picoxystrobin + penflufen + fludioxonil + picalbutrazox,
SX + metconazole + picoxystrobin + penflufen + thiophanate methyl + metalaxyl M,
SX + metconazole + picoxystrobin + penflufen + thiophanate methyl + picalbutrazox,
SX + metconazole + picoxystrobin + penflufen + thiabendazole + metalaxyl M,
SX + metconazole + picoxystrobin + penflufen + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + penflufen + thiuram + metalaxyl M,
SX + metconazole + picoxystrobin + penflufen + thiuram + picarbutrazox,
SX + metconazole + picoxystrobin + penflufen + tolcrofosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + penflufen + tolcrofosmethyl + picalbutrazox,
SX + metconazole + picoxystrobin + penflufen + boscalid + metalaxyl M,
SX + metconazole + picoxystrobin + penflufen + boscalid + picarbutrazox,
SX + metconazole + picoxystrobin + penflufen + aminopyrifen + metalaxyl M,
SX + metconazole + picoxystrobin + penflufen + aminopyrifen + picalbutrazox,
SX + metconazole + picoxystrobin + penflufen + mancozeb + metalaxyl M,
SX + metconazole + picoxystrobin + penflufen + mancozeb + picarbutrazox,
SX + metconazole + picoxystrobin + penflufen + carbendazim + metalaxyl M,
SX + metconazole + picoxystrobin + penflufen + carbendazim + picarbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + fludioxonil + metalaxyl M,
SX + metconazole + picoxystrobin + tifluzamide + fludioxonil + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + thiophanate methyl + metalaxyl M,
SX + metconazole + picoxystrobin + tifluzamide + thiophanate methyl + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + thiabendazole + metalaxyl M,
SX + metconazole + picoxystrobin + tifluzamide + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + thiuram + metalaxyl M,
SX + metconazole + picoxystrobin + tifluzamide + thiuram + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + tifluzamide + tolcrofosmethyl + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + boscalid + metalaxyl M,
SX + metconazole + picoxystrobin + tifluzamide + boscalid + picarbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + aminopyrifen + metalaxyl M,
SX + metconazole + picoxystrobin + tifluzamide + aminopyrifen + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + mancozeb + metalaxyl M,
SX + metconazole + picoxystrobin + tifluzamide + mancozeb + picalbutrazox,
SX + metconazole + picoxystrobin + tifluzamide + carbendazim + metalaxyl M,
SX + metconazole + picoxystrobin + tifluzamide + carbendazim + picalbutrazox,
SX + metconazole + picoxystrobin + impylfluxam + fludioxonil + metalaxyl M,
SX + metconazole + picoxystrobin + impylfluxam + fludioxonil + picalbutrazox,
SX + metconazole + picoxystrobin + impylfluxam + thiophanate methyl + metalaxyl M,
SX + metconazole + picoxystrobin + impylfluxam + thiophanate methyl + picalbutrazox,
SX + metconazole + picoxystrobin + impylfluxam + thiabendazole + metalaxyl M,
SX + metconazole + picoxystrobin + impylfluxam + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + impylfluxam + thiuram + metalaxyl M,
SX + metconazole + picoxystrobin + impylfluxam + thiuram + picarbutrazox,
SX + metconazole + picoxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + impylfluxam + tolcrofosmethyl + picalbutrazox,
SX + metconazole + picoxystrobin + impylfluxam + boscalid + metalaxyl M,
SX + metconazole + picoxystrobin + impylfluxam + boscalid + picarbutrazox,
SX + metconazole + picoxystrobin + impylfluxam + aminopyrifen + metalaxyl M,
SX + metconazole + picoxystrobin + impylfluxam + aminopyrifen + picalbutrazox,
SX + metconazole + picoxystrobin + impylfluxam + mancozeb + metalaxyl M,
SX + metconazole + picoxystrobin + impylfluxam + mancozeb + pical butrazoz,
SX + metconazole + picoxystrobin + impylfluxam + carbendazim + metalaxyl M,
SX + metconazole + picoxystrobin + impylfluxam + carbendazim + picarbutrazox,
SX + metconazole + picoxystrobin + sedaxane + fludioxonil + metalaxyl M,
SX + metconazole + picoxystrobin + sedaxane + fludioxonil + picalbutrazox,
SX + metconazole + picoxystrobin + sedaxane + thiophanate methyl + metalaxyl M,
SX + metconazole + picoxystrobin + sedaxane + thiophanate methyl + picalbutrazox,
SX + metconazole + picoxystrobin + sedaxane + thiabendazole + metalaxyl M,
SX + metconazole + picoxystrobin + sedaxane + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + sedaxane + thiuram + metalaxyl M,
SX + metconazole + picoxystrobin + sedaxane + thiuram + picarbutrazox,
SX + metconazole + picoxystrobin + sedaxane + tolcrofosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + sedaxane + tolcrofosmethyl + picalbutrazox,
SX + metconazole + picoxystrobin + sedaxane + boscalid + metalaxyl M,
SX + metconazole + picoxystrobin + sedaxane + boscalid + pical butrazox,
SX + metconazole + picoxystrobin + sedaxane + aminopyrifen + metalaxyl M,
SX + metconazole + picoxystrobin + sedaxane + aminopyrifen + picalbutrazox,
SX + metconazole + picoxystrobin + sedaxane + mancozeb + metalaxyl M,
SX + metconazole + picoxystrobin + sedaxane + mancozeb + picarbutrazox,
SX + metconazole + picoxystrobin + sedaxane + carbendazim + metalaxyl M,
SX + metconazole + picoxystrobin + sedaxane + carbendazim + picarbutrazox,
SX + metconazole + picoxystrobin + pidiflumethophene + fludioxonil + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethophene + fludioxonil + picalbutrazox,
SX + metconazole + picoxystrobin + pidiflumethophene + thiophanate methyl + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethophene + thiophanate methyl + picalbutrazox,
SX + metconazole + picoxystrobin + pidiflumethophene + thiabendazole + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethophene + thiabendazole + picalbutrazoz,
SX + metconazole + picoxystrobin + pidiflumethophene + thiuram + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethofene + thiuram + picalbutrazox,
SX + metconazole + picoxystrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethofene + tolcrofosmethyl + picalbutrazox,
SX + metconazole + picoxystrobin + pidiflumethofene + boscalid + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethofene + boscalid + picarbutrazox,
SX + metconazole + picoxystrobin + pidiflumethophene + aminopyrifen + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethophene + aminopyrifen + picalbutrazox,
SX + metconazole + picoxystrobin + pidiflumethofene + mancozeb + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethophene + mancozeb + pical butrazoz,
SX + metconazole + picoxystrobin + pidiflumethofene + carbendazim + metalaxyl M,
SX + metconazole + picoxystrobin + pidiflumethofene + carbendazim + picalbutrazoz,
SX + metconazole + picoxystrobin + isoflucipram + fludioxonil + metalaxyl M,
SX + metconazole + picoxystrobin + isoflucipram + fludioxonil + picalbutrazox,
SX + metconazole + picoxystrobin + isoflucipram + thiophanate methyl + metalaxyl M,
SX + metconazole + picoxystrobin + isoflucipram + thiophanate methyl + picalbutrazox,
SX + metconazole + picoxystrobin + isoflucipram + thiabendazole + metalaxyl M,
SX + metconazole + picoxystrobin + isoflucipram + thiabendazole + picalbutrazox,
SX + metconazole + picoxystrobin + isoflucipram + thiuram + metalaxyl M,
SX + metconazole + picoxystrobin + isoflucipram + thiuram + picalbutrazox,
SX + metconazole + picoxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + picoxystrobin + isoflucipram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + picoxystrobin + isoflucipram + boscalid + metalaxyl M,
SX + metconazole + picoxystrobin + isoflucipram + boscalid + picalbutrazox,
SX + metconazole + picoxystrobin + isoflucipram + aminopyrifen + metalaxyl M,
SX + metconazole + picoxystrobin + isoflucipram + aminopyrifen + picalbutrazox,
SX + metconazole + picoxystrobin + isoflucipram + mancozeb + metalaxyl M,
SX + metconazole + picoxystrobin + isoflucipram + mancozeb + picalbutrazox,
SX + metconazole + picoxystrobin + isoflucipram + carbendazim + metalaxyl M,
SX + metconazole + picoxystrobin + isoflucipram + carbendazim + pical butrazoz,
SX + metconazole + methyltetraprole + fluopyram + fludioxonil + metalaxyl M,
SX + metconazole + methyltetraprole + fluopyram + fludioxonil + picalbutrazox,
SX + metconazole + methyltetraprole + fluopyram + thiophanate methyl + metalaxyl M,
SX + metconazole + methyltetraprol + fluopyram + thiophanate methyl + picalbutrazox,
SX + metconazole + methyltetraprole + fluopyram + thiabendazole + metalaxyl M,
SX + metconazole + methyltetraprole + fluopyram + thiabendazole + picalbutrazox,
SX + metconazole + methyltetraprole + fluopyram + thiuram + metalaxyl M,
SX + metconazole + methyltetraprol + fluopyram + thiuram + picarbutrazox,
SX + metconazole + methyltetraprole + fluopyram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + methyltetraprol + fluopyram + tolcrofosmethyl + picalbutrazox,
SX + metconazole + methyltetraprole + fluopyram + boscalid + metalaxyl M,
SX + metconazole + methyltetraprol + fluopyram + boscalid + picarbutrazox,
SX + metconazole + methyltetraprole + fluopyram + aminopyrifen + metalaxyl M,
SX + metconazole + methyltetraprol + fluopyram + aminopyrifen + picalbutrazox,
SX + metconazole + methyltetraprol + fluopyram + mancozeb + metalaxyl M,
SX + metconazole + methyltetraprol + fluopyram + mancozeb + picarbutrazox,
SX + metconazole + methyltetraprole + fluopyram + carbendazim + metalaxyl M,
SX + metconazole + methyltetraprol + fluopyram + carbendazim + picarbutrazox,
SX + metconazole + methyltetraprol + floxapyroxad + fludioxonil + metalaxyl M,
SX + metconazole + methyltetraprol + floxapyroxad + fludioxonil + picalbutrazox,
SX + metconazole + methyltetraprol + floxapyroxad + thiophanate methyl + metalaxyl M,
SX + metconazole + methyltetraprol + floxapyroxad + thiophanate methyl + picalbutrazox,
SX + metconazole + methyltetraprol + floxapyroxad + thiabendazole + metalaxyl M,
SX + metconazole + methyltetraprol + floxapyroxad + thiabendazole + picarbutrazox,
SX + metconazole + methyltetraprol + floxapyroxad + thiuram + metalaxyl M,
SX + metconazole + methyltetraprol + floxapyroxad + thiuram + picarbutrazox,
SX + metconazole + methyltetraprole + floxapyroxad + tolcrofosmethyl + metalaxyl M,
SX + metconazole + methyltetraprol + floxapyroxad + tolcrofosmethyl + picalbutrazox,
SX + metconazole + methyltetraprol + floxapyroxad + boscalid + metalaxyl M,
SX + metconazole + methyltetraprol + floxapyroxad + boscalid + picarbutrazox,
SX + metconazole + methyltetraprol + floxapyroxad + aminopyrifen + metalaxyl M,
SX + metconazole + methyltetraprol + floxapyroxad + aminopyrifen + picalbutrazox,
SX + metconazole + methyltetraprol + floxapyroxad + mancozeb + metalaxyl M,
SX + metconazole + methyltetraprol + floxapyroxado + mancozeb + picalbutrazox,
SX + metconazole + methyltetraprol + floxapyroxad + carbendazim + metalaxyl M,
SX + metconazole + methyltetraprol + floxapyroxad + carbendazim + picalbutrazox,
SX + metconazole + methyltetraprole + boscalid + fludioxonil + metalaxyl M,
SX + metconazole + methyltetraprole + boscalid + fludioxonil + picarbutrazox,
SX + metconazole + methyltetraprole + boscalid + thiophanate methyl + metalaxyl M,
SX + metconazole + methyltetraprol + boscalid + thiophanate methyl + picarbutrazox,
SX + metconazole + methyltetraprole + boscalid + thiabendazole + metalaxyl M,
SX + metconazole + methyltetraprole + boscalid + thiabendazole + picarbutrazox,
SX + metconazole + methyltetraprole + boscalid + thiuram + metalaxyl M,
SX + metconazole + methyltetraprol + boscalid + thiuram + picarbutrazox,
SX + metconazole + methyltetraprol + boscalid + tolcrofosmethyl + metalaxyl M,
SX + metconazole + methyltetraprole + boscalid + tolcrofosmethyl + picalbutrazox,
SX + metconazole + methyltetraprole + boscalid + boscalid + metalaxyl M,
SX + metconazole + methyltetraprole + boscalid + boscalid + picarbutrazox,
SX + metconazole + methyltetraprole + boscalid + aminopyrifen + metalaxyl M,
SX + metconazole + methyltetraprole + boscalid + aminopyrifen + picarbutrazox,
SX + metconazole + methyltetraprole + boscalid + mancozeb + metalaxyl M,
SX + metconazole + methyltetraprole + boscalid + mancozeb + picarbutrazox
SX + metconazole + methyltetraprole + boscalid + carbendazim + metalaxyl M,
SX + metconazole + methyltetraprol + boscalid + carbendazim + picarbutrazox,
SX + metconazole + methyltetraprole + penflufen + fludioxonil + metalaxyl M,
SX + metconazole + methyltetraprole + penflufen + fludioxonil + picalbutrazox,
SX + metconazole + methyltetraprole + penflufen + thiophanate methyl + metalaxyl M,
SX + metconazole + methyltetraprol + penflufen + thiophanate methyl + picalbutrazox,
SX + metconazole + methyltetraprole + penflufen + thiabendazole + metalaxyl M,
SX + metconazole + methyltetraprole + penflufen + thiabendazole + picarbutrazox,
SX + metconazole + methyltetraprole + penflufen + thiuram + metalaxyl M,
SX + metconazole + methyltetraprol + penflufen + thiuram + picarbutrazox,
SX + metconazole + methyltetraprole + penflufen + tolcrofosmethyl + metalaxyl M,
SX + metconazole + methyltetraprol + penflufen + tolcrofosmethyl + picalbutrazox,
SX + metconazole + methyltetraprole + penflufen + boscalid + metalaxyl M,
SX + metconazole + methyltetraprole + penflufen + boscalid + picarbutrazox,
SX + metconazole + methyltetraprole + penflufen + aminopyrifen + metalaxyl M,
SX + metconazole + methyltetraprole + penflufen + aminopyrifen + picarbutrazox,
SX + metconazole + methyltetraprole + penflufen + mancozeb + metalaxyl M,
SX + metconazole + methyltetraprole + penflufen + mancozeb + picarbutrazox,
SX + metconazole + methyltetraprole + penflufen + carbendazim + metalaxyl M,
SX + metconazole + methyltetraprol + penflufen + carbendazim + picarbutrazox,
SX + metconazole + methyltetraprole + tifluzamide + fludioxonil + metalaxyl M,
SX + metconazole + methyltetraprol + tifluzamide + fludioxonil + picalbutrazox,
SX + metconazole + methyltetraprol + tifluzamide + thiophanate methyl + metalaxyl M,
SX + metconazole + methyltetraprol + tifluzamide + thiophanate methyl + picalbutrazox,
SX + metconazole + methyltetraprol + tifluzamide + thiabendazole + metalaxyl M,
SX + metconazole + methyltetraprol + tifluzamide + thiabendazole + picalbutrazox,
SX + metconazole + methyltetraprol + tifluzamide + thiuram + metalaxyl M,
SX + metconazole + methyltetraprol + tifluzamide + thiuram + picarbutrazox,
SX + metconazole + methyltetraprol + tifluzamide + tolcrofosmethyl + metalaxyl M,
SX + metconazole + methyltetraprol + tifluzamide + tolcrofosmethyl + picalbutrazoz,
SX + metconazole + methyltetraprol + tifluzamide + boscalid + metalaxyl M,
SX + metconazole + methyltetraprol + tifluzamide + boscalid + picarbutrazox,
SX + metconazole + methyltetraprole + tifluzamide + aminopyrifen + metalaxyl M,
SX + metconazole + methyltetraprol + tifluzamide + aminopyrifen + picalbutrazox,
SX + metconazole + methyltetraprol + tifluzamide + mancozeb + metalaxyl M,
SX + metconazole + methyltetraprol + tifluzamide + mancozeb + picarbutrazox,
SX + metconazole + methyltetraprol + tifluzamide + carbendazim + metalaxyl M,
SX + metconazole + methyltetraprol + tifluzamide + carbendazim + picarbutrazox,
SX + metconazole + methyltetraprole + impylfluxam + fludioxonil + metalaxyl M,
SX + metconazole + methyltetraprole + impylfluxam + fludioxonil + picalbutrazox,
SX + metconazole + methyltetraprole + impylfluxam + thiophanate methyl + metalaxyl M,
SX + metconazole + methyltetraprol + impylfluxam + thiophanate methyl + picalbutrazox,
SX + metconazole + methyltetraprol + impylfluxam + thiabendazole + metalaxyl M,
SX + metconazole + methyltetraprol + impylfluxam + thiabendazole + picalbutrazox,
SX + metconazole + methyltetraprole + impylfluxam + thiuram + metalaxyl M,
SX + metconazole + methyltetraprol + impylfluxam + thiuram + picarbutrazoz,
SX + metconazole + methyltetraprole + impylfluxam + tolcrofosmethyl + metalaxyl M,
SX + metconazole + methyltetraprol + impylufluxam + tolcrofosmethyl + picalbutrazox,
SX + metconazole + methyltetraprole + impylfluxam + boscalid + metalaxyl M,
SX + metconazole + methyltetraprol + impylfluxam + boscalid + picarbutrazoz,
SX + metconazole + methyltetraprole + impylfluxam + aminopyrifen + metalaxyl M,
SX + metconazole + methyltetraprole + impylfluxam + aminopyrifen + picalbutrazox,
SX + metconazole + methyltetraprole + impylfluxam + mancozeb + metalaxyl M,
SX + metconazole + methyltetraprol + impylfluxam + mancozeb + picarbutrazox,
SX + metconazole + methyltetraprol + impylfluxam + carbendazim + metalaxyl M,
SX + metconazole + methyltetraprol + impylufluxam + carbendazim + picarbutrazox,
SX + metconazole + methyltetraprole + sedaxane + fludioxonil + metalaxyl M,
SX + metconazole + methyltetraprole + sedaxane + fludioxonil + picalbutrazox,
SX + metconazole + methyltetraprole + sedaxane + thiophanate methyl + metalaxyl M,
SX + metconazole + methyltetraprole + sedaxane + thiophanate methyl + picalbutrazox,
SX + metconazole + methyltetraprole + sedaxane + thiabendazole + metalaxyl M,
SX + metconazole + methyltetraprol + sedaxane + thiabendazole + picalbutrazox,
SX + metconazole + methyltetraprole + sedaxane + thiuram + metalaxyl M,
SX + metconazole + methyltetraprole + sedaxane + thiuram + picalbutrazox,
SX + metconazole + methyltetraprole + sedaxane + tolcrofosmethyl + metalaxyl M,
SX + metconazole + methyltetraprole + sedaxane + tolcrofosmethyl + picalbutrazox,
SX + metconazole + methyltetraprole + sedaxane + boscalid + metalaxyl M,
SX + metconazole + methyltetraprole + sedaxane + boscalid + picarbutrazox,
SX + metconazole + methyltetraprole + sedaxane + aminopyrifen + metalaxyl M,
SX + metconazole + methyltetraprole + sedaxane + aminopyrifen + picalbutrazox,
SX + metconazole + methyltetraprole + sedaxane + mancozeb + metalaxyl M,
SX + metconazole + methyltetraprol + sedaxane + mancozeb + picarbutrazox,
SX + metconazole + methyltetraprole + sedaxane + carbendazim + metalaxyl M,
SX + metconazole + methyltetraprole + sedaxane + carbendazim + picarbutrazox,
SX + metconazole + methyltetraprole + pidiflumethophene + fludioxonil + metalaxyl M,
SX + metconazole + methyltetraprole + pidiflumethophene + fludioxonil + picalbutrazox,
SX + metconazole + methyltetraprole + pidiflumethophene + thiophanate methyl + metalaxyl M,
SX + metconazole + methyltetraprol + pidiflumethophene + thiophanate methyl + picalbutrazox,
SX + metconazole + methyltetraprol + pidiflumethophene + thiabendazole + metalaxyl M,
SX + metconazole + methyltetraprole + pidiflumethophene + thiabendazole + picalbutrazox,
SX + metconazole + methyltetraprole + pidiflumethophene + thiuram + metalaxyl M,
SX + metconazole + methyltetraprol + pidiflumethophene + thiuram + picalbutrazox,
SX + metconazole + methyltetraprole + pidiflumethophene + tolcrofosmethyl + metalaxyl M,
SX + metconazole + methyltetraprol + pidiflumethofene + tolcrofosmethyl + picalbutrazox,
SX + metconazole + methyltetraprole + pidiflumethophene + boscalid + metalaxyl M,
SX + metconazole + methyltetraprol + pidiflumethophene + boscalid + picalbutrazoz,
SX + Metoconazole + Methyltetraprole + Pidiflumethophene + Aminopyrifen + Metalaxyl M,
SX + metconazole + methyltetraprole + pidiflumethophene + aminopyrifen + picalbutrazox,
SX + metconazole + methyltetraprole + pidiflumethophene + mancozeb + metalaxyl M,
SX + metconazole + methyltetraprol + pidiflumethophene + mancozeb + picalbutrazox,
SX + metconazole + methyltetraprol + pidiflumethophene + carbendazim + metalaxyl M,
SX + metconazole + methyltetraprol + pidiflumethofene + carbendazim + picalbutrazoz,
SX + metconazole + methyltetraprole + isoflucipram + fludioxonil + metalaxyl M,
SX + metconazole + methyltetraprol + isoflucipram + fludioxonil + picalbutrazox,
SX + metconazole + methyltetraprol + isoflucipram + thiophanate methyl + metalaxyl M,
SX + metconazole + methyltetraprol + isoflucipram + thiophanate methyl + picalbutrazox,
SX + metconazole + methyltetraprol + isoflucipram + thiabendazole + metalaxyl M,
SX + metconazole + methyltetraprole + isoflucipram + thiabendazole + picalbutrazox,
SX + metconazole + methyltetraprol + isoflucipram + thiuram + metalaxyl M,
SX + metconazole + methyltetraprol + isoflucipram + thiuram + picarbutrazox,
SX + metconazole + methyltetraprol + isoflucipram + tolcrofosmethyl + metalaxyl M,
SX + metconazole + methyltetraprol + isoflucipram + tolcrofosmethyl + picalbutrazoz,
SX + metconazole + methyltetraprol + isoflucipram + boscalid + metalaxyl M,
SX + metconazole + methyltetraprol + isoflucipram + boscalid + picarbutrazox,
SX + metconazole + methyltetraprole + isoflucipram + aminopyrifen + metalaxyl M,
SX + metconazole + methyltetraprol + isoflucipram + aminopyrifen + picalbutrazox,
SX + metconazole + methyltetraprol + isoflucipram + mancozeb + metalaxyl M,
SX + metconazole + methyltetraprol + isoflucipram + mancozeb + pical butrazox,
SX + metconazole + methyltetraprol + isoflucipram + carbendazim + metalaxyl M,
SX + metconazole + methyltetraprol + isoflucipram + carbendazim + picalbutrazox.

Group 2 ′ is composed of Composition A consisting of 1 part tebuconazole instead of 1 part metconazole contained in each composition of Group 1 ′.
Group 3 ′ is composed of composition A consisting of 1 part of difenoconazole instead of 1 part of metconazole contained in each composition of group 1 ′.
Group 4 ′ is composed of composition A consisting of 1 part of triticonazole instead of 1 part of metconazole contained in each composition of group 1 ′.
Group 5 ′ is composed of composition A consisting of 1 part of prothioconazole instead of 1 part of metconazole contained in each composition of group 1 ′.
Group 6 ′ is composed of Composition A consisting of 1 part diniconazole instead of 1 part metconazole contained in each composition of Group 1 ′.
Group 7 ′ is composed of composition A consisting of 1 part of diniconazole M instead of 1 part of metconazole contained in each composition of group 1 ′.
Group 8 ′ is composed of composition A consisting of 1 part ipconazole instead of 1 part metconazole contained in each composition of group 1 ′.
Group 9 ′ is composed of composition A consisting of 1 part of prochloraz instead of 1 part of metconazole contained in each composition of group 1 ′.
Group 10 ′ is composed of Composition A consisting of 1 part of fluquinconazole instead of 1 part of metconazole contained in each composition of Group 1 ′.
Group 11 ′ is composed of Composition A consisting of 1 part bromoconazole instead of 1 part metconazole contained in each composition of Group 1 ′.
Group 12 ′ is composed of composition A consisting of 1 part mefentrifluconazole instead of 1 part metconazole contained in each composition of group 1 ′.

  In the group 13 ′, the combination of SX, main component 1, main component 2, main component 3, main component 4 and main component 5 is a combination of any one of the above “6 active ingredient lists”. It consists of a composition A consisting of 1 part of this component 1, 1 part of this component 2, 1 part of this component 3, 1 part of this component 4 and 1 part of this component 5.

Group 14 ′ is composed of composition A consisting of 1 part tebuconazole instead of 1 part metconazole contained in each composition of group 13 ′.
Group 15 'is composed of composition A consisting of 1 part difenoconazole instead of 1 part metconazole contained in each composition of group 13'.
Group 16 ′ is composed of composition A consisting of 1 part of triticonazole instead of 1 part of metconazole contained in each composition of group 13 ′.
Group 17 ′ is composed of Composition A consisting of 1 part prothioconazole instead of 1 part metconazole contained in each composition of group 13 ′.
Group 18 ′ is composed of composition A consisting of 1 part diniconazole instead of 1 part metconazole contained in each composition of group 13 ′.
Group 19 ′ is composed of composition A consisting of 1 part of diniconazole M instead of 1 part of metconazole contained in each composition of group 13 ′.
Group 20 ′ is composed of composition A consisting of 1 part ipconazole instead of 1 part metconazole contained in each composition of group 13 ′.
Group 21 ′ is composed of composition A consisting of 1 part of prochloraz instead of 1 part of metconazole contained in each composition of group 13 ′.
Group 22 ′ is composed of composition A consisting of 1 part of fluquinconazole instead of 1 part of metconazole contained in each composition of group 13 ′.
Group 23 'is composed of composition A consisting of 1 part bromconazole instead of 1 part metconazole contained in each composition of group 13'.
Group 24 'is composed of composition A consisting of 1 part mefentrifluconazole instead of 1 part metconazole contained in each composition of group 13'.

Group 25 'is from Composition A wherein each composition of Groups 1'-12' is further supplemented with 1000 parts clothianidin, 1000 parts chlorantraniliprole, 1000 parts tefluthrin and 1000 parts fipronil. Composed.
Group 26 'is from Composition A, wherein each composition of Groups 1'-12' is further supplemented with 1000 parts clothianidin, 1000 parts chlorantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Composed.
Group 27 'is from Composition A wherein each composition of Groups 1'-12' is further supplemented with 1000 parts clothianidin, 1000 parts chlorantraniliprole, 1000 parts bifenthrin, and 1000 parts fipronil. Composed.
Group 28 'is from Composition A, wherein each composition of Groups 1'-12' is further supplemented with 1000 parts clothianidin, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Composed.
Group 29 ′ comprises Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts clothianidin, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts fipronil. Is done.
Group 30 ′ comprises composition A, in which 1000 parts clothianidin, 1000 parts cyantraniliprole, 1000 parts teflutrin, and 1000 parts brofuranilide are added to each of the compositions of groups 1 ′ to 12 ′. Is done.
Group 31 ′ is composed of Composition A in which 1000 parts clothianidin, 1000 parts cyantraniliprolol, 1000 parts bifenthrin and 1000 parts fipronil are further added to each composition of groups 1 ′ to 12 ′. Is done.
Group 32 'is composed of Composition A in which 1000 parts clothianidin, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide are added to each composition of groups 1'-12'. Is done.
Group 33 ′ is composed of Composition A in which 1000 parts of clothianidin, 1000 parts of tetraniliprolol, 1000 parts of tefluthrin and 1000 parts of fipronil are further added to the compositions of groups 1 ′ to 12 ′. The
Group 34 ′ is composed of Composition A in which 1000 parts of clothianidin, 1000 parts of tetraniliprolol, 1000 parts of tefluthrin, and 1000 parts of brofuranilide are added to each composition of groups 1 ′ to 12 ′. The
Group 35 ′ is composed of Composition A in which 1000 parts of clothianidin, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of fipronil are added to each composition of groups 1 ′ to 12 ′. The
Group 36 ′ is composed of Composition A in which 1000 parts clothianidin, 1000 parts tetraniliprolol, 1000 parts bifenthrin, and 1000 parts brofuranilide are added to each of the compositions of groups 1 ′ to 12 ′. The
Group 37 'is from Composition A, wherein each composition of Groups 1'-12' is further supplemented with 1000 parts imidacloprid, 1000 parts chlorantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Composed.
Group 38 ′ comprises a composition A in which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 1 ′ to 12 ′. Composed.
Group 39 ′ is from Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts imidacloprid, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 40 ′ comprises a composition A in which 1000 parts of imidacloprid, 1000 parts of chlorantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each composition of groups 1 ′ to 12 ′. Composed.
Group 41 ′ is composed of Composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil are further added to each composition of groups 1 ′ to 12 ′. Is done.
Group 42 'consists of composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 1' to 12 '. Is done.
Group 43 ′ is composed of Composition A in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each composition of groups 1 ′ to 12 ′. Is done.
Group 44 ′ comprises composition A, in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 1 ′ to 12 ′. Is done.
Group 45 ′ is composed of Composition A in which 1000 parts of imidacloprid, 1000 parts of tetraniliprolol, 1000 parts of tefluthrin and 1000 parts of fipronil are added to each of the compositions of Groups 1 ′ to 12 ′. The
Group 46 ′ is composed of Composition A, in which 1000 parts of imidacloprid, 1000 parts of tetraniliprolol, 1000 parts of tefluthrin, and 1000 parts of brofuranilide are added to the compositions of Groups 1 ′ to 12 ′. The
Group 47 ′ is composed of Composition A, in which 1000 parts of imidacloprid, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each composition of groups 1 ′ to 12 ′. The
Group 48 ′ is composed of Composition A, in which 1000 parts of imidacloprid, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each of the compositions of Groups 1 ′ to 12 ′. The
Group 49 'is from Composition A, wherein each composition of Groups 1'-12' is further supplemented with 1000 parts thiamethoxam, 1000 parts chlorantraniliprole, 1000 parts tefluthrin, and 1000 parts fipronil. Composed.
Group 50 'is from Composition A wherein each composition of Groups 1'-12' is further supplemented with 1000 parts thiamethoxam, 1000 parts chlorantraniliprole, 1000 parts tefluthrin and 1000 parts brofuranilide. Composed.
Group 51 'is from Composition A wherein each composition of Groups 1'-12' is further supplemented with 1000 parts thiamethoxam, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 52 ′ comprises a composition A in which 1000 parts of thiamethoxam, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide are added to each of the compositions of groups 1 ′ to 12 ′. Composed.
Group 53 ′ is composed of Composition A in which 1000 parts of thiamethoxam, 1000 parts of cyantranylprolol, 1000 parts of tefluthrin, and 1000 parts of fipronil are further added to each of the compositions of Groups 1 ′ to 12 ′. Is done.
Group 54 'comprises composition A, in which 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide are added to each composition of groups 1'-12'. Is done.
Group 55 ′ comprises Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Is done.
Group 56 ′ comprises Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Is done.
Group 57 ′ is composed of Composition A in which 1000 parts of thiamethoxam, 1000 parts of tetraniliprolol, 1000 parts of teflutrin, and 1000 parts of fipronil are further added to each composition of Groups 1 ′ to 12 ′. The
Group 58 ′ is composed of Composition A in which 1000 parts of thiamethoxam, 1000 parts of tetraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added to each composition of Groups 1 ′ to 12 ′. The
Group 59 ′ is composed of Composition A in which 1000 parts of thiamethoxam, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each composition of Groups 1 ′ to 12 ′. The
Group 60 ′ is composed of Composition A, in which 1000 parts of thiamethoxam, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each composition of Groups 1 ′ to 12 ′. The
Group 61 'is from Composition A wherein each composition of Groups 1'-12' is further supplemented with 1000 parts thiacloprid, 1000 parts chlorantraniliprole, 1000 parts tefluthrin and 1000 parts fipronil. Composed.
Group 62 ′ comprises a composition A in which 1000 parts of thiacloprid, 1000 parts of chlorantraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 1 ′ to 12 ′. Composed.
Group 63 ′ is from Composition A wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts thiacloprid, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 64 ′ comprises a composition A in which 1000 parts of thiacloprid, 1000 parts of chlorantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 1 ′ to 12 ′. Composed.
Group 65 ′ comprises composition A, in which 1000 parts of thiacloprid, 1000 parts cyantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil are further added to each of the compositions of groups 1 ′ to 12 ′. Is done.
Group 66 ′ comprises Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Is done.
Group 67 ′ comprises composition A, in which 1000 parts of thiacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each of the compositions of groups 1 ′ to 12 ′. Is done.
Group 68 ′ comprises composition A, in which 1000 parts of thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide are added to each composition of groups 1 ′ to 12 ′. Is done.
Group 69 ′ is composed of Composition A in which 1000 parts of thiacloprid, 1000 parts of tetraniliprolol, 1000 parts of tefritrin and 1000 parts of fipronil are further added to each composition of Groups 1 ′ to 12 ′. The
Group 70 'is composed of Composition A, in which 1000 parts of thiacloprid, 1000 parts of tetraniliprolol, 1000 parts of teflutrin and 1000 parts of brofuranilide are further added to each of the compositions of Groups 1' to 12 '. The
Group 71 ′ is composed of Composition A in which 1000 parts of thiacloprid, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each composition of Groups 1 ′ to 12 ′. The
Group 72 ′ is composed of Composition A in which 1000 parts of thiacloprid, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each of the compositions of Groups 1 ′ to 12 ′. The
Group 73 ′ is from Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts flupirazifurone, 1000 parts chlorantraniliprole, 1000 parts tefluthrin, and 1000 parts fipronil. Composed.
Group 74 ′ comprises a composition A comprising each of the compositions of groups 1 ′ to 12 ′ plus 1000 parts flupirazifuron, 1000 parts chlorantraniliprole, 1000 parts tefluthrin and 1000 parts brofuranilide. Composed.
Group 75 ′ is from Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts flupirazifurone, 1000 parts chlorantraniliprole, 1000 parts bifenthrin, and 1000 parts fipronil. Composed.
Group 76 ′ comprises a composition A in which each composition of groups 1 ′ to 12 ′ is further supplemented with 1000 parts flupirazifuron, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Composed.
Group 77 ′ comprises Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts flupirazifurone, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts fipronil. Is done.
Group 78 ′ comprises composition A, in which each composition of groups 1 ′ to 12 ′ is further supplemented with 1000 parts flupirazifurone, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Is done.
Group 79 ′ comprises composition A, in which 1000 parts of flupiradifurone, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each composition of groups 1 ′ to 12 ′. Is done.
Group 80 ′ is composed of Composition A in which 1000 parts of Flupyrazifurone, 1000 parts of Cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each composition of Groups 1 ′ to 12 ′. Is done.
Group 81 ′ is composed of Composition A, in which 1000 parts of flupirazifurone, 1000 parts of tetraniliprole, 1000 parts of teflutrin, and 1000 parts of fipronil are further added to the compositions of Groups 1 ′ to 12 ′. The
Group 82 ′ is composed of Composition A in which 1000 parts of flupirazifurone, 1000 parts of tetraniprolol, 1000 parts of tefluthrin, and 1000 parts of brofuranilide are added to the compositions of Groups 1 ′ to 12 ′. The
Group 83 ′ is composed of Composition A in which 1000 parts of flupiradifurone, 1000 parts of tetraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to the compositions of Groups 1 ′ to 12 ′. The
Group 84 ′ is composed of Composition A in which 1000 parts of flupirazifurone, 1000 parts of tetraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each composition of groups 1 ′ to 12 ′. The
Group 85 ′ is from Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts flupirimine, 1000 parts chlorantraniliprole, 1000 parts tefluthrin, and 1000 parts fipronil. Composed.
Group 86 ′ comprises a composition A in which each composition of groups 1′-12 ′ is further supplemented with 1000 parts flupirmine, 1000 parts chlorantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Composed.
Group 87 ′ is from Composition A wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts flupirmine, 1000 parts chlorantraniliprole, 1000 parts bifenthrin, and 1000 parts fipronil. Composed.
Group 88 ′ comprises a composition A in which each composition of groups 1 ′ to 12 ′ is further supplemented with 1000 parts flupirmine, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Composed.
Group 89 ′ comprises Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts flupirmine, 1000 parts cyantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Is done.
Group 90 'is composed of Composition A, in which each composition of Groups 1'-12' is further supplemented with 1000 parts flupirimine, 1000 parts cyantraniliprole, 1000 parts teflutrin and 1000 parts brofuranilide. Is done.
Group 91 ′ is composed of Composition A in which 1000 parts of flupirmine, 1000 parts of cyantraniliprolol, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each composition of Groups 1 ′ to 12 ′. Is done.
Group 92 ′ comprises Composition A, in which each composition of Groups 1 ′ to 12 ′ is further supplemented with 1000 parts flupirimine, 1000 parts cyantraniliprole, 1000 parts bifenthrin, and 1000 parts brofuranilide. Is done.
Group 93 ′ is composed of Composition A, in which 1000 parts of flupyrimine, 1000 parts of tetraniliprolol, 1000 parts of tefritrin, and 1000 parts of fipronil are further added to each composition of Groups 1 ′ to 12 ′. The
Group 94 ′ is composed of Composition A, in which each composition of Groups 1 ′ to 12 ′ is further supplemented with 1000 parts flupirmine, 1000 parts tetraniliprolol, 1000 parts teflutrin, and 1000 parts brofuranilide. The
Group 95 ′ is composed of Composition A in which 1000 parts of flupyrimine, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each composition of groups 1 ′ to 12 ′. The
Group 96 ′ is composed of Composition A in which 1000 parts of flupyrimine, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are added to each composition of Groups 1 ′ to 12 ′. The
Group 97 ′ is a composition obtained by adding 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprole, 1000 parts of tefluthrin and 1000 parts of fipronil to each composition of Groups 1 ′ to 12 ′. Consists of A.
Group 98 ′ is a composition obtained by adding 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprole, 1000 parts of tefluthrin, and 1000 parts of brofuranilide to each composition of groups 1 ′ to 12 ′. Consists of A.
Group 99 ′ is a composition obtained by adding 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil to each composition of groups 1 ′ to 12 ′ Consists of A.
Group 100 ′ is a composition obtained by adding 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide to each composition of groups 1 ′ to 12 ′. Consists of A.
Group 101 'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts cyantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil are added to each of the compositions of groups 1'-12'. Consists of
Group 102 'is a composition A in which 1000 parts of triflumezopyrim, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide are added to each composition of groups 1'-12'. Consists of
Group 103 ′ is a composition A comprising each of the compositions of groups 1 ′ to 12 ′ plus 1000 parts triflumezopyrim, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Consists of
Group 104 ′ is a composition A in which 1000 parts of triflumezopyrim, 1000 parts cyantraniliprole, 1000 parts bifenthrin, and 1000 parts brofuranilide are added to each composition of groups 1 ′ to 12 ′. Consists of
Group 105 ′ is from Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts triflumezopyrim, 1000 parts tetraniliprolol, 1000 parts tefluthrin, and 1000 parts fipronil. Composed.
Group 106 ′ comprises a composition A in which each composition of groups 1′-12 ′ is further supplemented with 1000 parts triflumezopyrim, 1000 parts tetraniliprolol, 1000 parts tefluthrin, and 1000 parts brofuranilide. Composed.
Group 107 ′ is from Composition A, wherein each composition of Groups 1′-12 ′ is further supplemented with 1000 parts triflumezopyrim, 1000 parts tetraniliprolol, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 108 'is from Composition A, wherein each composition of Groups 1'-12' is further supplemented with 1000 parts triflumezopyrim, 1000 parts tetraniliprolol, 1000 parts bifenthrin and 1000 parts brofuranilide. Composed.

Group 109 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part clothianidin, 1 part chlorantraniliprole, 1 part teflutrin, and 1 part fipronil. Composed.
Group 110 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part clothianidin, 1 part chlorantraniliprole, 1 part teflutrin and 1 part brofuranilide. Composed.
Group 111 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part clothianidin, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 112 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part clothianidin, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 113 'is composed of Composition A in which 1 part clothianidin, 1 part cyantraniliprolol, 1 part tefluthrin and 1 part fipronil are added to each composition of groups 13'-24'. Is done.
Group 114 ′ comprises composition A, wherein each composition of groups 13′-24 ′ is further supplemented with 1 part clothianidin, 1 part cyantraniliprole, 1 part teflutrin, and 1 part brofuranilide. Is done.
Group 115 'comprises composition A, wherein each composition of groups 13'-24' is further supplemented with 1 part clothianidin, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Is done.
Group 116 'comprises composition A, wherein each composition of groups 13'-24' is further supplemented with 1 part clothianidin, 1 part cyantraniliprolol, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 117 ′ is composed of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part clothianidin, 1 part tetraniliprolol, 1 part tefluthrin and 1 part fipronil. The
Group 118 'is composed of Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part clothianidin, 1 part tetraniliprolol, 1 part tefluthrin and 1 part brofuranilide. The
Group 119 ′ is composed of Composition A, in which 1 part clothianidin, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil are added to each composition of groups 13′-24 ′. The
Group 120 ′ is composed of Composition A, in which 1 part clothianidin, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide are added to each composition of groups 13 ′ to 24 ′. The
Group 121 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part imidacloprid, 1 part chlorantraniliprole, 1 part tefluthrin and 1 part fipronil. Composed.
Group 122 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part imidacloprid, 1 part chlorantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Composed.
Group 123 ′ is from Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part imidacloprid, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 124 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part imidacloprid, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 125 ′ comprises Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part imidacloprid, 1 part cyantraniliprole, 1 part teflutrin, and 1 part fipronil. Is done.
Group 126 'comprises composition A, wherein each composition of groups 13' to 24 'is further supplemented with 1 part imidacloprid, 1 part cyantraniliprole, 1 part teflutrin and 1 part brofuranilide. Is done.
Group 127 ′ comprises Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Is done.
Group 128 'comprises composition A, wherein each composition of groups 13'-24' is further supplemented with 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 129 ′ is composed of Composition A, in which each composition of Groups 13′-24 ′ is further supplemented with 1 part imidacloprid, 1 part tetraniliprole, 1 part teflutrin and 1 part fipronil. The
Group 130 'is composed of Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part imidacloprid, 1 part tetraniliprolol, 1 part tefluthrin and 1 part brofuranilide. The
Group 131 ′ is composed of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part imidacloprid, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil. The
Group 132 'is composed of Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part imidacloprid, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. The
Group 133 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part thiamethoxam, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part fipronil. Composed.
Group 134 'is from Composition A wherein each composition of Groups 13'-24' is further supplemented with 1 part thiamethoxam, 1 part chlorantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Composed.
Group 135 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part thiamethoxam, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 136 'is from Composition A wherein each composition of Groups 13'-24' is further supplemented with 1 part thiamethoxam, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 137 ′ comprises Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part thiamethoxam, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Is done.
Group 138 ′ comprises Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part thiamethoxam, 1 part cyantraniliprole, 1 part teflutrin, and 1 part brofuranilide. Is done.
Group 139 ′ comprises Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Is done.
Group 140 ′ comprises composition A, wherein each composition of groups 13′-24 ′ is further supplemented with 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 141 ′ is composed of Composition A in which 1 part of thiamethoxam, 1 part of tetraniliprolol, 1 part of tefluthrin and 1 part of fipronil is added to each composition of groups 13 ′ to 24 ′. The
Group 142 ′ comprises Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part thiamethoxam, 1 part tetraniliprolol, 1 part tefluthrin and 1 part brofuranilide. The
Group 143 ′ is comprised of Composition A with each part of Group 13′-24 ′ plus 1 part thiamethoxam, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil. The
Group 144 ′ is comprised of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part thiamethoxam, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. The
Group 145 ′ is from Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part thiacloprid, 1 part chlorantraniliprole, 1 part tefluthrin and 1 part fipronil. Composed.
Group 146 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part thiacloprid, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part brofuranilide. Composed.
Group 147 ′ is from Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part thiacloprid, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 148 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part thiacloprid, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 149 'comprises Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part thiacloprid, 1 part cyantraniliprole, 1 part teflutrin, and 1 part fipronil. Is done.
Group 150 'is composed of Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part thiacloprid, 1 part cyantraniliprole, 1 part teflutrin and 1 part brofuranilide. Is done.
Group 151 ′ is composed of Composition A in which 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin, and 1 part fipronil are further added to each composition of groups 13 ′ to 24 ′. Is done.
Group 152 'is composed of Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 153 ′ is composed of Composition A in which 1 part of thiacloprid, 1 part of tetraniliprol, 1 part of tefluthrin and 1 part of fipronil is further added to each composition of groups 13 ′ to 24 ′. The
Group 154 ′ is composed of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part thiacloprid, 1 part tetraniliprolol, 1 part tefluthrin and 1 part brofuranilide. The
Group 155 ′ is composed of Composition A in which 1 part thiacloprid, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil are added to each of the compositions of groups 13 ′ to 24 ′. The
Group 156 ′ is composed of Composition A, in which each composition of Groups 13′-24 ′ is further supplemented with 1 part thiacloprid, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. The
Group 157 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part flupirazifurone, 1 part chlorantraniliprole, 1 part tefluthrin and 1 part fipronil. Composed.
Group 158 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part flupirazifurone, 1 part chlorantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Composed.
Group 159 ′ is from Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupiradifurone, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 160 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part flupiradifurone, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 161 ′ is composed of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupiradifurone, 1 part cyantraniliprole, 1 part teflutrin, and 1 part fipronil. Is done.
Group 162 'comprises composition A, in which each composition of groups 13'-24' is further supplemented with 1 part flupirazifuron, 1 part cyantraniliprole, 1 part teflutrin and 1 part brofuranilide. Is done.
Group 163 ′ is composed of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupiradifurone, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Is done.
Group 164 ′ comprises Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupiradifurone, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 165 ′ is composed of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupirazifurone, 1 part tetraniliprolol, 1 part teflutrin and 1 part fipronil. The
Group 166 ′ is comprised of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part of flupyrazyflon, 1 part of tetraniliprol, 1 part of tefluthrin and 1 part of brofuranilide. The
Group 167 ′ is composed of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupirazifurone, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil. The
Group 168 ′ is composed of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupiradifurone, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. The
Group 169 ′ is from Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupirmine, 1 part chlorantraniliprole, 1 part teflutrin, and 1 part fipronil. Composed.
Group 170 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part flupirmine, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part brofuranilide. Composed.
Group 171 ′ is from Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupirmine, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 172 ′ is from Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupirmine, 1 part chlorantraniliprole, 1 part bifenthrin, and 1 part brofuranilide. Composed.
Group 173 ′ comprises composition A, wherein each composition of groups 13′-24 ′ is further supplemented with 1 part flupirmine, 1 part cyantraniliprole, 1 part tefritrin and 1 part fipronil. Is done.
Group 174 'comprises composition A, wherein each composition of groups 13'-24' is further supplemented with 1 part flupirmine, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Is done.
Group 175 'is composed of Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part flupirmine, 1 part cyantraniliprolol, 1 part bifenthrin and 1 part fipronil. Is done.
Group 176 'comprises composition A, wherein each composition of groups 13'-24' is further supplemented with 1 part flupirmine, 1 part cyantraniliprolol, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 177 ′ is composed of Composition A, in which each composition of Groups 13 ′ to 24 ′ is further added with 1 part flupirmine, 1 part tetraniliprolol, 1 part tefluthrin and 1 part fipronil. The
Group 178 ′ is composed of Composition A, in which each composition of Groups 13′-24 ′ is further supplemented with 1 part flupirmine, 1 part tetraniliprolol, 1 part teflutrin and 1 part brofuranilide. The
Group 179 ′ is composed of Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part flupirmine, 1 part tetraniliprole, 1 part bifenthrin and 1 part fipronil. The
Group 180 ′ is composed of Composition A, in which each composition of Groups 13′-24 ′ is further supplemented with 1 part flupirmine, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. The
Group 181 ′ is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chlorantraniliprole, 1 part of tefluthrin and 1 part of fipronil to each composition of groups 13 ′ to 24 ′. Consists of A.
Group 182 ′ is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chlorantraniliprole, 1 part of tefluthrin and 1 part of brofuranilide to each composition of groups 13 ′ to 24 ′. Consists of A.
Group 183 ′ is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chlorantraniliprole, 1 part of bifenthrin and 1 part of fipronil to each composition of groups 13 ′ to 24 ′. Consists of A.
Group 184 ′ is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chlorantraniliprole, 1 part of bifenthrin and 1 part of brofuranilide to each composition of groups 13 ′ to 24 ′. Consists of A.
Group 185 ′ is a composition A wherein each part of groups 13′-24 ′ is further supplemented with 1 part triflumezopyrim, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Consists of
Group 186 'is a composition A wherein each part of groups 13'-24' is further supplemented with 1 part trifluoromesopyrim, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Consists of
Group 187 ′ is a composition A in which each composition of groups 13′-24 ′ is further supplemented with 1 part triflumesopyrim, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Consists of
Group 188 'is a composition A wherein each part of groups 13'-24' is further supplemented with 1 part trifluoromesopyrim, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Consists of
Group 189 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part triflumezopyrim, 1 part tetraniliprolol, 1 part teflutrin, and 1 part fipronil. Composed.
Group 190 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part triflumezopyrim, 1 part tetraniliprolol, 1 part tefluthrin and 1 part brofuranilide. Composed.
Group 191 ′ is from Composition A, wherein each composition of Groups 13′-24 ′ is further supplemented with 1 part triflumezopyrim, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil. Composed.
Group 192 'is from Composition A, wherein each composition of Groups 13'-24' is further supplemented with 1 part triflumezopyrim, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. Composed.

The group 193 ′ is composed of the composition A obtained by adding 1000 parts of Bacillus subutilis strain QST713 to each composition of the groups 25 ′ to 108 ′.
Group 194 ′ is composed of Composition A, in which 1000 parts of Agrobactrerium radiobacter strain K84 is further added to each composition of Groups 25 ′ to 108 ′.
The group 195 ′ is composed of the composition A obtained by adding 1000 parts of Bacillus amyloliquefaciens strain MBI 600 to each composition of the groups 25 ′ to 108 ′.
Group 196 ′ is composed of composition A obtained by adding 1000 parts of Bacillus pumilus strain QST2808 to each composition of groups 25 ′ to 108 ′.
The group 197 ′ is composed of the composition A obtained by adding 1000 parts of Burkholderia cepacia to each of the compositions of the groups 25 ′ to 108 ′.
Group 198 ′ is composed of Composition A, in which 1000 parts of Gliocladium catenulatum strain J1446 is further added to each of the compositions of Groups 25 ′ to 108 ′.
Group 199 ′ is composed of composition A obtained by adding 1000 parts of Pseudomonas chlororaphis strain MA342 to each composition of groups 25 ′ to 108 ′.
The group 200 ′ is composed of the composition A obtained by adding 1000 parts of Pseudomonas fluorescens to each of the compositions of the groups 25 ′ to 108 ′.
The group 201 ′ is composed of the composition A obtained by adding 1000 parts of Pythium oligandrum strain DV74 to each composition of the groups 25 ′ to 108 ′.
The group 202 ′ is composed of the composition A obtained by adding 1000 parts of Streptomyces griseoviridis strain K61 to each composition of the groups 25 ′ to 108 ′.
The group 203 ′ is composed of a composition A obtained by adding 1000 parts of Trichoderma gamsii to each of the compositions of the groups 25 ′ to 108 ′.
The group 204 ′ is composed of the composition A obtained by adding 1000 parts of Trichoderma asperellum to each of the compositions of the groups 25 ′ to 108 ′.
Group 205 ′ is composed of composition A, in which 1000 parts of Trichoderma harzianum strain T-22 is further added to each composition of groups 25 ′ to 108 ′.
Group 206 ′ is composed of composition A, in which 1000 parts of Trichoderma virens strain GL-21 are further added to each composition of groups 25 ′ to 108 ′.
Group 207 ′ is composed of composition A obtained by adding 1000 parts of Streptomyces lydicus strain WYEC108 to each composition of groups 25 ′ to 108 ′.
Group 208 ′ is composed of composition A, in which 1000 parts of Bacillus thuringiensis subsp. Kurstraki strain ABTS-351 is added to each composition of groups 25 ′ to 108 ′.
The group 209 ′ is composed of the composition A obtained by adding 1000 parts of Bacillus thuringiensis subs. Kurstraki strain MBP123 to each composition of the groups 25 ′ to 108 ′.
Group 210 ′ is composed of composition A, in which 1000 parts of Bacillus thuringiensis subs. Aizawai strain ABTS-1857 is added to each composition of groups 25 ′ to 108 ′.
Group 211 ′ is composed of composition A obtained by adding 1000 parts of Bacillus thuringiensis strain EX297512 to each composition of groups 25 ′ to 108 ′.
The group 212 ′ is composed of the composition A obtained by adding 1000 parts of Metarhizium anisopliae strain F52 to each composition of the groups 25 ′ to 108 ′.
Group 213 ′ is composed of composition A obtained by adding 1000 parts of Bacillus firmus strain l-1582 to each composition of groups 25 ′ to 108 ′.
Group 214 ′ is composed of composition A obtained by adding 1000 parts of Pasteuria nishizawae strain Pn1 to each composition of groups 25 ′ to 108 ′.
Group 215 ′ is composed of Composition A, in which 10,000 parts of Bradyrhizobium japonicum strain TA-11 are added to each of the compositions of Groups 25 ′ to 108 ′.
Group 216 ′ is comprised of Composition A, in which 10,000 parts of Sinorhizobium meliloti are added to each of the compositions of Groups 25 ′ to 108 ′.
Group 217 ′ is composed of Composition A, in which 10000 parts of Rhizobium leguminosarum is further added to each of the compositions of Groups 25 ′ to 108 ′.
Group 218 ′ is composed of Composition A in which 10,000 parts of Rhizophagus intraradices strain RTI-801 are added to each of the compositions of Groups 25 ′ to 108 ′.
Group 219 ′ is composed of Composition A, in which 10000 parts of Bacillus amyloliquefaciens and 10000 parts of Trichoderma virens are further added to each composition of groups 25 ′ to 108 ′.
Group 220 ′ is composed of Composition A, in which 10000 parts Penicillium bilaiae and 10000 parts Bradyrhizobium japonicum are added to each of the compositions of Groups 25 ′ to 108 ′.
Group 221 ′ is composed of composition A, in which 10000 parts of Penicillium bilaiae and 10000 parts of Mesorhizobium ciceri are added to each of the compositions of groups 25 ′ to 108 ′.
Group 222 ′ is composed of composition A, in which 10,000 parts of Bradyrhizobium japonicum and 10,000 parts of lipochitooligosaccharide are added to each of the compositions of groups 25 ′ to 108 ′.

Group 223 ′ is composed of composition A obtained by adding one part of Bacillus subutilis strain QST713 to each composition of groups 109 ′ to 192 ′.
The group 224 ′ is composed of the composition A obtained by adding one part of the Agrobactrerium radiobacter strain K84 to each composition of the groups 109 ′ to 192 ′.
Group 225 ′ is composed of composition A in which one part of Bacillus amyloliquefaciens strain MBI 600 is further added to each composition of groups 109 ′ to 192 ′.
The group 226 ′ is composed of the composition A obtained by adding one part of Bacillus pumilus strain QST2808 to each composition of the groups 109 ′ to 192 ′.
The group 227 ′ is composed of the composition A obtained by adding one part of Burkholderia cepacia to each of the compositions of the groups 109 ′ to 192 ′.
Group 228 'consists of composition A, in which one part of Gliocladium catenulatum strain J1446 is further added to each of the compositions of groups 109' to 192 '.
Group 229 ′ is composed of composition A in which one part of Pseudomonas chlororaphis strain MA342 is further added to each composition of groups 109 ′ to 192 ′.
Group 230 ′ is composed of composition A, in which one part of Pseudomonas fluorescens is further added to each composition of groups 109 ′ to 192 ′.
The group 231 ′ is composed of the composition A obtained by adding 1 part of Pythium oligandrum strain DV74 to each composition of the groups 109 ′ to 192 ′.
The group 232 ′ is composed of the composition A obtained by adding one part of Streptomyces griseoviridis strain K61 to each composition of the groups 109 ′ to 192 ′.
The group 233 ′ is composed of a composition A obtained by adding one part of Trichoderma gamsii to each composition of the groups 109 ′ to 192 ′.
The group 234 ′ is composed of the composition A obtained by adding one part of Trichoderma asperellum to each of the compositions of the groups 109 ′ to 192 ′.
Group 235 ′ is composed of composition A, in which one part of Trichoderma harzianum strain T-22 is further added to each composition of groups 109 ′ to 192 ′.
Group 236 ′ is composed of composition A, in which one part of Trichoderma virens strain GL-21 is further added to each composition of groups 109 ′ to 192 ′.
Group 237 ′ is composed of composition A obtained by adding one part of Streptomyces lydicus strain WYEC108 to each composition of groups 109 ′ to 192 ′.
Group 238 ′ is composed of composition A, in which one part of Bacillus thuringiensis subsp. Kurstraki strain ABTS-351 is added to each of the compositions of groups 109 ′ to 192 ′.
Group 239 ′ is composed of composition A obtained by adding one part of Bacillus thuringiensis subs. Kurstraki strain MBP123 to each of the compositions of groups 109 ′ to 192 ′.
The group 240 ′ is composed of the composition A obtained by adding 1 part of Bacillus thuringiensis subs.aizawai strain ABTS-1857 to each composition of the groups 109 ′ to 192 ′.
The group 241 ′ is composed of a composition A obtained by adding 1 part of Bacillus thuringiensis strain EX297512 to each composition of the groups 109 ′ to 192 ′.
The group 242 ′ is composed of the composition A obtained by adding 1 part of Metarhizium anisopliae strain F52 to each composition of the groups 109 ′ to 192 ′.
The group 243 ′ is composed of the composition A obtained by adding 1 part of Bacillus firmus strain l-1582 to each composition of the groups 109 ′ to 192 ′.
The group 244 ′ is composed of a composition A obtained by adding 1 part of Pasteuria nishizawae strain Pn1 to each composition of the groups 109 ′ to 192 ′.
Group 245 ′ is composed of composition A, in which 1 part of Bradyrhizobium japonicum strain TA-11 is added to each composition of groups 109 ′ to 192 ′.
Group 246 ′ is composed of composition A, in which one part of Sinorhizobium meliloti is further added to each of the compositions of groups 109 ′ to 192 ′.
The group 247 ′ is composed of the composition A obtained by adding 1 part of Rhizobium leguminosarum to each composition of the groups 109 ′ to 192 ′.
Group 248 ′ is composed of composition A, in which one part of Rhizophagus intraradices strain RTI-801 is added to each composition of groups 109 ′ to 192 ′.
Group 249 ′ is composed of composition A, in which 1 part of Bacillus amyloliquefaciens and 1 part of Trichoderma virens are further added to each composition of groups 109 ′ to 192 ′.
Group 250 ′ is composed of composition A, in which 1 part of Penicillium bilaiae and 1 part of Bradyrhizobium japonicum are added to each composition of groups 109 ′ to 192 ′.
The group 251 ′ is composed of the composition A obtained by adding 1 part of Penicillium bilaiae and 1 part of Mesorhizobium ciceri to each composition of the groups 109 ′ to 192 ′.
The group 252 ′ is composed of the composition A obtained by adding 1 part of Bradyrhizobium japonicum and 1 part of lipochitooligosaccharide to each composition of the groups 109 ′ to 192 ′.

The group 253 ′ is composed of the composition A obtained by adding 1000 parts of fluazaindolizine to each of the compositions of the groups 193 ′ to 222 ′.
The group 254 ′ is composed of a composition A obtained by adding 1000 parts of tioxazaphene to each of the compositions of the groups 193 ′ to 222 ′.
The group 255 ′ is composed of the composition A obtained by adding 1000 parts of fluorene sulfone to each composition of the groups 193 ′ to 222 ′.
The group 256 ′ is composed of a composition A obtained by adding 1000 parts of abamectin to each of the compositions of the groups 193 ′ to 222 ′.
The group 257 ′ is composed of the composition A obtained by adding 1000 parts of fluopyram to each of the compositions of the groups 193 ′ to 222 ′.

The group 258 ′ is composed of the composition A obtained by adding 1 part of fluazaindolizine to each of the compositions of the groups 223 ′ to 252 ′.
The group 259 ′ is composed of a composition A obtained by adding 1 part of thioxazaphene to each composition of the groups 223 ′ to 252 ′.
The group 260 ′ is composed of the composition A obtained by adding 1 part of fluorene sulfone to each of the compositions of the groups 223 ′ to 252 ′.
The group 261 ′ is composed of a composition A obtained by adding 1 part of abamectin to each of the compositions of the groups 223 ′ to 252 ′.
The group 262 ′ is composed of a composition A obtained by adding 1 part of fluopyram to each composition of the groups 223 ′ to 252 ′.

  In the group 263 ′, the combination of SX, component 1, component 2, component 3, component 4, component 5, and component 6 is any combination of the following “7 active component list”. A composition comprising 1000 parts of SX, 1 part of this ingredient 1, 1 part of this ingredient 2, 1 part of this ingredient 3, 1 part of this ingredient 4, 1 part of this ingredient 5 and 1 part of this ingredient 6. Consists of A.

  In “7 active ingredient list”, for example, SX + metconazole + mandestrobin + fluopyram + fludioxonil + metalaxyl + ethaboxam means a combination of SX, metconazole, mandestrobin, fluopyram, fludioxonil, metalaxyl and ethaboxam. 1 is metconazole, this component 2 is mandestrobin, this component 3 is fluopyram, this component 4 is fludioxonil, this component 5 is metalaxyl, and this component 6 is ethaboxam.

"7 Active ingredient list":
SX + metconazole + mandestrobin + fluopyram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + fluopyram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + fluopyram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + fluopyram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + fluopyram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + fluopyram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + fluopyram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + fluopyram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + fluopyram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + fluopyram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + fluopyram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + fluopyram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + fluopyram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + fluopyram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + fluopyram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + fluopyram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + fluopyram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + fluopyram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + fluopyram + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + floxapyroxad + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + floxapyroxad + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + floxapyroxad + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + floxapyroxad + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + floxapyroxad + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + floxapyroxad + thiophanate methyl + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + floxapyroxad + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + floxapyroxad + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + floxapyroxad + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + floxapyroxad + thiuram + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + floxapyroxad + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + floxapyroxad + thiuram + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + floxapyroxad + boscalid + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + floxapyroxad + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + floxapyroxad + boscalid + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + floxapyroxad + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + floxapyroxad + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + floxapyroxad + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + floxapyroxad + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + floxapyroxad + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + floxapyroxad + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + floxapyroxad + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + floxapyroxad + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + floxapyroxad + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + boscalid + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + boscalid + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + boscalid + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + boscalid + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + boscalid + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + boscalid + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + boscalid + thiuram + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + boscalid + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + boscalid + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + boscalid + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + boscalid + boscalid + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + boscalid + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + boscalid + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + boscalid + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + boscalid + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + boscalid + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + boscalid + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + boscalid + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + boscalid + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + penflufen + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + penflufen + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + penflufen + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + penflufen + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + penflufen + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + penflufen + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + penflufen + thiuram + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + penflufen + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + thiuram + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + penflufen + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + penflufen + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + penflufen + boscalid + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + penflufen + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + penflufen + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + penflufen + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + penflufen + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + penflufen + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + penflufen + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + penflufen + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + penflufen + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + tifluzamide + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + tifluzamide + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + thifluzamide + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + tifluzamide + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + thiuram + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + tifluzamide + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + tifluzamide + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + boscalid + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + tifluzamide + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + tifluzamide + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + tifluzamide + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + tifluzamide + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + tifluzamide + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + tifluzamide + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + impylfluxam + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + impylfluxam + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + impylfluxam + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + impylfluxam + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + impylfluxam + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + impylfluxam + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + impylfluxam + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + impylfluxam + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + impylfluxam + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + impylfluxam + thiuram + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + impylfluxam + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + impylfluxam + thiuram + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + impylfluxam + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + impylfluxam + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + impylfluxam + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + impylfluxam + boscalid + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + impylfluxam + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + impylfluxam + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + impylfluxam + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + impylfluxam + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + impylfluxam + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + impylfluxam + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + impylfluxam + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + impylfluxam + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + impylfluxam + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + impylfluxam + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + impylfluxam + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + sedaxane + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + sedaxane + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxane + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + sedaxane + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxane + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + sedaxane + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxane + thiuram + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + sedaxane + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxane + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + sedaxane + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxane + boscalid + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + sedaxane + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxane + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + sedaxane + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxane + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + sedaxane + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + sedaxane + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + sedaxane + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + sedaxane + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + pidiflumethophene + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + pidiflumethofene + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + pidiflumethophene + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + thiuram + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + pidiflumethofene + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + boscalid + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + pidiflumethofene + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + pidiflumethofene + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + pidiflumethofene + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + pidiflumethofene + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + pidiflumethofene + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + isoflucipram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + isoflucipram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + isoflucipram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + isoflucipram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + isoflucipram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + isoflucipram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + isoflucipram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + isoflucipram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + isoflucipram + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + isoflucipram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + isoflucipram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + isoflucipram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + isoflucipram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + isoflucipram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + isoflucipram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + mandestrobin + isoflucipram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + isoflucipram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + isoflucipram + boscalid + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + isoflucipram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + isoflucipram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + isoflucipram + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + isoflucipram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + isoflucipram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + isoflucipram + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + mandestrobin + isoflucipram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + mandestrobin + isoflucipram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + mandestrobin + isoflucipram + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + fluopyram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + fluopyram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + fluopyram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + fluopyram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + fluopyram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + fluopyram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + fluopyram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + fluopyram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + fluopyram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + fluopyram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + fluopyram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + fluopyram + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + floxapyroxad + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + floxapyroxad + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + thiophanate methyl + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + floxapyroxad + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + thiuram + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + floxapyroxad + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + thiuram + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + boscalid + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + floxapyroxad + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + boscalid + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + floxapyroxad + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + floxapyroxad + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + floxapyroxad + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + floxapyroxad + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + boscalid + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + boscalid + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalid + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + boscalid + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalid + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + boscalid + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalid + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + thiuram + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + boscalid + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalid + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + boscalid + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalid + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + boscalid + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + boscalid + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalid + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + boscalid + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalid + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + boscalid + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalid + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + boscalid + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + boscalid + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + boscalid + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + penflufen + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + penflufen + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + penflufen + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + penflufen + thiuram + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + penflufen + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + penflufen + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + boscalid + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + penflufen + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + penflufen + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + penflufen + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + penflufen + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + penflufen + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + penflufen + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + penflufen + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + tifluzamide + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + tifluzamide + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + thifluzamide + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + tifluzamide + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + thiuram + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + tifluzamide + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + boscalid + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + tifluzamide + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + tifluzamide + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + tifluzamide + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + tifluzamide + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + tifluzamide + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + tifluzamide + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + impylfluxam + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + impylfluxam + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + impylfluxam + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + impylfluxam + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + impylfluxam + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + impylfluxam + thiophanate methyl + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + impylfluxam + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + impylfluxam + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + impylfluxam + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + impylfluxam + thiuram + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + impylfluxam + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + impylfluxam + thiuram + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + impylfluxam + boscalid + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + impylfluxam + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + impylfluxam + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + impylfluxam + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + impylfluxam + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + impylfluxam + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + impylfluxam + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + impylfluxam + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + impylfluxam + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + impylfluxam + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + impylfluxam + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + impylfluxam + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + sedaxane + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + sedaxane + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxane + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + sedaxane + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxane + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + sedaxane + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxane + thiuram + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + sedaxane + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxane + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + sedaxane + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxane + boscalid + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + sedaxane + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxane + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + sedaxane + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxane + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + sedaxane + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + sedaxane + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + sedaxane + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + sedaxane + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + pidiflumethophene + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofene + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + pidiflumethophene + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + pidiflumethophene + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofene + thiuram + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + pidiflumethophene + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofene + boscalid + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + pidiflumethofene + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofene + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + pidiflumethophene + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethophene + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofene + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + pidiflumethofene + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethofene + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + pidiflumethofene + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + pidiflumethofene + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + pidiflumethofene + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflucipram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + isoflucipram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflucipram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflucipram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + isoflucipram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflucipram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflucipram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + isoflucipram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflucipram + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + isoflucipram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + isoflucipram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflucipram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflucipram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + isoflucipram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflucipram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + azoxystrobin + isoflucipram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + isoflucipram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflucipram + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + isoflucipram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + isoflucipram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflucipram + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + azoxystrobin + isoflucipram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + azoxystrobin + isoflucipram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + azoxystrobin + isoflucipram + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + fluopyram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + fluopyram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + fluopyram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + fluopyram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + fluopyram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + fluopyram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + fluopyram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + fluopyram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + fluopyram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + fluopyram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + fluopyram + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + floxastrobin + floxapyroxad + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + floxastrobin + floxapyroxad + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + floxastrobin + floxapyroxad + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + floxastrobin + floxapyroxad + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + floxastrobin + floxapyroxad + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + floxastrobin + floxapyroxado + thiophanate methyl + metalaxyl + floxapiproline,
SX + metconazole + floxastrobin + floxapyroxad + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + floxastrobin + floxapyroxad + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + floxastrobin + floxapyroxad + thiabendazole + metalaxyl + floxapiproline,
SX + Metoconazole + Fluoxastrobin + Floxapyroxad + Thiuram + Metalaxyl + Etaboxam,
SX + metconazole + floxastrobin + floxapyroxad + thiuram + metalaxyl + oxathiapiproline,
SX + Metoconazole + Fluoxastrobin + Fluxapiroxado + Thiuram + Metalaxyl + Fluoxapiproline,
SX + Metoconazole + Fluoxastrobin + Fluxapiroxado + Tolcrofosmethyl + Metalaxyl + Etaboxam,
SX + metconazole + floxastrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + floxastrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + Metoconazole + Fluoxastrobin + Floxapyroxad + Boscalid + Metalaxyl + Etaboxam,
SX + metconazole + floxastrobin + floxapyroxad + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + floxastrobin + floxapyroxad + boscalid + metalaxyl + floxapiproline,
SX + metconazole + floxastrobin + floxapyroxado + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + floxastrobin + floxapyroxad + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + floxastrobin + floxapyroxad + aminopyrifen + metalaxyl + floxapiproline,
SX + Metoconazole + Fluoxastrobin + Floxapyroxad + Mancozeb + Metalaxyl + Etaboxam,
SX + metconazole + floxastrobin + floxapyroxad + mancozeb + metalaxyl + oxathiapiproline,
SX + Metoconazole + Fluoxastrobin + Floxapyroxad + Mancozeb + Metalaxyl + Fluoxapiproline,
SX + Metoconazole + Fluoxastrobin + Floxapyroxad + Carbendazim + Metalaxyl + Etaboxam,
SX + metconazole + floxastrobin + floxapyroxad + carbendazim + metalaxyl + oxathiapiproline,
SX + Metoconazole + Fluoxastrobin + Floxapyroxad + Carbendazim + Metalaxyl + Fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + boscalid + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalid + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + boscalid + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalid + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + boscalid + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalid + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + thiuram + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + boscalid + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalid + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + boscalid + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalid + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + boscalid + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + boscalid + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalid + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + boscalid + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalid + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + boscalid + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalid + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + boscalid + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + boscalid + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + boscalid + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + penflufen + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + penflufen + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + penflufen + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + thiuram + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + penflufen + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + penflufen + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + boscalid + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + penflufen + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + penflufen + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + penflufen + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + penflufen + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + penflufen + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + penflufen + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + thiuram + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + boscalid + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + tifluzamide + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + tifluzamide + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + impylfluxam + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + impylfluxam + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + impylfluxam + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + thiuram + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + impylfluxam + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + impylfluxam + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + boscalid + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + impylfluxam + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + impylfluxam + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + impylfluxam + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + impylfluxam + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + impylfluxam + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + sedaxane + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + sedaxane + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + sedaxane + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + thiuram + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + sedaxane + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + sedaxane + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + boscalid + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + sedaxane + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + sedaxane + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + sedaxane + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + sedaxane + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + sedaxane + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + sedaxane + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofene + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + pidiflumethophene + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethophene + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + pidiflumethofene + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofene + thiuram + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethophene + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethophene + boscalid + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + pidiflumethophene + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofene + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofene + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + pidiflumethophene + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofene + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofene + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + pidiflumethophene + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofene + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofene + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + pidiflumethofene + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + pidiflumethofene + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + isoflucipram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + isoflucipram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + isoflucipram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + isoflucipram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + isoflucipram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + isoflucipram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + isoflucipram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + isoflucipram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + fluoxastrobin + isoflucipram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + fluoxastrobin + isoflucipram + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopyram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + fluopyram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopyram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopyram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + fluopyram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopyram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopyram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + fluopyram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopyram + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopyram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + fluopyram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopyram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopyram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + fluopyram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopyram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopyram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + fluopyram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopyram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopyram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + fluopyram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopyram + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopyram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + fluopyram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopyram + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + fluopyram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + fluopyram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + fluopyram + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + floxapyroxad + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + floxapyroxad + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + thiophanate methyl + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + floxapyroxad + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + thiuram + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + floxapyroxad + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + thiuram + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + boscalid + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + floxapyroxad + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + boscalid + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + floxapyroxad + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + floxapyroxad + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + floxapyroxad + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + floxapyroxad + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + boscalid + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + boscalid + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + boscalid + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + boscalid + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + boscalid + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + boscalid + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + boscalid + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + boscalid + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + boscalid + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + boscalid + thiuram + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + boscalid + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + boscalid + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + boscalid + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + boscalid + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + boscalid + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + boscalid + boscalid + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + boscalid + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + boscalid + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + boscalid + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + boscalid + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + boscalid + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + boscalid + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + boscalid + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + boscalid + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + boscalid + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + boscalid + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + boscalid + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + penflufen + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + penflufen + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + penflufen + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + penflufen + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + penflufen + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + penflufen + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + penflufen + thiuram + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + penflufen + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + thiuram + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + penflufen + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + penflufen + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + penflufen + boscalid + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + penflufen + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + penflufen + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + penflufen + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + penflufen + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + penflufen + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + penflufen + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + penflufen + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + penflufen + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + thiuram + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + boscalid + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + tifluzamide + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + tifluzamide + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + impylfluxam + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + impylfluxam + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + impylfluxam + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + thiuram + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + impylfluxam + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + thiuram + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + boscalid + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + impylfluxam + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + boscalid + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + impylfluxam + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + impylfluxam + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + impylfluxam + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + impylfluxam + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + sedaxane + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + sedaxane + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + sedaxane + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiuram + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + sedaxane + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + sedaxane + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + boscalid + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + sedaxane + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + sedaxane + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + sedaxane + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + sedaxane + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + sedaxane + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + sedaxane + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + pidiflumethofene + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + pidiflumethophene + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + pidiflumethophene + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiuram + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + pidiflumethofene + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + pidiflumethophene + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + boscalid + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + pidiflumethofene + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + pidiflumethophene + aminopyrifen + metalaxyl + oxathiapiproline,
SX + Metoconazole + Trifloxystrobin + Pidiflumethophene + Aminopyrifen + Metalaxyl + Fluoxapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + pidiflumethofene + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + pidiflumethofene + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + pidiflumethofene + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + isoflucipram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + isoflucipram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + isoflucipram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + isoflucipram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + thiuram + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + isoflucipram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + isoflucipram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + isoflucipram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + trifloxystrobin + isoflucipram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + trifloxystrobin + isoflucipram + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + fluopyram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + fluopyram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + fluopyram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + fluopyram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + fluopyram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + fluopyram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + fluopyram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + fluopyram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + fluopyram + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + fluopyram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + fluopyram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + fluopyram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + fluopyram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + fluopyram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + fluopyram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + fluopyram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + fluopyram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + fluopyram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + fluopyram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + fluopyram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + fluopyram + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + fluopyram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + fluopyram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + fluopyram + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + fluopyram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + fluopyram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + fluopyram + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + floxapyroxad + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + floxapyroxad + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + thiophanate methyl + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + floxapyroxad + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + thiuram + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + floxapyroxad + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + thiuram + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + boscalid + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + floxapyroxad + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + boscalid + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + floxapyroxad + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + floxapyroxad + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + floxapyroxad + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + floxapyroxad + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + boscalid + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + boscalid + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + boscalid + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + boscalid + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + boscalid + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + boscalid + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + boscalid + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + boscalid + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + boscalid + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + boscalid + thiuram + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + boscalid + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + boscalid + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + boscalid + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + boscalid + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + boscalid + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + boscalid + boscalid + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + boscalid + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + boscalid + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + boscalid + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + boscalid + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + boscalid + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + boscalid + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + boscalid + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + boscalid + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + boscalid + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + boscalid + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + boscalid + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + penflufen + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + penflufen + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + penflufen + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + penflufen + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + penflufen + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + penflufen + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + penflufen + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + penflufen + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + penflufen + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + penflufen + thiuram + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + penflufen + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + penflufen + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + penflufen + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + penflufen + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + penflufen + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + penflufen + boscalid + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + penflufen + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + penflufen + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + penflufen + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + penflufen + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + penflufen + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + penflufen + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + penflufen + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + penflufen + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + penflufen + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + penflufen + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + penflufen + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + tifluzamide + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + tifluzamide + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + tifluzamide + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + thiuram + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + tifluzamide + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + tifluzamide + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + boscalid + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + tifluzamide + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + tifluzamide + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + tifluzamide + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + tifluzamide + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + tifluzamide + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + impylfluxam + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + impylfluxam + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + impylfluxam + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + thiuram + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + impylfluxam + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + thiuram + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + impylfluxam + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + boscalid + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + impylufluxam + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + impylfluxam + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + impylfluxam + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + impylfluxam + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + impylfluxam + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + sedaxane + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + sedaxane + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + sedaxane + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + sedaxane + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + sedaxane + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + sedaxane + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + sedaxane + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + sedaxane + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + sedaxane + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + sedaxane + thiuram + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + sedaxane + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + sedaxane + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + sedaxane + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + sedaxane + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + sedaxane + tolcrophosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + sedaxane + boscalid + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + sedaxane + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + sedaxane + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + sedaxane + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + sedaxane + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + sedaxane + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + sedaxane + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + sedaxane + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + sedaxane + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + sedaxane + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + sedaxane + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + sedaxane + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + pidiflumethophene + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiuram + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + pidiflumethofene + boscalid + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + pidiflumethofene + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + pidiflumethophene + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + pidiflumethofene + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + pidiflumethofene + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + pidiflumethophene + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + pidiflumethofene + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + pidiflumethophene + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + pidiflumethofene + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + isoflucipram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + isoflucipram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + isoflucipram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + isoflucipram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + isoflucipram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + isoflucipram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + isoflucipram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + isoflucipram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + pyraclostrobin + isoflucipram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + pyraclostrobin + isoflucipram + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + fluopyram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + fluopyram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + fluopyram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + fluopyram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + fluopyram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + fluopyram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + fluopyram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + fluopyram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + fluopyram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + fluopyram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + fluopyram + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + floxapyroxad + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + floxapyroxad + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + thiophanate methyl + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + floxapyroxad + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + thiuram + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + floxapyroxad + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + thiuram + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + boscalid + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + floxapyroxad + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + boscalid + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + floxapyroxad + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + floxapyroxad + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + floxapyroxad + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + floxapyroxad + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + boscalid + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + boscalid + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + boscalid + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + boscalid + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + thiuram + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + boscalid + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + boscalid + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + boscalid + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + boscalid + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + boscalid + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + boscalid + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + boscalid + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + boscalid + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + boscalid + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + penflufen + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + penflufen + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + penflufen + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + penflufen + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + penflufen + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + penflufen + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + penflufen + thiuram + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + penflufen + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + penflufen + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + penflufen + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + penflufen + boscalid + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + penflufen + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + penflufen + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + penflufen + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + penflufen + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + penflufen + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + penflufen + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + penflufen + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + penflufen + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + tifluzamide + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + tifluzamide + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + tifluzamide + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + tifluzamide + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + tifluzamide + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + tifluzamide + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + tifluzamide + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + tifluzamide + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + tifluzamide + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + tifluzamide + thiuram + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + tifluzamide + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + tifluzamide + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + tifluzamide + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + tifluzamide + boscalid + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + tifluzamide + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + tifluzamide + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + tifluzamide + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + tifluzamide + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + tifluzamide + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + tifluzamide + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + tifluzamide + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + tifluzamide + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + tifluzamide + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + tifluzamide + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + tifluzamide + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + impylfluxam + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + impylfluxam + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + impylfluxam + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + impylfluxam + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + impylfluxam + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + impylfluxam + thiophanate methyl + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + impylfluxam + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + impylfluxam + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + impylfluxam + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + impylfluxam + thiuram + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + impylfluxam + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + impylfluxam + thiuram + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + impylfluxam + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + impylfluxam + boscalid + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + impylfluxam + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + impylfluxam + boscalid + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + impylfluxam + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + impylfluxam + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + impylfluxam + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + impylfluxam + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + impylfluxam + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + impylfluxam + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + impylfluxam + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + impylfluxam + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + impylfluxam + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + sedaxane + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + sedaxane + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + sedaxane + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + sedaxane + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + sedaxane + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + sedaxane + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + sedaxane + thiuram + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + sedaxane + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + sedaxane + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + sedaxane + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + sedaxane + boscalid + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + sedaxane + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + sedaxane + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + sedaxane + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + sedaxane + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + sedaxane + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + sedaxane + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + sedaxane + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + sedaxane + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + pidiflumethophene + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + pidiflumethophene + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + pidiflumethophene + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + pidiflumethofene + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + pidiflumethophene + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + pidiflumethophene + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + pidiflumethophene + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + thiuram + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + pidiflumethofene + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + pidiflumethophene + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + pidiflumethophene + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + boscalid + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + pidiflumethofene + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + pidiflumethophene + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + pidiflumethophene + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + pidiflumethofene + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + pidiflumethofene + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + pidiflumethofene + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + isoflucipram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + isoflucipram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + isoflucipram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + isoflucipram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + isoflucipram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + isoflucipram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + isoflucipram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + isoflucipram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + isoflucipram + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + isoflucipram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + isoflucipram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + isoflucipram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + isoflucipram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + isoflucipram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + isoflucipram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + isoflucipram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + picoxystrobin + isoflucipram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + isoflucipram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + isoflucipram + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + isoflucipram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + isoflucipram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + isoflucipram + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + picoxystrobin + isoflucipram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + picoxystrobin + isoflucipram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + picoxystrobin + isoflucipram + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprole + fluopyram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + fluopyram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + fluopyram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + fluopyram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + fluopyram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + fluopyram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + fluopyram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + fluopyram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + fluopyram + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + fluopyram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + fluopyram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + fluopyram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + fluopyram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + fluopyram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + fluopyram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + fluopyram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + fluopyram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + fluopyram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + fluopyram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + fluopyram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + fluopyram + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + fluopyram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + fluopyram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + fluopyram + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + fluopyram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + fluopyram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + fluopyram + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + floxapyroxad + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + floxapyroxad + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + thiophanate methyl + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + floxapyroxad + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + thiuram + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + floxapyroxad + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + thiuram + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + floxapyroxad + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + tolcrofosmethyl + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + boscalid + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + floxapyroxad + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + boscalid + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + floxapyroxad + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + floxapyroxad + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + floxapyroxad + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + floxapyroxad + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + floxapyroxad + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprole + boscalid + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + boscalid + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + boscalid + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + boscalid + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + boscalid + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + boscalid + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + boscalid + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + boscalid + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + boscalid + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + boscalid + thiuram + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + boscalid + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + boscalid + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + boscalid + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + boscalid + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + boscalid + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + boscalid + boscalid + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + boscalid + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + boscalid + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + boscalid + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + boscalid + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + boscalid + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + boscalid + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + boscalid + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + boscalid + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + boscalid + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + boscalid + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + boscalid + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + penflufen + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + penflufen + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + penflufen + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + penflufen + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + penflufen + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + penflufen + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + penflufen + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + penflufen + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + penflufen + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + penflufen + thiuram + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + penflufen + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + penflufen + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + penflufen + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + penflufen + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + penflufen + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + penflufen + boscalid + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + penflufen + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + penflufen + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + penflufen + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + penflufen + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + penflufen + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + penflufen + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + penflufen + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + penflufen + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + penflufen + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + penflufen + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + penflufen + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + tifluzamide + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + tifluzamide + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + tifluzamide + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + tifluzamide + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + tifluzamide + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + tifluzamide + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + tifluzamide + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + tifluzamide + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + tifluzamide + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + tifluzamide + thiuram + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + tifluzamide + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + tifluzamide + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + tifluzamide + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + tifluzamide + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + tifluzamide + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + tifluzamide + boscalid + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + tifluzamide + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + tifluzamide + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + tifluzamide + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + tifluzamide + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + tifluzamide + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + tifluzamide + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + tifluzamide + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + tifluzamide + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + tifluzamide + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + tifluzamide + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + tifluzamide + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + impylfluxam + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + impylfluxam + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + impylfluxam + fludioxonil + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprole + impylfluxam + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + impylfluxam + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + impylfluxam + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + impylfluxam + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + impylfluxam + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + impylfluxam + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprole + impylfluxam + thiuram + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + impylfluxam + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + impylfluxam + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + impylfluxam + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + impylfluxam + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + impylfluxam + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + impylfluxam + boscalid + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + impylfluxam + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + impylfluxam + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + impylfluxam + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + impylfluxam + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + impylfluxam + aminopyrifen + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + impylfluxam + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + impylfluxam + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + impylfluxam + mancozeb + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + impylfluxam + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + impylfluxam + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + impylfluxam + carbendazim + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprole + sedaxane + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + sedaxane + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + sedaxane + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + sedaxane + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + sedaxane + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + sedaxane + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + sedaxane + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + sedaxane + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + sedaxane + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + sedaxane + thiuram + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + sedaxane + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + sedaxane + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + sedaxane + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + sedaxane + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + sedaxane + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + sedaxane + boscalid + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + sedaxane + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + sedaxane + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + sedaxane + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + sedaxane + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + sedaxane + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + sedaxane + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + sedaxane + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + sedaxane + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + sedaxane + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + sedaxane + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + sedaxane + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + pidiflumethophen + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + pidiflumethophene + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + pidiflumethophene + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + pidiflumethophene + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + thiabendazole + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + thiuram + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + pidiflumethophene + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + pidiflumethophene + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + pidiflumethofene + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + pidiflumethofene + boscalid + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + pidiflumethofene + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + pidiflumethophene + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + pidiflumethofene + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + pidiflumethofene + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + pidiflumethofene + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + pidiflumethophene + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + pidiflumethophene + carbendazim + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + isoflucipram + fludioxonil + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + isoflucipram + fludioxonil + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + isoflucipram + fludioxonil + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + isoflucipram + thiophanate methyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + isoflucipram + thiophanate methyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + isoflucipram + thiophanate methyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + isoflucipram + thiabendazole + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + isoflucipram + thiabendazole + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + isoflucipram + thiabendazole + metalaxyl + floxapiproline,
SX + metconazole + methyltetraprol + isoflucipram + thiuram + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + isoflucipram + thiuram + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + isoflucipram + thiuram + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + isoflucipram + tolcrofosmethyl + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + isoflucipram + tolcrofosmethyl + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + isoflucipram + tolcrofosmethyl + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + isoflucipram + boscalid + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + isoflucipram + boscalid + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + isoflucipram + boscalid + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprole + isoflucipram + aminopyrifen + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprole + isoflucipram + aminopyrifen + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + isoflucipram + aminopyrifen + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + isoflucipram + mancozeb + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + isoflucipram + mancozeb + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprol + isoflucipram + mancozeb + metalaxyl + fluoxapiproline,
SX + metconazole + methyltetraprol + isoflucipram + carbendazim + metalaxyl + ethaboxam,
SX + metconazole + methyltetraprol + isoflucipram + carbendazim + metalaxyl + oxathiapiproline,
SX + metconazole + methyltetraprole + isoflucipram + carbendazim + metalaxyl + fluoxapiproline.

Group 264 ′ is composed of Composition A consisting of 1 part tebuconazole instead of 1 part metconazole contained in each composition of group 263 ′.
Group 265 ′ is composed of composition A consisting of 1 part difenoconazole instead of 1 part metconazole contained in each composition of group 263 ′.
Group 266 ′ is composed of composition A consisting of 1 part triticonazole instead of 1 part metconazole contained in each composition of group 263 ′.
Group 267 ′ is composed of composition A consisting of 1 part prothioconazole instead of 1 part metconazole contained in each composition of group 263 ′.
Group 268 ′ is composed of composition A consisting of 1 part diniconazole instead of 1 part metconazole contained in each composition of group 263 ′.
Group 269 ′ is composed of composition A consisting of 1 part of diniconazole M instead of 1 part of metconazole contained in each composition of group 263 ′.
Group 270 'is composed of composition A consisting of 1 part ipconazole instead of 1 part metconazole contained in each composition of group 263'.
Group 271 ′ is composed of composition A consisting of 1 part of prochloraz instead of 1 part of metconazole contained in each composition of group 263 ′.
Group 272 ′ is composed of composition A consisting of 1 part fluquinconazole instead of 1 part metconazole contained in each composition of group 263 ′.
Group 273 ′ is composed of composition A consisting of 1 part bromoconazole instead of 1 part metconazole contained in each composition of group 263 ′.
Group 274 ′ is composed of composition A consisting of 1 part of mefentrifluconazole instead of 1 part of metconazole contained in each composition of group 263 ′.

  In the group 275 ′, the combination of SX, main component 1, main component 2, main component 3, main component 4, main component 5 and main component 6 is a combination of any of the above “7 active ingredient lists”. A composition comprising 1 part SX, 1 part present component 1, 1 part present component 2, 1 part present component 3, 1 part present component 4, 1 part present component 5 and 1 part present component 6. Consists of A.

Group 276 ′ is composed of composition A consisting of 1 part tebuconazole instead of 1 part metconazole contained in each composition of group 275 ′.
Group 277 'is composed of composition A consisting of 1 part difenoconazole instead of 1 part metconazole contained in each composition of group 275'.
Group 278 ′ is composed of Composition A consisting of 1 part triticonazole instead of 1 part metconazole contained in each composition of group 275 ′.
Group 279 ′ is composed of composition A consisting of 1 part prothioconazole instead of 1 part metconazole contained in each composition of group 275 ′.
Group 280 'is composed of composition A consisting of 1 part diniconazole instead of 1 part metconazole contained in each composition of group 275'.
Group 281 'is composed of Composition A consisting of 1 part Diniconazole M in place of 1 part metconazole contained in each composition of Group 275'.
Group 282 ′ is composed of Composition A consisting of 1 part ipconazole instead of 1 part metconazole contained in each composition of group 275 ′.
Group 283 ′ is composed of Composition A consisting of 1 part prochloraz instead of 1 part metconazole contained in each composition of Group 275 ′.
Group 284 ′ is composed of Composition A consisting of 1 part fluquinconazole instead of 1 part metconazole contained in each composition of group 275 ′.
Group 285 'is composed of Composition A consisting of 1 part bromoconazole instead of 1 part metconazole contained in each composition of group 275'.
Group 286 ′ is composed of Composition A consisting of 1 part of mefentrifluconazole instead of 1 part of metconazole contained in each composition of Group 275 ′.

Group 287 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts clothianidin, 1000 parts chlorantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Composed.
Group 288 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts clothianidin, 1000 parts chlorantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Composed.
Group 289 'is from Composition A wherein each composition of Groups 263'-274' is further supplemented with 1000 parts clothianidin, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 290 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts clothianidin, 1000 parts chlorantraniliprole, 1000 parts bifenthrin, and 1000 parts brofuranilide. Composed.
Group 291 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts clothianidin, 1000 parts cyantraniliprole, 1000 parts tefluthrin and 1000 parts fipronil. Is done.
Group 292 ′ comprises composition A, in which 1000 parts clothianidin, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide are added to each of the compositions of groups 263′-274 ′. Is done.
Group 293 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts clothianidin, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Is done.
Group 294 ′ is composed of Composition A with each composition of Groups 263′-274 ′ plus 1000 parts clothianidin, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Is done.
Group 295 ′ is comprised of Composition A with each composition of Groups 263′-274 ′ plus 1000 parts clothianidin, 1000 parts tetraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. The
Group 296 ′ is composed of Composition A in which 1000 parts clothianidin, 1000 parts tetraniliprolol, 1000 parts tefluthrin, and 1000 parts brofuranilide are added to each composition of groups 263′-274 ′. The
Group 297 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts clothianidin, 1000 parts tetraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. The
Group 298 ′ is composed of Composition A, in which 1000 parts clothianidin, 1000 parts tetraniliprolol, 1000 parts bifenthrin, and 1000 parts brofuranilide are added to each of the compositions of groups 263′-274 ′. The
Group 299 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts imidacloprid, 1000 parts chlorantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Composed.
Group 300 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts imidacloprid, 1000 parts chlorantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Composed.
Group 301 ′ is from Composition A wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts imidacloprid, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 302 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts imidacloprid, 1000 parts chlorantraniliprole, 1000 parts bifenthrin, and 1000 parts brofuranilide. Composed.
Group 303 ′ is composed of Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts imidacloprid, 1000 parts cyantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Is done.
Group 304 ′ is composed of Composition A with each composition of Groups 263′-274 ′ plus 1000 parts imidacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Is done.
Group 305 ′ comprises composition A, in which 1000 parts of imidacloprid, 1000 parts of cyantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each of the compositions of groups 263 ′ to 274 ′. Is done.
Group 306 ′ comprises composition A, in which 1000 parts imidacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin, and 1000 parts brofuranilide are added to each of the compositions of groups 263′-274 ′. Is done.
Group 307 ′ is composed of Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts imidacloprid, 1000 parts tetraniliprole, 1000 parts tefritrin and 1000 parts fipronil. The
Group 308 ′ is comprised of Composition A, in which 1000 parts of imidacloprid, 1000 parts of tetraniliprolol, 1000 parts of tefritrin and 1000 parts of brofuranilide are further added to each composition of groups 263′-274 ′. The
Group 309 ′ is comprised of Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts imidacloprid, 1000 parts tetraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. The
Group 310 ′ is composed of Composition A, in which 1000 parts of imidacloprid, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each of the compositions of groups 263 ′ to 274 ′. The
Group 311 ′ is from Composition A wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiamethoxam, 1000 parts chlorantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Composed.
Group 312 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiamethoxam, 1000 parts chlorantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Composed.
Group 313 ′ is from Composition A wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiamethoxam, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 314 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiamethoxam, 1000 parts chlorantraniliprole, 1000 parts bifenthrin, and 1000 parts brofuranilide. Composed.
Group 315 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts fipronil. Is done.
Group 316 ′ is comprised of Composition A with each composition of Groups 263′-274 ′ plus 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts teflutrin, and 1000 parts brofuranilide. Is done.
Group 317 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Is done.
Group 318 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiamethoxam, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Is done.
Group 319 ′ is comprised of Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiamethoxam, 1000 parts tetraniliprole, 1000 parts tefluthrin and 1000 parts fipronil. The
Group 320 ′ is composed of Composition A, in which 1000 parts of thiamethoxam, 1000 parts of tetraniliprolol, 1000 parts of tefluthrin and 1000 parts of brofuranilide are added to each of the compositions of groups 263 ′ to 274 ′. The
Group 321 ′ is composed of Composition A in which 1000 parts of thiamethoxam, 1000 parts of tetraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each composition of groups 263′-274 ′. The
Group 322 ′ is composed of Composition A, in which 1000 parts of thiamethoxam, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each composition of groups 263′-274 ′. The
Group 323 ′ is from Composition A wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiacloprid, 1000 parts chlorantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Composed.
Group 324 ′ is from Composition A wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiacloprid, 1000 parts chlorantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Composed.
Group 325 'is from Composition A wherein each composition of Groups 263'-274' is further supplemented with 1000 parts thiacloprid, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 326 ′ is from Composition A wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiacloprid, 1000 parts chlorantraniliprole, 1000 parts bifenthrin, and 1000 parts brofuranilide. Composed.
Group 327 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts fipronil. Is done.
Group 328 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Is done.
Group 329 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Is done.
Group 330 'is composed of Composition A with each composition of Groups 263'-274' plus 1000 parts thiacloprid, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Is done.
Group 331 ′ is composed of Composition A in which 1000 parts of thiacloprid, 1000 parts of tetraniliprolol, 1000 parts of tefluthrin and 1000 parts of fipronil are further added to each composition of groups 263 ′ to 274 ′. The
Group 332 ′ is composed of Composition A, in which 1000 parts of thiacloprid, 1000 parts of tetraniliprole, 1000 parts of tefluthrin and 1000 parts of brofuranilide are further added to each composition of groups 263 ′ to 274 ′. The
Group 333 ′ is composed of Composition A in which 1000 parts of thiacloprid, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of fipronil are further added to each composition of groups 263 ′ to 274 ′. The
Group 334 ′ is composed of Composition A, in which 1000 parts of thiacloprid, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each composition of groups 263 ′ to 274 ′. The
Group 335 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupirazifuron, 1000 parts chlorantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Composed.
Group 336 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupirazifuron, 1000 parts chlorantraniliprole, 1000 parts teflutrin, and 1000 parts brofuranilide. Composed.
Group 337 ′ is from Composition A wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupirazifuron, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 338 ′ is from Composition A wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupirazifuron, 1000 parts chlorantraniliprole, 1000 parts bifenthrin, and 1000 parts brofuranilide. Composed.
Group 339 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupiradifurone, 1000 parts cyantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Is done.
Group 340 ′ is comprised of Composition A with each composition of Groups 263′-274 ′ plus 1000 parts flupirazifuron, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Is done.
Group 341 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupiradifurone, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Is done.
Group 342 ′ is comprised of Composition A with each composition of Groups 263′-274 ′ plus 1000 parts flupirazifuron, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Is done.
Group 343 ′ is composed of Composition A, in which each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupirazifurone, 1000 parts tetraniliprole, 1000 parts tefritrin, and 1000 parts fipronil. The
Group 344 ′ is composed of Composition A, in which each composition of Groups 263′-274 ′ is further added with 1000 parts flupirazifuron, 1000 parts tetraniliprole, 1000 parts tefluthrin and 1000 parts brofuranilide. The
Group 345 ′ is composed of Composition A, in which each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupiradifurone, 1000 parts tetraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. The
Group 346 ′ is comprised of Composition A, in which each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupiradifurone, 1000 parts tetraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. The
Group 347 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupirmine, 1000 parts chlorantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Composed.
Group 348 'is from Composition A, wherein each composition of Groups 263'-274' is further supplemented with 1000 parts flupirmine, 1000 parts chlorantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Composed.
Group 349 'is from Composition A wherein each composition of Groups 263'-274' is further supplemented with 1000 parts flupirmine, 1000 parts chlorantraniliprole, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 350 'is from Composition A, wherein each composition of Groups 263'-274' is further supplemented with 1000 parts flupirmine, 1000 parts chlorantraniliprole, 1000 parts bifenthrin, and 1000 parts brofuranilide. Composed.
Group 351 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupirmine, 1000 parts cyantraniliprole, 1000 parts tefritrin and 1000 parts fipronil. Is done.
Group 352 ′ is comprised of Composition A with each composition of Groups 263′-274 ′ plus 1000 parts flupirmine, 1000 parts cyantraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. Is done.
Group 353 ′ comprises Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupirmine, 1000 parts cyantraniliprole, 1000 parts bifenthrin, and 1000 parts fipronil. Is done.
Group 354 ′ is composed of Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupirimine, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Is done.
Group 355 ′ is composed of Composition A in which 1000 parts of flupyrimine, 1000 parts of tetraniliprolol, 1000 parts of tefluthrin and 1000 parts of fipronil are further added to each composition of groups 263′-274 ′. The
Group 356 ′ is composed of Composition A, in which each composition of Groups 263′-274 ′ is further supplemented with 1000 parts flupirmine, 1000 parts tetraniliprole, 1000 parts tefluthrin, and 1000 parts brofuranilide. The
Group 357 ′ is composed of Composition A in which 1000 parts flupirmine, 1000 parts tetraniliprolol, 1000 parts bifenthrin, and 1000 parts fipronil are further added to each composition of groups 263′-274 ′. The
Group 358 ′ is composed of Composition A in which 1000 parts of flupyrimine, 1000 parts of tetraniliprolol, 1000 parts of bifenthrin and 1000 parts of brofuranilide are further added to each composition of groups 263 ′ to 274 ′. The
Group 359 ′ is a composition obtained by adding 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprole, 1000 parts of teflutrin, and 1000 parts of fipronil to each composition of groups 263 ′ to 274 ′. Consists of A.
Group 360 ′ is a composition obtained by adding 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprole, 1000 parts of teflutrin, and 1000 parts of brofuranilide to each composition of groups 263 ′ to 274 ′. Consists of A.
Group 361 ′ is a composition obtained by adding 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprole, 1000 parts of bifenthrin and 1000 parts of fipronil to each composition of groups 263 ′ to 274 ′. Consists of A.
Group 362 ′ is a composition obtained by adding 1000 parts of triflumezopyrim, 1000 parts of chlorantraniliprole, 1000 parts of bifenthrin and 1000 parts of brofuranilide to each composition of groups 263 ′ to 274 ′. Consists of A.
Group 363 ′ is a composition A comprising each of the compositions of groups 263′-274 ′ plus 1000 parts triflumezopyrim, 1000 parts cyantraniliprole, 1000 parts teflutrin, and 1000 parts fipronil. Consists of
Group 364 'is a composition A comprising each of the compositions of groups 263'-274' plus 1000 parts triflumezopyrim, 1000 parts cyantraniliprole, 1000 parts teflutrin, and 1000 parts brofuranilide. Consists of
Group 365 ′ is a composition A in which 1000 parts of triflumezopyrim, 1000 parts cyantraniliprole, 1000 parts bifenthrin, and 1000 parts fipronil are further added to each composition of groups 263′-274 ′. Consists of
Group 366 'is a composition A comprising each of the compositions of groups 263'-274' plus 1000 parts triflumezopyrim, 1000 parts cyantraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Consists of
Group 367 'is from Composition A wherein each composition of Groups 263'-274' is further supplemented with 1000 parts triflumezopyrim, 1000 parts tetraniliprole, 1000 parts tefritrin, and 1000 parts fipronil. Composed.
Group 368 ′ is from Composition A wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts triflumezopyrim, 1000 parts tetraniliprolol, 1000 parts tefritrin, and 1000 parts brofuranilide. Composed.
Group 369 'is from Composition A wherein each composition of Groups 263'-274' is further supplemented with 1000 parts triflumezopyrim, 1000 parts tetraniliprolol, 1000 parts bifenthrin and 1000 parts fipronil. Composed.
Group 370 ′ is from Composition A, wherein each composition of Groups 263′-274 ′ is further supplemented with 1000 parts triflumezopyrim, 1000 parts tetraniliprole, 1000 parts bifenthrin and 1000 parts brofuranilide. Composed.

Group 371 ′ comprises Composition A wherein each part of Groups 275′-286 ′ is further supplemented with 1 part clothianidin, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part fipronil. Consists of
Group 372 ′ is from Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part clothianidin, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part brofuranilide. Composed.
Group 373 'is from Composition A wherein each composition of Groups 275'-286' is further supplemented with 1 part clothianidin, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 374 'is from Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part clothianidin, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 375 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part clothianidin, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Is done.
Group 376 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part clothianidin, 1 part cyantraniliprole, 1 part tefluthrin, and 1 part brofuranilide. Is done.
Group 377 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part clothianidin, 1 part cyantraniliprolol, 1 part bifenthrin and 1 part fipronil. Is done.
Group 378 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part clothianidin, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 379 ′ is composed of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part clothianidin, 1 part tetraniliprole, 1 part teflutrin, and 1 part fipronil. The
Group 380 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part clothianidin, 1 part tetraniliprole, 1 part teflutrin, and 1 part brofuranilide. The
Group 381 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part clothianidin, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil. The
Group 382 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part clothianidin, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. The
Group 383 'is from Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part imidacloprid, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part fipronil. Composed.
Group 384 'is from Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part imidacloprid, 1 part chlorantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Composed.
Group 385 ′ is from Composition A wherein each part of Groups 275′-286 ′ is further supplemented with 1 part imidacloprid, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 386 'is from Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part imidacloprid, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 387 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Is done.
Group 388 'comprises composition A, wherein each composition of groups 275'-286' is further supplemented with 1 part imidacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Is done.
Group 389 'comprises Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Is done.
Group 390 'comprises composition A, wherein each composition of groups 275'-286' is further supplemented with 1 part imidacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 391 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part imidacloprid, 1 part tetraniliprolol, 1 part tefluthrin and 1 part fipronil. The
Group 392 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part imidacloprid, 1 part tetraniliprole, 1 part tefluthrin and 1 part brofuranilide. The
Group 393 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part imidacloprid, 1 part tetraniliprole, 1 part bifenthrin and 1 part fipronil. The
Group 394 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part imidacloprid, 1 part tetraniliprole, 1 part bifenthrin and 1 part brofuranilide. The
Group 395 ′ is from Composition A wherein each part of Groups 275′-286 ′ is further supplemented with 1 part thiamethoxam, 1 part chlorantraniliprole, 1 part tefluthrin and 1 part fipronil. Composed.
Group 396 'is from Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part thiamethoxam, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part brofuranilide. Composed.
Group 397 'is from Composition A wherein each part of Groups 275'-286' is further supplemented with 1 part thiamethoxam, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 398 'is from Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part thiamethoxam, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 399 'comprises Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part thiamethoxam, 1 part cyantraniliprole, 1 part teflutrin, and 1 part fipronil. Is done.
Group 400 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiamethoxam, 1 part cyantraniliprole, 1 part teflutrin, and 1 part brofuranilide. Is done.
Group 401 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Is done.
Group 402 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiamethoxam, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 403 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiamethoxam, 1 part tetraniliprolol, 1 part teflutrin, and 1 part fipronil. The
Group 404 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiamethoxam, 1 part tetraniliprolol, 1 part teflutrin, and 1 part brofuranilide. The
Group 405 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiamethoxam, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil. The
Group 406 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiamethoxam, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. The
Group 407 'is from Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part thiacloprid, 1 part chlorantraniliprole, 1 part tefluthrin and 1 part fipronil. Composed.
Group 408 'is from Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part thiacloprid, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part brofuranilide. Composed.
Group 409 ′ is from Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiacloprid, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 410 ′ is from Composition A wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiacloprid, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 411 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Is done.
Group 412 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiacloprid, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Is done.
Group 413 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Is done.
Group 414 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiacloprid, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 415 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiacloprid, 1 part tetraniliprolol, 1 part tefluthrin and 1 part fipronil. The
Group 416 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiacloprid, 1 part tetraniliprole, 1 part tefluthrin, and 1 part brofuranilide. The
Group 417 ′ is composed of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiacloprid, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil. The
Group 418 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part thiacloprid, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. The
Group 419 ′ is from Composition A wherein each part of Groups 275′-286 ′ is further supplemented with 1 part flupiradifurone, 1 part chlorantraniliprole, 1 part tefluthrin and 1 part fipronil. Composed.
Group 420 'is from Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part flupirazifurone, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part brofuranilide. Composed.
Group 421 ′ is from Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupiradifurone, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 422 ′ is from Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupiradifurone, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 423 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupiradifurone, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Is done.
Group 424 'consists of Composition A in which each composition of Groups 275'-286' is further supplemented with 1 part flupiradifurone, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Is done.
Group 425 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupiradifurone, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Is done.
Group 426 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupiradifurone, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 427 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupiradifurone, 1 part tetraniliprolol, 1 part tefluthrin and 1 part fipronil. The
Group 428 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupirazifurone, 1 part tetraniliprolol, 1 part tefluthrin and 1 part brofuranilide. The
Group 429 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupiradifurone, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil. The
Group 430 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupiradifurone, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. The
Group 431 ′ is from Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part fipronil. Composed.
Group 432 ′ is from Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part chlorantraniliprole, 1 part tefluthrin, and 1 part brofuranilide. Composed.
Group 433 ′ is from Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part fipronil. Composed.
Group 434 ′ is from Composition A wherein each part of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part chlorantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Composed.
Group 435 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part cyantraniliprole, 1 part tefluthrin and 1 part fipronil. Is done.
Group 436 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part cyantraniliprole, 1 part tefluthrin, and 1 part brofuranilide. Is done.
Group 437 ′ comprises Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Is done.
Group 438 'comprises Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part flupirmine, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Is done.
Group 439 ′ is comprised of Composition A wherein each part of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part tetraniliprolol, 1 part tefritrin and 1 part fipronil. The
Group 440 ′ is comprised of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part tetraniliprolol, 1 part teflutrin, and 1 part brofuranilide. The
Group 441 ′ is composed of Composition A in which each composition of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil. The
Group 442 ′ is composed of Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part flupirmine, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. The
Group 443 ′ is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chlorantraniliprole, 1 part of tefluthrin and 1 part of fipronil to each composition of groups 275 ′ to 286 ′ Consists of A.
Group 444 ′ is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chlorantraniliprole, 1 part of tefluthrin and 1 part of brofuranilide to each composition of groups 275 ′ to 286 ′. Consists of A.
Group 445 ′ is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chlorantraniliprole, 1 part of bifenthrin and 1 part of fipronil to each composition of groups 275 ′ to 286 ′. Consists of A.
Group 446 ′ is a composition obtained by adding 1 part of triflumezopyrim, 1 part of chlorantraniliprole, 1 part of bifenthrin and 1 part of brofuranilide to each composition of groups 275 ′ to 286 ′. Consists of A.
Group 447 ′ comprises Composition A wherein each part of Groups 275′-286 ′ is further supplemented with 1 part triflumezopyrim, 1 part cyantraniliprolol, 1 part tefluthrin and 1 part fipronil. Consists of
Group 448 ′ comprises Composition A wherein each part of Groups 275′-286 ′ is further supplemented with 1 part triflumezopyrim, 1 part cyantraniliprole, 1 part tefluthrin and 1 part brofuranilide. Consists of
Group 449 ′ comprises Composition A wherein each part of Groups 275′-286 ′ is further supplemented with 1 part triflumezopyrim, 1 part cyantraniliprole, 1 part bifenthrin and 1 part fipronil. Consists of
Group 450 ′ is a composition A wherein each part of groups 275′-286 ′ is further supplemented with 1 part trifluoromesopyrim, 1 part cyantraniliprole, 1 part bifenthrin and 1 part brofuranilide. Consists of
Group 451 'is from Composition A, wherein each composition of Groups 275'-286' is further supplemented with 1 part triflumezopyrim, 1 part tetraniliprole, 1 part tefluthrin and 1 part fipronil. Composed.
Group 452 ′ is from Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part triflumezopyrim, 1 part tetraniliprolol, 1 part tefluthrin, and 1 part brofuranilide. Composed.
Group 453 ′ is from Composition A wherein each part of Groups 275′-286 ′ is further supplemented with 1 part triflumezopyrim, 1 part tetraniliprolol, 1 part bifenthrin and 1 part fipronil. Composed.
Group 454 ′ is from Composition A, wherein each composition of Groups 275′-286 ′ is further supplemented with 1 part triflumezopyrim, 1 part tetraniliprolol, 1 part bifenthrin and 1 part brofuranilide. Composed.

Group 455 ′ is composed of composition A obtained by adding 1000 parts of Bacillus subutilis strain QST713 to each composition of groups 287 ′ to 370 ′.
The group 456 ′ is composed of the composition A obtained by adding 1000 parts of Agrobactrerium radiobacter strain K84 to each composition of the groups 287 ′ to 370 ′.
Group 457 ′ is composed of composition A obtained by adding 1000 parts of Bacillus amyloliquefaciens strain MBI 600 to each composition of groups 287 ′ to 370 ′.
The group 458 ′ is composed of the composition A obtained by adding 1000 parts of Bacillus pumilus strain QST2808 to each composition of the groups 287 ′ to 370 ′.
Group 459 ′ is composed of Composition A obtained by adding 1000 parts of Burkholderia cepacia to each of the compositions of Groups 287 ′ to 370 ′.
Group 460 ′ is composed of composition A, in which 1000 parts of Gliocladium catenulatum strain J1446 is further added to each composition of groups 287 ′ to 370 ′.
The group 461 ′ is composed of the composition A obtained by adding 1000 parts of Pseudomonas chlororaphis strain MA342 to each composition of the groups 287 ′ to 370 ′.
The group 462 ′ is composed of the composition A obtained by adding 1000 parts of Pseudomonas fluorescens to each composition of the groups 287 ′ to 370 ′.
The group 463 ′ is composed of the composition A obtained by adding 1000 parts of Pythium oligandrum strain DV74 to each composition of the groups 287 ′ to 370 ′.
Group 464 ′ is composed of composition A, in which 1000 parts of Streptomyces griseoviridis strain K61 is further added to each composition of groups 287 ′ to 370 ′.
Group 465 ′ is composed of composition A obtained by adding 1000 parts of Trichoderma gamsii to each composition of groups 287 ′ to 370 ′.
The group 466 ′ is composed of the composition A obtained by adding 1000 parts of Trichoderma asperellum to each composition of the groups 287 ′ to 370 ′.
Group 467 ′ is composed of composition A, in which 1000 parts of Trichoderma harzianum strain T-22 is further added to each composition of groups 287 ′ to 370 ′.
Group 468 ′ is composed of composition A, in which 1000 parts of Trichoderma virens strain GL-21 are further added to each composition of groups 287 ′ to 370 ′.
Group 469 ′ is composed of composition A obtained by adding 1000 parts of Streptomyces lydicus strain WYEC108 to each composition of groups 287 ′ to 370 ′.
Group 470 ′ is composed of composition A, in which 1000 parts of Bacillus thuringiensis subsp. Kurstraki strain ABTS-351 is added to each composition of groups 287 ′ to 370 ′.
The group 471 ′ is composed of the composition A obtained by adding 1000 parts of Bacillus thuringiensis subs. Kurstraki strain MBP123 to each composition of the groups 287 ′ to 370 ′.
Group 472 ′ is composed of composition A obtained by adding 1000 parts of Bacillus thuringiensis subs.aizawai strain ABTS-1857 to each composition of groups 287′-370 ′.
Group 473 ′ is composed of composition A obtained by adding 1000 parts of Bacillus thuringiensis strain EX297512 to each composition of groups 287 ′ to 370 ′.
The group 474 ′ is composed of the composition A obtained by adding 1000 parts of Metarhizium anisopliae strain F52 to each composition of the groups 287 ′ to 370 ′.
Group 475 ′ is composed of composition A, in which 1000 parts of Bacillus firmus strain l-1582 is added to each of the compositions of groups 287 ′ to 370 ′.
The group 476 ′ is composed of the composition A obtained by adding 1000 parts of Pasteuria nishizawae strain Pn1 to each composition of the groups 287 ′ to 370 ′.
Group 477 ′ is composed of composition A, in which 10000 parts of Bradyrhizobium japonicum strain TA-11 is further added to each of the compositions of groups 287 ′ to 370 ′.
Group 478 ′ is composed of Composition A, in which 10000 parts of Sinorhizobium meliloti are further added to each of the compositions of Groups 287 ′ to 370 ′.
Group 479 ′ is composed of Composition A, in which 10000 parts of Rhizobium leguminosarum is further added to each of the compositions of Groups 287 ′ to 370 ′.
Group 480 ′ is composed of Composition A obtained by adding 10,000 parts of Rhizophagus intraradices strain RTI-801 to each of the compositions of Groups 287 ′ to 370 ′.
Group 481 ′ is composed of Composition A, in which 10000 parts of Bacillus amyloliquefaciens and 10000 parts of Trichoderma virens are further added to each composition of Groups 287 ′ to 370 ′.
Group 482 ′ is comprised of Composition A with each composition of Groups 287′-370 ′ plus 10000 parts Penicillium bilaiae and 10000 parts Bradyrhizobium japonicum.
Group 483 ′ is composed of composition A, in which 10000 parts of Penicillium bilaiae and 10000 parts of Mesorhizobium ciceri are added to each composition of groups 287 ′ to 370 ′.
Group 484 ′ is composed of Composition A, in which 10000 parts Bradyrhizobium japonicum and 10000 parts lipochitooligosaccharide are added to each of the compositions of groups 287 ′ to 370 ′.

Group 485 ′ is composed of composition A, in which 1 part of Bacillus subutilis strain QST713 is added to each of the compositions of groups 371 ′ to 454 ′.
Group 486 ′ is composed of composition A, in which one part of Agrobactrerium radiobacter strain K84 is further added to each composition of groups 371 ′ to 454 ′.
The group 487 ′ is composed of the composition A obtained by adding 1 part of Bacillus amyloliquefaciens strain MBI 600 to each composition of the groups 371 ′ to 454 ′.
Group 488 ′ is composed of composition A, in which one part of Bacillus pumilus strain QST2808 is further added to each of the compositions of groups 371 ′ to 454 ′.
The group 489 ′ is composed of the composition A obtained by adding 1 part of Burkholderia cepacia to each composition of the groups 371 ′ to 454 ′.
Group 490 'is composed of composition A, in which 1 part of Gliocladium catenulatum strain J1446 is further added to each of the compositions of groups 371'-454'.
The group 491 ′ is composed of a composition A obtained by adding 1 part of Pseudomonas chlororaphis strain MA342 to each composition of the groups 371 ′ to 454 ′.
The group 492 ′ is composed of a composition A obtained by adding 1 part of Pseudomonas fluorescens to each composition of the groups 371 ′ to 454 ′.
The group 493 ′ is composed of the composition A obtained by adding 1 part of Pythium oligandrum strain DV74 to each composition of the groups 371 ′ to 454 ′.
Group 494 ′ is composed of composition A, in which one part of Streptomyces griseoviridis strain K61 is further added to the composition of each of groups 371 ′ to 454 ′.
The group 495 ′ is composed of the composition A obtained by adding 1 part of Trichoderma gamsii to each composition of the groups 371 ′ to 454 ′.
The group 496 ′ is composed of the composition A obtained by adding 1 part of Trichoderma asperellum to each composition of the groups 371 ′ to 454 ′.
Group 497 ′ is composed of composition A, in which one part of Trichoderma harzianum strain T-22 is further added to each composition of groups 371 ′ to 454 ′.
Group 498 ′ is composed of composition A, in which one part of Trichoderma virens strain GL-21 is further added to each of the compositions of groups 371 ′ to 454 ′.
Group 499 ′ is composed of composition A, in which one part of Streptomyces lydicus strain WYEC108 is further added to each composition of groups 371 ′ to 454 ′.
The group 500 ′ is composed of the composition A obtained by adding one part of Bacillus thuringiensis subsp. Kurstraki strain ABTS-351 to each composition of the groups 371 ′ to 454 ′.
The group 501 ′ is composed of the composition A obtained by adding one part of Bacillus thuringiensis subs. Kurstraki strain MBP123 to each composition of the groups 371 ′ to 454 ′.
The group 502 ′ is composed of the composition A obtained by adding 1 part of Bacillus thuringiensis subs.aizawai strain ABTS-1857 to each composition of the groups 371 ′ to 454 ′.
The group 503 ′ is composed of the composition A obtained by adding one part of Bacillus thuringiensis strain EX297512 to each composition of the groups 371 ′ to 454 ′.
The group 504 ′ is composed of the composition A obtained by adding 1 part of Metarhizium anisopliae strain F52 to each composition of the groups 371 ′ to 454 ′.
The group 505 ′ is composed of the composition A obtained by adding 1 part of Bacillus firmus strain l-1582 to each composition of the groups 371 ′ to 454 ′.
The group 506 ′ is composed of a composition A obtained by adding 1 part of Pasteuria nishizawae strain Pn1 to each composition of the groups 371 ′ to 454 ′.
Group 507 ′ is composed of Composition A, in which 1 part of Bradyrhizobium japonicum strain TA-11 is added to each composition of Groups 371 ′ to 454 ′.
The group 508 ′ is composed of the composition A obtained by adding 1 part of Sinorhizobium meliloti to each composition of the groups 371 ′ to 454 ′.
Group 509 ′ is composed of composition A, in which one part of Rhizobium leguminosarum is further added to each of the compositions of groups 371 ′ to 454 ′.
Group 510 ′ is composed of composition A, in which one part of Rhizophagus intraradices strain RTI-801 is added to each of the compositions of groups 371 ′ to 454 ′.
The group 511 ′ is composed of the composition A obtained by adding 1 part of Bacillus amyloliquefaciens and 1 part of Trichoderma virens to each composition of the groups 371 ′ to 454 ′.
The group 512 ′ is composed of the composition A obtained by adding 1 part of Penicillium bilaiae and 1 part of Bradyrhizobium japonicum to each composition of the groups 371 ′ to 454 ′.
The group 513 ′ is composed of the composition A obtained by adding 1 part of Penicillium bilaiae and 1 part of Mesorhizobium ciceri to each composition of the groups 371 ′ to 454 ′.
The group 514 ′ is composed of a composition A obtained by adding 1 part of Bradyrhizobium japonicum and 1 part of lipochitooligosaccharide to each composition of the groups 371 ′ to 454 ′.

Group 515 ′ is composed of composition A, in which 1000 parts of fluazaindolizine is further added to each of the compositions of groups 455 ′ to 484 ′.
Group 515 ′ is composed of composition A, in which 1000 parts of fluazaindolizine is further added to each of the compositions of groups 455 ′ to 484 ′.
The group 516 ′ is composed of the composition A obtained by adding 1000 parts of tioxazaphene to each of the compositions of the groups 455 ′ to 484 ′.
The group 517 ′ is composed of the composition A obtained by adding 1000 parts of fluorene sulfone to each of the compositions of the groups 455 ′ to 484 ′.
The group 518 ′ is composed of a composition A obtained by adding 1000 parts of abamectin to each of the compositions of the groups 455 ′ to 484 ′.
The group 519 ′ is composed of the composition A obtained by adding 1000 parts of fluopyram to each of the compositions of the groups 455 ′ to 484 ′.

Group 520 ′ is composed of composition A, in which 1 part of fluazaindolizine is further added to each of the compositions of groups 485 ′ to 514 ′.
The group 521 ′ is composed of the composition A obtained by adding 1 part of thioxazaphene to each of the compositions of the groups 485 ′ to 514 ′.
The group 522 ′ is composed of the composition A obtained by adding 1 part of fluorene sulfone to each composition of the groups 485 ′ to 514 ′.
The group 523 ′ is composed of the composition A obtained by adding 1 part of abamectin to each of the compositions of the groups 485 ′ to 514 ′.
The group 524 ′ is composed of the composition A obtained by adding 1 part of fluopyram to each of the compositions of the groups 485 ′ to 514 ′.

Next, formulation examples are shown. In addition, a part represents a weight part.
The abbreviation SX means any one of the present compounds selected from the compound groups SX1 to SX2496. The abbreviation for MX means any one composition A selected from group 1 to 48 and group 1 ′ to 524 ′.

Formulation Example 1
In 40 parts of SX or 40 parts of MX, 35 parts of a mixture of wet silica and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) and 25 parts of water are sufficiently mixed to obtain a preparation.

Formulation Example 2
Each formulation is obtained by adding 3 parts calcium lignin sulfonate, 2 parts sodium lauryl sulfate and 55 parts wet silica to 40 parts SX or 40 parts MX and mixing.

Formulation Example 3
To 40 parts of SX or 40 parts of MX, 15 parts of a mixture of wet silica and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) and 45 parts of water are added and mixed well to obtain a preparation.

Formulation Example 4
To 20 parts of SX or 20 parts of MX, 35 parts of a mixture of wet silica and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) and 45 parts of water are added and mixed well to obtain a preparation.

Formulation Example 5
20 parts of SX or 20 parts of MX, 1.5 parts of sorbitan trioleate and 28.5 parts of an aqueous solution containing 2 parts of polyvinyl alcohol were mixed and finely pulverized by a wet pulverization method, and then 0.05 parts of xanthan gum and aluminum magnesium 90 parts of an aqueous solution containing 0.1 part of silicate is added, and further 10 parts of propylene glycol is added and mixed by stirring to obtain a preparation.

Formulation Example 6
A drug product is obtained by thoroughly crushing and mixing 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and wet silica part into 20 parts of SX or 20 parts of MX.

Formulation Example 7
Add 3 parts of SX or 3 parts of MX, 1 part of wet silica, 2 parts of calcium lignin sulfonate, 30 parts of bentonite and the remainder of kaolin clay to make a total amount of 100 parts and mix. Next, an appropriate amount of water is added to the mixture, and the mixture is further stirred, granulated with a granulator, and dried by ventilation to obtain granules.

Formulation Example 8
Add 1 part of SX or 1 part of MX, 10 parts of talc and the remainder of kaolin clay to make a total amount of 100 parts, and mix to obtain a powder.

Formulation Example 9
Mix 0.1 parts of SX or 0.1 part of MX with a mixture of 5 parts of xylene and 5 parts of trichloroethane and mix with 89.9 parts of kerosene to obtain a preparation.

Formulation Example 10
SX10mg or MX10mg and acetone 0.5mL are mixed and the obtained mixture is dripped at 5g of animal solid feed powder (solid feed powder CE-2 for breeding breeding, a product of Nippon Claire Co., Ltd.) and mixed uniformly. The acetone is then evaporated to dryness to obtain a poisonous bait.

Formulation Example 11
SX 0.1 part or MX 0.1 part and neothiozole (manufactured by Chuo Kasei Co., Ltd.) 49.9 parts are put into an aerosol can, and after mounting an aerosol valve, 25 parts of dimethyl ether and 25 parts of LPG are filled, shaken, An oil aerosol is obtained by mounting the actuator.

Formulation Example 12
0.6 part of SX or 0.6 part of MX, 0.01 part of 2,6-di-tert-butyl-4-methylphenol, 5 parts of xylene, 3.39 parts of kerosene and 1 part of Rhedol® MO-60 And 50 parts of distilled water are filled into an aerosol container and a valve is attached, and then 40 parts of LPG is filled through the valve to obtain an aqueous aerosol.

Formulation Example 13
0.1 g of SX or 0.1 g of MX and 2 mL of propylene glycol are mixed and impregnated into a ceramic plate having a size of 4.0 cm × 4.0 cm and a thickness of 1.2 cm to obtain a heating smoke.

Formulation Example 14
5 parts of SX or 5 parts of MX and 95 parts of ethylene-methyl methacrylate copolymer (ratio of methyl methacrylate to the total weight of the copolymer: 10% by weight) are melt-kneaded, and the resulting kneaded product is extruded and molded To obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.

Formulation Example 15
5 parts of SX or 5 parts of MX and 95 parts of soft vinyl chloride resin are melt-kneaded, and the obtained kneaded product is extruded with an extrusion molding machine to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.

Formulation Example 16
SX100mg or MX100mg, lactose 68.75mg, corn starch 237.5mg, microcrystalline cellulose 43.75mg, polyvinylpyrrolidone 18.75mg, sodium carboxymethyl starch 28.75mg, and magnesium stearate 2.5mg The mixture is compressed to an appropriate size to obtain a tablet.

Formulation Example 17
SX25 mg or MX25 mg, lactose 60 mg, corn starch 25 mg, carmellose calcium 6 mg, and 5% hydroxypropylmethylcellulose are mixed in an appropriate amount, and the resulting mixture is filled into a hard shell gelatin capsule or hydroxypropylmethylcellulose capsule to obtain a capsule.

Formulation Example 18
SX100mg or MX100mg, fumaric acid 500mg, sodium chloride 2000mg, methylparaben 150mg, propylparaben 50mg, granule sugar 25000mg, sorbitol (70% solution) 13000mg, Veegum (R) K100mg, flavor 35mg, and coloring agent 500mg Distilled water is added to 100 mL and mixed to obtain a suspension for oral administration.

Formulation Example 19
After mixing 5 parts of SX or 5 parts of MX, 5 parts of emulsifier, 3 parts of benzyl alcohol, and 30 parts of propylene glycol, and further adding a phosphate buffer so that the pH is 6.0 to 6.5, Water is added so that the total is 100 parts to obtain a solution for oral administration.

Formulation Example 20
5 parts of aluminum distearate is added to 57 parts of fractionated coconut oil and 3 parts of polysorbate 85 and dispersed by heating. This is cooled to room temperature and 25 parts of saccharin is dispersed in the resulting oily vehicle. To this, 10 parts of SX or 10 parts of MX is added to obtain a paste preparation for oral administration.

Formulation Example 21
5 parts of SX or 5 parts of MX and 95 parts of limestone powder are mixed, and granules for oral administration are obtained using a wet granulation method.

Formulation Example 22
5 parts of SX or 5 parts of MX and 80 parts of diethylene glycol monoethyl ether are mixed, and 15 parts of propylene carbonate is mixed therewith to obtain a spot-on liquid agent.

Formulation Example 23
10 parts of SX or 10 parts of MX are mixed with 70 parts of diethylene glycol monoethyl ether, and 20 parts of 2-octyldodecanol is mixed with this to obtain a pour-on solution.

Formulation Example 24
Add OX 0.1 part or MX 0.1 part polyoxyethylene lauryl ether sodium sulfate (25% aqueous solution) 40 parts, lauric acid amidopropyl betaine 5 parts, coconut oil fatty acid ethanolamide 5 parts, carboxyvinyl polymer 0.5 part Stir well until a homogeneous solution is obtained, then add 49.4 parts of purified water and mix and stir further to obtain a shampoo agent.

Formulation Example 25
SX 0.15 part or MX 0.15 part, animal feed 95 parts, and 4.85 parts of a mixture consisting of calcium hydrogen phosphate, diatomaceous earth, Aerosil (registered trademark), and carbonate (or chalk) are sufficiently stirred and mixed, Obtain a feed premix.

Formulation Example 26
7.2 g of SX or 7.2 g of MX and 92.8 g of Phosco® S-55 are mixed at 100 ° C., poured into a suppository form, and cooled and solidified to obtain a suppository.

  Next, application examples of the composition B to plant seeds will be shown.

Application example 1 (application to sorghum seeds)
By applying 200 mL of any one of the preparations obtained by the method described in Preparation Example 3 to 100 kg of dried sorghum seeds using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) , Get treated seeds.

Application example 2 (application to sorghum seeds)
200 mL of any one of the preparations obtained by the method described in Preparation Example 1 is mixed with 180 g of Concep (registered trademark) II (manufactured by Syngenta) (including 136 g of oxabetalinyl). The obtained mixture is smeared on 100 kg of dried sorghum seeds using a rotary seed treatment machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) to obtain treated seeds.

Application example 3 (application to sorghum seeds)
200 mL of any one of the preparations obtained by the method described in Preparation Example 5 is mixed with 2.1 L of Concep (registered trademark) III (manufactured by Syngenta) (including 40 g of floxophenim). The obtained mixture is smeared with 100 kg of dried sorghum seeds using a rotary seed treatment machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) to obtain treated seeds.

Application example 4 (application to corn seeds)
10 mL of any one of the preparations obtained by the method described in Preparation Example 1 is used with a corn “SR corn” (acetyl CoA carboxylase inhibitor) using a rotary seed treatment machine (seed dresser, Hans-Ulrich Hege GmbH). Treated seeds are obtained by smearing 10 kg of dried maize seeds with resistance to corn.

Application Example 5 (Application to corn seeds)
Using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH), 40 ml of any one of the preparations obtained by the method described in Formulation Example 4 is used for maize “Mavera ™ YieldGard ™ Maize”. Treated seeds are obtained by smearing 10 kg of dried seeds of corn (increased lysine production and resistance to lepidopteran pests).

Application example 6 (application to corn seeds)
100 mL of any one of the preparations obtained by the method described in Preparation Example 5 is used with a corn “Herculex Xtra” (glufosinate resistant, lepidoptera) using a rotary seed treatment machine (seed dresser, Hans-Ulrich Hege GmbH). Treated seeds are obtained by smearing 10 kg of dried maize seeds with pest resistance and Coleoptera pest resistance.

Application example 7 (application to corn seeds)
50 g of any one of the formulations obtained by the method described in Formulation Example 2 is powder-coated on 10 kg of dried seeds of corn “ZFN-12 maize” (corn with reduced phytic acid content), thereby treating the treated seeds. obtain.

Application example 8 (application to soybean seeds)
20 mL of any one of the preparations obtained by the method described in Preparation Example 15 was used to prepare soybean “Plenish (trademark)” (oleic acid content) using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH). And 10 kg of dried seeds of soybeans to which resistance to sulfonylurea-based ALS-inhibiting herbicides has been imparted, a treated seed is obtained.

Application example 9 (application to soybean seeds)
100 mL of any one of the preparations obtained by the method described in Preparation Example 5 is used for the soybean “Intacta (trademark) Roundup Ready (trademark) using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH). The treated seeds are obtained by smearing 10 kg of dried seeds of “2 Pro” (glyphosate-resistant and lepidopterous pest-resistant soybeans).

Application Example 10 (Application to Cotton Seeds)
Using a rotary seed treatment machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH), 50 ml of any one of the formulations obtained by the method described in Formulation Example 5 is used for cotton “Bollgard (registered trademark) 3 XtendFlex (registered) (Trademark) "(cotton imparted with dicamba tolerance, glyphosate tolerance, glyphosate tolerance and lepidopteran pest resistance) is smeared to obtain treated seeds.

Application Example 11 (Application to canola seed)
Using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH), 50 mL of any one of the formulations obtained by the method described in Formulation Example 5 is used. Each treated seed is obtained by smearing 10 kg of dried seed of canola, which has been given resistance to a linone-based ALS-inhibiting herbicide.

Application Example 12 (Application to Rapeseed Seeds)
By applying 10 mL of any one of the preparations obtained by the method described in Formulation Example 4 to 10 kg of rapeseed dry seeds using a rotary seed processor (seed dresser, manufactured by Hans-Ulrich Hege GmbH) , Get treated seeds.

Application Example 13 (Application to wheat seeds)
By applying 50 mL of any one of the preparations obtained by the method described in Preparation Example 5 to 10 kg of dried wheat seeds using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) , Get treated seeds.

Application example 14 (application to potato seeds)
6 mL of any one of the preparations obtained by the method described in Preparation Example 3 is smeared so as to be uniform in 10 kg of potato seed meal to obtain a treated seed meal.

Application Example 15
10 kg of dried rice seed (dried rice cake) is put in a net bag and immersed in a 50-fold water dilution solution of Benrate (registered trademark) wettable powder (Benomil wettable powder, manufactured by Sumitomo Chemical Co., Ltd.) for 10 minutes, Immerse in water for 3 days. While draining rice seeds into a rotary pan-type rice seed coating machine and rotating, 5 kg of reduced iron powder 5 kg, calcined gypsum 600 g, and 100 g of any one of the formulations obtained by the method described in Formulation Example 5 After adding a water dilution and powdering, 300 g of calcined gypsum is further powdered. Thereafter, the rice seeds are taken out from the coating machine, dispersed on a vinyl sheet so as to have a thickness of 1 cm or less, and then allowed to stand and dried to obtain treated seeds.

Application Example 16
After putting 10 kg of dried rice seed (dried rice cake) in a net bag and immersing it in a 20-fold water dilution of Stana (registered trademark) wettable powder (oxolinic acid wettable powder, manufactured by Sumitomo Chemical Co., Ltd.) for 10 minutes, Immerse in tap water for 3 days. Dehydrated rice seeds are placed in a rotating pan-type rice seed coating machine and rotated, and 20 kg of Calper (registered trademark) powder 16 (calcium peroxide powder, Hodogaya UPL Co., Ltd.) and formulation example 2 100 g of any one of the preparations obtained by the above method is added and dressed. Thereafter, the rice seeds are taken out from the coating machine, dispersed on a vinyl sheet so as to have a thickness of 1 cm or less, and then allowed to stand and dried to obtain treated seeds.

Application Example 17
10 kg of dried rice seeds (dry rice cake) is put in a net bag and sterilized by immersing in paddy SG aqueous solvent (Cartap hydrochloride aqueous solvent, manufactured by Sumitomo Chemical Co., Ltd.) in a 1500-fold aqueous diluted solution for 24 hours, and then tap water Soak for 3 days to germinate. While draining rice seeds into a rotary pan-type rice seed coating machine and rotating, an appropriate amount of Zojirushinol laundry paste (polyvinyl alcohol, Sanwa Yushi Kogyo Co., Ltd.) and molybdenum trioxide (Japan Inorganic Chemical Industry Co., Ltd.) 200 g; One of 100 g of a formulation obtained by the method described in Formulation Example 5 is added with a 2-fold water dilution, and the surface of rice seed is treated. Thereafter, the rice seeds are taken out from the coating machine, dispersed on a vinyl sheet so as to have a thickness of 1 cm or less, and then allowed to stand and dried to obtain treated seeds.

  Hereinafter, the effects of the present invention will be shown by test examples.

Test example 1
Treated corn seeds obtained by the method described in Application Example 4 are sown at 15 cm intervals to a depth of 5 cm using a seeder.
As a result, the corn treated with SX or MX can be confirmed to have an effect on harmful arthropods that harm the Rhizotonia solani and Phythium spp.

Test example 2
The soybean seeds obtained by the method described in Application Example 8 are sown and cultivated.
As a result, soybean treated with SX or MX can be confirmed to have an effect on Fusarium oxysporum, Rhizoctonia root rot, soybean cyst nematode, and harmful arthropods that harm soybean.

Test example 3
The treated seed of canola obtained by the method described in Application Example 11 is sown and cultivated.
As a result, soybean treated with SX or MX can be confirmed to have an effect on harmful arthropods that harm Rhizotonia solani, Negusare nematode, and canola.

Test example 4
Rice seeds obtained in Application Example 15 are sown and cultivated in paddy fields.
As a result, rice treated with SX or MX can confirm the effects on rice weevil, rice beetle, brown planthopper, white-tailed planthopper, Japanese brown planthopper, leafhopper leafhopper, white-bellied moth, butterfly moth, bitter moth, locust bean. Furthermore, rice treated with SX or MX can be used to control planthoppers and leafhoppers, thereby causing rice dwarf disease, tundra disease, rice grassy stunt disease, rice rugged stunt disease, rice stripe leaf wilt mediated by these insects. The effects on the disease, black stripe atrophy, rice southern black stripe atrophy, yellowing atrophy, rice yellow leaf disease, transition yellowing disease and rice atrophy disease can be confirmed.

Test Example 5
24 kg of rice seeds are packed in a cloth bag and immersed in water for 24 hours together with the bag. The soaked rice seeds are placed on the concrete ground together with the above bags and allowed to stand for 36 hours with appropriate watering so as not to dry. Rice seeds taken out from the cloth bag after standing still are spread on a sheet, and a water-diluted solution of the preparation obtained by the method described in Preparation Example 6 is sprayed thereon, and the mixture is thoroughly stirred on the sheet. After plowing, watering, shaving, etc. in advance, the rice seeds are sown by evenly spreading the rice seeds by hand evenly in a paddy field where the flooding depth is maintained at about 2 cm. Cultivate.
As a result, the rice treated with SX or MX can confirm the effects on rice weevil, rice beetle, brown planthopper, white-tailed planthopper, scallop planthopper, leafhopper leafhopper, white-tailed moth, butterfly moth, squid moth and itten eel moth. The effect can also be confirmed against rice weevil, rice weevil, white planthopper, white-tailed planthopper, white-bellied planthopper, leafhopper, corn borer, ft. In particular, the effect can be confirmed against rice weevil, rice squirrel, rice planthopper, white-tailed planthopper, rice planthopper, and leafhopper with reduced sensitivity to one or more compounds selected from group a4. In addition, by controlling harmful insects belonging to the planthopper family and leafhopper family, these insect-borne rice dwarf disease, tundra disease, rice grassy stunt disease, rice rugid stunt disease, rice stripe leaf blight, black stripe atrophy Rice can be protected from diseases, rice southern black stripe atrophy, yellow dwarf disease, rice yellow leaf disease, transition yellowing disease, rice atrophy disease.

Test Example 6
After pruning, rice seeds obtained in Application Example 16 are sown in a streak-like manner and cultivated in a paddy sowing machine in a paddy field that has been managed to fall for several days. At this time, the seeding amount per 10 ares is 4 kg in dry rice.
As a result, rice treated with SX or MX can confirm the effects on rice weevil, rice beetle, brown planthopper, white-tailed planthopper, Japanese brown planthopper, leafhopper leafhopper, leafhopper leafhopper, rice leafhopper, and leafhopper. Furthermore, the effect with respect to 1 or more types of compounds chosen from the group a1-group a26 can be also confirmed with respect to the rice weevil, the rice beetle, the brown planthopper, the white-winged planthopper, the brown planthopper, the green leafhopper, the green leafhopper, the tiger moth, and the green moth. In particular, the effect on the rice weevil, rice rot beetle, rice planthopper, white-tailed planthopper, tiger leafhopper, and leafhopper of the rice weevil, rice plant beetle, sensitivity to one or more compounds selected from group a4 can be confirmed.

Test Example 7
The corn seed obtained in Application Example 7 is sown at 15 cm intervals to a depth of 5 cm using a seeding machine and cultivated.
As a result, corn treated with SX or MX can be confirmed to have an effect on larvae of the beetles belonging to the genus Diabrotica such as Western corn rootworm and the genus Agriotes and Melanotus (collectively referred to as wire worms). The effect can also be confirmed against the larvae of the above-mentioned beetles whose sensitivity to one or more compounds selected from group a1 to group a26 is reduced.

Test Example 8
Soybean seeds obtained in Application Example 9 are sown and cultivated.
As a result, soybean treated with SX or MX can confirm the effect on the fly larvae. The effect can also be confirmed against the fly larvae having reduced sensitivity to one or more compounds selected from the group a1 to the group a26.

Test Example 9
The canola seed obtained in Application Example 11 is sown and cultivated.
As a result, canola treated with SX or MX can confirm the effect on larvae of the beetle family. Moreover, an effect can be confirmed also to the larva of the beetle family in which the sensitivity with respect to 1 or more types of compounds chosen from the group a1-group a26 fell.

Test Example 10
Wheat seeds obtained in Application Example 13 are sown and cultivated.
As a result, the wheat treated with SX or MX can confirm the effect on the larvae of the beetles. The effect can also be confirmed against the larvae of the beetles whose sensitivity to one or more compounds selected from group a1 to group a26 is reduced.

Test Example 11
The potato seed meal obtained in Application Example 14 is planted and cultivated in soil.
As a result, potato treated with SX or MX can be confirmed to be effective against larvae of Chrysomelidae. Moreover, an effect can be confirmed also to the larva of the beetle family in which the sensitivity with respect to the 1 or more types of compound chosen from the group a1-group a26 fell.

Test Example 12
The granules obtained in Formulation Example 7 are mixed with soil, and sugarcane stem fragments are planted and cultivated there.
As a result, sugarcane treated with SX or MX can be confirmed to be effective against larvae of the beetles. Moreover, an effect can also be confirmed with respect to the larvae of the click beetle whose sensitivity to one or more compounds selected from the group a1 to the group a26 is reduced.

Test Example 13
A water-diluted solution of the preparation obtained by the method described in Formulation Example 5 is sprayed before the covering soil and cultivated by covering the planting groove in which the sugarcane stem fragments are planted.
As a result, sugarcane treated with SX or MX can be confirmed to be effective against larvae of the beetles. Moreover, an effect can also be confirmed with respect to the larvae of the click beetle whose sensitivity to one or more compounds selected from the group a1 to the group a26 is reduced.

Test Example 14
Rice seeds (150 g with dry straw) are sterilized with a mixture of ipconazole and cupric hydroxide. In a seedling box (approximately 60 cm wide, approximately 30 cm long), floor soil is spread, and seed disinfected rice seeds are uniformly sown on it. Subsequently, 50 g of a granule obtained by the method described in Formulation Example 7 is uniformly sprayed, covered with soil, and grown. Rice seedlings grown at the 2.5 leaf stage are transplanted and cultivated in paddy fields using a rice planting machine.
As a result, the rice treated with SX or MX can confirm the effects of rice weevil, rice beetle, leafhopper, white-tailed planthopper, Japanese brown planthopper, leafhopper leafhopper, leafhopper leafhopper, white-tailed rice moth, Phterophyllum bitumen, leafhopper, rice-nettle leafworm, and rice leafworm. In addition, against rice weevil, rice beetle, brown planthopper, white-throated planthopper, brown-bellied planthopper, leafhopper leafhopper, leafhopper leafhopper, leafhopper leafhopper, leaf-butterfly, rice-bitter beetle, rice-bole beetle and rice-bellied rice leaf with reduced sensitivity to one or more compounds selected from group a1 to group a26 The effect can be confirmed. In particular, the effect can be confirmed against rice weevil, rice squirrel, rice planthopper, white-tailed planthopper, rice planthopper, and leafhopper with reduced sensitivity to one or more compounds selected from group a4. In addition, by controlling harmful insects belonging to the planthopper family and leafhopper family, these insect-borne rice dwarf disease, tundra disease, rice grassy stunt disease, rice rugid stunt disease, rice stripe leaf blight, black stripe atrophy Rice can be protected from diseases, rice southern black stripe atrophy, yellow dwarf disease, rice yellow leaf disease, transition yellowing disease, rice atrophy disease.

Test Example 15
The preparation obtained by the method described in Preparation Example 4 is diluted 400 times with water. 500 ml of the resulting diluted solution is irrigated using a irrigation apparatus to rice seedlings at the 3.5 leaf stage cultivated in a seedling box (about 60 cm wide, about 30 cm long). The treated rice seedlings are transplanted and cultivated in paddy fields using a rice planting machine.
As a result, the rice treated with SX or MX can confirm the effects of rice weevil, rice beetle, leafhopper, white-tailed planthopper, Japanese brown planthopper, leafhopper leafhopper, leafhopper leafhopper, white-tailed rice moth, Phterophyllum bitumen, leafhopper, rice-nettle leafworm, and rice leafworm. In addition, against rice weevil, rice beetle, brown planthopper, white-throated planthopper, brown-bellied planthopper, leafhopper leafhopper, leafhopper leafhopper, leafhopper leafhopper, leaf-butterfly, rice-bitter beetle, rice-bole beetle and rice-bellied rice leaf with reduced sensitivity to one or more compounds selected from group a1 to group a26 The effect can be confirmed. In particular, the effect can be confirmed against rice weevil, rice squirrel, rice planthopper, white-tailed planthopper, rice planthopper, and leafhopper with reduced sensitivity to one or more compounds selected from group a4. In addition, by controlling harmful insects belonging to the planthopper family and leafhopper family, these insect-borne rice dwarf disease, tundra disease, rice grassy stunt disease, rice rugid stunt disease, rice stripe leaf blight, black stripe atrophy Rice can be protected from diseases, rice southern black stripe atrophy, yellow dwarf disease, rice yellow leaf disease, transition yellowing disease, rice atrophy disease.

Test Example 16
The preparation obtained by the method described in Preparation Example 5 is diluted 200 times with water. 500 ml of the resulting diluted solution is irrigated with watering to rice seedlings at the 2.5 leaf stage cultivated in a seedling box (about 60 cm wide, about 30 cm long). The treated rice seedlings are transplanted and cultivated in paddy fields using a rice planting machine.
As a result, the rice treated with SX or MX can confirm the effects of rice weevil, rice beetle, leafhopper, white-tailed planthopper, Japanese brown planthopper, leafhopper leafhopper, leafhopper leafhopper, white-tailed rice moth, Phterophyllum bitumen, leafhopper, rice-nettle leafworm, and rice leafworm. In addition, against rice weevil, rice beetle, brown planthopper, white-throated planthopper, brown-bellied planthopper, leafhopper leafhopper, leafhopper leafhopper, leafhopper leafhopper, leaf-butterfly, rice-bitter beetle, rice-bole beetle and rice-bellied rice leaf with reduced sensitivity to one or more compounds selected from group a1 to group a26 The effect can be confirmed. In particular, the effect can be confirmed against rice weevil, rice squirrel, rice planthopper, white-tailed planthopper, rice planthopper, and leafhopper with reduced sensitivity to one or more compounds selected from group a4. In addition, by controlling harmful insects belonging to the planthopper family and leafhopper family, these insect-borne rice dwarf disease, tundra disease, rice grassy stunt disease, rice rugid stunt disease, rice stripe leaf blight, black stripe atrophy Rice can be protected from diseases, rice southern black stripe atrophy, yellow dwarf disease, rice yellow leaf disease, transition yellowing disease, rice atrophy disease.

Test Example 17
SX or MX is prepared according to the method described in Formulation Example 4. Similarly, triflumezopyrim, flupiradifurone or flupyrimine is prepared according to the method described in Preparation Example 4. Spreading agent (trade name: Cyndyne (registered trademark)) so that the active ingredient concentration is 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume to obtain each dilution. Commercially available Admeier wettable powder (active ingredient: imidacloprid, manufactured by Bayer CropScience Co., Ltd.) and Actara granule wettable powder (active ingredient: thiamethoxam, manufactured by Syngenta Japan Co., Ltd.) with an active ingredient concentration of 0.05 ppm, Diluted with water containing 0.05% by volume of a spreading agent (trade name: Cyndyne (registered trademark)) to 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, Obtain a diluted solution. Cucumber seedlings planted in containers (second true leaf development stage) are susceptible lines (lines that have been bred in succession within Sumitomo Chemical Co., Ltd., Health Agriculture and Related Business Research Laboratories) or reduced sensitivity lines (in Miyazaki Prefecture in 2016) After collection, inoculate 30 cotton aphids (including all growth stages) of a line that has been reared without generation. One day later, the resulting diluted solution is sprayed on the seedlings at a rate of 10 mL / seedling. On the other hand, cucumbers are cultivated in the same manner as in the treated area except that the diluted solution containing SX or MX is not sprayed (this is referred to as an untreated area). Six days after spraying, the number of live insects is observed, and the control value is determined by the formula 1).
Formula 1); control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
The characters in the formula have the following meanings.
Cb: number of test insects in the untreated group Cai: number of surviving insects in the survey in the untreated group Tb: number of test insects in the treated group Tai: number of surviving insects in the survey in the treated group As a result, the nicotinic properties of the group a4 It is confirmed that the treatment group of triflumezopyrim, flupiradifuron, flupirimine, imidacloprid, or thiamethoxam, which are acetylcholine receptor competitive modulators, is less effective against the susceptible strain than the treated strain. This confirms that the sensitivity-reduced strain used in this study is a strain with reduced sensitivity to the nicotinic acetylcholine receptor competitive modulator. On the other hand, the treatment group of SX or MX can confirm the same effect as that for the sensitive line even for the line with reduced sensitivity.

Test Example 18
SX or MX is prepared according to the method described in Formulation Example 4. Similarly, flupiradiflon and flupyrimine are each prepared according to the method described in Preparation Example 4. Spreading agent (trade name: Cyndyne (registered trademark)) so that the active ingredient concentration is 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume. Commercially available Admeier wettable powder (active ingredient: imidacloprid, manufactured by Bayer Crop Science Co., Ltd.), active ingredient concentration of 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or Dilute with water containing 0.05% by volume of a spreading agent (trade name: Cyndine (registered trademark)) to 200 ppm. The dilute solution obtained for rice (Oryza sativa) seedlings (2.5th leaf stage) planted in a container is sprayed at a rate of 10 mL / seedling. Subsequently, susceptible planthopper (Sumitomo Chemical Co., Ltd. health farming and related business research institute), or reduced sensitivity strain planter (collected in Nagasaki Prefecture in 2016, then breeding indefinitely 20 strains of 3rd instar larvae are released. After 6 days, the number of surviving insects is examined, and the death rate is obtained by the formula 2). On the other hand, rice is cultivated in the same manner as in the treated area except that the dilute solution containing SX or MX is not sprayed (this is defined as an untreated area).
Formula 2) Death rate (%) = {1−number of surviving insects / 20} × 100
As a result, it is confirmed that all of the treatment groups of flupiradifuron, flupyrimine or imidacloprid, which are nicotinic acetylcholine receptor competitive modulators of group a4, have a lower effect on the sensitivity-reduced strain than that on the sensitive strain. This confirms that the sensitivity-reduced strain used in this study is a strain with reduced sensitivity to the nicotinic acetylcholine receptor competitive modulator. On the other hand, the treatment group of SX or MX can confirm the same effect as that for the sensitive line even for the line with reduced sensitivity.

Test Example 19
SX or MX is prepared according to the method described in Formulation Example 4. Spreading agent (trade name: Cyndyne (registered trademark)) so that the active ingredient concentration is 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume. Commercially available phoenix granule wettable powder (active ingredient: fulvendiamide, manufactured by Nippon Agricultural Chemicals Co., Ltd.), Prevason Flowable 5 (active ingredient: chlorantraniliprole, manufactured by Nissan Chemical Co., Ltd.) and Venevia OD (active ingredient: Cyantraniprolol (manufactured by Kumiai Chemical Industry Co., Ltd.) is used as a spreading agent so that the active ingredient concentration is 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume of the trade name: Cyndyne (registered trademark). A dilute solution obtained from the cabbage (Brassicae oleracea) seedlings (3rd to 4th true leaf development stage) planted in the container is sprayed at a rate of 20 mL / seedling. Later, the sensitive strain Koaga (Sumitomo Chemical Co., Ltd., Health Agriculture and Related Business Research Institute), or the sensitivity-reduced strain Koga (collected in Kumamoto Prefecture in 2016, and then raised indefinitely 10 strains of 3rd instar larvae are released. After 5 days, the number of surviving insects is counted, and the mortality rate is obtained from Equation 3). On the other hand, cabbage is cultivated in the same manner as in the treated area except that the diluent containing SX or MX is not sprayed (this is referred to as an untreated area).
Formula 3) Death rate (%) = (1−number of live insects / 10) × 100
As a result, the treatment group of flubendiamide, chlorantraniliprole, or cyantraniliprolol, which is a ryanodine receptor modulator agent of group a17, may have a lower effect on the sensitivity-reduced strain compared to the sensitivity strain. It is confirmed. From this, it is confirmed that the sensitivity-reduced strain used in this test is a strain with reduced sensitivity to the ryanodine receptor modulator agent. On the other hand, the treatment group of SX or MX can confirm the same effect as that for the sensitive line even for the line with reduced sensitivity.

Test Example 20
SX or MX is prepared according to the method described in Formulation Example 4. Similarly, flupiradiflon and flupyrimine are each prepared according to the method described in Preparation Example 4. Spreading agent (trade name: Cyndyne (registered trademark)) so that the active ingredient concentration is 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume. Commercially available Admeier granule wettable powder (active ingredient: imidacloprid, manufactured by Bayer CropScience), Trebon emulsion (active ingredient: etofenprox, manufactured by Mitsui Chemicals Agro Co., Ltd.), Prince flowable (active ingredient: fipronil, BASF Japan Co., Ltd.), Kirup Floable (active ingredient: Ethiprole, Bayer CropScience Co., Ltd.), and Uploadable (active ingredient: buprofezin, manufactured by Nippon Agricultural Chemicals Co., Ltd.) have an active ingredient concentration of 0.05 ppm and 0, respectively. It is diluted with water containing 0.05% by volume of a spreading agent (trade name: Cyndyne (registered trademark)) so as to be 2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm. The dilute solution obtained for rice (Oryza sativa) seedlings (2.5th leaf stage) planted in a container is sprayed at a rate of 10 mL / seedling. Subsequently, the susceptible line damselfly (Sumitomo Chemical Co., Ltd. health farming and related business research line), or the susceptibility line cultivated Japanese beetle (collected in Nagasaki Prefecture in 2016, and then bred in succession. 20 strains of 3rd instar larvae are released. After 6 days, the number of surviving insects is examined, and the death rate is obtained by the formula 2). On the other hand, rice is cultivated in the same manner as in the treated area except that the dilute solution containing SX or MX is not sprayed (this is defined as an untreated area).
Formula 2) Death rate (%) = {1−number of surviving insects / 20} × 100
As a result, group a4 nicotinic acetylcholine receptor competitive modulators flupirazifuron, flupirmine or imidacloprid, group a2 GABAergic chloride channel blockers fipronil or etiprol, group a3 sodium channel modulator etofenprox or It is confirmed that all of the treatment groups of buprofezin, which is a chitin biosynthesis inhibitor of group a12, have a lower effect on the sensitivity-reduced line than the effect on the susceptible line. From this, it is confirmed that the sensitivity-reducing line used in this test is a line with reduced sensitivity to these compounds. On the other hand, the treatment group of SX or MX can confirm the same effect as that for the sensitive line even for the line with reduced sensitivity.

Test Example 21
SX or MX is prepared according to the method described in Formulation Example 4. Spreading agent (trade name: Cyndyne (registered trademark)) so that the active ingredient concentration is 0.05 ppm, 0.2 ppm, 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm, respectively. Dilute with water containing 0.05% by volume. The commercially available Prince Flowable (active ingredient: fipronil, manufactured by BASF Japan Ltd.) and Killup Flowable (active ingredient: Ethiprol, manufactured by Bayer CropScience Co., Ltd.) are respectively effective component concentrations of 0.05 ppm, 0.2 ppm, Dilute with water containing 0.05% by volume of a spreading agent (trade name: Cyndine (registered trademark)) to 0.8 ppm, 3.1 ppm, 12.5 ppm, 50 ppm or 200 ppm. The diluted solution obtained for rice seedlings (2.5th leaf stage) planted in a container is sprayed at a rate of 10 mL / seedling. Later, susceptible line cedar (Sumitomo sei Co., Ltd. health farming and related business research line), or reduced sensitivity line cedar (Sallo planta) collected in Nagasaki Prefecture in 2016, and then bred in succession. 20 strains of 3rd instar larvae are released. After 6 days, the number of surviving insects is examined, and the death rate is obtained by the formula 2). On the other hand, rice is cultivated in the same manner as in the treated area except that the dilute solution containing SX or MX is not sprayed (this is defined as an untreated area).
Formula 2) Death rate (%) = {1−number of surviving insects / 20} × 100
As a result, it is confirmed that the treatment group of fipronil or etiprol, which is the GABAergic chloride channel blocker of group a2, has a lower effect on the sensitivity-reduced strain than the effect on the susceptible strain. From this, it is confirmed that the sensitivity-reducing line used in this test is a line with reduced sensitivity to these compounds. On the other hand, the treatment group of the present SX or MX can confirm the same effect as that for the sensitive line even for the low sensitivity line.

Test Example 22
SX or MX is prepared according to the method described in Formulation Example 4.
The above formulation is diluted 100 times with water. The obtained diluted solution is irrigated with 500 mL of a cabbage cell-shaped nursery tray (about 60 cm wide, about 30 cm long) one day before planting, planted in a field, and cultivated.
As a result, the cabbage treated with SX or MX can confirm the effect on harmful insects belonging to the family Coniferaceae, Noctuidae and Whiteflies. The effect can also be confirmed against harmful insects belonging to the family Spodoptera, Noctuidae and Pieridae, which have a reduced sensitivity to one or more compounds selected from the groups a1 to a26. In particular, the effect can be confirmed against the diamondback moth having reduced sensitivity to one or more compounds selected from the group a17.

Test Example 23
SX or MX is prepared according to the method described in Formulation Example 7. After carrying out the pricking, the above-mentioned preparation at the rate of 1 kg / 10a was sown at a rate of 1 kg / 10a while sowing several rice seeds coated with iron oxide powder on a paddy seedling machine in a paddy field that was managed to fall for several days. Apply directly to the position with a depth of 1 cm. Then, rice is cultivated.
As a result, the rice treated with SX or MX can confirm the effects on rice weevil, rice beetle, brown planthopper, white-tailed planthopper, Japanese brown planthopper, leafhopper leafhopper, leafhopper leafhopper, white-tailed rice moth, winged rice moth, leafhopper, rice-leaf beetle and rice leafworm. The effects of rice weevil, rice beetle, leafhopper, white-tailed planthopper, white-footed planthopper, leafhopper leafhopper, leafhopper leafhopper, leaf-butterfly, leaf-bucky beetle, rice-bitter beetle, rice-bellied beetle and rice-bellied beetle are effective against one or more compounds selected from group a1 to group a26 I can confirm. In particular, the effect can be confirmed also for rice weevil, rice beetle, rice planthopper, white-tailed planthopper, rice planthopper, and leafhopper with reduced sensitivity to one or more compounds selected from group a4. In addition, by controlling harmful insects belonging to the planthopper family and leafhopper family, these insect-borne rice dwarf disease, tundra disease, rice grassy stunt disease, rice rugid stunt disease, rice stripe leaf blight, black stripe atrophy Rice can be protected from diseases, rice southern black stripe atrophy, yellow dwarf disease, rice yellow leaf disease, transition yellowing disease and rice dwarf disease.

Test Example 24
SX or MX is prepared according to the method described in Formulation Example 7. After plowing, rice seeds coated with Calper (registered trademark) granule 16 (calcium peroxide granule, Hodogaya UPL Co., Ltd.) were laid on a paddy field that had been managed for several days. While seeding several grains, the above preparation is applied at a rate of 1 kg / 10a to a position 3 cm to the side of the sowing position and 3 cm in depth. Then, rice is cultivated.
As a result, the rice treated with SX or MX can confirm the effects on rice weevil, rice beetle, brown planthopper, white-tailed planthopper, Japanese brown planthopper, leafhopper leafhopper, leafhopper leafhopper, white-tailed rice moth, winged rice moth, leafhopper, rice-leaf beetle and rice leafworm. The effects of rice weevil, rice beetle, leafhopper, white-tailed planthopper, white-footed planthopper, leafhopper leafhopper, leafhopper leafhopper, leaf-butterfly, leaf-bucky beetle, rice-bitter beetle, rice-bellied beetle and rice-bellied beetle are effective against one or more compounds selected from group a1 to group a26 I can confirm. In particular, the effect can be confirmed also for rice weevil, rice beetle, rice planthopper, white-tailed planthopper, rice planthopper, and leafhopper with reduced sensitivity to one or more compounds selected from group a4. In addition, by controlling harmful insects belonging to the planthopper family and leafhopper family, these insect-borne rice dwarf disease, tundra disease, rice grassy stunt disease, rice rugid stunt disease, rice stripe leaf blight, black stripe atrophy Rice can be protected from diseases, rice southern black stripe atrophy, yellow dwarf disease, rice yellow leaf disease, transition yellowing disease and rice dwarf disease.

  According to the present invention, harmful arthropods can be controlled.

Claims (4)

Formula (I)

[Where:
Q represents a group represented by the formula Q1, a group represented by the formula Q2, or a group represented by the formula Q3.

R ² represents a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a cyclopropylmethyl group,
n represents 0, 1 or 2;
G ¹ represents a nitrogen atom or CR ^3a ,
G ² represents a nitrogen atom or CR ^3b ,
G ³ represents a nitrogen atom or CR ^3c ,
G ⁴ represents a nitrogen atom or CR ^3d ,
R ^3a , R ^3b , R ^3c , and R ^3d are the same or different and are selected from group E and a C1-C6 chain hydrocarbon group that may have one or more substituents selected from group B A C3-C7 cycloalkyl group optionally having one or more substituents, a phenyl group optionally having one or more substituents selected from group H, and one or more substituents selected from group H; 5 or 6-membered aromatic heterocyclic group which may have, OR ¹² , NR ¹¹ R ¹² , NR ^11a R ^12a , NR ²⁴ NR ¹¹ R ¹² , NR ²⁴ OR ¹¹ , NR ¹¹ C (O) R ¹³ , ^{NR 24 NR 11 C (O)} R 13, NR 11 C (O) OR 14, NR 24 NR 11 C (O) OR 14, NR 11 C (O) NR 31 R 32, NR 24 NR 11 C (O) NR ³¹ R ³² , N = CHNR ³¹ R ³² , N = S (O) _p R ¹⁵ R ¹⁶ , C (O) R ¹³ , C (O) OR ¹⁷ , C (O) NR ^{3 1} R ³² , C (O) NR ¹¹ S (O) ₂ R ²³ , CR ³⁰ = NOR ¹⁷ , NR ¹¹ CR ²⁴ = NOR ¹⁷ , a cyano group, a nitro group, a hydrogen atom, or a halogen atom,
p represents 0 or 1,
A ¹ represents NR ⁵ , an oxygen atom or a sulfur atom,
Het represents a group of formula Het1, a group of formula Het2, or a group of formula Het3;

A ² represents a nitrogen atom or CR ^4a ,
A ³ represents a nitrogen atom or CR ^4b ,
A ⁴ represents a nitrogen atom or CR ^4c ,
W ¹ represents an oxygen atom or a sulfur atom,
R ^4a , R ^4b , and R ^4c are the same or different and may have one or more halogen atoms, C1-C6 chain hydrocarbon group, nitro group, OR ¹⁸ , NR ¹⁸ R ¹⁹ , cyano group Represents an amino group, a halogen atom, or a hydrogen atom,
R ⁶ is a C1-C6 chain hydrocarbon group which may have one or more substituents selected from group F, and C3-C6 which may have one or more substituents selected from group J. A cycloalkyl group, a phenyl group optionally having one or more substituents selected from group H, or a 5- or 6-membered aromatic heterocyclic ring optionally having one or more substituents selected from group H Represents a group,
T is a C1-C10 chain hydrocarbon group, a (C1-C5 alkoxy) C2-C5 alkyl group, a (C3-C5 alkenyloxy) C2-C5 alkyl group, a (C3-C5 alkynyloxy) C2-C5 alkyl group, (C1-C5 alkyl) -S (O) _w- (C2-C5 alkyl) group, (C3-C5 alkenyl) -S (O) _w- (C2-C5 alkyl) group, (C3-C5 alkynyl) -S (O) _w- (C2-C5 alkyl) group, (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group {the C1-C10 chain hydrocarbon group, the (C1-C5 alkoxy) group C2-C5 alkyl group, the (C3-C5 alkenyloxy) C2-C5 alkyl group, the (C3-C5 alkynyloxy) C2-C5 alkyl group, the (C1-C5 alkyl) -S (O) _w- (C2 − 5 alkyl) group, the (C3-C5 _{alkenyl) -S (O) w - (} C2-C5 alkyl) group, the (C3-C5 _{alkynyl) -S (O) w - (} C2-C5 alkyl) group, and, The (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group has one or more substituents selected from the group consisting of a cyano group and a halogen atom}, one or more selected from the group G having substituent (C3-C7 cycloalkyl) C1-C3 alkyl group, C3-C7 cycloalkyl group having one or more substituents selected from the group ^{G, oR 1, S (O} ) v R 1, OS (O _{^{) 2 R 1, CH 2 OR}} 1, NR 1 R 29, C (O) R 1, C (O) NR 1 R 29, NR 29 C (O) R 1, N = CR 1 R 30, wherein T- A group represented by formula 1, a group represented by formula T-2, a group represented by formula T-3, and a group represented by formula T-4 A group represented by formula T-5, a group represented by formula T-6, a group represented by formula T-7, a group represented by formula T-8, a group represented by formula T-9, a formula T- A group represented by formula 10, a group represented by formula T-11, or a group represented by formula T-12;

X ¹ represents a nitrogen atom or CR ^1a ,
X ² represents a nitrogen atom or CR ^1b ,
X ³ represents a nitrogen atom or CR ^1c ,
X ⁴ represents a nitrogen atom or CR ^1d ,
X ⁵ represents a nitrogen atom or CR ^1e ,
R ^1x is a C1-C5 chain hydrocarbon group having one or more halogen atoms, OR ⁷ , OS (O) ₂ R ⁷ , S (O) _m R ⁷ , NR ⁸ S (O) ₂ R ⁷ , or Represents a halogen atom,
R ^1a , R ^1b , R ^1c , R ^1d , and R ^1e are the same or different and have a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, and having one or more halogen atoms. An optionally substituted C3-C6 cycloalkyl group, a halogen atom, or a hydrogen atom;
Y ¹ represents NR ²⁵ , an oxygen atom or a sulfur atom,
Y ² represents a nitrogen atom or CR ²⁶ ,
Y ³ represents a nitrogen atom or CR ²⁷ ,
Y ⁴ represents a nitrogen atom or CR ²⁸ ,
R ⁵ and R ²⁵ are the same or different, a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, and a C1-C6 alkoxy group optionally having one or more halogen atoms. Represents a C3-C7 cycloalkyl group optionally having one or more halogen atoms, a (C3-C7 cycloalkyl) C1-C6 alkyl group optionally having one or more halogen atoms, or a hydrogen atom. ,
R ²⁶ , R ²⁷ , and R ²⁸ are the same or different and are a C1-C6 chain hydrocarbon group that may have one or more halogen atoms, and C3 that may have one or more halogen atoms. -C6 represents a cycloalkyl group, a halogen atom, or a hydrogen atom,
R ^1y is a C1-C5 chain hydrocarbon group having one or more halogen atoms, OR ⁷ , OS (O) ₂ R ⁷ , S (O) _m R ⁷ , NR ⁸ S (O) ₂ R ⁷ , cyano Represents a group, or a halogen atom,
R ^1ay and R ⁷ are the same or different and each represents a C1-C6 chain hydrocarbon group having one or more halogen atoms,
m and v are the same or different and represent 0, 1 or 2,
w and t are the same or different and represent 0, 1 or 2,
R ¹ is a C1-C10 chain hydrocarbon group, a (C1-C5 alkoxy) C2-C5 alkyl group, a (C3-C5 alkenyloxy) C2-C5 alkyl group, a (C3-C5 alkynyloxy) C2-C5 alkyl group. , (C1-C5 alkyl) -S (O) _t- (C2-C5 alkyl) group, (C3-C5 alkenyl) -S (O) _t- (C2-C5 alkyl) group, (C3-C5 alkynyl)- S (O) _t- (C2-C5 alkyl) group, (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group {the C1-C10 chain hydrocarbon group, the (C1-C5 alkoxy) ) C2-C5 alkyl group, the (C3-C5 alkenyloxy) C2-C5 alkyl group, the (C3-C5 alkynyloxy) C2-C5 alkyl group, the (C1-C5 alkyl) -S (O) _t- ( C2 C5 alkyl) group, the (C3-C5 _{alkenyl) -S (O) t - (} C2-C5 alkyl) group, the (C3-C5 _{alkynyl) -S (O) t - (} C2-C5 alkyl) group, and, The (C1-C5 alkyl) -C (O)-(C1-C5 alkyl) group has one or more substituents selected from the group consisting of a cyano group and a halogen atom}, one or more selected from the group G A C1-C3 alkyl group having a substituent (C3-C7 cycloalkyl), or a C3-C7 cycloalkyl group having one or more substituents selected from Group G;
R ³⁰ represents a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, a halogen atom, OR ³⁵ , NR ³⁶ R ³⁷ , or a hydrogen atom,
R ¹⁸ and R ³⁵ are the same or different and each represents a C1-C6 chain hydrocarbon group which may have one or more halogen atoms,
R ¹⁷ represents a C1-C6 chain hydrocarbon group which may have one or more halogen atoms, a phenyl group which may have one or more substituents selected from Group D, or a hydrogen atom. ,
R ⁸ , R ¹¹ , R ¹⁹ , R ²⁴ , R ²⁹ , R ³⁶ and R ³⁷ are the same or different and each is a C1-C6 chain hydrocarbon group which may have one or more halogen atoms, or hydrogen Represents an atom,
R ¹² is a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, and a C1-C6 chain hydrocarbon group optionally having one or more substituents selected from Group F. C3-C7 cycloalkyl group optionally having one or more substituents selected from group J, C3-C7 cycloalkenyl group optionally having one or more substituents selected from group J, group A phenyl group optionally having one or more substituents selected from D, a 6-membered aromatic heterocyclic group optionally having one or more substituents selected from Group D, a hydrogen atom, or S ( O) ₂ R ²³
R ²³ represents a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, or a phenyl group optionally having one or more substituents selected from Group D;
R ^11a and R ^12a together with the nitrogen atom to which they are attached represent a 3-7 membered non-aromatic heterocyclic group optionally having one or more substituents selected from group E;
R ¹³ represents a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, a C3-C7 cycloalkyl group optionally having one or more halogen atoms, and one or more halogen atoms. (C3-C6 cycloalkyl) which may have C1-C3 alkyl group, phenyl group which may have one or more substituents selected from group D, one or more substituents selected from group D Represents a 5- or 6-membered aromatic heterocyclic group which may have, or a hydrogen atom,
R ¹⁴ represents a C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, a C3-C7 cycloalkyl group optionally having one or more halogen atoms, and one or more halogen atoms. (C3-C6 cycloalkyl) which may have a C1-C3 alkyl group or a phenyl C1-C3 alkyl group {the phenyl moiety in the phenyl C1-C3 alkyl group has one or more substituents selected from group D May represent}
R ¹⁵ and R ¹⁶ are the same or different and each represents a C1-C6 alkyl group optionally having one or more halogen atoms,
R ³¹ represents a C1-C6 alkyl group optionally having one or more halogen atoms, or a hydrogen atom,
R ³² is a C1-C6 chain hydrocarbon group which may have one or more substituents selected from group F, and C3-C7 which may have one or more substituents selected from group J. Represents a cycloalkyl group, S (O) ₂ R ²³ , or a hydrogen atom.
Group B: C1-C6 alkoxy group optionally having one or more halogen atoms, C3-C6 alkenyloxy group optionally having one or more halogen atoms, having one or more halogen atoms A C3-C6 alkynyloxy group, a C1-C6 alkylsulfanyl group optionally having one or more halogen atoms, a C1-C6 alkylsulfinyl group optionally having one or more halogen atoms, one or more A group consisting of a C1-C6 alkylsulfonyl group optionally having a halogen atom, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, a cyano group, a hydroxy group, and a halogen atom.
Group C: C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, C1-C6 alkoxy group optionally having one or more halogen atoms, having one or more halogen atoms A group consisting of a C3-C6 alkenyloxy group which may have one, a C3-C6 alkynyloxy group which may have one or more halogen atoms, and a halogen atom.
Group D: C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, hydroxy group, C1-C6 alkoxy group optionally having one or more halogen atoms, one or more halogen atoms A C3-C6 alkenyloxy group that may have one or more, a C3-C6 alkynyloxy group that may have one or more halogen atoms, a sulfanyl group, or a C1-C6 that may have one or more halogen atoms. C6 alkylsulfanyl group, C1-C6 alkylsulfinyl group optionally having one or more halogen atoms, C1-C6 alkylsulfonyl group optionally having one or more halogen atoms, amino group, NHR ²¹ , NR ^A group consisting of ²¹ R ²² , C (O) R ²¹ , OC (O) R ²¹ , C (O) OR ²¹ , a cyano group, a nitro group, and a halogen atom.
R ²¹ and R ²² are the same or different and represent a C1-C6 alkyl group which may have one or more halogen atoms.
Group E: C1-C6 chain hydrocarbon group optionally having one or more halogen atoms, C1-C6 alkoxy group optionally having one or more halogen atoms, having one or more halogen atoms A group consisting of a C3-C6 alkenyloxy group which may have one or more, a C3-C6 alkynyloxy group which may have one or more halogen atoms, a halogen atom, an oxo group, a hydroxy group, a cyano group, and a nitro group.
Group F: C1-C6 alkoxy group optionally having one or more halogen atoms, phenyl group optionally having one or more substituents selected from Group D, one or more substitutions selected from Group D A 5- or 6-membered aromatic heterocyclic group which may have a group, a C3-C7 cycloalkyl group which may have one or more halogen atoms, and one or more substituents selected from group C A group consisting of a 3-7 membered non-aromatic heterocyclic group, an amino group, NHR ²¹ , NR ²¹ R ²² , a halogen atom, and a cyano group, which may be optionally present.
Group G: A group consisting of a halogen atom, a C1-C6 haloalkyl group and a cyano group.
Group H: 1 or more halogen atoms optionally may C1-C6 alkyl group optionally ^{having, OR 10, NR 9 R 10} , C (O) R 10, C (O) NR 9 R 10, OC (O) R ⁹ , OC (O) OR ⁹ , NR ¹⁰ C (O) R ⁹ , NR ¹⁰ C (O) OR ⁹ , C (O) OR ¹⁰ , halogen atom, nitro group, cyano group, amino group, and 5 or 6 A group consisting of membered aromatic heterocyclic groups.
R ⁹ represents a C1-C6 alkyl group optionally having one or more halogen atoms, or a C3-C6 cycloalkyl group optionally having one or more halogen atoms,
R ¹⁰ represents a C1-C6 alkyl group optionally having one or more halogen atoms, a C3-C6 cycloalkyl group optionally having one or more halogen atoms, or a hydrogen atom.
Group J: A group consisting of a C1-C6 alkyl group optionally having one or more halogen atoms, a halogen atom, and a cyano group. ]
A method for controlling harmful arthropods, which comprises applying an effective amount of the compound represented by the above or a compound represented by N oxide thereof to harmful arthropods, habitats, plants or soils of harmful arthropods. A compound represented by the formula (I) according to claim 1 and a group (a), a group (b), a group (c), a group (d), a group (e), a group (f), a group (g) A composition comprising one or more components selected from the group consisting of group (h), group (i) and group (j):
Group (a): a group consisting of an insecticidal active ingredient, an acaricidal active ingredient and a nematicidal active ingredient;
Group (b): bactericidal active ingredient;
Group (c): plant growth regulating component;
Group (d): phytotoxicity reducing component;
Group (e): synergist;
Group (f): repellent ingredients;
Group (g): molluscicidal components;
Group (h): insect pheromone;
Group (i): herbicidal active ingredient;
Group (j): Microbial material.   A method for controlling harmful arthropods, which comprises applying an effective amount of the composition according to claim 2 to harmful arthropods, habitats, plants or soil of harmful arthropods.   A seed or vegetative organ holding an effective amount of a compound of formula (I) according to claim 1 or a composition according to claim 2.